Citrus Sinensis ID: 023764

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------
Protein Sequence
MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Secondary Structure (PSIPRED)
ccEEEEEcccccccccccccEEEEccccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccHHHHHHHcHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHcc
Secondary Structure Prediction (SSPRO)
ccEEEEHHccccccHHHcccEEEEHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEHEccHcccccccHHHHcccHHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHHHHHccccccccccHHHccccccHHHHHHHHHHccccHHHcccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
mqvvairdiipppqresfnDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAnvlhrdlkpsnlllnancdlkicdfglarvtsetdFMTEYVVTrwyrapelllnssdytaAIDVWSVGCIFMelmdrkplfpgrdhVHQLRLLIELigtpseaelgFLNENAKKYICqlpryqrqsftekfpnvhpsAIDLVEKMltfdprqritvedalahpylgslhdisdepvcmspfsfdfeQHALTEGQMKELIYQEALafnpeyrqq
Flexible Loop (DISEMBL)
mqvvairdiipppqresFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Low Complexity Region (SEG)
MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Disordered region (IsUnstruct)
*****IRDII*****ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF*******
Disordered Region (DISOPRED)
MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP*****SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP*****
Disordered Region (DISEMBL)
MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Disordered Region (DISPRO)
MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	277	2.2.26 [Sep-21-2011]
Q06060	394	Mitogen-activated protein	N/A	no	0.992	0.697	0.930	1e-152
Q07176	387	Mitogen-activated protein	N/A	no	0.992	0.710	0.930	1e-152
Q40532	393	Mitogen-activated protein	N/A	no	0.992	0.699	0.912	1e-150
Q84UI5	398	Mitogen-activated protein	yes	no	0.989	0.688	0.901	1e-147
Q39026	395	Mitogen-activated protein	yes	no	0.992	0.696	0.890	1e-139
Q39023	370	Mitogen-activated protein	no	no	0.985	0.737	0.759	1e-125
Q10N20	369	Mitogen-activated protein	no	no	0.989	0.742	0.741	1e-124
A2XFC8	369	Mitogen-activated protein	N/A	no	0.989	0.742	0.741	1e-124
Q39024	376	Mitogen-activated protein	no	no	0.981	0.723	0.714	1e-120
Q9M1Z5	393	Mitogen-activated protein	no	no	0.981	0.692	0.738	1e-119

>sp|Q06060|MAPK_PEA Mitogen-activated protein kinase homolog D5 OS=Pisum sativum PE=2 SV=1

 Score =  537 bits (1383), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 266/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 120 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 179

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 180 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 239

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 240 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 299

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE+ALAHPYL SLHDISDEPVC
Sbjct: 300 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDISDEPVC 359

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
            +PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 360 TTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 394

Pisum sativum (taxid: 3888)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q07176|MMK1_MEDSA Mitogen-activated protein kinase homolog MMK1 OS=Medicago sativa GN=MMK1 PE=1 SV=1

 Score =  536 bits (1381), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 266/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 113 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 172

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 173 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 232

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK+YI 
Sbjct: 233 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAKRYIR 292

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 293 QLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 352

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

May play a role in the mitogenic induction of symbiotic root nodules on Alfalfa by Rhizobium signal molecules.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  530 bits (1365), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 251/275 (91%), Positives = 265/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            +VAIRDIIPPPQRE+FNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 118 NIVAIRDIIPPPQREAFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYI 177

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 178 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 237

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAE+ FLNENAK+YI 
Sbjct: 238 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAEMEFLNENAKRYIR 297

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+V+P+AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 298 QLPLYRRQSFVEKFPHVNPAAIDLVEKMLTFDPRRRITVEDALAHPYLTSLHDISDEPVC 357

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           M+PF+FDFEQHALTE QMKELIY+E LAFNPEY+ 
Sbjct: 358 MTPFNFDFEQHALTEEQMKELIYREGLAFNPEYQH 392

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  521 bits (1343), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 247/274 (90%), Positives = 261/274 (95%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            +VAIRDIIPPPQR SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 125 NIVAIRDIIPPPQRNSFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 184

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLAR TSETDFMTEYVVTRWYRAPELLLNSS+
Sbjct: 185 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWYRAPELLLNSSE 244

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTP+EA+L F+NENA++YI 
Sbjct: 245 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPNEADLDFVNENARRYIR 304

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLPR+ RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE ALAHPYL SLHDISDEPVC
Sbjct: 305 QLPRHARQSFPEKFPHVHPLAIDLVEKMLTFDPRQRITVEGALAHPYLASLHDISDEPVC 364

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
            SPFSFDFEQHAL+E QMK+LIYQE LAFNP+Y+
Sbjct: 365 SSPFSFDFEQHALSEEQMKDLIYQEGLAFNPDYQ 398

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39026|MPK6_ARATH Mitogen-activated protein kinase 6 OS=Arabidopsis thaliana GN=MPK6 PE=1 SV=1

 Score =  493 bits (1270), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/275 (89%), Positives = 257/275 (93%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            +VAIRDIIPPP R +FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 121 NIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 180

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE+DFMTEYVVTRWYRAPELLLNSSD
Sbjct: 181 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSD 240

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE EL FLNENAK+YI 
Sbjct: 241 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAKRYIR 300

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y RQS T+KFP VHP AIDL+EKMLTFDPR+RITV DALAHPYL SLHDISDEP C
Sbjct: 301 QLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPEC 360

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
             PF+FDFE HAL+E QMKELIY+EALAFNPEY+Q
Sbjct: 361 TIPFNFDFENHALSEEQMKELIYREALAFNPEYQQ 395

Involved in oxidative stress-mediated signaling cascade (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Phosphorylates 1-aminocyclopropane-1-carboxylic acid synthases (ACS2 and ACS6) and may be involved in the regulation of bacterial elicitor flagellin-induced ethylene production. Regulates locally gene-mediated and basal resitance response to certain pathogens. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39023|MPK3_ARATH Mitogen-activated protein kinase 3 OS=Arabidopsis thaliana GN=MPK3 PE=1 SV=2

 Score =  447 bits (1150), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 208/274 (75%), Positives = 240/274 (87%), Gaps = 1/274 (0%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++AIRD++PPP R  F+DVYI+ ELMDTDLHQIIRSNQ+LSEEHCQYFLYQ+LRGLKYI
Sbjct: 96  NIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYI 155

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE DFMTEYVVTRWYRAPELLLNSSD
Sbjct: 156 HSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLLNSSD 215

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           YTAAIDVWSVGCIFMELM+RKPLFPG+DHVHQ+RLL EL+GTP+E++LGF  NE+AK+YI
Sbjct: 216 YTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYI 275

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
            QLP + RQ   + F +V+P AIDLV++MLTFDP +RITVE AL H YL  LHD +DEP+
Sbjct: 276 RQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPI 335

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 274
           C  PFSF+FEQ  L E Q+KE+IYQEA+A NP Y
Sbjct: 336 CQKPFSFEFEQQPLDEEQIKEMIYQEAIALNPTY 369

Involved in oxidative stress-mediated signaling cascade to oxidative (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Mediates the phosphorylation of VIP1 and subsequent stress genes transcription in response to Agrobacterium.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q10N20|MPK5_ORYSJ Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. japonica GN=MPK5 PE=1 SV=1

 Score =  445 bits (1144), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 204/275 (74%), Positives = 242/275 (88%), Gaps = 1/275 (0%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ IRD+IPPP  ++FNDVYIA ELMDTDLH IIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 94  NIIGIRDVIPPPIPQAFNDVYIATELMDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYI 153

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANV+HRDLKPSNLLLNANCDLKICDFGLAR +SE+D MTEYVVTRWYRAPELLLNS+D
Sbjct: 154 HSANVIHRDLKPSNLLLNANCDLKICDFGLARPSSESDMMTEYVVTRWYRAPELLLNSTD 213

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y+AAIDVWSVGCIFMEL++R+PLFPGRDH+HQ+RL+ E+IGTP++ ELGF+ NE+A+KY+
Sbjct: 214 YSAAIDVWSVGCIFMELINRQPLFPGRDHMHQMRLITEVIGTPTDDELGFIRNEDARKYM 273

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP+Y R++F   FP V P+A+DL+E+MLTF+P QRITVE+AL HPYL  LHDI+DEP+
Sbjct: 274 RHLPQYPRRTFASMFPRVQPAALDLIERMLTFNPLQRITVEEALDHPYLERLHDIADEPI 333

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           C+ PFSFDFEQ AL E QMK+LI+ EA+  NP  R
Sbjct: 334 CLEPFSFDFEQKALNEDQMKQLIFNEAIEMNPNIR 368

Involved in disease resistance and abiotic stress tolerance signaling pathways. Acts as a positive regulator of drought, salt and cold tolerance. Negatively modulates pathogenesis-related (PR) gene expression and broad-spectrum disease resistance.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|A2XFC8|MPK5_ORYSI Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. indica GN=MPK5 PE=1 SV=2

 Score =  445 bits (1144), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 204/275 (74%), Positives = 242/275 (88%), Gaps = 1/275 (0%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ IRD+IPPP  ++FNDVYIA ELMDTDLH IIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 94  NIIGIRDVIPPPIPQAFNDVYIATELMDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYI 153

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANV+HRDLKPSNLLLNANCDLKICDFGLAR +SE+D MTEYVVTRWYRAPELLLNS+D
Sbjct: 154 HSANVIHRDLKPSNLLLNANCDLKICDFGLARPSSESDMMTEYVVTRWYRAPELLLNSTD 213

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y+AAIDVWSVGCIFMEL++R+PLFPGRDH+HQ+RL+ E+IGTP++ ELGF+ NE+A+KY+
Sbjct: 214 YSAAIDVWSVGCIFMELINRQPLFPGRDHMHQMRLITEVIGTPTDDELGFIRNEDARKYM 273

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP+Y R++F   FP V P+A+DL+E+MLTF+P QRITVE+AL HPYL  LHDI+DEP+
Sbjct: 274 RHLPQYPRRTFASMFPRVQPAALDLIERMLTFNPLQRITVEEALDHPYLERLHDIADEPI 333

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           C+ PFSFDFEQ AL E QMK+LI+ EA+  NP  R
Sbjct: 334 CLEPFSFDFEQKALNEDQMKQLIFNEAIEMNPNIR 368

Involved in disease resistance and abiotic stress tolerance signaling pathways.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  430 bits (1106), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 195/273 (71%), Positives = 238/273 (87%), Gaps = 1/273 (0%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            V+A++DII PPQRE+FNDVYI YELMDTDLHQIIRSNQ L+++HC++FLYQ+LRGLKY+
Sbjct: 101 NVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYV 160

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLK+ DFGLAR  SETDFMTEYVVTRWYRAPELLLN S+
Sbjct: 161 HSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSE 220

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           YTAAID+WSVGCI  E M R+PLFPG+D+VHQLRL+ ELIG+P ++ LGFL ++NA++Y+
Sbjct: 221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
            QLP+Y RQ+F  +FPN+   A+DL+EKML FDP +RITV++AL HPYL  LHDI++EPV
Sbjct: 281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
           C+ PF+FDFEQ  LTE  +KELIY+E + FNP+
Sbjct: 341 CVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9M1Z5|MPK10_ARATH Mitogen-activated protein kinase 10 OS=Arabidopsis thaliana GN=MPK10 PE=1 SV=1

 Score =  427 bits (1099), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 201/272 (73%), Positives = 235/272 (86%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            +VAIRD+I PPQR+SF DVYI  ELM+ DL++ ++S+Q L+++H  YF+YQILRGLKYI
Sbjct: 118 NIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYI 177

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MTEYVVTRWYRAPELLL SSD
Sbjct: 178 HSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLGSSD 237

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFME+M+R+PLFPG+D V+QLRLL+ELIGTPSE ELG L+E AK+YI 
Sbjct: 238 YTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSLSEYAKRYIR 297

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP   RQSFTEKFPNV P AIDLVEKMLTFDP+QRI+V++ALAHPYL S HDI+DEP C
Sbjct: 298 QLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDEPEC 357

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
             PF+FD ++H  +E Q +ELIY EALAFNPE
Sbjct: 358 SEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	277
255567750	402	big map kinase/bmk, putative [Ricinus co	0.996	0.686	0.938	1e-152
7649153	389	mitogen-activated protein kinase [Euphor	0.996	0.709	0.931	1e-151
224095467	363	predicted protein [Populus trichocarpa]	0.992	0.757	0.927	1e-151
449452881	405	PREDICTED: mitogen-activated protein kin	0.996	0.681	0.934	1e-151
351721680	391	mitogen-activated protein kinase 2 [Glyc	0.992	0.703	0.927	1e-150
585454	394	RecName: Full=Mitogen-activated protein	0.992	0.697	0.930	1e-150
357475629	387	Mitogen-activated protein kinase [Medica	0.992	0.710	0.930	1e-150
585519	387	RecName: Full=Mitogen-activated protein	0.992	0.710	0.930	1e-150
71068415	397	mitogen-activated protein kinase 1 [Arac	0.989	0.690	0.927	1e-150
356521451	433	PREDICTED: mitogen-activated protein kin	0.992	0.635	0.927	1e-150

>gi|255567750|ref|XP_002524853.1| big map kinase/bmk, putative [Ricinus communis] gi|223535816|gb|EEF37477.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  543 bits (1398), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 259/276 (93%), Positives = 268/276 (97%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDIIPPP+RE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 127 NVVAIRDIIPPPKRELFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 186

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 187 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 246

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAELGFLNENAK+YI 
Sbjct: 247 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAELGFLNENAKRYIR 306

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSFT+KFPNVHP+AIDLVEKMLTFDPR RITVEDALAHPYL SLHDISDEPVC
Sbjct: 307 QLPLYRRQSFTDKFPNVHPAAIDLVEKMLTFDPRLRITVEDALAHPYLTSLHDISDEPVC 366

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
            +PFSFDFEQHALTE QMKELIY+EALAFNPEY+QQ
Sbjct: 367 TTPFSFDFEQHALTEDQMKELIYREALAFNPEYQQQ 402

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7649153|gb|AAF65766.1|AF242308_1 mitogen-activated protein kinase [Euphorbia esula]

 Score =  541 bits (1394), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 257/276 (93%), Positives = 267/276 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 114 NVVAIRDIMPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 173

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 174 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 233

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE ELGFLNENAK+YI 
Sbjct: 234 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELGFLNENAKRYIR 293

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           Q+  ++RQSFTEKFP VHP+AIDLVEKMLTFDPRQRITVEDALAHPYL SLHDISDEPVC
Sbjct: 294 QMSVFRRQSFTEKFPTVHPAAIDLVEKMLTFDPRQRITVEDALAHPYLTSLHDISDEPVC 353

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+QQ
Sbjct: 354 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQQ 389

Source: Euphorbia esula

Species: Euphorbia esula

Genus: Euphorbia

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224095467|ref|XP_002310398.1| predicted protein [Populus trichocarpa] gi|222853301|gb|EEE90848.1| predicted protein [Populus trichocarpa]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 255/275 (92%), Positives = 267/275 (97%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 89  NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQVLSEEHCQYFLYQILRGLKYI 148

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 149 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 208

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGC+FMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAELGFLNENAK+YI 
Sbjct: 209 YTAAIDVWSVGCVFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAELGFLNENAKRYIR 268

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP ++RQSFTEKFP VHP+AIDL+EKMLTFDPRQRITVE+ALAHPYL SLHDISDEP+C
Sbjct: 269 QLPLHRRQSFTEKFPTVHPAAIDLIEKMLTFDPRQRITVEEALAHPYLTSLHDISDEPIC 328

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+ 
Sbjct: 329 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQN 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452881|ref|XP_004144187.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like [Cucumis sativus] gi|449511404|ref|XP_004163946.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like [Cucumis sativus]

 Score =  539 bits (1388), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 258/276 (93%), Positives = 265/276 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDIIPPP RE+FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 130 NVVAIRDIIPPPLRETFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 189

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 190 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 249

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 250 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLLELIGTPSEADLGFLNENAKRYIR 309

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y RQSFTEKFP+VHP+AIDLVEKMLTFDP QRITVEDALAHPYL SLHDISDEPVC
Sbjct: 310 QLPHYHRQSFTEKFPHVHPAAIDLVEKMLTFDPGQRITVEDALAHPYLTSLHDISDEPVC 369

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
           M+PFSFDFEQHALTE QMKELIY EALAFNPEY  Q
Sbjct: 370 MTPFSFDFEQHALTEEQMKELIYLEALAFNPEYHHQ 405

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721680|ref|NP_001235426.1| mitogen-activated protein kinase 2 [Glycine max] gi|33340593|gb|AAQ14867.1|AF329506_1 mitogen-activated protein kinase 2 [Glycine max]

 Score =  537 bits (1383), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 255/275 (92%), Positives = 266/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 117 NVVAIRDIVPPPQREIFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYI 176

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 177 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 236

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 237 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 296

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 297 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 356

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           M+PF+FDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 357 MTPFNFDFEQHALTEEQMKELIYREALAFNPEYQQ 391

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|585454|sp|Q06060.1|MAPK_PEA RecName: Full=Mitogen-activated protein kinase homolog D5 gi|20808|emb|CAA50036.1| MAP kinase homologue [Pisum sativum]

 Score =  537 bits (1383), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 266/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 120 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 179

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 180 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 239

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 240 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 299

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE+ALAHPYL SLHDISDEPVC
Sbjct: 300 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDISDEPVC 359

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
            +PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 360 TTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 394

Source: Pisum sativum

Species: Pisum sativum

Genus: Pisum

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357475629|ref|XP_003608100.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355509155|gb|AES90297.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  536 bits (1382), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 265/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 113 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 172

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 173 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 232

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK+YI 
Sbjct: 233 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAKRYIR 292

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 293 QLPPYRRQSFQEKFPQVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 352

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|585519|sp|Q07176.1|MMK1_MEDSA RecName: Full=Mitogen-activated protein kinase homolog MMK1; AltName: Full=MAP kinase ERK1; AltName: Full=MAP kinase MSK7 gi|289125|gb|AAB41548.1| MAP kinase [Medicago sativa] gi|298019|emb|CAA47099.1| MAP Kinase [Medicago sativa]

 Score =  536 bits (1381), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 266/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 113 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 172

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 173 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 232

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK+YI 
Sbjct: 233 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAKRYIR 292

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 293 QLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 352

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|71068415|gb|AAZ23128.1| mitogen-activated protein kinase 1 [Arachis hypogaea]

 Score =  536 bits (1381), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 254/274 (92%), Positives = 266/274 (97%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE+FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 124 NVVAIRDIVPPPQREAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 183

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET+FMTEYVVTRWYRAPELLLNSSD
Sbjct: 184 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETNFMTEYVVTRWYRAPELLLNSSD 243

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 244 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 303

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP VHP+AIDLVEKMLTFDPRQRITVEDALAHPYL SLHDISDEPVC
Sbjct: 304 QLPLYRRQSFQEKFPQVHPAAIDLVEKMLTFDPRQRITVEDALAHPYLTSLHDISDEPVC 363

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           M+PF+FDFE HALTE QMKELIY+EALAFNPEY+
Sbjct: 364 MTPFNFDFEHHALTEEQMKELIYREALAFNPEYQ 397

Source: Arachis hypogaea

Species: Arachis hypogaea

Genus: Arachis

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521451|ref|XP_003529369.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like isoform 1 [Glycine max]

 Score =  536 bits (1380), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 255/275 (92%), Positives = 266/275 (96%)

Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 159 NVVAIRDIVPPPQREIFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 218

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 219 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 278

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 279 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 338

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 339 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 398

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           ++PFSFDFEQHALTE QMKELIY+EALAFN EY+Q
Sbjct: 399 LTPFSFDFEQHALTEEQMKELIYREALAFNLEYQQ 433

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	277
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.989	0.693	0.894	2.7e-132
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.981	0.735	0.761	1.9e-115
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.978	0.720	0.716	2.9e-110
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.978	0.689	0.741	5.5e-109
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.974	0.718	0.701	2.8e-105
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.974	0.731	0.697	3.6e-105
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.967	0.738	0.691	2.5e-104
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.981	0.731	0.633	1.3e-98
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.978	0.512	0.602	4.6e-89
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.974	0.733	0.538	1.5e-81

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1297 (461.6 bits), Expect = 2.7e-132, P = 2.7e-132
 Identities = 245/274 (89%), Positives = 257/274 (93%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             +VAIRDIIPPP R +FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH
Sbjct:   122 IVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 181

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE+DFMTEYVVTRWYRAPELLLNSSDY
Sbjct:   182 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDY 241

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 182
             TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE EL FLNENAK+YI Q
Sbjct:   242 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAKRYIRQ 301

Query:   183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCM 242
             LP Y RQS T+KFP VHP AIDL+EKMLTFDPR+RITV DALAHPYL SLHDISDEP C 
Sbjct:   302 LPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPECT 361

Query:   243 SPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
              PF+FDFE HAL+E QMKELIY+EALAFNPEY+Q
Sbjct:   362 IPFNFDFENHALSEEQMKELIYREALAFNPEYQQ 395

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1138 (405.7 bits), Expect = 1.9e-115, P = 1.9e-115
 Identities = 208/273 (76%), Positives = 240/273 (87%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             ++AIRD++PPP R  F+DVYI+ ELMDTDLHQIIRSNQ+LSEEHCQYFLYQ+LRGLKYIH
Sbjct:    97 IIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIH 156

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE DFMTEYVVTRWYRAPELLLNSSDY
Sbjct:   157 SANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDY 216

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
             TAAIDVWSVGCIFMELM+RKPLFPG+DHVHQ+RLL EL+GTP+E++LGF  NE+AK+YI 
Sbjct:   217 TAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIR 276

Query:   182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             QLP + RQ   + F +V+P AIDLV++MLTFDP +RITVE AL H YL  LHD +DEP+C
Sbjct:   277 QLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPIC 336

Query:   242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 274
               PFSF+FEQ  L E Q+KE+IYQEA+A NP Y
Sbjct:   337 QKPFSFEFEQQPLDEEQIKEMIYQEAIALNPTY 369

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
 Identities = 195/272 (71%), Positives = 238/272 (87%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             V+A++DII PPQRE+FNDVYI YELMDTDLHQIIRSNQ L+++HC++FLYQ+LRGLKY+H
Sbjct:   102 VIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVH 161

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SANVLHRDLKPSNLLLNANCDLK+ DFGLAR  SETDFMTEYVVTRWYRAPELLLN S+Y
Sbjct:   162 SANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEY 221

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
             TAAID+WSVGCI  E M R+PLFPG+D+VHQLRL+ ELIG+P ++ LGFL ++NA++Y+ 
Sbjct:   222 TAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVR 281

Query:   182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             QLP+Y RQ+F  +FPN+   A+DL+EKML FDP +RITV++AL HPYL  LHDI++EPVC
Sbjct:   282 QLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVC 341

Query:   242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
             + PF+FDFEQ  LTE  +KELIY+E + FNP+
Sbjct:   342 VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
 Identities = 201/271 (74%), Positives = 235/271 (86%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             +VAIRD+I PPQR+SF DVYI  ELM+ DL++ ++S+Q L+++H  YF+YQILRGLKYIH
Sbjct:   119 IVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYIH 178

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MTEYVVTRWYRAPELLL SSDY
Sbjct:   179 SANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLGSSDY 238

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 182
             TAAIDVWSVGCIFME+M+R+PLFPG+D V+QLRLL+ELIGTPSE ELG L+E AK+YI Q
Sbjct:   239 TAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSLSEYAKRYIRQ 298

Query:   183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCM 242
             LP   RQSFTEKFPNV P AIDLVEKMLTFDP+QRI+V++ALAHPYL S HDI+DEP C 
Sbjct:   299 LPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDEPECS 358

Query:   243 SPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
              PF+FD ++H  +E Q +ELIY EALAFNPE
Sbjct:   359 EPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1042 (371.9 bits), Expect = 2.8e-105, P = 2.8e-105
 Identities = 190/271 (70%), Positives = 237/271 (87%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             VV I+DII PP++E F DVYI +ELMDTDLHQIIRSNQ+L+++HCQYFLYQILRGLKYIH
Sbjct:   102 VVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIH 161

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SANVLHRDLKPSNLLLN+NCDLKI DFGLAR TSET++MTEYVVTRWYRAPELLLNSS+Y
Sbjct:   162 SANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEY 221

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYIC 181
             T+AIDVWSVGCIF E+M R+PLFPG+D+VHQL+L+ ELIG+P  A L FL   NA+KY+ 
Sbjct:   222 TSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVK 281

Query:   182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             +LP++ RQ+F+ +FP+++ +AIDL+EKML FDP +RITVE+AL +PYL +LHD++DEPVC
Sbjct:   282 ELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVC 341

Query:   242 MSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              + FSF FE  + TE ++KEL++ E++ FNP
Sbjct:   342 SNHFSFHFEDPSSTEEEIKELVWLESVKFNP 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1041 (371.5 bits), Expect = 3.6e-105, P = 3.6e-105
 Identities = 189/271 (69%), Positives = 234/271 (86%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             V+AI DII PPQ ++FNDV+I YELMDTDLH IIRSNQ L+++H ++FLYQ+LRGLKY+H
Sbjct:    99 VIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVH 158

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SANVLHRDLKPSNLLLNANCDLKI DFGLAR  SETDFMTEYVVTRWYRAPELLLN S+Y
Sbjct:   159 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEY 218

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
             TAAID+WSVGCI  E+M R+PLFPGRD+V QLRL+ ELIG+P ++ LGFL ++NA++Y+ 
Sbjct:   219 TAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVR 278

Query:   182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             QLP+Y RQ+F  +FPN+  +A+DL++KML FDP +RITV++AL HPYL  LH+ ++EPVC
Sbjct:   279 QLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPVC 338

Query:   242 MSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
             + PF FDFEQ +LTE  +KELIY+E++ FNP
Sbjct:   339 VRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
 Identities = 186/269 (69%), Positives = 231/269 (85%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             V+ I+DII  P++E F DVYI YELMDTDLHQIIRS Q L+++HCQYFLYQILRGLKYIH
Sbjct:    92 VIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYIH 151

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SANVLHRDLKPSNL+LN NCDLKICDFGLAR ++ET+ MTEYVVTRWYRAPELLLNSS+Y
Sbjct:   152 SANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLLNSSEY 211

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
             T AID+WSVGCIFME++ R+ LFPG+D+V QL+L+ EL+G+P +++L FL ++NA+KY+ 
Sbjct:   212 TGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNARKYVK 271

Query:   182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             QLP  Q+QSF EKFPN+ P A+DL EKML FDP +RITV++AL  PYL SLH+I++EP C
Sbjct:   272 QLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEINEEPTC 331

Query:   242 MSPFSFDFEQHALTEGQMKELIYQEALAF 270
              +PFSFDFE+ AL E  +KEL+++E+L F
Sbjct:   332 PTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
 Identities = 173/273 (63%), Positives = 227/273 (83%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             V+ I+DI+ PPQR+ FNDVYI YELMDTDL +I+RSNQ L+ + C++ +YQ+LRGLKY+H
Sbjct:   100 VITIKDIVRPPQRDIFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVH 159

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
             SAN+LHRDL+PSN+LLN+  +LKI DFGLAR TS+TDFMTEYVVTRWYRAPELLLN S+Y
Sbjct:   160 SANILHRDLRPSNVLLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEY 219

Query:   123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
             TAAID+WSVGCI  E+M  +PLFPG+D+VHQLRL+ EL+G+P  + LGFL ++NA++Y+ 
Sbjct:   220 TAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVR 279

Query:   182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             QLPRY +Q F  +FP +  +AIDL+E+ML FDP +RI+V++AL H YL   HD++ EPVC
Sbjct:   280 QLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVC 339

Query:   242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 274
              +PFSFDFE  + TE  +KELIY+E++ FNP++
Sbjct:   340 STPFSFDFEHPSCTEEHIKELIYKESVKFNPDH 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 889 (318.0 bits), Expect = 4.6e-89, P = 4.6e-89
 Identities = 165/274 (60%), Positives = 210/274 (76%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             +++I+DI+ P  +E F DVYI  ELMDTDLHQII S Q LS++HCQYF+YQ+LRGLK+IH
Sbjct:   208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS 120
             SANVLHRDLKPSNLL+N +C LKICD GLARV   T   FMTEYV TRWYRAPE++L+ +
Sbjct:   268 SANVLHRDLKPSNLLINEDCLLKICDLGLARVEDATHQGFMTEYVATRWYRAPEVILSWN 327

Query:   121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 179
              YT AID+WSVGCIF EL+ RKPLF G+D++HQ+ L+IE IG+PSE ++    NE A+++
Sbjct:   328 KYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQARQF 387

Query:   180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
             I  +    + +F   FP  +P AIDL+E+ML FDP +R+TVE+ALAHPY  SLHD SDEP
Sbjct:   388 IRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPSDEP 447

Query:   240 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
             +C+  FS +FE   L    +KELIY E LA++PE
Sbjct:   448 ICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 818 (293.0 bits), Expect = 1.5e-81, P = 1.5e-81
 Identities = 147/273 (53%), Positives = 207/273 (75%)

Query:     3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
             V+A++D++ P  R SF DVY+ YELMDTDLHQII+S+Q+LS++HC+YFL+Q+LRGLKY+H
Sbjct:    91 VIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKSSQSLSDDHCKYFLFQLLRGLKYLH 150

Query:    63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSD 121
             SAN+LHRDLKP NLL+NANCDLKICDFGLAR +   + FMTEYVVTRWYRAPELLL   +
Sbjct:   151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSQGNEQFMTEYVVTRWYRAPELLLCCDN 210

Query:   122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
             Y  +IDVWSVGCIF E++ RKP+FPG + ++QL+L+I ++G+  E+++ F+ N  A+++I
Sbjct:   211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIINVVGSQQESDIRFIDNPKARRFI 270

Query:   181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
               LP  +    +  +P  +P AIDL+++ML FDP +RI+V DAL HPY+  L D    P 
Sbjct:   271 KSLPYSRGTHLSNLYPQANPLAIDLLQRMLVFDPTKRISVTDALLHPYMAGLFDPGSNPP 330

Query:   241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
                P S D +++ + E  ++E+++ E L ++PE
Sbjct:   331 AHVPISLDIDEN-MEEPVIREMMWNEMLYYHPE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.9309	0.9927	0.6979	N/A	no
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.9014	0.9891	0.6884	yes	no
P40417	ERKA_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.5145	0.9675	0.6291	yes	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7132	0.9783	0.7304	N/A	no
P28482	MK01_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9855	0.7583	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.9127	0.9927	0.6997	N/A	no
Q39026	MPK6_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8909	0.9927	0.6962	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.7418	0.9891	0.7425	N/A	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5218	0.9530	0.7096	yes	no
P63085	MK01_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9855	0.7625	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.9309	0.9927	0.7105	N/A	no
P63086	MK01_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9855	0.7625	yes	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7032	0.9819	0.7331	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.991
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_Genewise1_v1.C_LG_VII0515 hypothetical protein (363 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	277
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-162
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-144
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-129
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-121
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-119
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-117
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-101
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-101
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-95
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-94
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-89
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-88
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-87
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-86
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-82
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-81
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-78
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-77
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-76
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-74
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-72
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-72
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-71
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-70
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-67
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-66
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-66
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-65
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-62
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-62
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-62
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-61
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-60
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-60
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-60
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-60
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-58
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-58
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-57
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-56
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-55
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-54
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-54
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-53
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-52
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-51
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-51
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-49
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-47
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-46
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-46
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-42
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-41
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-40
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-33
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-17
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-15
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-13
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  548 bits (1414), Expect = 0.0
 Identities = 208/272 (76%), Positives = 238/272 (87%), Gaps = 2/272 (0%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           V+AI+DI+PPP RE+FNDVYI YELMDTDLHQIIRS+Q LS++HCQYFLYQ+LRGLKYIH
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSD 121
           SANVLHRDLKPSNLLLNANCDLKICDFGLAR TSE  DFMTEYVVTRWYRAPELLLN S+
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           YT AIDVWSVGCIF EL+ RKPLFPG+D+VHQL+L+ EL+G+PSE +LGF+ NE A++YI
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP   RQSF   FP+ +P AIDL+EKML FDP +RITVE+ALAHPYL SLHD SDEPV
Sbjct: 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV 305

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           C +PFSFDFE+ ALTE  +KELIY E LA++P
Sbjct: 306 CQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  453 bits (1167), Expect = e-162
 Identities = 168/270 (62%), Positives = 211/270 (78%), Gaps = 6/270 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ + DI+ PP  E FNDVYI  ELM+TDLH++I+S Q L+++H QYFLYQILRGLKY+H
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLN 118
           SANV+HRDLKPSN+L+N+NCDLKICDFGLAR       E  F+TEYVVTRWYRAPELLL+
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF-LNENAK 177
           SS YT AID+WSVGCIF EL+ RKPLFPGRD++ QL L++E++GTPSE +L F  +E A+
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
            Y+  LP+  ++  ++ FP   P AIDL+EKML FDP++RIT ++ALAHPYL  LHD  D
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300

Query: 238 EPVCMSPFSFDFEQHA-LTEGQMKELIYQE 266
           EPV   PF FDF     LTE ++KELIY+E
Sbjct: 301 EPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  407 bits (1048), Expect = e-144
 Identities = 163/272 (59%), Positives = 207/272 (76%), Gaps = 7/272 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ I DII PP  ESFNDVYI  ELM+TDL+++I++ Q LS +H QYFLYQILRGLKYIH
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIH 123

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLN 118
           SANVLHRDLKPSNLLLN NCDLKICDFGLAR+       T F+TEYV TRWYRAPE++LN
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAK 177
           S  YT AID+WSVGCI  E++  +PLFPG+D++HQL L++ ++GTPS+ +L   ++  A+
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
            YI  LP   +  + + FPN  P A+DL++KMLTF+P +RITVE+ALAHPYL   HD SD
Sbjct: 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303

Query: 238 EPVCMSPFSFDFEQH-ALTEGQMKELIYQEAL 268
           EPV   PF FDFE    L + ++KELI++E +
Sbjct: 304 EPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  370 bits (951), Expect = e-129
 Identities = 154/273 (56%), Positives = 202/273 (73%), Gaps = 13/273 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++AIRDI+ PP  + F DVY+  +LM++DLH II S+Q L+EEH +YFLYQ+LRGLKYIH
Sbjct: 66  IIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPELLL 117
           SANV+HRDLKPSNLL+N +C+L+I DFG+AR   +S T+   FMTEYV TRWYRAPELLL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN---- 173
           +  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++G+PSE     LN    
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE---EVLNRIGS 241

Query: 174 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 233
           +  +KYI  LPR Q   +++ FP   P A+DL+ +ML FDP +RITVE AL HP+L   H
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301

Query: 234 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 266
           D  DEP C  PF FDFE   L+  Q+KE I +E
Sbjct: 302 DPDDEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  349 bits (898), Expect = e-121
 Identities = 147/265 (55%), Positives = 189/265 (71%), Gaps = 10/265 (3%)

Query: 8   DIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVL 67
           DI+ P    +FN++Y+  ELM+ DLHQIIRS Q L++ H Q F+YQIL GLKYIHSANVL
Sbjct: 71  DIVFP---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVL 127

Query: 68  HRDLKPSNLLLNANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAPELLLNSSDY 122
           HRDLKP NLL+NA+C+LKICDFGLAR  SE       FMTEYV TRWYRAPE++L+   Y
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Query: 123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENAKKYIC 181
           T AIDVWSVGCI  EL+ RKP+F G+D+V QL  +++++GTP E  L    +  A+ YI 
Sbjct: 188 TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR 247

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
            LP   ++ F   FPN +P A+DL+EK+L FDP +RI+VE+AL HPYL   HD  DEPVC
Sbjct: 248 SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC 307

Query: 242 MSPFSFDFEQHALTEGQMKELIYQE 266
             PF F FE    +  +++++I +E
Sbjct: 308 QKPFDFSFE-SEDSMEELRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  343 bits (883), Expect = e-119
 Identities = 136/263 (51%), Positives = 177/263 (67%), Gaps = 5/263 (1%)

Query: 11  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
           P    E F DVY+   LM  DL+ I++  Q LS++H Q+ +YQILRGLKYIHSA ++HRD
Sbjct: 85  PASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143

Query: 71  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           LKPSN+ +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WS
Sbjct: 144 LKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQ 189
           VGCI  EL+  K LFPG DH+ QL+ ++ L+GTP E  L  ++ E+A+ YI  LP+  ++
Sbjct: 202 VGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK 261

Query: 190 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF 249
            F E F   +P AIDL+EKML  DP +RIT  +ALAHPYL   HD  DEPV   P+   F
Sbjct: 262 DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA-PPYDQSF 320

Query: 250 EQHALTEGQMKELIYQEALAFNP 272
           E   LT  + KEL+Y+E + F P
Sbjct: 321 ESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  339 bits (870), Expect = e-117
 Identities = 143/278 (51%), Positives = 195/278 (70%), Gaps = 8/278 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           +V I+ I+ PP R  F D+Y+ +ELM++DLHQ+I++N  L+ EH Q+FLYQ+LR LKYIH
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPELLLN 118
           +ANV HRDLKP N+L NA+C LKICDFGLARV    T    F T+YV TRWYRAPEL  +
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 119 -SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENA 176
             S YT AID+WS+GCIF E++  KPLFPG++ VHQL L+ +L+GTPS E      NE A
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240

Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           ++Y+  + + Q   F++KFPN  P A+ L+E++L FDP+ R T E+ALA PY   L  + 
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300

Query: 237 DEPVC--MSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
            EP    ++   F+FE+  LT+  ++ELIY+E L ++P
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  299 bits (766), Expect = e-101
 Identities = 131/265 (49%), Positives = 181/265 (68%), Gaps = 8/265 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++++ DI   P      D+Y   EL+ TDLH+++ S + L ++  QYFLYQILRGLKY+H
Sbjct: 71  IISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVH 125

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
           SA V+HRDLKPSN+L+N NCDLKICDFGLAR+      MT YV TR+YRAPE++L    Y
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKY 183

Query: 123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
              +D+WS GCIF E+++ KPLFPG+DHV+Q  ++ +L+GTP +  +  + +EN  +++ 
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
            LP+ +   F+EKF N  PSAIDL+EKML FDP++RI+  +ALAHPYL   HD +DEPV 
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA 303

Query: 242 MSPFSFDFEQHALTEGQMKELIYQE 266
              F + F    L     K ++Y E
Sbjct: 304 EEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  298 bits (766), Expect = e-101
 Identities = 115/256 (44%), Positives = 167/256 (65%), Gaps = 9/256 (3%)

Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            D+Y+ +E M+TDLH +IR+N  L + H +Y +YQ+L+ LKYIHS NV+HRDLKPSN+LL
Sbjct: 82  KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140

Query: 79  NANCDLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           N++C +K+ DFGLAR  SE +       +T+YV TRWYRAPE+LL S+ YT  +D+WSVG
Sbjct: 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG 200

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYICQLPRYQRQSF 191
           CI  E++  KPLFPG   ++QL  +IE+IG PS  ++  +    A   +  LP   R+  
Sbjct: 201 CILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPL 260

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF-E 250
            E  P     A+DL++K+L F+P +R+T E+AL HPY+   H+ SDEPV   P +    +
Sbjct: 261 DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDD 320

Query: 251 QHALTEGQMKELIYQE 266
              L+  + +  +Y+E
Sbjct: 321 NVKLSVAEYRNKLYEE 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  282 bits (723), Expect = 2e-95
 Identities = 102/229 (44%), Positives = 138/229 (60%), Gaps = 7/229 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 61
           ++ + D+          D+Y+ +E MDTDL+++I+  Q  L E   + +LYQ+L+GL + 
Sbjct: 60  IIKLLDVFRHKG-----DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  +LHRDLKP NLL+N    LK+ DFGLAR   S     T YVVTRWYRAPELLL   
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y+  +D+WSVGCIF EL+ R+PLFPG+  + QL  +   +GTP           A+ Y 
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              P+       + FPN  P A+DL+ +ML +DP +RIT E ALAHPY 
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  282 bits (724), Expect = 2e-94
 Identities = 127/288 (44%), Positives = 179/288 (62%), Gaps = 26/288 (9%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           V++  DI+ PP  + F ++Y+  ELM +DLH+II S Q LS +H + FLYQILRGLKY+H
Sbjct: 61  VLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPELLLNSS 120
           SA +LHRD+KP NLL+N+NC LKICDFGLARV    E+  MT+ VVT++YRAPE+L+ S 
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            YT+A+D+WSVGCIF EL+ R+ LF  +  + QL L+ +L+GTPS   +    E A+ +I
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240

Query: 181 CQLPRYQ--RQS-FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL-------- 229
            + P         +T      H  A+ L+ +ML FDP +RI+  DALAHPYL        
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATH-EAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYH 299

Query: 230 ------------GSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQ 265
                       G ++    EP    PF  ++E++  +  Q+KE ++Q
Sbjct: 300 TCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  267 bits (684), Expect = 6e-89
 Identities = 130/272 (47%), Positives = 176/272 (64%), Gaps = 6/272 (2%)

Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKYI
Sbjct: 78  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 136

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH 194

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ YI
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEPV
Sbjct: 255 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 314

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              P+   FE   L   + K L Y E ++F P
Sbjct: 315 A-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  263 bits (675), Expect = 3e-88
 Identities = 91/229 (39%), Positives = 134/229 (58%), Gaps = 8/229 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYI 61
           +V + D+I      +   +Y+ +E  D DL + +      LS    +  +YQ+LRGL Y 
Sbjct: 60  IVKLLDVIH-----TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  +LHRDLKP N+L+N +  LK+ DFGLAR         T  VVT WYRAPE+LL S 
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y+ A+D+WSVGCIF E++  KPLFPG   + QL  + +++GTP+E     + +    Y 
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL-PDYK 233

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              P++  +   +  P + P  IDL+ KML ++P +RI+ ++AL HPY 
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  262 bits (672), Expect = 5e-87
 Identities = 121/272 (44%), Positives = 178/272 (65%), Gaps = 6/272 (2%)

Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    + F+D Y+    M TDL ++++ ++ LSE+  Q+ +YQ+L+GLKYI
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H+A ++HRDLKP NL +N +C+LKI DFGLAR T     MT YVVTRWYRAPE++LN   
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMH 192

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           YT  +D+WSVGCI  E++  KPLF G DH+ QL  ++++ GTPS+  +  L +E+AK Y+
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
            +LPR++++ F    PN +P A++++EKML  D   RIT  +ALAHPY    HD  DE  
Sbjct: 253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETE 312

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              P+   F++   +  + K L + E L+F P
Sbjct: 313 -APPYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  261 bits (668), Expect = 1e-86
 Identities = 130/272 (47%), Positives = 177/272 (65%), Gaps = 6/272 (2%)

Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    E+FN+VY+   LM  DL+ I++  Q LS+EH Q+ +YQ+LRGLKYI
Sbjct: 76  VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYI 134

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+ +N +C+L+I DFGLAR     D MT YV TRWYRAPE++LN   
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEIMLNWMH 192

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+KYI
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP   +Q   + F   +P AIDL+EKML  D  +RI+  +ALAHPY    HD  DEP 
Sbjct: 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPE 312

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              P+    E    T  + KEL Y+E  +F P
Sbjct: 313 A-EPYDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  250 bits (639), Expect = 4e-82
 Identities = 118/272 (43%), Positives = 164/272 (60%), Gaps = 7/272 (2%)

Query: 3   VVAIRDI-IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+       + F D Y+    M TDL +I+     LSE+  QY +YQ+L GLKYI
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMH 191

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYI 180
           Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  L +  AK YI
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP+Y R+ F+  FP   P A+DL+EKML  D  +R+T  +AL HPY  S  D  +E  
Sbjct: 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE 311

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              P+    E   L+  + K+ IY+E  +F+P
Sbjct: 312 -QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  249 bits (638), Expect = 1e-81
 Identities = 119/273 (43%), Positives = 161/273 (58%), Gaps = 25/273 (9%)

Query: 13  PQR--ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
           PQ+  E F DVY+  ELMD +L Q+I     L  E   Y LYQ+L G+K++HSA ++HRD
Sbjct: 86  PQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 143

Query: 71  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           LKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WS
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 202

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           VGCI  E++    LFPG DH+ Q   +IE +GTPS+  +  L    + Y+   P+Y   S
Sbjct: 203 VGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYS 262

Query: 191 FTEKFPNV-------HPS------AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
           F E FP+V         +      A DL+ KML  DP +RI+V+DAL HPY+   +D   
Sbjct: 263 FEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD-PS 321

Query: 238 EPVCMSPF----SFDFEQHALTEGQMKELIYQE 266
           E     P     S D  +H + E   KELIY+E
Sbjct: 322 EVEAPPPAPYDHSIDEREHTVEE--WKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  238 bits (611), Expect = 1e-78
 Identities = 85/238 (35%), Positives = 138/238 (57%), Gaps = 23/238 (9%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 61
           +V +++I+    +     +Y+ +E MD DL  ++ S +   +E   + ++ Q+L GL+Y+
Sbjct: 60  IVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPELLLNS 119
           HS  +LHRD+K SN+L+N +  LK+ DFGLAR  +   +   T  V+T WYR PELLL +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           + Y   +D+WSVGCI  EL   KP+F G   + QL  + EL G+P         +     
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP--------TDENWPG 228

Query: 180 ICQLPRYQ--------RQSFTEKFPNVH-PSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           + +LP ++        ++   E F ++  PSA+DL++K+LT DP++RI+ + AL H Y
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  238 bits (608), Expect = 2e-77
 Identities = 105/239 (43%), Positives = 151/239 (63%), Gaps = 6/239 (2%)

Query: 17  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
             N VYI  E M+TDL  ++     LSEEH + F+YQ+LRGLKYIHSANVLHRDLKP+N+
Sbjct: 87  ELNSVYIVQEYMETDLANVLEQGP-LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145

Query: 77  LLNA-NCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            +N  +  LKI DFGLAR+     S   +++E +VT+WYR+P LLL+ ++YT AID+W+ 
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           GCIF E++  KPLF G   + Q++L++E +    E +   L      ++       R+  
Sbjct: 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL 265

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 250
            +  P V+P A+D +E++LTF+P  R+T E+AL HPY+       DEPV + PF  + E
Sbjct: 266 RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDE 324

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  230 bits (590), Expect = 7e-76
 Identities = 80/228 (35%), Positives = 120/228 (52%), Gaps = 33/228 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + D+      E  + +Y+  E  +  DL  +++    LSE+  +++L QIL  L+Y+
Sbjct: 59  IVRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HS  ++HRDLKP N+LL+ +  +K+ DFGLAR     + +T +V T  Y APE+LL    
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG- 172

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y  A+D+WS+G I  EL+  KP FPG D   QL  L + IG P                 
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKP--------------- 214

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                    F     ++ P A DL+ K+L  DP +R+T E+AL HP+ 
Sbjct: 215 --------PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  228 bits (584), Expect = 2e-74
 Identities = 88/216 (40%), Positives = 123/216 (56%), Gaps = 16/216 (7%)

Query: 21  VYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           + + +E M+TDL ++I+     L+    + ++   LRGL+Y+HS  +LHRDLKP+NLL+ 
Sbjct: 77  INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA 136

Query: 80  ANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           ++  LK+ DFGLAR   S    MT  VVTRWYRAPELL  +  Y   +D+WSVGCIF EL
Sbjct: 137 SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196

Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY------QRQSFT 192
           + R P  PG   + QL  + E +GTP+E                LP Y            
Sbjct: 197 LLRVPFLPGDSDIDQLGKIFEALGTPTEEN----WPGVTS----LPDYVEFKPFPPTPLK 248

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           + FP     A+DL++++LT +P +RIT   AL HPY
Sbjct: 249 QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  223 bits (571), Expect = 2e-72
 Identities = 89/238 (37%), Positives = 138/238 (57%), Gaps = 24/238 (10%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYI 61
           VV + D+ P           +  E M +DL +++R   + L E   + ++  +L+G+ Y+
Sbjct: 61  VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS 119
           H+  ++HRDLKP+NLL++A+  LKI DFGLAR+ SE +    +  V TRWYRAPELL  +
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
             Y   +D+W+VGCIF EL++  PLFPG + + QL ++   +GTP+E     L       
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT------ 229

Query: 180 ICQLPRYQRQSFTEK--------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              LP Y + +F E         FP+  P A+DL++ +L +DP +R++  +AL HPY 
Sbjct: 230 --SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  222 bits (569), Expect = 3e-72
 Identities = 90/239 (37%), Positives = 140/239 (58%), Gaps = 27/239 (11%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKY 60
           +V ++++     RE+ +++Y  +E M+ +L+Q+++  +    SE   +  +YQIL+GL +
Sbjct: 60  IVKLKEVF----REN-DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IH     HRDLKP NLL++    +KI DFGLAR        T+YV TRWYRAPE+LL S+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE----------LG 170
            Y++ +D+W++GCI  EL   +PLFPG   + QL  +  ++GTP++ +          LG
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 171 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           F          + P++   S  +  PN  P AIDL++ ML +DP++R T   AL HPY 
Sbjct: 235 F----------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  219 bits (560), Expect = 8e-71
 Identities = 91/229 (39%), Positives = 132/229 (57%), Gaps = 6/229 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKY 60
           +V + D+   P+ +    + + +E +D DL   +       L  E  +  + Q+LRG+ +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  ++HRDLKP N+L+ ++  +KI DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS 182

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF EL  R+PLF G     QL  + ++IG PSE E      N     
Sbjct: 183 -YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE---WPRNVSLPR 238

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              P Y  +SF    P +    +DL++KMLTF+P +RI+  +AL HPY 
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  216 bits (553), Expect = 9e-70
 Identities = 96/216 (44%), Positives = 133/216 (61%), Gaps = 8/216 (3%)

Query: 19  NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           + +Y+  E ++ DL  ++    Q   +   +  + Q+L G+ ++H   +LHRDLK SNLL
Sbjct: 79  DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138

Query: 78  LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           LN    LKICDFGLAR   S     T+ VVT WYRAPELLL + +Y+ AID+WSVGCIF 
Sbjct: 139 LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFA 198

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKKYICQLPRYQRQSFTEK 194
           EL+ +KPLFPG+  + QL  + +L+GTP+E    GF     AKK      +Y      +K
Sbjct: 199 ELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK--KTFTKYPYNQLRKK 256

Query: 195 FPNVHPS--AIDLVEKMLTFDPRQRITVEDALAHPY 228
           FP +  S    DL+ ++LT+DP +RI+ EDAL HPY
Sbjct: 257 FPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  212 bits (542), Expect = 3e-67
 Identities = 115/273 (42%), Positives = 163/273 (59%), Gaps = 22/273 (8%)

Query: 13  PQR--ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
           PQ+  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L G+K++HSA ++HRD
Sbjct: 91  PQKSLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148

Query: 71  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           LKPSN+++ ++C LKI DFGLAR       MT YVVTR+YRAPE++L    Y   +D+WS
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 207

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           VGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    + Y+   P+Y   S
Sbjct: 208 VGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGIS 267

Query: 191 FTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           F E FP+ + PS           A DL+ KML  DP +RI+V++AL HPY+   +D ++ 
Sbjct: 268 FEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEA 327

Query: 239 ---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              P  +     +  +HA+   + KELIY+E +
Sbjct: 328 EAPPPQIYDAQLEEREHAIE--EWKELIYKEVM 358

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  206 bits (526), Expect = 5e-66
 Identities = 77/216 (35%), Positives = 115/216 (53%), Gaps = 25/216 (11%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E  + +Y+  E  +  DL   +     LSE+  +    QILRGL+Y+HS  ++HRDLKP 
Sbjct: 68  EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPE 127

Query: 75  NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N+LL+ N  +KI DFGLA+   ++   +T +V T WY APE+LL  + Y   +DVWS+G 
Sbjct: 128 NILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGV 187

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I  EL+  KP F G + + QL+L+  ++G P E +                         
Sbjct: 188 ILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE-----------------------P 224

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           K+ +    A DL++K L  DP +R T E+ L HP+ 
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  209 bits (532), Expect = 9e-66
 Identities = 114/273 (41%), Positives = 158/273 (57%), Gaps = 20/273 (7%)

Query: 11  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
           P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++HSA ++HRD
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151

Query: 71  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           LKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WS
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 210

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           VGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+   P+Y   S
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS 270

Query: 191 FTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           F + FP+V               A DL+ KML  D  +RI+V++AL HPY+   +D S+ 
Sbjct: 271 FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA 330

Query: 239 ---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              P  +     D  +H + E   KELIY+E +
Sbjct: 331 EAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  206 bits (526), Expect = 5e-65
 Identities = 113/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)

Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 135

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V++AL HPY+
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  198 bits (506), Expect = 1e-62
 Identities = 88/232 (37%), Positives = 133/232 (57%), Gaps = 10/232 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + DII    +++   V+   E +DTDL Q +      LS  + + FL+Q+LRGL Y 
Sbjct: 65  IVTLHDIIH--TKKTLTLVF---EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 120
           H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL S+
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           +Y+ ++D+W VGCIF E+   +PLFPG  D   QL  +  ++GTP+E     ++ N +  
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239

Query: 180 ICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               P Y  +      P +   P   +L  K L ++P++RI+  +A+ HPY 
Sbjct: 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  197 bits (503), Expect = 2e-62
 Identities = 91/231 (39%), Positives = 136/231 (58%), Gaps = 12/231 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLK 59
           +V + D+I      + N + + +E MD DL + + ++    AL     + F YQ+L+G+ 
Sbjct: 60  IVRLHDVI-----HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTEYVVTRWYRAPELLL 117
           + H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT WYRAP++LL
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLL 173

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
            S  Y+ +ID+WSVGCI  E++  +PLFPG ++  QL  +  ++GTP+E+    ++    
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLP 232

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           +Y    PRY  Q   + FP+  P  IDL+ ++L  +P  RI+  DAL HP+
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  195 bits (499), Expect = 9e-62
 Identities = 95/235 (40%), Positives = 138/235 (58%), Gaps = 19/235 (8%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           +V + D++      S N +Y+ +E +D DL + + S     L     + +LYQ+L+G+ Y
Sbjct: 60  IVRLLDVV-----HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---VTSETDFMTEYVVTRWYRAPELLL 117
            HS  VLHRDLKP NLL++    LK+ DFGLAR   V   T   T  VVT WYRAPE+LL
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILL 172

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA---ELGFLNE 174
            S  Y+  +D+WS+GCIF E+++R+PLFPG   + QL  +   +GTP E     +  L +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232

Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               Y    P++ RQ  ++  PN+    +DL+ KML +DP +RI+ + AL HPY 
Sbjct: 233 ----YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  196 bits (501), Expect = 1e-61
 Identities = 86/251 (34%), Positives = 130/251 (51%), Gaps = 34/251 (13%)

Query: 3   VVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY--FLYQILRG 57
           VV + D+    P   +     VY+    MD DL  ++  N ++     Q   ++ Q+L G
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQIKCYMLQLLEG 127

Query: 58  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------------TSETDFMTEY 104
           + Y+H  ++LHRD+K +N+L++    LKI DFGLAR                   + T  
Sbjct: 128 INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNL 186

Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 164
           VVTRWYR PELLL    YT A+D+W +GC+F E+  R+P+  G+  + QL L+ +L GTP
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246

Query: 165 SEAEL-------GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
           +E          G    ++         Y R +  E+F  + P  +DL+ K+L+ DP +R
Sbjct: 247 TEETWPGWRSLPGCEGVHSF------TNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKR 299

Query: 218 ITVEDALAHPY 228
           +T  DAL HPY
Sbjct: 300 LTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  192 bits (490), Expect = 2e-60
 Identities = 88/231 (38%), Positives = 134/231 (58%), Gaps = 13/231 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKY 60
           +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL +
Sbjct: 61  IVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---VTSETDFMTEYVVTRWYRAPELLL 117
            HS  VLHRDLKP NLL+N    +K+ DFGLAR   V   T   T  VVT WYRAPE+LL
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILL 173

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +     
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-LP 232

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
            Y    P++ RQ F++  P +     DL+ +ML +DP +RI+ + ALAHP+
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  193 bits (492), Expect = 2e-60
 Identities = 88/230 (38%), Positives = 135/230 (58%), Gaps = 9/230 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 61
           +V +++++     +  + +++  E  + DL  ++ +     SE   +  + Q+LRGL+Y+
Sbjct: 68  IVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSS 120
           H   ++HRDLK SNLLL     LKI DFGLAR        MT  VVT WYRAPELLL  +
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE--NAKK 178
            YT AID+W+VGCI  EL+  KPL PG+  + QL L+I+L+GTP+E+     ++     K
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           +   LP+    +   KFP +  + + L+  +L +DP++R T E+AL   Y
Sbjct: 245 FT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  192 bits (490), Expect = 3e-60
 Identities = 74/214 (34%), Positives = 128/214 (59%), Gaps = 5/214 (2%)

Query: 21  VYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+ +E ++  L +++ ++   L  +  + +++Q+L+ + Y HS N++HRD+KP N+L++
Sbjct: 75  LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS 134

Query: 80  ANCDLKICDFGLARVTSE--TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
            +  LK+CDFG AR         +T+YV TRWYRAPELL+  ++Y   +DVW++GCI  E
Sbjct: 135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194

Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFP 196
           L+D +PLFPG   + QL L+ + +G    +     + N +      P   Q +S   ++P
Sbjct: 195 LLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYP 254

Query: 197 NVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYL 229
               S A+D ++  L  DP++R+T ++ L HPY 
Sbjct: 255 GKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  192 bits (490), Expect = 3e-60
 Identities = 74/204 (36%), Positives = 119/204 (58%), Gaps = 3/204 (1%)

Query: 26  ELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 84
           ELMD +L+++I+   + L E+  + ++YQ+L+ L ++H   + HRD+KP N+L+  +  L
Sbjct: 80  ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-L 138

Query: 85  KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           K+ DFG  R        TEY+ TRWYRAPE LL    Y   +D+W+VGC+F E++   PL
Sbjct: 139 KLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL 198

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
           FPG + + Q+  + +++GTP    L    ++        P  +     +  PN     +D
Sbjct: 199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY-NFPSKKGTGLRKLLPNASAEGLD 257

Query: 205 LVEKMLTFDPRQRITVEDALAHPY 228
           L++K+L +DP +RIT + AL HPY
Sbjct: 258 LLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  189 bits (482), Expect = 2e-58
 Identities = 86/234 (36%), Positives = 124/234 (52%), Gaps = 30/234 (12%)

Query: 20  DVY-------IAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           DVY       +  ++M +DL +++     L+E   +  L QIL GL  +H    +HRDL 
Sbjct: 87  DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146

Query: 73  PSNLLLNANCDLKICDFGLAR---------------VTSETDFMTEYVVTRWYRAPELLL 117
           P+N+ +N+    KI DFGLAR                    + MT  VVT WYRAPELL+
Sbjct: 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM 206

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
            +  Y  A+D+WSVGCIF EL+  KPLFPG + + QL  + EL+GTP+E      N    
Sbjct: 207 GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED-----NWPQA 261

Query: 178 KYI---CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           K +    +    + +     FPN    AIDL++ +L  +P +RI+ ++AL H Y
Sbjct: 262 KKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  186 bits (473), Expect = 8e-58
 Identities = 86/231 (37%), Positives = 132/231 (57%), Gaps = 10/231 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI---IRSNQALSEEHCQYFLYQILRGLK 59
           +V ++D++    R     +Y+ +E +  DL +    +   Q +  E  + +LYQIL+G+ 
Sbjct: 61  IVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL++    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
           S  Y+  +D+WS+G IF E+  +KPLF G   + QL  +  ++GTP+E     +  +   
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-TSLPD 234

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++++ S      N+    +DL+EKML +DP +RI+ + AL HPY 
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  184 bits (469), Expect = 5e-57
 Identities = 84/216 (38%), Positives = 132/216 (61%), Gaps = 11/216 (5%)

Query: 21  VYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
           +Y+ +E +D+DL + + SN     + L  +  + F+YQ+L+G+ + H   V+HRDLKP N
Sbjct: 81  LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140

Query: 76  LLLNANCD-LKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           LL++     LKI D GL R  +      T  +VT WYRAPE+LL S+ Y+  +D+WSVGC
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKYICQLPRYQRQSFT 192
           IF E+  ++PLFPG   + QL  + +L+GTP+E    G       +   + P+++ Q  +
Sbjct: 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK---LRDWHEFPQWKPQDLS 257

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
              P++ P  +DL++KML +DP +RI+ + AL HPY
Sbjct: 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  183 bits (466), Expect = 1e-56
 Identities = 92/237 (38%), Positives = 138/237 (58%), Gaps = 10/237 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH--CQYFLYQILRGLKY 60
           +V ++D++   +R     +Y+ +E +D DL + + S+   ++     + +LYQILRG+ Y
Sbjct: 63  IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 61  IHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
            HS  VLHRDLKP NLL++   + LK+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
           S  Y+  +D+WSVGCIF E++++KPLFPG   + +L  +  ++GTP+E     +  +   
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT-SLPD 236

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 235
           Y    P++  +      P + P+ +DL+ KML  DP +RIT   AL H Y   L D 
Sbjct: 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  179 bits (457), Expect = 3e-55
 Identities = 90/217 (41%), Positives = 123/217 (56%), Gaps = 15/217 (6%)

Query: 22  YIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ +E MD DL  ++ S     SE+H + F+ Q+L GL Y H  N LHRD+K SN+LLN 
Sbjct: 92  YLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN 151

Query: 81  NCDLKICDFGLARV--TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
              +K+ DFGLAR+  + E+   T  V+T WYR PELLL    Y  AIDVWS GCI  EL
Sbjct: 152 KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEA------ELGFLNENAKKYICQLPRYQRQSFT 192
             +KP+F     + QL L+  L G+P  A      +L + N    K      +  R+   
Sbjct: 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPK------KQYRRRLR 265

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           E+F  +   A+DL++ MLT DP +R T E+AL  P+L
Sbjct: 266 EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  176 bits (448), Expect = 6e-54
 Identities = 95/234 (40%), Positives = 132/234 (56%), Gaps = 11/234 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH-CQYFLYQILRGLKYI 61
           +V + DII      +   + + +E +D DL Q +         H  + FL+Q+LRGL Y 
Sbjct: 66  IVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 120
           H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL S+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL-NENAKK 178
           DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L NE  K 
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
           Y    P+Y+        P +     +L+ K+L F+ R+RI+ E+A+ HPY   L
Sbjct: 241 Y--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  176 bits (448), Expect = 7e-54
 Identities = 92/232 (39%), Positives = 134/232 (57%), Gaps = 7/232 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + DI+      +   + + +E +D DL Q +      +S  + + FLYQILRGL Y 
Sbjct: 66  IVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 120
           H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL SS
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
           +Y+  ID+W VGCIF E+   +PLFPG     +L L+  L+GTP+E     ++ N +   
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
              P+Y+ Q      P +    I+L+ K L ++ ++RI+ E+A+ H Y  SL
Sbjct: 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  174 bits (442), Expect = 3e-53
 Identities = 86/220 (39%), Positives = 124/220 (56%), Gaps = 26/220 (11%)

Query: 23  IAYELMDTDLHQIIRSNQALSEEH-CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           + +E  D DL +   S     +    + F++Q+L+GL + HS NVLHRDLKP NLL+N N
Sbjct: 76  LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135

Query: 82  CDLKICDFGLAR-----VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
            +LK+ DFGLAR     V     +  E VVT WYR P++L  +  Y+ +ID+WS GCIF 
Sbjct: 136 GELKLADFGLARAFGIPVRC---YSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 191

Query: 137 ELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-------R 188
           EL +  +PLFPG D   QL+ +  L+GTP         E +   + +LP Y+        
Sbjct: 192 ELANAGRPLFPGNDVDDQLKRIFRLLGTP--------TEESWPGVSKLPDYKPYPMYPAT 243

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
            S     P ++ +  DL++ +L  +P QRI+ E+AL HPY
Sbjct: 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  173 bits (440), Expect = 2e-52
 Identities = 91/263 (34%), Positives = 136/263 (51%), Gaps = 48/263 (18%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII---RSNQA--LSEEHCQYFLYQILRG 57
           VV++ ++      +S   VY+ ++  + DL QII   R  +   +     +  L+QIL G
Sbjct: 64  VVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 58  LKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSE--TDFMTE--YVVTRW 109
           + Y+HS  VLHRDLKP+N+L+         +KI D GLAR+ +            VVT W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIEL 160
           YRAPELLL +  YT AID+W++GCIF EL+  +P+F GR+            QL  + E+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPN------VH------PSAIDL 205
           +GTP+E +           I ++P Y        T+ +P+      +           DL
Sbjct: 241 LGTPTEKDW--------PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292

Query: 206 VEKMLTFDPRQRITVEDALAHPY 228
           + K+L +DP +RIT E+AL HPY
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  168 bits (427), Expect = 6e-51
 Identities = 85/229 (37%), Positives = 130/229 (56%), Gaps = 7/229 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + DII      +   + + +E +D+DL Q + +    +S  + + F++Q+LRGL Y 
Sbjct: 65  IVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 120
           H   +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL S+
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
           +Y+  ID+W VGCI  E+   +P+FPG     +L L+  L+GTP+E     +  N +   
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              P+Y+ Q      P +    IDL+  +L ++ + RI+ E AL H Y 
Sbjct: 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  167 bits (426), Expect = 8e-51
 Identities = 73/208 (35%), Positives = 121/208 (58%), Gaps = 5/208 (2%)

Query: 25  YELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD 83
           +E  D T L+++ ++ + + E   +  ++Q L+ + + H  N +HRD+KP N+L+     
Sbjct: 79  FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ 138

Query: 84  LKICDFGLARVTSETDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK 142
           +K+CDFG AR+ +      T+YV TRWYRAPELL+  + Y   +DVW++GC+F EL+  +
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198

Query: 143 PLFPGRDHVHQLRLLIELIG--TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP 200
           PL+PG+  V QL L+ + +G   P   ++   N+  K      P   R+    KFPN+  
Sbjct: 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE-TREPLESKFPNISS 257

Query: 201 SAIDLVEKMLTFDPRQRITVEDALAHPY 228
            A+  ++  L  DP +R++ E+ L HPY
Sbjct: 258 PALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  164 bits (418), Expect = 2e-49
 Identities = 73/210 (34%), Positives = 122/210 (58%), Gaps = 3/210 (1%)

Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ +E +D T L  + +    L E   + +L+QILRG+++ HS N++HRD+KP N+L++ 
Sbjct: 76  YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135

Query: 81  NCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  +K+CDFG AR + +  +  T+YV TRWYRAPELL+  + Y  A+D+W+VGC+  E++
Sbjct: 136 SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNV 198
             +PLFPG   + QL  +I+ +G           +N      +LP  +  +   ++FP +
Sbjct: 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKL 255

Query: 199 HPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
               +DL ++ L  DP  R +    L H +
Sbjct: 256 SGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  159 bits (404), Expect = 1e-47
 Identities = 90/240 (37%), Positives = 136/240 (56%), Gaps = 26/240 (10%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + DII   +  +F      +E M TDL Q +I+    L   + + F++Q+LRGL YI
Sbjct: 65  IVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 120
           H  ++LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL ++
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKY 179
           DY++A+D+W  GCIF+E++  +P FPG   V  QL  +  ++G P+        E+    
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT--------EDTWPG 231

Query: 180 ICQLPRYQRQSFT-EKFPNVH---------PSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           + +LP Y+ + F   K   +          P A DL  +ML   P+ RI+ +DAL HPY 
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  157 bits (399), Expect = 2e-46
 Identities = 78/226 (34%), Positives = 117/226 (51%), Gaps = 26/226 (11%)

Query: 20  DVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
             Y+ +E  + DL  ++ SN+ +  +    +  +  +L GL YIH   +LHRD+K +N+L
Sbjct: 93  SFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151

Query: 78  LNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           +  +  LK+ DFGLAR  S +     +  T  VVT WYR PELLL   DY   ID+W  G
Sbjct: 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIG--TPSEAELGFLNENAKKY----ICQLPRY 186
           CI  E+  R P+  G    HQL L+ +L G  TP       +     K       +LP+ 
Sbjct: 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE------VWPGVDKLELFKKMELPQG 265

Query: 187 QRQSFTEK----FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           Q++   E+      + H  A+DL++K+L  DP +RI  + AL H +
Sbjct: 266 QKRKVKERLKPYVKDPH--ALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  155 bits (394), Expect = 5e-46
 Identities = 84/229 (36%), Positives = 124/229 (54%), Gaps = 6/229 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKY 60
           +V + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL +
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S+
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +  +  +      
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRDVTLPRG 240

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              PR  R       P +  S   L+ +MLTF+P +RI+   AL HP+ 
Sbjct: 241 AFSPRGPR-PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  150 bits (381), Expect = 1e-42
 Identities = 77/200 (38%), Positives = 119/200 (59%), Gaps = 4/200 (2%)

Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVT 95
           R+N AL     + + YQ+ R L YIHS  + HRDLKP NLL++ N   LK+CDFG A+  
Sbjct: 162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
                   Y+ +R+YRAPEL+L +++YT  ID+WS+GCI  E++   P+F G+  V QL 
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP-SAIDLVEKMLTFDP 214
            +I+++GTP+E +L  +N N      + P  + +   + FP   P  AI+ + + L ++P
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339

Query: 215 RQRITVEDALAHPYLGSLHD 234
            +R+   +ALA P+   L D
Sbjct: 340 LKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  144 bits (365), Expect = 1e-41
 Identities = 85/228 (37%), Positives = 130/228 (57%), Gaps = 6/228 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL +
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +  +  + A    
Sbjct: 186 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED--WPRDVALPRQ 242

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
               +   Q   +   ++     DL+ K LTF+P +RI+   AL+HPY
Sbjct: 243 AFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  141 bits (356), Expect = 3e-40
 Identities = 88/244 (36%), Positives = 134/244 (54%), Gaps = 28/244 (11%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 61
           +V + DII      +   + + +E + TDL Q +  +   L  E+ + FL+Q+LRGL YI
Sbjct: 65  IVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 120
           H   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL S+
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           +Y+  +D+W VGCIF+E++     FPG +D   QL  +  ++GTP        NE+    
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP--------NEDTWPG 231

Query: 180 ICQLPRYQRQSFT-----------EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           +  LP ++ + FT            K   V+  A DL  K+L   P+ R++ + AL+H Y
Sbjct: 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVN-HAEDLASKLLQCFPKNRLSAQAALSHEY 290

Query: 229 LGSL 232
              L
Sbjct: 291 FSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  138 bits (350), Expect = 2e-39
 Identities = 73/213 (34%), Positives = 122/213 (57%), Gaps = 8/213 (3%)

Query: 21  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +Y+ +E ++ ++ +++    N    E+  + ++YQ+++ + + H  +++HRD+KP NLL+
Sbjct: 75  LYLVFEYVEKNMLELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI 133

Query: 79  NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           + N  LK+CDFG AR  SE      TEYV TRWYR+PELLL +  Y  A+D+WSVGCI  
Sbjct: 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILG 192

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKF 195
           EL D +PLFPG   + QL  + +++G     ++     N + +  + P     QS   ++
Sbjct: 193 ELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRY 252

Query: 196 PNVHPSA-IDLVEKMLTFDPRQRITVEDALAHP 227
             +     +DL++ +L  +P  R   E  L HP
Sbjct: 253 LGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (345), Expect = 2e-39
 Identities = 50/129 (38%), Positives = 78/129 (60%), Gaps = 4/129 (3%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E  N +Y+  E  +   L  +++ N+  LSE+     L QIL GL+Y+HS  ++HRDLKP
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 74  SNLLLNANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N+LL+++   +K+ DFGL++ +TS+   +   V T  Y APE+LL    Y+   D+WS+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180

Query: 132 GCIFMELMD 140
           G I  EL +
Sbjct: 181 GVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  133 bits (338), Expect = 7e-38
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 31/201 (15%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L  +++    L E   + +  QIL GL Y+HS  ++HRD+K +N+L++++  +K+ DFG 
Sbjct: 88  LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147

Query: 92  ARV--TSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
           A+     ET   T  V  T ++ APE ++   +Y  A D+WS+GC  +E+   KP +   
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
            +       I   G P                 ++P            ++   A D + K
Sbjct: 207 GNPMAALYKIGSSGEPP----------------EIP-----------EHLSEEAKDFLRK 239

Query: 209 MLTFDPRQRITVEDALAHPYL 229
            L  DP++R T ++ L HP+L
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 6e-35
 Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 31/247 (12%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           +    +Y+  E +D   L  +++       LSE    + L QIL  L+Y+HS  ++HRD+
Sbjct: 68  QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127

Query: 72  KPSNLLLNAN-CDLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNSSD-- 121
           KP N+LL+ +   +K+ DFGLA++  +           +  V T  Y APE+LL  S   
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
            +++ D+WS+G    EL+   P F G  +       +++I                    
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII-----------------LEL 230

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             P             +  +A DL++K+L  DP+ R++    L+H  L  L     +   
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 242 MSPFSFD 248
           +      
Sbjct: 291 LLKPDDS 297

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  125 bits (316), Expect = 1e-34
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 41/225 (18%)

Query: 15  RESFND---VYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANV 66
            ESF +   + I  E  D  DL Q I+      +   EE    +  Q+   LKY+HS  +
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124

Query: 67  LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAA 125
           LHRD+KP N+ L +N  +K+ DFG+++V S T  + + VV T +Y +PEL  N   Y   
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYK 183

Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            D+WS+GC+  EL   K  F G +++ +L L I                           
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEG-ENLLELALKI--------------------------- 215

Query: 186 YQRQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
             +  +    P+ + S + +LV  +L  DP +R ++   L  P++
Sbjct: 216 -LKGQY-PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  123 bits (310), Expect = 2e-33
 Identities = 84/247 (34%), Positives = 129/247 (52%), Gaps = 42/247 (17%)

Query: 21  VYIAYELMDTDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           V++ ++  + DL  II+ ++A         L     +  LYQIL G+ Y+H+  VLHRDL
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 72  KPSNLLLNANCD----LKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYT 123
           KP+N+L+         +KI D G AR+ +        +   VVT WYRAPELLL +  YT
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194

Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNE 174
            AID+W++GCIF EL+  +P+F  R          H  QL  +  ++G P++ +     E
Sbjct: 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW----E 250

Query: 175 NAKK---YICQLPRYQRQSFTE----KFPNVH-----PSAIDLVEKMLTFDPRQRITVED 222
           + KK   +   +  ++R ++T     K+   H       A  L++K+LT DP +RIT E 
Sbjct: 251 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310

Query: 223 ALAHPYL 229
           A+  PY 
Sbjct: 311 AMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  120 bits (303), Expect = 2e-32
 Identities = 84/247 (34%), Positives = 127/247 (51%), Gaps = 42/247 (17%)

Query: 21  VYIAYELMDTDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           V++ ++  + DL  II+ ++A         L     +  LYQIL G+ Y+H+  VLHRDL
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 72  KPSNLLLNANCD----LKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYT 123
           KP+N+L+         +KI D G AR+ +        +   VVT WYRAPELLL +  YT
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194

Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNE 174
            AID+W++GCIF EL+  +P+F  R          H  QL  +  ++G P++ +     E
Sbjct: 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDW----E 250

Query: 175 NAKK---YICQLPRYQRQSFTE----KFPNVHPSAID-----LVEKMLTFDPRQRITVED 222
           + +K   Y      ++R ++      K+   H    D     L++K+LT DP +RIT E 
Sbjct: 251 DIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310

Query: 223 ALAHPYL 229
           AL  PY 
Sbjct: 311 ALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (301), Expect = 3e-32
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 49/223 (21%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           +++++  E MD    TD+  I ++   ++E    Y   ++L+GL+Y+HS NV+HRD+K  
Sbjct: 88  DELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145

Query: 75  NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N+LL+ +  +K+ DFG  A++T E       V T ++ APE++    DY   +D+WS+G 
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGI 204

Query: 134 IFMEL-------MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 186
           + +E+       +   PL        +   LI   G P    L    +N +K        
Sbjct: 205 MCIEMAEGEPPYLREPPL--------RALFLITTKGIP---PL----KNPEK-------- 241

Query: 187 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                        P   D + K L  DP +R + E+ L HP+L
Sbjct: 242 -----------WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 4e-32
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 37/203 (18%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   +      SEE  +++  +I+  L+Y+HS  +++RDLKP N+LL+A+  +K+ DFG
Sbjct: 79  ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138

Query: 91  LAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           LA+ ++SE      +  T  Y APE+LL    Y  A+D WS+G +  E++  KP F   D
Sbjct: 139 LAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197

Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEK 208
                  + E I                                +FP  + P A DL+  
Sbjct: 198 RK----EIYEKI---------------------------LKDPLRFPEFLSPEARDLISG 226

Query: 209 MLTFDPRQRIT---VEDALAHPY 228
           +L  DP +R+     E+  AHP+
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (292), Expect = 4e-31
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 77
           ++ I  E MD   L  +++    + E    Y   QIL+GL Y+H+  +++HRD+KPSNLL
Sbjct: 73  EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132

Query: 78  LNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           +N+  ++KI DFG+++V   T      +V T  Y +PE +   S Y+ A D+WS+G   +
Sbjct: 133 INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLL 191

Query: 137 EL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRYQRQSFTE 193
           E  + + P  P               G PS  EL        + IC    P    + F+ 
Sbjct: 192 ECALGKFPFLPP--------------GQPSFFEL-------MQAICDGPPPSLPAEEFSP 230

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +F        D +   L  DP++R +  + L HP++
Sbjct: 231 EF-------RDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  113 bits (286), Expect = 3e-30
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 42/228 (18%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
            ++Y+  E +   DL  ++ +  +L E+  + ++ +I+  L+Y+HS  ++HRDLKP N+L
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 78  LNANCDLKICDFGLARV--TSETDFM-------TEYVVTRWYRAPELLLNSSDYTAAIDV 128
           +++N  LK+ DFGL++V        +          V T  Y APE++L    ++  +D 
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDW 184

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           WS+GCI  E +   P F G               TP E     + +N      + P    
Sbjct: 185 WSLGCILYEFLVGIPPFHGE--------------TPEE-----IFQNILNGKIEWP---- 221

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLH 233
                +   V   AIDL+ K+L  DP +R+   ++E+   HP+   + 
Sbjct: 222 -----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (285), Expect = 3e-30
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 30/212 (14%)

Query: 19  NDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ++++I  E      L  +++S NQ L+E    Y   ++L+GL+Y+HS  ++HRD+K +N+
Sbjct: 70  DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129

Query: 77  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           LL ++ ++K+ DFGL+   S+T      V T ++ APE ++N   Y    D+WS+G   +
Sbjct: 130 LLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAI 188

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
           EL + KP +       +    I   G P     G  N          P      F     
Sbjct: 189 ELAEGKPPY-SELPPMKALFKIATNGPP-----GLRN----------PEKWSDEFK---- 228

Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
                  D ++K L  +P +R T E  L HP+
Sbjct: 229 -------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (272), Expect = 5e-28
 Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 60/241 (24%)

Query: 17  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +F D   +Y   E   + +L Q IR   +L E+  +++  +IL  L+Y+HS  ++HRDLK
Sbjct: 70  TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTE---------------------YVVTRWYR 111
           P N+LL+ +  +KI DFG A+V                              +V T  Y 
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           +PELL        + D+W++GCI  +++  KP F G                 +E    F
Sbjct: 190 SPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRG----------------SNEYLT-F 231

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL----AHP 227
                 +Y          SF   FP   P A DL+EK+L  DP+ R+ V +      AHP
Sbjct: 232 QKILKLEY----------SFPPNFP---PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278

Query: 228 Y 228
           +
Sbjct: 279 F 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (265), Expect = 3e-27
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 36/222 (16%)

Query: 15  RESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
             SF D    Y ++D     DL   +      SEE  ++++ +I+  L+Y+HS  ++HRD
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125

Query: 71  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           +KP N+LL+    + I DF +A   +     T    T  Y APE +L    Y+ A+D WS
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLCRQGYSVAVDWWS 184

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G    E +  K  + G       R + + I                       R ++++
Sbjct: 185 LGVTAYECLRGKRPYRGHS-----RTIRDQI-----------------------RAKQET 216

Query: 191 FTEKFPNVHPS-AIDLVEKMLTFDPRQRI--TVEDALAHPYL 229
               +P    + AID + K+L  DP++R+   ++D   HPY 
Sbjct: 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (262), Expect = 6e-27
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)

Query: 14  QRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +RE  N +YI  EL+    L ++++   +  E   + +  QIL GL+Y+H  N +HRD+K
Sbjct: 71  EREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
            +N+L++ N  +K+ DFG+A+   E  F   +  + ++ APE++     Y  A D+WS+G
Sbjct: 130 GANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG 189

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIEL--IGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           C  +E+   KP +       QL  +  +  IG   E                +P      
Sbjct: 190 CTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPP-------------IPD----- 225

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                 ++   A D + K L  DP  R T  + L HP++
Sbjct: 226 ------HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  104 bits (261), Expect = 1e-26
 Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 46/234 (19%)

Query: 7   RDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYI 61
           R I    Q      +YI  E  +  DL Q+I    +  + + EE     L Q+L  L   
Sbjct: 67  RIIDRSNQT-----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 62  H-----SANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 115
           H        VLHRDLKP+N+ L+AN ++K+ DFGLA++   ++ F   YV T +Y +PE 
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 175
           L + S Y    D+WS+GC+  EL    P F  R+ + QL   I+                
Sbjct: 182 LNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQL-QLASKIK---------------- 223

Query: 176 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             K+     RY  +               +++ ML  DP +R + E+ L  P +
Sbjct: 224 EGKFRRIPYRYSSELNE------------VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (261), Expect = 1e-26
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 34/219 (15%)

Query: 19  NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
             VYI  E      L +++   + L E   + +  Q+L GL Y+HS  ++HRD+KP+N+ 
Sbjct: 72  EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131

Query: 78  LNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWS 130
           L+ N  +K+ DFG A       T+  + +     T  Y APE++       +  A D+WS
Sbjct: 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +GC+ +E+   K  +   D+  Q+   +     P                  +P   + S
Sbjct: 192 LGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-----------------PIPDSLQLS 234

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                    P   D +++ L  DP++R T  + L HP++
Sbjct: 235 ---------PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 9e-25
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 35/207 (16%)

Query: 30  TDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           TDL + + +  + L EE   Y L + LRGL Y+H   V+HRD+K  N+LL  N ++K+ D
Sbjct: 97  TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156

Query: 89  FGLAR-VTSETDFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKP 143
           FG++  + S       ++ T ++ APE++         Y A  DVWS+G   +EL D KP
Sbjct: 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Query: 144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSA 202
             P  D +H +R L ++   P                   P     +++++KF       
Sbjct: 217 --PLCD-MHPMRALFKIPRNPP------------------PTLKSPENWSKKF------- 248

Query: 203 IDLVEKMLTFDPRQRITVEDALAHPYL 229
            D + + L  +  QR  +E+ L HP++
Sbjct: 249 NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.2 bits (245), Expect = 2e-24
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 19  NDVYIAYELMD-TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN 75
            D+ I  E MD   L +I+      + E         +L+GL Y+H    ++HRD+KPSN
Sbjct: 72  GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131

Query: 76  LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           +L+N+   +K+CDFG++     +   T +V T  Y APE  +  +DY+   D+WS+G   
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSL 189

Query: 136 MEL-MDRKPL-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +EL   R P             LL  ++  P                 +LP       + 
Sbjct: 190 IELATGRFPYPPENDPPDGIFELLQYIVNEPPP---------------RLP-------SG 227

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           KF    P   D V   L  DPR+R + ++ L HP++
Sbjct: 228 KFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 3e-24
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 22  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E  +   L QII+      E     ++YQ+L+GL Y+H   V+HRD+K +N+L   
Sbjct: 75  YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134

Query: 81  NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  +K+ DFG+A ++   +      V T ++ APE ++  S  + A D+WS+GC  +EL+
Sbjct: 135 DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIEMSGASTASDIWSLGCTVIELL 193

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY-ICQLPRYQRQSFTEKFP-N 197
              P +   + +  L                        + I Q             P  
Sbjct: 194 TGNPPYYDLNPMAAL------------------------FRIVQDDHP-------PLPEG 222

Query: 198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           + P   D + +    DP  R T +  L HP++
Sbjct: 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 3e-24
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           D   +I++   L E+  + ++ +++ G++ +H   ++HRD+KP NLL++    LK+ DFG
Sbjct: 83  DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           L+R   E     ++V T  Y APE +L   D     D WS+GC+  E             
Sbjct: 143 LSRNGLEN---KKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEF------------ 186

Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
                    L G P      F  E        +   +     E      P A+DL+ ++L
Sbjct: 187 ---------LFGYPP-----FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 211 TFDPRQRI---TVEDALAHPYLGSL 232
             DP +R+     ++  +HP+  S+
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 3e-24
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 33/201 (16%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           D+ +I   N+ L+EE     LYQ L+GL+Y+HS   +HRD+K  N+LLN     K+ DFG
Sbjct: 87  DIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144

Query: 91  LARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           ++   ++T      V+ T ++ APE++     Y    D+WS+G   +E+ + KP  P   
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP--P-YS 200

Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEK 208
            +H +R +                         +P     + ++  P    P   D V+K
Sbjct: 201 DIHPMRAIFM-----------------------IPNKPPPTLSD--PEKWSPEFNDFVKK 235

Query: 209 MLTFDPRQRITVEDALAHPYL 229
            L  DP +R +    L HP++
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 6e-24
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 30/189 (15%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDF 100
           L E +  + L ++L GL+Y+H    +HRD+K +N+LL+   D+K+ DFG++ ++TS    
Sbjct: 95  LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154

Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
              +V T ++ APE++  S  Y    D+WS+G   +EL   +P  P    +H +R+L  +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLI 210

Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
                                  P  +   F++ F        D V   L  DP++R + 
Sbjct: 211 PKNNP------------------PSLEGNKFSKPFK-------DFVSLCLNKDPKERPSA 245

Query: 221 EDALAHPYL 229
           ++ L H ++
Sbjct: 246 KELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 94.5 bits (236), Expect = 5e-23
 Identities = 47/127 (37%), Positives = 63/127 (49%), Gaps = 13/127 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  E M+  DL   +R N+  LS      F  QI RG++Y+ S N +HRDL   N L+
Sbjct: 76  LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
             N  +KI DFGL+R   + D    Y         RW  APE L     +T+  DVWS G
Sbjct: 136 GENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-APESLKEGK-FTSKSDVWSFG 190

Query: 133 CIFMELM 139
            +  E+ 
Sbjct: 191 VLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 9e-23
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)

Query: 14  QRESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
              +F D    Y LM+     +L  I+R      E   ++++  ++   +Y+H+  +++R
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 70  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           DLKP NLLL++N  +K+ DFG A+          +  T  Y APE++LN   Y  ++D W
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYW 176

Query: 130 SVGCIFMELMDRKPLFPGRDH----VHQLRL-LIELIGTPSEAELGFLNENAKKYICQL 183
           S+G +  EL+  +P F   D     ++   L     +  P+     ++++ AK  I QL
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN-----YIDKAAKDLIKQL 230

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 93.8 bits (234), Expect = 1e-22
 Identities = 47/128 (36%), Positives = 62/128 (48%), Gaps = 14/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           + I  E M   DL   +R N+   LS      F  QI RG++Y+ S N +HRDL   N L
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSV 131
           +  N  +KI DFGL+R   + D    Y V       RW  APE L     +T+  DVWS 
Sbjct: 136 VGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-APESLKEGK-FTSKSDVWSF 190

Query: 132 GCIFMELM 139
           G +  E+ 
Sbjct: 191 GVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.7 bits (233), Expect = 1e-22
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 16  ESFNDVYIAYELM----DTDLHQIIRSNQA----LSEEHCQYFLYQILRGLKYIHSANVL 67
           E+F D      +M      DL + I   +     + E+       Q+LRGL+ +H   +L
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 68  HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           HRDLK +N+LL AN  +KI D G+++V  +    T+ + T  Y APE +     Y+   D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPE-VWKGRPYSYKSD 183

Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+GC+  E+    P F  R  +  LR                             + Q
Sbjct: 184 IWSLGCLLYEMATFAPPFEARS-MQDLRY----------------------------KVQ 214

Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           R  +    P       + +  ML   P+ R   +  LA P +
Sbjct: 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.0 bits (226), Expect = 1e-21
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 30/199 (15%)

Query: 35  IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 94
            +R+     E+  ++F  Q+L GL Y+HS  +LHRDLK  NLL++A+   KI DFG+++ 
Sbjct: 98  CLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157

Query: 95  TSE---TDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELM-DRKPLFPGRD 149
           + +    D       + ++ APE++ + S  Y+A +D+WS+GC+ +E+   R+P     +
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDE 215

Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
                             +LG      K+    +P        +   N+ P A+D +   
Sbjct: 216 EAIAAMF-----------KLG-----NKRSAPPIP-------PDVSMNLSPVALDFLNAC 252

Query: 210 LTFDPRQRITVEDALAHPY 228
            T +P  R T  + L HP+
Sbjct: 253 FTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 5e-21
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 33/201 (16%)

Query: 32  LHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           L+  I  +  Q   EE   ++L+QI+  + YIH A +LHRD+K  N+ L     +K+ DF
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145

Query: 90  GLARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
           G++++      M E VV T +Y +PE L     Y    D+W++GC+  EL+  K  F   
Sbjct: 146 GISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF--- 201

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
           D  + L L+++++                 Y   +  Y  +             I LV  
Sbjct: 202 DATNPLNLVVKIV--------------QGNYTPVVSVYSSE------------LISLVHS 235

Query: 209 MLTFDPRQRITVEDALAHPYL 229
           +L  DP +R T ++ L  P L
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 1e-20
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 24/178 (13%)

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE--TDFMTEYVVTRWYR 111
           +L+GL Y+HS  ++HRD+KPSN+LL     +K+CDFG   V+ E        +  T +Y 
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG---VSGELVNSLAGTFTGTSFYM 170

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           APE +     Y+   DVWS+G   +E             V Q R      G P    +  
Sbjct: 171 APERIQGKP-YSITSDVWSLGLTLLE-------------VAQNRFPFPPEGEPPLGPIEL 216

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           L+     YI  +P  + +              D +++ L  DP +R T  D L HP++
Sbjct: 217 LS-----YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 1e-19
 Identities = 40/128 (31%), Positives = 71/128 (55%), Gaps = 6/128 (4%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           + I  E M    +   +++  AL+E   + +  QIL G++Y+HS  ++HRD+K +N+L +
Sbjct: 79  LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD 138

Query: 80  ANCDLKICDFG----LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           +  ++K+ DFG    L  + S    M     T ++ +PE +++   Y    DVWSVGC  
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTV 197

Query: 136 MELMDRKP 143
           +E++  KP
Sbjct: 198 VEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.9 bits (210), Expect = 2e-19
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 16  ESFNDVYIAYELMD----TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           ESF D      +M+     DLH++++    + L E+    F  QIL GL ++HS  +LHR
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 70  DLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 128
           D+K  NL L+A  ++KI D G+A++ S  T+F    V T +Y +PE L     Y    DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDV 184

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           W++G +  E    K  F   +    +  +I  +  P              Y  QL     
Sbjct: 185 WALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ----------MYSQQL----- 229

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                           L+++ LT D RQR      L +P L
Sbjct: 230 --------------AQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 37/218 (16%)

Query: 20  DVYIAYELMDTDLH----QIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 74
           DV+I  E+MDT L     ++      + E+        I++ L+Y+HS  +V+HRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSV 131
           N+L+N N  +K+CDFG++    ++   T     + Y APE +   LN   Y    DVWS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 132 GCIFMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           G   +EL   R P    +    QL+ ++E    PS                  P+   + 
Sbjct: 194 GITMIELATGRFPYDSWKTPFQQLKQVVE---EPS------------------PQLPAEK 232

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           F+ +F        D V K L  + ++R    + L HP+
Sbjct: 233 FSPEF-------QDFVNKCLKKNYKERPNYPELLQHPF 263

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 34/199 (17%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 100
           L+E   +Y   Q+L  L ++HS  V+HRDLK  N+LL  + D+K+ DFG+ A+  S    
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159

Query: 101 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 156
              ++ T ++ APE++      D  Y    D+WS+G   +EL   +P  P  + ++ +R+
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRV 216

Query: 157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDLVEKMLTFDPR 215
           L++++ +                    P   + S ++  F        D ++  L  DP 
Sbjct: 217 LLKILKSEP------------------PTLDQPSKWSSSFN-------DFLKSCLVKDPD 251

Query: 216 QRITVEDALAHPYLGSLHD 234
            R T  + L HP++    D
Sbjct: 252 DRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 4e-19
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 32/203 (15%)

Query: 30  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
            D++Q+ R    LSE    Y   + L+GL Y+H    +HRD+K +N+LL  + D+K+ DF
Sbjct: 88  QDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 90  GL-ARVTSETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFP 146
           G+ A++T+       ++ T ++ APE+        Y    D+W++G   +EL + +P  P
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P 203

Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDL 205
             D +H +R L  LI                K     P+ + +  ++  F        D 
Sbjct: 204 MFD-LHPMRALF-LIS---------------KSNFPPPKLKDKEKWSPVF-------HDF 239

Query: 206 VEKMLTFDPRQRITVEDALAHPY 228
           ++K LT DP++R T    L HP+
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 5e-19
 Identities = 42/186 (22%), Positives = 84/186 (45%), Gaps = 29/186 (15%)

Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSET 98
             ++E++    + ++L  LKYIH   V+HRD+K +N+L+    ++K+CDFG+ A +   +
Sbjct: 96  GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
              + +V T ++ APE++     Y    D+WS+G    E+    P +   D    + L+ 
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215

Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           +                      + PR +   ++           + V   L  +P++R+
Sbjct: 216 K---------------------SKPPRLEDNGYS-------KLLREFVAACLDEEPKERL 247

Query: 219 TVEDAL 224
           + E+ L
Sbjct: 248 SAEELL 253

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 7e-19
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 10/128 (7%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----RVTSETDFMTE 103
           +  Q+LRGL Y+H   ++HRD+K +NLL+++    L+I DFG A     + T   +F  +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 104 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL--- 160
            + T  + APE+L     Y  + DVWSVGC+ +E+   KP +    H + L L+ ++   
Sbjct: 168 LLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226

Query: 161 IGTPSEAE 168
              PS  E
Sbjct: 227 TTAPSIPE 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 82.9 bits (206), Expect = 9e-19
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 14/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  E M   DL   +R + + L+ +       QI +G++Y+ S N +HRDL   N L+
Sbjct: 76  LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
             N  +KI DFGL+R   E D    Y          +W  APE L +   +T+  DVWS 
Sbjct: 136 TENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-APESLKDGK-FTSKSDVWSF 190

Query: 132 GCIFMELM 139
           G +  E+ 
Sbjct: 191 GVLLWEIF 198

Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 7/120 (5%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     +L   +R +    E   +++  Q++  L+Y+HS ++++RDLK
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           P NLLL+++  +KI DFG A+      +      T  Y APE++L S  Y  A+D W++G
Sbjct: 129 PENLLLDSDGYIKITDFGFAKRVKGRTYTL--CGTPEYLAPEIIL-SKGYGKAVDWWALG 185

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 1e-18
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 17  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +F D   +Y+A E +   D   ++ +   LSE+H ++++ ++   +  +H    +HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           P N L++A+  +K+ DFGL++      +    V +  Y APE +L    Y   +D WS+G
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLG 185

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           C+  E +   P F G               TP+E       EN K +   L   QR  + 
Sbjct: 186 CMLYEFLCGFPPFSG--------------STPNETW-----ENLKYWKETL---QRPVYD 223

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 233
           +   N+   A DL+ K++    R+  ++ED   HP+   + 
Sbjct: 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 83.5 bits (206), Expect = 1e-18
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 39/214 (18%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARV 94
           I S   L+EE        +L+ L Y+HS  V+HRD+K  ++LL  +  +K+ DFG  A++
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167

Query: 95  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 154
           + +       V T ++ APE +++ + Y   +D+WS+G + +E++D +P +     V  +
Sbjct: 168 SKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Query: 155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLT 211
           + L                              R S   K  N H   P   D +E+MLT
Sbjct: 227 KRL------------------------------RDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 212 FDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 245
            +P++R T ++ L HP+L      +  P C+ P 
Sbjct: 257 REPQERATAQELLDHPFLLQ----TGLPECLVPL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 82.7 bits (204), Expect = 2e-18
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)

Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           D   H     N    EE   ++  +IL GL+ +H  N ++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISD 145

Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            GLA    E + +   V T  Y APE +LN+  YT + D W +GC+  E+++ +  F GR
Sbjct: 146 LGLAVKIPEGESIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
               +   +   +    E      +E AK  IC++                         
Sbjct: 205 KEKVKREEVDRRVLETEEVYSAKFSEEAKS-ICKM------------------------- 238

Query: 209 MLTFDPRQRITVEDALA-----HPYLGSLHDISDEPVCMSP 244
           +LT DP+QR+  ++  A     HP+  +++    E   + P
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 22/228 (9%)

Query: 17  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI---HSANVLHRDLK 72
           S  ++ I  E MD   L Q+++    + E         +LRGL Y+   H   ++HRD+K
Sbjct: 70  SDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVK 127

Query: 73  PSNLLLNANCDLKICDFGLARVTSE-TDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           PSN+L+N+  ++K+CDFG   V+ +  D M   +V TR Y +PE  L  + YT   D+WS
Sbjct: 128 PSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWS 183

Query: 131 VGCIFMEL-MDRKPLFPGRDHVHQLRLL------IELIGTPSEAELGFLNENAKKYICQL 183
           +G   +E+ + R P+ P  D      +        E   +         +      I +L
Sbjct: 184 LGLSLVEMAIGRYPI-PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242

Query: 184 PRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             Y       K P+        D V+K L  +P++R  +++   HP++
Sbjct: 243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.8 bits (202), Expect = 3e-18
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 27/191 (14%)

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETDFMTEYVVTRWYR 111
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+CDFG++   V S       YV T  Y 
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYM 160

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           APE +     Y    DVWS+G  FMEL   +  +P         + ++L+          
Sbjct: 161 APERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-------I 212

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           ++E+        P      F+EKF       +  + + +   P++R   E+ + HP++  
Sbjct: 213 VDEDP-------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Query: 232 LHDISDEPVCM 242
            +D + E V M
Sbjct: 259 YNDGNAEVVSM 269

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.0 bits (202), Expect = 3e-18
 Identities = 60/254 (23%), Positives = 114/254 (44%), Gaps = 45/254 (17%)

Query: 2   QVVAIRDIIPPPQRESFN------DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQIL 55
           +VV +RD       E +N      ++++  E ++      I ++  ++EE        +L
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 126

Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPE 114
           + L  +H+  V+HRD+K  ++LL  +  +K+ DFG  A+V+ E       V T ++ APE
Sbjct: 127 KALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 186

Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 174
           L+ +   Y   +D+WS+G + +E++D +P +     +  ++++                 
Sbjct: 187 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------- 228

Query: 175 NAKKYICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
                        R +   K  N+H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 229 -------------RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Query: 232 LHDISDEPVCMSPF 245
               +  P C+ P 
Sbjct: 276 ----AGPPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.6 bits (201), Expect = 4e-18
 Identities = 55/185 (29%), Positives = 96/185 (51%), Gaps = 21/185 (11%)

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRW 109
           L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 169
           + APE++  S+ Y +  D+WS+G   +EL   +P  P  D +H +R+L  +         
Sbjct: 167 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLT 222

Query: 170 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           G  ++  K++I         +   K P+  P+A +L+        + +  V++A    YL
Sbjct: 223 GEFSKPFKEFI--------DACLNKDPSFRPTAKELL--------KHKFIVKNAKKTSYL 266

Query: 230 GSLHD 234
             L D
Sbjct: 267 TELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.8 bits (199), Expect = 5e-18
 Identities = 51/138 (36%), Positives = 71/138 (51%), Gaps = 8/138 (5%)

Query: 15  RESFN---DVYIAYELMDT-DLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLH 68
           +ESF     +YI  E  D  DL Q I+  +     E+    +  Q+  G+++IH   VLH
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123

Query: 69  RDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           RD+K  N+ L  N  +K+ DFG AR+ TS   +   YV T +Y  PE+  N   Y    D
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSD 182

Query: 128 VWSVGCIFMELMDRKPLF 145
           +WS+GCI  EL   K  F
Sbjct: 183 IWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.6 bits (199), Expect = 7e-18
 Identities = 42/127 (33%), Positives = 72/127 (56%), Gaps = 9/127 (7%)

Query: 19  NDVYIAYELMDT-DLHQII---RSNQALSEEHC--QYFLYQILRGLKYIHSANVLHRDLK 72
           N++ I  EL D  DL ++I   +  + L  E    +YF  Q+   L+++HS  ++HRD+K
Sbjct: 75  NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLCSALEHMHSKRIMHRDIK 133

Query: 73  PSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P+N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+
Sbjct: 134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSL 192

Query: 132 GCIFMEL 138
           GC+  E+
Sbjct: 193 GCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.8 bits (199), Expect = 7e-18
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 28  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 87
           +D  L ++  + + LSE     +  Q+L G+ Y+H   +LHRDLK  N+ L  N  LKI 
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 88  DFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 146
           DFG++R +    D  T +  T +Y +PE  L    Y +  D+WS+GCI  E+      F 
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 206
           G++    L +++ ++  P                           T   P  +   ++ +
Sbjct: 207 GQNF---LSVVLRIVEGP---------------------------TPSLPETYSRQLNSI 236

Query: 207 -EKMLTFDPRQRITVEDALAHPYL 229
            + ML  DP  R +  + L +P++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.3 bits (198), Expect = 7e-18
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 31/192 (16%)

Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R N  L E+   +F  QIL  L ++H+  +LHRDLK  N+LL+ +   +KI DFG++++ 
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
           S        V T  Y +PE L     Y    D+W++GC+  EL   K  F   +    L 
Sbjct: 153 SSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LP 207

Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 215
            L+  I + + A +               RY             P    L+  ML  DP 
Sbjct: 208 ALVLKIMSGTFAPIS-------------DRYS------------PDLRQLILSMLNLDPS 242

Query: 216 QRITVEDALAHP 227
           +R  +   +A P
Sbjct: 243 KRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 39/204 (19%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV- 94
           +   +  SE+  +++  +I+  L Y+HS +V++RDLK  NL+L+ +  +KI DFGL +  
Sbjct: 86  LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145

Query: 95  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 154
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 146 ISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 200

Query: 155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFD 213
             L ELI          L E                   +FP  + P A  L+  +L  D
Sbjct: 201 EKLFELI----------LMEEI-----------------RFPRTLSPEAKSLLAGLLKKD 233

Query: 214 PRQRI--TVEDAL---AHPYLGSL 232
           P+QR+    EDA     H +  S+
Sbjct: 234 PKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 37/196 (18%)

Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF 100
           A  E   + F+ QIL+GL Y+H+  ++HRD+K +N+L++    +KI DFG+++       
Sbjct: 102 AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161

Query: 101 MTEYVVTR-------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+    R       ++ APE++  +S YT   D+WS+GC+ +E++  K  FP       
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFP------- 213

Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 213
                              +    + I ++             N+   AID +EK    D
Sbjct: 214 -------------------DCTQLQAIFKIGENASPEIPS---NISSEAIDFLEKTFEID 251

Query: 214 PRQRITVEDALAHPYL 229
             +R T  + L HP+L
Sbjct: 252 HNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 41/196 (20%)

Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMT 102
               +++  ++L  L+ +H  NV++RDLKP N+LL+    + +CDFGL ++   + D   
Sbjct: 92  LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151

Query: 103 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 162
            +  T  Y APELLL    YT A+D W++G +  E+                     L G
Sbjct: 152 TFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEM---------------------LTG 189

Query: 163 TPSEAELGFLNENAKKYICQLPRYQRQSFTE--KFP-NVHPSAIDLVEKMLTFDPRQRIT 219
            P      F +EN       +    R+   E  +FP      A DL+  +L+ DP +R+ 
Sbjct: 190 LPP-----FYDEN-------VNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237

Query: 220 V---EDALAHPYLGSL 232
               ++   HP+   L
Sbjct: 238 YNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           D   H     N    EE   ++  +I  GL+ +H   +++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISD 145

Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            GLA    E + +   V T  Y APE ++ +  YT + D W +GC+  E+++ K  F  R
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKK-YICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
                                    E  K+  + +  +  ++ ++EKF     +A  +  
Sbjct: 205 ------------------------KEKVKREEVERRVKEDQEEYSEKFS---EAARSICR 237

Query: 208 KMLTFDPRQRI-----TVEDALAHPYLGSL 232
           ++LT DP  R+       E+  AHP+  + 
Sbjct: 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.0 bits (195), Expect = 3e-17
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 29/189 (15%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 100
           ++EE        +L+ L ++H+  V+HRD+K  ++LL ++  +K+ DFG  A+V+ E   
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171

Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
               V T ++ APE +++   Y   +D+WS+G + +E++D +P +     +  ++ + + 
Sbjct: 172 RKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230

Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
                                 LP   +         V P     +++ML  DP QR T 
Sbjct: 231 ----------------------LPPKLKNLH-----KVSPRLRSFLDRMLVRDPAQRATA 263

Query: 221 EDALAHPYL 229
            + L HP+L
Sbjct: 264 AELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (196), Expect = 3e-17
 Identities = 32/98 (32%), Positives = 62/98 (63%), Gaps = 1/98 (1%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDF 100
            SE+  ++++ +++  L+++H  ++++RDLKP N+LL+A   + +CDFGL++   ++   
Sbjct: 93  FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152

Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
              +  T  Y APE+LL+   YT  +D WS+G +  E+
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.5 bits (193), Expect = 3e-17
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 35/216 (16%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
             ++I  E  D  DL + I   + +  SE+    +  QI  GLK+IH   +LHRD+K  N
Sbjct: 72  GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQN 131

Query: 76  LLLNANCDL-KICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           + L+ N  + K+ DFG+AR  +++ +     V T +Y +PE+  N   Y    D+WS+GC
Sbjct: 132 IFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGC 190

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  EL   K  F G +++HQL L                       ICQ        F  
Sbjct: 191 VLYELCTLKHPFEG-NNLHQLVL----------------------KICQ------GYFAP 221

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             PN       L+ ++    PR R ++   L  P+L
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.9 bits (194), Expect = 4e-17
 Identities = 57/228 (25%), Positives = 109/228 (47%), Gaps = 33/228 (14%)

Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 92  DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151

Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
            ++  +K+ DFG  A+V+ E       V T ++ APE++ +   Y   +D+WS+G + +E
Sbjct: 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIE 210

Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P +     +  +R + +                       LP   + S   K  +
Sbjct: 211 MIDGEPPYFNEPPLQAMRRIRD----------------------NLPPRVKDS--HKVSS 246

Query: 198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 245
           V    +DL   ML  +P QR T ++ L HP+L     ++  P C+ P 
Sbjct: 247 VLRGFLDL---MLVREPSQRATAQELLQHPFL----KLAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 78.0 bits (193), Expect = 5e-17
 Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 22/136 (16%)

Query: 21  VYIAYELMD-TDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
           +Y+  E M+  DL   +R +           LS +    F  QI +G++Y+ S   +HRD
Sbjct: 71  LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130

Query: 71  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYT 123
           L   N L+  +  +KI DFGL+R   + D+   Y          RW  APE  L    +T
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWM-APE-SLKDGIFT 185

Query: 124 AAIDVWSVGCIFMELM 139
           +  DVWS G +  E+ 
Sbjct: 186 SKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 7e-17
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 43/223 (19%)

Query: 19  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNL 76
           N++ +  E MD   L +I +    +  E        ++ GL Y+++ + ++HRD+KPSN+
Sbjct: 76  NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI 135

Query: 77  LLNANCDLKICDFGLA--RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           L+N+   +K+CDFG++   + S  D    +V T  Y +PE  +    YT   DVWS+G  
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSIAD---TFVGTSTYMSPE-RIQGGKYTVKSDVWSLGIS 191

Query: 135 FMELMDRKPLFP---------GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            +EL   K  FP         G+D    +  L++ I          + E   +    LP 
Sbjct: 192 IIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQI----------VQEPPPR----LP- 234

Query: 186 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
                 +  FP       D V+  L  DP +R T +   A P 
Sbjct: 235 ------SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.4 bits (190), Expect = 1e-16
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 31/189 (16%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E +    L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
              +V T ++ APE++  S+ Y    D+WS+G   +EL   +P  P  D +H +R+L   
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-- 211

Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
                      + +N+       P  + Q +++ F        + VE  L  DPR R T 
Sbjct: 212 ----------LIPKNSP------PTLEGQ-YSKPFK-------EFVEACLNKDPRFRPTA 247

Query: 221 EDALAHPYL 229
           ++ L H ++
Sbjct: 248 KELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 1e-16
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 34  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 93
            I+     L E     +  QIL G+ Y+H+  V+HRD+K +N++L  N  +K+ DFG AR
Sbjct: 91  SILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Query: 94  V-------TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 146
                    + ++ +     T ++ APE ++N S Y    D+WS+GC   E+   KP   
Sbjct: 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLA 209

Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 206
             D +  +                F     +  + +LP     SF+        +AID V
Sbjct: 210 SMDRLAAM----------------FYIGAHRGLMPRLP----DSFSA-------AAIDFV 242

Query: 207 EKMLTFDPRQRITVEDALAHPYL 229
              LT D  +R +    L H +L
Sbjct: 243 TSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.2 bits (190), Expect = 1e-16
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)

Query: 21  VYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           +YI  +L++   L +   S     Q  +EE       Q++  L+Y+H    ++HRDL P+
Sbjct: 84  LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N++L  +  + I DFGLA+       +T  V T  Y  PE++ N   Y    DVW+ GCI
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCI 202

Query: 135 FMELMDRKPLF 145
             ++   +P F
Sbjct: 203 LYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 16  ESFNDVYIAYELMDT-DLH-QIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           E+ +D+ +   LM+  DL   I    +    E    ++  QI+ GL+++H   +++RDLK
Sbjct: 63  ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           P N+LL+ + +++I D GLA        +     T  Y APE+L     Y  ++D +++G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALG 181

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           C   E++  +   P R                 E       E  K+   ++       F+
Sbjct: 182 CTLYEMIAGRS--PFRQR-----------KEKVE------KEELKRRTLEMAVEYPDKFS 222

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL 232
                  P A DL E +L  DP +R+     + ++   HP    L
Sbjct: 223 -------PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 31/191 (16%)

Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSET 98
           + L E     +  QI   L+Y+H  ++LHRDLK  N+ L     +K+ D G+ARV  ++ 
Sbjct: 97  KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156

Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
           D  +  + T +Y +PEL  N   Y    DVW++GC   E+   K  F  +D    +  +I
Sbjct: 157 DMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII 215

Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           E          G L    K Y  +L                    +L+  ML+  P +R 
Sbjct: 216 E----------GKLPPMPKDYSPEL-------------------GELIATMLSKRPEKRP 246

Query: 219 TVEDALAHPYL 229
           +V+  L  PY+
Sbjct: 247 SVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 28/200 (14%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L  I      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N D+K+ DFG+
Sbjct: 93  LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGV 152

Query: 92  -ARVTSETDFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            A++T+       ++ T ++ APE+  +  +  Y    D+W+VG   +EL + +P  P  
Sbjct: 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
           D +H +R L             FL     K   Q P+ + +  T+     H    + V+ 
Sbjct: 211 D-LHPMRAL-------------FL---MSKSNFQPPKLKDK--TKWSSTFH----NFVKI 247

Query: 209 MLTFDPRQRITVEDALAHPY 228
            LT +P++R T E  L H +
Sbjct: 248 SLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.3 bits (187), Expect = 3e-16
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 34/205 (16%)

Query: 30  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           TDL +  + N  L EE   Y   +ILRGL ++H   V+HRD+K  N+LL  N ++K+ DF
Sbjct: 97  TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155

Query: 90  GL-ARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPL 144
           G+ A++         ++ T ++ APE++    +    Y    D+WS+G   +E+ +  P 
Sbjct: 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
            P  D +H +R L  +   P+                  PR + + +++KF +       
Sbjct: 215 -PLCD-MHPMRALFLIPRNPA------------------PRLKSKKWSKKFQS------- 247

Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            +E  L  +  QR T E  + HP++
Sbjct: 248 FIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 20  DVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLL 77
           DV+I  ELM T L ++  R    + E+        I++ L Y+     V+HRD+KPSN+L
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL 147

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCI 134
           L+A+ ++K+CDFG++    ++   T       Y APE +     +  Y    DVWS+G  
Sbjct: 148 LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
            +EL      FP ++   +  +L ++           L E        LP    + F+  
Sbjct: 208 LVELA--TGQFPYKNCKTEFEVLTKI-----------LQEEPPS----LP--PNEGFSPD 248

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           F          V+  LT D R+R    + L HP++
Sbjct: 249 F-------CSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 3e-16
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 8/138 (5%)

Query: 15  RESFNDVYIAYELMD----TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLH 68
           +ESF +    Y +MD     DL++ I + +     E+    +  QI   LK++H   +LH
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124

Query: 69  RDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           RD+K  N+ L  +  +K+ DFG+ARV + T +     + T +Y +PE+  N   Y    D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSD 183

Query: 128 VWSVGCIFMELMDRKPLF 145
           +W++GC+  E+   K  F
Sbjct: 184 IWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 76.6 bits (188), Expect = 3e-16
 Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 13/192 (6%)

Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSE 97
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  ++  
Sbjct: 90  RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 98  TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL- 156
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH     L 
Sbjct: 150 AT-MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Query: 157 LIELIGTP----SEAE---LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
           L+E I  P     EA+    G L ++ K+ +   P   ++    +F     +  D+V+K 
Sbjct: 208 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL-SINWQDVVQKK 266

Query: 210 LTFDPRQRITVE 221
           L    + ++T E
Sbjct: 267 LLPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.5 bits (186), Expect = 5e-16
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 21  VYIAYELMDT-DLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           VYI  ELM+   L   +RS   Q L          Q+  G+ Y+   N +HRDL   N+L
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136

Query: 78  LNANCDLKICDFGLARVTSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           +  +   K+ DFGLAR+  E  +++    +  +W  APE   +   ++   DVWS G + 
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILL 194

Query: 136 MELMDRKPL-FPGRDHVHQLRLLIELIGTPSEAE 168
            E+     + +PG ++      +      P  A+
Sbjct: 195 YEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK 228

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 34/205 (16%)

Query: 30  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           TDL +  + N AL E+   Y   +ILRGL ++H+  V+HRD+K  N+LL  N ++K+ DF
Sbjct: 107 TDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165

Query: 90  GL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPL 144
           G+ A++         ++ T ++ APE++       + Y    D+WS+G   +E+ +  P 
Sbjct: 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP- 224

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
            P  D +H +R L  +   P                   P+ + + +++KF       ID
Sbjct: 225 -PLCD-MHPMRALFLIPRNPP------------------PKLKSKKWSKKF-------ID 257

Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            +E  L  +   R + E  L HP++
Sbjct: 258 FIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 1e-15
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 34/217 (15%)

Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 98
           N    E    ++  QI+ GL+++H   +++RDLKP N+LL+ + +++I D GLA    + 
Sbjct: 91  NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150

Query: 99  DFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
              T+ Y  T  + APELL    +Y  ++D +++G    E++  +  F  R         
Sbjct: 151 QSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRAR--------- 200

Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
               G   E      N+  K+ I         ++ +KF    P++    E +L  DP +R
Sbjct: 201 ----GEKVE------NKELKQRILNDS----VTYPDKFS---PASKSFCEALLAKDPEKR 243

Query: 218 ITVEDA-----LAHPYLGSLH-DISDEPVCMSPFSFD 248
           +   D        HP    L+    +  +   PF  D
Sbjct: 244 LGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 42/102 (41%), Positives = 63/102 (61%), Gaps = 6/102 (5%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYR 111
           QIL G+ Y+H  +++HRD+KPSNLL+N+  ++KI DFG++R+ ++T D     V T  Y 
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 235

Query: 112 APELL---LNSSDYTA-AIDVWSVGCIFMEL-MDRKPLFPGR 148
           +PE +   LN   Y   A D+WS+G   +E  + R P   GR
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 44/130 (33%), Positives = 76/130 (58%), Gaps = 5/130 (3%)

Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNLL 77
           ++ I  E MD   L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           +N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 138 L-MDRKPLFP 146
           L + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 57/181 (31%), Positives = 85/181 (46%), Gaps = 40/181 (22%)

Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMT 102
           E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     +KI DFG ++  +  +  T
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 103 E-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
           E +  T  Y APE++      Y A  D+WS+GC  +E+   KP F            IEL
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------------IEL 214

Query: 161 IGTPSEA--ELGF----------LNENAKKYI--CQLPRYQRQSFTEKFPNVHPSAIDLV 206
            G P  A  ++G           L+  AK +I  C  P           P+   SA DL+
Sbjct: 215 -GEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD----------PDKRASAHDLL 263

Query: 207 E 207
           +
Sbjct: 264 Q 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 73.3 bits (180), Expect = 5e-15
 Identities = 38/96 (39%), Positives = 57/96 (59%), Gaps = 6/96 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 112
             L+GL Y+HS   +HRD+K  N+LL     +K+ DFG A + S  +    +V T ++ A
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMA 179

Query: 113 PELLL--NSSDYTAAIDVWSVGCIFMELMDRK-PLF 145
           PE++L  +   Y   +DVWS+G   +EL +RK PLF
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 37/91 (40%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 55  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L+GL Y+HS N++HRD+K  N+LL     +K+ DFG A  +S  +    +V T ++ APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPE 187

Query: 115 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 143
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 6e-15
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 28/200 (14%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L  I      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N  +K+ DFG+
Sbjct: 93  LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152

Query: 92  -ARVTSETDFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            A++T+       ++ T ++ APE+  +     Y    D+W+VG   +EL + +P  P  
Sbjct: 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
           D +H +R L   + T S  +   L +  K             ++  F +        V+ 
Sbjct: 211 D-LHPMRAL--FLMTKSNFQPPKLKDKMK-------------WSNSFHH-------FVKM 247

Query: 209 MLTFDPRQRITVEDALAHPY 228
            LT +P++R T E  L HP+
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 8e-15
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 44/229 (19%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNAN------------- 81
           I  +   S  H    ++Q    L Y H+  +++H DLKP N+L+  +             
Sbjct: 222 IMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281

Query: 82  ---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
              C ++ICD G      E    T  V TR YR+PE++L    +  + D+WS+GCI  EL
Sbjct: 282 PDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYEL 338

Query: 139 MDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAK---------------KYICQ 182
              K L+   D++  L L+ + +G  PSE       E A+               K++ +
Sbjct: 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398

Query: 183 LPRYQ--RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           + R +  R+   +          DL+  +L +D ++R+       HPY+
Sbjct: 399 IARARPVREVIRDDL------LCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.0 bits (179), Expect = 8e-15
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 27/195 (13%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYR 111
           QIL GL+Y+H+  ++HRD+K  N+ +N    + I D G A+       F+     T    
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETN 223

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELM----------DRKPLFPGRD-HVHQLRLLIEL 160
           APE+L     Y +  D+WS G +  E++             P    +  H H L+++  L
Sbjct: 224 APEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282

Query: 161 IGTPSEAELGFLNENAKKYICQLPRY---QRQSFTEKFP-----NVHPSAIDLVEKMLTF 212
              P E    F  +   + +     Y   +RQ +T ++P     N+      LV KMLTF
Sbjct: 283 KVHPEE----FPRDPGSRLVRGFIEYASLERQPYT-RYPCFQRVNLPIDGEFLVHKMLTF 337

Query: 213 DPRQRITVEDALAHP 227
           D   R + E+ L +P
Sbjct: 338 DAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.8 bits (178), Expect = 9e-15
 Identities = 39/120 (32%), Positives = 68/120 (56%), Gaps = 2/120 (1%)

Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSET 98
           +  SE+  +++  +I+  L Y+HS  +++RDLK  NL+L+ +  +KI DFGL +   ++ 
Sbjct: 90  RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149

Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH     L++
Sbjct: 150 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.4 bits (177), Expect = 9e-15
 Identities = 37/91 (40%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 55  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L+GL Y+HS N++HRD+K  N+LL     +K+ DFG A + S  +    +V T ++ APE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPE 191

Query: 115 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 143
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 51/198 (25%)

Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 103
           E+   ++L +I   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 104 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 162
            +  T  Y APE+L+ S  +  A+D WS+G +  ++                     L G
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDM---------------------LTG 196

Query: 163 TPSEAELGFLNENAKKYI-------CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 215
            P      F  EN KK I         LP Y           + P A DL++K+L  +P 
Sbjct: 197 APP-----FTAENRKKTIDKILKGKLNLPPY-----------LTPEARDLLKKLLKRNPS 240

Query: 216 QRI--TVEDAL---AHPY 228
            R+     DA    +HP+
Sbjct: 241 SRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 10/137 (7%)

Query: 35  IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-AR 93
           ++   Q L E    Y LY  L GL+++H+  ++HRD+K +N+LL     +K+ DFG+ A+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 94  VTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR 148
           +TS        V T ++ APE++         Y A  DVWS+G   +EL D   PLF   
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--- 234

Query: 149 DHVHQLRLLIELIGTPS 165
             +H ++ L ++   P 
Sbjct: 235 -DMHPVKTLFKIPRNPP 250

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 29/178 (16%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 111
           + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP------- 233

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                     +L   ++ S             D + + L  D  +R + ++ L HP+L
Sbjct: 234 ----------ELQNPEKLS---------AIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)

Query: 17  SF---NDVYIAYELMDT-DLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           SF   +++++    +    L  I++S      L E      L ++L+GL+Y+HS   +HR
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126

Query: 70  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-----YVVTRWYRAPELLLNSSDYTA 124
           D+K  N+LL  +  +KI DFG++   ++    T      +V T  + APE++     Y  
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186

Query: 125 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 184
             D+WS G   +EL       P   +     L++ L   P   E      + KKY     
Sbjct: 187 KADIWSFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPPSLE---TGADYKKY----- 236

Query: 185 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
               +SF             ++   L  DP +R T E+ L H +
Sbjct: 237 ---SKSFR-----------KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 13/147 (8%)

Query: 20  DVYIAYELMDTDL-------HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDL 71
           D +I  ELMD  L       +++++S   + EE         ++ L Y+     ++HRD+
Sbjct: 77  DCWICMELMDISLDKFYKYVYEVLKSV--IPEEILGKIAVATVKALNYLKEELKIIHRDV 134

Query: 72  KPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVW 129
           KPSN+LL+ N ++K+CDFG++    ++   T     R Y APE +  S+   Y    DVW
Sbjct: 135 KPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194

Query: 130 SVGCIFMELMDRKPLFPGRDHV-HQLR 155
           S+G    E+   K  +P  + V  QL 
Sbjct: 195 SLGITLYEVATGKFPYPKWNSVFDQLT 221

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 43/130 (33%), Positives = 74/130 (56%), Gaps = 12/130 (9%)

Query: 26  ELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 84
           +LM+  DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  +
Sbjct: 77  DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136

Query: 85  KICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
           +I D GLA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+ 
Sbjct: 137 RISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL- 190

Query: 141 RKPLFPGRDH 150
            +   P R H
Sbjct: 191 -RGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY--- 110
           +LR ++Y+H   ++HRD+K  N+ +N   D+ + DFG A       F  +    ++Y   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWA 244

Query: 111 -----RAPELLLNSSDYTAAIDVWSVGCIFME-------LMDRKPLFPGRDHVHQLRLLI 158
                 APELL     Y  A+D+WS G +  E       L ++  L    D   Q++L+I
Sbjct: 245 GTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303

Query: 159 ELIGT-PSEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAID---LVEKMLTFD 213
              GT P+E  +       + YI    +  R+  +   + N++   ID   L+ KML FD
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363

Query: 214 PRQRITVEDALAHPYLGSLHDISDEPV 240
              R + E  L       + D    P+
Sbjct: 364 AHHRPSAEALLDFAAFQDIPDPYPNPM 390

Length = 391

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 37/113 (32%), Positives = 68/113 (60%), Gaps = 3/113 (2%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 111
           + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 164
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 44/227 (19%)

Query: 19  NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           N++ I  EL D  DL Q+I    +  + + E     +  Q+   ++++HS  V+HRD+KP
Sbjct: 75  NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP 134

Query: 74  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 193

Query: 133 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           C+  E+   + P +  + ++  L   IE                     C  P    + +
Sbjct: 194 CLLYEMAALQSPFYGDKMNLFSLCQKIEQ--------------------CDYPPLPTEHY 233

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           +EK         +LV   +  DP QR         P +G +H I+ +
Sbjct: 234 SEKLR-------ELVSMCIYPDPDQR---------PDIGYVHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 3e-14
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 53/230 (23%)

Query: 21  VYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN 75
           VY+  E MD      L+    + + + E+  +   Y +++GLK++    N++HRD+KP+N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 76  LLLNANCDLKICDFG----LARVTSETDFMTEYVVTRWYRAPELL--LNSSD---YTAAI 126
           +L+N N  +K+CDFG    L    ++T+     +  + Y APE +     +    YT   
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 127 DVWSVGCIFMEL-MDRKPLFPGRDHVH---QLRLLIELIGTPSEAELGFLNENAKKYICQ 182
           DVWS+G   +E+ + R P +P   + +   QL  +++  G P                  
Sbjct: 189 DVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDPP----------------T 229

Query: 183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
           LP                 A D V K L   P +R T    L HP+L   
Sbjct: 230 LP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 36/91 (39%), Positives = 58/91 (63%), Gaps = 5/91 (5%)

Query: 55  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  +    +V T ++ APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPE 181

Query: 115 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 143
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 33/182 (18%)

Query: 39  NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARV-TS 96
            +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    
Sbjct: 89  ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148

Query: 97  ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 156
           +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      
Sbjct: 149 DGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EK 203

Query: 157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 216
           L ELI          L E  +      PR            + P A  L+  +L  DP+Q
Sbjct: 204 LFELI----------LMEEIR-----FPR-----------TLSPEAKSLLSGLLKKDPKQ 237

Query: 217 RI 218
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 4e-14
 Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 21/194 (10%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157

Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +   P    +H +++L  +
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI 213

Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
                    G  ++  K+++        ++   K P+  P+A +L+        + +  V
Sbjct: 214 PKNNPPTLEGNYSKPLKEFV--------EACLNKEPSFRPTAKELL--------KHKFIV 257

Query: 221 EDALAHPYLGSLHD 234
             A    YL  L D
Sbjct: 258 RFAKKTSYLTELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 20/231 (8%)

Query: 17  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 74  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 191

Query: 135 FMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-------------FLNENAKKYI 180
            +E+ + R P+ P      +L     + G P+E+E                 +      I
Sbjct: 192 LVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAI 251

Query: 181 CQLPRYQRQSFTEKFPNVHPSA--IDLVEKMLTFDPRQRITVEDALAHPYL 229
            +L  Y       K P+    A   D V K L  +P +R  ++  + H ++
Sbjct: 252 FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.0 bits (171), Expect = 5e-14
 Identities = 38/113 (33%), Positives = 68/113 (60%), Gaps = 9/113 (7%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DLH  +  +   SE+  +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 91  LARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA      DF  +     V T  Y APE+L   + Y ++ D +S+GC+  +L+
Sbjct: 143 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 7/135 (5%)

Query: 19  NDVYIAYELMDT-DLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           N++ I  EL D  DL ++I+      + + E+    +  Q+   L+++HS  V+HRD+KP
Sbjct: 75  NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP 134

Query: 74  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 193

Query: 133 CIFMELMDRKPLFPG 147
           C+  E+   +  F G
Sbjct: 194 CLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.0 bits (171), Expect = 6e-14
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 35/207 (16%)

Query: 30  TDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           TDL +  ++  + + E    Y L++ L GL+++H    +HRD+K +N+LL     +K+ D
Sbjct: 108 TDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167

Query: 89  FGL-ARVTSETDFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGCIFMELMDRK 142
           FG+ A++TS        V T ++ APE++     L+S+ Y A  DVWS+G   +EL D  
Sbjct: 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGD 226

Query: 143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA 202
           P  P  D +H +R L ++   P                   P      F           
Sbjct: 227 P--PLAD-LHPMRALFKIPRNPPPT-------------LHQPELWSNEFN---------- 260

Query: 203 IDLVEKMLTFDPRQRITVEDALAHPYL 229
            D + K LT D  +R TV D L H ++
Sbjct: 261 -DFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 6e-14
 Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 38/227 (16%)

Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           D   H     N    E+   ++  ++  GL+ +    +++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISD 145

Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            GLA    E + +   V T  Y APE++ N   YT + D W +GC+  E++  +   P R
Sbjct: 146 LGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQS--PFR 202

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
               +++                  E   + + +     ++ ++EKF      A  +   
Sbjct: 203 KRKERVK-----------------REEVDRRVKE----DQEEYSEKFSE---DAKSICRM 238

Query: 209 MLTFDPRQRITVEDALA-----HPYLGSLH------DISDEPVCMSP 244
           +LT +P++R+      A     HP   +++      ++ + P C  P
Sbjct: 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 69.7 bits (171), Expect = 8e-14
 Identities = 36/125 (28%), Positives = 65/125 (52%), Gaps = 12/125 (9%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+ +    E   +++  +I+ GL+++H   +++RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 91  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           + +     + +   V T        Y APE+L     Y  A+D W++G +  E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 145 FPGRD 149
           F G D
Sbjct: 196 FEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.8 bits (170), Expect = 8e-14
 Identities = 49/178 (27%), Positives = 91/178 (51%), Gaps = 29/178 (16%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 111
           + L+ L+++H+  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP   EL  
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP---EL-- 235

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +N +K                   + P   D + + L  D  +R + ++ L HP+L
Sbjct: 236 --QNPEK-------------------LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+S+    E   +++  +I+ GL+++H   +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 91  LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +     +     +  T  Y APE+L     Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 150 HVHQLRLLIELIGTPSEAEL--GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
                           E EL    LN+         PR+           +   A D + 
Sbjct: 201 ----------------EDELFDSILNDRP-----HFPRW-----------ISKEAKDCLS 228

Query: 208 KMLTFDPRQRITVE-DALAHPY 228
           K+   DP +R+ V+ D   HP+
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 1e-13
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 29/178 (16%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 111
           + L+ L ++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP------- 233

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                     +L   +R S   +         D + + L  D  +R + ++ L HP+L
Sbjct: 234 ----------ELQNPERLSAVFR---------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 47/181 (25%), Positives = 88/181 (48%), Gaps = 28/181 (15%)

Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSE 97
           ++ L+E   Q    Q+L  L+Y+HS  ++HRDLK  N+LL  + D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 98  TDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 220

Query: 154 LRLLIEL-------IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 206
           +R+L+++       +  PS+  + F  +  K  +            +K P   PSA  L+
Sbjct: 221 MRVLLKIAKSEPPTLSQPSKWSMEF-RDFLKTAL------------DKHPETRPSAAQLL 267

Query: 207 E 207
           E
Sbjct: 268 E 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 42/206 (20%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I ++   SE    ++   ++ GL+Y+H   +++RDLK  NLLL+    +KI DFG
Sbjct: 88  DLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146

Query: 91  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           L +      D  + +  T  + APE+L  +S YT A+D W +G +  E++  +  FPG D
Sbjct: 147 LCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Query: 150 HVHQLRLLIELIGTPSEAEL--GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
                           E E+    +N+          RY R    E        AI ++ 
Sbjct: 206 ----------------EEEVFDSIVNDE--------VRYPRFLSRE--------AISIMR 233

Query: 208 KMLTFDPRQRI-----TVEDALAHPY 228
           ++L  +P +R+       ED    P+
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 54/261 (20%), Positives = 98/261 (37%), Gaps = 80/261 (30%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     D+  ++      +EE  ++++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128

Query: 73  PSNLLLNANCDLKICDFGL-----------------------ARVTSETDFMTEYVVTRW 109
           P NLLL+A   +K+ DFGL                                 ++     W
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188

Query: 110 ----------------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
                           Y APE+ L +  Y    D WS+G I  E+               
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEM--------------- 232

Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP---NVHPSAIDLVEKML 210
                 L+G P      F ++N ++   +     ++  T +FP    + P A DL++++ 
Sbjct: 233 ------LVGYPP-----FCSDNPQE-TYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLC 278

Query: 211 TFDPRQRI---TVEDALAHPY 228
             +  +R+    V +  +HP+
Sbjct: 279 C-EAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 29/171 (16%)

Query: 1   MQVVAIRDIIPPPQRE----------------------SFNDVYIAYELMD----TDLHQ 34
           ++V+AI ++I   Q +                      + +D    Y LM+     +L  
Sbjct: 31  LKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS 90

Query: 35  IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 94
            +R++   S     ++  +I+  L+Y+HS  +++RDLKP N+LL+    +K+ DFG A+ 
Sbjct: 91  YLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150

Query: 95  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
               D       T  Y APE ++ S  +  A+D W++G +  E++   P F
Sbjct: 151 LR--DRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 35/112 (31%), Positives = 65/112 (58%), Gaps = 5/112 (4%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 93
           ++S  AL+E   + +  QIL G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Query: 94  --VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
             +      M     T ++ +PE +++   Y    D+WSVGC  +E++  KP
Sbjct: 157 QTICLSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 9/143 (6%)

Query: 1   MQVVAIRDIIPPPQRESF-NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 59
              V   DI        +   +  A E    D   +I  + ALS      F YQ+  G++
Sbjct: 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDT--LINESPALSYMDLVGFSYQVANGME 253

Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPEL 115
           ++ S N +HRDL   N+L+     +KICDFGLAR +  +++++++   ++  +W  APE 
Sbjct: 254 FLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APES 312

Query: 116 LLNSSDYTAAIDVWSVGCIFMEL 138
           + N+  YT   DVWS G +  E+
Sbjct: 313 IFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 6/104 (5%)

Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + L+++    F YQ+ RG++++ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 100 FMTEYVVTR----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  +    R    W  APE L +   YT   DVWS G +  E+ 
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (164), Expect = 4e-13
 Identities = 35/113 (30%), Positives = 68/113 (60%), Gaps = 7/113 (6%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           +++  AL+E   + +  QIL+G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156

Query: 96  SETDFMTEYVV-----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
            +T  M+   +     T ++ +PE +++   Y    DVWSV C  +E++  KP
Sbjct: 157 -QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 45/119 (37%), Positives = 61/119 (51%), Gaps = 18/119 (15%)

Query: 31  DLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           DL   +R  +   L+ E    F YQ+ +G+ ++ S N +HRDL   N+LL     +KICD
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184

Query: 89  FGLARVTSETDFMTE--YVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           FGLAR     D M +  YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 185 FGLAR-----DIMNDSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.4 bits (164), Expect = 4e-13
 Identities = 34/112 (30%), Positives = 64/112 (57%), Gaps = 5/112 (4%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG----L 91
           +++  AL+E   + +  QIL G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG    L
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Query: 92  ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
             +      +     T ++ +PE +++   Y    DVWS+GC  +E++  KP
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 36/120 (30%), Positives = 67/120 (55%), Gaps = 3/120 (2%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV- 94
           ++  ++  E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +  
Sbjct: 87  LQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 95  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 154
            +++D  T +  T  Y APE ++    Y   +D W +G +  E++   P F  RD V ++
Sbjct: 147 IAQSDTTTTFCGTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 42/131 (32%), Positives = 72/131 (54%), Gaps = 13/131 (9%)

Query: 12  PPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           P   +  ND  +   L+  D  + + +   LS      F YQ+ RG++++ S N +HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263

Query: 72  KPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAID 127
              N+LL     +KICDFGLAR +  +++++++   ++  +W  APE + ++  YT   D
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFDNL-YTTLSD 321

Query: 128 VWSVGCIFMEL 138
           VWS G +  E+
Sbjct: 322 VWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.6 bits (162), Expect = 8e-13
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 86  DLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISD 145

Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++  +  F  R
Sbjct: 146 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQR 204

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
                                    +  ++ + +L +  ++ ++EKF    P A  L + 
Sbjct: 205 K-----------------------KKIKREEVERLVKEVQEEYSEKFS---PDARSLCKM 238

Query: 209 MLTFDPRQRI-----TVEDALAHPYLGSLH 233
           +L  DP++R+        +   HP    ++
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.5 bits (162), Expect = 9e-13
 Identities = 47/133 (35%), Positives = 67/133 (50%), Gaps = 17/133 (12%)

Query: 18  FNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRG----LKYIHSANVLHRDLK 72
           F    I  E M+   L + +R +     E   Y L  +LRG    +KY+   N +HRDL 
Sbjct: 78  FKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA 134

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAI 126
             N+L+N+N + K+ DFGL+RV  E D    Y  +      RW  APE  +    +T+A 
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRW-TAPE-AIAYRKFTSAS 191

Query: 127 DVWSVGCIFMELM 139
           DVWS G +  E+M
Sbjct: 192 DVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.8 bits (163), Expect = 9e-13
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 19  NDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           N VY   E ++  +L   +R       +  +++  +++   +Y+HS ++++RDLKP NLL
Sbjct: 91  NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           L+    +K+ DFG A+   +  F      T  Y APE ++ S  +  A+D W++G +  E
Sbjct: 151 LDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYE 207

Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKFP 196
                                 + G P      F ++   +       Y++  +   KFP
Sbjct: 208 F---------------------IAGYPP-----FFDDTPFRI------YEKILAGRLKFP 235

Query: 197 N-VHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
           N     A DLV+ +L  D  +R+      V D   HPY
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 67.2 bits (164), Expect = 9e-13
 Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 21/130 (16%)

Query: 17  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           S+ D  +  E+++ D         AL  E    F YQ+ +G+ ++ S N +HRDL   N+
Sbjct: 193 SYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245

Query: 77  LLNANCDLKICDFGLAR-VTSETDFMTEYVV-------TRWYRAPELLLNSSDYTAAIDV 128
           LL      KICDFGLAR + ++++    YVV        +W  APE + N   YT   DV
Sbjct: 246 LLTHGRITKICDFGLARDIRNDSN----YVVKGNARLPVKWM-APESIFNCV-YTFESDV 299

Query: 129 WSVGCIFMEL 138
           WS G +  E+
Sbjct: 300 WSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 9e-13
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 2/109 (1%)

Query: 43  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFM 101
            E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +   
Sbjct: 94  PEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153

Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           + +  T  Y APE+L     Y   +D W +G +  E++   P F  RD 
Sbjct: 154 STFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 9e-13
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 21  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   ++S   + L          QI  G+ Y+ S N +HRDL   N+L
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCI 134
           +  N   KI DFGLAR+  E D  T     ++   + APE   N   +T   DVWS G +
Sbjct: 136 VGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKSDVWSFGIL 193

Query: 135 FMELMD--RKPLFPG---RDHVHQL 154
             E++   R P +PG   R+ + Q+
Sbjct: 194 LTEIVTYGRVP-YPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 41/145 (28%), Positives = 79/145 (54%), Gaps = 12/145 (8%)

Query: 43  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 102
           +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155

Query: 103 -EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
             +  T  Y APE ++N   +T + D WS G +  E++     F G+D    + +++   
Sbjct: 156 YSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--- 211

Query: 162 GTPSEAELG---FLNENAKKYICQL 183
               +A+LG   FL+  A+  +  L
Sbjct: 212 ----KAKLGMPQFLSPEAQSLLRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 41/138 (29%), Positives = 75/138 (54%), Gaps = 7/138 (5%)

Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           ++  QI  G+ ++HS ++++RD+KP N+LL+   + ++ D GLA    +   +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 168
            Y APE+L     Y+  +D +++GC   E++  +   P +DH  ++    EL     E E
Sbjct: 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVAKE-ELKRRTLEDE 214

Query: 169 LGFLNEN---AKKYICQL 183
           + F ++N     K IC+L
Sbjct: 215 VKFEHQNFTEESKDICRL 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGLA+V  E     +Y   + 
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKE 170

Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 141
                  WY APE  L +S +++A DVWS G    EL   
Sbjct: 171 PGESPIFWY-APE-CLRTSKFSSASDVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.9 bits (160), Expect = 2e-12
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 91  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 196

Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
                    +++G+    +     +N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 197 ---------DIVGSSDNPD-----QNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 239

Query: 210 LTFDPRQRITV------EDALAHPYLGSLH-DISDEPVCMSPF 245
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPF 282

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 5/109 (4%)

Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSET 98
           + L+E   +    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T   
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 99  DFMTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKP 143
                ++ T ++ APE+++   S D  Y    DVWS+G   +E+   +P
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 72/230 (31%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--- 92
           IR +    EE  ++++ +++  L  +H    +HRD+KP N+L++A+  +K+ DFGL    
Sbjct: 93  IRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151

Query: 93  ---------RVTSETDFMTEYVVTRW------------------YRAPELLLNSSDYTAA 125
                       S      + V+ R                   Y APE+L   + Y   
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLE 210

Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAELGFLNENAKKYICQ 182
            D WS+G I  E+                     L G P   S+     L E   K I  
Sbjct: 211 CDWWSLGVILYEM---------------------LYGFPPFYSDT----LQETYNKII-- 243

Query: 183 LPRYQRQSFTEKFP---NVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPY 228
                ++S    FP    V P AIDL+ ++L  DP  R+   E+  +HP+
Sbjct: 244 ---NWKESLR--FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 2/107 (1%)

Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 103
           E H  ++  +I  GL ++HS  +++RDLK  N++L+A   +KI DFG+ +        T 
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159

Query: 104 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +  T  Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 8/126 (6%)

Query: 31  DLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 86
           DL Q I+S    N+   E        Q+L  + ++HS +++HRD+K +N+LL +N  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 87  CDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
            DFG +++ + T   D    +  T +Y APE +     Y+   D++S+G +  EL+  K 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKR 243

Query: 144 LFPGRD 149
            F G +
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134

Query: 78  LNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 192

Query: 135 FMELMD--RKPLFPGRDHVHQLRLL 157
            ME++   R P +PG  +   +R L
Sbjct: 193 LMEIVTYGRIP-YPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 4e-12
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 12/127 (9%)

Query: 21  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V I  E M+   L + +R N    +       L  I  G+KY+   N +HRDL   N+L+
Sbjct: 80  VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV 139

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           N+N   K+ DFGL+R   +++    Y         RW  APE  +    +T+A DVWS G
Sbjct: 140 NSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIRW-TAPE-AIAYRKFTSASDVWSFG 195

Query: 133 CIFMELM 139
            +  E+M
Sbjct: 196 IVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ E    + +Q+ +G++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.2 bits (156), Expect = 7e-12
 Identities = 34/115 (29%), Positives = 61/115 (53%), Gaps = 2/115 (1%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           ++  +   E   +++  ++   + Y+HS N+++RDLKP N+LL++   + + DFGL +  
Sbjct: 87  LQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 96  SETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            E +  T  +  T  Y APE +L    Y   +D W +G +  E++   P F  RD
Sbjct: 147 VEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 8e-12
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 16/196 (8%)

Query: 17  SFND---VYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D   +Y+  E ++  +    +R N+    +   ++  QI+   +Y+ S N+++RDLK
Sbjct: 99  SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK 158

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           P NLLL+ +  +K+ DFG A+V     +      T  Y APE+LLN     AA D W++G
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLG 215

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
               E++   P F   + +   + ++E +I  P      FL+ N K  + +L  +     
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK-----FLDNNCKHLMKKLLSH---DL 267

Query: 192 TEKFPNVHPSAIDLVE 207
           T+++ N+   A ++ E
Sbjct: 268 TKRYGNLKKGAQNVKE 283

Length = 340

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 2/107 (1%)

Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 103
           E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T 
Sbjct: 95  EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154

Query: 104 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +  T  Y APE +L+   Y   +D W +G +  E++   P F  R+
Sbjct: 155 TFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VT 95
             +  +E   + ++ +I+  L ++H   +++RD+K  N+LL++   + + DFGL++  + 
Sbjct: 98  QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157

Query: 96  SETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 154
            E +    +  T  Y APE++   S  +  A+D WS+G +  EL+     F         
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----- 212

Query: 155 RLLIELIGTPSEAELGFLNENAKKYI-CQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTF 212
                     S++E+      +++ +  + P          FP  +   A D ++K+L  
Sbjct: 213 -------EQNSQSEI------SRRILKSKPP----------FPKTMSAEARDFIQKLLEK 249

Query: 213 DPRQRITVEDA---LAHPYLGSL 232
           DP++R+    A     HP+   +
Sbjct: 250 DPKKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 2/120 (1%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFG 141

Query: 91  LARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +     D  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 204 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   +  +  L  E       ++L  L Y+H   ++HRD+K  N+ L+   +  + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 91  LARVTSETDFMTE---YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFME-LMDRKPLF 145
            A          +   +  T    +PELL L+   Y A  D+WS G +  E  +    LF
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 146 PGRDHV--HQLRLLIELIGTPSEAELGF-LNENA------KKYICQL------PRYQRQS 190
             +      QLR +I  +       L F  N +       K+Y   L      P   R+ 
Sbjct: 289 GKQVKSSSSQLRSIIRCMQV---HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKY 345

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                  +H     L+ KMLTFD   R + +D L+ P
Sbjct: 346 ------GMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376

Length = 392

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 6/93 (6%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFM---TEYV 105
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             +W  APE + +   YT   DVWS G +  E+
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 34/116 (29%), Positives = 65/116 (56%), Gaps = 2/116 (1%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L ++H   +++RDLK  N+LL+A+  +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141

Query: 91  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           + +      D  + +  T  Y APE +L   +Y  ++D W++G +  E+M  +  F
Sbjct: 142 MCKEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 50/218 (22%), Positives = 98/218 (44%), Gaps = 37/218 (16%)

Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y++   M T L+Q        SE+  +++  +I+  L+++H   +++RD+K  N+LL++ 
Sbjct: 86  YVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE 141

Query: 82  CDLKICDFGLAR--VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
             + + DFGL++  ++ E +    +  T  Y APE++     +  A+D WS+G +  EL+
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
                F                    E E    +E +++ +   P +           + 
Sbjct: 202 TGASPF------------------TLEGERNTQSEVSRRILKCDPPFP--------SFIG 235

Query: 200 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL 232
           P A DL+ K+L  DP++R+        +   HP+   L
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 40/109 (36%), Positives = 57/109 (52%), Gaps = 19/109 (17%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE--YVV- 106
           F  Q+ +G+ ++ S N +HRD+   N+LL      KICDFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 107 ------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 147
                  +W  APE + +   YT   DVWS G +  E+  + + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 3e-11
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 6/103 (5%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGR 148
            +W  APE  +N   +T   DVWS G +  E++   K  +PG 
Sbjct: 168 IKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.8 bits (151), Expect = 3e-11
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 38/206 (18%)

Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKIC 87
           D DL  +++    LSE   +  + Q++  L  +H  N++H D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 88  DFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           D+GL ++    S  D   +Y       +PE  +   +Y  + D W+VG +  EL+  K  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
            P ++   +     EL                      L + Q++       NV  +A D
Sbjct: 204 HPFKEDEDE-----EL--DLES----------------LLKRQQKKLP-FIKNVSKNAND 239

Query: 205 LVEKMLTFDPRQR-ITVEDALAHPYL 229
            V+ ML ++   R     + + HP+L
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 6/108 (5%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
             + QALS +   +   QI  G+ Y+H   V+H+D+   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 96  SETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
              D+      E    +W  A E L+N  +Y++A DVWS G +  ELM
Sbjct: 168 FPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 34/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 91  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.0 bits (150), Expect = 4e-11
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
            + APE L +   YT   DVWS G +  E+       +PG
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 4e-11
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR   + D+  +    R   
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200

Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT--- 107
           L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y      
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGK 170

Query: 108 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
              RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 171 IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ E    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D+
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229

Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 230 VRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 28  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 87
           ++  + Q ++ +    E       YQI+  L  +HS  ++HRDLK +N+ L     +K+ 
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 88  DFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           DFG ++  S++   D  + +  T +Y APE L     Y+   D+WS+G I  EL+     
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRP 270

Query: 145 FPG 147
           F G
Sbjct: 271 FKG 273

Length = 478

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 7e-11
 Identities = 32/110 (29%), Positives = 62/110 (56%), Gaps = 5/110 (4%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ ++E++    ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWYAPE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 207 KWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 26/195 (13%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY--VVTRWY 110
           Q+L  ++YIH   ++HRD+K  N+ LN +  + + DFG A    +     +Y  V T   
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRK--PLFPGRDHVH-QLRLLIELIGTPSEA 167
            +PE+L     Y    D+WS G I ++++     P+  G      QL  +I+        
Sbjct: 335 NSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID-------- 385

Query: 168 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI-----------DLVEKMLTFDPRQ 216
            L   +E      C+L  Y   +  +   +  P  I            LV KMLTFD   
Sbjct: 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV-KMLTFDWHL 444

Query: 217 RITVEDALAHPYLGS 231
           R    + LA P   +
Sbjct: 445 RPGAAELLALPLFSA 459

Length = 501

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 13/151 (8%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++HS  +++RDLK  
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130

Query: 75  NLLLNANCDLKICDFGLAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 128
           N++L++   +KI DFG+ +      VT++T     +  T  Y APE ++    Y  ++D 
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKT-----FCGTPDYIAPE-IIAYQPYGKSVDW 184

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
           W+ G +  E++  +  F G D     + ++E
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 8/101 (7%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPGR 148
             APE  +N   +T   DVWS G +  E++   R P +PG 
Sbjct: 170 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)

Query: 47  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV 106
           C Y + QI  G++Y+ S   +HRDL   N+LL ++  +KI DFGL R   + +   ++ V
Sbjct: 100 CDYAV-QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYV 155

Query: 107 TRWYR-------APELLLNSSDYTAAIDVWSVGCIFMEL 138
              +        APE  L +  ++ A DVW  G    E+
Sbjct: 156 MEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 38/224 (16%)

Query: 19  NDVYIAYELM-DTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           +++Y+  E     DL  ++ R      E+  Q++L +++  +  +H    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 77  LLNANCDLKICDFG-LARVTSE-TDFMTEYVVTRWYRAPELL--LNSSD---YTAAIDVW 129
           L++    +K+ DFG  AR+T+         V T  Y APE+L  +N      Y    D W
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193

Query: 130 SVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           S+G I  E++  R P   G        ++                 N ++++        
Sbjct: 194 SLGVIAYEMIYGRSPFHEGTSAKTYNNIM-----------------NFQRFL-------- 228

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
             F E  P V    +DL++ +L    ++R+  E    HP+   +
Sbjct: 229 -KFPED-PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 15/104 (14%)

Query: 45  EHCQYFLY--QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 102
           +H +  LY  QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGL +V  +     
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---K 162

Query: 103 EYVVTR--------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           EY   R        WY APE  L  S ++ A DVWS G +  EL
Sbjct: 163 EYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 34/116 (29%), Positives = 61/116 (52%), Gaps = 2/116 (1%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+ ++   E   +++  ++   L ++H   V++RDLK  N+LL+A    K+ DFG
Sbjct: 82  DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG 141

Query: 91  LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           + +        T  +  T  Y APE +L   +Y  ++D W++G +  E+M  +P F
Sbjct: 142 MCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 43/192 (22%), Positives = 87/192 (45%), Gaps = 33/192 (17%)

Query: 30  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           T L Q  R      E+  Q +  +I+  L+++H   +++RD+K  N+LL++N  + + DF
Sbjct: 94  THLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149

Query: 90  GLAR--VTSETDFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRKPLFP 146
           GL++     E +    +  T  Y AP+++      +  A+D WS+G +  EL+     F 
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF- 208

Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 206
                              + E     E +++ +   P Y ++        +   A D++
Sbjct: 209 -----------------TVDGEKNSQAEISRRILKSEPPYPQE--------MSALAKDII 243

Query: 207 EKMLTFDPRQRI 218
           +++L  DP++R+
Sbjct: 244 QRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMTE 103
           L  I  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +       T  +  
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 104 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +  RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 172 KIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L + ++  + +     +   +Q+  G+ Y+ S + +HRDL   N+LL      KI DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 92  ARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 132
           +R          Y  T       +WY APE  +N   +++  DVWS G
Sbjct: 142 SRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 20/131 (15%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICD 88
           L +++ ++ AL        + Q+L  L   H+  ++HRDLKP N++++        K+ D
Sbjct: 66  LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125

Query: 89  FGL------------ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           FG+            A +T      TE + T  Y APE L      T   D+++ G IF+
Sbjct: 126 FGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFL 180

Query: 137 ELMDRKPLFPG 147
           E +  + +  G
Sbjct: 181 ECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 17/128 (13%)

Query: 21  VYIAYELMDTD-LHQIIRSNQALSE-----EHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++I  E M    L   +R  +         + C      +   ++Y+ S   +HRDL   
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEYLESNGFIHRDLAAR 129

Query: 75  NLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N L+  +  +K+ DFGLAR   +  +     T++ V +W  AP  + + S +++  DVWS
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-KW--APPEVFDYSRFSSKSDVWS 186

Query: 131 VGCIFMEL 138
            G +  E+
Sbjct: 187 FGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 47/206 (22%)

Query: 7   RDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQIL 55
           RDI+     E       +F D    Y +M+     DL  ++ SN  + E+  +++  +++
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVV 152

Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-------ARVTSETDFMTEYVVTR 108
             L  IHS   +HRD+KP N+LL+ +  LK+ DFG          V  +T      V T 
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-----VGTP 207

Query: 109 WYRAPELLLN---SSDYTAAIDVWSVGCIFMELMDRKPLFPGR----------DHVHQLR 155
            Y +PE+L +      Y    D WSVG    E++     F             DH + L 
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT 267

Query: 156 LLIELIGTPSEAELGFLNENAKKYIC 181
                   P + E   +++ AK  IC
Sbjct: 268 F-------PDDIE---ISKQAKDLIC 283

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 38/100 (38%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI  G+ Y+HS + +HRDL   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 168

Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 141
                  WY A E L  +    A+ DVWS G    EL+  
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW--- 109
           Q+  G+ Y+ + N +HRDL   N+L+  N   K+ DFGLARV  E  +       ++   
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIK 169

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPG 147
           + APE     + ++   DVWS G +  E++   R P +PG
Sbjct: 170 WTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 38/95 (40%), Positives = 51/95 (53%), Gaps = 13/95 (13%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 108
           QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD   EY   +    
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLD 173

Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 174 SPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 34/103 (33%), Positives = 60/103 (58%), Gaps = 4/103 (3%)

Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETDFMTEYVV 106
           ++  +I+ GL+++HS  +++RDLK  N++L+ +  +KI DFG+ +  V  +    T +  
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCG 158

Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           T  Y APE+L     YT ++D WS G +  E++  +  F G D
Sbjct: 159 TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 6/102 (5%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR+  + ++          +W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDH 150
             APE  L    +T   DVWS G +  EL+ +  + +PG ++
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YV 105
           F +QI RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
             +W  A E L +   YT   DVWS G +  E++
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VV 106
              QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++         
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
            +W  APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 167 IKW-TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           QI  G+ YI   N +HRDL+ +N+L+  N   KI DFGLAR+  + ++          +W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL+ +  + +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 22/162 (13%)

Query: 2   QVVAIRDIIPPP---QRES-FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQ 53
           +V+A++D   PP   Q  S F  V   Y +M+     DL   I+      E    ++  +
Sbjct: 52  RVLALQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 109

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW---- 109
           I  GL ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR     
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGT 164

Query: 110 --YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
             Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 165 PDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.8 bits (144), Expect = 5e-10
 Identities = 42/127 (33%), Positives = 56/127 (44%), Gaps = 25/127 (19%)

Query: 53  QILRGLKYIHS-------ANVLHRDLKPSNLLL-----------------NANCDLKICD 88
           Q+L  L Y H+         VLHRDLKP N+ L                 N     KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPG 147
           FGL++           V T +Y +PELLL+ +  Y    D+W++GCI  EL   K  F  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 148 RDHVHQL 154
            ++  QL
Sbjct: 246 ANNFSQL 252

Length = 1021

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.6 bits (142), Expect = 6e-10
 Identities = 38/114 (33%), Positives = 61/114 (53%), Gaps = 19/114 (16%)

Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------------- 94
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL+++              
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 95  TSET-DFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMDRKPLF 145
             +T +F+ + V  T  Y APE++L    Y   +D W++G I  E L+   P F
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 6e-10
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           QI  G+KY+ S N +HRDL   N L+  N  +KI DFG++R     D+        +  R
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           W     +LL    +T A DVW+ G    E++
Sbjct: 198 WMSWESILLGK--FTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 58.0 bits (140), Expect = 6e-10
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 9/124 (7%)

Query: 21  VYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + + +E M+   L   +R+ +   S+E        +  G+ Y+ S+NV+HRDL   N L+
Sbjct: 74  ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133

Query: 79  NANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
             N  +K+ DFG+ R   +  +     T++ V +W  +PE + + S Y++  DVWS G +
Sbjct: 134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSKYSSKSDVWSFGVL 190

Query: 135 FMEL 138
             E+
Sbjct: 191 MWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.8 bits (140), Expect = 8e-10
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 42/194 (21%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV--- 106
           + YQ+   L Y+ S   +HRD+   N+L+++   +K+ DFGL+R   +  +         
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171

Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIELIGTP 164
            +W  APE  +N   +T+A DVW  G    E++    KP                  G  
Sbjct: 172 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVK 213

Query: 165 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
           +   +G + EN ++    LP           PN  P+   L+ K   +DP +R    +  
Sbjct: 214 NNDVIGRI-ENGER----LP---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259

Query: 225 AHPYLGSLHDISDE 238
           A      L DI  E
Sbjct: 260 A-----QLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 7/125 (5%)

Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS  ++HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176

Query: 80  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 134
            +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 135 FMELM 139
             E++
Sbjct: 237 LFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 57.7 bits (139), Expect = 9e-10
 Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 8/130 (6%)

Query: 19  NDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
           N +YI  ELM   +L   +R+     +S      F   +  G++Y+ S  ++HRDL   N
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN 130

Query: 76  LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           +L++ +   K+ DFGLARV S     ++  V +W  APE L +   +++  DVWS G + 
Sbjct: 131 ILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKHKK-FSSKSDVWSYGVLL 187

Query: 136 MELMD--RKP 143
            E+    R P
Sbjct: 188 WEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 10/87 (11%)

Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM------TEYVVTRWY 110
           G++Y+ S N +HRDL   N L+  N  LKI DFG++R   E   +       + +  +W 
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW- 161

Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFME 137
            APE  LN   YT+  DVWS G +  E
Sbjct: 162 TAPE-ALNYGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 107
           +I  G+ Y+ +   +HRDL   N ++  +  +KI DFG+ R   ETD+   Y        
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLL 183

Query: 108 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             RW  APE  L    +T   DVWS G +  E+
Sbjct: 184 PVRWM-APE-SLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F+  I  G++Y+ S N +HRDL   N +LN N  + + DFGL++     D+  +   +  
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 108 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 141
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 178 PVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 39/129 (30%), Positives = 57/129 (44%), Gaps = 23/129 (17%)

Query: 27  LMDTDLHQIIRSNQALSEEHCQY------FLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +   DL   IRS     E H         F  Q+ +G++Y+ S   +HRDL   N +L+ 
Sbjct: 79  MKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE 133

Query: 81  NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL--------LLNSSDYTAAIDVWSVG 132
           +  +K+ DFGLAR   +     EY     +   +L         L +  +T   DVWS G
Sbjct: 134 SFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFG 189

Query: 133 CIFMELMDR 141
            +  ELM R
Sbjct: 190 VLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 15/112 (13%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 107
           QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    +   EY        
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVP 174

Query: 108 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPL--FPGRDHVHQL 154
            +W  A E +L+   YT   DVWS G    ELM    KP    P  + +  L
Sbjct: 175 IKWM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 74/313 (23%), Positives = 117/313 (37%), Gaps = 101/313 (32%)

Query: 2   QVVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYF 50
            V A RDI+     E       SF D    Y +MD     D+  ++       E+  +++
Sbjct: 47  HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY 106

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSET--------- 98
           + ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL    R T ++         
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 99  -----DFMTEY-------------------------------VVTRWYRAPELLLNSSDY 122
                DF  E+                               V T  Y APE+LL +  Y
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-Y 225

Query: 123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 182
           T   D WSVG I  E++  +P F              L  TP E ++  +N     +I  
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPF--------------LAQTPLETQMKVINWQTSLHI-- 269

Query: 183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLHDISDEP 239
            P   + S         P A DL+ K L   P  R+     ++  AHP+  ++       
Sbjct: 270 -PPQAKLS---------PEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID------ 312

Query: 240 VCMSPFSFDFEQH 252
                FS D  Q 
Sbjct: 313 -----FSSDLRQQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 59/207 (28%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------- 92
           LSEE  +++  ++L  L+Y+H   +++RDLKP N+LL+ +  + + DF L+         
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 93  --------------------RVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
                                 + E  F +  +V T  Y APE +++   + +A+D W++
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTL 218

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +  E+     L+ G               TP      F   N  +    + + +  +F
Sbjct: 219 GILLYEM-----LY-GT--------------TP------FKGSNRDETFSNILK-KEVTF 251

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRI 218
               P V  SA DL+ K+L  DP +R+
Sbjct: 252 PGS-PPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 41/169 (24%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     D+  ++     LSEE  Q+++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128

Query: 73  PSNLLLNANCDLKICDFGLA---RVTSETDFMTEY------------------------- 104
           P NLLL+A   +K+ DFGL    +    T+F                             
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 105 --------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
                   V T  Y APE+ + +  Y    D WS+G I  E++   P F
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 72/308 (23%), Positives = 114/308 (37%), Gaps = 93/308 (30%)

Query: 2   QVVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYF 50
            V A RDI+     E       SF D    Y +MD     D+  ++   +   E   +++
Sbjct: 47  HVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY 106

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL------------------- 91
           + ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                   
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166

Query: 92  -----------------------------ARVTSETDFMTEYVVTRWYRAPELLLNSSDY 122
                                        A    +       V T  Y APE+LL    Y
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-Y 225

Query: 123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYIC 181
           T   D WSVG I  E++  +P F              L  TP+E +L  +N EN      
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENT----L 267

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKM-LTFDPR-QRITVEDALAHPYLGSL---HDIS 236
            +P   + S         P A+DL+ K+  + + R  R   +D  AHP+   +    DI 
Sbjct: 268 HIPPQVKLS---------PEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIR 318

Query: 237 DEPVCMSP 244
            +P    P
Sbjct: 319 TQPAPYVP 326

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 39/123 (31%), Positives = 61/123 (49%), Gaps = 6/123 (4%)

Query: 19  NDVYIAYELMDT-DLHQIIRS-NQALSEEHCQY-FLYQILRGLKYIHSANVLHRDLKPSN 75
           N +YI  E M    L   +RS  +A+     Q  F   +  G++Y+   N +HRDL   N
Sbjct: 73  NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132

Query: 76  LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           +L++ +   K+ DFGLA+  S+     +  V +W  APE L     ++   DVWS G + 
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPEALREKK-FSTKSDVWSFGILL 189

Query: 136 MEL 138
            E+
Sbjct: 190 WEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 7/123 (5%)

Query: 21  VYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  E M+   L   +R  Q  LS++        +  G++Y+   + +HRDL   N L+
Sbjct: 74  LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133

Query: 79  NANCDLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           ++   +K+ DFG+ R   + ++ +        +W   PE + N S Y++  DVWS G + 
Sbjct: 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSKYSSKSDVWSFGVLM 191

Query: 136 MEL 138
            E+
Sbjct: 192 WEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF 100
           ++S  +  Y   QI  G+KY+ S N +HRDL   N L+  +  +KI DFG++R     D+
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 101 M----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
                   +  RW     +LL    +T A DVW+ G    E+
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTE--YVVTR 108
           QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+    ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPL--FPGRD 149
           W  A E +L+   +T   DVWS G    ELM    KP    P R+
Sbjct: 177 WM-ALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 109
           F+  I  G++Y+ S + +HRDL   N +LN N ++ + DFGL++     D+  +  + + 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 110 ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPG 147
              + A E L +   YT   DVWS G    E+  R +  +PG
Sbjct: 177 PVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 8e-09
 Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 7/122 (5%)

Query: 21  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  EL+     L  + +    L  +    F      G+ Y+ S N +HRDL   N L+
Sbjct: 67  IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126

Query: 79  NANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  LKI DFG++R   +  + +   + +  +W  APE  LN   Y++  DVWS G + 
Sbjct: 127 GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILL 184

Query: 136 ME 137
            E
Sbjct: 185 WE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 28/171 (16%)

Query: 22  YIAYELMDT-DLHQIIRSN--------------QALSEEHCQYFLYQILRGLKYIHSANV 66
            + +E M+  DL++ +RS+                L+         QI  G+ Y+ S + 
Sbjct: 84  IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF 143

Query: 67  LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDY 122
           +HRDL   N L+  +  +KI DFG++R    TD+        +  RW   PE ++    +
Sbjct: 144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-PPESIMYRK-F 201

Query: 123 TAAIDVWSVGCIFMELMD--RKPLFPGRD-----HVHQLRLLIELIGTPSE 166
           T   DVWS G +  E+    ++P +   +      + Q RLL      PSE
Sbjct: 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSE 252

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 41/169 (24%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     D+  ++     L+EE  Q+++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128

Query: 73  PSNLLLNANCDLKICDFGLARVTSE---------------TDFMTEYVVTR-----WYR- 111
           P NLLL++   +K+ DFGL     +               +DF  + + ++     W R 
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188

Query: 112 ---------------APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
                          APE+ + +  Y    D WS+G I  E++   P F
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 39/125 (31%), Positives = 56/125 (44%), Gaps = 16/125 (12%)

Query: 31  DLHQIIRSNQALSEEHC-----QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           DL   +RS +            Q    +I  GL ++H  N +H DL   N LL A+  +K
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK 140

Query: 86  ICDFGLARVTSETDFMTE----YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 135
           I D+GL+    + D+       +V  RW  APEL+      L   D T   +VWS+G   
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTI 199

Query: 136 MELMD 140
            EL +
Sbjct: 200 WELFE 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 55/242 (22%), Positives = 94/242 (38%), Gaps = 46/242 (19%)

Query: 19  NDVYIAYELMD----TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +++Y+   LM      DL   ++++  + L E    + L  +L  L YIHS   +HR +K
Sbjct: 72  SELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK 128

Query: 73  PSNLLLNANCDLKICDFGLA--------RVTSETDFMTEYVVTRWYRAPELL-LNSSDYT 123
            S++LL+ +  + +     +        R     DF    V    + +PE+L  N   Y 
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN 188

Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----------------SEA 167
              D++SVG    EL +     P +D      LL ++ GT                 S++
Sbjct: 189 EKSDIYSVGITACELAN--GHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246

Query: 168 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                + N +     +     ++F+E F   H      VE  L  DP  R +    L H 
Sbjct: 247 RSSNEHPNNRD---SVDHPYTRTFSEHF---H----QFVELCLQRDPESRPSASQLLNHS 296

Query: 228 YL 229
           + 
Sbjct: 297 FF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 7/106 (6%)

Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 96
            +   LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--G 173

Query: 97  ETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  ++ +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 174 QEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 39/125 (31%), Positives = 57/125 (45%), Gaps = 16/125 (12%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQ-----ILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           DL   +RSN+ +  +  Q  + Q     +  GL ++H A+ +H DL   N  L A+  +K
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK 140

Query: 86  ICDFGLARVTSETDFMT----EYVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 135
           I D+GLA      D+        V  RW  APEL+      L   D T   ++WS+G   
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Query: 136 MELMD 140
            EL  
Sbjct: 200 WELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 4/88 (4%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG---LARVTSETDFMTEYVVTRW 109
           Q+L  + YIH   ++HRD+K  N+L+N   D+ + DFG    AR +  T F      T  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFME 137
             APE+L     YT ++D+WS G +  E
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 8/118 (6%)

Query: 34  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 93
           Q  ++   L      +   QI  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 94  VTSETDFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 145
               TD+        +  RW   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 12/94 (12%)

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV----- 106
            QI  G++Y+ S + +HRDL   N L+     +KI DFGL+R     D+   Y V     
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSL 187

Query: 107 --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
              RW   PE +L    +T   D+WS G +  E+
Sbjct: 188 LPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W     +  N   YT   DVW+ G +  E+
Sbjct: 198 WMPPESIFYNR--YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 40/230 (17%)

Query: 17  SFNDVYIAYELMD----TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           +F D    Y +MD     DL  ++ +    L E+  ++++ +++  +  IH  + +HRD+
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128

Query: 72  KPSNLLLNANCDLKICDFG--LARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAA 125
           KP N+LL+ N  +++ DFG  L      T   +  V T  Y +PE+L    D    Y   
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188

Query: 126 IDVWSVG-CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 184
            D WS+G C++  L    P +           L+E  G     E                
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHE---------------- 224

Query: 185 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL 232
             +R  F     +V   A DL+++++    R+  +  +ED   H +   +
Sbjct: 225 --ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 1/81 (1%)

Query: 16  ESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           +S N+VY+  E L+  D+  ++       EE    ++ ++   L Y+H   ++HRDLKP 
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133

Query: 75  NLLLNANCDLKICDFGLARVT 95
           N+L++    +K+ DFGL++VT
Sbjct: 134 NMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 7/109 (6%)

Query: 36  IRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 94
           +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++
Sbjct: 99  VREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Query: 95  --TSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               E ++  E   V  +W  A E +L+   YT   DVWS G    ELM
Sbjct: 159 LGADEKEYHAEGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)

Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 80  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 134
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 135 FMELM 139
             E++
Sbjct: 237 LYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 8/86 (9%)

Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYR 111
           G++Y+ S + +HRDL   N L+     LKI DFG++R     V + T  M + +  +W  
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ-IPVKW-T 163

Query: 112 APELLLNSSDYTAAIDVWSVGCIFME 137
           APE  LN   Y++  DVWS G +  E
Sbjct: 164 APE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 31/115 (26%), Positives = 58/115 (50%), Gaps = 12/115 (10%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+ ++   E   +++  +I   L ++H   +++RDLK  N+LL+     K+ DFG
Sbjct: 82  DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 91  LAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           + +       T+ T     +  T  Y APE +L    Y  ++D W++G +  E++
Sbjct: 142 MCKEGIFNGKTTST-----FCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 7/91 (7%)

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVT 107
             +  G+ Y+ S   +HRDL   N L++    +K+ DFGL+R   + ++     +++ V 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV- 165

Query: 108 RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           RW   PE+LL S  +++  DVW+ G +  E+
Sbjct: 166 RW-SPPEVLLYSK-FSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 5e-08
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG--LARVTSETD 99
           L E+  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG  L  +   T 
Sbjct: 99  LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 100 FMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMDRKPLFPGRDHVHQL 154
             +  V T  Y +PE+L    D    Y    D WS+G C++  L    P +         
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-------- 210

Query: 155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
             L+E  G               K +    R+Q   F  +  +V   A DL+ +++    
Sbjct: 211 ESLVETYG---------------KIMNHKERFQ---FPAQVTDVSEDAKDLIRRLICSRE 252

Query: 215 RQ--RITVEDALAHPYLGSLHDISDEPVCMSPF 245
            +  +  +ED   HP+   + D  +   C +P+
Sbjct: 253 HRLGQNGIEDFKQHPFFTGI-DWDNIRNCEAPY 284

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.2 bits (125), Expect = 7e-08
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 8/123 (6%)

Query: 22  YIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           YI  E M   +L   +R    Q ++     Y   QI   ++Y+   N +HRDL   N L+
Sbjct: 78  YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  +K+ DFGL+R+ +  D  T +   ++   + APE L  +  ++   DVW+ G + 
Sbjct: 138 GENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLL 195

Query: 136 MEL 138
            E+
Sbjct: 196 WEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           QI  G+KY+ S N +HRDL   N L+  N  +KI DFG++R     D+        +  R
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           W     +L+    +T A DVW+ G    E++
Sbjct: 206 WMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 52.0 bits (124), Expect = 8e-08
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L++    +   QI  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+ 
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 102 T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                  +  RW   PE ++    +T   DVWS+G +  E+ 
Sbjct: 177 RVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 13/96 (13%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
            ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL++     D    Y   R 
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD---SYYKARS 156

Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFME 137
                  WY APE  +N   +++  DVWS G    E
Sbjct: 157 AGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 187 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 23/127 (18%)

Query: 31  DLHQIIRSNQALSEEHCQY--------FLY---QILRGLKYIHSANVLHRDLKPSNLLLN 79
           DL+Q ++ + A +               LY   QI  G++Y+ S N +HRDL   N L+ 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164

Query: 80  ANCDLKICDFGLARVTSETDFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVG 132
            N  +KI DFG++R    +D+   Y V        RW     +LL    +T   DVW+ G
Sbjct: 165 KNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFG 219

Query: 133 CIFMELM 139
               E++
Sbjct: 220 VTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 88/289 (30%)

Query: 3   VVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 51
           V A RDI+     E       SF D    Y +MD     D+  ++       E+  ++++
Sbjct: 48  VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYI 107

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL------------------AR 93
            ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                   R
Sbjct: 108 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 94  VTSETDFMTEY---------------------------VVTRWYRAPELLLNSSDYTAAI 126
             S  +   E+                           V T  Y APE+LL +  YT   
Sbjct: 168 QDS-MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 225

Query: 127 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 186
           D WSVG I  E++  +P F              L  TP+E +L  +N     +I      
Sbjct: 226 DWWSVGVILYEMLVGQPPF--------------LADTPAETQLKVINWETTLHI----PS 267

Query: 187 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL 232
           Q          +   A DL+ ++       R+     ++  AHP+   +
Sbjct: 268 Q--------AKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L+ +    F   +  G++Y+     +HRDL   N+L+  N   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 102 TEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 187 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)

Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 109
           F+  I  G++Y+ + N +HRDL   N +L  +  + + DFGL++     D+   Y   R 
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY---YRQGRI 174

Query: 110 YRAPE--LLLNS-SD--YTAAIDVWSVGCIFMELMDR 141
            + P   + + S +D  YT+  DVW+ G    E+  R
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 15/130 (11%)

Query: 22  YIAYELMD-TDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           Y+  E  D  DL Q +R+ ++         LS +       QI  G+ ++ +A  +HRDL
Sbjct: 84  YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143

Query: 72  KPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDV 128
              N L+++  ++K+    L++    ++        +  RW  APE +    D++   DV
Sbjct: 144 AARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-APEAVQE-DDFSTKSDV 201

Query: 129 WSVGCIFMEL 138
           WS G +  E+
Sbjct: 202 WSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 3e-07
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   +  ++
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 166

Query: 102 TEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 167 KKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.6 bits (118), Expect = 5e-07
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 3/102 (2%)

Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 96
           R    L  +    F   +   ++Y+ + N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 94  RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153

Query: 97  ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            T    +  V +W  APE  L    ++   DVWS G +  E+
Sbjct: 154 STQDTGKLPV-KW-TAPE-ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 5e-07
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARVTSETDF 100
           L E+  +++L +++  +  +H    +HRD+KP N+LL+ N  +++ DFG   R+ ++   
Sbjct: 99  LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158

Query: 101 MTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMDRKPLFP-------G 147
            +   V T  Y +PE+L    D    Y    D WS+G C++  L    P +        G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218

Query: 148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 183
           +   H+          P +     ++E AK  I +L
Sbjct: 219 KIMNHKEHFQF-----PPDVTD--VSEEAKDLIRRL 247

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 92
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 52/217 (23%), Positives = 79/217 (36%), Gaps = 33/217 (15%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--- 98
           +SE    Y L  +L+ L YIH    +HR +K S++L++   D K+   GL    S     
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHG 155

Query: 99  -------DFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
                  DF    V    + +PE+L  N   Y A  D++SVG    EL +     P +D 
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDM 213

Query: 151 VHQLRLLIELIGT-----------PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
                LL +L GT             E  +      A   + +         +    + H
Sbjct: 214 PATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273

Query: 200 P-------SAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           P            VE+ L  +P  R +    L H + 
Sbjct: 274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 4/80 (5%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     DL  ++      SE+  ++++ + +  ++ +H    +HRD+K
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128

Query: 73  PSNLLLNANCDLKICDFGLA 92
           P N+L++    +K+ DFGL+
Sbjct: 129 PDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 11/98 (11%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTR 108
           +I  G+ ++H  N LH DL   N  L ++  +K+ D+G+     + D++     + V  R
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 109 WYRAPELL------LNSSDYTAAIDVWSVGCIFMELMD 140
           W  APEL+      L +++ T   +VW++G    EL +
Sbjct: 167 WL-APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           QI  G+ Y+ S + +HRDL   N L+     +KI DFG++R    TD+        +  R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W   PE +L    +T   D+WS G +  E+
Sbjct: 190 WM-PPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 103
           EE  + +  +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D    
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDG 141

Query: 104 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
             V   Y APE +   S+ T A D WS+G I  EL+  K L
Sbjct: 142 EAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTE--YVVTR 108
           QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+    E ++  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           W       ++   +T   DVWS G    ELM
Sbjct: 177 WMALE--CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.7 bits (108), Expect = 9e-06
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRW 109
           QI +G+ Y+    ++HR+L   N+LL ++  ++I DFG+A +    D   F +E+     
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           + A E +L    YT   DVWS G    E+M
Sbjct: 177 WMALESILFGR-YTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 19/136 (13%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQIL-------RGLKYIHSANVLHRDLK 72
            YI  ELM+  DL   +R  +          L ++L       +G  Y+   + +HRDL 
Sbjct: 74  QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133

Query: 73  PSNLLLNA---NCD--LKICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYT 123
             N L++    + D  +KI DFGLAR   ++D+  +     +  RW  APE LL+   +T
Sbjct: 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM-APESLLDGK-FT 191

Query: 124 AAIDVWSVGCIFMELM 139
              DVWS G +  E++
Sbjct: 192 TQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 47/191 (24%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR------------------- 93
           +I   ++Y+HS  VLHRDLKP N+LL    ++ I D+G A                    
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
             S      + V T  Y APE LL     + + D++++G I  +++     FP R    +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLS--FPYRRKKGR 237

Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 213
                ++I +P E                            +  + P    +  K L  D
Sbjct: 238 KISYRDVILSPIE-------------------------VAPYREIPPFLSQIAMKALAVD 272

Query: 214 PRQRITVEDAL 224
           P +R +    L
Sbjct: 273 PAERYSSVQEL 283

Length = 932

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           QI  G++Y+ S   +H+DL   N+L+     +KI D GL+R     D+        +  R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W   PE ++    +++  D+WS G +  E+
Sbjct: 192 WM-PPEAIMYGK-FSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 3e-05
 Identities = 29/130 (22%), Positives = 48/130 (36%), Gaps = 19/130 (14%)

Query: 32  LHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           L  I+    + L+EE       Q L  L+ +H        L   + LL           G
Sbjct: 3   LADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DG 54

Query: 91  -LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +A  T E      Y +     APE++     YT   D++S+G    E +D +      +
Sbjct: 55  SVAFKTPEQSRPDPYFM-----APEVIQG-QSYTEKADIYSLGITLYEALDYE---LPYN 105

Query: 150 HVHQLRLLIE 159
              +L  ++E
Sbjct: 106 EERELSAILE 115

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 6/90 (6%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           QI  G++++ S +V+H+DL   N+L+    ++KI D GL R     D+        +  R
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  +PE ++    ++   D+WS G +  E+
Sbjct: 192 WM-SPEAIMYGK-FSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 5/92 (5%)

Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARVTSETDF--MTEYVVT 107
           L  +  G+KY+     +H+ L    +L+N++   KI  F  L    SE  +  M+     
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 108 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            W  APE  +    +++A DVWS G +  E+M
Sbjct: 173 LW-AAPE-AIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 15/92 (16%)

Query: 6   IRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN 65
           I D+ P           +   +   DL  ++  N  L  +        +   +  +H A 
Sbjct: 403 IYDVDP------EEKTIVMEYIGGKDLKDVLEGNPELVRK--------VGEIVAKLHKAG 448

Query: 66  VLHRDLKPSNLLLNANCDLKICDFGLARVTSE 97
           ++H DL  SN ++  +  L + DFGL + +  
Sbjct: 449 IVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 5e-04
 Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 5/66 (7%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L  +I SN     E  +     + +    +HSA ++H DL  SN++L+    + + DFGL
Sbjct: 86  LKDLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGL 140

Query: 92  ARVTSE 97
           A  + +
Sbjct: 141 AEFSKD 146

Length = 211

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 17/133 (12%)

Query: 22  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR-------GLKYIHSANVLHRDLKP 73
           +I  ELM   DL   +R N+   E      +  +L        G KY+   + +HRD+  
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144

Query: 74  SNLLLNANCD---LKICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAI 126
            N LL         KI DFG+AR      +  +     +  +W   PE  L+   +T+  
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM-PPEAFLDGI-FTSKT 202

Query: 127 DVWSVGCIFMELM 139
           DVWS G +  E+ 
Sbjct: 203 DVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.9 bits (94), Expect = 5e-04
 Identities = 13/37 (35%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 97
           +H A ++H DL  SN+++  +  L + DFGL + + E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 60/218 (27%)

Query: 48  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMT---- 102
           Q  + QIL  L  +HS  ++HRD+KP N++ +      KI D G A      D       
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----ADLRVGINY 312

Query: 103 ---EYVVTRWYRAPELLLNSSDYTAA---------------------IDVWSVGCIFMEL 138
              E+++   Y APE  + S+   +A                      D++S G IF+++
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 198
                 FP       LR    LI      +L   + +   +   +           F   
Sbjct: 373 A-----FPN------LRSDSNLIQF--NRQLKRNDYDLVAWRKLVEPRASPDLRRGF--- 416

Query: 199 HPSAID--------LVEKMLTFDPRQRITVEDALAHPY 228
               +D        L++ M+ F  RQRI+ + ALAHPY
Sbjct: 417 --EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452

Length = 566

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 11/28 (39%), Positives = 16/28 (57%)

Query: 200 PSAIDLVEKMLTFDPRQRITVEDALAHP 227
           P   DL+ KML  DP +R + ++ L H 
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	277
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.98
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG3653	534	consensus Transforming growth factor beta/activin	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.91
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.9
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.9
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.77
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
PRK12274	218	serine/threonine protein kinase; Provisional	99.68
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.62
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.58
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.58
PRK09188	365	serine/threonine protein kinase; Provisional	99.58
PRK10345	210	hypothetical protein; Provisional	99.56
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
smart00090	237	RIO RIO-like kinase.	99.4
PRK14879	211	serine/threonine protein kinase; Provisional	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.35
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.3
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.28
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.27
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.2
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.12
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.08
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.05
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.97
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.93
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.92
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.91
KOG3087	229	consensus Serine/threonine protein kinase [General	98.78
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.76
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.72
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.7
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.64
PRK09902	216	hypothetical protein; Provisional	98.53
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.22
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.18
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.14
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.79
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.71
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.09
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.01
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.0
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.94
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.85
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.71
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.55
PLN02876	822	acyl-CoA dehydrogenase	95.14
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.01
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.77
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.67
PRK05231	319	homoserine kinase; Provisional	94.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.28
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.22
PF01636	239	APH: Phosphotransferase enzyme family This family	93.73
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.41
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.27
PRK10271	188	thiK thiamine kinase; Provisional	93.18
COG2334	331	Putative homoserine kinase type II (protein kinase	93.03
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.45
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.43
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.16
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	91.88
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.82
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	91.63
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.88
PLN02236	344	choline kinase	90.87
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	90.52
KOG2270	520	consensus Serine/threonine protein kinase involved	89.66
PRK11768	325	serine/threonine protein kinase; Provisional	89.37
PRK14559	645	putative protein serine/threonine phosphatase; Pro	89.06
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	88.83
PRK06148	1013	hypothetical protein; Provisional	88.79
PRK06149	972	hypothetical protein; Provisional	88.72
PHA03111	444	Ser/Thr kinase; Provisional	88.34
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	88.07
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	86.55
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	85.55
KOG1236	565	consensus Predicted unusual protein kinase [Genera	81.63

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-62  Score=404.19  Aligned_cols=274  Identities=64%  Similarity=1.129  Sum_probs=257.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+.+++++..+..+.++++|+|+|+|+.+|.+.++.+..++++.++.+++|++.||+|+|+.|++|||+||.|++++.
T Consensus        81 eNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~  160 (359)
T KOG0660|consen   81 ENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA  160 (359)
T ss_pred             CCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc
Confidence            79999999999977888999999999999999999999888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccC---CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +..+|++|||+++....   ....+.++.|.+|+|||++.....|+.+.||||+|||++||++|++.|+|.+...++..|
T Consensus       161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI  240 (359)
T KOG0660|consen  161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI  240 (359)
T ss_pred             CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            99999999999998753   455678889999999999998889999999999999999999999999999999999999


Q ss_pred             HHHhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          158 IELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      .+.+|+|+++.+..+ ++....|+.+.+..++.++...+|+.++.+.||+.+||..||.+|+|++|+|+|||++.+++++
T Consensus       241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence            999999999999888 5778889999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChhhhc
Q 023764          237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ  276 (277)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (277)
                      ++|++...+.. ++.. ++.++++++++.++++|+|..++
T Consensus       321 dEP~~~~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~~~~  358 (359)
T KOG0660|consen  321 DEPVCQPIFDS-FEHE-LTEEELRELIYKEILDFHPDVSK  358 (359)
T ss_pred             cCCCCCCCCcc-cccc-ccHHHHHHHHHHHHHhhCccccC
Confidence            99988776654 3333 99999999999999999998753

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-53  Score=357.29  Aligned_cols=230  Identities=37%  Similarity=0.692  Sum_probs=216.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+|++++.+..    +.+|+|||||+.+|.++++.+ +.|++..++.|++||+.||+|+|++|+.|||+||+|||+.
T Consensus        69 pniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~  144 (538)
T KOG0661|consen   69 PNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS  144 (538)
T ss_pred             CcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec
Confidence            89999999999971    399999999999999999876 5699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      ....+||+|||+|+........+.++.|++|+|||++.+.+.|+.+.|+|++|||++|+.+-++.|+|.++.+++-+|-+
T Consensus       145 ~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  145 GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence            88899999999999998888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .+|+|....|..-..-.......++......+....|..+.++.++|.+||.|||.+||||+++|+||||+....
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            999999998877666677778889999999999999999999999999999999999999999999999987543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-50  Score=325.63  Aligned_cols=269  Identities=42%  Similarity=0.754  Sum_probs=237.8

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      +||++++.+|+... .+.+.++|+|||+|+.+|.+.+.  -.++.+.+..+++|++.|++|||+.||+|||+||+||++.
T Consensus        75 ~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~  152 (369)
T KOG0665|consen   75 KNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN  152 (369)
T ss_pred             cceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence            69999999999864 56778999999999999999988  4478899999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+|+.|||+++.....-..+..+.+..|.|||++.+.+ +...+||||+||++.||++|+..|+|.+..+++.++.+
T Consensus       153 ~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  153 SDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE  231 (369)
T ss_pred             chhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence            99999999999998776655677888999999999998776 99999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCC------------ChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      .+|+|......++......+....++++...+++.+|+.            +..+++++.+||..||++|.|++++|+||
T Consensus       232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence            999999999999999999998888888888888887753            35689999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcCCC-CCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          228 YLGSLHDISDEPVCMS-PFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       228 ~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      |++-|.+........+ +.+...+....+.++|+++|++++.+|++
T Consensus       312 Y~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  312 YIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             eeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            9997755433222222 23344566677799999999999999987

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-50  Score=331.48  Aligned_cols=270  Identities=32%  Similarity=0.631  Sum_probs=228.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      ||||+|..+|......+.-...+|||||+.+|.++++.    +..++.-.++-+++||++||.|||+.||+||||||.|+
T Consensus        77 pNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNl  156 (364)
T KOG0658|consen   77 PNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNL  156 (364)
T ss_pred             cCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheE
Confidence            89999999998754322235678999999999999984    57789999999999999999999999999999999999


Q ss_pred             EEecC-CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           77 LLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        77 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      |++.+ |.+||||||.|+....++...++.+|+.|+|||.+.+...|+.+.||||.||+++||+.|++.|+|.+..+++.
T Consensus       157 LvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~  236 (364)
T KOG0658|consen  157 LVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV  236 (364)
T ss_pred             EEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence            99976 99999999999998888888899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .|.+.+|+|+.+++...+.+..  ....++.....+.+ .....++++.+|+.++|+.+|.+|.|+.+++.||||..+++
T Consensus       237 eIik~lG~Pt~e~I~~mn~~y~--~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  237 EIIKVLGTPTREDIKSMNPNYT--EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHHHhCCCCHHHHhhcCcccc--cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            9999999999999988776654  33456666666656 55678999999999999999999999999999999999987


Q ss_pred             CCCC-C---cCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          235 ISDE-P---VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       235 ~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +.-. +   .....+++...+...+..-+..++..++..++.
T Consensus       315 ~~~~l~~g~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~  356 (364)
T KOG0658|consen  315 PNTKLPNGRPLPPLFNFKRAELGISPELVNVLIPEHLREQEK  356 (364)
T ss_pred             cCccCcCCCcCCCccCchHHHhccchHHHHhhccHhhhhhcc
Confidence            6332 1   112344555455555666666666666655544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.1e-50  Score=323.41  Aligned_cols=228  Identities=32%  Similarity=0.689  Sum_probs=200.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||+|.|+++|+-+     ..+++|+|||+.++.+.++.. ..++.+.++.+++|++.|+.|+|+++++||||||+|||++
T Consensus        61 ~NLVnLiEVFrrk-----rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit  135 (396)
T KOG0593|consen   61 ENLVNLIEVFRRK-----RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT  135 (396)
T ss_pred             chHHHHHHHHHhc-----ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe
Confidence            7999999999988     899999999999888888765 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||||||+|+... .++..+.++.|++|+|||.+.+...|+.++||||+||++.||++|.+.|+|.++.+++-.|.
T Consensus       136 ~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~  215 (396)
T KOG0593|consen  136 QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR  215 (396)
T ss_pred             cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence            99999999999999776 55667788999999999999998889999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+|........-+..+....--.+|.. ...+++..+|.++..+.||+++||+.||.+|+|.+++|.|+||.++.
T Consensus       216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            9999888765554443322222222222 23568889999999999999999999999999999999999997764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-51  Score=338.75  Aligned_cols=205  Identities=32%  Similarity=0.576  Sum_probs=175.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|..+     +..|+||||++ |+|.+.+-.++.+.++..+.+++|++.|+.|||+.||+||||||+|||++
T Consensus       236 P~IV~~~d~f~~~-----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~  310 (475)
T KOG0615|consen  236 PNIVRIKDFFEVP-----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLS  310 (475)
T ss_pred             CCEEEEeeeeecC-----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEec
Confidence            8999999999998     88899999996 69999999999999999999999999999999999999999999999997


Q ss_pred             cC---CCeEEeeccceeeccCCCcccccccccccCChhhhhCCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 AN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .+   ..+||+|||+++..+......+.||||.|.|||++...+  .+..++|+||+||++|-+++|.+||.+......+
T Consensus       311 ~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  311 NDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             cCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence            76   678999999999999888999999999999999996543  2456899999999999999999999877654433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .+.+.....                         ...+..+..+|.++++||..||..||++|||++|+|+||||+....
T Consensus       391 ~eQI~~G~y-------------------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  391 KEQILKGRY-------------------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             HHHHhcCcc-------------------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            332221111                         1112333468889999999999999999999999999999997553


Q ss_pred             C
Q 023764          235 I  235 (277)
Q Consensus       235 ~  235 (277)
                      .
T Consensus       446 ~  446 (475)
T KOG0615|consen  446 L  446 (475)
T ss_pred             c
Confidence            3

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-49  Score=321.47  Aligned_cols=230  Identities=40%  Similarity=0.692  Sum_probs=208.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||.+.++..-++   .+++|+|||||+.+|..++..-+ +|+..+++.++.|++.|++|||.++|+|||+|++|+|++
T Consensus       135 ~NIV~vkEVVvG~~---~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~  211 (419)
T KOG0663|consen  135 PNIVEVKEVVVGSN---MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS  211 (419)
T ss_pred             CCeeeeEEEEeccc---cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec
Confidence            89999999997653   37899999999999999998765 899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      ..|.+|++|||+|+..+.+ ...+..+-|.+|+|||.+.+...|+.++|+||+|||+.||+++++.|+|.+..+++.+|.
T Consensus       212 ~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If  291 (419)
T KOG0663|consen  212 HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF  291 (419)
T ss_pred             cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH
Confidence            9999999999999988766 456677889999999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCC--hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+|+|++..|..+..........++..+...+...|+..+  ....+|+.++|.+||.+|.||+++|.|.||....
T Consensus       292 ~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  292 KLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             HHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            99999999999888766555555666666677777777654  9999999999999999999999999999999743

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-49  Score=341.66  Aligned_cols=204  Identities=32%  Similarity=0.534  Sum_probs=182.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +++|||.|+|. ++|..+++.++.++|.+++++++||+.||.|||+++|+|||||..|++++
T Consensus        78 pnIV~f~~~FEDs-----~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~  152 (592)
T KOG0575|consen   78 PNIVQFYHFFEDS-----NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN  152 (592)
T ss_pred             CcEEeeeeEeecC-----CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec
Confidence            8999999999999     99999999998 79999999889999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      ++..+||+|||+|..... .+...+.||||.|.|||++.+. .++..+||||+||++|.||.|++||...+-.+.+.+|.
T Consensus       153 ~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik  231 (592)
T KOG0575|consen  153 ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK  231 (592)
T ss_pred             CcCcEEecccceeeeecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence            999999999999987764 4677889999999999999754 48999999999999999999999999998888888776


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..--.-|                              ..+|.++++||.+||+.||.+|||++++|.|+||++-..+...
T Consensus       232 ~~~Y~~P------------------------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l  281 (592)
T KOG0575|consen  232 LNEYSMP------------------------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARL  281 (592)
T ss_pred             hcCcccc------------------------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence            5211111                              1688999999999999999999999999999999665555554


Q ss_pred             Cc
Q 023764          239 PV  240 (277)
Q Consensus       239 ~~  240 (277)
                      |.
T Consensus       282 p~  283 (592)
T KOG0575|consen  282 PS  283 (592)
T ss_pred             Cc
Confidence            44

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-48  Score=309.07  Aligned_cols=226  Identities=40%  Similarity=0.746  Sum_probs=201.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+.|.|+|-..     +.+.||+|||+.+|...++.+ ..++...++.++.+++.|++|||+++|+|||+||+|+|++
T Consensus        61 ~nIi~LiD~F~~~-----~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis  135 (318)
T KOG0659|consen   61 PNIIELIDVFPHK-----SNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS  135 (318)
T ss_pred             cchhhhhhhccCC-----CceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc
Confidence            7999999999998     899999999999999999865 5699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc-ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++..+.... ....+.|.+|+|||.+.+.+.|+..+|+||.|||++||+.|.+.|+|.++.+++..|.
T Consensus       136 ~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If  215 (318)
T KOG0659|consen  136 SDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF  215 (318)
T ss_pred             CCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence            999999999999998776543 3344789999999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhh-HHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNEN-AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+|+|.+..|..+..- .-..+   ...+..+....++..+.++.||+.+||..||.+|+|+.++|+|+||++...
T Consensus       216 ~~LGTP~~~~WP~~~~lpdY~~~---~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  216 RALGTPTPDQWPEMTSLPDYVKI---QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHcCCCCcccCccccccccHHHH---hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            99999999988776322 11111   144455555689999999999999999999999999999999999997543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-48  Score=328.53  Aligned_cols=227  Identities=38%  Similarity=0.672  Sum_probs=196.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+|.+++++..   ...+|+|+|||+.+|..++... -.|++.+++.++.||+.||+|||++||+|||||..|||++
T Consensus       176 pNIikL~eivt~~~---~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid  252 (560)
T KOG0600|consen  176 PNIIKLEEIVTSKL---SGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID  252 (560)
T ss_pred             CcccceeeEEEecC---CceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc
Confidence            89999999998862   2789999999999999999874 4799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .+|.+||+|||+++.....  ...+..+.|.+|+|||++++...|+.++|+||+|||+.||+.|++.|.|.+..+++.+|
T Consensus       253 n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI  332 (560)
T KOG0600|consen  253 NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI  332 (560)
T ss_pred             CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence            9999999999999965433  35677788999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .+..|+|.+..|................+ ...+.+.+..++..+.+|+.+||..||.+|.||.++|.|+||..
T Consensus       333 fklcGSP~e~~W~~~kLP~~~~~kp~~~y-~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  333 FKLCGSPTEDYWPVSKLPHATIFKPQQPY-KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             HHHhCCCChhccccccCCcccccCCCCcc-cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            99999999998873322211111111111 22345557789999999999999999999999999999999944

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=316.71  Aligned_cols=200  Identities=29%  Similarity=0.525  Sum_probs=170.0

Q ss_pred             CceeeeeccccCCCCCCCC-cEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~-~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil   77 (277)
                      ||||++|++|..+     + .++|+||||+ |+|.+++...+++++.....++.++++||.|||+ ++|+||||||+|+|
T Consensus       137 pyIV~~ygaF~~~-----~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlL  211 (364)
T KOG0581|consen  137 PYIVGFYGAFYSN-----GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLL  211 (364)
T ss_pred             CCeeeEeEEEEeC-----CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHee
Confidence            8999999999997     6 4999999997 6999999988999999999999999999999995 89999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-----ChHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-----DHVH  152 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~  152 (277)
                      ++..|.+||||||.+...... ...++.||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||...     +..+
T Consensus       212 vNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~  289 (364)
T KOG0581|consen  212 VNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE  289 (364)
T ss_pred             eccCCCEEeccccccHHhhhh-hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH
Confidence            999999999999999876655 6788999999999999965 46999999999999999999999999764     2222


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+..|.   ..|+.                       .+++.  ..|+++++|+..||++||.+|+|+.++++|||++..
T Consensus       290 Ll~~Iv---~~ppP-----------------------~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  290 LLCAIV---DEPPP-----------------------RLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHHh---cCCCC-----------------------CCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            222222   11111                       11110  378899999999999999999999999999999986


Q ss_pred             CCC
Q 023764          233 HDI  235 (277)
Q Consensus       233 ~~~  235 (277)
                      ...
T Consensus       342 ~~~  344 (364)
T KOG0581|consen  342 EDP  344 (364)
T ss_pred             ccc
Confidence            543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.5e-46  Score=321.47  Aligned_cols=272  Identities=51%  Similarity=0.984  Sum_probs=224.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.......+.++|+||||++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus        59 pniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~  138 (338)
T cd07859          59 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA  138 (338)
T ss_pred             CCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence            79999999987655445567999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC----CcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           81 NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      ++.++|+|||++......    .......+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+......
T Consensus       139 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~  218 (338)
T cd07859         139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD  218 (338)
T ss_pred             CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence            999999999998754321    112345789999999987542 457899999999999999999999999998888888


Q ss_pred             HHHHHhCCCChHhhhhhh-hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .+....+.|+...+..+. .....+...........+...++..++++.++|.+||+.||++|||++++++||||+....
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            888888988877665542 3333444444444445566677888999999999999999999999999999999998776


Q ss_pred             CCCCCcCC--CCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          235 ISDEPVCM--SPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      ....+...  ....+.++...++.++.++.+..+.+..||
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         299 VEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP  338 (338)
T ss_pred             cccccccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence            55444332  234556788899999999999999888776

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-46  Score=322.74  Aligned_cols=272  Identities=76%  Similarity=1.289  Sum_probs=236.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.......+.++|+|+||++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.
T Consensus        64 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~  143 (337)
T cd07858          64 ENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  143 (337)
T ss_pred             CCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence            79999999988754445567999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      ++.++|+|||++...... .......++..|+|||.+.....++.++|+||+||++++|++|++||.+.+.......+.+
T Consensus       144 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  223 (337)
T cd07858         144 NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE  223 (337)
T ss_pred             CCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence            999999999998765433 2333456788899999886555588999999999999999999999999888888888888


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+....+... .....++....+...........+.+++++++||++||+.||++|||++++++||||+.++++...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~  303 (337)
T cd07858         224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE  303 (337)
T ss_pred             HhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence            8888887766444 344555555566555555666677899999999999999999999999999999999999999999


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +....++.+++++...+.++++++++.++++++|
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (337)
T cd07858         304 PVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP  337 (337)
T ss_pred             ccCCCccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence            9999999999999999999999999999999886

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-47  Score=332.36  Aligned_cols=203  Identities=31%  Similarity=0.532  Sum_probs=183.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++|+|+|.+.     .++|+|.||++ |.|++++..++++++.+++++++||+.|+.|+|..+|+|||+||+|+|++
T Consensus        72 pnVl~LydVwe~~-----~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd  146 (786)
T KOG0588|consen   72 PNVLRLYDVWENK-----QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD  146 (786)
T ss_pred             CCeeeeeeeeccC-----ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh
Confidence            8999999999998     99999999996 79999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      ..+.+||+|||+|..-..+....+.||+|+|+|||++.+....+.++||||+|||+|.||+|+.||++.+....+.++..
T Consensus       147 ~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~  226 (786)
T KOG0588|consen  147 VKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR  226 (786)
T ss_pred             cccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence            99999999999999888888899999999999999998888779999999999999999999999998877666655432


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      -                   ..++|           ..+++++.+||++||+.||.+|+|.++++.|||+.........
T Consensus       227 G-------------------~f~MP-----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  227 G-------------------VFEMP-----------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             C-------------------cccCC-----------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            1                   01111           2689999999999999999999999999999999988765554

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.6e-47  Score=310.68  Aligned_cols=235  Identities=39%  Similarity=0.774  Sum_probs=204.7

Q ss_pred             Cc-eeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQ-VVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pn-iv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~----~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      +| |++|++++...+ .++...+|+|+||++.+|..++...+    .++...++.+++||+.||+|||++||+|||+||.
T Consensus        70 ~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQ  149 (323)
T KOG0594|consen   70 ANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQ  149 (323)
T ss_pred             CcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcc
Confidence            46 999999998763 13334899999999999999998765    5888899999999999999999999999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           75 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      ||+++.+|.+||+|||+++..+-+ ....+..+|.+|+|||++.+...|+...||||+|||++||+++.+.|+|.++.++
T Consensus       150 NlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q  229 (323)
T KOG0594|consen  150 NLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ  229 (323)
T ss_pred             eEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH
Confidence            999999999999999999877643 4467788999999999999988899999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCccc-CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +..|.+..|+|....|...... ..+....+.+. ...+....+..++++.+++.+||+.+|.+|.||+.+|.||||...
T Consensus       230 l~~If~~lGtP~e~~Wp~v~~~-~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  230 LFRIFRLLGTPNEKDWPGVSSL-PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             HHHHHHHcCCCCccCCCCcccc-ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            9999999999999988766432 12222444454 556777888888999999999999999999999999999999987


Q ss_pred             CCCC
Q 023764          233 HDIS  236 (277)
Q Consensus       233 ~~~~  236 (277)
                      ....
T Consensus       309 ~~~~  312 (323)
T KOG0594|consen  309 PEKS  312 (323)
T ss_pred             ccch
Confidence            5433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-46  Score=322.25  Aligned_cols=195  Identities=32%  Similarity=0.566  Sum_probs=175.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +++|+||||+. |+|.+++.+.+++++..++.+++|++.|++|||++||+||||||+|++++
T Consensus        80 pnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld  154 (370)
T KOG0583|consen   80 PNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD  154 (370)
T ss_pred             CCEeEEEEEEecC-----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec
Confidence            8999999999998     88999999997 59999999999999999999999999999999999999999999999999


Q ss_pred             cC-CCeEEeeccceeec-cCCCcccccccccccCChhhhhCCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 AN-CDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~-~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .+ +.+||+|||++... .......+.+|++.|+|||++.+.. ..+.++||||+||++|.|++|..||.+.+......+
T Consensus       155 ~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k  234 (370)
T KOG0583|consen  155 GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK  234 (370)
T ss_pred             CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            99 99999999999988 5667788999999999999997766 457999999999999999999999998777766666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CC-ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NV-HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +.+..-                               .+| .+ |+++++|+++||..||.+|+|+.+++.||||+.
T Consensus       235 i~~~~~-------------------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  235 IRKGEF-------------------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HhcCCc-------------------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            432100                               111 23 899999999999999999999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=318.92  Aligned_cols=196  Identities=29%  Similarity=0.528  Sum_probs=176.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |-|++|+..|.+.     ..+|+|+||++ |+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||++
T Consensus       134 PgivkLy~TFQD~-----~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd  208 (604)
T KOG0592|consen  134 PGIVKLYFTFQDE-----ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD  208 (604)
T ss_pred             CCeEEEEEEeecc-----cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc
Confidence            7899999999998     99999999997 79999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--------------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           80 ANCDLKICDFGLARVTSETD--------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      .+|.++|+|||.++......              ...+++||..|.+||++. ....+..+|||+||||+|+|+.|.+||
T Consensus       209 ~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPF  287 (604)
T KOG0592|consen  209 KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPF  287 (604)
T ss_pred             CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCC
Confidence            99999999999997643221              124588999999999985 455899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+.-...++|++..-.-+                              ++.++.++||++++|..||++|+|+.+|.+
T Consensus       288 ra~NeyliFqkI~~l~y~fp------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  288 RAANEYLIFQKIQALDYEFP------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ccccHHHHHHHHHHhcccCC------------------------------CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            99999999998887532211                              256789999999999999999999999999


Q ss_pred             CCCCCCC
Q 023764          226 HPYLGSL  232 (277)
Q Consensus       226 hp~f~~~  232 (277)
                      ||||..+
T Consensus       338 HpFF~~V  344 (604)
T KOG0592|consen  338 HPFFEGV  344 (604)
T ss_pred             CcccccC
Confidence            9999976

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-46  Score=305.54  Aligned_cols=196  Identities=29%  Similarity=0.538  Sum_probs=176.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.||+++..|++.     .++|+|+||+. |+|+-.+++.+.|+++.++.++..|+.||.|||+.||+|||+||+|||++
T Consensus        85 PFiv~l~ysFQt~-----~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd  159 (357)
T KOG0598|consen   85 PFIVKLIYSFQTE-----EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD  159 (357)
T ss_pred             CcEeeeEEecccC-----CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec
Confidence            8999999999998     99999999996 69999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.++|+|||+|+..- ......+.+||+.|||||++.+. .|+.++|.||||+++|+|++|.+||.+.+.....+++.
T Consensus       160 ~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~  238 (357)
T KOG0598|consen  160 EQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL  238 (357)
T ss_pred             CCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence            99999999999998543 34455668999999999999766 59999999999999999999999999999888888776


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCC----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRI----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~----t~~ell~hp~f~~~  232 (277)
                      ..-..                              ..| .++.++++|++++|..||++|.    .+.++-+||||..+
T Consensus       239 ~~k~~------------------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  239 KGKLP------------------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             cCcCC------------------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            53211                              112 3788999999999999999996    68999999999976

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-46  Score=299.06  Aligned_cols=202  Identities=30%  Similarity=0.567  Sum_probs=179.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++|.|+|..+     ..+++|+|+|. |.|+|++.+.-.+|++..++|+.|+++|++|||.++|+|||+||+|||++
T Consensus        83 P~II~l~D~yes~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld  157 (411)
T KOG0599|consen   83 PYIIDLQDVYESD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD  157 (411)
T ss_pred             CcEEEeeeeccCc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec
Confidence            8999999999998     89999999997 89999999988999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++..++|+|||++.....++.....||||+|+|||.+.+     ...|+..+|+|++|||+|.++.|++||........+
T Consensus       158 dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML  237 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML  237 (411)
T ss_pred             cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH
Confidence            999999999999999988888889999999999999854     345888999999999999999999999877766666


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +.|++-.-.-                          -+..+.++|.+.+|||++||+.||.+|.|++|+|+||||..+.
T Consensus       238 R~ImeGkyqF--------------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  238 RMIMEGKYQF--------------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             HHHHhccccc--------------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence            6666421111                          1233457888999999999999999999999999999997653

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.8e-44  Score=312.59  Aligned_cols=266  Identities=41%  Similarity=0.746  Sum_probs=215.7

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+...++|+||||++++|.+.+..  .+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        83 ~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  160 (364)
T cd07875          83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  160 (364)
T ss_pred             CCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC
Confidence            79999999987643 234467899999999999888864  488999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.+
T Consensus       161 ~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  239 (364)
T cd07875         161 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  239 (364)
T ss_pred             CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999987655544455678999999999865 4589999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC------------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..+.|.......+......+....+......+.+.++            ..+..+++||.+||+.||.+|||++++|+||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            9999888776666666556655555444333333222            2356789999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcCCCCC-CcchhhhhcCHHHHHHHHHHHHHh
Q 023764          228 YLGSLHDISDEPVCMSPF-SFDFEQHALTEGQMKELIYQEALA  269 (277)
Q Consensus       228 ~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  269 (277)
                      ||..+.++.......... ....+....+.++++++++.++++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (364)
T cd07875         320 YINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD  362 (364)
T ss_pred             ccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHHHc
Confidence            999887766544332222 223345567888899999998865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=321.83  Aligned_cols=224  Identities=35%  Similarity=0.656  Sum_probs=187.1

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |+|+++|+|...     +|+|||+|+++.+|.++++.+  ..++...++.++.||+.||.+||+.||||+||||+|||+.
T Consensus       249 n~Vrm~d~F~fr-----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~  323 (586)
T KOG0667|consen  249 NIVRMLDYFYFR-----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLK  323 (586)
T ss_pred             eEEEeeeccccc-----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeec
Confidence            899999999998     999999999999999999977  4699999999999999999999999999999999999996


Q ss_pred             cC--CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 AN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ..  ..+||+|||.+...++.-.  ++..+++|+|||++++.. |+.+.||||||||++||.+|.++|+|.+..++++.|
T Consensus       324 ~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  324 DPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             cCCcCceeEEecccccccCCcce--eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence            54  3699999999988776533  788999999999998765 999999999999999999999999999999999999


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhh--hCCccc------------------------------CCcccccCC-CCChhHHH
Q 023764          158 IELIGTPSEAELGFLNENAKKYIC--QLPRYQ------------------------------RQSFTEKFP-NVHPSAID  204 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------------------~~~~~~~~~-~~~~~~~~  204 (277)
                      ++.+|.|+..++.........+..  ..+...                              ...+....+ .....+.|
T Consensus       401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d  480 (586)
T KOG0667|consen  401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID  480 (586)
T ss_pred             HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence            999999999877654443222222  000000                              001111111 22356899


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          205 LVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       205 li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ||++||++||.+|+|+.++|+||||....
T Consensus       481 flk~~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  481 FLKRCLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHHhccCchhcCCHHHHhcCccccccc
Confidence            99999999999999999999999999544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.9e-44  Score=303.49  Aligned_cols=224  Identities=38%  Similarity=0.743  Sum_probs=188.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        63 ~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~  137 (288)
T cd07871          63 ANIVTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN  137 (288)
T ss_pred             CCEeeEEEEEcCC-----CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            7999999999887     7899999999999999887654 578999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|++||.+.+..+.+..+.
T Consensus       138 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  217 (288)
T cd07871         138 EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF  217 (288)
T ss_pred             CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998764332 223345678999999998765668999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.|+...+..............+.....+.....+.++.++++||++||++||.+|||++|+++||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            99999988877665332222222233333334444556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-43  Score=307.64  Aligned_cols=268  Identities=48%  Similarity=0.883  Sum_probs=221.0

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+....+|+++++++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus        74 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~  152 (343)
T cd07878          74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN  152 (343)
T ss_pred             CchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence            79999999997543 234467899999999999888764 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....+++.|+|||++.+...++.++||||+||++++|++|..||.+.+..+.+..+.+
T Consensus       153 ~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07878         153 EDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME  230 (343)
T ss_pred             CCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            9999999999999765443  33457899999999987656689999999999999999999999999988888888888


Q ss_pred             HhCCCChHhhhhhh-hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+......... .....+....+......+...+...++.+.+||.+||+.||.+|||+.++++||||.....+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~  310 (343)
T cd07878         231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE  310 (343)
T ss_pred             HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccc
Confidence            88888776655543 33344455555555555566666788899999999999999999999999999999998776554


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +.. .+............+++++..+.+..++.|
T Consensus       311 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07878         311 PEA-EPYDESPENKERTIEEWKELTYEEVSSFKP  343 (343)
T ss_pred             ccc-CccccchhhhhccHHHHHHHHHHHHHhcCC
Confidence            433 344444556677889999999999988876

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.2e-43  Score=307.52  Aligned_cols=270  Identities=46%  Similarity=0.762  Sum_probs=215.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.......+.++|+||||++++|.+.+...+.+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus        59 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~  138 (372)
T cd07853          59 DNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS  138 (372)
T ss_pred             CCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC
Confidence            79999999998764444458999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      ++.++|+|||++......  .......+++.|+|||.+.+...++.++||||+||++++|++|++||.+.+....+..+.
T Consensus       139 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  218 (372)
T cd07853         139 NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT  218 (372)
T ss_pred             CCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            999999999998764332  222344678899999998765667899999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCc--ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC--
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQS--FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD--  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~--  234 (277)
                      +..+.++...+.........+....+......  .....+..++++.+||.+||+.||++|||+.++++||||.....  
T Consensus       219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  298 (372)
T cd07853         219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRY  298 (372)
T ss_pred             HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchh
Confidence            99999888766544333333333222222110  11223456889999999999999999999999999999987421  


Q ss_pred             ------------------CCCCCcCCCCCCcchhhhhcCHHHHHHHHHHHHHhh
Q 023764          235 ------------------ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF  270 (277)
Q Consensus       235 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (277)
                                        ...++....+++.+.+....+..++++.+...+..+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         299 HTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             ccccccccccccccccCCcccCCCCCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence                              111233344556666777788889999988877654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=288.39  Aligned_cols=193  Identities=31%  Similarity=0.546  Sum_probs=175.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |++++|.+.|.+.     +++|+||||.+ |.|+.++++.++|++..++.++.||+.||+|||+++|++||+||+|||++
T Consensus       104 PFlv~l~~t~~d~-----~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD  178 (355)
T KOG0616|consen  104 PFLVKLYGTFKDN-----SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD  178 (355)
T ss_pred             ceeEEEEEeeccC-----CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec
Confidence            7899999999998     99999999996 69999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+||+|||+++.....  ..+.||||-|+|||++.. +.++.++|.|||||++|||+.|.+||.+.+..+.+.+|.+
T Consensus       179 ~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~  255 (355)
T KOG0616|consen  179 QNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE  255 (355)
T ss_pred             cCCcEEEEeccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence            9999999999999887765  567899999999999854 5699999999999999999999999999999888888876


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      -.-                               .+| ..+++++|||+++|+.|-.+|.     ...++..||||+++
T Consensus       256 ~~v-------------------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  256 GKV-------------------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             Ccc-------------------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            311                               112 4788999999999999999994     47899999999975

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5e-43  Score=305.63  Aligned_cols=263  Identities=42%  Similarity=0.746  Sum_probs=205.6

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+.+..+|+||||++++|.+.+..  .+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        80 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~  157 (359)
T cd07876          80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  157 (359)
T ss_pred             CCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            79999999997653 234467899999999998888753  488999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.............+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+....+..+.+
T Consensus       158 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~  236 (359)
T cd07876         158 SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE  236 (359)
T ss_pred             CCCCEEEecCCCccccccCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999876544444455678999999999865 4588999999999999999999999999998889999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC------------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..+.|..............+....+......+.+.++            ..++++++||.+||+.||++|||+.|+|+||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            9999888766655555555555555544444333332            2367899999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcCCCCCCc-chhhhhcCHHHHHHHHHHH
Q 023764          228 YLGSLHDISDEPVCMSPFSF-DFEQHALTEGQMKELIYQE  266 (277)
Q Consensus       228 ~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  266 (277)
                      ||..+.++............ ..+........+++++...
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (359)
T cd07876         317 YITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE  356 (359)
T ss_pred             hhhhhcCcccccCCCccccccccccccccHHHHHHHHHHH
Confidence            99987765543322221211 2233344455566655544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.1e-44  Score=307.39  Aligned_cols=200  Identities=27%  Similarity=0.502  Sum_probs=171.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |+||||+-.|+++     ..+||||||++ |++..+|.+.+.|+++.++.++.+++.|++.+|+.|+|||||||+|+|++
T Consensus       201 ~~vVKLyYsFQD~-----~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD  275 (550)
T KOG0605|consen  201 PWVVKLYYSFQDK-----EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID  275 (550)
T ss_pred             CcEEEEEEEecCC-----CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec
Confidence            7899999999998     99999999996 69999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC----------------------C--C------------------------cccccccccccC
Q 023764           80 ANCDLKICDFGLARVTSE----------------------T--D------------------------FMTEYVVTRWYR  111 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~----------------------~--~------------------------~~~~~~~~~~~~  111 (277)
                      ..|.+||+|||+|.....                      .  .                        ...+.+|||-|+
T Consensus       276 ~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYi  355 (550)
T KOG0605|consen  276 AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYI  355 (550)
T ss_pred             CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcccc
Confidence            999999999999842110                      0  0                        012357899999


Q ss_pred             ChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc
Q 023764          112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF  191 (277)
Q Consensus       112 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (277)
                      |||++.+.+ |+..+|.||||||+||||.|.+||.+.+..+.+++|+.--..                    ..++.   
T Consensus       356 APEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------------l~fP~---  411 (550)
T KOG0605|consen  356 APEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------------LKFPE---  411 (550)
T ss_pred             chHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------------ccCCC---
Confidence            999998765 999999999999999999999999999999999988752110                    00000   


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCC
Q 023764          192 TEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLH  233 (277)
Q Consensus       192 ~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~~  233 (277)
                         -...+++++|||.+||+ ||.+|..   ++||.+||||+.+.
T Consensus       412 ---~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  412 ---EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             ---cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence               02466899999999999 9999996   89999999999863

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=286.87  Aligned_cols=217  Identities=29%  Similarity=0.489  Sum_probs=175.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||.++|+|... ..+-..+.+|||.|+ |+|+..++.++.  |++.++..|+.||..|+.|||+.+|.|||+||+|+|
T Consensus       115 ~~iV~IidVyeNs-~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL  193 (400)
T KOG0604|consen  115 PHIVSIIDVYENS-YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL  193 (400)
T ss_pred             CceEEeehhhhhh-ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence            8999999999874 333378999999996 699999988765  999999999999999999999999999999999999


Q ss_pred             Eec---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           78 LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ...   +..+||+|||+++....+....+.+.||+|.|||++ +...|+..+|+||+||++|-|+||.+||.+......-
T Consensus       194 yt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais  272 (400)
T KOG0604|consen  194 YTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_pred             eecCCCCcceEecccccccccCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence            964   456899999999988877778889999999999998 5566999999999999999999999999765432111


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .-+...+...                    +  .....+.|..+|.+++|+|+++|..+|.+|.|++++++|||+++...
T Consensus       273 pgMk~rI~~g--------------------q--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  273 PGMKRRIRTG--------------------Q--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hhHHhHhhcc--------------------C--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            1111111100                    0  00112233467889999999999999999999999999999998776


Q ss_pred             CCCCCcC
Q 023764          235 ISDEPVC  241 (277)
Q Consensus       235 ~~~~~~~  241 (277)
                      ..+-+.+
T Consensus       331 vp~tpl~  337 (400)
T KOG0604|consen  331 VPQTPLS  337 (400)
T ss_pred             CCCCCch
Confidence            5554443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=310.90  Aligned_cols=198  Identities=26%  Similarity=0.532  Sum_probs=172.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||.+++.|...     +.+++|||||+ |+|.+++.+ -.++|.++..|+++++.||+|||.+||+|||||.+|||++
T Consensus       330 ~NiVnfl~Sylv~-----deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~  403 (550)
T KOG0578|consen  330 PNIVNFLDSYLVG-----DELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT  403 (550)
T ss_pred             hHHHHHHHHhccc-----ceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence            7999999999998     89999999997 599998876 4599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+|...... ....+.+|||+|||||++. ...|+.++||||||++++||+.|.+||-..+...-+..|.
T Consensus       404 ~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa  482 (550)
T KOG0578|consen  404 MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  482 (550)
T ss_pred             cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh
Confidence            9999999999999876554 3677889999999999985 4569999999999999999999999998766655555443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      . .|+|.-                          +..+.+|+.++|||.+||+.|+.+|+||.|||+||||+..
T Consensus       483 ~-ng~P~l--------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  483 T-NGTPKL--------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             h-cCCCCc--------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            3 333322                          2234789999999999999999999999999999999653

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-44  Score=278.84  Aligned_cols=199  Identities=31%  Similarity=0.524  Sum_probs=172.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++|++.+.+.     +..|+|+|+|.| +|..-+-.+--+++..+..++.||++||.|+|.+||+|||+||+|+++-
T Consensus        70 P~IvrL~~ti~~~-----~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA  144 (355)
T KOG0033|consen   70 PNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA  144 (355)
T ss_pred             CcEeehhhhhccc-----ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence            8999999999887     889999999975 8877766666789999999999999999999999999999999999984


Q ss_pred             c---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 A---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .   ..-+||+|||++...++....-...|+|.|||||++.+ .+|+..+|||+.|||+|-++.|++||.+.+....++.
T Consensus       145 SK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~  223 (355)
T KOG0033|consen  145 SKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ  223 (355)
T ss_pred             eccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Confidence            3   34589999999988776655566789999999999955 4599999999999999999999999999888877777


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      |+.-.-.                          -....++++++++++|+++||..||.+|+|+.|+|+|||+..
T Consensus       224 I~~g~yd--------------------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  224 IKAGAYD--------------------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HhccccC--------------------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            7642111                          112346789999999999999999999999999999999976

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-42  Score=302.52  Aligned_cols=265  Identities=40%  Similarity=0.736  Sum_probs=207.8

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+.....|+||||+++++.+.+..  .+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        76 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~  153 (355)
T cd07874          76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  153 (355)
T ss_pred             CchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence            79999999987643 234467899999999999888764  488999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.............+++.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+..+....+.+
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (355)
T cd07874         154 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  232 (355)
T ss_pred             CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999987655544556678999999999854 4589999999999999999999999999998899999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCccccc------------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK------------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..+.+....+..+......+....+......+...            ....+.++++||.+||+.||++|||+.++|+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence            88888877666655555555444443322211111            122456789999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcCCCC-CCcchhhhhcCHHHHHHHHHHHHH
Q 023764          228 YLGSLHDISDEPVCMSP-FSFDFEQHALTEGQMKELIYQEAL  268 (277)
Q Consensus       228 ~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  268 (277)
                      ||+.+.++.......+. +.....+...+..++++.+..+++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T cd07874         313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_pred             chhcccChhhccCCCccccccchhhhhccHHHHHHHHHHHhh
Confidence            99987665443322211 222334445567788888877654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-42  Score=300.77  Aligned_cols=268  Identities=51%  Similarity=0.953  Sum_probs=228.3

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+... ..+.+.|+|+||++++|.+++.. ..+++..+..++.|++.||.+||+.|++||||+|+||+++
T Consensus        74 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~  152 (343)
T cd07851          74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  152 (343)
T ss_pred             CCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence            789999998876532 44467999999999999999876 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....++..|+|||.+.+...++.++||||+||+++++++|+.||.+.+.......+.+
T Consensus       153 ~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~  230 (343)
T cd07851         153 EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN  230 (343)
T ss_pred             CCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999999998765433  33446788899999986544578999999999999999999999999888888888888


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+++..+..+ ......+....+......+...++..+..+.+||++||+.||.+|||+.++++||||..+....++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~  310 (343)
T cd07851         231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE  310 (343)
T ss_pred             hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc
Confidence            8888777655544 344455566666666666666677789999999999999999999999999999999999888766


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +. ...++.+++...+..++|+++++.++.+|.|
T Consensus       311 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         311 PV-APPYDQSFESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             cc-ccccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence            64 6677788899999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=298.75  Aligned_cols=267  Identities=60%  Similarity=1.066  Sum_probs=218.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++......+..+.|+|+||++++|.+.+.. ..+++..++.++.|++.||.+||++|++||||||+||+++.
T Consensus        63 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~  141 (336)
T cd07849          63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT  141 (336)
T ss_pred             CCcCchhheeecccccccceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence            79999999987765555578999999999999988864 57999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++|+|||++.......    ......+++.|+|||.+.+...++.++||||+||++++|++|++||.+.+.......
T Consensus       142 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~  221 (336)
T cd07849         142 NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL  221 (336)
T ss_pred             CCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999987654322    122346788999999876555688999999999999999999999999888888888


Q ss_pred             HHHHhCCCChHhhhhhhh-hHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      +....+.++...+..+.. ....+....+......+....+..++++.+||.+||+.||++|||+.++++||||+.+.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            888888887766654432 2233333344444444555667789999999999999999999999999999999999988


Q ss_pred             CCCCcCCCCCCcch-hhhhcCHHHHHHHHHHHHH
Q 023764          236 SDEPVCMSPFSFDF-EQHALTEGQMKELIYQEAL  268 (277)
Q Consensus       236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (277)
                      +.++....++.+++ ....+..+..|+.|+.+++
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (336)
T cd07849         302 SDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM  335 (336)
T ss_pred             CCcccCCCCCChhhccccccCHHHHHHHHHHHhc
Confidence            88887766666655 3355668899999998875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-42  Score=309.06  Aligned_cols=233  Identities=34%  Similarity=0.654  Sum_probs=186.9

Q ss_pred             CceeeeeccccCCCC---CCCCcEEEEeecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 023764            1 MQVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~   73 (277)
                      |||++++++|.....   +....+|+||||++++|.+++.    ....+++..++.++.|++.||+|||++||+||||||
T Consensus       119 ~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp  198 (440)
T PTZ00036        119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKP  198 (440)
T ss_pred             CCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCH
Confidence            799999998754321   1123578999999998887765    346799999999999999999999999999999999


Q ss_pred             CcEEEecCC-CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           74 SNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        74 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +||+++.++ .+||+|||+++............+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+
T Consensus       199 ~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  278 (440)
T PTZ00036        199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD  278 (440)
T ss_pred             HHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999998665 6999999999866544444456789999999998766668999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .+..+.+..+.|....+..........  ..+......+...+| ..++++++||.+||++||.+|||+.++++||||..
T Consensus       279 ~~~~i~~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        279 QLVRIIQVLGTPTEDQLKEMNPNYADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHHHHhCCCCHHHHHHhchhhhcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence            999999999998876655433221111  122222223333344 46789999999999999999999999999999998


Q ss_pred             CCCC
Q 023764          232 LHDI  235 (277)
Q Consensus       232 ~~~~  235 (277)
                      +.+.
T Consensus       357 ~~~~  360 (440)
T PTZ00036        357 LRDP  360 (440)
T ss_pred             hhcc
Confidence            7653

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-42  Score=294.02  Aligned_cols=225  Identities=37%  Similarity=0.659  Sum_probs=186.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..........+|+||||++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        64 pniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~  143 (290)
T cd07862          64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV  143 (290)
T ss_pred             CCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence            799999999875433334679999999999999998754  458999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++.............+++.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus       144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~  222 (290)
T cd07862         144 TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  222 (290)
T ss_pred             cCCCCEEEccccceEeccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            9999999999999987655444455678999999999854 458899999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.|....+........   ..........+....+.++..+++|+.+||+.||++|||+.++++||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         223 DVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHhCCCChhhchhhhcccc---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            8888777655433211100   1112223344555667889999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-42  Score=300.16  Aligned_cols=266  Identities=62%  Similarity=1.126  Sum_probs=229.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.+....+++.+|+||||++++|.+++..+..+++..+..++.|++.||++||++|++|+||||.||+++.
T Consensus        59 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~  138 (330)
T cd07834          59 ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS  138 (330)
T ss_pred             cchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence            78999999998865455578999999999999999988788999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++|+|||.+.......    ......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+..+....
T Consensus       139 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~  218 (330)
T cd07834         139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL  218 (330)
T ss_pred             CCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence            9999999999998665442    234456788999999986654689999999999999999999999999999999999


Q ss_pred             HHHHhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      +....+.+....+... ......+...........+....+..+.++.+||++||++||.+|||+++++.||||+.+..+
T Consensus       219 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            9999998887766533 333444555455555556666777889999999999999999999999999999999999999


Q ss_pred             CCCCcCCCCCCc-chhhhhcCHHHHHHHHHHH
Q 023764          236 SDEPVCMSPFSF-DFEQHALTEGQMKELIYQE  266 (277)
Q Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  266 (277)
                      ++++....++++ .++...+++.+.+++|+++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd07834         299 EDEPVAKPPFDFDFFDDDELTEEELKELIYEE  330 (330)
T ss_pred             ccCCCCCCcccccccchhhcCHHHHhHHhhcC
Confidence            999988888887 5688889999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-42  Score=299.57  Aligned_cols=264  Identities=57%  Similarity=1.050  Sum_probs=224.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.... ...+.+|+||||++++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        64 ~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~  142 (334)
T cd07855          64 DNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE  142 (334)
T ss_pred             CCccCHHHhccccC-CCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence            79999999987643 23378999999999999999988788999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      ++.++|+|||++.......     ......++..|+|||.+.+...++.++||||+||++++|++|++||.+.+....+.
T Consensus       143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~  222 (334)
T cd07855         143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK  222 (334)
T ss_pred             CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence            9999999999987543221     12234678899999998665568899999999999999999999999999888899


Q ss_pred             HHHHHhCCCChHhhhhhh-hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .+....+.|+...+.... ..........+......+....+..+.+++++|++||+.||.+|||+++++.||||+....
T Consensus       223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence            999999988877655442 2233344444444455556667788999999999999999999999999999999999999


Q ss_pred             CCCCCcCCCCCCcchhhhhcCHHHHHHHHHH
Q 023764          235 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQ  265 (277)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (277)
                      +..++.+..++..+++....+.+.+.+.|..
T Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (334)
T cd07855         303 PDDEPTCPPPFDFDFEAIELSREQLKEAIVK  333 (334)
T ss_pred             CcccccCCCCCCCChhhhhcChhhHHHHhhc
Confidence            9999999999999999999999988887643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-42  Score=295.30  Aligned_cols=229  Identities=40%  Similarity=0.764  Sum_probs=193.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     ++.|+||||++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        64 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~  138 (309)
T cd07872          64 ANIVTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN  138 (309)
T ss_pred             CCcceEEEEEeeC-----CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            7999999999887     889999999999999988764 4589999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||.+.+...++.++||||+||++++|++|++||.+.+..+....+.
T Consensus       139 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  218 (309)
T cd07872         139 ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF  218 (309)
T ss_pred             CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999999998754332 223345678899999998766668899999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ...+.|....+..+...........+...........+.++.++++||++||+.||.+|||++|+++||||+.+..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            9999998887766544333333334444444444556778999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=294.54  Aligned_cols=204  Identities=29%  Similarity=0.462  Sum_probs=163.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++......  + ..+++.|||+. |+|.+++.+.+ .+++..+++++.|+++||+|||++||+|+||||+|||+
T Consensus        74 p~IV~~~G~~~~~~--~-~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl  150 (313)
T KOG0198|consen   74 PNIVQYYGSSSSRE--N-DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL  150 (313)
T ss_pred             CCEEeeCCcccccc--C-eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence            79999999866541  1 37999999996 69999999877 79999999999999999999999999999999999999


Q ss_pred             ec-CCCeEEeeccceeeccC----CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NA-NCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~-~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +. ++.+||+|||++.....    ........||+.|||||++..+...+.++||||+||++.||+||++||...  ...
T Consensus       151 ~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~  228 (313)
T KOG0198|consen  151 DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEE  228 (313)
T ss_pred             eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cch
Confidence            99 79999999999876553    223446789999999999975333446999999999999999999999653  111


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...+......                         ...+.....+|.++++||++||.+||++||||+++|.|||...-.
T Consensus       229 ~~~~~~ig~~-------------------------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  229 AEALLLIGRE-------------------------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHHhcc-------------------------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            1111111100                         011122336889999999999999999999999999999998754


Q ss_pred             C
Q 023764          234 D  234 (277)
Q Consensus       234 ~  234 (277)
                      .
T Consensus       284 ~  284 (313)
T KOG0198|consen  284 I  284 (313)
T ss_pred             c
Confidence            3

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-42  Score=294.43  Aligned_cols=228  Identities=36%  Similarity=0.656  Sum_probs=177.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +..|+||||++++|.+++.+. +.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        63 ~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~  137 (303)
T cd07869          63 ANIVLLHDIIHTK-----ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS  137 (303)
T ss_pred             CCcCeEEEEEecC-----CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            7999999999887     889999999999999888764 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i  157 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|..||.+.. ....+..+
T Consensus       138 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  217 (303)
T cd07869         138 DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI  217 (303)
T ss_pred             CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence            9999999999998754322 223445678999999998665668899999999999999999999998754 34566677


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ....+.|....+.....................+...+.  ..++++++|+++||+.||++|||++++++||||+.+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            777777765544332111000000001111111111121  2457899999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-41  Score=296.66  Aligned_cols=263  Identities=43%  Similarity=0.797  Sum_probs=211.9

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++++++|.... .++..+.|+||||++++|.+.+...  +++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        75 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~  152 (353)
T cd07850          75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  152 (353)
T ss_pred             CCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence            79999999987653 2344678999999999999988754  89999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.............++..|+|||.+.+ ..++.++||||+||++++|++|+.||.+.+....+..+..
T Consensus       153 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~  231 (353)
T cd07850         153 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE  231 (353)
T ss_pred             CCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            999999999999987655444445567889999999865 4589999999999999999999999999998889999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-------------CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-------------NVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+.|+......+......+....+......+.+.++             ..+..+++||.+||+.||++|||+.++|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            9999988776666655555555544443333333222             235678999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCcC-CCCCCcchhhhhcCHHHHHHHHHHH
Q 023764          227 PYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQE  266 (277)
Q Consensus       227 p~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  266 (277)
                      |||..+....+.... ....+...+....+.++|++.++.+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T cd07850         312 PYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKE  352 (353)
T ss_pred             hhHhhccCCccCCCCCCCccccccccccccHHHHHHHHHhh
Confidence            999988776554332 2233334456677778888877765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-41  Score=292.30  Aligned_cols=264  Identities=55%  Similarity=0.977  Sum_probs=217.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||++++++.... ..+.+.+|+++|+++++|.+.+.....+++..++.++.|++.||+|||+.|++||||||+||+++.
T Consensus        62 ~~iv~~~~~~~~~-~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~  140 (332)
T cd07857          62 KNITCLYDMDIVF-PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA  140 (332)
T ss_pred             CChheeeeeeeec-cccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC
Confidence            7899999875432 123367899999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      ++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+......
T Consensus       141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~  220 (332)
T cd07857         141 DCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN  220 (332)
T ss_pred             CCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH
Confidence            9999999999987544321     12334678899999988655567899999999999999999999999998888999


Q ss_pred             HHHHHhCCCChHhhhhhhh-hHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .+....+.|+...+..+.. ....+...........+....+..+..+++|+.+||+.||++|||+.+++.||||+.+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             HHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence            9999999888766555432 223333344444444555666778899999999999999999999999999999999999


Q ss_pred             CCCCCcCCCCCCcchhhhhcCHHHHHHHHHHH
Q 023764          235 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQE  266 (277)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (277)
                      +...+.|..++.++++... +..+++.+|.++
T Consensus       301 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  331 (332)
T cd07857         301 PDDEPVCQKPFDFSFESED-SMEELRDMIIEE  331 (332)
T ss_pred             ccccccccccccCCccccc-cHHHHHHHHhhc
Confidence            9999999999888875543 556777777654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=288.69  Aligned_cols=198  Identities=29%  Similarity=0.515  Sum_probs=171.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++|++..+     +++|+|||||. |+|.++++..+.++++.++.++.||+.|+++||+++|+||||||.|||++
T Consensus        69 ~nIV~l~d~~~~~-----~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs  143 (429)
T KOG0595|consen   69 PNIVRLLDCIEDD-----DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLS  143 (429)
T ss_pred             cceeeEEEEEecC-----CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEec
Confidence            8999999999998     99999999997 79999999999999999999999999999999999999999999999997


Q ss_pred             cC------CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           80 AN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        80 ~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      ..      ..+||+|||+++.........+.+|++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.
T Consensus       144 ~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  144 TTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             cCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            65      5689999999999998888889999999999999964 4599999999999999999999999988877766


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ...+.+-....+                           ......+...++++...|..+|..|.+..+-+.|++...
T Consensus       223 ~~~~~k~~~~~~---------------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  223 LLYIKKGNEIVP---------------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             HHHHhccccccC---------------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence            553322111100                           000134566789999999999999999999999998875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-41  Score=290.17  Aligned_cols=268  Identities=45%  Similarity=0.863  Sum_probs=220.8

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... ......+|+||||++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++
T Consensus        74 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~  152 (343)
T cd07880          74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN  152 (343)
T ss_pred             CCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence            79999999997653 233456899999998899888864 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....+++.|+|||.+.+...++.++|+||+||+++++++|.+||.+.+.......+..
T Consensus       153 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07880         153 EDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK  230 (343)
T ss_pred             CCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999998765432  23346688899999986545578999999999999999999999998888777777777


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.++......+ ......+....+......+....+..++++.++|.+||+.||++|||+.+++.||||+.+.....+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~  310 (343)
T cd07880         231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE  310 (343)
T ss_pred             hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence            7666665544443 223344555555555555555567889999999999999999999999999999999999876665


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      + ...++....+....+.++|+.+...++++|+|
T Consensus       311 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         311 T-EAPPYDDSFDEVDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             c-CCCCccccHHhhccchHHHHHHHHHHHHhcCC
Confidence            5 34467777888899999999999999999986

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=299.81  Aligned_cols=203  Identities=32%  Similarity=0.579  Sum_probs=179.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ||||++++.|..+     +++++|+||+.|+|+.++...+.++++.++.+++|++.||.|||+++|.|||+||.||+++.
T Consensus        61 pniv~m~esfEt~-----~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~  135 (808)
T KOG0597|consen   61 PNIVEMLESFETS-----AHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK  135 (808)
T ss_pred             cchhhHHHhhccc-----ceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC
Confidence            8999999999998     99999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .|.+|+||||+++..+... .....-|||.|||||++. ...|+..+|.||+|||+||+..|++||...+..+..+.|..
T Consensus       136 ~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~  214 (808)
T KOG0597|consen  136 GGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK  214 (808)
T ss_pred             CCceeechhhhhhhcccCceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence            9999999999999887754 345567999999999985 56799999999999999999999999987776666555543


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP  239 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~  239 (277)
                      ---.|+                              +.+|..++.|+.++|.+||.+|.|..+++.|||+++-....+.+
T Consensus       215 d~v~~p------------------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~  264 (808)
T KOG0597|consen  215 DPVKPP------------------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELP  264 (808)
T ss_pred             CCCCCc------------------------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccc
Confidence            211111                              26788999999999999999999999999999998765444433

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2e-41  Score=286.61  Aligned_cols=225  Identities=36%  Similarity=0.644  Sum_probs=184.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..........+++|||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus        62 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili  141 (288)
T cd07863          62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV  141 (288)
T ss_pred             CCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            799999999876544444679999999999999988764  348999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++.............++..|+|||++.+ ..++.++||||+||++++|++|.+||.+....+.+.++.
T Consensus       142 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~  220 (288)
T cd07863         142 TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  220 (288)
T ss_pred             CCCCCEEECccCccccccCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence            9999999999999876654444445577889999999865 458999999999999999999999999988888888888


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.+....+.......   ................+.++..+++||.+||+.||++|||+.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         221 DLIGLPPEDDWPRDVTLP---RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHhCCCChhhCccccccc---ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            888777665443211100   00111222333455567788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.9e-41  Score=286.84  Aligned_cols=228  Identities=39%  Similarity=0.759  Sum_probs=187.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++++|.+++.+. ..+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus        64 ~nI~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~  138 (301)
T cd07873          64 ANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN  138 (301)
T ss_pred             CCcceEEEEEecC-----CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC
Confidence            7999999999887     889999999999999988764 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||.+.+...++.++||||+||++++|++|++||.+.+..+....+.
T Consensus       139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~  218 (301)
T cd07873         139 ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF  218 (301)
T ss_pred             CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998754332 122334568899999998766667899999999999999999999999998888888888


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...+.+....+..+...........+......+....+.+++.+++||.+||+.||.+|||++++++||||+.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            888888776665442222111222222222223344457889999999999999999999999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8e-42  Score=275.96  Aligned_cols=228  Identities=40%  Similarity=0.727  Sum_probs=186.8

Q ss_pred             CceeeeeccccC-CCCCCCCcEEEEeecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPP-PQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~-~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||++|..+|.. +     ..+++++||.+.+|.++|+..     +.++...++.|++||+.|+.|||++.|+|||+||.
T Consensus        87 ~nvi~Lv~Vfl~~d-----~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPa  161 (438)
T KOG0666|consen   87 PNVISLVKVFLSHD-----KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPA  161 (438)
T ss_pred             CcchhHHHHHhccC-----ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcc
Confidence            799999999987 4     889999999999999999743     45888999999999999999999999999999999


Q ss_pred             cEEEecC----CCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           75 NLLLNAN----CDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        75 nil~~~~----~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      ||++..+    |++||+|||+++....+    ......+.|.+|+|||.+.+...|+.+.|+|++|||+.||++-.+.|.
T Consensus       162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            9999888    99999999999876544    123445678999999999999999999999999999999999999997


Q ss_pred             CCC---------hHHHHHHHHHHhCCCChHhhhhhhhh--HHHHhhhCC--cccCCcccc---cCCCCChhHHHHHHHhc
Q 023764          147 GRD---------HVHQLRLLIELIGTPSEAELGFLNEN--AKKYICQLP--RYQRQSFTE---KFPNVHPSAIDLVEKML  210 (277)
Q Consensus       147 ~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~li~~~L  210 (277)
                      +..         ..+++.+|.+.+|.|.+..|..+...  ....+..+.  .+..-++..   ....-++.+.+|+.+||
T Consensus       242 g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL  321 (438)
T KOG0666|consen  242 GREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLL  321 (438)
T ss_pred             chhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHh
Confidence            653         46789999999999999998776432  111122111  111111111   11223556999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCC
Q 023764          211 TFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       211 ~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..||.+|.|++++|+|+||..-.
T Consensus       322 ~yDP~kRIta~qAleh~yF~~d~  344 (438)
T KOG0666|consen  322 TYDPIKRITAEQALEHPYFTEDP  344 (438)
T ss_pred             ccCchhhccHHHHhcccccccCC
Confidence            99999999999999999998743

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.4e-41  Score=284.43  Aligned_cols=223  Identities=32%  Similarity=0.665  Sum_probs=174.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +.+|+||||+++++.+.+. ....+++..++.++.|++.||.|||+.|++||||||+||+++
T Consensus        60 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~  134 (287)
T cd07848          60 ENIVELKEAFRRR-----GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS  134 (287)
T ss_pred             ccccchhhhEecC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence            7999999999887     8999999999876555554 345799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++.......  ......+++.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+
T Consensus       135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~  213 (287)
T cd07848         135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI  213 (287)
T ss_pred             CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999987654321  22345688999999998654 4899999999999999999999999998888877777


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcc--cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRY--QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+..+..+...+..............+..  ...........+|.++++||++||++||++|||++++++||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            77777766554433221110000000100  0001112223478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=289.04  Aligned_cols=199  Identities=28%  Similarity=0.495  Sum_probs=179.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+||++....     ..+|||+|+-+ |+|+++|.++ ..++++.+++++.||+.|+.|+|+..++|||+||+|+.+
T Consensus        77 pNiVRLYEViDTQ-----TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVF  151 (864)
T KOG4717|consen   77 PNIVRLYEVIDTQ-----TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVF  151 (864)
T ss_pred             cCeeeeeehhccc-----ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEE
Confidence            8999999999888     88999999997 5999999876 579999999999999999999999999999999999866


Q ss_pred             -ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 -NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                       ..-|.+||.|||++.....+....+.||+..|.|||++.+...-.+++||||||||+|-++||.+||...++.+.+-.|
T Consensus       152 FEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI  231 (864)
T KOG4717|consen  152 FEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI  231 (864)
T ss_pred             eeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh
Confidence             5569999999999998888888899999999999999998876689999999999999999999999999988888887


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +.-.-+.+                              .++|.++++||..||+.||++|.|.++|..++|++....
T Consensus       232 mDCKYtvP------------------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  232 MDCKYTVP------------------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             hcccccCc------------------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            76432222                              267889999999999999999999999999999998643

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-40  Score=285.03  Aligned_cols=268  Identities=48%  Similarity=0.902  Sum_probs=220.1

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... ....+..|+++++++++|.+++.. ..+++..++.++.|++.||+|||+.|++||||+|+||+++
T Consensus        76 ~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~  154 (345)
T cd07877          76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN  154 (345)
T ss_pred             CcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc
Confidence            79999999987543 233367899999999999888765 4699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....++..|+|||.+.+...++.++||||+||++++|++|++||.+.+.......+..
T Consensus       155 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         155 EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999998765432  23456788899999986655678899999999999999999999998888888888888


Q ss_pred             HhCCCChHhhhhhhh-hHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+.......+.. ....+....+......+.......++++++||.+||+.||.+|+|+.++++||||+.+..+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~  312 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  312 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence            888777766655532 2334444455554445555555678899999999999999999999999999999998887776


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +.. .++...+....+..+++....|.++.+|.|
T Consensus       313 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         313 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             ccC-CCccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence            654 356666677777889999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=283.50  Aligned_cols=209  Identities=23%  Similarity=0.405  Sum_probs=171.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||++++..|..+     +.+|+||.+|. |++.+++...  ..++|..+..|+++++.||.|||.+|.||||+|+.|||
T Consensus        84 PNIv~~~~sFvv~-----~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL  158 (516)
T KOG0582|consen   84 PNIVTYHCSFVVD-----SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL  158 (516)
T ss_pred             CCcceEEEEEEec-----ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence            8999999999998     99999999996 7999999864  45999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC-----cccccccccccCChhh-hhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           78 LNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPEL-LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~-~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      ++.+|.++|+|||.+....+..     .+.+..|++.|||||+ ......|+.|+||||+|+...|+.+|..||..-...
T Consensus       159 i~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm  238 (516)
T KOG0582|consen  159 IDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM  238 (516)
T ss_pred             EcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence            9999999999999875433221     1266789999999999 444556999999999999999999999999776655


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +.+  +.+..+.|+.........                  +.....+..++.++..||++||++||||+++|+|+||+.
T Consensus       239 kvL--l~tLqn~pp~~~t~~~~~------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  239 KVL--LLTLQNDPPTLLTSGLDK------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             HHH--HHHhcCCCCCcccccCCh------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence            532  334445555322111111                  111235668999999999999999999999999999998


Q ss_pred             CCC
Q 023764          232 LHD  234 (277)
Q Consensus       232 ~~~  234 (277)
                      ...
T Consensus       299 ~k~  301 (516)
T KOG0582|consen  299 AKS  301 (516)
T ss_pred             ccc
Confidence            754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-42  Score=275.61  Aligned_cols=187  Identities=29%  Similarity=0.481  Sum_probs=156.1

Q ss_pred             Cceeeeec-cccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecC
Q 023764            1 MQVVAIRD-IIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHS--AN--VLHRD   70 (277)
Q Consensus         1 pniv~l~~-~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~--~~--i~H~d   70 (277)
                      ||||++++ -|.++.    .-++||||||+ |+|.++++.    ++.+++..+++++.|++.||.++|+  ..  |+|||
T Consensus        78 pNIVqYy~~~f~~~~----evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRD  153 (375)
T KOG0591|consen   78 PNIVQYYAHSFIEDN----EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRD  153 (375)
T ss_pred             chHHHHHHHhhhccc----hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeecc
Confidence            89999999 565541    34999999997 799999863    3579999999999999999999999  44  99999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |||.||+++.+|.+||+|||+++..... ....+.+|||+||+||.+.. ..|+.++||||+||++|||..-.+||.|.+
T Consensus       154 IKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n  232 (375)
T KOG0591|consen  154 IKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDN  232 (375)
T ss_pred             CcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence            9999999999999999999999877655 34567899999999999865 459999999999999999999999999996


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  220 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  220 (277)
                      -.....+|.. ...|+-..                           ..+|.++..||..|+..||..||+.
T Consensus       233 ~~~L~~KI~q-gd~~~~p~---------------------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  233 LLSLCKKIEQ-GDYPPLPD---------------------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHHHc-CCCCCCcH---------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence            6555555433 22211100                           2578899999999999999999986

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=293.19  Aligned_cols=230  Identities=22%  Similarity=0.316  Sum_probs=176.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||++++++|...     +..|+|+|+++++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus       143 pnIv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~  217 (391)
T PHA03212        143 PSIIQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH  217 (391)
T ss_pred             CCCCCEeEEEEEC-----CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC
Confidence            8999999999887     88999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-------ChH
Q 023764           81 NCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-------DHV  151 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~  151 (277)
                      ++.++|+|||++......  .......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.       ...
T Consensus       218 ~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~  296 (391)
T PHA03212        218 PGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD  296 (391)
T ss_pred             CCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchh
Confidence            999999999998643221  22334578999999999855 45899999999999999999999877543       234


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHH-H---hhhCCccc-CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKK-Y---ICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+..+....+.++............. +   ........ ..+.......++.++.+||.+||++||.+|||++|+|+|
T Consensus       297 ~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        297 RQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            567777777776554322111111111 1   01000000 001111122456789999999999999999999999999


Q ss_pred             CCCCCCCCCC
Q 023764          227 PYLGSLHDIS  236 (277)
Q Consensus       227 p~f~~~~~~~  236 (277)
                      |||+.+..+.
T Consensus       377 p~f~~~~~~~  386 (391)
T PHA03212        377 AAFQDIPDPY  386 (391)
T ss_pred             hhhccCCCCC
Confidence            9999876543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.7e-40  Score=284.14  Aligned_cols=258  Identities=50%  Similarity=0.969  Sum_probs=217.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++....    +..|+|+||++++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|.||+++.
T Consensus        69 pniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~  143 (328)
T cd07856          69 ENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE  143 (328)
T ss_pred             CCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC
Confidence            79999999987632    67899999999999888865 56888999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL  160 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  160 (277)
                      ++.++|+|||.+......  .....++..|+|||.+.....++.++|+||+||++++|++|.+||.+.........+.+.
T Consensus       144 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~  221 (328)
T cd07856         144 NCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL  221 (328)
T ss_pred             CCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999999999998754332  234467888999998765456889999999999999999999999998888888888888


Q ss_pred             hCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 023764          161 IGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP  239 (277)
Q Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~  239 (277)
                      .+.++....... .....++....+.....+.....+..+..++++|++||+.+|++|||+++++.||||...+.+..++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         222 LGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             hCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence            888877655433 2223333333443344445556677889999999999999999999999999999999999998889


Q ss_pred             cCCCCCCcchhhhhcCHHHHHHHHHH
Q 023764          240 VCMSPFSFDFEQHALTEGQMKELIYQ  265 (277)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (277)
                      .....|++.++...+..+.|+-+++.
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (328)
T cd07856         302 VAEEKFDWSFNDADLPVDTWKVMMYS  327 (328)
T ss_pred             CchhhcCCchhcccCCHHHHHHHhcC
Confidence            98899999999999999999988875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-40  Score=299.21  Aligned_cols=227  Identities=24%  Similarity=0.415  Sum_probs=176.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~~   79 (277)
                      +||++++++|....    +++|+|||+++++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+||+++
T Consensus       191 ~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~  266 (467)
T PTZ00284        191 FPLMKIQRYFQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME  266 (467)
T ss_pred             cceeeeEEEEEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence            36888999887542    689999999999999999888899999999999999999999998 5999999999999998


Q ss_pred             cCC----------------CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           80 ANC----------------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        80 ~~~----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      .++                .+||+|||.+.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~  343 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKL  343 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence            765                499999998754322  23456789999999998654 58999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhh-hhHHHHhhhCCccc----CCccccc-----C--CCCChhHHHHHHHhcC
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQ----RQSFTEK-----F--PNVHPSAIDLVEKMLT  211 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~-----~--~~~~~~~~~li~~~L~  211 (277)
                      ||.+.+..+.+..+.+..+.++........ .....+........    ...+...     .  ...++.++|||.+||+
T Consensus       344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  423 (467)
T PTZ00284        344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH  423 (467)
T ss_pred             CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence            999999988888888888887765443221 11111111111100    0000000     0  0124678899999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCC
Q 023764          212 FDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       212 ~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +||.+|||++|+|+||||.....
T Consensus       424 ~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        424 YDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             cChhhCCCHHHHhcCccccccCC
Confidence            99999999999999999998654

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-40  Score=283.78  Aligned_cols=226  Identities=35%  Similarity=0.655  Sum_probs=173.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++....   ...+|+||||++++|.+++...         ..+++..++.++.|++.||.|||++||+||||
T Consensus        58 ~niv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDl  134 (317)
T cd07868          58 PNVISLQKVFLSHA---DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL  134 (317)
T ss_pred             CCCcceeeeEecCC---CcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCC
Confidence            79999999986542   1679999999999998887532         25899999999999999999999999999999


Q ss_pred             CCCcEEE----ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           72 KPSNLLL----NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        72 ~~~nil~----~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      ||+||++    +.++.+||+|||++.......    ......+++.|+|||++.+...++.++||||+||++++|++|.+
T Consensus       135 kp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  214 (317)
T cd07868         135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP  214 (317)
T ss_pred             CHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999    456789999999997654321    22345788999999998766668999999999999999999999


Q ss_pred             CCCCCCh---------HHHHHHHHHHhCCCChHhhhhhhhhHH--HHhhhCCc--ccC----CcccccCCCCChhHHHHH
Q 023764          144 LFPGRDH---------VHQLRLLIELIGTPSEAELGFLNENAK--KYICQLPR--YQR----QSFTEKFPNVHPSAIDLV  206 (277)
Q Consensus       144 pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~----~~~~~~~~~~~~~~~~li  206 (277)
                      ||.+...         ...+..+....+.|....+........  ........  ...    ...+......+..+.+||
T Consensus       215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli  294 (317)
T cd07868         215 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL  294 (317)
T ss_pred             CccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHH
Confidence            9975432         466778888888888776655422110  00000000  000    011111223466799999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCC
Q 023764          207 EKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       207 ~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ++||++||.+|||++|+|+||||
T Consensus       295 ~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         295 QKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-41  Score=289.45  Aligned_cols=196  Identities=27%  Similarity=0.487  Sum_probs=165.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. ++|.+.+.+++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        55 p~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~  129 (323)
T cd05571          55 PFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD  129 (323)
T ss_pred             CCCCCEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence            7999999999887     89999999997 59999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+.
T Consensus       130 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  208 (323)
T cd05571         130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  208 (323)
T ss_pred             CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999987532 2223345678999999999854 458999999999999999999999998776544433322


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ..  .                         .   .....+++++++||++||+.||++||     ++.++++||||..+
T Consensus       209 ~~--~-------------------------~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         209 ME--E-------------------------I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             cC--C-------------------------C---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            10  0                         0   01125788999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-40  Score=283.94  Aligned_cols=267  Identities=44%  Similarity=0.833  Sum_probs=214.7

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .....++|+|+||+..+|.+.+.  ..+++..+..++.|++.||+|||++|++||||+|+||+++
T Consensus        74 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~  151 (342)
T cd07879          74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN  151 (342)
T ss_pred             CCccchhheecccccCCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            79999999987643 12335689999999988887753  4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....++..|+|||.+.+...++.++|+||+||++++|++|+.||.+.+....+..+..
T Consensus       152 ~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~  229 (342)
T cd07879         152 EDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  229 (342)
T ss_pred             CCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999998754332  23446788899999986555578999999999999999999999999888888888888


Q ss_pred             HhCCCChHhhhhhhh-hHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+.......+.. ....+....+......+...++..++.+++||.+||+.||.+|||+++++.||||..+++...+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~  309 (342)
T cd07879         230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE  309 (342)
T ss_pred             hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence            777766655444322 2233333444444555666677889999999999999999999999999999999999875544


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      + +..+++..-+...++.+++..-++.+..+|.|
T Consensus       310 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         310 T-EQQPYDDSLENEKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             C-CCCcccchhhhhhCCHHHHHHHhhhhhhccCC
Confidence            4 34556666666678889999999999888765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=280.49  Aligned_cols=195  Identities=28%  Similarity=0.506  Sum_probs=177.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+.+|++|..+     +.+.|||||.. |+|.+++...+.+++.+++.++.||+.|+.|+|+++++|||+|.+|||++
T Consensus       113 PhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD  187 (668)
T KOG0611|consen  113 PHIIQIYEVFENK-----DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD  187 (668)
T ss_pred             CceeehhhhhcCC-----ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence            8999999999998     99999999996 79999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||++....+....+++||+|.|++||++.+...-++.+|.|||||++|.++.|..||+|.+.....+.|..
T Consensus       188 ~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~  267 (668)
T KOG0611|consen  188 QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR  267 (668)
T ss_pred             CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc
Confidence            99999999999999999999999999999999999997766668999999999999999999999999987776666543


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      -.-                               ..|.-+.++.-||+.||..||.+|.|++++.+|=|++=
T Consensus       268 GaY-------------------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  268 GAY-------------------------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             ccc-------------------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            110                               11345678999999999999999999999999988863

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=284.78  Aligned_cols=200  Identities=28%  Similarity=0.468  Sum_probs=167.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+|+++..++.   .+++|||+|||. |.+... -..++ +++.+++.++..++.||+|||.+||+||||||.|+|+
T Consensus       168 ~nVV~LiEvLDDP~---s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPE---SDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL  243 (576)
T ss_pred             cCeeEEEEeecCcc---cCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE
Confidence            89999999998873   389999999997 444332 23344 9999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeecc------CCCcccccccccccCChhhhhCC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           79 NANCDLKICDFGLARVTS------ETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~------~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      +.+|.+||+|||.+....      .........|||.|+|||....+   ...+.+.||||+||++|.|+.|..||.+..
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            999999999999997652      22334557899999999998652   235789999999999999999999999998


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..+...+|+..--..                            ...|.++.+++|||.+||++||.+|+++.++..|||.
T Consensus       324 ~~~l~~KIvn~pL~f----------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  324 ELELFDKIVNDPLEF----------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHHHHHHHhcCcccC----------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            888888877531111                            1223567899999999999999999999999999999


Q ss_pred             CCC
Q 023764          230 GSL  232 (277)
Q Consensus       230 ~~~  232 (277)
                      ..-
T Consensus       376 t~~  378 (576)
T KOG0585|consen  376 TRD  378 (576)
T ss_pred             ccC
Confidence            865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=282.04  Aligned_cols=195  Identities=24%  Similarity=0.389  Sum_probs=165.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        61 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~  135 (291)
T cd05612          61 PFIIRLFWTEHDQ-----RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD  135 (291)
T ss_pred             CcHhhhHhhhccC-----CeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence            7999999999887     89999999996 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.++|+|||++......  .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       136 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~  212 (291)
T cd05612         136 KEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA  212 (291)
T ss_pred             CCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999999998765432  234578999999999854 4578999999999999999999999988766554444332


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~~  233 (277)
                      ..  +                            ......++.+++||++||+.||.+|++     ++++++||||..+.
T Consensus       213 ~~--~----------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         213 GK--L----------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             CC--c----------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence            10  0                            001245778999999999999999995     99999999998653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=286.50  Aligned_cols=202  Identities=35%  Similarity=0.578  Sum_probs=175.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||.++++|.++     +.+|+|||+|. |+|++.+.+. .+++..+..++.|++.|++|||+.|++|||+||+|+|+.
T Consensus        96 pniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~  169 (382)
T KOG0032|consen   96 PNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLA  169 (382)
T ss_pred             CCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeec
Confidence            8999999999998     89999999996 6999998876 599999999999999999999999999999999999995


Q ss_pred             c----CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 A----NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .    ++.++++|||++............+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+......
T Consensus       170 ~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~  248 (382)
T KOG0032|consen  170 SKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL  248 (382)
T ss_pred             cccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence            3    35799999999998877777888999999999999853 559999999999999999999999999888766555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      .+....-                          ......|+.++..+++||++||..||.+|+|+.++|+|||++.....
T Consensus       249 ~i~~~~~--------------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  249 AILRGDF--------------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             HHHcCCC--------------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence            4432110                          11234567889999999999999999999999999999999876433

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-40  Score=276.09  Aligned_cols=223  Identities=39%  Similarity=0.735  Sum_probs=183.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.++     +.+|+||||++++|.+++...   ..+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil  133 (285)
T cd07861          59 PNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL  133 (285)
T ss_pred             CCEeeeEEEEeeC-----CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE
Confidence            7999999999887     899999999999999888643   46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||++....... ......+++.|+|||.+.+...++.++|+||+||++++|++|++||.+.........
T Consensus       134 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~  213 (285)
T cd07861         134 IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR  213 (285)
T ss_pred             EcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999987654322 223345678899999986655678999999999999999999999998888877777


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +.+..+.+....+..... ...+....+.............+++++++||++||+.||.+|||+.+++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         214 IFRILGTPTEDVWPGVTS-LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHhCCCChhhhhcchh-hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            777777776665543321 222333333444444444556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-40  Score=285.59  Aligned_cols=196  Identities=21%  Similarity=0.415  Sum_probs=166.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+.+.+.+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        56 ~~iv~~~~~~~~~-----~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~  130 (320)
T cd05590          56 PFLTQLYCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD  130 (320)
T ss_pred             CchhceeeEEEcC-----CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence            7999999999887     88999999997 69999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus       131 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  209 (320)
T cd05590         131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  209 (320)
T ss_pred             CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence            99999999999987532 2223345578999999999854 458899999999999999999999998877665544443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~f~~~  232 (277)
                      ....                              ...+.++.++++||++||+.||.+|+++      +++++||||..+
T Consensus       210 ~~~~------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         210 NDEV------------------------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             cCCC------------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            2100                              0012467889999999999999999998      999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-40  Score=288.01  Aligned_cols=194  Identities=26%  Similarity=0.416  Sum_probs=167.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+++..++.+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        91 p~Iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~  165 (340)
T PTZ00426         91 PFCVNLYGSFKDE-----SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD  165 (340)
T ss_pred             CCCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC
Confidence            8999999999887     88999999995 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....|++.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+..
T Consensus       166 ~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~  242 (340)
T PTZ00426        166 KDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE  242 (340)
T ss_pred             CCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence            9999999999999765432  2356789999999998654 478999999999999999999999988766555444432


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ...                              ...+..++.++++|++||+.||.+|+     |++++++||||+.+
T Consensus       243 ~~~------------------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        243 GII------------------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             CCC------------------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            100                              01124678899999999999999996     89999999999875

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-39  Score=282.15  Aligned_cols=262  Identities=44%  Similarity=0.845  Sum_probs=212.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++....   ....|+||||++++|.+++.++ .+++..+..++.|++.||+|||++|++|+||+|+||+++.
T Consensus        67 ~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~  142 (337)
T cd07852          67 PNIVKLLNVIKAEN---DKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS  142 (337)
T ss_pred             CCccceeeeeccCC---CceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence            79999999986542   1578999999999999998875 7889999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           81 NCDLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++.++|+|||.+.......      ......++..|+|||.+.+...++.++|+||+||++++|++|++||.+.......
T Consensus       143 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~  222 (337)
T cd07852         143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL  222 (337)
T ss_pred             CCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9999999999987543321      2233467889999998866566789999999999999999999999999988888


Q ss_pred             HHHHHHhCCCChHhhhhhhhhH-HHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENA-KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .++....+.+....+..+.... ...................+..+.++.++|.+||+.||++|||+.++++||||+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence            9998888888877666553332 223333333444455566677899999999999999999999999999999999988


Q ss_pred             CCCCCCcCCCCCCcc-hhhhhcCHHHHHHHHHHH
Q 023764          234 DISDEPVCMSPFSFD-FEQHALTEGQMKELIYQE  266 (277)
Q Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  266 (277)
                      ..+.++....+.... .....++..+.+..++.+
T Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (337)
T cd07852         303 NPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE  336 (337)
T ss_pred             cCCCCCCCCCCccCCccccceeeHHHHHhhhhhc
Confidence            777766555444432 366778888888877765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=251.27  Aligned_cols=224  Identities=40%  Similarity=0.744  Sum_probs=195.8

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++...+     +.+.+|+|+|+.+|..+..+ ++.++.+.++.++.|++.|+.++|++++.|||+||.|.+++.
T Consensus        62 nivrl~dvlhsd-----kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~  136 (292)
T KOG0662|consen   62 NIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR  136 (292)
T ss_pred             ceeehhhhhccC-----ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc
Confidence            899999999888     89999999999999998875 578999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~  158 (277)
                      +|.+|++|||+++..+-+. ..+..+.|.+|++|.++.+.+.|+.+.|+||.|||+.|+. .|.+.|+|.+..+++.+|.
T Consensus       137 ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif  216 (292)
T KOG0662|consen  137 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_pred             CCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence            9999999999999877664 4455678999999999998888999999999999999997 4899999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ..+|.|+++.|.....- .. ....|-+ ...++....|.++...+|+++++|.-+|.+|++|+++++||||...
T Consensus       217 ~~lg~p~ed~wps~t~l-pd-yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  217 RLLGTPTEDQWPSMTKL-PD-YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             HHhCCCccccCCccccC-CC-CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            99999999877543211 00 1112222 2235778889999999999999999999999999999999999864

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.2e-40  Score=275.86  Aligned_cols=222  Identities=38%  Similarity=0.709  Sum_probs=178.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+|+||++++|.+++.+ .+.+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~  133 (284)
T cd07839          59 KNIVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN  133 (284)
T ss_pred             CCeeeHHHHhccC-----CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc
Confidence            7999999999887     88999999999999988865 46799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++...... .......++..|+|||.+.+...++.++||||+||++++|++|..| |.+.+....+..+
T Consensus       134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  213 (284)
T cd07839         134 KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  213 (284)
T ss_pred             CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence            9999999999998755432 1223345688899999987656678999999999999999998777 5666667778888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+..+.+....+.........  ...+.. ....+....+.+++++++||.+||+.||.+|||+++++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         214 FRLLGTPTEESWPGVSKLPDY--KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHhCCCChHHhHHhhhcccc--cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            888887776655433211110  011111 1112344556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=282.52  Aligned_cols=196  Identities=27%  Similarity=0.530  Sum_probs=165.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. |+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        53 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~  127 (312)
T cd05585          53 PFIVPLKFSFQSP-----EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD  127 (312)
T ss_pred             CcEeceeeEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+.
T Consensus       128 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~  206 (312)
T cd05585         128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL  206 (312)
T ss_pred             CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            999999999999875332 222344578999999999865 458999999999999999999999998776554443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~hp~f~~~  232 (277)
                      ..   +                           ....+.+++++++||.+||+.||.+||   ++.+++.||||...
T Consensus       207 ~~---~---------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         207 QE---P---------------------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             cC---C---------------------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            10   0                           011135678999999999999999997   58999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-40  Score=285.15  Aligned_cols=194  Identities=25%  Similarity=0.417  Sum_probs=165.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+.+.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        78 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~  152 (329)
T PTZ00263         78 PFIVNMMCSFQDE-----NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD  152 (329)
T ss_pred             CCCCcEEEEEEcC-----CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC
Confidence            7999999999887     89999999996 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+
T Consensus       153 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  229 (329)
T PTZ00263        153 NKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA  229 (329)
T ss_pred             CCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            9999999999999866443  234578999999999865 4478999999999999999999999987765544443322


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      .  .+                            .....++..+++||++||+.||.+|++     ++++++||||+..
T Consensus       230 ~--~~----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        230 G--RL----------------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             C--Cc----------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            0  00                            001136778999999999999999997     7999999999874

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-40  Score=259.29  Aligned_cols=194  Identities=23%  Similarity=0.436  Sum_probs=175.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||.++|++|.++     ..+|+++||.. |+|...+.  ...++++..+..+++|++.|+.|+|..+++||||||+|+|
T Consensus        82 pnilrlY~~fhd~-----~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL  156 (281)
T KOG0580|consen   82 PNILRLYGYFHDS-----KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL  156 (281)
T ss_pred             ccHHhhhhheecc-----ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence            8999999999998     99999999996 79999998  5578999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.+|.+|++|||.+.... .....+.|||.-|.+||...+ ..++..+|+|++|++.|+++.|.+||.+.+..+.+++|
T Consensus       157 lg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI  234 (281)
T KOG0580|consen  157 LGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI  234 (281)
T ss_pred             cCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence            9999999999999997766 445678899999999999854 45899999999999999999999999998888888888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .+.--.-+                              +.++.+++|+|.+||.++|.+|++..|++.|||+..
T Consensus       235 ~k~~~~~p------------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  235 RKVDLKFP------------------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHccccCC------------------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            76422211                              368899999999999999999999999999999865

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-40  Score=274.56  Aligned_cols=199  Identities=24%  Similarity=0.438  Sum_probs=168.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |.+++||..|..+     +..|+|||||. |+|..+.+++  +.|++..++.++..++.||+|||-.|||+||+||+|||
T Consensus       137 PFlPTLYa~fet~-----~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL  211 (459)
T KOG0610|consen  137 PFLPTLYASFETD-----KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL  211 (459)
T ss_pred             Cccchhhheeecc-----ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence            7899999999998     99999999996 6999998875  57999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccC-----------------------------------C----------------------Cc
Q 023764           78 LNANCDLKICDFGLARVTSE-----------------------------------T----------------------DF  100 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~-----------------------------------~----------------------~~  100 (277)
                      +-++|.+.|+||.++.....                                   .                      ..
T Consensus       212 vredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~R  291 (459)
T KOG0610|consen  212 VREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGAR  291 (459)
T ss_pred             EecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcc
Confidence            99999999999988732100                                   0                      01


Q ss_pred             ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHh
Q 023764          101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI  180 (277)
Q Consensus       101 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  180 (277)
                      ..+++||-.|.|||++.+.+ .+.++|.|+|||++|||+.|..||.|.++.+.+..++..--.                 
T Consensus       292 SnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-----------------  353 (459)
T KOG0610|consen  292 SNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-----------------  353 (459)
T ss_pred             ccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-----------------
Confidence            12346788899999996655 899999999999999999999999999998877766542111                 


Q ss_pred             hhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC----HHHHhcCCCCCCCC
Q 023764          181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----VEDALAHPYLGSLH  233 (277)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~hp~f~~~~  233 (277)
                           ++      ..|.++.+++|||+++|.+||++|..    |.||-+||||++++
T Consensus       354 -----Fp------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  354 -----FP------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             -----CC------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence                 11      11356789999999999999999998    99999999999874

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.8e-40  Score=280.72  Aligned_cols=197  Identities=24%  Similarity=0.443  Sum_probs=164.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. ++|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        56 ~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~  130 (316)
T cd05620          56 PFLTHLYCTFQTK-----EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD  130 (316)
T ss_pred             CCccCeeEEEEeC-----CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence            7999999999887     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~  209 (316)
T cd05620         131 RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR  209 (316)
T ss_pred             CCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999864321 223345678999999999864 458999999999999999999999998776554443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-EDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~ell~hp~f~~~~  233 (277)
                      ..  .+                            .....++.++++||++||+.||++|+++ +++++||||+...
T Consensus       210 ~~--~~----------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         210 VD--TP----------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             hC--CC----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            10  00                            0011367889999999999999999997 5899999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.3e-40  Score=281.51  Aligned_cols=196  Identities=21%  Similarity=0.398  Sum_probs=166.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +++|+||||++ ++|...+.+.+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        56 p~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~  130 (321)
T cd05591          56 PFLTALHCCFQTK-----DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD  130 (321)
T ss_pred             CCccceeeEEEcC-----CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence            7999999999887     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       131 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~  209 (321)
T cd05591         131 AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL  209 (321)
T ss_pred             CCCCEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999875322 223344578999999999854 458999999999999999999999998877666555443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-------CHHHHhcCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-------TVEDALAHPYLGS  231 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-------t~~ell~hp~f~~  231 (277)
                      ....                              .....++.++++||.+||+.||++|+       +++++++||||..
T Consensus       210 ~~~~------------------------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         210 HDDV------------------------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             cCCC------------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            2100                              00113678899999999999999999       9999999999987


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      +
T Consensus       260 ~  260 (321)
T cd05591         260 I  260 (321)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-39  Score=274.02  Aligned_cols=225  Identities=38%  Similarity=0.771  Sum_probs=186.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~  133 (286)
T cd07832          59 PYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS  133 (286)
T ss_pred             CCCcceeeEEecC-----CeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc
Confidence            7999999999886     88999999998899999865 35699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||.+.......  ......++..|+|||.+.....++.++||||+||++++|++|.++|.+.........+
T Consensus       134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~  213 (286)
T cd07832         134 ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV  213 (286)
T ss_pred             CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence            99999999999987654432  2334567889999998866556789999999999999999999999998888888888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      .+..+.+....+..............+......+...++..+.++.+||++||..||.+|||++++++||||.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         214 FRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            8888888776555433221111112222223334556677889999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.5e-40  Score=282.04  Aligned_cols=197  Identities=26%  Similarity=0.473  Sum_probs=165.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ ++|..++.+.+.+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus        55 p~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  129 (323)
T cd05595          55 PFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD  129 (323)
T ss_pred             CCCcceeeEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc
Confidence            7999999999887     88999999997 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       130 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~  208 (323)
T cd05595         130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  208 (323)
T ss_pred             CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            999999999999865322 223344578999999999854 458999999999999999999999998776554443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~~  233 (277)
                      ...                           .   .....+++++++||.+||+.||++|+     ++.++++||||.+..
T Consensus       209 ~~~---------------------------~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         209 MEE---------------------------I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             cCC---------------------------C---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            100                           0   01124688999999999999999998     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.3e-40  Score=282.68  Aligned_cols=196  Identities=24%  Similarity=0.462  Sum_probs=164.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus        55 p~iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~  129 (328)
T cd05593          55 PFLTSLKYSFQTK-----DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD  129 (328)
T ss_pred             CCCcceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC
Confidence            7999999999887     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       130 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~  208 (328)
T cd05593         130 KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  208 (328)
T ss_pred             CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence            999999999999875322 223344578999999999854 458999999999999999999999998766544333321


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ..  .                         .   ...+.+++++.+||++||+.||++|+     ++.++++||||...
T Consensus       209 ~~--~-------------------------~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         209 ME--D-------------------------I---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             cC--C-------------------------c---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            10  0                         0   01125688999999999999999997     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-39  Score=275.17  Aligned_cols=201  Identities=23%  Similarity=0.396  Sum_probs=164.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +..|+||||++ |+|.+.+...  ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        60 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil  134 (285)
T cd05631          60 RFVVSLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL  134 (285)
T ss_pred             CcEEEEEEEEccC-----CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence            6899999999887     88999999997 6898877543  46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.++.++|+|||++.............|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+
T Consensus       135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~  213 (285)
T cd05631         135 LDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV  213 (285)
T ss_pred             ECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence            99999999999999987654444445678999999999864 45899999999999999999999999876543322222


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ......+                          ........+.++.+||++||+.||.+|||     ++++++||||..+
T Consensus       214 ~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         214 DRRVKED--------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHHhhcc--------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            2111110                          00112357889999999999999999997     8999999999886


Q ss_pred             C
Q 023764          233 H  233 (277)
Q Consensus       233 ~  233 (277)
                      .
T Consensus       268 ~  268 (285)
T cd05631         268 N  268 (285)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.5e-39  Score=275.75  Aligned_cols=232  Identities=38%  Similarity=0.679  Sum_probs=184.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++....   .+.+|+||||++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus        66 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~  142 (309)
T cd07845          66 PNIVELKEVVVGKH---LDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT  142 (309)
T ss_pred             CCCcceEEEEecCC---CCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            78999999987642   2578999999999999888753 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+.......+.
T Consensus       143 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~  222 (309)
T cd07845         143 DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII  222 (309)
T ss_pred             CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998765543 122333457789999998665667899999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      ...+.+....+..+...........+......+...++..++.+.+||.+||+.||++|||++++++||||....-+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            88888877655433221110001111111122333445578899999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.3e-39  Score=270.79  Aligned_cols=224  Identities=33%  Similarity=0.706  Sum_probs=180.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++.   .+.+|+||||++++|.+.+... ..+++..+..++.|++.||+|||+.|++||||+|.||+++
T Consensus        58 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~  134 (282)
T cd07831          58 PNILRLIEVLFDRK---TGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK  134 (282)
T ss_pred             CCccceEEEEecCC---CCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc
Confidence            79999999997642   2678999999999998888764 5789999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      . +.++|+|||.+.............++..|+|||.+.....++.++||||+||++++|++|.+||.+.+..+....+.+
T Consensus       135 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~  213 (282)
T cd07831         135 D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD  213 (282)
T ss_pred             C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH
Confidence            9 999999999997665444444556788999999876555578999999999999999999999999988888888888


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..+.+........... .......+......+....+..+.++++||.+||..||++|||++++++||||
T Consensus       214 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         214 VLGTPDAEVLKKFRKS-RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HcCCCCHHHHHhhccc-ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            8887776542221111 00111112222222333445678999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.1e-39  Score=272.20  Aligned_cols=226  Identities=40%  Similarity=0.772  Sum_probs=183.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..++   .+..|+||||++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++
T Consensus        64 ~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~  140 (293)
T cd07843          64 PNIVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN  140 (293)
T ss_pred             CCEEEEEEEEEecC---CCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC
Confidence            79999999987642   2789999999999999988764 3589999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+...... .......+++.|+|||.+.+....+.++|+||+||++++|++|.+||.+........++.
T Consensus       141 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~  220 (293)
T cd07843         141 NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF  220 (293)
T ss_pred             CCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999999998866554 223345578889999998665556899999999999999999999999999888889898


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.|....+..+..................+...++.  +++.+.++|++||+.||++|||+.|++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         221 KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             HHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            888888877665443211111111111112223344554  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.5e-39  Score=275.36  Aligned_cols=226  Identities=35%  Similarity=0.647  Sum_probs=170.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++....   .+.+|+||||++++|.+++...         ..+++..++.++.|++.||.|||+.|++||||
T Consensus        58 ~niv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dl  134 (317)
T cd07867          58 PNVIALQKVFLSHS---DRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDL  134 (317)
T ss_pred             CCeeeEEEEEeccC---CCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCC
Confidence            79999999986532   1678999999999998887521         24888999999999999999999999999999


Q ss_pred             CCCcEEE----ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           72 KPSNLLL----NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        72 ~~~nil~----~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      ||+||++    +.++.++|+|||+++......    ......+++.|+|||.+.+...++.++||||+||++++|++|.+
T Consensus       135 kp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~  214 (317)
T cd07867         135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP  214 (317)
T ss_pred             CHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCC
Confidence            9999999    456789999999997654321    22345678999999998765668999999999999999999999


Q ss_pred             CCCCCC---------hHHHHHHHHHHhCCCChHhhhhhhhhHH--HHhh--hCCcccCCc----ccccCCCCChhHHHHH
Q 023764          144 LFPGRD---------HVHQLRLLIELIGTPSEAELGFLNENAK--KYIC--QLPRYQRQS----FTEKFPNVHPSAIDLV  206 (277)
Q Consensus       144 pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~----~~~~~~~~~~~~~~li  206 (277)
                      ||....         .......+....+.+....+..+.....  ....  .........    ....-...+..+.+||
T Consensus       215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  294 (317)
T cd07867         215 IFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLL  294 (317)
T ss_pred             CcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHH
Confidence            997543         2355677777778777666544321100  0000  000000011    1111123466799999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCC
Q 023764          207 EKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       207 ~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+||+.||.+|||++|+|+||||
T Consensus       295 ~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         295 QKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHHhccCcccccCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=284.57  Aligned_cols=198  Identities=24%  Similarity=0.470  Sum_probs=166.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +++|+||||+. |+|.+.+.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        56 p~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~  130 (330)
T cd05586          56 PFIVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD  130 (330)
T ss_pred             CcCcceEEEEecC-----CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence            7999999999887     89999999996 69999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       131 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~  210 (330)
T cd05586         131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA  210 (330)
T ss_pred             CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence            999999999999865322 2233456789999999998665557899999999999999999999998776554433332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~ell~hp~f~~~  232 (277)
                      ....                           .+.  ...+++++++||++||+.||.+||    ++.++++||||...
T Consensus       211 ~~~~---------------------------~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         211 FGKV---------------------------RFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             cCCC---------------------------CCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            1000                           000  013678899999999999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-39  Score=278.10  Aligned_cols=196  Identities=24%  Similarity=0.464  Sum_probs=165.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ |+|.+.+...+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        56 p~i~~~~~~~~~~-----~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~  130 (316)
T cd05592          56 PFLTHLFCTFQTK-----EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD  130 (316)
T ss_pred             CCccceeeEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC
Confidence            7999999999887     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+.
T Consensus       131 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~  209 (316)
T cd05592         131 KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL  209 (316)
T ss_pred             CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999875432 223345578999999999864 458999999999999999999999998877655444332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~ell~hp~f~~~  232 (277)
                      ..  .+                            .....++.++.+||.+||+.||.+|+++ .+++.||||...
T Consensus       210 ~~--~~----------------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         210 ND--RP----------------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             cC--CC----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            10  00                            0012467889999999999999999986 589999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=271.81  Aligned_cols=224  Identities=38%  Similarity=0.752  Sum_probs=179.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     ++.|+||||++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus        63 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~  137 (291)
T cd07844          63 ANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS  137 (291)
T ss_pred             cceeeEEEEEecC-----CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc
Confidence            7999999999887     899999999999999988764 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i  157 (277)
                      .++.++|+|||.+...... .......++..|+|||.+.+...++.++||||+||++++|++|..||.+.. ..+....+
T Consensus       138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~  217 (291)
T cd07844         138 ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI  217 (291)
T ss_pred             CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence            9999999999998654322 112223467889999998665567899999999999999999999997665 56677777


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCC--hhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....+.+....+..........................+.++  .++.+++.+||+.||++|||+.++++||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            788888777665544332222222222222233344444555  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.2e-40  Score=282.02  Aligned_cols=196  Identities=27%  Similarity=0.484  Sum_probs=164.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++...+.+++..++.++.|++.||+|||+ .||+||||||+||++
T Consensus        55 p~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll  129 (325)
T cd05594          55 PFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML  129 (325)
T ss_pred             CCCCceEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE
Confidence            7999999999887     89999999997 5899999888889999999999999999999997 799999999999999


Q ss_pred             ecCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus       130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i  208 (325)
T cd05594         130 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  208 (325)
T ss_pred             CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence            999999999999987532 2223344578999999999854 45899999999999999999999999877654443332


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ....                           .   .....+++++.+||.+||+.||++|+     ++.++++||||...
T Consensus       209 ~~~~---------------------------~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         209 LMEE---------------------------I---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             hcCC---------------------------C---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            2100                           0   00124678999999999999999997     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-39  Score=279.25  Aligned_cols=196  Identities=24%  Similarity=0.484  Sum_probs=165.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +.+|+||||+. ++|.+.+...+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        60 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~  134 (323)
T cd05584          60 PFIVDLIYAFQTG-----GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD  134 (323)
T ss_pred             CchhceeeEEecC-----CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence            7999999999887     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~  213 (323)
T cd05584         135 AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL  213 (323)
T ss_pred             CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999875332 222334578999999999865 447899999999999999999999998776555444332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ..  .                            ....+.+++++++||++||+.||++||     +++++++||||...
T Consensus       214 ~~--~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         214 KG--K----------------------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             cC--C----------------------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            20  0                            011235678999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-40  Score=289.30  Aligned_cols=194  Identities=26%  Similarity=0.525  Sum_probs=170.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.|+.|+..|+.+     +++|+||||+. |++.. +...+.|++..++.++..++.||.|||++||||||+|.+|||++
T Consensus       429 PFL~~L~~~fQT~-----~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD  502 (694)
T KOG0694|consen  429 PFLVNLFSCFQTK-----EHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD  502 (694)
T ss_pred             CeEeecccccccC-----CeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc
Confidence            7899999999998     99999999996 57333 33447899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++..- ......+.+|||-|+|||++.+ ..|+.++|.|||||++|+|+.|..||+|.+..+....|.
T Consensus       503 ~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~  581 (694)
T KOG0694|consen  503 TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV  581 (694)
T ss_pred             ccCcEEecccccccccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence            99999999999998543 5556788999999999999965 459999999999999999999999999999988877776


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      .--                               ..+| .+|.++.++|+++|.+||++|..     ++++..||||+.+
T Consensus       582 ~d~-------------------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  582 NDE-------------------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             cCC-------------------------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            411                               1122 47889999999999999999996     5899999999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.3e-39  Score=270.05  Aligned_cols=223  Identities=39%  Similarity=0.752  Sum_probs=183.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||+.++|.+++..  ...+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill  133 (284)
T cd07860          59 PNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI  133 (284)
T ss_pred             CCCcchhhhcccC-----CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            7999999999876     88999999999899998865  3568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++++|++|+.||.+.+.......+
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~  213 (284)
T cd07860         134 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI  213 (284)
T ss_pred             CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999998654432 12233456788999998866555688999999999999999999999988888888888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+..+.+....+..... ...+....+......+....+.++++++++|.+||+.||++|||+++++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         214 FRTLGTPDEVVWPGVTS-LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHhCCCChhhhhhhhH-HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            88888877654443222 122223334444444555566788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-39  Score=282.55  Aligned_cols=199  Identities=24%  Similarity=0.419  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+.+.     +.+|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~  135 (363)
T cd05628          61 LWVVKMFYSFQDK-----LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD  135 (363)
T ss_pred             CCcceEEEEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence            7999999999887     89999999996 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC------------------------------------cccccccccccCChhhhhCCCCCC
Q 023764           80 ANCDLKICDFGLARVTSETD------------------------------------FMTEYVVTRWYRAPELLLNSSDYT  123 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~  123 (277)
                      .++.++|+|||++.......                                    .....+||+.|+|||++.+ ..++
T Consensus       136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~  214 (363)
T cd05628         136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYN  214 (363)
T ss_pred             CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCC
Confidence            99999999999986432110                                    0123578999999999865 4589


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHH
Q 023764          124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  203 (277)
Q Consensus       124 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (277)
                      .++||||+||++|+|++|..||.+.+.......+.......                         .++. ...++++++
T Consensus       215 ~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~p~-~~~~s~~~~  268 (363)
T cd05628         215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL-------------------------IFPP-EVPISEKAK  268 (363)
T ss_pred             CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcc-------------------------cCCC-cCCCCHHHH
Confidence            99999999999999999999998877666555544311110                         0000 114678999


Q ss_pred             HHHHHhcCCCCC---CCCCHHHHhcCCCCCCC
Q 023764          204 DLVEKMLTFDPR---QRITVEDALAHPYLGSL  232 (277)
Q Consensus       204 ~li~~~L~~dP~---~R~t~~ell~hp~f~~~  232 (277)
                      +||.+|+. +|.   .||+++++++||||+..
T Consensus       269 ~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         269 DLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            99999886 454   45899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.4e-39  Score=277.97  Aligned_cols=196  Identities=23%  Similarity=0.442  Sum_probs=165.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+.+.+.+.+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus        56 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~  130 (318)
T cd05570          56 PFLTQLHSCFQTK-----DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD  130 (318)
T ss_pred             CCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC
Confidence            7999999999887     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... .......++++.|+|||++.+ ..++.++|+||+||++++|++|..||.+.+.......+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~  209 (318)
T cd05570         131 SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL  209 (318)
T ss_pred             CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            999999999999865322 222334568999999999854 458999999999999999999999998776554443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~f~~~  232 (277)
                      ...                      .        .....++..+++||++||+.||++|||+     .++++||||+..
T Consensus       210 ~~~----------------------~--------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         210 EDE----------------------V--------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCC----------------------C--------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            100                      0        0012467889999999999999999999     999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=279.83  Aligned_cols=202  Identities=27%  Similarity=0.480  Sum_probs=168.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~  135 (333)
T cd05600          61 EWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID  135 (333)
T ss_pred             CCCccEEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.....  ......|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus       136 ~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~  212 (333)
T cd05600         136 ASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY  212 (333)
T ss_pred             CCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence            999999999999876543  23456789999999998654 589999999999999999999999988776555444332


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .....                      ...........++.++.+||.+||..+|.+|||++++++||||...
T Consensus       213 ~~~~~----------------------~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         213 WKETL----------------------QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             ccccc----------------------cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            11000                      0000111113568899999999999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-39  Score=280.21  Aligned_cols=201  Identities=21%  Similarity=0.357  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ |+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~  139 (332)
T cd05614          65 PFLVTLHYAFQTE-----AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD  139 (332)
T ss_pred             CCcccEEEEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC
Confidence            7899999999887     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++......  .......|++.|+|||++.+...++.++|||||||++++|++|..||...........+
T Consensus       140 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  219 (332)
T cd05614         140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV  219 (332)
T ss_pred             CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH
Confidence            9999999999998754322  22234578999999999865555788999999999999999999999643321111111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ......                  ..        ....+.+++.+++||.+||+.||++||     +++++++||||+..
T Consensus       220 ~~~~~~------------------~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         220 SRRILK------------------CD--------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHhc------------------CC--------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            110000                  00        011124688899999999999999999     88999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.7e-39  Score=275.89  Aligned_cols=197  Identities=24%  Similarity=0.450  Sum_probs=165.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        56 p~iv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~  130 (316)
T cd05619          56 PFLTHLYCTFQTK-----ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD  130 (316)
T ss_pred             CcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence            7999999999887     88999999996 69999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~  209 (316)
T cd05619         131 TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR  209 (316)
T ss_pred             CCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999875322 122334568999999999854 458999999999999999999999998776554443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-ell~hp~f~~~~  233 (277)
                      ..  .+                            ...+.++.++++||.+||+.||++|+++. ++++||||....
T Consensus       210 ~~--~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         210 MD--NP----------------------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hC--CC----------------------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence            10  00                            00123677899999999999999999996 999999998853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-38  Score=273.90  Aligned_cols=247  Identities=43%  Similarity=0.809  Sum_probs=186.4

Q ss_pred             CceeeeeccccCCCCC---------CCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRE---------SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~---------~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++......         .....|+||||++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||
T Consensus        62 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~di  140 (342)
T cd07854          62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDL  140 (342)
T ss_pred             CcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            7899999888765321         1246899999999999988865 56899999999999999999999999999999


Q ss_pred             CCCcEEEec-CCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           72 KPSNLLLNA-NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        72 ~~~nil~~~-~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      ||+||+++. ++.++++|||.+......    .......++..|+|||.+.....++.++||||+||++++|++|..||.
T Consensus       141 kp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  220 (342)
T cd07854         141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA  220 (342)
T ss_pred             CHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999974 557899999998754322    111233568889999987665567889999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +.+.......+.+....+.........................+.....+.++.++++||.+||+.||.+|||+++++.|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         221 GAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            88877776666655444433322222111111111111222233445566788999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCcCCCCCCcc
Q 023764          227 PYLGSLHDISDEPVCMSPFSFD  248 (277)
Q Consensus       227 p~f~~~~~~~~~~~~~~~~~~~  248 (277)
                      |||+.+..+.+.++...++..+
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~  322 (342)
T cd07854         301 PYMSCYSCPFDEPVSLHPFHIE  322 (342)
T ss_pred             CccccccCCccccCCCCCcccc
Confidence            9999887776666665555433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.4e-39  Score=277.05  Aligned_cols=196  Identities=23%  Similarity=0.443  Sum_probs=164.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ++|+++++++.+.     +.+|+||||+. |+|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~  135 (324)
T cd05587          61 PFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD  135 (324)
T ss_pred             CceeeeEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc
Confidence            4688899999887     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+.......+.
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (324)
T cd05587         136 AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (324)
T ss_pred             CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999986432 2223344578999999999864 458899999999999999999999998877655554443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~f~~~  232 (277)
                      ....                              .....+++++.+++++||..||.+|+++     +++++||||+..
T Consensus       215 ~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         215 EHNV------------------------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             cCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            2100                              0112467889999999999999999986     899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-39  Score=282.66  Aligned_cols=226  Identities=23%  Similarity=0.295  Sum_probs=174.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++...     +.+|+|||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus       146 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~  220 (392)
T PHA03207        146 RAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE  220 (392)
T ss_pred             CCccceeeeEeeC-----CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC
Confidence            7999999999887     88999999999999999987788999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hHHHH
Q 023764           81 NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---HVHQL  154 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~  154 (277)
                      ++.++|+|||++.......   ......|++.|+|||++.. ..++.++||||+||++|+|++|..||.+..   ....+
T Consensus       221 ~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l  299 (392)
T PHA03207        221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL  299 (392)
T ss_pred             CCCEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH
Confidence            9999999999987554332   1234568999999999854 458999999999999999999999997654   35566


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCC--cccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ--SFTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ..+.+..+..+................+.......  ..+..+  ...+.++.+||++||..||++|||+.++|.||||.
T Consensus       300 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        300 RSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             HHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence            66666665544322111111111111111111111  111111  14567899999999999999999999999999997


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      ..
T Consensus       380 ~~  381 (392)
T PHA03207        380 KE  381 (392)
T ss_pred             cc
Confidence            63

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-39  Score=279.23  Aligned_cols=197  Identities=25%  Similarity=0.484  Sum_probs=166.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus        56 p~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~  130 (323)
T cd05575          56 PFLVGLHYSFQTA-----DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD  130 (323)
T ss_pred             CCCCCeeEEEEeC-----CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence            7999999999887     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  209 (323)
T cd05575         131 SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL  209 (323)
T ss_pred             CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999865322 223344578999999999854 458999999999999999999999998776555444332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~f~~~~  233 (277)
                      ..   +                           ....+.++..+.++|++||+.||.+||++    .++++||||..+.
T Consensus       210 ~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         210 NK---P---------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             cC---C---------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            10   0                           01224578899999999999999999997    6999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-38  Score=270.18  Aligned_cols=229  Identities=38%  Similarity=0.739  Sum_probs=185.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~  136 (298)
T cd07841          62 PNIIGLLDVFGHK-----SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA  136 (298)
T ss_pred             CCChhhhheeecC-----CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc
Confidence            7999999999886     8999999999889999998765 799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+||++++|++|.++|.+........++.
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~  216 (298)
T cd07841         137 SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF  216 (298)
T ss_pred             CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence            99999999999997665432 22334567789999988665567899999999999999999999998888877788887


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      ...+.+....+....... .+ .........+....++..+..+++||.+||.+||++|||+.+++.|+||++...+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         217 EALGTPTEENWPGVTSLP-DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             HHcCCCchhhhhhccccc-cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            777776665443221110 11 11111122233445566788999999999999999999999999999999865543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-39  Score=278.36  Aligned_cols=205  Identities=23%  Similarity=0.452  Sum_probs=161.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus        56 p~Iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~  130 (329)
T cd05588          56 PFLVGLHSCFQTE-----SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD  130 (329)
T ss_pred             CCCCceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence            7999999999887     89999999996 59999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeec-cCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++... ..........|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.......      
T Consensus       131 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------  203 (329)
T cd05588         131 AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD------  203 (329)
T ss_pred             CCCCEEECcCccccccccCCCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccc------
Confidence            9999999999998642 22233345678999999999864 458899999999999999999999996321100      


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~f~~~  232 (277)
                          .+.........   .......     .   .....++..+.++|++||+.||.+|+|      ++++++||||..+
T Consensus       204 ----~~~~~~~~~~~---~~~~~~~-----~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         204 ----NPDQNTEDYLF---QVILEKQ-----I---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             ----cccccchHHHH---HHHHcCC-----C---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence                00000000000   0000000     0   111246788999999999999999997      7899999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.6e-39  Score=276.79  Aligned_cols=196  Identities=22%  Similarity=0.409  Sum_probs=166.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+.+...+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~  135 (323)
T cd05616          61 PFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD  135 (323)
T ss_pred             CeEeeEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC
Confidence            6889999999887     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       136 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~  214 (323)
T cd05616         136 SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  214 (323)
T ss_pred             CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999875432 223345678999999999864 458999999999999999999999998877665555443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      .....                              ....++.++++++.+||+.||.+|++     ..++++||||+.+
T Consensus       215 ~~~~~------------------------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         215 EHNVA------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             hCCCC------------------------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            31100                              01246789999999999999999998     4899999999865

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.5e-39  Score=276.45  Aligned_cols=195  Identities=26%  Similarity=0.456  Sum_probs=163.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. ++|...+.. +.+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        62 p~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~  135 (324)
T cd05589          62 PFLVNLFACFQTE-----DHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD  135 (324)
T ss_pred             CChhceeeEEEcC-----CEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence            7999999999887     89999999997 588887764 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~  214 (324)
T cd05589         136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV  214 (324)
T ss_pred             CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999998864322 223345678999999999854 458999999999999999999999998776655444332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ....                              ...+.+++.+.++|++||+.||.+||     ++.++++||||+.+
T Consensus       215 ~~~~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         215 NDEV------------------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             hCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            2100                              01124678899999999999999999     69999999999875

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=282.53  Aligned_cols=199  Identities=27%  Similarity=0.493  Sum_probs=164.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~  135 (364)
T cd05599          61 PWVVKLYYSFQDE-----NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD  135 (364)
T ss_pred             CCCcceEEEEEcC-----CeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence            7999999999987     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC---------------------------------------cccccccccccCChhhhhCCC
Q 023764           80 ANCDLKICDFGLARVTSETD---------------------------------------FMTEYVVTRWYRAPELLLNSS  120 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~---------------------------------------~~~~~~~~~~~~aPE~~~~~~  120 (277)
                      .++.++|+|||++.......                                       .....+||+.|+|||++.+ .
T Consensus       136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  214 (364)
T cd05599         136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-T  214 (364)
T ss_pred             CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-C
Confidence            99999999999986432110                                       1112468999999999855 4


Q ss_pred             CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCCh
Q 023764          121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  200 (277)
Q Consensus       121 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (277)
                      .++.++||||+||++|+|++|..||.+.+.......+......                         ..+.. ...+++
T Consensus       215 ~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~-------------------------~~~~~-~~~~s~  268 (364)
T cd05599         215 GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET-------------------------LQFPD-EVPLSP  268 (364)
T ss_pred             CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc-------------------------cCCCC-CCCCCH
Confidence            5899999999999999999999999887765544443321000                         00000 114688


Q ss_pred             hHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCC
Q 023764          201 SAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  232 (277)
Q Consensus       201 ~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~  232 (277)
                      ++++||++||. +|.+|++   ++++++||||+..
T Consensus       269 ~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         269 EAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             HHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99999999997 9999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-38  Score=268.36  Aligned_cols=223  Identities=40%  Similarity=0.796  Sum_probs=184.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     ++.|+||||++++|.+++...   ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        58 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~  132 (284)
T cd07836          58 ENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLL  132 (284)
T ss_pred             CCEeeeeeeEeeC-----CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence            7999999999887     889999999999999988754   35899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||.+...... .......++..|++||.+.+...++.++|+||+||++++|++|.+||.+.+..+....
T Consensus       133 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~  212 (284)
T cd07836         133 INKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK  212 (284)
T ss_pred             ECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999998654332 1223445678899999986655678999999999999999999999999998888888


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +.+..+.|....+..+.. ...+....+...........+..++.+++++.+||+.||.+|||++++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         213 IFRIMGTPTESTWPGISQ-LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHhCCCChhhHHHHhc-CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            888888888766554431 112222222222233344456678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-39  Score=279.51  Aligned_cols=225  Identities=24%  Similarity=0.365  Sum_probs=165.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+|||++.++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       117 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~  191 (357)
T PHA03209        117 PSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN  191 (357)
T ss_pred             CCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            7999999999887     88999999999999998865 36799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCh--------
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDH--------  150 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~--------  150 (277)
                      .++.++|+|||++.............|+..|+|||++.+ ..++.++||||+||++|+|+++. ++|.+...        
T Consensus       192 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~  270 (357)
T PHA03209        192 DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS  270 (357)
T ss_pred             CCCCEEEecCccccccccCcccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHH
Confidence            999999999999875443333345678999999999865 45899999999999999999754 44443221        


Q ss_pred             -HHHHHHHHHHhCCCChHhhhhh-hhhHHHHhhhCCcccCCccc----ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          151 -VHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFT----EKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       151 -~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                       ...+..+....+..+....... ......+.. .......+..    ......+.++.+||.+||+.||.+|||+.|+|
T Consensus       271 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l  349 (357)
T PHA03209        271 CHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIE-YASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL  349 (357)
T ss_pred             HHHHHHHHHHHhccChhhcCCCCccHHHHHHHh-hcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence             2233344444443332211000 001111111 0000001100    11125677899999999999999999999999


Q ss_pred             cCCCCCCC
Q 023764          225 AHPYLGSL  232 (277)
Q Consensus       225 ~hp~f~~~  232 (277)
                      +||||+.+
T Consensus       350 ~hp~f~~~  357 (357)
T PHA03209        350 NYPMFAQL  357 (357)
T ss_pred             cCchhccC
Confidence            99999863

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=279.31  Aligned_cols=198  Identities=29%  Similarity=0.476  Sum_probs=178.5

Q ss_pred             CceeeeeccccCCCCCCCCc-EEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFND-VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~-~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      ||||.+++.|.++     +. +||||+||+ |+|.+.+.+.  ..++++.+..++.|++.|+.|||+++|+|||||+.||
T Consensus        63 P~iv~y~ds~~~~-----~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Ni  137 (426)
T KOG0589|consen   63 PNIVEYKDSFEED-----GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANI  137 (426)
T ss_pred             CCeeeeccchhcC-----CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhh
Confidence            8999999999998     77 999999997 5999998765  4699999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           77 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      +++.++.++|+|||+++..+... ...+..||+.|++||.+. ..+|+.++|||||||++|||++-+++|.+.+-...+.
T Consensus       138 fltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~  216 (426)
T KOG0589|consen  138 FLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL  216 (426)
T ss_pred             hccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccchHHHHH
Confidence            99999999999999999888776 778889999999999985 4569999999999999999999999999999888888


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ++......|..                             ..++.+++.+++.||..+|..||++.++|.+|......
T Consensus       217 ki~~~~~~Plp-----------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  217 KINRGLYSPLP-----------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHhhccCCCCC-----------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            87775544332                             25788999999999999999999999999999988554

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=280.67  Aligned_cols=199  Identities=28%  Similarity=0.514  Sum_probs=166.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. ++|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~  135 (350)
T cd05573          61 PWIVKLYYSFQDE-----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID  135 (350)
T ss_pred             CCccchhhheecC-----CeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC------------------------------cccccccccccCChhhhhCCCCCCcchhHH
Q 023764           80 ANCDLKICDFGLARVTSETD------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVW  129 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  129 (277)
                      .++.++|+|||++.......                              ......|++.|+|||++.+. .++.++|||
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  214 (350)
T cd05573         136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWW  214 (350)
T ss_pred             CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeE
Confidence            99999999999987544332                              22345689999999998654 589999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHh
Q 023764          130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  209 (277)
Q Consensus       130 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  209 (277)
                      ||||++|+|++|..||.+.+.......+.......                         .. ...+.+++++++||.+|
T Consensus       215 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~-p~~~~~~~~~~~li~~l  268 (350)
T cd05573         215 SLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL-------------------------RF-PPDPPVSPEAIDLICRL  268 (350)
T ss_pred             ecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcc-------------------------cC-CCCCCCCHHHHHHHHHH
Confidence            99999999999999998877655544443311000                         00 01123688999999999


Q ss_pred             cCCCCCCCCC-HHHHhcCCCCCCC
Q 023764          210 LTFDPRQRIT-VEDALAHPYLGSL  232 (277)
Q Consensus       210 L~~dP~~R~t-~~ell~hp~f~~~  232 (277)
                      |. ||.+|++ ++++++||||+.+
T Consensus       269 l~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         269 LC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             cc-ChhhcCCCHHHHhcCCCcCCC
Confidence            97 9999999 9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.5e-38  Score=267.66  Aligned_cols=228  Identities=38%  Similarity=0.751  Sum_probs=181.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.....++....|+||||++++|.+++...     ..+++..+..++.|++.||.|||++|++||||+|+|
T Consensus        61 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~n  140 (295)
T cd07837          61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN  140 (295)
T ss_pred             CCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence            799999999987533222458999999999999988643     357999999999999999999999999999999999


Q ss_pred             EEEec-CCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           76 LLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        76 il~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      |+++. ++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++++|++|.+||.+.+....
T Consensus       141 il~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~  220 (295)
T cd07837         141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ  220 (295)
T ss_pred             EEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            99998 889999999998754332 1222335678899999886655678999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ...+....+.|....+........  ....+...........+.++..+.+||.+||..||.+|||+++++.||||+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         221 LLHIFKLLGTPTEQVWPGVSKLRD--WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHHHhCCCChhhCcchhhccc--hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            888888887777655432211110  011222233334445567899999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=266.70  Aligned_cols=224  Identities=45%  Similarity=0.848  Sum_probs=189.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+|+||++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus        58 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~  132 (283)
T cd05118          58 PNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN  132 (283)
T ss_pred             CCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC
Confidence            7899999999887     899999999999999888764 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+....... ......++..|+|||.+.+....+.++|+||+||++++|++|+.||.+.+..+...++.
T Consensus       133 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~  212 (283)
T cd05118         133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF  212 (283)
T ss_pred             CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999987665443 22334577889999998765468999999999999999999999999999888888888


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +..+.+....+..............+...........+.++..+++||.+||+.||.+||++.+++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            88888877666555443333333344444444455566789999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.7e-39  Score=281.02  Aligned_cols=200  Identities=25%  Similarity=0.431  Sum_probs=160.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||++ |+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++
T Consensus        61 ~~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~  135 (381)
T cd05626          61 EWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID  135 (381)
T ss_pred             CCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC------------------------------------------------CcccccccccccC
Q 023764           80 ANCDLKICDFGLARVTSET------------------------------------------------DFMTEYVVTRWYR  111 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~~~~  111 (277)
                      .++.++|+|||++......                                                .......||+.|+
T Consensus       136 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  215 (381)
T cd05626         136 LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI  215 (381)
T ss_pred             CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcccc
Confidence            9999999999987432100                                                0012346899999


Q ss_pred             ChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc
Q 023764          112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF  191 (277)
Q Consensus       112 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (277)
                      |||++.+ ..++.++||||+||++|+|++|..||.+.+.......+........                          
T Consensus       216 aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------  268 (381)
T cd05626         216 APEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH--------------------------  268 (381)
T ss_pred             CHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC--------------------------
Confidence            9999865 4589999999999999999999999987765544333322110000                          


Q ss_pred             cccCCCCChhHHHHHHHhcCC--CCCCCCCHHHHhcCCCCCCC
Q 023764          192 TEKFPNVHPSAIDLVEKMLTF--DPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       192 ~~~~~~~~~~~~~li~~~L~~--dP~~R~t~~ell~hp~f~~~  232 (277)
                      ......+++++++||.+||..  +|.+|+|++++++||||+..
T Consensus       269 ~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         269 IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            001124788999999997655  44459999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.6e-39  Score=277.70  Aligned_cols=196  Identities=24%  Similarity=0.468  Sum_probs=165.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +.+|+||||+. ++|...+.+.+.+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus        56 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~  130 (325)
T cd05604          56 PFLVGLHYSFQTT-----EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD  130 (325)
T ss_pred             CCCccEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence            7999999999887     89999999997 58999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+..+....+.
T Consensus       131 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~  209 (325)
T cd05604         131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL  209 (325)
T ss_pred             CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999986532 2223345678999999999854 458899999999999999999999998776555444332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~f~~~  232 (277)
                      ..                              .....+..+..+.++|++||+.||.+||++    .+++.||||+..
T Consensus       210 ~~------------------------------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         210 HK------------------------------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cC------------------------------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            20                              001124578889999999999999999986    599999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.5e-39  Score=276.09  Aligned_cols=196  Identities=24%  Similarity=0.482  Sum_probs=166.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. ++|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        56 ~~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~  130 (325)
T cd05602          56 PFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD  130 (325)
T ss_pred             CCCCceeEEEEcC-----CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence            7999999999887     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+....+..+.
T Consensus       131 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (325)
T cd05602         131 SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL  209 (325)
T ss_pred             CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999865322 223345578999999999854 458899999999999999999999998877665544433


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH----HHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE----DALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----ell~hp~f~~~  232 (277)
                      ..   +                           ....+.+++.+.++|.+||+.||.+|+++.    ++++|+||...
T Consensus       210 ~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         210 NK---P---------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             hC---C---------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            21   0                           011246788999999999999999999876    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-39  Score=278.01  Aligned_cols=196  Identities=23%  Similarity=0.468  Sum_probs=166.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+.+.+...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus        58 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  132 (318)
T cd05582          58 PFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD  132 (318)
T ss_pred             CCcccEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus       133 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~  211 (318)
T cd05582         133 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL  211 (318)
T ss_pred             CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH
Confidence            9999999999998754433 22344578999999999854 447899999999999999999999998776655444332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ....                              ...+.+++++++||++||+.||.+|||     +++++.||||..+
T Consensus       212 ~~~~------------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         212 KAKL------------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             cCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            2100                              011246788999999999999999999     7889999999875

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.1e-38  Score=265.27  Aligned_cols=224  Identities=32%  Similarity=0.682  Sum_probs=172.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +..|+||||+++ .|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        60 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~  134 (286)
T cd07847          60 PNLVNLIEVFRRK-----RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT  134 (286)
T ss_pred             CCEeeeeeEEeeC-----CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc
Confidence            7999999999887     889999999986 5555666666799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+..+....+.
T Consensus       135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~  214 (286)
T cd07847         135 KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR  214 (286)
T ss_pred             CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999999997655432 22334577889999998665567899999999999999999999999888777666665


Q ss_pred             HHhCCCChHhhhhhhhhH-HHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENA-KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.........+.... .............+....++.++..+.+||.+||+.||++|||+.+++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            555443332111111000 00000000011112334456778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=282.06  Aligned_cols=199  Identities=24%  Similarity=0.430  Sum_probs=161.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +++|+||||++ |+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++
T Consensus        61 p~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~  135 (377)
T cd05629          61 PWVVSLYYSFQDA-----QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID  135 (377)
T ss_pred             CCcceEEEEEEcC-----CeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC------------------------------------------------cccccccccccC
Q 023764           80 ANCDLKICDFGLARVTSETD------------------------------------------------FMTEYVVTRWYR  111 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~------------------------------------------------~~~~~~~~~~~~  111 (277)
                      .++.++|+|||++.......                                                ......||+.|+
T Consensus       136 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  215 (377)
T cd05629         136 RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI  215 (377)
T ss_pred             CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc
Confidence            99999999999885321100                                                001246899999


Q ss_pred             ChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc
Q 023764          112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF  191 (277)
Q Consensus       112 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (277)
                      |||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+.......                         .+
T Consensus       216 aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~  269 (377)
T cd05629         216 APEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL-------------------------YF  269 (377)
T ss_pred             CHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc-------------------------CC
Confidence            9999854 458999999999999999999999998776655544443210000                         00


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCCCCCCC
Q 023764          192 TEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDALAHPYLGSL  232 (277)
Q Consensus       192 ~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~ell~hp~f~~~  232 (277)
                      + ....++.++++||.+||. +|.+|   +|+.+++.||||+..
T Consensus       270 p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         270 P-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             C-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            0 012467899999999998 77765   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6e-39  Score=282.18  Aligned_cols=199  Identities=25%  Similarity=0.457  Sum_probs=162.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +.+|+|||||+ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~  135 (382)
T cd05625          61 EWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID  135 (382)
T ss_pred             CcCCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC------------------------------------------------CcccccccccccC
Q 023764           80 ANCDLKICDFGLARVTSET------------------------------------------------DFMTEYVVTRWYR  111 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~~~~  111 (277)
                      .+|.++|+|||++......                                                ......+||+.|+
T Consensus       136 ~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  215 (382)
T cd05625         136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI  215 (382)
T ss_pred             CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccC
Confidence            9999999999986421100                                                0012346899999


Q ss_pred             ChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc
Q 023764          112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF  191 (277)
Q Consensus       112 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (277)
                      |||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+........                         .
T Consensus       216 aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~  269 (382)
T cd05625         216 APEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------I  269 (382)
T ss_pred             CHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------C
Confidence            9999865 4589999999999999999999999988766554443332110000                         0


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCC
Q 023764          192 TEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  232 (277)
Q Consensus       192 ~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~  232 (277)
                       .....++++++++|.+|+ .||.+|++   ++++++||||+.+
T Consensus       270 -p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         270 -PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             -CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence             011357889999999987 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=265.64  Aligned_cols=223  Identities=41%  Similarity=0.798  Sum_probs=184.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|.||++
T Consensus        58 ~~iv~~~~~~~~~-----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~  132 (283)
T cd07835          58 PNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI  132 (283)
T ss_pred             CCccCHhheeccC-----CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE
Confidence            7999999999877     8999999999989999998765  68999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+.......+
T Consensus       133 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  212 (283)
T cd07835         133 DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI  212 (283)
T ss_pred             cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998654322 11223356788999998765555788999999999999999999999988888888888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+..+.|....+..... ...+....+...........+.++.++.++|.+||+.||.+|||+++++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         213 FRTLGTPDEDVWPGVTS-LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHhCCCChHHhhhhhh-chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            88888877765543311 122233334444444455567788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.4e-39  Score=275.49  Aligned_cols=200  Identities=24%  Similarity=0.468  Sum_probs=160.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. ++|...+...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        56 p~iv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~  130 (329)
T cd05618          56 PFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD  130 (329)
T ss_pred             CcCCceeeEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence            7999999999887     89999999997 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH-----HH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-----HQ  153 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~  153 (277)
                      .++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++|+|++|..||......     ..
T Consensus       131 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~  209 (329)
T cd05618         131 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT  209 (329)
T ss_pred             CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc
Confidence            99999999999986532 2223345578999999999864 45889999999999999999999999532110     00


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHP  227 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp  227 (277)
                      ...+.+.+                  ...     .   .......+..+++||++||+.||++|+|      +.++++||
T Consensus       210 ~~~~~~~i------------------~~~-----~---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05618         210 EDYLFQVI------------------LEK-----Q---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  263 (329)
T ss_pred             HHHHHHHH------------------hcC-----C---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence            00000000                  000     0   0111256788999999999999999998      58999999


Q ss_pred             CCCCC
Q 023764          228 YLGSL  232 (277)
Q Consensus       228 ~f~~~  232 (277)
                      ||+.+
T Consensus       264 ~f~~~  268 (329)
T cd05618         264 FFRNV  268 (329)
T ss_pred             CCCCC
Confidence            99875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=265.41  Aligned_cols=223  Identities=41%  Similarity=0.784  Sum_probs=189.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus        58 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~  132 (282)
T cd07829          58 PNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN  132 (282)
T ss_pred             CCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc
Confidence            7899999999887     899999999999999999876 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+....... ......++..|+|||.+.....++.++|+||+||+++++++|.+||.+....+.+..+.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  212 (282)
T cd07829         133 RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF  212 (282)
T ss_pred             CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            99999999999987654332 22334557789999998665468899999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +..+.+....+....... .+....+..........++..+..+.++|++||+.||++||++++++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         213 QILGTPTEESWPGVTKLP-DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHhCCCcHHHHHhhcccc-cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            988888887665443322 2233344444445556677788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=265.71  Aligned_cols=224  Identities=39%  Similarity=0.753  Sum_probs=186.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +..|+||||++++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|.||++
T Consensus        58 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i  132 (283)
T cd07830          58 PNIVKLKEVFREN-----DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV  132 (283)
T ss_pred             CCchhHHHHhhcC-----CcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence            7899999999886     8999999999999999887764  78999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||.+.............++..|+|||.+.....++.++|+||+|+++++|++|++||++....+...++.
T Consensus       133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~  212 (283)
T cd07830         133 SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC  212 (283)
T ss_pred             cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence            99999999999999876554444455678899999988665667899999999999999999999999999888888888


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.+....+..............+..........++..+.++++||++||+.||++|||++|++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            88888877654333222222222222222233344455667899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-38  Score=278.82  Aligned_cols=200  Identities=25%  Similarity=0.387  Sum_probs=164.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus       103 ~~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~  176 (370)
T cd05596         103 EWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD  176 (370)
T ss_pred             CCcceEEEEEecC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc
Confidence            7999999999887     89999999996 699998865 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||++.......  ......|++.|+|||++...   ..++.++||||+||++|+|++|.+||.+.+.....
T Consensus       177 ~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~  256 (370)
T cd05596         177 KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY  256 (370)
T ss_pred             CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH
Confidence            99999999999987654322  22345789999999998543   23788999999999999999999999887765554


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~~~  232 (277)
                      ..+.......                         .+ ...+.+|.++++||++||+.+|.+  |+|++++++||||+..
T Consensus       257 ~~i~~~~~~~-------------------------~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         257 SKIMDHKNSL-------------------------TF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHcCCCcC-------------------------CC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            4443211000                         00 011257889999999999999988  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.4e-39  Score=277.11  Aligned_cols=200  Identities=23%  Similarity=0.442  Sum_probs=165.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll  135 (330)
T cd05601          61 PWIPQLQYAFQDK-----DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI  135 (330)
T ss_pred             CCCcceeeEEecC-----CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE
Confidence            7899999999887     88999999996 6999999876 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +.++.++|+|||++........  .....+++.|+|||++..     ...++.++||||+||++|+|++|..||.+.+..
T Consensus       136 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~  215 (330)
T cd05601         136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA  215 (330)
T ss_pred             CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence            9999999999999976543322  223468899999999853     344788999999999999999999999877665


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .....+.......                    .     + ...+.+++++++||++||. ||.+|||++++++||||+.
T Consensus       216 ~~~~~i~~~~~~~--------------------~-----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         216 KTYNNIMNFQRFL--------------------K-----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHcCCCcc--------------------C-----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            5544443211000                    0     0 1123578899999999998 9999999999999999987


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      +
T Consensus       269 ~  269 (330)
T cd05601         269 I  269 (330)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.2e-38  Score=272.95  Aligned_cols=201  Identities=23%  Similarity=0.428  Sum_probs=161.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|..++...+.+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus        56 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~  130 (327)
T cd05617          56 PFLVGLHSCFQTT-----SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD  130 (327)
T ss_pred             CCEeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence            7999999999887     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH---HHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH---QLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~  155 (277)
                      .++.++|+|||++.... .........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.......   ...
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~  209 (327)
T cd05617         131 ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED  209 (327)
T ss_pred             CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH
Confidence            99999999999987532 2233345678999999999854 458999999999999999999999995432110   000


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~f  229 (277)
                      .+......                   .    .   ......++..+.++|++||+.||++|++      ++++++||||
T Consensus       210 ~~~~~~~~-------------------~----~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f  263 (327)
T cd05617         210 YLFQVILE-------------------K----P---IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF  263 (327)
T ss_pred             HHHHHHHh-------------------C----C---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence            01000000                   0    0   0111246788999999999999999998      5799999999


Q ss_pred             CCCC
Q 023764          230 GSLH  233 (277)
Q Consensus       230 ~~~~  233 (277)
                      +.+.
T Consensus       264 ~~~~  267 (327)
T cd05617         264 RSID  267 (327)
T ss_pred             CCCC
Confidence            8763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-38  Score=273.76  Aligned_cols=217  Identities=25%  Similarity=0.438  Sum_probs=165.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +.+|+||||++ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus        63 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  137 (331)
T cd06649          63 PYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV  137 (331)
T ss_pred             CCCCeEEEEEEEC-----CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE
Confidence            7999999999887     88999999997 59999998888899999999999999999999986 69999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++...... ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+ 
T Consensus       138 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~-  214 (331)
T cd06649         138 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF-  214 (331)
T ss_pred             cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-
Confidence            99999999999998755432 2344578999999999864 45899999999999999999999999776654432221 


Q ss_pred             HHhCCCChHh----hhhhh-----------------------hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcC
Q 023764          159 ELIGTPSEAE----LGFLN-----------------------ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       159 ~~~~~~~~~~----~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  211 (277)
                         +.+....    .....                       .....+....   ...  .......++++++||.+||+
T Consensus       215 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~~l~~li~~~L~  286 (331)
T cd06649         215 ---GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE---PPP--KLPNGVFTPDFQEFVNKCLI  286 (331)
T ss_pred             ---cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhC---CCc--CCCCccccHHHHHHHHHHcc
Confidence               1111000    00000                       0000000000   000  00012467899999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCC
Q 023764          212 FDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       212 ~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +||++|||++++++||||+...
T Consensus       287 ~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         287 KNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             CCcccCCCHHHHhcChHHhhcc
Confidence            9999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.7e-38  Score=265.88  Aligned_cols=201  Identities=25%  Similarity=0.439  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++...     ++.|+||||++ |+|.+.+.    .+..+++..+..++.|++.||.|||++||+||||||+|
T Consensus        53 ~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  127 (280)
T cd05608          53 RFIVSLAYAFQTK-----TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN  127 (280)
T ss_pred             CcEeeeeEEEcCC-----CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence            7999999999887     88999999996 68987774    23569999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      |+++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.......
T Consensus       128 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~  206 (280)
T cd05608         128 VLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN  206 (280)
T ss_pred             EEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH
Confidence            999999999999999987654332 2234568899999999865 45889999999999999999999999765432211


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  229 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f  229 (277)
                      ..+.......+                          ....+.++.++.+++.+||+.||++||     |++++++||||
T Consensus       207 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         207 KELKQRILNDS--------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             HHHHHhhcccC--------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            11111110000                          011135788999999999999999999     88999999999


Q ss_pred             CCCC
Q 023764          230 GSLH  233 (277)
Q Consensus       230 ~~~~  233 (277)
                      +...
T Consensus       261 ~~~~  264 (280)
T cd05608         261 RDLN  264 (280)
T ss_pred             hcCC
Confidence            8854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-38  Score=271.30  Aligned_cols=226  Identities=37%  Similarity=0.675  Sum_probs=185.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++...     +..|+||||++++|.+++.....+++..+..++.|++.||++||+.|++|+||+|+||+++.
T Consensus        80 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~  154 (335)
T PTZ00024         80 ENIMGLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS  154 (335)
T ss_pred             cceeeeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECC
Confidence            7999999999877     88999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC---------------CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           81 NCDLKICDFGLARVTSET---------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      ++.++|+|||.+......               .......++..|+|||.+.+...++.++|+||+||++++|++|.+||
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999998765411               11223346778999999866555789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+....+..+.+..+.|....+...... ..+ ...............+..+.+++++|++||+.||++|||+++++.
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        235 PGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCHHHHHHHHHHHhCCCchhhCcchhhc-ccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            999988888999988888876554332110 000 001111122334445667889999999999999999999999999


Q ss_pred             CCCCCCCC
Q 023764          226 HPYLGSLH  233 (277)
Q Consensus       226 hp~f~~~~  233 (277)
                      ||||+...
T Consensus       313 ~~~~~~~~  320 (335)
T PTZ00024        313 HEYFKSDP  320 (335)
T ss_pred             CcccCCCC
Confidence            99999764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=266.35  Aligned_cols=221  Identities=29%  Similarity=0.581  Sum_probs=176.5

Q ss_pred             eeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         3 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      +|.+.++|.-.     +|.|||+|.+|.++.+++.++  .+++.+.++.+++|++.++++||+.+++|.|+||+||++..
T Consensus       153 cv~m~~wFdyr-----ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  153 CVQMRDWFDYR-----GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVS  227 (415)
T ss_pred             EEeeehhhhcc-----CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEec
Confidence            46677778776     999999999999999999886  47999999999999999999999999999999999999831


Q ss_pred             --------------------CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           81 --------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        81 --------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                                          +..++++|||.+....+..  ...+.|..|+|||++.+.+ ++.++||||+|||++|+.+
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeec
Confidence                                2358999999998766543  5678899999999998765 8999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhC-Cccc--------------CCcccccCCCC---ChhH
Q 023764          141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL-PRYQ--------------RQSFTEKFPNV---HPSA  202 (277)
Q Consensus       141 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------------~~~~~~~~~~~---~~~~  202 (277)
                      |..+|.+.++.+.++.+...+|+.+..++....  ..+|.... ..+.              ..++....-..   ..++
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhh--hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            999999999999998888888877776654432  11111111 1111              11111111111   2358


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          203 IDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       203 ~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .|||++||..||.+|+|+.|+|.||||+...
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            8999999999999999999999999998753

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=270.35  Aligned_cols=192  Identities=28%  Similarity=0.394  Sum_probs=163.4

Q ss_pred             CceeeeeccccCCCCCCCC-cEEEEeecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~-~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~-i~H~di~~~n   75 (277)
                      ||||++++++..+     . .++|||||++ |+|.+++.+  ++.++...+..++.||+.|+.|||+++ ||||||||+|
T Consensus        99 pNIV~f~G~~~~~-----~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~N  173 (362)
T KOG0192|consen   99 PNIVQFYGACTSP-----PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDN  173 (362)
T ss_pred             CCeeeEEEEEcCC-----CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhh
Confidence            8999999999986     4 7999999997 799999987  578999999999999999999999999 9999999999


Q ss_pred             EEEecCC-CeEEeeccceeeccCC-CcccccccccccCChhhhhC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           76 LLLNANC-DLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        76 il~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +|++.++ .+||+|||+++..... .......||+.|||||++.+ ...|+.++||||+|+++|||+||..||.+....+
T Consensus       174 iLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~  253 (362)
T KOG0192|consen  174 ILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ  253 (362)
T ss_pred             EEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence            9999998 9999999999876654 34445789999999999964 3569999999999999999999999999888754


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+.....+|..                            ....++.+..||..|+..||.+||+..+++.
T Consensus       254 ~~~~v~~~~~Rp~~----------------------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  254 VASAVVVGGLRPPI----------------------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHhcCCCCCC----------------------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            44444332222221                            0126778999999999999999999988765

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-38  Score=273.62  Aligned_cols=196  Identities=23%  Similarity=0.451  Sum_probs=163.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|...+...+.+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus        56 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~  130 (321)
T cd05603          56 PFLVGLHYSFQTA-----EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD  130 (321)
T ss_pred             CCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence            7999999999887     89999999997 59999888878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.++|+|||++..... ........+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (321)
T cd05603         131 SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL  209 (321)
T ss_pred             CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence            999999999999875322 223344578999999999854 458899999999999999999999998776544433322


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~f~~~  232 (277)
                      .   .+                           ....+..+.++.++|.+||+.||.+|+++    .++++|+||..+
T Consensus       210 ~---~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         210 H---KP---------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             c---CC---------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            1   00                           01113567789999999999999999975    599999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.9e-38  Score=271.00  Aligned_cols=196  Identities=21%  Similarity=0.415  Sum_probs=164.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |+|+++++++.+.     +.+|+||||++ |+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~  135 (323)
T cd05615          61 PFLTQLHSCFQTV-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD  135 (323)
T ss_pred             CchhheeeEEecC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence            5788899999887     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......|++.|+|||++.+ ..++.++|+||+||++++|++|..||.+.+.......+.
T Consensus       136 ~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (323)
T cd05615         136 SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (323)
T ss_pred             CCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998754322 22334568999999999854 458999999999999999999999998877655554443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ....                              .....++.++++++.+||+.||.+|++     .+++++||||..+
T Consensus       215 ~~~~------------------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         215 EHNV------------------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             hCCC------------------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            2110                              001246788999999999999999997     5799999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-38  Score=276.87  Aligned_cols=200  Identities=27%  Similarity=0.395  Sum_probs=163.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus       103 p~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~  176 (370)
T cd05621         103 PWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD  176 (370)
T ss_pred             CCEeeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC
Confidence            8999999999887     89999999996 699999875 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.+||+|||++.......  ......||+.|+|||++.+..   .++.++|+||+||++|+|++|..||.+.+.....
T Consensus       177 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~  256 (370)
T cd05621         177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY  256 (370)
T ss_pred             CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999998654332  223567999999999986432   3678999999999999999999999887766555


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~~~  232 (277)
                      ..+........                         ++. ...++..+++++.+||..++.+  |+|++++++||||+..
T Consensus       257 ~~i~~~~~~~~-------------------------~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         257 SKIMDHKNSLN-------------------------FPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHhCCcccC-------------------------CCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            54443111100                         000 1246788999999999866544  8899999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-37  Score=263.75  Aligned_cols=228  Identities=40%  Similarity=0.771  Sum_probs=181.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     ++.|+||||++++|.+.+.....  +++..+..++.|++.||+|||++|++|+||+|+||++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill  135 (294)
T PLN00009         61 GNIVRLQDVVHSE-----KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI  135 (294)
T ss_pred             CCEeeEEEEEecC-----CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEE
Confidence            7999999999887     89999999999999988876543  5788899999999999999999999999999999999


Q ss_pred             ec-CCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +. ++.++|+|||++...... .......+++.|+|||.+.+...++.++|+||+||++++|++|.+||.+.+..+....
T Consensus       136 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~  215 (294)
T PLN00009        136 DRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK  215 (294)
T ss_pred             ECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            85 457899999998754332 2223446678899999986655678999999999999999999999998888888888


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +....+.|....+..... ...+....+.+.........+..++.+++++.+||+.||++||++.+++.||||..+..
T Consensus       216 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        216 IFRILGTPNEETWPGVTS-LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             HHHHhCCCChhhcccccc-chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            877777777655432211 11111122222223333445678899999999999999999999999999999987653

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.9e-38  Score=262.86  Aligned_cols=202  Identities=22%  Similarity=0.361  Sum_probs=161.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +++|+||||+. ++|.+.+...  ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        53 p~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nil  127 (277)
T cd05607          53 PFIVNLAYAFESK-----THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL  127 (277)
T ss_pred             CcEEEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEE
Confidence            7999999999887     88999999996 6898887644  35888999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.++.++|+|||++.............++..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.........+
T Consensus       128 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~  206 (277)
T cd05607         128 LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL  206 (277)
T ss_pred             EcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Confidence            9999999999999987765544444557889999999986544 899999999999999999999999754332111111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~f~~~~  233 (277)
                      ......                         .........++.++++||++||+.||.+|||+    ++++.||||+.+.
T Consensus       207 ~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         207 KRRTLE-------------------------DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             HHHhhc-------------------------cccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            110000                         00001112568899999999999999999999    6788999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-38  Score=277.60  Aligned_cols=199  Identities=28%  Similarity=0.475  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+.+.     +++|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~  135 (360)
T cd05627          61 AWVVKMFYSFQDK-----RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD  135 (360)
T ss_pred             CCEeeEEEEEEcC-----CEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC
Confidence            7999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC------------------------------------cccccccccccCChhhhhCCCCCC
Q 023764           80 ANCDLKICDFGLARVTSETD------------------------------------FMTEYVVTRWYRAPELLLNSSDYT  123 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~  123 (277)
                      .+|.++|+|||++.......                                    .....+||+.|+|||++.+ ..++
T Consensus       136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~  214 (360)
T cd05627         136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYN  214 (360)
T ss_pred             CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCC
Confidence            99999999999876432110                                    0123468999999999865 4589


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHH
Q 023764          124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  203 (277)
Q Consensus       124 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (277)
                      .++||||+||++|+|++|.+||.+.+.......+......                         ..++. ...++.+++
T Consensus       215 ~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~-------------------------~~~p~-~~~~s~~~~  268 (360)
T cd05627         215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET-------------------------LVFPP-EVPISEKAK  268 (360)
T ss_pred             CcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCc-------------------------eecCC-CCCCCHHHH
Confidence            9999999999999999999999887765554444321000                         00000 113678999


Q ss_pred             HHHHHhcCCCCCCCCC---HHHHhcCCCCCCC
Q 023764          204 DLVEKMLTFDPRQRIT---VEDALAHPYLGSL  232 (277)
Q Consensus       204 ~li~~~L~~dP~~R~t---~~ell~hp~f~~~  232 (277)
                      +||.+|+. ||.+|++   ++++++||||+.+
T Consensus       269 ~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         269 DLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             HHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            99999874 9999984   8999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-38  Score=271.32  Aligned_cols=198  Identities=29%  Similarity=0.509  Sum_probs=157.0

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l-~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      +||.|+||-..+     +.+|+||||-+.+|..++.+.... ..-.++.+..|++.|+.++|.+||||.|+||.|+++ -
T Consensus       421 ~IIqL~DYEv~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-V  494 (677)
T KOG0596|consen  421 KIIQLYDYEVTD-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-V  494 (677)
T ss_pred             eEEEEeeeeccC-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-E
Confidence            699999998887     899999999999999999987543 334789999999999999999999999999999887 4


Q ss_pred             CCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCC----------CCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           81 NCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      .|.+||+|||.+..+...   ....+.+||+.||+||.+....          ..++++||||||||+|+|+.|++||..
T Consensus       495 kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  495 KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            578999999999876554   3456789999999999985321          257899999999999999999999943


Q ss_pred             CChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCC--hhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      -.  ..++++.. +..|                         .-+-.||..+  .++.++++.||.+||++|||+.++|+
T Consensus       575 ~~--n~~aKl~a-I~~P-------------------------~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  575 II--NQIAKLHA-ITDP-------------------------NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HH--HHHHHHHh-hcCC-------------------------CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            21  11222211 1111                         1112233332  24899999999999999999999999


Q ss_pred             CCCCCCCC
Q 023764          226 HPYLGSLH  233 (277)
Q Consensus       226 hp~f~~~~  233 (277)
                      |||++.+.
T Consensus       627 hpFl~~~~  634 (677)
T KOG0596|consen  627 HPFLQIQP  634 (677)
T ss_pred             Cccccccc
Confidence            99998743

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-38  Score=279.41  Aligned_cols=199  Identities=24%  Similarity=0.431  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+.+.     +.+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~  135 (376)
T cd05598          61 EWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID  135 (376)
T ss_pred             CCcceEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC
Confidence            7999999999887     89999999996 69999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC--------------------------------------------CcccccccccccCChhh
Q 023764           80 ANCDLKICDFGLARVTSET--------------------------------------------DFMTEYVVTRWYRAPEL  115 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~--------------------------------------------~~~~~~~~~~~~~aPE~  115 (277)
                      .++.++|+|||++......                                            .......|++.|+|||+
T Consensus       136 ~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  215 (376)
T cd05598         136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV  215 (376)
T ss_pred             CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHH
Confidence            9999999999987421100                                            00113468999999999


Q ss_pred             hhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC
Q 023764          116 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF  195 (277)
Q Consensus       116 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (277)
                      +.+ ..++.++||||+||++|+|++|+.||.+.+.......+......                      .   .. ...
T Consensus       216 ~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------------~---~~-~~~  268 (376)
T cd05598         216 LLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT----------------------L---HI-PSQ  268 (376)
T ss_pred             HcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc----------------------c---cC-CCC
Confidence            854 45899999999999999999999999877655443332210000                      0   00 011


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCC
Q 023764          196 PNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  232 (277)
Q Consensus       196 ~~~~~~~~~li~~~L~~dP~~R~---t~~ell~hp~f~~~  232 (277)
                      ..+++++.++|.+|+ .+|.+|+   |+.++++||||+.+
T Consensus       269 ~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         269 AKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            357889999999977 5999999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=276.53  Aligned_cols=189  Identities=29%  Similarity=0.515  Sum_probs=161.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~-   78 (277)
                      |||+++++++.+.     .+.|+|||++.| .+.+-+...+.++ ..+..|+.||+.|+.|||++|++|||+||+|||+ 
T Consensus       376 ~niv~~~~v~~~~-----~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~  449 (612)
T KOG0603|consen  376 PNIVKSHDVYEDG-----KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD  449 (612)
T ss_pred             CcceeecceecCC-----ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence            7999999999998     999999999974 6777776666566 7888899999999999999999999999999999 


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +..|.++|+|||.++.....  ..+.+.|..|.|||++. ...+++++|+||||+++|+||+|+.||......   ..+.
T Consensus       450 ~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~  523 (612)
T KOG0603|consen  450 GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIH  523 (612)
T ss_pred             CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHH
Confidence            69999999999998765544  44567888999999986 556999999999999999999999999766555   2333


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..++.|+..                            ..+|.++++||++||+.||.+|+++.+++.||||
T Consensus       524 ~~i~~~~~s----------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  524 TRIQMPKFS----------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HhhcCCccc----------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            444443321                            2689999999999999999999999999999999

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-38  Score=282.43  Aligned_cols=197  Identities=25%  Similarity=0.395  Sum_probs=164.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      ||||++++++...     +++||||||+. |+|.+.+..    ..++++..+..++.|++.||.|||++||+||||||+|
T Consensus       125 pniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N  199 (478)
T PTZ00267        125 FGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN  199 (478)
T ss_pred             CCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHh
Confidence            7999999999887     89999999996 699887753    3568999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      |+++.++.++|+|||++.......   .....+||+.|+|||++.+ ..++.++||||+||++++|++|..||.+.+...
T Consensus       200 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~  278 (478)
T PTZ00267        200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQRE  278 (478)
T ss_pred             EEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999998654332   2344568999999998854 458999999999999999999999998776655


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+..+......                             .....++.++++||.+||..||++|||+++++.|+|++..
T Consensus       279 ~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        279 IMQQVLYGKYD-----------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHhCCCC-----------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            44443321000                             0112467889999999999999999999999999998753

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-40  Score=274.48  Aligned_cols=197  Identities=25%  Similarity=0.456  Sum_probs=167.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||.++|+.|...     ..++++||||+ |++.+.++....+++..+..++.+++.|+.|||..+.+|||||+.||++.
T Consensus        71 ~~it~yygsyl~g-----~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s  145 (467)
T KOG0201|consen   71 PNITEYYGSYLKG-----TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS  145 (467)
T ss_pred             chHHhhhhheeec-----ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe
Confidence            6889999999987     88999999997 69999999877779999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||.+...... ....+++|||+|||||++. ...|+.++||||||++.+||++|.+|+.+......     
T Consensus       146 ~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----  219 (467)
T KOG0201|consen  146 ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----  219 (467)
T ss_pred             ccCcEEEEecceeeeeechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----
Confidence            9999999999998765544 3347889999999999996 44599999999999999999999999966543111     


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                                           +...+....+.+.   ...|+.+++|+..||++||+.||||.++|+|+|++..
T Consensus       220 ---------------------lflIpk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  220 ---------------------LFLIPKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             ---------------------EEeccCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                                 1111222222222   2678899999999999999999999999999999873

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-38  Score=248.91  Aligned_cols=231  Identities=32%  Similarity=0.588  Sum_probs=186.8

Q ss_pred             CceeeeeccccCCC---CCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      ||++.|.+++....   ...-..+|+|+++|+.+|..++... .+++..+++.++.+++.||.|+|++.|+|||+|++|+
T Consensus        76 env~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNv  155 (376)
T KOG0669|consen   76 ENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANV  155 (376)
T ss_pred             hhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhE
Confidence            57777777776542   2222459999999999999999876 6799999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +|+.+|.++|+|||+++..+...     ..+..+.|.+|++||.+.+...|+++.|||..|||+.+|++|.+.+.+.++.
T Consensus       156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq  235 (376)
T KOG0669|consen  156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ  235 (376)
T ss_pred             EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence            99999999999999997665442     2233456889999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhh-hHHHHhhh--CCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNE-NAKKYICQ--LPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +++..|..+.|....+.|..... ..-.-+..  ++..+....+....  .-++++.||+.+||..||.+|++++++++|
T Consensus       236 qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  236 QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            99999999999988887765532 11111111  22222222222221  125689999999999999999999999999


Q ss_pred             CCCCC
Q 023764          227 PYLGS  231 (277)
Q Consensus       227 p~f~~  231 (277)
                      .||..
T Consensus       316 ~~F~k  320 (376)
T KOG0669|consen  316 DFFWK  320 (376)
T ss_pred             hhhhc
Confidence            99975

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=262.24  Aligned_cols=200  Identities=28%  Similarity=0.437  Sum_probs=163.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +++|+||||++ ++|.+.+...  ..+++..+..++.|++.|+.|||+.|++||||+|+||+
T Consensus        60 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil  134 (285)
T cd05605          60 RFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL  134 (285)
T ss_pred             CCEeeeeeeecCC-----CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEE
Confidence            7999999999887     88999999996 6898887643  46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.++.++|+|||++.............++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.........+
T Consensus       135 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~  213 (285)
T cd05605         135 LDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV  213 (285)
T ss_pred             ECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence            99999999999999877554433345578899999999854 45889999999999999999999999876544333322


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ...+....                          ....+.++..+++||.+||..||.+||     +++++++||||...
T Consensus       214 ~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         214 ERRVKEDQ--------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHhhhcc--------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            22111000                          011134678899999999999999999     99999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=254.34  Aligned_cols=231  Identities=48%  Similarity=0.838  Sum_probs=197.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      .||...+|+...+...=|..+|+|+|+|..+|..++-+...++.+.++-+++||++||+|||+.||.||||||-|.+++.
T Consensus       112 dNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS  191 (449)
T KOG0664|consen  112 DNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS  191 (449)
T ss_pred             ccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence            47888888888876666678999999999999999998889999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +..+||||||+++.....  ...+..+.|.+|+|||++.+...|+.++||||.|||+.|++.++..|...+..+++..|.
T Consensus       192 NCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt  271 (449)
T KOG0664|consen  192 NCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII  271 (449)
T ss_pred             CceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence            999999999999876543  345666789999999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +.+|+|+-+.+..-.+-...-+.+.+..+ +++...+.     +-..+..+++.+||..||++|.+.++++.|+|....
T Consensus       272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~-Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  272 DLLGTPSQEAMKYACEGAKNHVLRAGLRA-PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HHhCCCcHHHHHHHhhhhHHHhhccCCCC-CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            99999999988776555555444433221 22222222     233568899999999999999999999999999764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=267.07  Aligned_cols=202  Identities=21%  Similarity=0.401  Sum_probs=163.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +++|+||||+. ++|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill  135 (331)
T cd05597          61 RWITNLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL  135 (331)
T ss_pred             CCCCceEEEEecC-----CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE
Confidence            7899999999887     89999999995 699999976 4579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +.++.++|+|||++........  .....|++.|+|||++..    ...++.++||||+||++|+|++|..||.+.+..+
T Consensus       136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~  215 (331)
T cd05597         136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  215 (331)
T ss_pred             CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH
Confidence            9999999999999876543322  223468999999999863    2346889999999999999999999998776655


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLG  230 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~  230 (277)
                      ....+.....                         ...+....+.++..+++||++||..++++  |++++++++||||.
T Consensus       216 ~~~~i~~~~~-------------------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~  270 (331)
T cd05597         216 TYGKIMNHKE-------------------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE  270 (331)
T ss_pred             HHHHHHcCCC-------------------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence            5444432110                         01111222357889999999999765544  78999999999998


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      ..
T Consensus       271 ~~  272 (331)
T cd05597         271 GI  272 (331)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-37  Score=275.47  Aligned_cols=224  Identities=23%  Similarity=0.315  Sum_probs=164.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++...     +..|+|||++.++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       220 pnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~  294 (461)
T PHA03211        220 PAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN  294 (461)
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence            7999999999876     889999999999999988764 4699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------
Q 023764           80 ANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-------  149 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------  149 (277)
                      .++.++|+|||+++......   ......||..|+|||++.+ ..++.++|||||||++|+|++|..++.+..       
T Consensus       295 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~  373 (461)
T PHA03211        295 GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP  373 (461)
T ss_pred             CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC
Confidence            99999999999987543221   1223568999999999865 458999999999999999998775543221       


Q ss_pred             hHHHHHHHHHHhCCCChHhhh----hhhhhHHH--HhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          150 HVHQLRLLIELIGTPSEAELG----FLNENAKK--YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ....+..++...+........    .+......  .....+......+ ..+..++.++.+||.+||+.||.+|||+.|+
T Consensus       374 ~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~el  452 (461)
T PHA03211        374 YDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAEL  452 (461)
T ss_pred             cHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence            123344444433321111000    01000000  0011111111112 2223567789999999999999999999999


Q ss_pred             hcCCCCCC
Q 023764          224 LAHPYLGS  231 (277)
Q Consensus       224 l~hp~f~~  231 (277)
                      |+||||++
T Consensus       453 L~hp~f~~  460 (461)
T PHA03211        453 LRLPLFQS  460 (461)
T ss_pred             hhCcccCC
Confidence            99999974

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5e-37  Score=260.18  Aligned_cols=224  Identities=37%  Similarity=0.676  Sum_probs=170.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+++++.+.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus        63 ~ni~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~  137 (291)
T cd07870          63 ANIVLLHDIIHTK-----ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS  137 (291)
T ss_pred             CCEeEEEEEEecC-----CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc
Confidence            7999999999876     789999999998888877543 5678889999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i  157 (277)
                      .++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++++|++|..||.+.+ ..+.+..+
T Consensus       138 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~  217 (291)
T cd07870         138 YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI  217 (291)
T ss_pred             CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Confidence            9999999999988754322 122334568889999988655557889999999999999999999997654 34566666


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....+.|....+..+........................  ..+.++.+++.+||+.||++|||+.+++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         218 WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            677777766554433211100000011111111111111  136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.3e-37  Score=260.96  Aligned_cols=200  Identities=26%  Similarity=0.426  Sum_probs=162.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+. ++|.+++..++.+++..+..++.|++.||+|||+.|++|+||||+||+++
T Consensus        57 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~  131 (279)
T cd05633          57 PFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD  131 (279)
T ss_pred             CcEeEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC
Confidence            6899999999886     88999999997 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++....... .....++..|+|||.+.....++.++|+||+||++++|++|..||.+....... .+..
T Consensus       132 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~  209 (279)
T cd05633         132 EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR  209 (279)
T ss_pred             CCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH
Confidence            99999999999986554332 223468899999998865455789999999999999999999999654321110 0100


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~~  233 (277)
                      ....                          ......+..+.+++++|++||..||++|+     |+.++++||||+.+.
T Consensus       210 ~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         210 MTLT--------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             Hhhc--------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            0000                          00011235678999999999999999999     699999999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-37  Score=268.05  Aligned_cols=202  Identities=22%  Similarity=0.425  Sum_probs=164.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili  135 (332)
T cd05623          61 QWITTLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM  135 (332)
T ss_pred             CCEeeEEEEEecC-----CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence            6899999999887     89999999996 699999976 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +.++.++|+|||++.......  ......|++.|+|||++..    ...++.++||||+||++|+|++|+.||.+.+..+
T Consensus       136 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~  215 (332)
T cd05623         136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE  215 (332)
T ss_pred             CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999987543322  1223578999999999852    3457889999999999999999999998877666


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLG  230 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~  230 (277)
                      ....+.....                         ...++.....+++++++||++||+.++.+  |++++++++||||.
T Consensus       216 ~~~~i~~~~~-------------------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~  270 (332)
T cd05623         216 TYGKIMNHKE-------------------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT  270 (332)
T ss_pred             HHHHHhCCCc-------------------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence            5554432110                         00111222357889999999999765554  68999999999998


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      .+
T Consensus       271 ~~  272 (332)
T cd05623         271 GI  272 (332)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-37  Score=271.81  Aligned_cols=200  Identities=25%  Similarity=0.360  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus       103 p~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~  176 (371)
T cd05622         103 PWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD  176 (371)
T ss_pred             CCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC
Confidence            7999999999887     88999999996 699998875 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||++.......  ......||+.|+|||++....   .++.++||||+||++|+|++|..||.+.+.....
T Consensus       177 ~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  256 (371)
T cd05622         177 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY  256 (371)
T ss_pred             CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999997654332  223567899999999986432   3788999999999999999999999887765555


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~~~  232 (277)
                      ..+........                         + ...+.++..+++||.+||..++.+  |++++++++|+||+..
T Consensus       257 ~~i~~~~~~~~-------------------------~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         257 SKIMNHKNSLT-------------------------F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHcCCCccc-------------------------C-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            44432111000                         0 112357889999999999844433  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.9e-37  Score=262.18  Aligned_cols=229  Identities=34%  Similarity=0.613  Sum_probs=173.1

Q ss_pred             CceeeeeccccCCC---CCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++....   .......|+||||++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        71 ~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~ni  150 (310)
T cd07865          71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANI  150 (310)
T ss_pred             CCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            79999999886542   1222567999999999998888764 3689999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.++|+|||++.......     ......++..|+|||.+.+...++.++||||+||++++|++|.+||.+.+..
T Consensus       151 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~  230 (310)
T cd07865         151 LITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ  230 (310)
T ss_pred             EECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999987554321     1123456788999998866555788999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC-C-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-P-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .....+....+..+...+..............+........... + ..++.+++||.+||..||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            77777777777665544332211110000111111111111111 1 235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.9e-37  Score=258.89  Aligned_cols=224  Identities=33%  Similarity=0.701  Sum_probs=174.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+++ .|.++......+++..+..++.|++.|+.|||+.|++|+|++|+||+++
T Consensus        60 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~  134 (286)
T cd07846          60 ENLVNLIEVFRRK-----KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS  134 (286)
T ss_pred             cchhhHHHhcccC-----CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence            7999999999876     889999999986 6666666656799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......++..|+|||.+.+...++.++||||+||++++|++|.+||.+....+....+.
T Consensus       135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~  214 (286)
T cd07846         135 QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII  214 (286)
T ss_pred             CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence            9999999999998765432 222334578889999998665557889999999999999999999998888777777777


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ...+.....................+.. .........+.++..+++|+.+||+.||++|||+.++++||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            6665543322111111000000001111 1112233456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.8e-37  Score=263.02  Aligned_cols=229  Identities=36%  Similarity=0.681  Sum_probs=178.8

Q ss_pred             CceeeeeccccCCCC---CCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++.+...   +....+|+||||+++++.+.+.. ...+++..++.++.|++.||.|||+.|++|+|++|+||
T Consensus        67 ~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~ni  146 (311)
T cd07866          67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANI  146 (311)
T ss_pred             CCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            799999998866421   22356899999999988887765 35799999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCCc------------ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 023764           77 LLNANCDLKICDFGLARVTSETDF------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  144 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  144 (277)
                      +++.++.++|+|||++........            .....+++.|+|||.+.+...++.++||||+||++++|++|++|
T Consensus       147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~  226 (311)
T cd07866         147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI  226 (311)
T ss_pred             EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence            999999999999999865432211            12234678899999886655678999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      |.+.+.....+.+....+.+....+.....-...............+...++..++.+++||.+||..||.+|||+.+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            99999888888888888877665543321111000000011111223344556778899999999999999999999999


Q ss_pred             cCCCC
Q 023764          225 AHPYL  229 (277)
Q Consensus       225 ~hp~f  229 (277)
                      .||||
T Consensus       307 ~~~~f  311 (311)
T cd07866         307 EHPYF  311 (311)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=287.71  Aligned_cols=198  Identities=26%  Similarity=0.449  Sum_probs=172.1

Q ss_pred             eeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC
Q 023764            3 VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN   81 (277)
Q Consensus         3 iv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~   81 (277)
                      |+.|+-+|.+.     +++|+|||||. |+|..++.+..+++++.+++++..|+.||.-||+.|+|||||||+|||++..
T Consensus       137 iv~LhyAFQD~-----~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~  211 (1317)
T KOG0612|consen  137 IVQLHYAFQDE-----RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS  211 (1317)
T ss_pred             HHHHHHHhcCc-----cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc
Confidence            67889999998     99999999995 7999999998899999999999999999999999999999999999999999


Q ss_pred             CCeEEeeccceeeccCCC--cccccccccccCChhhhhC---C-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           82 CDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLN---S-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        82 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~---~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      |.+||+|||.|-.+...+  .....+|||-|.+||++..   + +.|++.+|.||+||++|||+.|..||...+..+.+.
T Consensus       212 GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~  291 (1317)
T KOG0612|consen  212 GHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG  291 (1317)
T ss_pred             CcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH
Confidence            999999999987665433  3456789999999999853   2 468999999999999999999999999999888888


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  232 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~  232 (277)
                      +|+......                         .++ ....+|.++++||.++|. +|..|..   ++++..||||.++
T Consensus       292 KIm~hk~~l-------------------------~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  292 KIMNHKESL-------------------------SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             HHhchhhhc-------------------------CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            888641110                         111 112589999999999997 8999998   9999999999875

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=258.97  Aligned_cols=226  Identities=37%  Similarity=0.695  Sum_probs=179.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++....   .+..|+||||++++|.+++... ..+++..+..++.|++.|+++||+.|++|+||+|.||+++
T Consensus        58 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~  134 (287)
T cd07840          58 PNIVRLKEIVTSKG---KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN  134 (287)
T ss_pred             CCeeeheeeEecCC---CCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc
Confidence            79999999997652   2689999999999999998765 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||.+.......  ......++..|+|||.+.+...++.++||||+||++++|++|..||.+.+.......+
T Consensus       135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~  214 (287)
T cd07840         135 NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI  214 (287)
T ss_pred             CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999987665432  1233456788999998765556789999999999999999999999998888888888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCC-ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV-HPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+..+.+....+.........-...........+...+... +..+.+++++||..||.+|||+++++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         215 FELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            88888777665543322100000000111111222333444 8899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-37  Score=258.41  Aligned_cols=201  Identities=34%  Similarity=0.565  Sum_probs=165.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+|||++++ +|.+++.+.+.+++..+..++.|++.||++||++|++|+||||+||+++
T Consensus        58 ~~i~~~~~~~~~~-----~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~  132 (260)
T PF00069_consen   58 PNIVQILDVFQDD-----NYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD  132 (260)
T ss_dssp             TTBCHEEEEEEES-----SEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES
T ss_pred             ccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            7999999999987     899999999986 9999999778899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeec-cCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+... ..........++..|+|||++......+.++|+||+|+++++|++|..||...........+.
T Consensus       133 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~  212 (260)
T PF00069_consen  133 ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE  212 (260)
T ss_dssp             TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence            9999999999998763 333445566788999999998635568999999999999999999999998774444433333


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +...........                       .....+..++++|.+||+.||++|||++++++||||
T Consensus       213 ~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  213 KILKRPLPSSSQ-----------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHTHHHHHTT-----------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hccccccccccc-----------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            322111110000                       000112689999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.7e-37  Score=260.45  Aligned_cols=200  Identities=27%  Similarity=0.441  Sum_probs=161.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++.+.+.     +..|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus        60 ~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil  134 (285)
T cd05630          60 RFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL  134 (285)
T ss_pred             CCeeeeeEEEecC-----CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence            6899999999887     88999999996 6899888543  35899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.++.++|+|||++.............++..|+|||++.+ ..++.++||||+||++++|++|..||.+..........
T Consensus       135 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~  213 (285)
T cd05630         135 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV  213 (285)
T ss_pred             ECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence            99999999999999876554433344578999999999865 45899999999999999999999999765432111111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ........                          .......++++++|+.+||+.||.+|||     ++++++||||+.+
T Consensus       214 ~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         214 ERLVKEVQ--------------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             Hhhhhhhh--------------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            11000000                          0111246788999999999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.8e-37  Score=256.10  Aligned_cols=195  Identities=24%  Similarity=0.430  Sum_probs=160.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     +.+|+||||++ ++|.+++..+..+++..+..++.|++.|+.+||+.|++||||+|+||+++
T Consensus        69 ~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~  143 (267)
T PHA03390         69 PNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD  143 (267)
T ss_pred             CCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence            7999999999987     88999999996 69999998877899999999999999999999999999999999999999


Q ss_pred             cCC-CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHH
Q 023764           80 ANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ-LRLL  157 (277)
Q Consensus        80 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i  157 (277)
                      .++ .++|+|||.+......   ....++..|+|||++.+ ..++.++|+||+||++++|++|..||........ ...+
T Consensus       144 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~  219 (267)
T PHA03390        144 RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL  219 (267)
T ss_pred             CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence            998 9999999998765533   23457888999999865 4478999999999999999999999975433221 1111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPYLGS  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~ell~hp~f~~  231 (277)
                      .....                           ......+..++.+++||.+||+.||.+|++ ++++++||||.+
T Consensus       220 ~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        220 LKRQQ---------------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHhhc---------------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            11000                           001122357889999999999999999996 599999999974

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=257.06  Aligned_cols=225  Identities=40%  Similarity=0.715  Sum_probs=179.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+....+...+|++|||++++|.+++....  .+++..+..++.|++.||.+||+.|++|+|++|+||++
T Consensus        61 ~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili  140 (287)
T cd07838          61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV  140 (287)
T ss_pred             CCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE
Confidence            7999999999876333334599999999999999887643  58999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++++|++|.+||.+.+..+...++.
T Consensus       141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~  219 (287)
T cd07838         141 TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF  219 (287)
T ss_pred             ccCCCEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence            99999999999998776544444445678889999998654 47899999999999999999999999988888888888


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +..+.+....+......   .....+...........+.+++.+.++|.+||+.||++|||+++++.||||
T Consensus       220 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         220 DVIGLPSEEEWPRNVSL---PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHcCCCChHhcCCCccc---chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            77666544322211000   000111222222344455678889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=252.32  Aligned_cols=209  Identities=24%  Similarity=0.436  Sum_probs=164.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      +||+.|+++|.++     ..+|||||-|. |.|...|.+++.|++.++.+++..|+.||.|||.+||.|||+||+|||-.
T Consensus       136 ~nilqLiefFEdd-----~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~  210 (463)
T KOG0607|consen  136 KNILQLIEFFEDD-----TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCE  210 (463)
T ss_pred             ccHHHHHHHhccc-----ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeec
Confidence            6999999999998     89999999995 79999999999999999999999999999999999999999999999975


Q ss_pred             cCC---CeEEeeccceeeccCC--------CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCC
Q 023764           80 ANC---DLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPL  144 (277)
Q Consensus        80 ~~~---~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p  144 (277)
                      ...   -+|||||.++......        ....+.+|+..|||||++.-    ...|+.++|.||||||+|-|++|.+|
T Consensus       211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP  290 (463)
T KOG0607|consen  211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP  290 (463)
T ss_pred             CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence            443   3799999876432211        22345688899999999732    23478999999999999999999999


Q ss_pred             CCCC-------ChHHH----HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCC
Q 023764          145 FPGR-------DHVHQ----LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  213 (277)
Q Consensus       145 f~~~-------~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  213 (277)
                      |.|.       +..+.    .+++.+.+..                    ..+  ....+.|.++|.+++|+++++|..|
T Consensus       291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE--------------------GkY--eFPdkdWahIS~eakdlisnLlvrd  348 (463)
T KOG0607|consen  291 FVGHCGADCGWDRGEVCRVCQNKLFESIQE--------------------GKY--EFPDKDWAHISSEAKDLISNLLVRD  348 (463)
T ss_pred             ccCccCCcCCccCCCccHHHHHHHHHHHhc--------------------cCC--cCChhhhHHhhHHHHHHHHHHHhcc
Confidence            9543       11111    1111111100                    000  0112445678999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCCC
Q 023764          214 PRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       214 P~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      +..|.++.++++|||++.+....
T Consensus       349 a~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  349 AKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             HHhhhhhhhccCCccccccchhc
Confidence            99999999999999999886543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-37  Score=277.28  Aligned_cols=225  Identities=23%  Similarity=0.311  Sum_probs=164.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++...     +..|+|+++++++|.+++...     .......++.++.|++.||+|||++||+||||||+|
T Consensus       223 pnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N  297 (501)
T PHA03210        223 ENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN  297 (501)
T ss_pred             CCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            7999999999887     889999999999998887542     224466788999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCC-CCC--CCh
Q 023764           76 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG--RDH  150 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~--~~~  150 (277)
                      |+++.++.++|+|||++.......  ......|+..|+|||++.+ ..++.++||||+||++|+|++|..+ +.+  ...
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            999999999999999997654432  2234578999999999865 4589999999999999999998754 432  234


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCC-cccCCcccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-RYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ...+.++....+.+.... .........++.... ......+...+  ..++.++.++|.+||++||.+|||+.|+|+||
T Consensus       377 ~~~~~~~~~~~~~~~~~~-p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEF-PDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHHHHHHhcccChhhc-CCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            455555555554333221 111111111111100 00111111111  13567899999999999999999999999999


Q ss_pred             CCCCC
Q 023764          228 YLGSL  232 (277)
Q Consensus       228 ~f~~~  232 (277)
                      ||+..
T Consensus       456 ~f~~~  460 (501)
T PHA03210        456 LFSAE  460 (501)
T ss_pred             hhhcC
Confidence            99864

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-37  Score=257.79  Aligned_cols=224  Identities=34%  Similarity=0.744  Sum_probs=173.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~-~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +..|+||||+++++.+ +..+...+++..+..++.|++.|+.|||+.|++|+|++|+||+++
T Consensus        60 ~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~  134 (288)
T cd07833          60 ENIVNLKEAFRRK-----GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS  134 (288)
T ss_pred             CCeeehhheEEEC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence            7999999999886     8899999999875544 455556799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||.+.......  ......++..|+|||++.....++.++|+||+|+++++|++|.+||.+....+....+
T Consensus       135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~  214 (288)
T cd07833         135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI  214 (288)
T ss_pred             CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999987655432  3344567888999999876546889999999999999999999999988877777777


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCc-ccCCcccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....+...................+.+. .........++. ++.++++||++||..||++|||+++++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         215 QKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            7766665543332221100000000100 011112223344 38899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=260.63  Aligned_cols=226  Identities=38%  Similarity=0.682  Sum_probs=171.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+..   .+.+|+||||++++|.+.+...     ..+++..++.++.|++.||.|||+.|++||||+|+|
T Consensus        62 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~N  138 (316)
T cd07842          62 ENVVSLVEVFLEHA---DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPAN  138 (316)
T ss_pred             CCccceEEEEeCCC---CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHH
Confidence            79999999998752   2679999999998888877532     368999999999999999999999999999999999


Q ss_pred             EEEec----CCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           76 LLLNA----NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        76 il~~~----~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      |+++.    ++.++|+|||++.......    ......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+
T Consensus       139 il~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  218 (316)
T cd07842         139 ILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG  218 (316)
T ss_pred             EEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            99999    9999999999987654322    123345688899999987666688999999999999999999999976


Q ss_pred             CChH---------HHHHHHHHHhCCCChHhhhhhhhh--HHHH--hhhCCcccCCccccc---CCCCChhHHHHHHHhcC
Q 023764          148 RDHV---------HQLRLLIELIGTPSEAELGFLNEN--AKKY--ICQLPRYQRQSFTEK---FPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       148 ~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~  211 (277)
                      ....         ..+..+.+.++.+....+......  ....  ...............   ....+.++.+++.+||+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  298 (316)
T cd07842         219 REAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE  298 (316)
T ss_pred             CcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhc
Confidence            5432         356667777777666544332111  0000  000011110111111   12567889999999999


Q ss_pred             CCCCCCCCHHHHhcCCCC
Q 023764          212 FDPRQRITVEDALAHPYL  229 (277)
Q Consensus       212 ~dP~~R~t~~ell~hp~f  229 (277)
                      .||++|||+.+++.||||
T Consensus       299 ~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         299 YDPTKRITAEEALEHPYF  316 (316)
T ss_pred             CCcccCcCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-37  Score=254.74  Aligned_cols=195  Identities=24%  Similarity=0.428  Sum_probs=160.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+|+||+. ++|.+.+.+.+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        64 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~  138 (263)
T cd06625          64 ERIVQYYGCLRDD-----ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD  138 (263)
T ss_pred             CCeeeeEEEEccC-----CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence            7999999999887     79999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||++........    .....++..|+|||.+.+. .++.++||||+||++++|++|+.||.+........
T Consensus       139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  217 (263)
T cd06625         139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF  217 (263)
T ss_pred             CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence            999999999999875432211    1234577889999998654 48899999999999999999999997654433322


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+.....                            ........+..+.++|++||..||.+|||+.++++||||
T Consensus       218 ~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         218 KIATQPT----------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHhccCC----------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            2111000                            001112567889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.7e-37  Score=264.39  Aligned_cols=224  Identities=23%  Similarity=0.397  Sum_probs=163.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +++|+||||+. ++|.+++...+.+++..+..++.|++.|+.|||+. +++|+||||+||++
T Consensus        63 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili  137 (333)
T cd06650          63 PYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV  137 (333)
T ss_pred             CcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE
Confidence            7999999999987     89999999996 69999999888899999999999999999999975 79999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+.
T Consensus       138 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~  215 (333)
T cd06650         138 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG  215 (333)
T ss_pred             cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc
Confidence            99999999999998654322 2234568899999999854 458899999999999999999999997665433222111


Q ss_pred             HH-hCCCChHhhhh-----------hhh------hHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 023764          159 EL-IGTPSEAELGF-----------LNE------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  220 (277)
Q Consensus       159 ~~-~~~~~~~~~~~-----------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  220 (277)
                      .. .+.+.......           ...      .................  .....+.++++||.+||++||++|||+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~  293 (333)
T cd06650         216 CPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADL  293 (333)
T ss_pred             CcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCH
Confidence            00 00110000000           000      00000000000000000  011357789999999999999999999


Q ss_pred             HHHhcCCCCCCCC
Q 023764          221 EDALAHPYLGSLH  233 (277)
Q Consensus       221 ~ell~hp~f~~~~  233 (277)
                      ++++.||||+...
T Consensus       294 ~ell~h~~~~~~~  306 (333)
T cd06650         294 KQLMVHAFIKRSE  306 (333)
T ss_pred             HHHhhCHHHhcCc
Confidence            9999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.7e-36  Score=258.16  Aligned_cols=229  Identities=39%  Similarity=0.682  Sum_probs=177.1

Q ss_pred             CceeeeeccccCCC-----CCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQ-----RESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~-----~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||+++++++.+..     .++.+.+|+|+||+++++.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|.
T Consensus        66 ~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~  145 (302)
T cd07864          66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCS  145 (302)
T ss_pred             CCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            79999999987652     1122489999999999888887754 46899999999999999999999999999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           75 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      ||+++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++||||+||++++|++|++||...+...
T Consensus       146 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~  225 (302)
T cd07864         146 NILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA  225 (302)
T ss_pred             HEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            9999999999999999987654322  12223457789999988655557899999999999999999999999888888


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+..+.+..+.+....+.........................+..++..+.+++.+||..||.+|||+++++.||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            88888888777766544332111000000000000011222344568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.5e-37  Score=265.52  Aligned_cols=200  Identities=26%  Similarity=0.368  Sum_probs=155.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. ++|.+.    ...++..+..++.||+.||+|||++|++||||||+||+++
T Consensus       132 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  202 (353)
T PLN00034        132 PNVVKCHDMFDHN-----GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN  202 (353)
T ss_pred             CCcceeeeEeccC-----CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence            7999999999887     88999999997 476542    3467788899999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||++...... .......|+..|+|||.+..    ....+.++|||||||++|+|++|+.||......+..
T Consensus       203 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  282 (353)
T PLN00034        203 SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA  282 (353)
T ss_pred             CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence            9999999999998765433 22344578999999998742    122456899999999999999999999643322111


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+.....                          .......+..+.++++||.+||..||++|||+.|+++||||.....
T Consensus       283 ~~~~~~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        283 SLMCAICM--------------------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHHHhc--------------------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            11111000                          0001112356789999999999999999999999999999998654


Q ss_pred             C
Q 023764          235 I  235 (277)
Q Consensus       235 ~  235 (277)
                      .
T Consensus       337 ~  337 (353)
T PLN00034        337 G  337 (353)
T ss_pred             c
Confidence            4

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-38  Score=273.74  Aligned_cols=200  Identities=23%  Similarity=0.426  Sum_probs=177.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++.+...+     ..+|+||||+. |.+++++.++++..+..++.++.|++.|++|||+++|+|||||.+|++++
T Consensus       115 PnIvkl~~v~~t~-----~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~  189 (596)
T KOG0586|consen  115 PNIVKLFSVIETE-----ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD  189 (596)
T ss_pred             cceeeeeeeeeec-----ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc
Confidence            8999999999988     99999999985 79999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+..+||+|||++..........+.+|++.|+|||++.+....++.+|+||+|+++|.|++|..||+|.+....-...+.
T Consensus       190 ~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~  269 (596)
T KOG0586|consen  190 ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR  269 (596)
T ss_pred             cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee
Confidence            99999999999999888888889999999999999998888779999999999999999999999988765443222111


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      .                   ..+.+           --++.++.++|+++|..+|.+|++.++++.|.|....+..
T Consensus       270 g-------------------k~rIp-----------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 G-------------------KYRIP-----------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             e-------------------eeccc-----------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            0                   00011           1367899999999999999999999999999999988765

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=253.01  Aligned_cols=198  Identities=26%  Similarity=0.480  Sum_probs=163.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+|+||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|.||+++
T Consensus        57 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~  131 (260)
T cd05611          57 PYVAKLYYSFQSK-----DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID  131 (260)
T ss_pred             CCeeeeeeeEEcC-----CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence            7999999999876     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.....   .....++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.+.+.......+..
T Consensus       132 ~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  207 (260)
T cd05611         132 QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS  207 (260)
T ss_pred             CCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            999999999998875443   22345778899999986544 78999999999999999999999987665443332221


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~~  233 (277)
                      ...                      .    ......+.+++++.++|.+||+.||++|||   ++++++||||+.+.
T Consensus       208 ~~~----------------------~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         208 RRI----------------------N----WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ccc----------------------C----CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            000                      0    001112356889999999999999999995   57999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.1e-37  Score=263.27  Aligned_cols=226  Identities=21%  Similarity=0.314  Sum_probs=160.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..+     +..|+||||+. ++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        59 pniv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil  133 (327)
T cd08227          59 PNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL  133 (327)
T ss_pred             CCeeeEEEEEEEC-----CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEE
Confidence            8999999999887     88999999997 6999998653  45899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCC--------CcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           78 LNANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      ++.++.++++||+........        .......++..|+|||++.+. ..++.++||||+||++++|++|..||.+.
T Consensus       134 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         134 ISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             EecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999999764322111        011223456779999998653 35789999999999999999999999765


Q ss_pred             ChHHHHHHHHHHhCCCChH-hhhhhhhh-----HHHH-----hh-------hCCcccCCcccccCCCCChhHHHHHHHhc
Q 023764          149 DHVHQLRLLIELIGTPSEA-ELGFLNEN-----AKKY-----IC-------QLPRYQRQSFTEKFPNVHPSAIDLVEKML  210 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~-~~~~~~~~-----~~~~-----~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L  210 (277)
                      ...........  +..+.. ........     ....     ..       ..+.............+++++.+||++||
T Consensus       214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  291 (327)
T cd08227         214 PATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL  291 (327)
T ss_pred             chhHHHHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHH
Confidence            54433222211  111100 00000000     0000     00       00000000011112245778999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCC
Q 023764          211 TFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       211 ~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +.||++|||++++++||||+.+.
T Consensus       292 ~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         292 QRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhCchhcCCHHHHhcChhhhhcc
Confidence            99999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.5e-37  Score=263.27  Aligned_cols=202  Identities=22%  Similarity=0.418  Sum_probs=164.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||+. |+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        61 ~~i~~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill  135 (331)
T cd05624          61 QWITTLHYAFQDE-----NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL  135 (331)
T ss_pred             CCEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE
Confidence            6899999999887     89999999996 699999987 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +.++.++|+|||++.........  ....|++.|+|||++.+.    ..++.++|+||+||++|+|++|+.||.+.+..+
T Consensus       136 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~  215 (331)
T cd05624         136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE  215 (331)
T ss_pred             cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH
Confidence            99999999999998765443221  234689999999988542    347889999999999999999999998776655


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLG  230 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~  230 (277)
                      ....+.....                         ...++.....++.+++++|.+||+.++++  |++++++++||||+
T Consensus       216 ~~~~i~~~~~-------------------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~  270 (331)
T cd05624         216 TYGKIMNHEE-------------------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE  270 (331)
T ss_pred             HHHHHHcCCC-------------------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence            4444332110                         01122223457889999999999976654  56899999999998


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      ..
T Consensus       271 ~~  272 (331)
T cd05624         271 GI  272 (331)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=260.20  Aligned_cols=201  Identities=26%  Similarity=0.421  Sum_probs=169.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |.||.|--+|.++     +.+|+|+..|. |+|.-.|.+.+  .|++..+..++.+|+.||++||+.+||+||+||+|||
T Consensus       245 ~FiVslaYAfeTk-----d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNIL  319 (591)
T KOG0986|consen  245 PFIVSLAYAFETK-----DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENIL  319 (591)
T ss_pred             CcEEEEeeeecCC-----CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhee
Confidence            4688888888887     99999999995 69988877654  7999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +++.|.++|+|+|++....+.......+||..|||||++.+.. |+.+.|.|||||++|+|+.|+.||.......-...+
T Consensus       320 LDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv  398 (591)
T KOG0986|consen  320 LDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV  398 (591)
T ss_pred             eccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence            9999999999999999988887777779999999999997655 999999999999999999999999765443333222


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      -.....-+                          .+.....|+++++|++.+|.+||.+|..     ++++.+||||+.+
T Consensus       399 drr~~~~~--------------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  399 DRRTLEDP--------------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHhcch--------------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            22211111                          1112367899999999999999999985     7899999999986


Q ss_pred             C
Q 023764          233 H  233 (277)
Q Consensus       233 ~  233 (277)
                      .
T Consensus       453 n  453 (591)
T KOG0986|consen  453 N  453 (591)
T ss_pred             C
Confidence            3

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=268.94  Aligned_cols=200  Identities=25%  Similarity=0.459  Sum_probs=165.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+|++.|.-.     +.++|..|+|+| ....++.. ...+++.++..+++|++.||.|||+.+|||||+|.-|||+
T Consensus        89 P~ivkLl~ayy~e-----nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~  163 (1187)
T KOG0579|consen   89 PVIVKLLSAYYFE-----NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL  163 (1187)
T ss_pred             hHHHHHHHHHhcc-----CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE
Confidence            8999999999987     999999999986 45554443 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeecc-CCCcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.+|.++|+|||.+.... ......++.|||+|||||++.+    ..+|+.++||||||+.+.+|..+.+|-...+..-.
T Consensus       164 TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV  243 (1187)
T KOG0579|consen  164 TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV  243 (1187)
T ss_pred             EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH
Confidence            999999999999875433 2345667899999999999854    35689999999999999999999999877666555


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +-++.+.- +|.                    ..      ...+.+..++||+.+||.+||..||+++++|.||||+++
T Consensus       244 llKiaKSe-PPT--------------------Ll------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  244 LLKIAKSE-PPT--------------------LL------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHhhcC-CCc--------------------cc------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            44443310 111                    00      011467789999999999999999999999999999864

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.3e-36  Score=254.68  Aligned_cols=200  Identities=27%  Similarity=0.445  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+++...+.+++..++.++.|++.|+.|||+.+++||||+|+||+++
T Consensus        57 ~~i~~~~~~~~~~-----~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~  131 (278)
T cd05606          57 PFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD  131 (278)
T ss_pred             CcEeeeeeeeecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC
Confidence            7899999999887     88999999996 68999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++....... .....++..|+|||.+.+...++.++||||+||++++|++|..||.+........ +..
T Consensus       132 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~  209 (278)
T cd05606         132 EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR  209 (278)
T ss_pred             CCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHH
Confidence            99999999999986544322 2345788999999998655557899999999999999999999997653211110 000


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~~  233 (277)
                      ....                       ...   ...+..+..+.+++.+||..||.+|+     ++.++++||||+...
T Consensus       210 ~~~~-----------------------~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         210 MTLT-----------------------MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             Hhhc-----------------------cCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            0000                       000   11124578999999999999999999     999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-36  Score=256.51  Aligned_cols=195  Identities=27%  Similarity=0.511  Sum_probs=165.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC-cccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||+ +++|.+++.+.+.+++..+..++.|++.||.+||++|++|+||+|.||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~  135 (290)
T cd05580          61 PFLVNLYGSFQDD-----SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD  135 (290)
T ss_pred             CCccceeeEEEcC-----CeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence            7999999999887     8899999999 579999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....+++.|+|||.+.+. ..+.++|+||+|+++++|++|..||.+.+.......+..
T Consensus       136 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  212 (290)
T cd05580         136 SDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE  212 (290)
T ss_pred             CCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            9999999999998766544  3345678899999988544 578899999999999999999999977664433333221


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~~  233 (277)
                        +.+                            ...+..+..++++|++||..||.+|+     +++++++||||+.+.
T Consensus       213 --~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         213 --GKV----------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             --CCc----------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence              000                            01124578899999999999999999     999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=253.35  Aligned_cols=195  Identities=29%  Similarity=0.512  Sum_probs=169.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.+..|.-.|+..     +++|+||||.. |.|+-.+...+.|+++.++.+...|+.||.|||+++|++||+|.+|.+++
T Consensus       228 PFLt~LKYsFQt~-----drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD  302 (516)
T KOG0690|consen  228 PFLTSLKYSFQTQ-----DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD  302 (516)
T ss_pred             cHHHHhhhhhccC-----ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec
Confidence            3455566667776     89999999995 69998888888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceee-ccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||.|||+|+. +.......+.||||.|+|||++. ...|+.++|.|.+||++|||+||+.||.+.+.......|.
T Consensus       303 kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl  381 (516)
T KOG0690|consen  303 KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL  381 (516)
T ss_pred             cCCceEeeecccchhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence            999999999999974 44456678899999999999995 4569999999999999999999999999988877666654


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      -.--                               .|| .++++++.|+.++|.+||.+|..     |.|+.+|+||.++
T Consensus       382 ~ed~-------------------------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  382 MEDL-------------------------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             hhhc-------------------------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            3211                               112 58999999999999999999985     8999999999976

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-36  Score=252.79  Aligned_cols=198  Identities=26%  Similarity=0.479  Sum_probs=163.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+.+.     +.+|+||||++ ++|.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||+++
T Consensus        53 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~  127 (262)
T cd05572          53 PFIVKLYRTFKDK-----KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD  127 (262)
T ss_pred             CCEeeeeeeEEcC-----CccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc
Confidence            7999999999876     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD--HVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i  157 (277)
                      .++.++|+|||.+.............+++.|++||.+.. ..++.++|+||+||++|+|++|..||....  .......+
T Consensus       128 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         128 SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence            999999999999876655433344567889999998754 447899999999999999999999997665  33222222


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ......+                            ...+..+.+++++|.+||+.||++|+|     ++|+++||||+++
T Consensus       207 ~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         207 LKGNGKL----------------------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hccCCCC----------------------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            2100000                            001134678999999999999999999     9999999999875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.9e-36  Score=251.52  Aligned_cols=198  Identities=28%  Similarity=0.450  Sum_probs=159.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++
T Consensus        66 ~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~  140 (267)
T cd06645          66 SNIVAYFGSYLRR-----DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT  140 (267)
T ss_pred             CCeeeEEEEEEeC-----CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            7999999999887     88999999997 59999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhh--CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++...... .......++..|+|||.+.  ....++.++|+||+||++++|++|..||...........
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~  220 (267)
T cd06645         141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL  220 (267)
T ss_pred             CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence            9999999999998755432 2223456889999999874  233478899999999999999999999865443222111


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      .....                        ...... .....++..++++|.+||..||++|||++++++|||
T Consensus       221 ~~~~~------------------------~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         221 MTKSN------------------------FQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             hhccC------------------------CCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            11100                        000000 111245678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.3e-36  Score=257.35  Aligned_cols=225  Identities=23%  Similarity=0.389  Sum_probs=164.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +++|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .+++|+||+|.||++
T Consensus        59 ~~iv~~~~~~~~~-----~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~  133 (308)
T cd06615          59 PYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV  133 (308)
T ss_pred             CCCCeEEEEEeeC-----CEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE
Confidence            7999999999887     89999999997 5999999888889999999999999999999997 599999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||...+.......+.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~  211 (308)
T cd06615         134 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG  211 (308)
T ss_pred             ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhc
Confidence            99999999999988654332 2234567889999998854 457899999999999999999999997665333222111


Q ss_pred             HHhCCCChHhh----h-h-h----hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          159 ELIGTPSEAEL----G-F-L----NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       159 ~~~~~~~~~~~----~-~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      ...........    . . .    .................  .......+.++++|+.+||..||++|||++++++|||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            11000000000    0 0 0    00000000000000000  0011136778999999999999999999999999999


Q ss_pred             CCCCCC
Q 023764          229 LGSLHD  234 (277)
Q Consensus       229 f~~~~~  234 (277)
                      |..+..
T Consensus       290 ~~~~~~  295 (308)
T cd06615         290 IKRAEL  295 (308)
T ss_pred             hhhccc
Confidence            987643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-36  Score=253.40  Aligned_cols=200  Identities=28%  Similarity=0.448  Sum_probs=164.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+||||+. ++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||+|+||+
T Consensus        60 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nil  134 (285)
T cd05632          60 QFVVNLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL  134 (285)
T ss_pred             cCceeEEEEEecC-----CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE
Confidence            6899999999887     88999999997 5888877543  46999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.++.++|+|||++.............++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.........+
T Consensus       135 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~  213 (285)
T cd05632         135 LDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV  213 (285)
T ss_pred             ECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999876544433345578999999999854 45899999999999999999999999876654433333


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ........                          ....+..+.++.+|+.+||+.||++|||     +++++.|+||...
T Consensus       214 ~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         214 DRRVLETE--------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHhhhccc--------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            22111110                          0112356788999999999999999999     8999999999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.1e-36  Score=251.31  Aligned_cols=194  Identities=27%  Similarity=0.507  Sum_probs=159.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..++||||++ ++|.+++...+.+++..+..++.|++.||++||++|++|+||+|+||+++
T Consensus        66 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~  140 (267)
T cd06628          66 ENIVQYLGSSLDA-----DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD  140 (267)
T ss_pred             CCeeeEEEEEEeC-----CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc
Confidence            7999999999887     88999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           80 ANCDLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      .++.++|+|||.+.......       ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+...
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  219 (267)
T cd06628         141 NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ  219 (267)
T ss_pred             CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence            99999999999887554211       1123457788999998854 447889999999999999999999997765433


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....+....                             ........+..+.++|++||+.||.+||++.++++||||
T Consensus       220 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         220 AIFKIGENA-----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHhccC-----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            322221100                             001112467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-36  Score=254.02  Aligned_cols=194  Identities=19%  Similarity=0.220  Sum_probs=158.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+. .++...+++||||+. |+|.+++.+.+.+++.....++.|++.|+.+||+ .+++||||||+||++
T Consensus        78 ~nIv~~~g~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill  156 (283)
T PHA02988         78 NNILKIYGFIIDI-VDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV  156 (283)
T ss_pred             CCEEEEeeeEEec-ccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE
Confidence            7999999998761 112267899999997 5999999988889999999999999999999998 499999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.+||+|||++.......  ....++..|+|||++.+. ..++.++||||+||++|+|++|..||.+.+..+....+
T Consensus       157 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        157 TENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI  234 (283)
T ss_pred             CCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999987654332  345678899999998542 45899999999999999999999999877665554443


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ......++                            .....++.+++|+.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        235 INKNNSLK----------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HhcCCCCC----------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            32111111                            01146778999999999999999999999985

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-36  Score=252.75  Aligned_cols=201  Identities=26%  Similarity=0.428  Sum_probs=162.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+||||+. ++|.+++.+.+  .+++..+..++.|++.|+.|||+.|++|+||+|.||+
T Consensus        53 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil  127 (277)
T cd05577          53 RFIVSLAYAFETK-----DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVL  127 (277)
T ss_pred             CCEeeeeeEEecC-----CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence            7999999999887     88999999997 59999987765  7999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+||++++|++|+.||.+.........+
T Consensus       128 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  206 (277)
T cd05577         128 LDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL  206 (277)
T ss_pred             ECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH
Confidence            9999999999999887654433334456778899999986544 889999999999999999999999765432111111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      .....                          .......+..++.++++|++||+.||.+||     ++.++++||||..+
T Consensus       207 ~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         207 KRRTL--------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             Hhccc--------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence            11000                          000011234688999999999999999999     89999999999765


Q ss_pred             C
Q 023764          233 H  233 (277)
Q Consensus       233 ~  233 (277)
                      .
T Consensus       261 ~  261 (277)
T cd05577         261 N  261 (277)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.5e-36  Score=249.76  Aligned_cols=201  Identities=24%  Similarity=0.420  Sum_probs=158.3

Q ss_pred             CceeeeeccccCCCCC-CCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRE-SFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~-~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++...... ....+|+||||++ ++|.+++...  ..+++..+..++.|++.|+.|||++|++|+|++|+||
T Consensus        63 ~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ni  142 (272)
T cd06637          63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV  142 (272)
T ss_pred             CCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHE
Confidence            7999999998764322 1257899999997 5999998863  4689999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.++|+|||++...... .......++..|+|||++..    ...++.++|+||+||++++|++|..||......
T Consensus       143 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~  222 (272)
T cd06637         143 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  222 (272)
T ss_pred             EECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            9999999999999998765432 22334568889999999853    234778999999999999999999999654432


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .....+..   .                       ...  .......+.++++||.+||..||.+|||+.+++.||||
T Consensus       223 ~~~~~~~~---~-----------------------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         223 RALFLIPR---N-----------------------PAP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHhc---C-----------------------CCC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22211110   0                       000  01112467789999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=264.25  Aligned_cols=198  Identities=27%  Similarity=0.512  Sum_probs=180.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC-cccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.||+||..|+++     ..+|+.||.| +|.|...+++++.|++..++.++.-+++|++|||++||++||+||+|++++
T Consensus       480 ~fIvrLYrTfrd~-----kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd  554 (732)
T KOG0614|consen  480 DFIVRLYRTFRDS-----KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD  554 (732)
T ss_pred             hHHHHHHHHhccc-----hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec
Confidence            6799999999998     9999999997 789999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+||.|||+++..+.+....+++|||.|.|||++.+.+ .+.++|.||||++++||++|.+||.+.+....+..|.+
T Consensus       555 ~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk  633 (732)
T KOG0614|consen  555 NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK  633 (732)
T ss_pred             cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence            99999999999999999988889999999999999998765 79999999999999999999999999999999888876


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      -+....                 +|           ..++..+.+||+++..-+|.+|..     +.++-.|.||.++
T Consensus       634 Gid~i~-----------------~P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  634 GIDKIE-----------------FP-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             hhhhhh-----------------cc-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            332100                 00           146778999999999999999997     8999999999875

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-35  Score=250.70  Aligned_cols=200  Identities=24%  Similarity=0.426  Sum_probs=160.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+|+||++ ++|..++.+ ..++++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus        62 ~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili  136 (282)
T cd06643          62 PNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF  136 (282)
T ss_pred             CCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE
Confidence            7999999999887     88999999997 588777754 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhh----CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.++++|||++...... .......++..|+|||++.    ....++.++|+||+||++++|++|.+||.+.+....
T Consensus       137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~  216 (282)
T cd06643         137 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV  216 (282)
T ss_pred             ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence            99999999999998654332 2233456788999999874    233467899999999999999999999977654443


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ...+....  ++                        . ......++..+++||.+||+.||.+|||++++++||||...
T Consensus       217 ~~~~~~~~--~~------------------------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         217 LLKIAKSE--PP------------------------T-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHhhcC--CC------------------------C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            33322110  00                        0 00112457789999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-35  Score=246.57  Aligned_cols=194  Identities=29%  Similarity=0.441  Sum_probs=161.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +..|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nil  133 (256)
T cd08529          59 SYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF  133 (256)
T ss_pred             CCeehheeeeccC-----CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence            7999999999887     88999999996 6999998764  57899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||++....... ......+++.|+|||++... .++.++|+|||||++++|++|..||...+.......
T Consensus       134 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  212 (256)
T cd08529         134 LDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK  212 (256)
T ss_pred             EeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999987655432 22334678899999998654 478999999999999999999999987765444333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +.....                             ......++.++++++.+||+.+|++||++.++++|||+
T Consensus       213 ~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         213 IIRGVF-----------------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHcCCC-----------------------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            322100                             01111467789999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-35  Score=248.74  Aligned_cols=196  Identities=28%  Similarity=0.433  Sum_probs=160.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+|+||+. ++|.+++.+.+.+++..+..++.|++.||++||+.|++|+||+|.||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~  136 (265)
T cd06631          62 VNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM  136 (265)
T ss_pred             CCEeeEeeEeecC-----CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC
Confidence            7999999999887     89999999996 59999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-------CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           80 ANCDLKICDFGLARVTSE-------TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      .++.++|+|||.+.....       ........++..|+|||.+.+ ..++.++|+||+||++++|++|..||...+...
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~  215 (265)
T cd06631         137 PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA  215 (265)
T ss_pred             CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence            999999999998865321       112233467889999998854 447899999999999999999999997655433


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....+....+                           ......+.++.++.++|++||+.||.+|||+.++++||||
T Consensus       216 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         216 AMFYIGAHRG---------------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHhhhccC---------------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            2222111100                           0111223567889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-36  Score=235.57  Aligned_cols=228  Identities=29%  Similarity=0.638  Sum_probs=182.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+|+++..++..   ...-+|+||... +...+..   .++.-.++.+++|++.||.|+|+.||+|||+||.|++++
T Consensus        93 ~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId  166 (338)
T KOG0668|consen   93 PNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID  166 (338)
T ss_pred             CCeeehhhhhcCccc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec
Confidence            899999999998743   567899999985 6666553   488889999999999999999999999999999999998


Q ss_pred             cC-CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHH
Q 023764           80 AN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i  157 (277)
                      .. -.++|+|+|++.........+-.+.+..|--||.+.....|+.+.|+||+||+++.|+..+-| |.|.++.+++-+|
T Consensus       167 h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  167 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            65 469999999998766655555667788999999999888899999999999999999887655 5799999999999


Q ss_pred             HHHhCCCChHhhhhhhhh----HHHHhhhCCcccCCcccccCC-----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          158 IELIGTPSEAELGFLNEN----AKKYICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      .+.+|+-.-  ...+.+.    ..++..-+.+..+..++...+     -+++++.||+.++|..|..+|+||.|++.|||
T Consensus       247 akVLGt~el--~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy  324 (338)
T KOG0668|consen  247 AKVLGTDEL--YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY  324 (338)
T ss_pred             HHHhChHHH--HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence            999987322  1221111    112222223334444444332     35799999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 023764          229 LGSLHDIS  236 (277)
Q Consensus       229 f~~~~~~~  236 (277)
                      |...++..
T Consensus       325 F~~~~~~~  332 (338)
T KOG0668|consen  325 FAPVREAE  332 (338)
T ss_pred             HHHHHHHh
Confidence            99876543

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=265.37  Aligned_cols=197  Identities=22%  Similarity=0.429  Sum_probs=167.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~nil   77 (277)
                      ||||++|+.|.+..+   ..+.+|+|+|. |+|..|+++.+.++...++.|++||+.||.|||++.  |+|||||.+|||
T Consensus       101 ~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF  177 (632)
T KOG0584|consen  101 PNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF  177 (632)
T ss_pred             CceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence            899999999998743   67999999995 899999999999999999999999999999999996  999999999999


Q ss_pred             EecC-CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC-CCChHHHHH
Q 023764           78 LNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-GRDHVHQLR  155 (277)
Q Consensus        78 ~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~  155 (277)
                      |+++ |.+||+|+|+|....... ..+..|||-|||||++.  ..|+..+||||||+.++||+|+..||. ..+..++++
T Consensus       178 inG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK  254 (632)
T KOG0584|consen  178 VNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK  254 (632)
T ss_pred             EcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH
Confidence            9764 999999999998766543 34579999999999995  459999999999999999999999997 445555666


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ++.+  |..|..                       +.+   --.+++++||.+||.. .+.|+|+.|+|.||||..-
T Consensus       255 KV~S--GiKP~s-----------------------l~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  255 KVTS--GIKPAA-----------------------LSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHc--CCCHHH-----------------------hhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            6554  222211                       111   1267899999999998 9999999999999999874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-35  Score=245.00  Aligned_cols=195  Identities=29%  Similarity=0.500  Sum_probs=158.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++.+....    +.+|+||||++ ++|.+.+...  ..+++.++..++.|++.|+.+||+.|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil  134 (257)
T cd08223          59 PNIVAYRESWEGED----GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF  134 (257)
T ss_pred             CCeeeeeeeecCCC----CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEE
Confidence            78999998876431    56899999997 5899988763  45899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......
T Consensus       135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  213 (257)
T cd08223         135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR  213 (257)
T ss_pred             EecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            999999999999998765432 22334567889999998854 4578899999999999999999999977654443332


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +...  ..                           ....+..++.+.+|+.+||+.||.+|||+.++++||||
T Consensus       214 ~~~~--~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         214 IIEG--KL---------------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhc--CC---------------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            2211  00                           01112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-35  Score=251.53  Aligned_cols=203  Identities=26%  Similarity=0.418  Sum_probs=159.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++........+..|+||||++ ++|.+++..    ...+++..++.++.|++.||++||+.|++|+||+|+|
T Consensus        79 ~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n  158 (291)
T cd06639          79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN  158 (291)
T ss_pred             CCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence            79999999987653333367999999996 589888752    4578999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      |+++.++.++|+|||++....... ......++..|+|||.+....    .++.++||||+||++++|++|++||.....
T Consensus       159 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            999999999999999987544322 223346788899999875432    257899999999999999999999976654


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ......+..   .+..                       .. ...+..+..+.+||.+||+.||++|||+.++++||||+
T Consensus       239 ~~~~~~~~~---~~~~-----------------------~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         239 VKTLFKIPR---NPPP-----------------------TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHhc---CCCC-----------------------CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            433322211   0000                       00 00123566899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=249.87  Aligned_cols=198  Identities=24%  Similarity=0.431  Sum_probs=163.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     ...|+|+||++ ++|.+++... ++++..+..++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~  132 (274)
T cd06609          59 PYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS  132 (274)
T ss_pred             CCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            7999999999887     88999999997 5999998865 799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......++..|+|||.+.+.. ++.++|+||+||++++|++|..||.+.+.......+.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~  211 (274)
T cd06609         133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP  211 (274)
T ss_pred             CCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh
Confidence            9999999999998776543 2234456788899999986544 8999999999999999999999997665433322221


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ... .                         .....  ...+.++.+++.+||..||++|||++++++||||+...
T Consensus       212 ~~~-~-------------------------~~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         212 KNN-P-------------------------PSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             hcC-C-------------------------CCCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            110 0                         00000  12677899999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-35  Score=250.83  Aligned_cols=202  Identities=23%  Similarity=0.423  Sum_probs=160.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..+     +..|+||||+++ +|..++.+ ...+++..+..++.|++.|+.+||++|++||||+|+||++
T Consensus        69 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili  143 (292)
T cd06644          69 PYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL  143 (292)
T ss_pred             CcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence            7999999999887     889999999975 77777654 4578999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++...... .......+++.|+|||.+..    ...++.++|+||+||++|+|++|.+||...+....
T Consensus       144 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  223 (292)
T cd06644         144 TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV  223 (292)
T ss_pred             cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH
Confidence            99999999999988654322 22234567889999998742    23467899999999999999999999976554332


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...+..   ...                        +.......++.++.++|++||+.||++||+++++++||||..+.
T Consensus       224 ~~~~~~---~~~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         224 LLKIAK---SEP------------------------PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHhc---CCC------------------------ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            222111   000                        00011124677899999999999999999999999999998765


Q ss_pred             C
Q 023764          234 D  234 (277)
Q Consensus       234 ~  234 (277)
                      .
T Consensus       277 ~  277 (292)
T cd06644         277 S  277 (292)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.6e-36  Score=269.76  Aligned_cols=203  Identities=24%  Similarity=0.431  Sum_probs=162.9

Q ss_pred             CceeeeeccccCCCC---CCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQR---ESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++.+.....   +....+++||||+. |+|.+++...    ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        91 ~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLK  170 (496)
T PTZ00283         91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK  170 (496)
T ss_pred             CcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            688888887754321   11124789999997 6999988643    468999999999999999999999999999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |+||+++.++.++|+|||+++.....   .......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+
T Consensus       171 P~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             HHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999998764422   22345678999999999854 458999999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....+..+....                             .....+..++++.+++.+||+.||.+|||+.++++|||+
T Consensus       250 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~  300 (496)
T PTZ00283        250 MEEVMHKTLAGR-----------------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC  300 (496)
T ss_pred             HHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence            554443332110                             011224578899999999999999999999999999998


Q ss_pred             CCCC
Q 023764          230 GSLH  233 (277)
Q Consensus       230 ~~~~  233 (277)
                      +...
T Consensus       301 ~~~~  304 (496)
T PTZ00283        301 KLFI  304 (496)
T ss_pred             HHhh
Confidence            7643

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-35  Score=249.98  Aligned_cols=202  Identities=24%  Similarity=0.502  Sum_probs=165.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+|+||+. ++|.+++.. +++++..+..++.|++.|+++||++|++||||+|+||+++
T Consensus        76 ~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~  149 (285)
T cd06648          76 PNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT  149 (285)
T ss_pred             CChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc
Confidence            7999999999876     88999999996 599999877 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+.
T Consensus       150 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~  228 (285)
T cd06648         150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR  228 (285)
T ss_pred             CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            99999999999876543321 2233457889999999854 448899999999999999999999997765544443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      ... .+                          .....+..+..+.+|+.+||..||++|||+.++++||||+...++.
T Consensus       229 ~~~-~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         229 DNL-PP--------------------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             hcC-CC--------------------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence            210 00                          0011123677899999999999999999999999999999877543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=249.79  Aligned_cols=200  Identities=27%  Similarity=0.478  Sum_probs=161.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +..|+||||++ ++|.+++.+. ..+++..++.++.|++.|+.|||+.|++|+||+|+||++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili  136 (280)
T cd06611          62 PNIVGLYEAYFYE-----NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL  136 (280)
T ss_pred             CceeEEEEEEecC-----CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence            7999999999887     88999999997 5899988764 569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||.+...... .......+++.|+|||.+..    ...++.++|+||+||++|+|++|.+||.+.+....
T Consensus       137 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~  216 (280)
T cd06611         137 TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV  216 (280)
T ss_pred             CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH
Confidence            99999999999987654332 22334567889999998742    23467799999999999999999999977654433


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ...+..  +.++                         ........+.++.++|.+||+.||.+|||++++++||||...
T Consensus       217 ~~~~~~--~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         217 LLKILK--SEPP-------------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHhc--CCCC-------------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            322211  0000                         000112467789999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.3e-36  Score=251.85  Aligned_cols=200  Identities=28%  Similarity=0.456  Sum_probs=159.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~n   75 (277)
                      |||+++++++..+     +..|+||||++++|.+++..    ...+++..+..++.|++.|++|||++ +++||||||+|
T Consensus        60 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~n  134 (283)
T cd06617          60 PYTVTFYGALFRE-----GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN  134 (283)
T ss_pred             CCeeeeeEEEecC-----CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence            7999999999887     88999999999998887754    24689999999999999999999997 99999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hH
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HV  151 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~  151 (277)
                      |+++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+||++++|++|+.||.... ..
T Consensus       135 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  214 (283)
T cd06617         135 VLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF  214 (283)
T ss_pred             EEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH
Confidence            99999999999999998765443333335678889999987542   336789999999999999999999996432 22


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +.+......  ..                        ...  ....++.++++||.+||..+|.+|||++++++||||..
T Consensus       215 ~~~~~~~~~--~~------------------------~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         215 QQLKQVVEE--PS------------------------PQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             HHHHHHHhc--CC------------------------CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence            222211110  00                        000  01136788999999999999999999999999999998


Q ss_pred             CC
Q 023764          232 LH  233 (277)
Q Consensus       232 ~~  233 (277)
                      ..
T Consensus       267 ~~  268 (283)
T cd06617         267 HL  268 (283)
T ss_pred             cc
Confidence            54

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-35  Score=256.65  Aligned_cols=192  Identities=25%  Similarity=0.425  Sum_probs=149.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------------------------------
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------------------------------   39 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------------------------   39 (277)
                      |||+++++++....    +.+|+||||++ |+|.+++...                                        
T Consensus        71 ~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (338)
T cd05102          71 LNVVNLLGACTKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLF  146 (338)
T ss_pred             cceeeEEeEecCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccc
Confidence            79999999887641    56899999997 6999988752                                        


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccC
Q 023764           40 ----------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE   97 (277)
Q Consensus        40 ----------------------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~   97 (277)
                                            .++++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         147 SRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             cccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccccc
Confidence                                  2477888899999999999999999999999999999999999999999999875432


Q ss_pred             CC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhh
Q 023764           98 TD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN  173 (277)
Q Consensus        98 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  173 (277)
                      ..   ......++..|+|||++.+ ..++.++||||+||++|+|++ |..||.+................          
T Consensus       227 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----------  295 (338)
T cd05102         227 DPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----------  295 (338)
T ss_pred             CcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC----------
Confidence            21   1122345678999999854 458999999999999999996 99999875433222211110000          


Q ss_pred             hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          174 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                                        .......++++.+|+.+||+.||.+|||+.++++
T Consensus       296 ------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 ------------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                              0011246778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.8e-36  Score=252.90  Aligned_cols=202  Identities=25%  Similarity=0.479  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     +..|+||||++ ++|.+++.. +.+++..+..++.|++.|+.|||++|++||||+|+||+++
T Consensus        79 ~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~  152 (292)
T cd06658          79 ENVVDMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT  152 (292)
T ss_pred             CcHHHHHHheecC-----CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence            7899999999876     88999999997 488887754 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+.
T Consensus       153 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~  231 (292)
T cd06658         153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR  231 (292)
T ss_pred             CCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999988654322 12234567889999998854 457899999999999999999999998766544333222


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      .....                          . .......+..+.+++.+||..||.+|||++++++||||.....++
T Consensus       232 ~~~~~--------------------------~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         232 DNLPP--------------------------R-VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             hcCCC--------------------------c-cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            11100                          0 001124677899999999999999999999999999999765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=254.06  Aligned_cols=199  Identities=24%  Similarity=0.457  Sum_probs=162.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++.+...     +..|+||||+. ++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  135 (316)
T cd05574          61 PFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENIL  135 (316)
T ss_pred             CCchhheeeeecC-----CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeE
Confidence            7999999999876     88999999996 5999998754  56899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC------------------------------cccccccccccCChhhhhCCCCCCcchh
Q 023764           78 LNANCDLKICDFGLARVTSETD------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAID  127 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D  127 (277)
                      ++.++.++|+|||++.......                              ......|+..|+|||.+.+. .++.++|
T Consensus       136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~D  214 (316)
T cd05574         136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVD  214 (316)
T ss_pred             EcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHH
Confidence            9999999999999876432211                              11233578889999998654 4789999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHH
Q 023764          128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  207 (277)
Q Consensus       128 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  207 (277)
                      |||+||++|+|++|..||.+.+.......+.....                           .+ .....++..++++|.
T Consensus       215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------------------~~-~~~~~~~~~~~~li~  266 (316)
T cd05574         215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV---------------------------TF-PGSPPVSSSARDLIR  266 (316)
T ss_pred             HHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc---------------------------cC-CCccccCHHHHHHHH
Confidence            99999999999999999987765544433321000                           00 001126789999999


Q ss_pred             HhcCCCCCCCCC----HHHHhcCCCCCCCC
Q 023764          208 KMLTFDPRQRIT----VEDALAHPYLGSLH  233 (277)
Q Consensus       208 ~~L~~dP~~R~t----~~ell~hp~f~~~~  233 (277)
                      +||+.||++|||    +++++.||||++..
T Consensus       267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         267 KLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            999999999999    99999999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-35  Score=250.37  Aligned_cols=203  Identities=26%  Similarity=0.460  Sum_probs=162.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~n   75 (277)
                      |||+++++++...     +.+|+||||+++ +|..++...   ..+++..+..++.|++.|+.|||+ .|++|+||+|+|
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n  133 (286)
T cd06622          59 PYIVDFYGAFFIE-----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN  133 (286)
T ss_pred             CcHHhhhhheecC-----CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHH
Confidence            7999999999887     899999999974 898888763   379999999999999999999997 599999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      |+++.++.++|+|||.+...... ......+++.|+|||.+.+..     .++.++|+||+||++++|++|..||.....
T Consensus       134 il~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  212 (286)
T cd06622         134 VLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY  212 (286)
T ss_pred             EEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence            99999999999999998654332 223346778899999874332     247899999999999999999999976543


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ......+......                          ......+.++.++++||.+||+.+|++||++++++.||||.
T Consensus       213 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~  266 (286)
T cd06622         213 ANIFAQLSAIVDG--------------------------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV  266 (286)
T ss_pred             hhHHHHHHHHhhc--------------------------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence            3322222211110                          01112235788999999999999999999999999999998


Q ss_pred             CCCCC
Q 023764          231 SLHDI  235 (277)
Q Consensus       231 ~~~~~  235 (277)
                      .....
T Consensus       267 ~~~~~  271 (286)
T cd06622         267 KYKNA  271 (286)
T ss_pred             hccCC
Confidence            87643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-35  Score=252.02  Aligned_cols=200  Identities=23%  Similarity=0.455  Sum_probs=161.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     .+.|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        77 ~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~  150 (296)
T cd06654          77 PNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  150 (296)
T ss_pred             CCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence            7999999999886     88999999996 599998865 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+||++++|++|..||...........+.
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~  229 (296)
T cd06654         151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (296)
T ss_pred             CCCCEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence            99999999999887543322 2233467889999998854 447899999999999999999999997665433222111


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      . .+.+.                          ....+.++..+.+++.+||..||.+|||+.++++||||...+.
T Consensus       230 ~-~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         230 T-NGTPE--------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             c-CCCCC--------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            1 00000                          0111246778999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-35  Score=250.73  Aligned_cols=204  Identities=26%  Similarity=0.447  Sum_probs=158.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-----SNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~   74 (277)
                      |||+++++++..+     +..+++|||+++++.++..     ....+++..+..++.|++.||+|||+. |++||||||+
T Consensus        63 ~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~  137 (288)
T cd06616          63 PYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPS  137 (288)
T ss_pred             CCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHH
Confidence            7999999998876     8899999999876655432     236799999999999999999999974 9999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           75 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      ||+++.++.++|+|||++.............++..|+|||.+...  ..++.++||||+||++++|++|++||.....  
T Consensus       138 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--  215 (288)
T cd06616         138 NILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--  215 (288)
T ss_pred             HEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--
Confidence            999999999999999998755444333445678889999998654  3578999999999999999999999965431  


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ....+.+......                  +..    .......++.++.+||.+||+.||++|||+++++.||||...
T Consensus       216 ~~~~~~~~~~~~~------------------~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         216 VFDQLTQVVKGDP------------------PIL----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             HHHHHhhhcCCCC------------------CcC----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            1111111111000                  000    001113478899999999999999999999999999999874


Q ss_pred             C
Q 023764          233 H  233 (277)
Q Consensus       233 ~  233 (277)
                      .
T Consensus       274 ~  274 (288)
T cd06616         274 E  274 (288)
T ss_pred             h
Confidence            3

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-35  Score=245.26  Aligned_cols=196  Identities=28%  Similarity=0.499  Sum_probs=162.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+|+||++ ++|.+++.+.+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~  136 (258)
T cd06632          62 PNIVQYLGTEREE-----DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD  136 (258)
T ss_pred             CCchheeeeEecC-----CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            7999999998876     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||.+.............++..|++||.+.....++.++|+||+||++++|++|..||...........+..
T Consensus       137 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (258)
T cd06632         137 TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR  216 (258)
T ss_pred             CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence            99999999999987655443334556788899999985443478999999999999999999999976553332222111


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..                            ......+.+++++++++++||+.||.+|||+.+++.|||+
T Consensus       217 ~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         217 SK----------------------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cc----------------------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            00                            0111223567889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.8e-35  Score=249.56  Aligned_cols=201  Identities=24%  Similarity=0.437  Sum_probs=157.3

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++..... ...+.+|++|||++ ++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+|++|+||
T Consensus        73 ~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ni  152 (282)
T cd06636          73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV  152 (282)
T ss_pred             CcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            799999999865321 22368999999997 5999988753  4588889999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.++|+|||++...... .......+++.|+|||.+..    ...++.++|+||+||++++|++|..||......
T Consensus       153 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~  232 (282)
T cd06636         153 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM  232 (282)
T ss_pred             EECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence            9999999999999998654322 22334568889999998752    234678999999999999999999999665433


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .....+..   .+                         .........+.++.+||++||+.||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~---~~-------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         233 RALFLIPR---NP-------------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             hhhhhHhh---CC-------------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            22211110   00                         0001112467899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-35  Score=251.18  Aligned_cols=203  Identities=23%  Similarity=0.485  Sum_probs=164.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+|+||+. ++|.+++.+ ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        76 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~  149 (296)
T cd06655          76 PNIVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG  149 (296)
T ss_pred             CceeeeeeeEecC-----ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            7999999999887     89999999996 588888865 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~  228 (296)
T cd06655         150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  228 (296)
T ss_pred             CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999887544332 2234467889999998854 447899999999999999999999998776544332221


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      .. ..+.                          ......+++.+.+||++||..||.+|||+.+++.||||+.......
T Consensus       229 ~~-~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~  280 (296)
T cd06655         229 TN-GTPE--------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS  280 (296)
T ss_pred             hc-CCcc--------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccccc
Confidence            10 0100                          0111246788999999999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-35  Score=245.09  Aligned_cols=196  Identities=28%  Similarity=0.479  Sum_probs=159.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     ...|+++||++ ++|.+++.. ...+++..+..++.|++.|+.|||+.|++|+||+|.||++
T Consensus        58 ~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~  132 (256)
T cd06612          58 PYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL  132 (256)
T ss_pred             CcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE
Confidence            7999999999887     88999999997 599999875 4568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||++....... ......++..|+|||.+.+. .++.++||||+||++++|++|+.||...........+
T Consensus       133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~  211 (256)
T cd06612         133 NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI  211 (256)
T ss_pred             CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence            999999999999987655432 22334578889999998544 5789999999999999999999999765443221111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..   .                       ... .....+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       212 ~~---~-----------------------~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         212 PN---K-----------------------PPP-TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             cc---C-----------------------CCC-CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            00   0                       000 000112456789999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-35  Score=254.73  Aligned_cols=227  Identities=19%  Similarity=0.256  Sum_probs=161.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.++     +..|++|||++ ++|.+++...  ..+++..+..++.|++.||.|||++||+||||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nil  133 (314)
T cd08216          59 PNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL  133 (314)
T ss_pred             cchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEE
Confidence            7999999999887     88999999997 6899998753  46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--------cccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           78 LNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      ++.++.++++|||.+.......        ......++..|+|||.+... ..++.++|+||+||++++|++|..||.+.
T Consensus       134 i~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             EecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999876443211        12233466789999998543 34788999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCChHhhh-hhhhhHHHHhh-----hCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          149 DHVHQLRLLIELIGTPSEAELG-FLNENAKKYIC-----QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .........  ..+........ ...........     ..+.............++.++.+|+.+||+.||++|||+++
T Consensus       214 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         214 PATQMLLEK--VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             CHHHHHHHH--HhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence            544322111  11111100000 00000000000     00000000000011134568899999999999999999999


Q ss_pred             HhcCCCCCCCCC
Q 023764          223 ALAHPYLGSLHD  234 (277)
Q Consensus       223 ll~hp~f~~~~~  234 (277)
                      +++||||+.+++
T Consensus       292 ll~~p~~~~~~~  303 (314)
T cd08216         292 LLNHSFFKQCKR  303 (314)
T ss_pred             HhcCchHhhhcc
Confidence            999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=278.99  Aligned_cols=202  Identities=28%  Similarity=0.421  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------Ccee
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSA-------NVLH   68 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~-------~i~H   68 (277)
                      ||||+++++|....   ...+||||||++ ++|.+++..    .+.+++..++.|+.||+.||.|||+.       +|+|
T Consensus        72 PNIVrl~d~f~de~---~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVH  148 (1021)
T PTZ00266         72 KNIVRYIDRFLNKA---NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH  148 (1021)
T ss_pred             CCcCeEEEEEEecC---CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCcee
Confidence            79999999986542   167999999997 699998865    35799999999999999999999985       4999


Q ss_pred             cCCCCCcEEEec-----------------CCCeEEeeccceeeccCCCcccccccccccCChhhhhCC-CCCCcchhHHH
Q 023764           69 RDLKPSNLLLNA-----------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWS  130 (277)
Q Consensus        69 ~di~~~nil~~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Diws  130 (277)
                      |||||+|||++.                 .+.++|+|||++.............+++.|+|||++... ..++.++||||
T Consensus       149 RDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS  228 (1021)
T PTZ00266        149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA  228 (1021)
T ss_pred             ccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHH
Confidence            999999999964                 345899999999876544444556789999999998543 34789999999


Q ss_pred             HHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhc
Q 023764          131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  210 (277)
Q Consensus       131 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  210 (277)
                      |||++|+|++|..||...+....+...+..  .|.                           ...+..+.++.+||..||
T Consensus       229 LG~ILYELLTGk~PF~~~~~~~qli~~lk~--~p~---------------------------lpi~~~S~eL~dLI~~~L  279 (1021)
T PTZ00266        229 LGCIIYELCSGKTPFHKANNFSQLISELKR--GPD---------------------------LPIKGKSKELNILIKNLL  279 (1021)
T ss_pred             HHHHHHHHHHCCCCCCcCCcHHHHHHHHhc--CCC---------------------------CCcCCCCHHHHHHHHHHh
Confidence            999999999999999766544332222111  000                           011346788999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          211 TFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       211 ~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+|.+|||+.++|.|+|+..+..
T Consensus       280 ~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        280 NLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cCChhHCcCHHHHhccHHHhhcCC
Confidence            999999999999999999986643

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.9e-35  Score=251.18  Aligned_cols=199  Identities=24%  Similarity=0.392  Sum_probs=161.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     +++|+||||++ ++|.+++...+.+++..+..++.|++.|+.|||++|++||||+|.||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~  135 (305)
T cd05609          61 PFVVSMFCSFETK-----RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT  135 (305)
T ss_pred             CCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC
Confidence            7999999999876     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC----------------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           80 ANCDLKICDFGLARVTSETD----------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      .++.++|+|||.++......                ......++..|+|||.+.+ ..++.++|+||+||++++|++|..
T Consensus       136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~  214 (305)
T cd05609         136 SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCV  214 (305)
T ss_pred             CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999876321100                0112346778999998865 447999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---H
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---V  220 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~  220 (277)
                      ||.+....+....+......                           .....+..+.+++++|++||+.||++|||   +
T Consensus       215 pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~  267 (305)
T cd05609         215 PFFGDTPEELFGQVISDDIE---------------------------WPEGDEALPADAQDLISRLLRQNPLERLGTGGA  267 (305)
T ss_pred             CCCCCCHHHHHHHHHhcccC---------------------------CCCccccCCHHHHHHHHHHhccChhhccCccCH
Confidence            99876654433332221000                           00111246788999999999999999998   7


Q ss_pred             HHHhcCCCCCCC
Q 023764          221 EDALAHPYLGSL  232 (277)
Q Consensus       221 ~ell~hp~f~~~  232 (277)
                      .++++||||...
T Consensus       268 ~~ll~~~~~~~~  279 (305)
T cd05609         268 FEVKQHRFFLGL  279 (305)
T ss_pred             HHHHhCccccCC
Confidence            999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.1e-35  Score=246.75  Aligned_cols=200  Identities=25%  Similarity=0.432  Sum_probs=161.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++.+..+     +..|+|||++. ++|.+++...   ..+++..+..++.|++.|+++||+.|++|+|++|+||
T Consensus        59 ~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni  133 (267)
T cd06610          59 PNVVKYYTSFVVG-----DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNI  133 (267)
T ss_pred             CCEEEEEEEEeeC-----CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence            7999999999887     89999999996 5999998764   4589999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.++|+|||++.......     ......++..|+|||.+.....++.++|+||+||++++|++|..||...+..
T Consensus       134 ~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~  213 (267)
T cd06610         134 LLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM  213 (267)
T ss_pred             EEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence            99999999999999986544332     1233467889999999866546889999999999999999999999766554


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .........  .++                      ..........+++.+++++.+||..||.+|||+++++.||||
T Consensus       214 ~~~~~~~~~--~~~----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         214 KVLMLTLQN--DPP----------------------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             hhHHHHhcC--CCC----------------------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            433332221  000                      000001123567889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.5e-36  Score=245.23  Aligned_cols=187  Identities=25%  Similarity=0.398  Sum_probs=153.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+.+.+...+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus        45 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~  119 (237)
T cd05576          45 PNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD  119 (237)
T ss_pred             CceeehhhheecC-----CeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence            7999999999887     88999999997 59999998877899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++++|||.+......  .....++..|+|||... ...++.++|+||+||++++|++|..||.......       
T Consensus       120 ~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------  189 (237)
T cd05576         120 DRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG-ISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------  189 (237)
T ss_pred             CCCCEEEecccchhccccc--cccCCcCccccCCcccC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------
Confidence            9999999999987655433  22345567799999874 3457889999999999999999998774321100       


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYL  229 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~f  229 (277)
                        ..                        ... ....+.+++.++++|.+||+.||++|+|+     +++++||||
T Consensus       190 --~~------------------------~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         190 --NT------------------------HTT-LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             --cc------------------------ccc-cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence              00                        000 01112467889999999999999999995     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=247.33  Aligned_cols=202  Identities=27%  Similarity=0.477  Sum_probs=158.5

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||+++++++..... .....+|+||||++ ++|.+++..    +..+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        63 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~  142 (275)
T cd06608          63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQ  142 (275)
T ss_pred             CChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHH
Confidence            799999999977532 33367999999997 488888764    357999999999999999999999999999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           75 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      ||+++.++.++|+|||++...... .......++..|+|||.+...    ..++.++||||+||++++|++|.+||.+..
T Consensus       143 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  222 (275)
T cd06608         143 NILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH  222 (275)
T ss_pred             HEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence            999999999999999998754432 223345678899999987432    346788999999999999999999997654


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .......+..   .+..                       .. ......+.++++||.+||..||++|||+.++++|||+
T Consensus       223 ~~~~~~~~~~---~~~~-----------------------~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         223 PMRALFKIPR---NPPP-----------------------TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hHHHHHHhhc---cCCC-----------------------CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            4333222211   0000                       00 0011357789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-35  Score=251.34  Aligned_cols=203  Identities=23%  Similarity=0.466  Sum_probs=163.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     ++.|+||||++ ++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus        76 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~  149 (297)
T cd06656          76 PNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG  149 (297)
T ss_pred             CCEeeEEEEEecC-----CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            7999999999887     88999999996 589998865 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+||+++++++|..||.+.+.......+.
T Consensus       150 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~  228 (297)
T cd06656         150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  228 (297)
T ss_pred             CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec
Confidence            99999999999987654332 2234467889999999854 457899999999999999999999997654322111110


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      . .+.+.                          ......++..+++|+.+||..||++|||+++++.||||...+....
T Consensus       229 ~-~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         229 T-NGTPE--------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             c-CCCCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            0 01100                          0111246778999999999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.6e-35  Score=247.77  Aligned_cols=198  Identities=28%  Similarity=0.439  Sum_probs=157.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++..++.+++..+..++.|++.|+.|||+.|++|||++|+||+++
T Consensus        66 ~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~  140 (267)
T cd06646          66 CNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT  140 (267)
T ss_pred             CCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence            7999999999877     88999999997 59999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++....... ......++..|+|||.+..  ...++.++|+||+||++++|++|..||...........
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~  220 (267)
T cd06646         141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL  220 (267)
T ss_pred             CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence            99999999999987654321 2234567889999998742  33467899999999999999999999864432211111


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      +...                        ....... .....++..+++||++||..||++|||++++++|+|
T Consensus       221 ~~~~------------------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         221 MSKS------------------------NFQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             eecC------------------------CCCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            0000                        0000000 111246789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=287.84  Aligned_cols=201  Identities=27%  Similarity=0.434  Sum_probs=172.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++-.+.     ..+||.||||+ |+|.+.++.++..++...+.+..|++.|+.|||++|||||||||+||+++
T Consensus      1294 pNlV~YyGVEvHR-----ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld 1368 (1509)
T KOG4645|consen 1294 PNLVRYYGVEVHR-----EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD 1368 (1509)
T ss_pred             ccccccCceeecH-----HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee
Confidence            8999999998887     88999999996 69999999988899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-----CcccccccccccCChhhhhCCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           80 ANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      .+|.+|++|||.+.....+     ...+...||+.|||||++.+..  ....++|||||||++.||+||+.||...++.-
T Consensus      1369 ~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1369 FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred             cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence            9999999999999876543     2345678999999999997643  35679999999999999999999997776655


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+...+....+|+.                         ++   .+|++.+|||..||+.||++|.++.+++.|.|-+..
T Consensus      1449 aIMy~V~~gh~Pq~-------------------------P~---~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQI-------------------------PE---RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHhHHhccCCCCC-------------------------ch---hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            55555544444432                         12   488999999999999999999999999999998876


Q ss_pred             CC
Q 023764          233 HD  234 (277)
Q Consensus       233 ~~  234 (277)
                      .+
T Consensus      1501 ~d 1502 (1509)
T KOG4645|consen 1501 TD 1502 (1509)
T ss_pred             cc
Confidence            54

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=262.05  Aligned_cols=220  Identities=20%  Similarity=0.313  Sum_probs=179.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++.++++-.     ..+|||||||. |.|..+++....++......|..+|+.|+.|||.+.|||||+|.-||||+
T Consensus       172 ~NII~FkGVCtqs-----PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs  246 (904)
T KOG4721|consen  172 PNIITFKGVCTQS-----PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS  246 (904)
T ss_pred             cceeeEeeeecCC-----ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee
Confidence            8999999999887     89999999997 89999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+..+||+|||-++...+..+.-.++||..|||||++. ..+++.++||||+||++||||||..||.+-+...++.-+  
T Consensus       247 ~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--  323 (904)
T KOG4721|consen  247 YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--  323 (904)
T ss_pred             ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchheeEEec--
Confidence            99999999999998877776777889999999999985 456999999999999999999999999766543322111  


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                          .+                       ..+.-..| ..+..++=||+.|+.-.|..||++.++|.|-=+.+       
T Consensus       324 ----Gs-----------------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~-------  369 (904)
T KOG4721|consen  324 ----GS-----------------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS-------  369 (904)
T ss_pred             ----cC-----------------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC-------
Confidence                00                       01111112 34567888999999999999999999999853322       


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHH
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQ  265 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (277)
                         ...+....++...+...|+|.+..
T Consensus       370 ---pell~~tee~yf~sq~swrEevk~  393 (904)
T KOG4721|consen  370 ---PELLSTTEETYFKSQASWREEVKL  393 (904)
T ss_pred             ---HHHhcccHHHHHHHHHHHHHHHHH
Confidence               223444556666677777765443

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=245.20  Aligned_cols=198  Identities=27%  Similarity=0.450  Sum_probs=159.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|++|||++ ++|.+++... ..+++..+..++.|++.|+.|||++|++|+||+|+||++
T Consensus        60 ~~i~~~~~~~~~~-----~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i  134 (262)
T cd06613          60 PNIVAYFGSYLRR-----DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL  134 (262)
T ss_pred             CChhceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE
Confidence            7999999999876     88999999997 4899988776 789999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||.+....... ......++..|+|||.+...  ..++.++|+||+||++++|++|.+||.+.+......
T Consensus       135 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~  214 (262)
T cd06613         135 TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF  214 (262)
T ss_pred             CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999986544321 22344678889999988543  257889999999999999999999998766444333


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      .+......+..                         ....+..+.++.+|+++||..||..|||+.+++.|+|
T Consensus       215 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         215 LISKSNFPPPK-------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHhccCCCcc-------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            22211000000                         0011234668999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=240.08  Aligned_cols=201  Identities=26%  Similarity=0.445  Sum_probs=167.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |.||+.+++|..+     .+++|.||.|...+..+++. .++++|..+-.+...++.||.||-+ +||+|||+||+|||+
T Consensus       151 pyIV~c~GyFi~n-----~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl  225 (391)
T KOG0983|consen  151 PYIVQCFGYFITN-----TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL  225 (391)
T ss_pred             CeeeeeeeEEeeC-----chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE
Confidence            7899999999988     88999999999877776653 3679999999999999999999985 589999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~  155 (277)
                      +..|.+||||||.+....+..-.+...|-+.|||||.+...  ..|+.++||||||+.++||.||..||.+.+ +.+.+.
T Consensus       226 De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt  305 (391)
T KOG0983|consen  226 DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT  305 (391)
T ss_pred             ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence            99999999999999887777666677888999999998532  358899999999999999999999998754 444455


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ++..  ..|+.                        +.. -...|+++++|+..||.+|+.+||.-.++|+|||+....
T Consensus       306 kvln--~ePP~------------------------L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  306 KVLN--EEPPL------------------------LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHh--cCCCC------------------------CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            4443  11111                        000 113789999999999999999999999999999998754

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-35  Score=245.41  Aligned_cols=199  Identities=26%  Similarity=0.487  Sum_probs=159.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++++|+||+. ++|.+++.+.+.+++..+..++.|++.||.+||++|++|+||+|.||+++
T Consensus        63 ~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~  137 (268)
T cd06630          63 PHIIRMLGATCED-----SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID  137 (268)
T ss_pred             CceehhhceeccC-----CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence            7999999999887     89999999997 59999998888899999999999999999999999999999999999998


Q ss_pred             cCC-CeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           80 ANC-DLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        80 ~~~-~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      .++ .++|+|||.+.......     ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||........
T Consensus       138 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  216 (268)
T cd06630         138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH  216 (268)
T ss_pred             CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch
Confidence            776 58999999986554321     1223457888999999854 4578999999999999999999999965543322


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ...+......                         .......+.+++++.+++.+||..||.+|||+.++++||||+
T Consensus       217 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         217 LALIFKIASA-------------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHhcc-------------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            2222111000                         000111124678899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-35  Score=247.15  Aligned_cols=200  Identities=29%  Similarity=0.515  Sum_probs=160.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+|+||++ ++|.+++... ..+++..+..++.|++.|+.+||+ .|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~  133 (265)
T cd06605          59 PYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNIL  133 (265)
T ss_pred             CchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEE
Confidence            7999999999887     89999999998 6999999876 789999999999999999999999 99999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--HHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH--VHQLR  155 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~  155 (277)
                      ++.++.++|+|||.+......... ...++..|+|||.+.+ ..++.++|+||+||++++|++|..||...+.  .....
T Consensus       134 ~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  211 (265)
T cd06605         134 VNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE  211 (265)
T ss_pred             ECCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH
Confidence            999999999999998655432221 2667888999999855 4589999999999999999999999965421  11111


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .+......+.                          ...... .+.+++++|.+||..||.+|||+.+++.||||+.+.
T Consensus       212 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         212 LLQYIVNEPP--------------------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHhcCCC--------------------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            1111000000                          000111 678899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.3e-35  Score=245.19  Aligned_cols=197  Identities=23%  Similarity=0.447  Sum_probs=156.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+..   .+.+|+++||++ ++|.+.+...+.+++..+..++.|++.||++||++|++|+||+|+||+++
T Consensus        64 ~~i~~~~~~~~~~~---~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~  140 (266)
T cd06651          64 ERIVQYYGCLRDRA---EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD  140 (266)
T ss_pred             CCeeeEEEEEEcCC---CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence            79999999886532   167899999997 59999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||++......    .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||..........
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~  219 (266)
T cd06651         141 SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF  219 (266)
T ss_pred             CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            9999999999998654321    11223457888999998854 457899999999999999999999997654433332


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      .+..   .+..                         .......++.+++++ +||..+|++|||++++++||||+
T Consensus       220 ~~~~---~~~~-------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         220 KIAT---QPTN-------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHhc---CCCC-------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            2211   1000                         011123567889999 56678999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=255.37  Aligned_cols=190  Identities=27%  Similarity=0.433  Sum_probs=160.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||+|++++...     .-+|||||||. |+|.+++++  ++.++..+...++.||++|++||+++++|||||-..|||
T Consensus       261 ~~lV~l~gV~~~~-----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiL  335 (468)
T KOG0197|consen  261 EKLVKLYGVCTKQ-----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNIL  335 (468)
T ss_pred             cCeEEEEEEEecC-----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhee
Confidence            6999999999886     67999999997 899999997  467899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCccc--ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.+..+||+|||+++...+.....  ..--+..|.|||.+.. ..++.++||||+||+++||+| |+.|+++.++.+.+
T Consensus       336 V~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~  414 (468)
T KOG0197|consen  336 VDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL  414 (468)
T ss_pred             eccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence            9999999999999999665543222  2223456999999965 459999999999999999987 99999999988887


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.+-..-|.                             .+..++.+-++|..|+..+|++|||.+.+..
T Consensus       415 ~~le~GyRlp~-----------------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  415 ELLERGYRLPR-----------------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHhccCcCCC-----------------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            77654322211                             1256788999999999999999999986643

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.5e-35  Score=244.39  Aligned_cols=200  Identities=27%  Similarity=0.502  Sum_probs=160.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+. ++|.+++.+.+.+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus        68 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~  142 (272)
T cd06629          68 LNIVQYLGFETTE-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD  142 (272)
T ss_pred             CCcceEEEEeccC-----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence            7999999998876     88999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++++|||++......   .......++..|+|||.+.... .++.++|+||+|++++++++|..||..........
T Consensus       143 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  222 (272)
T cd06629         143 ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF  222 (272)
T ss_pred             CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH
Confidence            9999999999998654322   1122345788899999986543 36889999999999999999999996554433222


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+......                        ........+.++..++++|.+||..||++|||++++++||||
T Consensus       223 ~~~~~~~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         223 KLGNKRSA------------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HhhccccC------------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            11110000                        001112234578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.8e-35  Score=249.62  Aligned_cols=200  Identities=27%  Similarity=0.506  Sum_probs=163.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+|+||++ ++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus        78 p~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~  151 (297)
T cd06659          78 QNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT  151 (297)
T ss_pred             CchhhhhhheeeC-----CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc
Confidence            7999999999887     88999999997 588887654 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||...+.......+.
T Consensus       152 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  230 (297)
T cd06659         152 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR  230 (297)
T ss_pred             cCCcEEEeechhHhhcccccccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            9999999999998654332 12234568889999999854 457899999999999999999999997766544433221


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .   .+                        .......+..+..+.++|++||+.||.+|||++++++||||.....
T Consensus       231 ~---~~------------------------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         231 D---SP------------------------PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             c---cC------------------------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            1   00                        0011122356778999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=247.96  Aligned_cols=200  Identities=26%  Similarity=0.440  Sum_probs=165.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |+|||+|+.|.-.     .+++||||||+ |++.++++- +++++++++..++...+.||+|||...-+|||||.-|||+
T Consensus        88 ~yVVKYYGSYFK~-----sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL  162 (502)
T KOG0574|consen   88 KYVVKYYGSYFKH-----SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL  162 (502)
T ss_pred             chhhhhhhhhccC-----CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE
Confidence            6899999988776     89999999998 899999875 4789999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.+|..||+|||.+....+. ...++..|||.|||||++..-+ |..++||||||+...||..|++||.+-...   +.|
T Consensus       163 NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAI  238 (502)
T KOG0574|consen  163 NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAI  238 (502)
T ss_pred             cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccccc---cee
Confidence            99999999999999765543 4566788999999999997655 899999999999999999999999554321   111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .-                       .|..+.+.+ +.....|.++-||+++||.++|++|.||.++++|||+++..
T Consensus       239 FM-----------------------IPT~PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  239 FM-----------------------IPTKPPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             Ee-----------------------ccCCCCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            10                       111111111 01124678899999999999999999999999999998754

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.6e-35  Score=245.29  Aligned_cols=196  Identities=28%  Similarity=0.457  Sum_probs=161.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+|+||+. ++|.+.+.+...+++..+..++.|++.||.|||++|++|+||+|.||+++
T Consensus        60 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~  134 (258)
T cd05578          60 PFLVNLWYSFQDE-----ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD  134 (258)
T ss_pred             CChHHHHHhhcCC-----CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc
Confidence            7999999999877     88999999996 59999998877899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||.+.............++..|+|||.+.. ..++.++|+||+||++++|++|..||...+... ...+..
T Consensus       135 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~  212 (258)
T cd05578         135 EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRA  212 (258)
T ss_pred             CCCCEEEeecccccccCCCccccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHH
Confidence            999999999999876654433445567888999999854 447899999999999999999999997665321 111111


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH--HHHhcCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--EDALAHPYL  229 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~ell~hp~f  229 (277)
                      ....                          ......+..+.++.++|++||..||.+||++  +++++||||
T Consensus       213 ~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         213 KQET--------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             Hhcc--------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            1100                          0001112456899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-34  Score=240.52  Aligned_cols=194  Identities=28%  Similarity=0.513  Sum_probs=162.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +..+++|||++ ++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~  133 (256)
T cd08221          59 PNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF  133 (256)
T ss_pred             CCeeEEEeEEecC-----CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEE
Confidence            7999999999887     88999999997 5999999765  46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||.+....... ......+++.|+|||.+.+. ..+.++|+||+||++++|++|..||.+....+....
T Consensus       134 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~  212 (256)
T cd08221         134 LTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK  212 (256)
T ss_pred             EeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999987654432 23445688999999988544 478899999999999999999999987665554444


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +..  +..                           ....+..+.++.+++.+||..||.+|||++++++|+|+
T Consensus       213 ~~~--~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         213 IVQ--GNY---------------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHc--CCC---------------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            321  110                           01113567889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.7e-35  Score=242.28  Aligned_cols=194  Identities=26%  Similarity=0.407  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++.+...     +..++||||++ ++|.+++...  ..+++..+..++.|++.|+.+||++|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil  133 (256)
T cd08220          59 PNIIEYYENFLED-----KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL  133 (256)
T ss_pred             CchhheeeeEecC-----CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            7899999998876     88999999996 5999999764  35899999999999999999999999999999999999


Q ss_pred             EecCC-CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++ .++|+|||.+.............++..|+|||.+.+ ...+.++|+||+|+++++|++|..||.+.+.......
T Consensus       134 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~  212 (256)
T cd08220         134 LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK  212 (256)
T ss_pred             EcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence            98654 579999999987665544445678889999998854 4478899999999999999999999977665443333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +.....                             .......+.++++++.+||..||++|||++++++||||
T Consensus       213 ~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         213 IMSGTF-----------------------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHhcCC-----------------------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            221100                             01112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.4e-35  Score=241.61  Aligned_cols=194  Identities=25%  Similarity=0.475  Sum_probs=159.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     ++.|+|+||+. ++|.+.+....  .+++..+..++.|++.|+.+||++|++|+||+|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil  133 (256)
T cd08218          59 PNIVQYQESFEEN-----GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF  133 (256)
T ss_pred             CCeeeeEeeecCC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence            7999999999887     89999999996 59999887643  5789999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++++|||.+....... ......+++.|+|||.+.+ ...+.++|+||+||++++|++|..||...+.......
T Consensus       134 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~  212 (256)
T cd08218         134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK  212 (256)
T ss_pred             EcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence            9999999999999987654432 1223457788999999854 4478899999999999999999999976665544333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +...  .                           ........+.++.++|.+||+.+|.+||++.+++.||||
T Consensus       213 ~~~~--~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         213 IIRG--S---------------------------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HhcC--C---------------------------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            3210  0                           001112467789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.5e-35  Score=244.20  Aligned_cols=198  Identities=31%  Similarity=0.561  Sum_probs=162.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     +..|+||||+. ++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus        53 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~  127 (265)
T cd05579          53 PYVVKLYYSFQGK-----KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID  127 (265)
T ss_pred             cchhHHHHheecC-----cEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc
Confidence            7899999998776     88999999996 59999998877899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC---------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           80 ANCDLKICDFGLARVTSETD---------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      .++.++|+|||++.......         ......++..|++||...... .+.++|+||+|++++++++|..||.....
T Consensus       128 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  206 (265)
T cd05579         128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP  206 (265)
T ss_pred             CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999986543321         123345778899999986544 78899999999999999999999977665


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---EDALAHP  227 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~ell~hp  227 (277)
                      ......+..  +..                         .... ....+..+.+|+++||+.+|++|||+   .++++||
T Consensus       207 ~~~~~~~~~--~~~-------------------------~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         207 EEIFQNILN--GKI-------------------------EWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             HHHHHHHhc--CCc-------------------------CCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence            443333221  000                         0000 01247889999999999999999999   9999999


Q ss_pred             CCCCC
Q 023764          228 YLGSL  232 (277)
Q Consensus       228 ~f~~~  232 (277)
                      ||+.+
T Consensus       259 ~~~~~  263 (265)
T cd05579         259 FFKGI  263 (265)
T ss_pred             cccCC
Confidence            99864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-34  Score=244.91  Aligned_cols=202  Identities=26%  Similarity=0.411  Sum_probs=156.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++........+..|+||||++ ++|.+++..    ...+++..+..++.|++.||.|||+.+++|||++|+|
T Consensus        75 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n  154 (286)
T cd06638          75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNN  154 (286)
T ss_pred             CCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHh
Confidence            79999999986543333378999999996 589887752    3568899999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      |+++.++.++|+|||++....... ......++..|+|||.+..    ...++.++|+||+||++++|++|..||.+...
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         155 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             EEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            999999999999999987654322 2234468899999998742    23468899999999999999999999976543


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ......+..   ..                       .... ......+..+++||.+||+.||++|||+.++++|+||
T Consensus       235 ~~~~~~~~~---~~-----------------------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         235 MRALFKIPR---NP-----------------------PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             hHHHhhccc---cC-----------------------CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            322211110   00                       0000 0011246689999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.2e-35  Score=249.86  Aligned_cols=203  Identities=27%  Similarity=0.447  Sum_probs=160.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||+++++.+++.. ...+++..+..++.|++.|+.|||+ .|++||||+|+||++
T Consensus        74 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill  148 (296)
T cd06618          74 PYIVKCYGYFITD-----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL  148 (296)
T ss_pred             CchHhhheeeecC-----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE
Confidence            7999999999887     88999999999888887765 4578999999999999999999997 599999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-VHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~  154 (277)
                      +.++.++|+|||++.............++..|+|||.+...   ..++.++|+||+||++++|++|+.||..... .+.+
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  228 (296)
T cd06618         149 DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL  228 (296)
T ss_pred             cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence            99999999999998765443333344577889999998543   2368899999999999999999999965322 1222


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+....                     .+     .. ......+.++++|+.+||..||.+|||+++++.||||.....
T Consensus       229 ~~~~~~~---------------------~~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         229 TKILQEE---------------------PP-----SL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHhcCC---------------------CC-----CC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            2111100                     00     00 000135778999999999999999999999999999997654


Q ss_pred             C
Q 023764          235 I  235 (277)
Q Consensus       235 ~  235 (277)
                      .
T Consensus       282 ~  282 (296)
T cd06618         282 A  282 (296)
T ss_pred             h
Confidence            3

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-35  Score=244.81  Aligned_cols=199  Identities=21%  Similarity=0.458  Sum_probs=160.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+. ++|.+++.. +.+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus        62 ~~vi~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~  135 (277)
T cd06917          62 PNITKYYGSYLKG-----PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT  135 (277)
T ss_pred             CCeeeEeeeeeeC-----CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc
Confidence            7999999999876     88999999996 589998866 4799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+....... ......++..|+|||.+.....++.++|+||+||++++|++|..||.+.........+.
T Consensus       136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~  215 (277)
T cd06917         136 NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP  215 (277)
T ss_pred             CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc
Confidence            99999999999987654432 22334678889999998655557889999999999999999999997654332211110


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .   .                       ....+..  ...+.++.+++.+||+.||++|||+.+++.|+||+...
T Consensus       216 ~---~-----------------------~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         216 K---S-----------------------KPPRLED--NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             c---C-----------------------CCCCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            0   0                       0000000  12567899999999999999999999999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.9e-35  Score=242.50  Aligned_cols=201  Identities=29%  Similarity=0.478  Sum_probs=163.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++..+     +..|+||||++ ++|.+++.....+++..+..++.|++.|+.+||+ .|++|+||+|+||++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~  133 (264)
T cd06623          59 PYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI  133 (264)
T ss_pred             CCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE
Confidence            7999999999887     89999999998 6999999887889999999999999999999999 999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc-cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||.+......... ....++..|+|||.+.. ..++.++|+||||+++++|++|..||............
T Consensus       134 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~  212 (264)
T cd06623         134 NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM  212 (264)
T ss_pred             CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH
Confidence            99999999999998766543322 24567888999998854 45789999999999999999999999766421111111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .......                          ....... .+..+.++|.+||..+|++|||+.++++||||+.+.
T Consensus       213 ~~~~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         213 QAICDGP--------------------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHhcCC--------------------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            1110000                          0011123 678899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-34  Score=244.61  Aligned_cols=191  Identities=21%  Similarity=0.349  Sum_probs=156.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +..|++|||++ ++|.+++...                ..++...+..++.|++.||.|||+
T Consensus        68 ~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~  142 (283)
T cd05048          68 PNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS  142 (283)
T ss_pred             cccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            7999999999876     78999999996 6999999764                457888999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++|+||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.. ..++.++||||+||++++|++
T Consensus       143 ~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~  221 (283)
T cd05048         143 HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFS  221 (283)
T ss_pred             CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999987653322   1223456788999998854 458999999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+.+..+....+.+...                             .......+.++.+|+.+||+.||.+|||
T Consensus       222 ~g~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~  272 (283)
T cd05048         222 YGLQPYYGFSNQEVIEMIRSRQL-----------------------------LPCPEDCPARVYALMIECWNEIPARRPR  272 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCc-----------------------------CCCcccCCHHHHHHHHHHccCChhhCcC
Confidence             9999987766554443322100                             0111356789999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +.+++++
T Consensus       273 ~~~i~~~  279 (283)
T cd05048         273 FKDIHTR  279 (283)
T ss_pred             HHHHHHH
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-34  Score=240.91  Aligned_cols=196  Identities=32%  Similarity=0.520  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIH-----SANVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH-----~~~i~H~d   70 (277)
                      |||+++++++....   ....|++|||++ ++|.+++..    ...+++..+..++.|++.||.+||     +.+++|+|
T Consensus        59 ~~i~~~~~~~~~~~---~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d  135 (265)
T cd08217          59 PNIVRYYDRIIDRS---NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD  135 (265)
T ss_pred             CccceeeeeeecCC---CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence            79999999886532   267899999996 599998865    367899999999999999999999     89999999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCCCc-ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |+|+||+++.++.++|+|||++........ .....+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...+
T Consensus       136 l~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         136 LKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             CCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence            999999999999999999999887654432 344568889999999855 447899999999999999999999998766


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .......+...                             ......+..+..+.+++.+||+.+|++|||+.++++|||+
T Consensus       215 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         215 QLQLASKIKEG-----------------------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHhcC-----------------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            43332222110                             0011112567889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-34  Score=247.56  Aligned_cols=196  Identities=24%  Similarity=0.411  Sum_probs=160.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +..|+||||++|++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++
T Consensus        75 ~niv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~  149 (307)
T cd06607          75 PNTIEYKGCYLRE-----HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT  149 (307)
T ss_pred             CCEEEEEEEEEeC-----CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC
Confidence            7999999999887     88999999999998887764 45799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++......   ....++..|+|||++..  ...++.++||||+||++++|++|.+||.+.+.......+
T Consensus       150 ~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~  226 (307)
T cd06607         150 EPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (307)
T ss_pred             CCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence            9999999999998755432   23467788999998742  345788999999999999999999999766544432222


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ...  .++                        ..  .....+..++++|.+||..||++|||+.+++.||||..-
T Consensus       227 ~~~--~~~------------------------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         227 AQN--DSP------------------------TL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             hcC--CCC------------------------CC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            110  000                        00  011356789999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.1e-35  Score=246.05  Aligned_cols=198  Identities=26%  Similarity=0.441  Sum_probs=155.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..++||||+++ +|..+    ..+++..+..++.|++.|+.|||+.|++|+||||+||+++
T Consensus        59 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~  129 (279)
T cd06619          59 PYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN  129 (279)
T ss_pred             CCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC
Confidence            7999999999887     889999999985 66443    3578899999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH---HHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ---LRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~  156 (277)
                      .++.++|+|||++...... ......++..|+|||.+.+. .++.++|+||+||++++|++|..||........   ...
T Consensus       130 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~  207 (279)
T cd06619         130 TRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ  207 (279)
T ss_pred             CCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH
Confidence            9999999999998765433 23345788999999988644 478999999999999999999999964321110   000


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .......+                        ..........++++++|+.+||+.||.+||+++++++||||....
T Consensus       208 ~~~~~~~~------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         208 LLQCIVDE------------------------DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHhcc------------------------CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            00000000                        000001124678899999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-34  Score=240.53  Aligned_cols=197  Identities=27%  Similarity=0.450  Sum_probs=154.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l--~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++...     +..|+|+||++ ++|.+++... ..+  ++..+..++.|++.|+.|||+.|++||||+|+||
T Consensus        65 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~ni  139 (268)
T cd06624          65 RNIVQYLGSDSEN-----GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNV  139 (268)
T ss_pred             CCeeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            7999999999887     88999999997 5999998764 455  7888999999999999999999999999999999


Q ss_pred             EEec-CCCeEEeeccceeeccCC-CcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           77 LLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        77 l~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +++. ++.++|+|||.+...... .......+++.|+|||.+... ..++.++|+||+||++++|++|..||........
T Consensus       140 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~  219 (268)
T cd06624         140 LVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA  219 (268)
T ss_pred             EEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence            9976 678999999998754332 222334578899999988543 2378899999999999999999999965432211


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .........                           .........++++++|+++||+.+|.+|||+.+++.||||
T Consensus       220 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         220 AMFKVGMFK---------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hHhhhhhhc---------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            100000000                           0001112467789999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.3e-35  Score=252.62  Aligned_cols=229  Identities=17%  Similarity=0.266  Sum_probs=160.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||++++++|...     +..|+|+||+. ++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        59 ~niv~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nil  133 (328)
T cd08226          59 PNIMTSWTVFTTG-----SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL  133 (328)
T ss_pred             CCcceEeeeEecC-----CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            7999999999887     88999999997 5999988764  35899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--------cccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           78 LNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      ++.++.++++||+.+.......        ......++..|+|||++.+. ..++.++||||+||++++|++|.+||.+.
T Consensus       134 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             EeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999997543221110        00112345669999998653 34689999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCc----------------c-cCCcc-cccCCCCChhHHHHHHHhc
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR----------------Y-QRQSF-TEKFPNVHPSAIDLVEKML  210 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~-~~~~~-~~~~~~~~~~~~~li~~~L  210 (277)
                      ................+.. .................                . ....+ .......++.+++||++||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  292 (328)
T cd08226         214 LRTQMLLQKLKGPPYSPLD-ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL  292 (328)
T ss_pred             ChHHHHHHHhcCCCCCCcc-ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHc
Confidence            6544333222211100000 00000000000000000                0 00000 0011235678999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          211 TFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       211 ~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      +.||++|||++++++||||......
T Consensus       293 ~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         293 QQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             cCCcccCCCHHHHhhCHHHHHHHHh
Confidence            9999999999999999999887653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-34  Score=243.44  Aligned_cols=193  Identities=33%  Similarity=0.618  Sum_probs=161.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC-cccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +..|+|||++ +++|.+++.+.+.+++..+..++.|++.||.+||++|++|+|++|+||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~  136 (280)
T cd05581          62 PGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD  136 (280)
T ss_pred             CCchhHHHHhcCC-----ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence            7999999999887     8899999999 579999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC---------------------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD---------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  138 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~l  138 (277)
                      .++.++++|||++.......                     ......++..|+|||.... ...+.++|+||+||+++++
T Consensus       137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l  215 (280)
T cd05581         137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQM  215 (280)
T ss_pred             CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHH
Confidence            99999999999987544321                     1123346788999998854 4478899999999999999


Q ss_pred             HcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC
Q 023764          139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  218 (277)
Q Consensus       139 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  218 (277)
                      ++|..||...+.......+.....                              ...+.+++.+.+||.+||+.||.+||
T Consensus       216 ~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~  265 (280)
T cd05581         216 LTGKPPFRGSNEYLTFQKILKLEY------------------------------SFPPNFPPDAKDLIEKLLVLDPQDRL  265 (280)
T ss_pred             HhCCCCCCCccHHHHHHHHHhcCC------------------------------CCCCccCHHHHHHHHHHhcCCHhhCC
Confidence            999999987764443333321100                              11124578899999999999999999


Q ss_pred             CH----HHHhcCCCC
Q 023764          219 TV----EDALAHPYL  229 (277)
Q Consensus       219 t~----~ell~hp~f  229 (277)
                      |+    +++++||||
T Consensus       266 ~~~~~~~~ll~~~~~  280 (280)
T cd05581         266 GVNEGYDELKAHPFF  280 (280)
T ss_pred             CcccCHHHHhcCCCC
Confidence            99    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.3e-34  Score=244.18  Aligned_cols=200  Identities=25%  Similarity=0.510  Sum_probs=162.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     ++.|+||||+++ +|.+++.. +.+++..+..++.|++.|++|||+.|++|+||+|+||+++
T Consensus        77 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~  150 (292)
T cd06657          77 ENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT  150 (292)
T ss_pred             cchhheeeEEEeC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            7999999999887     899999999974 88887654 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++....... ......++..|++||.+.. ..++.++|+||+||++++|++|..||.+.........+.
T Consensus       151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~  229 (292)
T cd06657         151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR  229 (292)
T ss_pred             CCCCEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999886544321 2233467888999998754 457899999999999999999999998765544433322


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ...  +                         ........+++.+.+++.+||+.||.+||++.+++.||||.....
T Consensus       230 ~~~--~-------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         230 DNL--P-------------------------PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             hhC--C-------------------------cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            110  0                         000112356788999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-34  Score=240.18  Aligned_cols=197  Identities=24%  Similarity=0.466  Sum_probs=157.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++..   +.+|+||||++ ++|.+++...+.+++..+..++.|++.||++||+.|++|+||+|+||+++
T Consensus        64 ~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~  140 (265)
T cd06652          64 ERIVQYYGCLRDPME---RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD  140 (265)
T ss_pred             CCeeeEEeEeccCCC---ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence            799999999876421   56899999996 59999998877899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||.+......    .......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||.+........
T Consensus       141 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  219 (265)
T cd06652         141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF  219 (265)
T ss_pred             CCCCEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH
Confidence            9999999999988754321    11233457888999999865 447899999999999999999999997654333322


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      .+.   ..+..                         ....+..+..+.++|++|+. +|++|||++++++|||+.
T Consensus       220 ~~~---~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         220 KIA---TQPTN-------------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHh---cCCCC-------------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            211   11100                         01112456789999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-34  Score=242.95  Aligned_cols=196  Identities=26%  Similarity=0.409  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.. +++++..+..++.|++.|+++||+.|++|+||+|+||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~  135 (277)
T cd06640          62 PYVTKYYGSYLKG-----TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS  135 (277)
T ss_pred             CCEeeEEEEEEEC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc
Confidence            7999999999887     89999999997 599998875 5789999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++++|||++....... ......++..|+|||.+.+ ...+.++|+||+||++++|++|..||.+.........+.
T Consensus       136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~  214 (277)
T cd06640         136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP  214 (277)
T ss_pred             CCCCEEEcccccceeccCCccccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh
Confidence            99999999999987654332 2223456788999998854 447899999999999999999999997655433221110


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      . ..                            ........+..+.+++.+||+.||.+|||++++++|+||...
T Consensus       215 ~-~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         215 K-NN----------------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             c-CC----------------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            0 00                            011122456789999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.1e-34  Score=245.01  Aligned_cols=196  Identities=26%  Similarity=0.422  Sum_probs=160.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||+.+++.+++.. ...+++..+..++.|++.|+.|||++|++|+||+|+||+++
T Consensus        81 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~  155 (313)
T cd06633          81 PNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT  155 (313)
T ss_pred             CCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC
Confidence            7999999999887     88999999999998888765 45689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++.....   .....++..|+|||.+..  ...++.++|+||+||++++|++|.+||.+.+.......+
T Consensus       156 ~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~  232 (313)
T cd06633         156 EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  232 (313)
T ss_pred             CCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            999999999998764332   234567889999998742  345788999999999999999999999776554433332


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ... ..+                           ....+..+..+++|+.+||+.+|.+|||+.+++.||||...
T Consensus       233 ~~~-~~~---------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         233 AQN-DSP---------------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             Hhc-CCC---------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            210 000                           01112456789999999999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.9e-34  Score=239.50  Aligned_cols=198  Identities=27%  Similarity=0.502  Sum_probs=158.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+++|+||++ ++|.+++.+.+.+++..++.++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~  133 (264)
T cd06626          59 PNLVKYYGVEVHR-----EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD  133 (264)
T ss_pred             CChhheeeeEecC-----CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            6899999998776     88999999997 69999998877799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc-----ccccccccccCChhhhhCCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           80 ANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      .++.++|+|||.+........     .....++..|+|||.+....  ..+.++||||+||+++++++|..||.+.....
T Consensus       134 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~  213 (264)
T cd06626         134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF  213 (264)
T ss_pred             CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence            999999999999876543322     12345678899999985433  26889999999999999999999997654332


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ........ +.++                        .+ .....++..+.+|+.+||+.||.+|||+.+++.|||+
T Consensus       214 ~~~~~~~~-~~~~------------------------~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         214 QIMFHVGA-GHKP------------------------PI-PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHhc-CCCC------------------------CC-CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            22211111 1000                        00 0112357889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-34  Score=238.95  Aligned_cols=191  Identities=27%  Similarity=0.404  Sum_probs=158.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC-cccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~~i~H~d   70 (277)
                      |||+++++++.+.     ..+|+||||+ +++|.+++...         ..+++..+..++.|++.||++||++|++|+|
T Consensus        56 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d  130 (262)
T cd00192          56 PNVVRLLGVCTEE-----EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD  130 (262)
T ss_pred             CChheeeeeecCC-----CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCc
Confidence            7999999999886     8899999999 57999999875         7799999999999999999999999999999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFP  146 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  146 (277)
                      |+|+||+++.++.++|+|||.+.......   ......++..|+|||.+... .++.++||||+||++++|++ |..||.
T Consensus       131 i~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~  209 (262)
T cd00192         131 LAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYP  209 (262)
T ss_pred             cCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCC
Confidence            99999999999999999999997665432   22344567889999988554 58999999999999999998 699998


Q ss_pred             CCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +.........+....                             .....+..+.++.+++.+||..||++|||+.+++++
T Consensus       210 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         210 GLSNEEVLEYLRKGY-----------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCCHHHHHHHHHcCC-----------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            776554444333200                             001112457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7e-35  Score=245.36  Aligned_cols=197  Identities=27%  Similarity=0.419  Sum_probs=159.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~  135 (277)
T cd06642          62 PYITRYYGSYLKG-----TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS  135 (277)
T ss_pred             CccHhhhcccccC-----CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe
Confidence            7999999999887     88999999997 589888865 5789999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++++|||++....... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||...........+.
T Consensus       136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~  214 (277)
T cd06642         136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP  214 (277)
T ss_pred             CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh
Confidence            99999999999987654332 1223457888999999854 457899999999999999999999986543322111110


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .                             ..........+.++.+++.+||+.+|.+|||+.++++||||..+.
T Consensus       215 ~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         215 K-----------------------------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             c-----------------------------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            0                             000011124577899999999999999999999999999997654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=237.87  Aligned_cols=193  Identities=30%  Similarity=0.538  Sum_probs=161.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC-cccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     +..|+||||+ +++|.+++.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        53 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~  127 (250)
T cd05123          53 PFIVKLHYAFQTE-----EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD  127 (250)
T ss_pred             CcHHHHHHHeecC-----CeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc
Confidence            7899999998876     8999999999 579999998887899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+...... .......++..|++||...+. ..+.++|+||+|++++++++|..||...+.......+.
T Consensus       128 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  206 (250)
T cd05123         128 ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL  206 (250)
T ss_pred             CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            9999999999998765443 223445678889999988544 47889999999999999999999997776544333332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---EDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~ell~hp~f  229 (277)
                      .  ...                            ......+..+.+++++||..||++|||+   +++++||||
T Consensus       207 ~--~~~----------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         207 K--DPL----------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             c--CCC----------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            2  000                            0111347789999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-34  Score=242.43  Aligned_cols=190  Identities=22%  Similarity=0.371  Sum_probs=153.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------------ALSEEHCQYFLYQILRGLKYIHSANV   66 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------------~l~~~~~~~i~~qll~al~~LH~~~i   66 (277)
                      |||+++++++...     +..|+||||++ ++|.+++...+             .+++..+..++.|++.||+|||++|+
T Consensus        67 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i  141 (288)
T cd05093          67 EHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF  141 (288)
T ss_pred             CCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            7999999999876     88999999997 69999987543             48999999999999999999999999


Q ss_pred             eecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CC
Q 023764           67 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  142 (277)
Q Consensus        67 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  142 (277)
                      +||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.. ..++.++|||||||++++|++ |.
T Consensus       142 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~  220 (288)
T cd05093         142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGK  220 (288)
T ss_pred             eecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987543321   1122344678999998854 457899999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      +||.+.........+...  ..                           .......+.++.+|+.+||+.||.+|||+.+
T Consensus       221 ~p~~~~~~~~~~~~i~~~--~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  271 (288)
T cd05093         221 QPWYQLSNNEVIECITQG--RV---------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKE  271 (288)
T ss_pred             CCCCCCCHHHHHHHHHcC--Cc---------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            999777655444333220  00                           0011245778999999999999999999999


Q ss_pred             Hhc
Q 023764          223 ALA  225 (277)
Q Consensus       223 ll~  225 (277)
                      +++
T Consensus       272 v~~  274 (288)
T cd05093         272 IHS  274 (288)
T ss_pred             HHH
Confidence            854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-34  Score=252.20  Aligned_cols=191  Identities=24%  Similarity=0.351  Sum_probs=150.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------------------------------
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------------------------------   39 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------------------------   39 (277)
                      |||+++++++...     +.+|+||||+. |+|.+++.+.                                        
T Consensus       102 ~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (374)
T cd05106         102 KNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ  176 (374)
T ss_pred             CceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccc
Confidence            7999999999887     88999999996 6999988542                                        


Q ss_pred             ------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeec
Q 023764           40 ------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF   89 (277)
Q Consensus        40 ------------------------------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~df   89 (277)
                                                    .++++..+.+++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~Df  256 (374)
T cd05106         177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDF  256 (374)
T ss_pred             ccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeec
Confidence                                          24788889999999999999999999999999999999999999999999


Q ss_pred             cceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCC
Q 023764           90 GLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPS  165 (277)
Q Consensus        90 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~  165 (277)
                      |++........   .....++..|+|||++.. ..++.++||||+||++++|++ |..||.+................+ 
T Consensus       257 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-  334 (374)
T cd05106         257 GLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-  334 (374)
T ss_pred             eeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-
Confidence            99875433221   112234567999999854 458999999999999999996 999997654333222222110000 


Q ss_pred             hHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          166 EAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                                                 ......++++.+++.+||+.||.+|||+.++++
T Consensus       335 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 ---------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ---------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       001135789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.2e-34  Score=240.02  Aligned_cols=190  Identities=18%  Similarity=0.244  Sum_probs=152.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     ++.|+||||++ |+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        66 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili  140 (266)
T cd05064          66 SNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV  140 (266)
T ss_pred             CCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE
Confidence            7999999999876     88999999997 5899988764 578999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~  155 (277)
                      +.++.++++|||.+.........  ....++..|+|||.+.. ..++.++||||+||++++++ +|..||.+.+......
T Consensus       141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~  219 (266)
T cd05064         141 NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK  219 (266)
T ss_pred             cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence            99999999999986543222111  12234567999998854 45899999999999999976 5999998776554433


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+......                             ...+..+..+.+++.+|++.+|.+|||++++++
T Consensus       220 ~~~~~~~~-----------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         220 AVEDGFRL-----------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHCCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            33211000                             111346778999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.7e-34  Score=244.31  Aligned_cols=191  Identities=24%  Similarity=0.314  Sum_probs=151.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++.+..                .+++..+..++.|++.||+|||+
T Consensus        63 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~  137 (297)
T cd05089          63 PNIINLLGACENR-----GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE  137 (297)
T ss_pred             CchhheEEEEccC-----CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999876     78999999996 69999997542                47889999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CC
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  142 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  142 (277)
                      +|++||||||+||+++.++.++|+|||++..............+..|+|||.... ..++.++|||||||++++|++ |.
T Consensus       138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~  216 (297)
T cd05089         138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGG  216 (297)
T ss_pred             CCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999999864322111111223456999998854 447899999999999999997 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||.+.........+.....                             ......++..+++|+.+||+.||.+|||+++
T Consensus       217 ~pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  267 (297)
T cd05089         217 TPYCGMTCAELYEKLPQGYR-----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQ  267 (297)
T ss_pred             CCCCCCCHHHHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99977665444333221000                             0111246788999999999999999999999


Q ss_pred             HhcC
Q 023764          223 ALAH  226 (277)
Q Consensus       223 ll~h  226 (277)
                      +++.
T Consensus       268 i~~~  271 (297)
T cd05089         268 ISVQ  271 (297)
T ss_pred             HHHH
Confidence            9764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-34  Score=247.13  Aligned_cols=197  Identities=25%  Similarity=0.404  Sum_probs=159.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+.|++.+.+.. ...+++..+..++.|++.|+.|||++|++||||+|.||+++
T Consensus        75 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~  149 (308)
T cd06634          75 PNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS  149 (308)
T ss_pred             CCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC
Confidence            7899999999886     88999999999988887754 45689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++......   ....++..|+|||.+.+  ...++.++||||+||++++|++|..||.+.+.......+
T Consensus       150 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  226 (308)
T cd06634         150 EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (308)
T ss_pred             CCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH
Confidence            9999999999998765432   23467888999999742  234688999999999999999999998665433322222


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ... ..+                           .......+..+++||++||..+|.+|||+++++.|||+....
T Consensus       227 ~~~-~~~---------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         227 AQN-ESP---------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             hhc-CCC---------------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            110 000                           001124667899999999999999999999999999998854

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-34  Score=242.13  Aligned_cols=202  Identities=20%  Similarity=0.373  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~  139 (290)
T cd05613          65 PFLVTLHYAFQTD-----TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD  139 (290)
T ss_pred             CChhceeeEeecC-----CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC
Confidence            7899999999887     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++.......  ......++..|+|||.+... ..++.++||||+||++++|++|..||...........
T Consensus       140 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~  219 (290)
T cd05613         140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE  219 (290)
T ss_pred             CCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH
Confidence            99999999999987654321  22234578889999988543 2367899999999999999999999964332222222


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~  231 (277)
                      +.......                  .     .+   ..+.+++.+.+++++||+.||++|+     ++++++.||||+.
T Consensus       220 ~~~~~~~~------------------~-----~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  273 (290)
T cd05613         220 ISRRILKS------------------E-----PP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK  273 (290)
T ss_pred             HHHHhhcc------------------C-----CC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence            21111000                  0     00   1124677899999999999999997     8999999999988


Q ss_pred             CC
Q 023764          232 LH  233 (277)
Q Consensus       232 ~~  233 (277)
                      +.
T Consensus       274 ~~  275 (290)
T cd05613         274 IN  275 (290)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.1e-34  Score=240.65  Aligned_cols=197  Identities=24%  Similarity=0.431  Sum_probs=155.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~~i~H~   69 (277)
                      |||+++++++.+.     +..|+||||++ |+|.+++.+.          ..++...+..++.|++.||.|||++|++||
T Consensus        69 ~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  143 (288)
T cd05061          69 HHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR  143 (288)
T ss_pred             CCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            7999999999877     78999999996 6999999753          234667888999999999999999999999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      ||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+||+||++++|++ |..||
T Consensus       144 dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~  222 (288)
T cd05061         144 DLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY  222 (288)
T ss_pred             CCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999875433221   112234667999998854 457899999999999999998 78899


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+....+....+... +.+                            ......++.+++++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~-~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  273 (288)
T cd05061         223 QGLSNEQVLKFVMDG-GYL----------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN  273 (288)
T ss_pred             CCCCHHHHHHHHHcC-CCC----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            776655433332210 000                            001134678999999999999999999999987


Q ss_pred             ------CCCCCCC
Q 023764          226 ------HPYLGSL  232 (277)
Q Consensus       226 ------hp~f~~~  232 (277)
                            ||||..+
T Consensus       274 ~l~~~~~~~~~~~  286 (288)
T cd05061         274 LLKDDLHPSFPEV  286 (288)
T ss_pred             HHHhhcCCCCCCC
Confidence                  8988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.1e-36  Score=255.05  Aligned_cols=223  Identities=34%  Similarity=0.619  Sum_probs=178.8

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |.++|+..|...     +|+|||+|-+.-+|.+++++.+   .|....++.++.|++.||..|-.+||+|.||||.|||+
T Consensus       495 Hclrl~r~F~hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  495 HCLRLFRHFKHK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV  569 (752)
T ss_pred             HHHHHHHHhhhc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe
Confidence            456777778777     9999999999999999998764   58889999999999999999999999999999999999


Q ss_pred             ecC-CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ++. ..+||||||.|...++.. .+.+..+.+|.|||++++. .|....|+||+||.+||+.||+..|+|.++.+.+...
T Consensus       570 NE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             ccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            876 457999999998877664 3566778899999999865 4899999999999999999999999999999999999


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCC-------cccC-------------Cccccc------CC----CCChhHHHHHH
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLP-------RYQR-------------QSFTEK------FP----NVHPSAIDLVE  207 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-------------~~~~~~------~~----~~~~~~~~li~  207 (277)
                      ++..|..+..++..-......|...+.       ....             ..+...      +|    ..-..+++||.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence            999999888766432111111111111       0000             011000      11    12246899999


Q ss_pred             HhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          208 KMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       208 ~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +||..||.+|.|+.++|.||||+.
T Consensus       728 kml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHhccChhhcCCHHHHhcCCcccC
Confidence            999999999999999999999974

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-34  Score=240.25  Aligned_cols=206  Identities=25%  Similarity=0.388  Sum_probs=160.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++.+.+.+++..+..++.|++.|+.|||+ .|++|+||+|+||++
T Consensus        63 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~  137 (284)
T cd06620          63 PYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV  137 (284)
T ss_pred             CCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence            7999999999887     89999999997 5899999888889999999999999999999997 699999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH----H
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ----L  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~  154 (277)
                      +.++.++|+|||++....... .....++..|+|||.+... .++.++|+||+||+++++++|..||........    .
T Consensus       138 ~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~  215 (284)
T cd06620         138 NSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP  215 (284)
T ss_pred             CCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh
Confidence            999999999999886543221 2345688899999988544 578999999999999999999999976543211    0


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+.+.               .......    ....+.  ....+..+.+|+.+||+.||.+|||++++++|+||.....
T Consensus       216 ~~~~~~---------------~~~~~~~----~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         216 MGILDL---------------LQQIVQE----PPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             hHHHHH---------------HHHHhhc----cCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            000000               0000000    000000  0125678999999999999999999999999999976443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.6e-34  Score=236.48  Aligned_cols=191  Identities=19%  Similarity=0.335  Sum_probs=153.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili  133 (256)
T cd05113          59 EKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV  133 (256)
T ss_pred             CCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE
Confidence            7999999999876     77899999996 6899998764 468999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCccc--ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||.+..........  ...++..|+|||.+... .++.++|||||||++++|++ |..||..........
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~  212 (256)
T cd05113         134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE  212 (256)
T ss_pred             cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence            999999999999987554332111  12345679999998543 48899999999999999998 999997666544433


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+......                             ......+..+++++.+||+.||.+|||+.+++.+
T Consensus       213 ~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         213 KVSQGLRL-----------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            33221100                             0011346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.6e-34  Score=240.81  Aligned_cols=190  Identities=24%  Similarity=0.395  Sum_probs=153.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +..++||||++ ++|.+++..++                .+++..+..++.|++.|++|||+
T Consensus        67 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  141 (291)
T cd05094          67 EHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS  141 (291)
T ss_pred             CCcceEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            7999999999876     78999999996 69999997542                37899999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.. ..++.++||||+||++++|++
T Consensus       142 ~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t  220 (291)
T cd05094         142 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFT  220 (291)
T ss_pred             CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999987554322   1223445778999998854 457889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||...+.......+..  +                           .........+..+.+++.+||+.||++|||
T Consensus       221 ~g~~p~~~~~~~~~~~~~~~--~---------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  271 (291)
T cd05094         221 YGKQPWFQLSNTEVIECITQ--G---------------------------RVLERPRVCPKEVYDIMLGCWQREPQQRLN  271 (291)
T ss_pred             CCCCCCCCCCHHHHHHHHhC--C---------------------------CCCCCCccCCHHHHHHHHHHcccChhhCcC
Confidence             9999977665443332211  0                           000111235678999999999999999999


Q ss_pred             HHHHhc
Q 023764          220 VEDALA  225 (277)
Q Consensus       220 ~~ell~  225 (277)
                      ++++++
T Consensus       272 ~~~v~~  277 (291)
T cd05094         272 IKEIYK  277 (291)
T ss_pred             HHHHHH
Confidence            999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.6e-34  Score=236.49  Aligned_cols=194  Identities=29%  Similarity=0.513  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      ||++++++.+...     +..++|+|+++ ++|.+.+...    ..++...+..++.|++.|+.+||++|++|+||+|+|
T Consensus        59 ~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n  133 (258)
T cd08215          59 PNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN  133 (258)
T ss_pred             CChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence            7899999999887     89999999997 5999998763    679999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      |+++.++.++|+|||.+....... ......+++.|+|||.+... .++.++|+||+|+++++|++|..||...+.....
T Consensus       134 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~  212 (258)
T cd08215         134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA  212 (258)
T ss_pred             eEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence            999999999999999987655442 33345678899999987544 4789999999999999999999999776644433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..+....                             ........+..+.+++++||..+|++|||+.++++||||
T Consensus       213 ~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         213 LKILKGQ-----------------------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            3322110                             001112467789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=253.15  Aligned_cols=199  Identities=23%  Similarity=0.453  Sum_probs=160.4

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      =||+||-.|.++     +++|+||||+. |++-.++.+-+.|.|+.++.++..+.+|+++.|+.|+|||||||+||||+.
T Consensus       690 WVVrLyySFQDk-----dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr  764 (1034)
T KOG0608|consen  690 WVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR  764 (1034)
T ss_pred             ceEEEEEEeccC-----CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc
Confidence            489999999999     99999999996 699999888899999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeec-----------cCC--------------------------------CcccccccccccCChhhhh
Q 023764           81 NCDLKICDFGLARVT-----------SET--------------------------------DFMTEYVVTRWYRAPELLL  117 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~-----------~~~--------------------------------~~~~~~~~~~~~~aPE~~~  117 (277)
                      +|.+||.|||+|...           ++.                                ......+||+.|+|||++.
T Consensus       765 dGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~  844 (1034)
T KOG0608|consen  765 DGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA  844 (1034)
T ss_pred             CCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc
Confidence            999999999998421           000                                0012346899999999997


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCC
Q 023764          118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  197 (277)
Q Consensus       118 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (277)
                      +.+ ++..+|.||.|||+|+|+.|.+||.+....+...+++.                +..+..          -....+
T Consensus       845 r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n----------------w~~~l~----------~~~~~~  897 (1034)
T KOG0608|consen  845 RTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN----------------WRNFLH----------IPYQGN  897 (1034)
T ss_pred             ccC-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee----------------hhhccc----------cccccc
Confidence            655 89999999999999999999999976654433222211                111000          001136


Q ss_pred             CChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCC
Q 023764          198 VHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLH  233 (277)
Q Consensus       198 ~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~~  233 (277)
                      +|+++.++|.++.+ ++++|+.   ++++..||||+.+.
T Consensus       898 ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  898 LSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             cCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            89999999998765 8889986   77899999999863

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.9e-34  Score=239.42  Aligned_cols=190  Identities=24%  Similarity=0.394  Sum_probs=153.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--------------ALSEEHCQYFLYQILRGLKYIHSAN   65 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--------------~l~~~~~~~i~~qll~al~~LH~~~   65 (277)
                      |||+++++++...     +..|+||||+. ++|.+++...+              .+++..+..++.|++.|+.+||++|
T Consensus        68 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~  142 (280)
T cd05049          68 ENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH  142 (280)
T ss_pred             CCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence            7999999999887     88999999996 69999997542              3788899999999999999999999


Q ss_pred             ceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-C
Q 023764           66 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  141 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g  141 (277)
                      ++||||+|+||+++.++.++|+|||.+.......   ......++..|+|||.+.. ..++.++|||||||++++|++ |
T Consensus       143 i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g  221 (280)
T cd05049         143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYG  221 (280)
T ss_pred             eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcC
Confidence            9999999999999999999999999987543221   1223345678999999854 458999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      ..||.+.+.......+...  .                           ........+..+++++++||+.||++|||+.
T Consensus       222 ~~p~~~~~~~~~~~~~~~~--~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  272 (280)
T cd05049         222 KQPWYGLSNEEVIECITQG--R---------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIK  272 (280)
T ss_pred             CCCCCCCCHHHHHHHHHcC--C---------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            9999776655443333210  0                           0011124678899999999999999999999


Q ss_pred             HHhc
Q 023764          222 DALA  225 (277)
Q Consensus       222 ell~  225 (277)
                      |+++
T Consensus       273 eil~  276 (280)
T cd05049         273 DIHE  276 (280)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.4e-34  Score=236.58  Aligned_cols=189  Identities=22%  Similarity=0.319  Sum_probs=152.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..      +..++||||++ ++|.+++...+.+++..+..++.|++.|+++||++|++||||||.||+++
T Consensus        56 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~  129 (257)
T cd05116          56 PYIVRMIGICEA------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV  129 (257)
T ss_pred             CCcceEEEEEcC------CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc
Confidence            799999998743      56799999997 68999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||++........    .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+.....
T Consensus       130 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  208 (257)
T cd05116         130 TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT  208 (257)
T ss_pred             CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999876543321    112233568999998853 457889999999999999997 99999876655444


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.+.. .+                            ...+..++++.++|.+||+.||++|||++++..
T Consensus       209 ~~i~~~~-~~----------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         209 QMIESGE-RM----------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHCCC-CC----------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            4332110 00                            111246789999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-33  Score=242.81  Aligned_cols=196  Identities=25%  Similarity=0.405  Sum_probs=160.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +..|+||||+.|+|.+.+.. ..++++..+..++.|++.|+.|||++|++|+||+|.||+++
T Consensus        85 ~~iv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~  159 (317)
T cd06635          85 PNSIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT  159 (317)
T ss_pred             CCEEEEEEEEeeC-----CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC
Confidence            7999999999887     88999999999988887754 46789999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++.....   .....++..|+|||.+..  .+.++.++|+||+||++++|++|..||.+.+.......+
T Consensus       160 ~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  236 (317)
T cd06635         160 EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  236 (317)
T ss_pred             CCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            999999999998765433   234467888999998742  344788999999999999999999999766544443333


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ......+                            ......++.+++|+.+||+.+|.+|||+.++++|+|+...
T Consensus       237 ~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         237 AQNESPT----------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HhccCCC----------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            2211100                            0112456789999999999999999999999999999663

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-33  Score=240.98  Aligned_cols=197  Identities=25%  Similarity=0.373  Sum_probs=151.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------------------ALSEEHCQYFLYQILRGLKY   60 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------------------~l~~~~~~~i~~qll~al~~   60 (277)
                      |||+++++++.+.     +..|+||||+. ++|.+++....                   .++...+..++.|++.||.|
T Consensus        79 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  153 (304)
T cd05096          79 PNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY  153 (304)
T ss_pred             CCeeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            7999999999887     78999999996 69999886531                   36778889999999999999


Q ss_pred             HHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHH
Q 023764           61 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  137 (277)
Q Consensus        61 LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~  137 (277)
                      ||++|++||||||+||+++.++.++|+|||++........   .....++..|+|||++.. ..++.++||||+||++++
T Consensus       154 lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         154 LSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             HHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHH
Confidence            9999999999999999999999999999999876543221   122344678999999854 458999999999999999


Q ss_pred             HHc--CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCC
Q 023764          138 LMD--RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  215 (277)
Q Consensus       138 ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  215 (277)
                      |++  +..||.+.+..+....+........                      ........+..+..+.+|+.+||+.||.
T Consensus       233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~  290 (304)
T cd05096         233 ILMLCKEQPYGELTDEQVIENAGEFFRDQG----------------------RQVYLFRPPPCPQGLYELMLQCWSRDCR  290 (304)
T ss_pred             HHHccCCCCCCcCCHHHHHHHHHHHhhhcc----------------------ccccccCCCCCCHHHHHHHHHHccCCch
Confidence            986  5678876655444433322111000                      0000111234677899999999999999


Q ss_pred             CCCCHHHHhc
Q 023764          216 QRITVEDALA  225 (277)
Q Consensus       216 ~R~t~~ell~  225 (277)
                      +|||+.++.+
T Consensus       291 ~RPs~~~i~~  300 (304)
T cd05096         291 ERPSFSDIHA  300 (304)
T ss_pred             hCcCHHHHHH
Confidence            9999999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.8e-34  Score=238.97  Aligned_cols=191  Identities=24%  Similarity=0.400  Sum_probs=151.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------ALSEEHCQYFLYQILRGLKYIHSANVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------~l~~~~~~~i~~qll~al~~LH~~~i~H~   69 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+..          .++...+..++.|++.||.|||+.|++|+
T Consensus        69 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~  143 (277)
T cd05062          69 HHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR  143 (277)
T ss_pred             CCeeeEEEEEcCC-----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            7999999999876     78999999997 69999987532          35677889999999999999999999999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      ||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++++|++ |..||
T Consensus       144 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~  222 (277)
T cd05062         144 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY  222 (277)
T ss_pred             CcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999865433211   112244677999999854 458999999999999999998 78999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.........+.... .+                            ......+..+++++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  273 (277)
T cd05062         223 QGMSNEQVLRFVMEGG-LL----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  273 (277)
T ss_pred             CCCCHHHHHHHHHcCC-cC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7766554443322210 00                            011245678999999999999999999999986


Q ss_pred             C
Q 023764          226 H  226 (277)
Q Consensus       226 h  226 (277)
                      +
T Consensus       274 ~  274 (277)
T cd05062         274 S  274 (277)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-34  Score=239.13  Aligned_cols=190  Identities=26%  Similarity=0.342  Sum_probs=149.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +..|+||||+. ++|.+++.+++                .+++..+..++.|++.|++|||+
T Consensus        56 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~  130 (270)
T cd05047          56 PNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  130 (270)
T ss_pred             CCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     77999999996 69999987543                47889999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CC
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  142 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  142 (277)
                      +|++|+||||+||+++.++.++++|||++..............+..|+|||.+.. ..++.++|+|||||++++|++ |.
T Consensus       131 ~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~  209 (270)
T cd05047         131 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGG  209 (270)
T ss_pred             CCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999999753222111112233556999998854 458899999999999999996 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||.+.+.......+....                          .   .......+.++.+++.+|+..||.+|||+.+
T Consensus       210 ~pf~~~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (270)
T cd05047         210 TPYCGMTCAELYEKLPQGY--------------------------R---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  260 (270)
T ss_pred             CCccccCHHHHHHHHhCCC--------------------------C---CCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence            9997665443333221100                          0   0011235678999999999999999999999


Q ss_pred             Hhc
Q 023764          223 ALA  225 (277)
Q Consensus       223 ll~  225 (277)
                      ++.
T Consensus       261 il~  263 (270)
T cd05047         261 ILV  263 (270)
T ss_pred             HHH
Confidence            875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3e-34  Score=244.73  Aligned_cols=191  Identities=26%  Similarity=0.337  Sum_probs=150.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+.+                .+++..+..++.|++.|++|||+
T Consensus        68 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  142 (303)
T cd05088          68 PNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  142 (303)
T ss_pred             CCcceEEEEECCC-----CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence            7999999999887     78999999996 69999987542                47889999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CC
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  142 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  142 (277)
                      +|++||||||+||+++.++.++|+|||++..............+..|+|||.+.. ..++.++||||+||++++|++ |.
T Consensus       143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~  221 (303)
T cd05088         143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGG  221 (303)
T ss_pred             CCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCC
Confidence            9999999999999999999999999999864322111112233567999998854 457899999999999999997 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||.+.+..+....+...  .                        ..   ......++++.+|+.+||+.||++|||+++
T Consensus       222 ~p~~~~~~~~~~~~~~~~--~------------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  272 (303)
T cd05088         222 TPYCGMTCAELYEKLPQG--Y------------------------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQ  272 (303)
T ss_pred             CCcccCChHHHHHHHhcC--C------------------------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            999766544332221100  0                        00   001135678999999999999999999999


Q ss_pred             HhcC
Q 023764          223 ALAH  226 (277)
Q Consensus       223 ll~h  226 (277)
                      ++.+
T Consensus       273 il~~  276 (303)
T cd05088         273 ILVS  276 (303)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=234.62  Aligned_cols=194  Identities=28%  Similarity=0.511  Sum_probs=160.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+|||+++ ++|.+++...+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~  133 (254)
T cd06627          59 PNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT  133 (254)
T ss_pred             CCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC
Confidence            7899999999876     88999999997 49999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc-ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||.+........ .....++..|+|||.+... ..+.++|+||+|+++++|++|..||.+...........
T Consensus       134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~  212 (254)
T cd06627         134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV  212 (254)
T ss_pred             CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            999999999999876654322 2344678889999988544 47899999999999999999999997655332222211


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .   .                          ......+.++..+++++.+||..+|++|||+.+++.||||
T Consensus       213 ~---~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         213 Q---D--------------------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             c---c--------------------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            0   0                          0011123567889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.2e-34  Score=242.72  Aligned_cols=203  Identities=23%  Similarity=0.474  Sum_probs=163.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+|+||++ ++|.+++.+ ..+++..+..++.|++.|+.+||++|++|+|++|+||+++
T Consensus        76 p~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~  149 (293)
T cd06647          76 PNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  149 (293)
T ss_pred             CCeeehhheeeeC-----CcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence            7999999999887     88999999996 599999876 4588999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++....... ......+++.|++||.+.. ..++.++|+||+||+++++++|..||...+.......+.
T Consensus       150 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~  228 (293)
T cd06647         150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  228 (293)
T ss_pred             CCCCEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh
Confidence            99999999999876543322 2233467888999998855 457899999999999999999999997665433221111


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      . .+.+.                         + .....++..++++|++||..+|.+||++++++.|+||+..+..+.
T Consensus       229 ~-~~~~~-------------------------~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~  280 (293)
T cd06647         229 T-NGTPE-------------------------L-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS  280 (293)
T ss_pred             c-CCCCC-------------------------C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence            0 00000                         0 011235678999999999999999999999999999998776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7e-34  Score=249.30  Aligned_cols=192  Identities=26%  Similarity=0.377  Sum_probs=150.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---------------------------------------
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------------------------------------   40 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---------------------------------------   40 (277)
                      |||+++++++.+.     +..|+||||++ |+|.+++....                                       
T Consensus        99 pnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (375)
T cd05104          99 INIVNLLGACTVG-----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKP  173 (375)
T ss_pred             cceeeeeeeeccC-----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCC
Confidence            8999999999887     88999999996 69998886421                                       


Q ss_pred             ------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCe
Q 023764           41 ------------------------------------ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL   84 (277)
Q Consensus        41 ------------------------------------~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~   84 (277)
                                                          .+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~  253 (375)
T cd05104         174 GVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT  253 (375)
T ss_pred             CcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcE
Confidence                                                46788899999999999999999999999999999999999999


Q ss_pred             EEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHH
Q 023764           85 KICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIEL  160 (277)
Q Consensus        85 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  160 (277)
                      +|+|||++........   .....++..|+|||.+.+ ..++.++||||+||++++|++ |..||.+.............
T Consensus       254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~  332 (375)
T cd05104         254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE  332 (375)
T ss_pred             EEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh
Confidence            9999999876543321   112234567999999854 458999999999999999997 89999765433322221110


Q ss_pred             hCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...                         .   ......+.++++|+.+||+.||++|||+.++++.
T Consensus       333 ~~~-------------------------~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         333 GYR-------------------------M---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             Ccc-------------------------C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            000                         0   0012346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.8e-34  Score=238.72  Aligned_cols=191  Identities=23%  Similarity=0.396  Sum_probs=151.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------ALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++.+.     +..|+||||+. ++|.+++...+       .+++..+..++.|++.|++|||++|++|+||+
T Consensus        69 ~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk  143 (277)
T cd05036          69 QNIVRLIGVSFER-----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIA  143 (277)
T ss_pred             CCEeeEEEEEccC-----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence            7999999998877     77899999995 69999987653       48999999999999999999999999999999


Q ss_pred             CCcEEEecCC---CeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           73 PSNLLLNANC---DLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        73 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      |+||+++.++   .++|+|||++........   ......+..|+|||.+.+. .++.++|||||||++++|++ |..||
T Consensus       144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf  222 (277)
T cd05036         144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPY  222 (277)
T ss_pred             hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCC
Confidence            9999998765   589999999876532211   1122334679999998654 48999999999999999996 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+.......+... ..+                            ...+..+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~-~~~----------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~  273 (277)
T cd05036         223 PGRTNQEVMEFVTGG-GRL----------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE  273 (277)
T ss_pred             CCCCHHHHHHHHHcC-CcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            877655443322210 000                            011346788999999999999999999999987


Q ss_pred             C
Q 023764          226 H  226 (277)
Q Consensus       226 h  226 (277)
                      |
T Consensus       274 ~  274 (277)
T cd05036         274 R  274 (277)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.4e-34  Score=235.82  Aligned_cols=194  Identities=29%  Similarity=0.504  Sum_probs=157.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++.+...     +..|+|+||+. ++|.+++....  .+++..+..++.|++.|+.|||+.|++|+|++|.||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil  133 (257)
T cd08225          59 PNIVTFFASFQEN-----GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF  133 (257)
T ss_pred             CChhhhhheeccC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence            7899999998877     89999999996 59999887643  4799999999999999999999999999999999999


Q ss_pred             EecCCC-eEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           78 LNANCD-LKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        78 ~~~~~~-~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      ++.++. ++++|||.+....... ......+++.|+|||.+... .++.++|+||+||++++|++|..||...+......
T Consensus       134 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  212 (257)
T cd08225         134 LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL  212 (257)
T ss_pred             EcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            988865 6999999887654332 22234578889999988544 47899999999999999999999997665443322


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+...                             ......+..+.+++++|++||..+|++|||+.++++||||
T Consensus       213 ~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         213 KICQG-----------------------------YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhcc-----------------------------cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            21110                             0111224567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-33  Score=233.15  Aligned_cols=195  Identities=29%  Similarity=0.525  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++.+..+     +..|+++||++ ++|.+++... +.+++..+..++.|++.|+.+||++|++|+||+|.||++
T Consensus        57 ~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i  131 (253)
T cd05122          57 PNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL  131 (253)
T ss_pred             CCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE
Confidence            7899999999887     88999999998 6999998876 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||.+.............++..|+|||.+... ..+.++|+||+|+++++|++|..||...+.........
T Consensus       132 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  210 (253)
T cd05122         132 TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA  210 (253)
T ss_pred             ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence            99999999999998766554323455678899999998544 47889999999999999999999997664333222211


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      . ...+.                         . ..-..++..+.++|.+||+.||++|||+.+++.|||
T Consensus       211 ~-~~~~~-------------------------~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         211 T-NGPPG-------------------------L-RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             h-cCCCC-------------------------c-CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            1 00000                         0 000123678999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=241.33  Aligned_cols=196  Identities=23%  Similarity=0.447  Sum_probs=173.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.++.|+.+|+.-     +.+|+||||+. |+|--.++.-+++.+..+..++..|+.||-+||++||++||+|.+||+++
T Consensus       410 pFL~qlHScFQTm-----DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd  484 (683)
T KOG0696|consen  410 PFLVQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD  484 (683)
T ss_pred             chHHHHHHHhhhh-----hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec
Confidence            5678899999887     99999999995 69988888889999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeec-cCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||.|||+++.. -......+.+|||.|+|||++. ..+|+.++|.||+||++|||+.|.+||.|.+..+..+.|+
T Consensus       485 ~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~  563 (683)
T KOG0696|consen  485 SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM  563 (683)
T ss_pred             cCCceEeeecccccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            9999999999999743 2334566789999999999885 5679999999999999999999999999999999888887


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      +..-.-+                              ..+|.++.++++..|.+.|.+|..     -.++-.||||+.+
T Consensus       564 ehnvsyP------------------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  564 EHNVSYP------------------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             HccCcCc------------------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence            6432211                              157889999999999999999986     3689999999876

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-33  Score=234.38  Aligned_cols=193  Identities=27%  Similarity=0.456  Sum_probs=159.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+    ...+++..+..++.|++.||.+||+.|++|+||+|.|
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n  133 (256)
T cd08530          59 PNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN  133 (256)
T ss_pred             CCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence            7999999999887     89999999996 589998866    3568999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      |+++.++.++|+|||++...... ......++..|++||.+.+ ..++.++|+||+|+++++|++|+.||...+......
T Consensus       134 i~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~  211 (256)
T cd08530         134 ILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY  211 (256)
T ss_pred             EEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999998765544 2334567889999999854 457889999999999999999999997766443322


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+...                             ......+..+.++++++.+||..+|.+|||+.++++||++
T Consensus       212 ~~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         212 KVQRG-----------------------------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHhcC-----------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            22110                             0111112467789999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-34  Score=236.73  Aligned_cols=187  Identities=18%  Similarity=0.269  Sum_probs=147.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..+     ...++||||++ ++|..++.. ...+++..+..++.|++.|++|||+.|++||||||.||++
T Consensus        64 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill  138 (262)
T cd05077          64 KHIVLLYGVCVRD-----VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILL  138 (262)
T ss_pred             CCEeeEEEEEecC-----CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEE
Confidence            8999999999876     77899999997 578777765 3568999999999999999999999999999999999999


Q ss_pred             ecCCC-------eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCh
Q 023764           79 NANCD-------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDH  150 (277)
Q Consensus        79 ~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~  150 (277)
                      +.++.       ++++|||.+......   ....++..|+|||.+.....++.++||||+||++|+|+ +|..||.+...
T Consensus       139 ~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (262)
T cd05077         139 AREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL  215 (262)
T ss_pred             ecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence            87664       899999987654322   23456788999998865566899999999999999997 68888865433


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+... ...   .                   .        .......+.++.+||.+||+.||.+||++.+++++
T Consensus       216 ~~~~~-~~~---~-------------------~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         216 AEKER-FYE---G-------------------Q--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             hHHHH-HHh---c-------------------C--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            22111 000   0                   0        00011235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.7e-34  Score=239.77  Aligned_cols=198  Identities=30%  Similarity=0.565  Sum_probs=162.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+|+||++ ++|.+++.... .++...+..++.|++.||.+||+.|++|+|++|+||++
T Consensus        75 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i  149 (286)
T cd06614          75 PNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL  149 (286)
T ss_pred             CCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence            7999999999887     88999999998 69999998876 89999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||.+....... ......++..|++||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+
T Consensus       150 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~  228 (286)
T cd06614         150 SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI  228 (286)
T ss_pred             cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999876443321 2233456788999998854 45789999999999999999999999766554433322


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ... +.+.                         . ...+.++..+++||.+||+.+|.+|||+.+++.|+||..
T Consensus       229 ~~~-~~~~-------------------------~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         229 TTK-GIPP-------------------------L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             Hhc-CCCC-------------------------C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            211 0000                         0 011236778999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.2e-34  Score=236.23  Aligned_cols=191  Identities=28%  Similarity=0.486  Sum_probs=156.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.++     +++|+||||++ ++|.+++...  ..+++..+..++.|++.|+.+||++|++|+||+|.||+
T Consensus        58 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nil  132 (255)
T cd08219          58 PNIVAFKESFEAD-----GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF  132 (255)
T ss_pred             CCcceEEEEEEEC-----CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence            7999999999887     89999999996 6899888643  45899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++++|||.+....... ......+++.|+|||++.+ ..++.++|+||+|+++++|++|..||.+.+.......
T Consensus       133 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~  211 (255)
T cd08219         133 LTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK  211 (255)
T ss_pred             ECCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence            9999999999999987654332 2234567888999999854 4588999999999999999999999987654443333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +...  .                           .......++..+++||++||+.||++|||+.++++-
T Consensus       212 ~~~~--~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         212 VCQG--S---------------------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhcC--C---------------------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            2210  0                           001112467789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-33  Score=235.71  Aligned_cols=190  Identities=24%  Similarity=0.405  Sum_probs=152.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil  136 (263)
T cd05052          62 PNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  136 (263)
T ss_pred             CChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence            7999999999877     88999999996 6999998754  35889999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+.........  .....+..|+|||.+.. ..++.++|||||||++++|++ |..||.+.+..+..
T Consensus       137 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~  215 (263)
T cd05052         137 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  215 (263)
T ss_pred             EcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999998765433211  11223567999998854 457899999999999999998 99999876554433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             ....+..+.++.+++.+||+.||++|||+.++++
T Consensus       216 ~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         216 ELLEKGYR-----------------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHCCCC-----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            33211000                             0111356789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-33  Score=238.77  Aligned_cols=208  Identities=26%  Similarity=0.441  Sum_probs=155.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+..   .+.+|+||||++ ++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|.|
T Consensus        59 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~n  135 (287)
T cd06621          59 PYIVKYYGAFLDES---SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN  135 (287)
T ss_pred             CCeeeeeeEEEccC---CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence            79999999986542   267999999997 588887643    3568999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--HHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH--VHQ  153 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~  153 (277)
                      |+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.....  ...
T Consensus       136 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  213 (287)
T cd06621         136 ILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP  213 (287)
T ss_pred             EEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh
Confidence            999999999999999986544322 123456788999998854 4588999999999999999999999975522  000


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .. .........                 .+.....  ...-...++.+++||.+||+.||.+|||+.|++.||||....
T Consensus       214 ~~-~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         214 IE-LLSYIVNMP-----------------NPELKDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             HH-HHHHHhcCC-----------------chhhccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            00 011000000                 0000000  000012456899999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-33  Score=234.33  Aligned_cols=190  Identities=20%  Similarity=0.355  Sum_probs=153.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ |+|.+++... +.+++..+..++.|++.||+|||++|++|+||+|+||++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i  133 (256)
T cd05114          59 PKLVQLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV  133 (256)
T ss_pred             CCceeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE
Confidence            7999999999887     88999999996 6999998753 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||.+.........  ....++..|+|||.+.. ..++.++|+||+||++++|++ |+.||.+.+..+...
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~  212 (256)
T cd05114         134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE  212 (256)
T ss_pred             cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999988754332211  12234567999999854 458899999999999999999 899998776655544


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+......                          .   .....+..+.+++.+|+..||++|||++++++
T Consensus       213 ~i~~~~~~--------------------------~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         213 MISRGFRL--------------------------Y---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHCCCCC--------------------------C---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            44321100                          0   00124668999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-33  Score=235.66  Aligned_cols=187  Identities=15%  Similarity=0.236  Sum_probs=147.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     ++.++||||++ |+|.+++..++ .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        59 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili  133 (258)
T cd05078          59 KHLVLNYGVCVCG-----DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLL  133 (258)
T ss_pred             CChhheeeEEEeC-----CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            7999999999886     78899999997 58999997654 58999999999999999999999999999999999999


Q ss_pred             ecCCC--------eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCC
Q 023764           79 NANCD--------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRD  149 (277)
Q Consensus        79 ~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~  149 (277)
                      +.++.        ++++|||.+......   ....++..|+|||++.+...++.++||||+||++|+|++|. +||...+
T Consensus       134 ~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~  210 (258)
T cd05078         134 IREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD  210 (258)
T ss_pred             ecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence            87765        689999987654322   23457788999999866555789999999999999999984 6665443


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..........                       ..        ...+..+.++.+|+.+||+.||++|||++++++.
T Consensus       211 ~~~~~~~~~~-----------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         211 SQKKLQFYED-----------------------RH--------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHc-----------------------cc--------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            3222111100                       00        0111345679999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=256.57  Aligned_cols=197  Identities=25%  Similarity=0.405  Sum_probs=166.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||+|.+.++|.-.     ...+||||||=|+-.|++.- .+++.+.++..|+.+.+.||+|||+++.||||||.-|||++
T Consensus        86 PntieYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs  160 (948)
T KOG0577|consen   86 PNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS  160 (948)
T ss_pred             CCcccccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec
Confidence            8999999999887     78899999998877777653 36799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      ..|.+||+|||.+....   +.++++|||+|||||++..  .+.|+-++||||||++..++...++|+.+.+...-+-.|
T Consensus       161 e~g~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI  237 (948)
T KOG0577|consen  161 EPGLVKLADFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  237 (948)
T ss_pred             CCCeeeeccccchhhcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence            99999999999987654   3578899999999999853  456899999999999999999999998777655544444


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...- +|                    ..       ..+..|..++.|+..||++=|..|||.+++|.|+|+..-+
T Consensus       238 AQNe-sP--------------------tL-------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  238 AQNE-SP--------------------TL-------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HhcC-CC--------------------CC-------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            3211 11                    11       1235677899999999999999999999999999998743

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-33  Score=234.02  Aligned_cols=190  Identities=22%  Similarity=0.363  Sum_probs=149.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|.||++
T Consensus        53 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~  127 (252)
T cd05084          53 PNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV  127 (252)
T ss_pred             CCcceEEEEEcCC-----CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE
Confidence            7999999999887     88999999996 5999998764 468999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||.+.........   .....+..|+|||.+.. ..++.++|+||+||++++|++ |..||.........
T Consensus       128 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~  206 (252)
T cd05084         128 TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR  206 (252)
T ss_pred             cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH
Confidence            99999999999998754322111   11122346999998854 448899999999999999997 88888655443322


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+....                          ..   ......+..+.+|+.+||+.||++|||+.++++
T Consensus       207 ~~~~~~~--------------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         207 EAIEQGV--------------------------RL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHcCC--------------------------CC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2211100                          00   011245778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.7e-34  Score=240.52  Aligned_cols=191  Identities=27%  Similarity=0.462  Sum_probs=153.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----------------NQALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----------------~~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +.+|+||||+. ++|.+++..                .+.+++..+..++.|++.||.|||+
T Consensus        76 ~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  150 (293)
T cd05053          76 KNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS  150 (293)
T ss_pred             CCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     78999999996 699999864                2458899999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||+||++|++++
T Consensus       151 ~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~  229 (293)
T cd05053         151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFT  229 (293)
T ss_pred             CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhc
Confidence            9999999999999999999999999999876543221   112234567999998754 457899999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+....+....+.....                             .......+.++.+|+.+||..||++|||
T Consensus       230 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps  280 (293)
T cd05053         230 LGGSPYPGIPVEELFKLLKEGYR-----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPT  280 (293)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcC
Confidence             9999987665544333221100                             0111245678999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +.+++++
T Consensus       281 ~~eil~~  287 (293)
T cd05053         281 FKQLVED  287 (293)
T ss_pred             HHHHHHH
Confidence            9999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-33  Score=236.95  Aligned_cols=196  Identities=26%  Similarity=0.420  Sum_probs=160.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.. ..++...+..++.|++.|+.+||+.|++|+||+|.||+++
T Consensus        62 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~  135 (277)
T cd06641          62 PYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS  135 (277)
T ss_pred             CCEeEEEEEEEeC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC
Confidence            7999999999887     88999999997 588888865 5689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++++|||++....... ......++..|+|||.+.. ...+.++|+||+||++++|++|..||...........+.
T Consensus       136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  214 (277)
T cd06641         136 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP  214 (277)
T ss_pred             CCCCEEEeecccceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence            99999999999987554322 1223457888999998854 457889999999999999999999997654433222211


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      . ..                            .......++.++.+++.+||+.+|.+||++.++++||||...
T Consensus       215 ~-~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         215 K-NN----------------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             c-CC----------------------------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            1 00                            001112467889999999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=255.30  Aligned_cols=199  Identities=27%  Similarity=0.451  Sum_probs=162.5

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l--~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||++++.+...     +++-|.||-++ |+|.++++. .+++  ++..+..+.+||++||.|||++.|+|||||.+|++
T Consensus       633 NIVrYLGs~sen-----Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVL  707 (1226)
T KOG4279|consen  633 NIVRYLGSVSEN-----GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVL  707 (1226)
T ss_pred             hHHHHhhccCCC-----CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEE
Confidence            899999998776     78899999986 699999985 4788  88899999999999999999999999999999999


Q ss_pred             Eec-CCCeEEeeccceeeccC-CCcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           78 LNA-NCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~-~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++. .|.+||+|||-++.... .....++.||.-|||||++..+ ..|+.++|||||||.+.||.||++||.....++  
T Consensus       708 vNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--  785 (1226)
T KOG4279|consen  708 VNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--  785 (1226)
T ss_pred             EeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--
Confidence            965 68899999999876543 4455678899999999998654 358999999999999999999999996443322  


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                                 ..+            .++..+..++  .....+|.+++.||.+|+..||.+||+|.++|.+||++.-
T Consensus       786 -----------AAM------------FkVGmyKvHP--~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  786 -----------AAM------------FKVGMYKVHP--PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             -----------Hhh------------hhhcceecCC--CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                       211            1122221111  1112467789999999999999999999999999999865

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-33  Score=233.57  Aligned_cols=191  Identities=19%  Similarity=0.295  Sum_probs=153.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|.+++..+ ..+++..+..++.|++.|++|||+.|++||||+|+||++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i  133 (256)
T cd05059          59 PNLVQLYGVCTKQ-----RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV  133 (256)
T ss_pred             CCEEEEEEEEcCC-----CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE
Confidence            7999999999876     78999999996 5899998764 468999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||.++........  ....++..|+|||.+.+ ..++.++|+||+||+++++++ |..||.+.+..+...
T Consensus       134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  212 (256)
T cd05059         134 GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE  212 (256)
T ss_pred             CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Confidence            99999999999998765432211  11123457999998864 458899999999999999998 899997766554433


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+......                             ...+..+..+.+++.+||..+|++|||+.++++.
T Consensus       213 ~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         213 SVSAGYRL-----------------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            32211000                             0112467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.7e-33  Score=231.57  Aligned_cols=198  Identities=27%  Similarity=0.462  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+.+..   .+.+|+|+|+++ ++|.+++.+...+++..+..++.|++.|+.|||+.|++|+|++|+||+++
T Consensus        59 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~  135 (260)
T cd06606          59 PNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD  135 (260)
T ss_pred             CCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence            79999999987652   267899999995 69999998877899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||.+........   .....++..|+|||.+... ..+.++|+||+|+++++|++|..||........  .
T Consensus       136 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~  212 (260)
T cd06606         136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--A  212 (260)
T ss_pred             CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H
Confidence            999999999999887665542   3455678889999988544 478999999999999999999999976652111  1


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      +.....                         ...........+..+++|+.+||+.||++|||+.+++.||||
T Consensus       213 ~~~~~~-------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         213 LYKIGS-------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHhccc-------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            111000                         000111122457889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-33  Score=236.44  Aligned_cols=190  Identities=23%  Similarity=0.393  Sum_probs=152.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------------ALSEEHCQYFLYQILRGLKYIHSA   64 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---------------~l~~~~~~~i~~qll~al~~LH~~   64 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...+               .+++..+..++.|++.|++|||++
T Consensus        67 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~  141 (280)
T cd05092          67 QHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL  141 (280)
T ss_pred             CCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC
Confidence            7999999999886     78999999996 69999987642               478899999999999999999999


Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  140 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  140 (277)
                      |++|+||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|||||||++++|++ 
T Consensus       142 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~  220 (280)
T cd05092         142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTY  220 (280)
T ss_pred             CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999999875433211   122234677999998854 448899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 023764          141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  220 (277)
Q Consensus       141 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  220 (277)
                      |.+||...........+.....                             .......++.+.+|+.+||+.||.+|||+
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~  271 (280)
T cd05092         221 GKQPWYQLSNTEAIECITQGRE-----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVI  271 (280)
T ss_pred             CCCCCccCCHHHHHHHHHcCcc-----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            9999976655443333221000                             01112467889999999999999999999


Q ss_pred             HHHhc
Q 023764          221 EDALA  225 (277)
Q Consensus       221 ~ell~  225 (277)
                      +++++
T Consensus       272 ~~l~~  276 (280)
T cd05092         272 KDIHS  276 (280)
T ss_pred             HHHHH
Confidence            99874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=233.72  Aligned_cols=190  Identities=25%  Similarity=0.370  Sum_probs=153.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC-cccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+||||+ +++|.+++....  .++...+..++.|++.|+.+||+.|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil  135 (261)
T cd05068          61 PKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL  135 (261)
T ss_pred             CCccceeEEEecC-----CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEE
Confidence            7999999998876     8899999999 579999997654  6899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCccc--ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||++..........  ....+..|+|||.... ..++.++|+||+||++++|++ |+.||.+.......
T Consensus       136 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  214 (261)
T cd05068         136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL  214 (261)
T ss_pred             EcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999998765332111  1122357999998754 457899999999999999998 99999876655444


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                             ...+..+..+.+++.+||+.||.+||++.++++
T Consensus       215 ~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         215 QQVDQGYRM-----------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            333211100                             011245778999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.5e-33  Score=236.55  Aligned_cols=191  Identities=18%  Similarity=0.341  Sum_probs=153.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +..++++||+. ++|.+++...                ..++...+..++.|++.||.|||+
T Consensus        68 ~~iv~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~  142 (283)
T cd05091          68 PNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS  142 (283)
T ss_pred             CCcCeEEEEEcCC-----CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     78999999997 5899888532                347888899999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||.||+++.++.++|+|||+++.......   .....+++.|+|||.+... .++.++||||+||++++|++
T Consensus       143 ~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~  221 (283)
T cd05091         143 HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFS  221 (283)
T ss_pred             cCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHc
Confidence            9999999999999999999999999999875433221   1233456789999998644 48899999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+....+....+......                             ......+..+.+|+.+||+.||.+|||
T Consensus       222 ~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~  272 (283)
T cd05091         222 YGLQPYCGYSNQDVIEMIRNRQVL-----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPR  272 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence             88898776655444433321100                             111256778999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      ++++++.
T Consensus       273 ~~~i~~~  279 (283)
T cd05091         273 FKDIHSR  279 (283)
T ss_pred             HHHHHHH
Confidence            9999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-33  Score=232.51  Aligned_cols=189  Identities=18%  Similarity=0.265  Sum_probs=151.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..      +..++||||+. ++|.+++.+.+.+++..+..++.|++.|+++||..|++|+||+|+||+++
T Consensus        56 ~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~  129 (257)
T cd05060          56 PCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV  129 (257)
T ss_pred             CCeeeEEEEEcC------CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc
Confidence            799999998753      56899999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCccc----ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||.+..........    ...++..|+|||.+.. ..++.++|||||||++++|++ |.+||...+..+..
T Consensus       130 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~  208 (257)
T cd05060         130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI  208 (257)
T ss_pred             CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            99999999999987654332111    1122356999998854 458999999999999999997 99999766554433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.... .                            ....+..+..++++|.+||..||++|||+.++++
T Consensus       209 ~~~~~~~-~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         209 AMLESGE-R----------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHcCC-c----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3322110 0                            0112346778999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-33  Score=237.86  Aligned_cols=202  Identities=20%  Similarity=0.367  Sum_probs=158.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     +..|+||||++ ++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|.||+++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~  139 (288)
T cd05583          65 PFLVTLHYAFQTD-----TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD  139 (288)
T ss_pred             cchhhhheeeecC-----CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence            7899999998876     78999999997 59999998777899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++.......  ......++..|++||.+.+.. ..+.++|+||+|+++++|++|..||...........
T Consensus       140 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  219 (288)
T cd05583         140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE  219 (288)
T ss_pred             CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH
Confidence            99999999999986543321  122345788999999875432 267899999999999999999999964332111111


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~~  233 (277)
                      +.+..                  ...        .....+..+..++++|.+||+.||++|||   +.++|+||||+.+.
T Consensus       220 ~~~~~------------------~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         220 ISRRI------------------LKS--------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHH------------------Hcc--------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            11100                  000        00111246778999999999999999998   57889999998864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-33  Score=234.80  Aligned_cols=187  Identities=19%  Similarity=0.275  Sum_probs=147.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|..++.+ .+.+++..+..++.|++.||+|||+.|++||||||.||++
T Consensus        76 ~niv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill  150 (274)
T cd05076          76 IHLAFVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL  150 (274)
T ss_pred             CCeeeEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEE
Confidence            7999999999877     78899999997 588888865 4678999999999999999999999999999999999999


Q ss_pred             ecCC-------CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHH-HcCCCCCCCCCh
Q 023764           79 NANC-------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MDRKPLFPGRDH  150 (277)
Q Consensus        79 ~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~l-l~g~~pf~~~~~  150 (277)
                      +..+       .++++|||.+......   ....++..|+|||.+.+...++.++|+||+||+++++ ++|..||.+...
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            7643       3799999987543222   2235677899999886555689999999999999998 479999976544


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...........                       .        .....++.+.++|.+||+.+|++|||+.+++++
T Consensus       228 ~~~~~~~~~~~-----------------------~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         228 SEKERFYEKKH-----------------------R--------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHHHhcc-----------------------C--------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            33211111000                       0        001235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.2e-33  Score=233.10  Aligned_cols=190  Identities=25%  Similarity=0.393  Sum_probs=153.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+||||+. ++|.+++...  ..++...+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil  135 (261)
T cd05072          61 DKLVRLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL  135 (261)
T ss_pred             CCeeeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence            7999999999876     78999999996 6999998653  56888999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++||||+||++|+|++ |..||.+.......
T Consensus       136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~  214 (261)
T cd05072         136 VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM  214 (261)
T ss_pred             ecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence            99999999999999976543321  122234567999998854 457889999999999999998 99999876654443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             .......+.++.+++.+||..||++|||++++.+
T Consensus       215 ~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         215 SALQRGYR-----------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            33221100                             0112346778999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.6e-33  Score=239.23  Aligned_cols=190  Identities=27%  Similarity=0.432  Sum_probs=152.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+++...                ..++...+..++.|++.||.|||+
T Consensus        78 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~  152 (314)
T cd05099          78 KNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES  152 (314)
T ss_pred             CCeeeEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999876     78999999996 6999999753                247888999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++||||+||++++|++
T Consensus       153 ~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~  231 (314)
T cd05099         153 RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFT  231 (314)
T ss_pred             CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHh
Confidence            9999999999999999999999999999875543211   112233457999998854 458899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+....+....+....                             .....+..+.++++++.+||..||++|||
T Consensus       232 ~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps  282 (314)
T cd05099         232 LGGSPYPGIPVEELFKLLREGH-----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPT  282 (314)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence             899997766544433322100                             00111345678999999999999999999


Q ss_pred             HHHHhc
Q 023764          220 VEDALA  225 (277)
Q Consensus       220 ~~ell~  225 (277)
                      +.++++
T Consensus       283 ~~~ll~  288 (314)
T cd05099         283 FKQLVE  288 (314)
T ss_pred             HHHHHH
Confidence            999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=239.01  Aligned_cols=229  Identities=29%  Similarity=0.502  Sum_probs=169.5

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      +||+|+|.|..+++.+ .|+|+|+|+++.+|..+|...  +.++...++.|++|++.||.|||+ .||||.||||+|||+
T Consensus       143 ~VV~LlD~FkhsGpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeeeccceecCCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            5899999999988877 899999999999999999865  579999999999999999999996 499999999999998


Q ss_pred             ecC-----------------------------------------------------------------------------
Q 023764           79 NAN-----------------------------------------------------------------------------   81 (277)
Q Consensus        79 ~~~-----------------------------------------------------------------------------   81 (277)
                      ..+                                                                             
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            400                                                                             


Q ss_pred             --------------------------------------------------------------------------------
Q 023764           82 --------------------------------------------------------------------------------   81 (277)
Q Consensus        82 --------------------------------------------------------------------------------   81 (277)
                                                                                                      
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                                                                                            


Q ss_pred             ---------CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC----
Q 023764           82 ---------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR----  148 (277)
Q Consensus        82 ---------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----  148 (277)
                               .++||+|||-+......  ++.-..|.-|+|||++.+.+ |+..+||||++|+++||+||..+|...    
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~  458 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGEN  458 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence                     01233333333222211  22334577899999998776 999999999999999999999999533    


Q ss_pred             --ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCC------cc----cccCC---CCChhHHHHHHHhcCCC
Q 023764          149 --DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ------SF----TEKFP---NVHPSAIDLVEKMLTFD  213 (277)
Q Consensus       149 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----~~~~~---~~~~~~~~li~~~L~~d  213 (277)
                        .+.+.++.|++++|..+...... -...+.|..........      ++    .+.+.   ....++.+||.-||+.+
T Consensus       459 Y~rDEDHiA~i~ELLG~iPr~ia~~-Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~  537 (590)
T KOG1290|consen  459 YSRDEDHIALIMELLGKIPRKIALG-GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD  537 (590)
T ss_pred             CCccHHHHHHHHHHHhhccHHHHhc-CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence              36789999999999877653311 01112222211111100      01    11110   12356899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCC
Q 023764          214 PRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       214 P~~R~t~~ell~hp~f~~~~~~  235 (277)
                      |.||+||.++|+|||+..+-.+
T Consensus       538 PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  538 PEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             ccccccHHHHhcCccccCCCCC
Confidence            9999999999999999987654

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-33  Score=242.58  Aligned_cols=193  Identities=24%  Similarity=0.406  Sum_probs=150.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------------------------------
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------------------------------   39 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------------------------   39 (277)
                      |||+++++++...+    ..+|++|||+. ++|.+++...                                        
T Consensus        71 ~niv~~~~~~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (337)
T cd05054          71 LNVVNLLGACTKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSG  146 (337)
T ss_pred             cchhheeeeEecCC----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccc
Confidence            79999999886542    67999999997 5899888542                                        


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCC
Q 023764           40 ---------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET   98 (277)
Q Consensus        40 ---------------------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~   98 (277)
                                           ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~  226 (337)
T cd05054         147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD  226 (337)
T ss_pred             cccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence                                 25788999999999999999999999999999999999999999999999998764322


Q ss_pred             C---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhh
Q 023764           99 D---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE  174 (277)
Q Consensus        99 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  174 (277)
                      .   ......++..|+|||++.+ ..++.++||||+||++++|++ |..||.+....+...........           
T Consensus       227 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  294 (337)
T cd05054         227 PDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-----------  294 (337)
T ss_pred             cchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-----------
Confidence            1   1122345667999998865 458999999999999999997 99999765433222221110000           


Q ss_pred             hHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                                    .   ......++++.+++.+||+.+|++|||+.++++|
T Consensus       295 --------------~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 --------------M---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --------------C---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          0   0012456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-33  Score=233.43  Aligned_cols=193  Identities=28%  Similarity=0.507  Sum_probs=155.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+.     +..|+||||+. ++|.+.+..    ...+++..++.++.|++.|+.+||+.|++|+|++|+|
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n  136 (260)
T cd08222          62 PAIVKFHASFLER-----DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN  136 (260)
T ss_pred             CcHHHHHHHHhcC-----CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence            7999999999876     78999999997 588887753    3568999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           76 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      |+++. +.++|+|||.+...... .......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||.+.......
T Consensus       137 ili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~  214 (260)
T cd08222         137 IFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV  214 (260)
T ss_pred             eEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            99975 57999999998765432 22334457888999998854 44788999999999999999999999766544433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..+..  +..                           .......+.++.++|.+||..||++||++.++++||||
T Consensus       215 ~~~~~--~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         215 LRIVE--GPT---------------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHc--CCC---------------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            32221  000                           01112467789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-33  Score=235.66  Aligned_cols=191  Identities=19%  Similarity=0.380  Sum_probs=152.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------------QALSEEHCQYFLYQILRGLKYIH   62 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------------~~l~~~~~~~i~~qll~al~~LH   62 (277)
                      |||+++++++...     +..|+||||++ ++|.+++...                 ..+++..+..++.|++.||.|||
T Consensus        67 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  141 (283)
T cd05090          67 PNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS  141 (283)
T ss_pred             CCeeeEEEEEecC-----CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     78999999997 6999988532                 23788889999999999999999


Q ss_pred             hCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHH
Q 023764           63 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  139 (277)
Q Consensus        63 ~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll  139 (277)
                      ++|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+||+||++++|+
T Consensus       142 ~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~  220 (283)
T cd05090         142 SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIF  220 (283)
T ss_pred             hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHH
Confidence            9999999999999999999999999999987643321   1223344667999998854 44899999999999999999


Q ss_pred             c-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC
Q 023764          140 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  218 (277)
Q Consensus       140 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  218 (277)
                      + |..||.+.........+.... .                            .......++.+++++.+||+.||.+||
T Consensus       221 ~~g~~p~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp  271 (283)
T cd05090         221 SFGLQPYYGFSNQEVIEMVRKRQ-L----------------------------LPCSEDCPPRMYSLMTECWQEGPSRRP  271 (283)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCC-c----------------------------CCCCCCCCHHHHHHHHHHcccCcccCc
Confidence            8 999997765443333322100 0                            011124677899999999999999999


Q ss_pred             CHHHHhcC
Q 023764          219 TVEDALAH  226 (277)
Q Consensus       219 t~~ell~h  226 (277)
                      ++.+++++
T Consensus       272 ~~~~i~~~  279 (283)
T cd05090         272 RFKDIHTR  279 (283)
T ss_pred             CHHHHHHH
Confidence            99998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=231.82  Aligned_cols=196  Identities=24%  Similarity=0.457  Sum_probs=157.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+..   .+.+++|+||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        64 ~~i~~~~~~~~~~~---~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~  140 (264)
T cd06653          64 DRIVQYYGCLRDPE---EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD  140 (264)
T ss_pred             CCcceEEEEEEcCC---CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence            79999999986642   157899999996 59999998877899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||++......    .......++..|+|||.+.+ ...+.++|+||+||+++++++|+.||.+........
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  219 (264)
T cd06653         141 SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF  219 (264)
T ss_pred             CCCCEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH
Confidence            9999999999998754321    11223457888999998865 347899999999999999999999997654433222


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .+   ...+..                         ....+.+++.+.+++.+||+ +|.+|||+.+++.|||.
T Consensus       220 ~~---~~~~~~-------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         220 KI---ATQPTK-------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HH---HcCCCC-------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            21   111110                         11123577889999999999 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-33  Score=234.50  Aligned_cols=190  Identities=24%  Similarity=0.422  Sum_probs=152.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~~i~H~   69 (277)
                      |||+++++++...     +..|+||||++ ++|.+++...          ..+++..+..++.|++.||.|||++|++|+
T Consensus        69 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  143 (277)
T cd05032          69 HHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR  143 (277)
T ss_pred             CceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            7999999999887     88999999996 6999998643          236778899999999999999999999999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      ||+|+||+++.++.++|+|||+++.......   .....++..|+|||.+.. ..++.++|||||||+++++++ |..||
T Consensus       144 di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~  222 (277)
T cd05032         144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY  222 (277)
T ss_pred             ccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC
Confidence            9999999999999999999999875443321   123345678999998854 448899999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+.......+.. ...+                            ......+.++.+++.+||+.+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         223 QGLSNEEVLKFVID-GGHL----------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ccCCHHHHHHHHhc-CCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            77665444333221 0000                            011234778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-33  Score=231.02  Aligned_cols=189  Identities=22%  Similarity=0.353  Sum_probs=150.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++....    +..|+||||++ ++|.+++.+.+  .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        59 ~~i~~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil  134 (256)
T cd05082          59 SNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL  134 (256)
T ss_pred             CCeeeEEEEEEcCC----CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEE
Confidence            68999998765431    67899999997 59999987653  4889999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||++.......  ....++..|+|||.+.. ..++.++||||+||++|+|++ |+.||...........
T Consensus       135 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05082         135 VSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  211 (256)
T ss_pred             EcCCCcEEecCCccceeccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999987554332  22344567999998854 457899999999999999997 9999976554433322


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +....                             .....+..++.+.+++.+||+.||++|||+.++++
T Consensus       212 ~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         212 VEKGY-----------------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HhcCC-----------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            21100                             00112356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.4e-33  Score=238.65  Aligned_cols=191  Identities=27%  Similarity=0.418  Sum_probs=151.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +..|+||||++ ++|.+++...+                .++...+..++.|++.||+|||+
T Consensus        84 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~  158 (307)
T cd05098          84 KNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS  158 (307)
T ss_pred             CCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     78999999997 69999997642                47888999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||.+.........   ....++..|+|||.+.+ ..++.++|+||+||++|+|++
T Consensus       159 ~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~  237 (307)
T cd05098         159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT  237 (307)
T ss_pred             CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHc
Confidence            99999999999999999999999999998755432111   11223467999998854 457899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+....+....+....                             ........+.++.+|+.+||..+|++|||
T Consensus       238 ~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps  288 (307)
T cd05098         238 LGGSPYPGVPVEELFKLLKEGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPT  288 (307)
T ss_pred             CCCCCCCcCCHHHHHHHHHcCC-----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcC
Confidence             889987655433332221100                             00111246789999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +.+++++
T Consensus       289 ~~evl~~  295 (307)
T cd05098         289 FKQLVED  295 (307)
T ss_pred             HHHHHHH
Confidence            9999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.3e-33  Score=236.94  Aligned_cols=191  Identities=26%  Similarity=0.380  Sum_probs=151.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+||||+. ++|.+++....  .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        99 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil  173 (302)
T cd05055          99 ENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL  173 (302)
T ss_pred             CCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEE
Confidence            7999999999876     78999999996 69999987543  3899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      ++.++.++++|||++........   .....++..|+|||.+... .++.++||||+||++++|++ |..||.+......
T Consensus       174 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~  252 (302)
T cd05055         174 LTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK  252 (302)
T ss_pred             EcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH
Confidence            99999999999999875443221   1123456789999988544 47899999999999999998 9999976654332


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..........                            ....+..++.+.+|+.+||..+|++|||+.++++
T Consensus       253 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         253 FYKLIKEGYR----------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2222110000                            0011245778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.5e-33  Score=235.02  Aligned_cols=197  Identities=23%  Similarity=0.357  Sum_probs=155.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------ALSEEHCQYFLYQILRGLKYIHSANVLH   68 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qll~al~~LH~~~i~H   68 (277)
                      |||+++++++..+     +..++|||++. ++|.+++....           .+++..+..++.|++.||+|||++|++|
T Consensus        79 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H  153 (296)
T cd05051          79 PNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH  153 (296)
T ss_pred             CCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence            7999999999887     88999999996 69999997755           6899999999999999999999999999


Q ss_pred             cCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc--CCC
Q 023764           69 RDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKP  143 (277)
Q Consensus        69 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~  143 (277)
                      +||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.. ..++.++||||+||++|+|++  |..
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~  232 (296)
T cd05051         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQ  232 (296)
T ss_pred             cccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCC
Confidence            9999999999999999999999987644332   1223345678999998864 348999999999999999987  778


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ||...+....+..+........                      ........+..+.++.+++.+||+.||.+|||+.++
T Consensus       233 p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         233 PYEHLTDQQVIENAGHFFRDDG----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             CCCCcChHHHHHHHHhcccccc----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence            8876665554444332211100                      000001123456789999999999999999999999


Q ss_pred             hc
Q 023764          224 LA  225 (277)
Q Consensus       224 l~  225 (277)
                      ++
T Consensus       291 ~~  292 (296)
T cd05051         291 HL  292 (296)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-33  Score=235.15  Aligned_cols=190  Identities=27%  Similarity=0.426  Sum_probs=150.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..++||||+. |+|.+++...  ..++...+..++.|++.||.|||+++++|++|++.||+
T Consensus        61 ~ni~~~~g~~~~~-----~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nil  135 (259)
T PF07714_consen   61 PNIVKLYGFCIEN-----EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNIL  135 (259)
T ss_dssp             TTBE-EEEEEESS-----SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred             ccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            8999999999965     77999999997 7999999986  67999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      ++.++.+||+|||++.......   ..........|+|||.+.... ++.++||||||++++|+++ |..||.+.+..+.
T Consensus       136 l~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~  214 (259)
T PF07714_consen  136 LDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI  214 (259)
T ss_dssp             EETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc
Confidence            9999999999999998763221   123345667899999986544 7999999999999999999 7899987766665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+.+...                             ....+..+..+.++|..||..||.+|||+.++++
T Consensus       215 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  215 IEKLKQGQR-----------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHTTEE-----------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccccccccc-----------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            554422110                             0111246788999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.8e-33  Score=232.85  Aligned_cols=196  Identities=23%  Similarity=0.370  Sum_probs=151.8

Q ss_pred             CceeeeeccccCC-CCCCCCcEEEEeecCc-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPP-QRESFNDVYIAYELMD-TDLHQIIRS------NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~-~~~~~~~~~lv~e~~~-~~L~~~l~~------~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++... ...+....++||||+. |+|.+++..      ...+++..+..++.|++.||+|||++||+|||||
T Consensus        60 ~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  139 (272)
T cd05075          60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA  139 (272)
T ss_pred             CCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            7999999976542 2233457899999997 699888742      2348899999999999999999999999999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  148 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  148 (277)
                      |+||+++.++.++|+|||++........   .....+++.|++||...+ ..++.++||||+||++++|++ |..||.+.
T Consensus       140 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         140 ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             hhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999876543321   122235667999998854 458999999999999999998 89999776


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ........+.... .                            ....+..+..++++|.+||+.||.+|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         219 ENSEIYDYLRQGN-R----------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CHHHHHHHHHcCC-C----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5544333222100 0                            01123567789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.4e-33  Score=231.67  Aligned_cols=190  Identities=22%  Similarity=0.378  Sum_probs=154.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+.  ..++...+..++.|++.|+.|||++|++|+||+|+||+
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nil  136 (261)
T cd05148          62 KHLISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL  136 (261)
T ss_pred             cchhheeeeEecC-----CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEE
Confidence            7999999999877     78999999997 5999999753  46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc-ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      ++.++.++|+|||.+........ .....++..|++||.+.. ..++.++||||+||++++|++ |..||.+.+..+...
T Consensus       137 v~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~  215 (261)
T cd05148         137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD  215 (261)
T ss_pred             EcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            99999999999999875543321 122334567999998854 457899999999999999998 899998776554444


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+......                             ...+..+..+.+++.+||+.||.+|||+.++++
T Consensus       216 ~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         216 QITAGYRM-----------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHhCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            33321100                             011356778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=249.12  Aligned_cols=197  Identities=32%  Similarity=0.601  Sum_probs=168.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |.||.|--.|..+     +.+++|||-+.|++.++|..  .+++++...+.++.||+.||+|||-+||+|+|+||+|||+
T Consensus       623 PGiV~le~M~ET~-----ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLL  697 (888)
T KOG4236|consen  623 PGIVNLECMFETP-----ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLL  697 (888)
T ss_pred             CCeeEEEEeecCC-----ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheee
Confidence            6788888888887     99999999999999998864  4789999999999999999999999999999999999999


Q ss_pred             ecC---CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHH
Q 023764           79 NAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQL  154 (277)
Q Consensus        79 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~  154 (277)
                      ...   ..+||||||+++.+++.....+.+|||.|+|||++.+. .|..+-|+||.|||+|.-+.|..||.... ..+++
T Consensus       698 as~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI  776 (888)
T KOG4236|consen  698 ASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI  776 (888)
T ss_pred             ccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHh
Confidence            654   46899999999999999888999999999999999665 49999999999999999999999996432 22332


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +-. .+                        .++..+    +..+++++.|||.++|+..=++|.|++..|.|||++..
T Consensus       777 QNA-aF------------------------MyPp~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  777 QNA-AF------------------------MYPPNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             hcc-cc------------------------ccCCCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            211 11                        111222    23578899999999999999999999999999999875

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-33  Score=232.31  Aligned_cols=191  Identities=23%  Similarity=0.367  Sum_probs=153.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++.+...     +..|+||||+. ++|.+++... +.++...+..++.|++.|+.|||++|++|+||+|+||++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili  139 (266)
T cd05033          65 PNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV  139 (266)
T ss_pred             CCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence            7999999999876     78999999996 5999998764 478999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-Ccc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++...... ...  ....++..|+|||.+.. ..++.++||||+||++++|++ |..||.........
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~  218 (266)
T cd05033         140 NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI  218 (266)
T ss_pred             cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence            99999999999998766421 111  12234567999998854 458899999999999999997 99999766555444


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+.+....+                             .....+..+.+++.+||+.||++|||+++++++
T Consensus       219 ~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         219 KAVEDGYRLP-----------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3332211100                             012457789999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=222.64  Aligned_cols=200  Identities=26%  Similarity=0.373  Sum_probs=152.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~   73 (277)
                      |||++++++...+...+....||+++|.. |+|.+.++.    +..+++.++..|+.++++||++||+..  ++||||||
T Consensus        78 ~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP  157 (302)
T KOG2345|consen   78 PNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKP  157 (302)
T ss_pred             cchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCc
Confidence            79999999987765555578999999986 889998864    346999999999999999999999999  99999999


Q ss_pred             CcEEEecCCCeEEeeccceeeccCCC----------cccccccccccCChhhhhCCC--CCCcchhHHHHHHHHHHHHcC
Q 023764           74 SNLLLNANCDLKICDFGLARVTSETD----------FMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        74 ~nil~~~~~~~~l~dfg~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g  141 (277)
                      .||+++..+.++++|||.+....-..          .-....+|..|+|||.+....  ..+.++|||||||++|+|+.|
T Consensus       158 ~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~  237 (302)
T KOG2345|consen  158 ANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFG  237 (302)
T ss_pred             ceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHc
Confidence            99999999999999999886432110          112235788899999984322  357899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      ..||.-         +.+..++..-.                -.....+++.. +.+|..+.+||+.||+.||.+||++.
T Consensus       238 ~sPfe~---------~~~~GgSlaLA----------------v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~  291 (302)
T KOG2345|consen  238 ESPFER---------IYQQGGSLALA----------------VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIP  291 (302)
T ss_pred             CCcchH---------HhhcCCeEEEe----------------eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHH
Confidence            999931         12211110000                00001111221 23788999999999999999999999


Q ss_pred             HHhcC
Q 023764          222 DALAH  226 (277)
Q Consensus       222 ell~h  226 (277)
                      +++.+
T Consensus       292 ~ll~~  296 (302)
T KOG2345|consen  292 ELLSK  296 (302)
T ss_pred             HHHHH
Confidence            99864

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-33  Score=229.81  Aligned_cols=188  Identities=23%  Similarity=0.379  Sum_probs=152.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus        60 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nil  134 (256)
T cd05039          60 PNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL  134 (256)
T ss_pred             cceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEE
Confidence            7999999999876     88999999997 69999998765  6999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||.+........  ....+..|+|||.+.. ..++.++|+||+||+++++++ |..||...........
T Consensus       135 i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         135 VSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             EeCCCCEEEcccccccccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999876643321  2334567999998854 457889999999999999997 9999976654433222


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +....                          .   .......++.+.++|++||..+|++|||+++++.
T Consensus       212 ~~~~~--------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         212 VEKGY--------------------------R---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HhcCC--------------------------C---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            21100                          0   0111245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.8e-33  Score=236.04  Aligned_cols=191  Identities=26%  Similarity=0.421  Sum_probs=152.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +..|+||||+. ++|.+++...                ..++...+..++.|++.||.|||+
T Consensus        81 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  155 (304)
T cd05101          81 KNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS  155 (304)
T ss_pred             CCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     88999999996 6999998753                246778889999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.++|||||||++++|++
T Consensus       156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~  234 (304)
T cd05101         156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT  234 (304)
T ss_pred             CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHc
Confidence            9999999999999999999999999999876543221   122334567999998854 458899999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+.+..+....+.....                             .......+..+++|+.+||..+|.+|||
T Consensus       235 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps  285 (304)
T cd05101         235 LGGSPYPGIPVEELFKLLKEGHR-----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPT  285 (304)
T ss_pred             CCCCCcccCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCC
Confidence             8888877655444333221000                             0011246778999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +.++++.
T Consensus       286 ~~e~l~~  292 (304)
T cd05101         286 FKQLVED  292 (304)
T ss_pred             HHHHHHH
Confidence            9999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=257.60  Aligned_cols=194  Identities=25%  Similarity=0.417  Sum_probs=150.7

Q ss_pred             Cceeeeecc-ccCCC-CCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCC
Q 023764            1 MQVVAIRDI-IPPPQ-RESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~-~~~~~-~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~   73 (277)
                      ||||.++|. ..... ..+--.++|.||||. |.|.+++.++  .+|++.++.+|++|+++|+.+||...  |||||||-
T Consensus        95 ~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKi  174 (738)
T KOG1989|consen   95 KNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKI  174 (738)
T ss_pred             CceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhh
Confidence            799999993 33221 211246899999998 6999999854  56999999999999999999999998  99999999


Q ss_pred             CcEEEecCCCeEEeeccceeeccCCCcc----------cccccccccCChhhhh--CCCCCCcchhHHHHHHHHHHHHcC
Q 023764           74 SNLLLNANCDLKICDFGLARVTSETDFM----------TEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        74 ~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g  141 (277)
                      +|||++.+|..||||||.+.-.......          -...-|+.|+|||++.  .+...++|+|||+|||++|-|...
T Consensus       175 ENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~  254 (738)
T KOG1989|consen  175 ENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYF  254 (738)
T ss_pred             hheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHh
Confidence            9999999999999999988532221100          0123588999999963  345689999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      ..||.+.....++.-                            .+.-    ..+|.++..+.+||+.||+.||.+||++-
T Consensus       255 t~PFe~sg~laIlng----------------------------~Y~~----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~  302 (738)
T KOG1989|consen  255 TTPFEESGKLAILNG----------------------------NYSF----PPFPNYSDRLKDLIRTMLQPNPDERPNIY  302 (738)
T ss_pred             CCCcCcCcceeEEec----------------------------cccC----CCCccHHHHHHHHHHHHhccCcccCCCHH
Confidence            999976533221110                            0000    11257888999999999999999999998


Q ss_pred             HHhcC
Q 023764          222 DALAH  226 (277)
Q Consensus       222 ell~h  226 (277)
                      +++.+
T Consensus       303 Qv~~~  307 (738)
T KOG1989|consen  303 QVLEE  307 (738)
T ss_pred             HHHHH
Confidence            87764

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-32  Score=230.30  Aligned_cols=190  Identities=23%  Similarity=0.368  Sum_probs=152.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.+. +.+++..+..++.|++.|++|||+.|++|+||||+||++
T Consensus        66 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili  140 (268)
T cd05063          66 HNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV  140 (268)
T ss_pred             CCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE
Confidence            7999999999877     88999999997 5999998754 578999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc----cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++++|||++.........    .....+..|+|||.+.. ..++.++|+||+||++|+|++ |..||...+..+.
T Consensus       141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~  219 (268)
T cd05063         141 NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV  219 (268)
T ss_pred             cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence            99999999999998755432111    11122456999998855 447899999999999999987 9999977665554


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+......|.                             ....+.++.+++.+|+..||++||++.++++
T Consensus       220 ~~~i~~~~~~~~-----------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         220 MKAINDGFRLPA-----------------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHhcCCCCCC-----------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            444332111110                             1145678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-32  Score=232.28  Aligned_cols=189  Identities=24%  Similarity=0.310  Sum_probs=149.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      ...++++||+. |+|.+++..+ +.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        69 ~~i~~~~~~~~~------~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~  142 (279)
T cd05109          69 PYVCRLLGICLT------STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV  142 (279)
T ss_pred             CCCceEEEEEcC------CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            789999998865      44689999996 6999998764 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.........   ....++..|+|||...+ ..++.++|||||||++|+|++ |..||.+.......
T Consensus       143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  221 (279)
T cd05109         143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP  221 (279)
T ss_pred             cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999998765433211   12234567999999854 458899999999999999998 89999765543332


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.. ...+                            ...+..+.++.+++.+||..||++|||+.+++.
T Consensus       222 ~~~~~-~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         222 DLLEK-GERL----------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHC-CCcC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22111 1110                            111346778999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.8e-33  Score=234.13  Aligned_cols=190  Identities=26%  Similarity=0.387  Sum_probs=150.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLYQIL   55 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~qll   55 (277)
                      |||+++++.+...     +..|+|+||+. ++|.+++.+.                        ..+++..+..++.|++
T Consensus        63 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  137 (290)
T cd05045          63 PHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS  137 (290)
T ss_pred             CCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHH
Confidence            7999999999877     77899999997 6999988642                        2478889999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHH
Q 023764           56 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  132 (277)
Q Consensus        56 ~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  132 (277)
                      .||+|||++|++||||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||
T Consensus       138 ~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG  216 (290)
T cd05045         138 RGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFG  216 (290)
T ss_pred             HHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHH
Confidence            999999999999999999999999999999999999875432211   122334567999998754 4588999999999


Q ss_pred             HHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcC
Q 023764          133 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       133 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  211 (277)
                      |++++|++ |..||.+.........+.+...                          .   ......+.++++|+.+||+
T Consensus       217 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~~~~~i~~cl~  267 (290)
T cd05045         217 VLLWEIVTLGGNPYPGIAPERLFNLLKTGYR--------------------------M---ERPENCSEEMYNLMLTCWK  267 (290)
T ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--------------------------C---CCCCCCCHHHHHHHHHHcc
Confidence            99999998 9999977654433322111000                          0   0012467789999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 023764          212 FDPRQRITVEDALA  225 (277)
Q Consensus       212 ~dP~~R~t~~ell~  225 (277)
                      .||++|||+.++++
T Consensus       268 ~~P~~Rp~~~~i~~  281 (290)
T cd05045         268 QEPDKRPTFADISK  281 (290)
T ss_pred             CCcccCCCHHHHHH
Confidence            99999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-32  Score=230.73  Aligned_cols=195  Identities=23%  Similarity=0.296  Sum_probs=149.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||+++++.+...     +.+|+||||++ |+|.+++....     ..++..+..++.|++.||+|||++|++||||||+
T Consensus        55 ~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  129 (269)
T cd05042          55 PNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR  129 (269)
T ss_pred             CCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHh
Confidence            7999999999887     88999999997 69999997643     2467788999999999999999999999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhC------CCCCCcchhHHHHHHHHHHHHc-CCCC
Q 023764           75 NLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMD-RKPL  144 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~p  144 (277)
                      ||+++.++.++|+|||++.......   ......++..|+|||++..      ...++.++||||+||++++|++ |..|
T Consensus       130 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p  209 (269)
T cd05042         130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP  209 (269)
T ss_pred             heEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999986432221   1122344567999998743      2346789999999999999998 7889


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      |......+............                     .   +........+....+++..|+ .||++|||+++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~---------------------~---~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~  264 (269)
T cd05042         210 YPDLSDEQVLKQVVREQDIK---------------------L---PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVH  264 (269)
T ss_pred             CCcCCHHHHHHHHhhccCcc---------------------C---CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHH
Confidence            97766555444333211110                     0   001112346778889999998 5999999999987


Q ss_pred             c
Q 023764          225 A  225 (277)
Q Consensus       225 ~  225 (277)
                      +
T Consensus       265 ~  265 (269)
T cd05042         265 E  265 (269)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-32  Score=229.03  Aligned_cols=189  Identities=18%  Similarity=0.283  Sum_probs=149.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      +..|+||||++ ++|.+++.. ...+++..+..++.|++.|+.|||++|++|+||||.||++
T Consensus        55 ~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~  128 (257)
T cd05115          55 PYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL  128 (257)
T ss_pred             CCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE
Confidence            799999998743      56899999996 699998875 4578999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++........    .....++..|+|||.+.. ..++.++|||||||+++++++ |..||.+......
T Consensus       129 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  207 (257)
T cd05115         129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV  207 (257)
T ss_pred             cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence            9999999999999875433221    111223467999998854 447899999999999999996 9999987665443


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+... ..                            ....+..++++.++|.+||..||++||++.++.+
T Consensus       208 ~~~~~~~-~~----------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         208 MSFIEQG-KR----------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHCC-CC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3322210 00                            0111245788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.6e-32  Score=228.89  Aligned_cols=189  Identities=26%  Similarity=0.400  Sum_probs=150.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..|+||||++ ++|.+++.+.  ..+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nil  134 (260)
T cd05070          61 DKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL  134 (260)
T ss_pred             CceEEEEeEECC------CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence            789999988743      55799999996 5999998753  45899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+.........  ....++..|+|||.... ..++.++|+|||||++++|++ |.+||.+.+..+..
T Consensus       135 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~  213 (260)
T cd05070         135 VGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL  213 (260)
T ss_pred             EeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999999765433211  12234567999998754 457899999999999999998 89999876655444


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                             ......+..+++|+.+||..||++|||++++.+
T Consensus       214 ~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         214 EQVERGYRM-----------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            433211000                             011246778999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-32  Score=228.40  Aligned_cols=190  Identities=29%  Similarity=0.456  Sum_probs=155.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +..|++||++. ++|.+++.....  +++..+..++.|++.|+++||+.|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil  135 (258)
T smart00219       61 PNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL  135 (258)
T ss_pred             CchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEE
Confidence            7999999999887     88999999996 599999976544  999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCccc--ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+..........  ...++..|+|||.+. ...++.++|+||+||++++|++ |.+||.+.+.....
T Consensus       136 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~  214 (258)
T smart00219      136 VGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL  214 (258)
T ss_pred             EccCCeEEEcccCCceecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987665442211  123567899999884 4558999999999999999998 88998776555444


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             .......+.++.+++.+||..||++|||+.++++
T Consensus       215 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      215 EYLKKGYR-----------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHhcCCC-----------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            43322100                             0111236788999999999999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.7e-33  Score=237.38  Aligned_cols=190  Identities=23%  Similarity=0.308  Sum_probs=150.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      +..++|+||+. |+|.+++.+. ..++...+..++.|++.||+|||+.|++||||||+||++
T Consensus        69 ~niv~~~g~~~~------~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill  142 (316)
T cd05108          69 PHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV  142 (316)
T ss_pred             CCCCeEEEEEcC------CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe
Confidence            799999999875      34679999986 7999998874 468899999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.........   .....+..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+....+..
T Consensus       143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~  221 (316)
T cd05108         143 KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  221 (316)
T ss_pred             cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999999865433221   12233567999998854 458999999999999999987 99999776544322


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      . +.+....+                            ...+..+.++.+++.+||..||.+|||+.+++.+
T Consensus       222 ~-~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         222 S-ILEKGERL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             H-HHhCCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2 21111000                            0112456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-32  Score=230.57  Aligned_cols=196  Identities=21%  Similarity=0.306  Sum_probs=153.0

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMD-TDLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++.... ..+....++|+||+. ++|..++...      ..+++..+..++.|++.||+|||+.|++|||||
T Consensus        61 ~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlk  140 (273)
T cd05035          61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLA  140 (273)
T ss_pred             CCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            79999999887643 233356899999997 6998887432      358999999999999999999999999999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  148 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  148 (277)
                      |+||+++.++.++|+|||+++.......   ......+..|+|||.+. ...++.++||||+||++++|++ |..||.+.
T Consensus       141 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         141 ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             hheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876543321   11223456799999874 4458899999999999999998 89999776


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...+....+....                             ........+..+.+++.+||+.||++|||+.+++.+
T Consensus       220 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         220 ENHEIYDYLRHGN-----------------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CHHHHHHHHHcCC-----------------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6544333222100                             001123567789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-32  Score=228.88  Aligned_cols=190  Identities=27%  Similarity=0.417  Sum_probs=153.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.+.  ..++...+..++.|++.|+.|||++|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil  135 (261)
T cd05034          61 DKLVQLYAVCSEE-----EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL  135 (261)
T ss_pred             CCEeeeeeeeecC-----CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE
Confidence            7999999999876     78999999996 5999999765  36899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+........  ......+..|+|||.+.+ ..++.++|+||+||+++++++ |+.||.+.......
T Consensus       136 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  214 (261)
T cd05034         136 VGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL  214 (261)
T ss_pred             EcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999876543211  112233567999998854 457899999999999999998 99999877655554


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......+                             .....+.++.+++.+||..||.+|||++++++
T Consensus       215 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         215 EQVERGYRMP-----------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            4433211110                             11234678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-32  Score=228.93  Aligned_cols=189  Identities=26%  Similarity=0.400  Sum_probs=150.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..|+||||++ ++|.+++.+.  ..++...+..++.|++.||++||+.|++|+||+|.||+
T Consensus        61 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil  134 (262)
T cd05071          61 EKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  134 (262)
T ss_pred             CCcceEEEEECC------CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence            799999988744      55799999997 5999999753  35889999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+.........  ....++..|+|||...+ ..++.++|+||+||++++|++ |..||.+.......
T Consensus       135 l~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~  213 (262)
T cd05071         135 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  213 (262)
T ss_pred             EcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence            999999999999998765443221  12345667999998754 448999999999999999999 88899776654443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                             ...+..+..+.+++.+||+.||++|||+.++++
T Consensus       214 ~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         214 DQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHhcCCCC-----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            332210000                             011246778999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.1e-32  Score=228.23  Aligned_cols=189  Identities=26%  Similarity=0.393  Sum_probs=150.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..|+||||+. ++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|.||+
T Consensus        61 ~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nil  134 (260)
T cd05069          61 DKLVPLYAVVSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANIL  134 (260)
T ss_pred             CCeeeEEEEEcC------CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence            789999988743      55799999997 5999999764  34789999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+........  .....++..|+|||...+ ...+.++|+||+||++|+|++ |..||.+.......
T Consensus       135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  213 (260)
T cd05069         135 VGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL  213 (260)
T ss_pred             EcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999876543321  112335567999998754 457899999999999999998 99999876654443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                             ......+..+++++++||..||++|||++++++
T Consensus       214 ~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         214 EQVERGYRM-----------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHcCCCC-----------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            332211000                             011246778999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=227.32  Aligned_cols=190  Identities=23%  Similarity=0.360  Sum_probs=151.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+. ..++...+..++.|++.||.+||++|++||||+|+||++
T Consensus        52 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili  126 (251)
T cd05041          52 PNIVKLIGVCVQK-----QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV  126 (251)
T ss_pred             CCeEEEEEEEecC-----CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE
Confidence            7999999999887     88999999996 6899998653 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||.+.........   .....+..|+|||.+.+ ..++.++|+||+||++++|++ |..||.+.......
T Consensus       127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~  205 (251)
T cd05041         127 GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR  205 (251)
T ss_pred             cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH
Confidence            99999999999998755422111   11223456999998854 458999999999999999998 88899776544333


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                          .   .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       206 ~~~~~~~~~--------------------------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         206 ERIESGYRM--------------------------P---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHhcCCCC--------------------------C---CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            322110000                          0   01145678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.2e-32  Score=230.57  Aligned_cols=189  Identities=23%  Similarity=0.328  Sum_probs=149.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      ...++++||+. |+|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus        69 ~~iv~~~~~~~~------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili  142 (279)
T cd05111          69 AYIVRLLGICPG------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL  142 (279)
T ss_pred             CCcceEEEEECC------CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE
Confidence            799999998743      45789999986 7999999754 578999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||.++......   ......++..|++||.+.. ..++.++||||+||++|++++ |..||.+.......
T Consensus       143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~  221 (279)
T cd05111         143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP  221 (279)
T ss_pred             cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999997643321   1223345678999998854 458999999999999999998 99999776543322


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      . +.+....++                            .....+.++.+++.+|+..||.+|||+.++++
T Consensus       222 ~-~~~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         222 D-LLEKGERLA----------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             H-HHHCCCcCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2 221111100                            00123567899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-32  Score=237.39  Aligned_cols=191  Identities=26%  Similarity=0.423  Sum_probs=152.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +.+|++|||++ ++|.+++.+..                .++...+..++.|++.||.|||+
T Consensus        78 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  152 (334)
T cd05100          78 KNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS  152 (334)
T ss_pred             CCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999999887     78999999996 69999987532                36778889999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++||||+||++++|++
T Consensus       153 ~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~  231 (334)
T cd05100         153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFT  231 (334)
T ss_pred             CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999876543221   112233467999999854 457899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+.+..+....+.....                             .......+..+.+|+.+||+.+|.+|||
T Consensus       232 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps  282 (334)
T cd05100         232 LGGSPYPGIPVEELFKLLKEGHR-----------------------------MDKPANCTHELYMIMRECWHAVPSQRPT  282 (334)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcC
Confidence             8899977665444333221000                             0111245678999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +.+++.+
T Consensus       283 ~~ell~~  289 (334)
T cd05100         283 FKQLVED  289 (334)
T ss_pred             HHHHHHH
Confidence            9999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-32  Score=229.38  Aligned_cols=192  Identities=26%  Similarity=0.451  Sum_probs=156.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~   74 (277)
                      |||+++++++.++     ++.|+||||++ ++|.+++..    ...+++..++.++.|++.|+.+||+ .|++|+||+|.
T Consensus        69 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~  143 (269)
T cd08528          69 PNIVRYYKTFLEN-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN  143 (269)
T ss_pred             CCeeeEEeeEccC-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence            7999999999887     89999999997 488887642    3568999999999999999999996 78999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           75 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ||+++.++.++|+|||.+.............++..|++||.+.+ ..++.++|+||+|+++++|++|.+||.........
T Consensus       144 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~  222 (269)
T cd08528         144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA  222 (269)
T ss_pred             HEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence            99999999999999999987655444445668889999999865 44799999999999999999999999766554433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+......+.                            .....++.+.+++.+||+.||++|||+.++.++
T Consensus       223 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         223 TKIVEAVYEPL----------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHhhccCCcC----------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            33322111100                            011356789999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.5e-32  Score=226.21  Aligned_cols=190  Identities=23%  Similarity=0.378  Sum_probs=151.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus        52 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili  126 (250)
T cd05085          52 PNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV  126 (250)
T ss_pred             CCcCeEEEEEecC-----CccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE
Confidence            7999999999876     78999999996 6999988753 468999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++.........  ....++..|+|||.+.. ..++.++||||+||+++++++ |..||.+........
T Consensus       127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~  205 (250)
T cd05085         127 GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE  205 (250)
T ss_pred             cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            99999999999998754332211  11233567999998854 457899999999999999998 999997765443332


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+....                          ..   ...+..+.++.+++.+||..+|++|||+.++++
T Consensus       206 ~~~~~~--------------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         206 QVEKGY--------------------------RM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHcCC--------------------------CC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            221100                          00   111246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-32  Score=229.42  Aligned_cols=192  Identities=28%  Similarity=0.430  Sum_probs=151.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+.     +..|+|+||++ ++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus        62 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~n  136 (267)
T cd08228          62 PNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN  136 (267)
T ss_pred             cceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHH
Confidence            7999999999887     88999999997 589888753    3458999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-VHQ  153 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~  153 (277)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||..... ...
T Consensus       137 il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~  215 (267)
T cd08228         137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS  215 (267)
T ss_pred             EEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence            999999999999999987654332 1223467888999998864 4478999999999999999999999865432 111


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ........+.++.                           .....+..+++++.+||..+|++|||++++++
T Consensus       216 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         216 LCQKIEQCDYPPL---------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHhcCCCCCC---------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            1111111111110                           01135678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-32  Score=241.93  Aligned_cols=156  Identities=28%  Similarity=0.393  Sum_probs=119.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhh
Q 023764           41 ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLL  117 (277)
Q Consensus        41 ~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~  117 (277)
                      .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  312 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF  312 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence            37778889999999999999999999999999999999999999999999987643321   112234567899999885


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC
Q 023764          118 NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  196 (277)
Q Consensus       118 ~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (277)
                      + ..++.++||||+||++++|++ |..||.+................                            .....
T Consensus       313 ~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  363 (400)
T cd05105         313 D-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR----------------------------MAKPD  363 (400)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC----------------------------CCCCc
Confidence            4 457999999999999999996 99999765432222111110000                            00112


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          197 NVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       197 ~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.++.+++.+||+.||++|||+.++.+
T Consensus       364 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         364 HATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             cCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            46778999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-32  Score=229.02  Aligned_cols=190  Identities=23%  Similarity=0.342  Sum_probs=152.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..+     +..|+||||++ ++|.+++.+. +.++...+..++.|++.|+.+||+.|++|+||||+||++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili  139 (267)
T cd05066          65 PNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV  139 (267)
T ss_pred             CCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE
Confidence            7999999999876     78999999996 5999998764 468999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||.+........    .....++..|++||.+.. ..++.++|+||+||+++++++ |..||.+....+.
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~  218 (267)
T cd05066         140 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV  218 (267)
T ss_pred             CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence            9999999999999876543211    111223457999999854 448999999999999999886 9999977665443


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+.+....                             ......++.+.+++.+||+.+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         219 IKAIEEGYRL-----------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHhCCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            3333211000                             011245778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.6e-32  Score=226.15  Aligned_cols=190  Identities=21%  Similarity=0.336  Sum_probs=152.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..++||||+. ++|.+.+....  .+++..+..++.|++.||++||++|++|+||+|+||+
T Consensus        56 ~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil  129 (257)
T cd05040          56 ENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL  129 (257)
T ss_pred             CCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence            799999998865      67899999996 69999998764  6899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 023764           78 LNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  152 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  152 (277)
                      ++.++.++|+|||++.......    ......++..|+|||.+.. ..++.++||||+||++++|++ |..||.+.+..+
T Consensus       130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  208 (257)
T cd05040         130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ  208 (257)
T ss_pred             EecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999987654321    1112345678999998754 458899999999999999998 999997766655


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+......                      .      ......+..+.+++.+||+.+|++|||+.++++
T Consensus       209 ~~~~~~~~~~~----------------------~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         209 ILKKIDKEGER----------------------L------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHhcCCc----------------------C------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            44443321000                      0      011235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-32  Score=227.52  Aligned_cols=190  Identities=26%  Similarity=0.416  Sum_probs=150.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++.++     +..|+||||++ ++|.+++...       ..+++..+..++.|++.|++|||+.+++|+||+
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~  133 (269)
T cd05044          59 PNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA  133 (269)
T ss_pred             CCeeeEeeeecCC-----CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            7999999999887     78999999996 6999998642       347889999999999999999999999999999


Q ss_pred             CCcEEEecCC-----CeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCC
Q 023764           73 PSNLLLNANC-----DLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKP  143 (277)
Q Consensus        73 ~~nil~~~~~-----~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~  143 (277)
                      |+||+++.++     .++++|||++........   .....++..|+|||.+.+ ..++.++|||||||++++|++ |..
T Consensus       134 p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~  212 (269)
T cd05044         134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQ  212 (269)
T ss_pred             hheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCC
Confidence            9999999887     899999999865432211   112234677999998854 458999999999999999997 999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ||...+..+....+... ..                            .......+..+.++|.+||..+|.+|||++++
T Consensus       213 p~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  263 (269)
T cd05044         213 PYPALNNQEVLQHVTAG-GR----------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRI  263 (269)
T ss_pred             CCcccCHHHHHHHHhcC-Cc----------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence            99776654433322110 00                            01112467789999999999999999999998


Q ss_pred             hc
Q 023764          224 LA  225 (277)
Q Consensus       224 l~  225 (277)
                      ++
T Consensus       264 ~~  265 (269)
T cd05044         264 QE  265 (269)
T ss_pred             HH
Confidence            65

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-32  Score=226.09  Aligned_cols=191  Identities=23%  Similarity=0.382  Sum_probs=152.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     ...|+||||+. ++|.+++... +.++++.+..++.|++.|+++||++|++|+||+|.||++
T Consensus        59 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i  133 (256)
T cd05112          59 PKLVQLYGVCTER-----SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV  133 (256)
T ss_pred             CCeeeEEEEEccC-----CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE
Confidence            7999999999876     78999999997 5899988754 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||+||++++|++ |..||..........
T Consensus       134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  212 (256)
T cd05112         134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE  212 (256)
T ss_pred             cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999876543321  112234567999998854 458899999999999999998 999997766544433


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+.+....                          .   .....+..+.+|+.+||+.+|++|||+.++++.
T Consensus       213 ~~~~~~~~--------------------------~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         213 TINAGFRL--------------------------Y---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHhCCCCC--------------------------C---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            32210000                          0   001246789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-32  Score=230.54  Aligned_cols=197  Identities=23%  Similarity=0.377  Sum_probs=151.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------ALSEEHCQYFLYQILRGLKYIHSANVL   67 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------~l~~~~~~~i~~qll~al~~LH~~~i~   67 (277)
                      |||+++++++...     +..|+||||+. ++|.+++....            .+++..+..++.|++.||.|||++|++
T Consensus        77 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~  151 (295)
T cd05097          77 PNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV  151 (295)
T ss_pred             CCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            7999999999887     88999999997 59999886431            367888999999999999999999999


Q ss_pred             ecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc--CC
Q 023764           68 HRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RK  142 (277)
Q Consensus        68 H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~  142 (277)
                      |+||||+||+++.++.++|+|||++........   .....++..|+|||.+.. ..++.++|+|||||++++|++  |.
T Consensus       152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999875432211   122234668999998854 448999999999999999987  67


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||...+..+....+.+......                      ........+..++.+++|+++||+.||.+|||+++
T Consensus       231 ~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~  288 (295)
T cd05097         231 QPYSLLSDEQVIENTGEFFRNQG----------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK  288 (295)
T ss_pred             CCCcccChHHHHHHHHHhhhhcc----------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            78877665554443332111000                      00001112345778999999999999999999999


Q ss_pred             Hhc
Q 023764          223 ALA  225 (277)
Q Consensus       223 ll~  225 (277)
                      +++
T Consensus       289 i~~  291 (295)
T cd05097         289 IHH  291 (295)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-32  Score=228.25  Aligned_cols=190  Identities=23%  Similarity=0.358  Sum_probs=150.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|.+++... +.++...+..++.|++.||.|||++|++|+||+|+||++
T Consensus        65 ~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili  139 (269)
T cd05065          65 PNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV  139 (269)
T ss_pred             cCcceEEEEECCC-----CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE
Confidence            7999999999876     78999999997 5899988754 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccc---cccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYV---VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  151 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~---~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  151 (277)
                      +.++.++|+|||++.........   ....   .+..|+|||.+.. ..++.++||||+||+++++++ |..||.+.+..
T Consensus       140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~  218 (269)
T cd05065         140 NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ  218 (269)
T ss_pred             cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence            99999999999988654332111   1111   1346999999854 457899999999999999886 99999776654


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .....+......|                             ..+..+..+.+++.+||..+|.+||++++++.
T Consensus       219 ~~~~~i~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         219 DVINAIEQDYRLP-----------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHcCCcCC-----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            4433332111000                             01245678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-32  Score=228.53  Aligned_cols=192  Identities=27%  Similarity=0.421  Sum_probs=151.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+.     +..|++|||+. ++|.+++..    ...+++..+..++.|++.|+.|||++|++|+||+|+|
T Consensus        62 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~n  136 (267)
T cd08229          62 PNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPAN  136 (267)
T ss_pred             CchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            7999999999887     88999999997 589988763    3568999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-H
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH-Q  153 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~  153 (277)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.. ..++.++|+||+|+++++|++|..||.+..... .
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T cd08229         137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS  215 (267)
T ss_pred             EEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence            999999999999999887554332 2233467889999998854 457889999999999999999999996543211 1


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..........++                           ......+..+++++.+||..||.+|||+.+++.
T Consensus       216 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         216 LCKKIEQCDYPP---------------------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HhhhhhcCCCCC---------------------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            111000000000                           011246778999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.3e-32  Score=230.35  Aligned_cols=190  Identities=22%  Similarity=0.346  Sum_probs=150.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------------ALSEEHCQYFLYQILRG   57 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------------~l~~~~~~~i~~qll~a   57 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++....                      .+++..+..++.|++.|
T Consensus        68 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a  142 (288)
T cd05050          68 PNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAG  142 (288)
T ss_pred             CchheEEEEEcCC-----CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHH
Confidence            7999999999876     78999999997 59999987432                      36788889999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHH
Q 023764           58 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  134 (277)
Q Consensus        58 l~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~i  134 (277)
                      |.+||++|++||||+|.||+++.++.++|+|||++........   ......+..|+|||.+.+ ..++.++|+||+||+
T Consensus       143 L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i  221 (288)
T cd05050         143 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVV  221 (288)
T ss_pred             HHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHH
Confidence            9999999999999999999999999999999999875433221   122234567999998854 458999999999999


Q ss_pred             HHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCC
Q 023764          135 FMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  213 (277)
Q Consensus       135 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  213 (277)
                      +++|++ |..||.+.+..+....+...                             ......+..+.++.+|+.+||+.|
T Consensus       222 l~el~~~~~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~  272 (288)
T cd05050         222 LWEIFSYGMQPYYGMAHEEVIYYVRDG-----------------------------NVLSCPDNCPLELYNLMRLCWSKL  272 (288)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHhcC-----------------------------CCCCCCCCCCHHHHHHHHHHcccC
Confidence            999997 88888766554433322110                             000111245778999999999999


Q ss_pred             CCCCCCHHHHhc
Q 023764          214 PRQRITVEDALA  225 (277)
Q Consensus       214 P~~R~t~~ell~  225 (277)
                      |.+|||+.|+++
T Consensus       273 p~~Rpt~~el~~  284 (288)
T cd05050         273 PSDRPSFASINR  284 (288)
T ss_pred             cccCCCHHHHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.7e-32  Score=227.87  Aligned_cols=189  Identities=25%  Similarity=0.401  Sum_probs=151.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+      +..|+||||+. ++|.+++.+.. .+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus        67 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili  140 (270)
T cd05056          67 PHIVKLIGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV  140 (270)
T ss_pred             CchhceeEEEcC------CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE
Confidence            799999998865      45689999996 69999997643 58999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++.........  ....++..|+|||.+.. ..++.++|||||||+++++++ |..||.+.+......
T Consensus       141 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~  219 (270)
T cd05056         141 SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG  219 (270)
T ss_pred             ecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99999999999998765433211  12233467999998754 457899999999999999885 999998776554433


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.....                             ....+..+..+.+++.+|+..+|.+|||+.+++.
T Consensus       220 ~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         220 RIENGER-----------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3221000                             0112356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.5e-32  Score=227.85  Aligned_cols=192  Identities=21%  Similarity=0.344  Sum_probs=153.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------ALSEEHCQYFLYQILRGLKYIHSANVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---------~l~~~~~~~i~~qll~al~~LH~~~i~H~d   70 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++....         .+++..+..++.|++.||+|||+.|++|+|
T Consensus        68 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d  142 (275)
T cd05046          68 KNVVRLLGLCREA-----EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRD  142 (275)
T ss_pred             cceeeeEEEECCC-----CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCc
Confidence            7999999999886     78899999997 69999998665         689999999999999999999999999999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPG  147 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  147 (277)
                      |||+||+++.++.++++|||++.......  ......++..|+|||.+.+. ..+.++||||+||+++++++ |..||.+
T Consensus       143 lkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         143 LAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             CccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999876432221  12233556779999987543 47889999999999999998 8889976


Q ss_pred             CChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .........+...  ..                         .+ ......+..+.+++.+||+.||.+|||+.++++.
T Consensus       222 ~~~~~~~~~~~~~--~~-------------------------~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         222 LSDEEVLNRLQAG--KL-------------------------EL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             cchHHHHHHHHcC--Cc-------------------------CC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            5544433322110  00                         00 0112467789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.3e-32  Score=226.43  Aligned_cols=195  Identities=22%  Similarity=0.271  Sum_probs=147.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||+++++++.+.     ..+|+||||++ |+|.+++...     ...+...+..++.|++.|++|||+.|++|+||||+
T Consensus        55 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~  129 (269)
T cd05087          55 SNLLQCLGQCTEV-----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR  129 (269)
T ss_pred             CCEeeEEEEEcCC-----CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence            7999999999887     77899999997 6999998753     24567788899999999999999999999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCC------CCCcchhHHHHHHHHHHHHc-CCCC
Q 023764           75 NLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSS------DYTAAIDVWSVGCIFMELMD-RKPL  144 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~p  144 (277)
                      ||+++.++.++|+|||.+.......   ......++..|+|||++.+..      .++.++|+||+||++++|++ |..|
T Consensus       130 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p  209 (269)
T cd05087         130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP  209 (269)
T ss_pred             eEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence            9999999999999999986543321   112234677899999885321      25789999999999999996 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      |......+..........                     .....   .......+..+.++++.|+ .+|++|||+++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~---------------------~~~~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~  264 (269)
T cd05087         210 YRHLSDEQVLTYTVREQQ---------------------LKLPK---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVH  264 (269)
T ss_pred             CCCCChHHHHHHHhhccc---------------------CCCCC---CccCCCCChHHHHHHHHHh-cCcccCCCHHHHH
Confidence            976654443222111000                     00000   0111235677899999998 6899999999987


Q ss_pred             c
Q 023764          225 A  225 (277)
Q Consensus       225 ~  225 (277)
                      .
T Consensus       265 ~  265 (269)
T cd05087         265 L  265 (269)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.2e-32  Score=245.97  Aligned_cols=203  Identities=24%  Similarity=0.364  Sum_probs=140.6

Q ss_pred             CCcEEEEeecCc-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764           18 FNDVYIAYELMD-TDLHQIIRSNQA--------------------LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus        18 ~~~~~lv~e~~~-~~L~~~l~~~~~--------------------l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      ...+++|+||++ ++|.+++.....                    .....+..++.|++.||+|||++||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            378999999997 589988865321                    12345678999999999999999999999999999


Q ss_pred             EEec-CCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCC---------------------CCCcchhHHHHH
Q 023764           77 LLNA-NCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSS---------------------DYTAAIDVWSVG  132 (277)
Q Consensus        77 l~~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~DiwslG  132 (277)
                      |++. ++.+||+|||++......  .......+++.|+|||.+....                     .+..++||||+|
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9986 588999999999754322  2234567889999999764321                     134456999999


Q ss_pred             HHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc---cccCCCCChhHHHHHHHh
Q 023764          133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF---TEKFPNVHPSAIDLVEKM  209 (277)
Q Consensus       133 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~  209 (277)
                      |++|+|+++..+  ..+.........+..+..... |...          .........   .+.....+..+.+||.+|
T Consensus       367 viL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        367 LIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVA-WRKL----------VEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             HHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHH-HHHh----------hccccchhhhhhhhhccccchHHHHHHHHH
Confidence            999999986644  333344444444333322111 1000          000000011   111122345677999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          210 LTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       210 L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      |+.||++|||++++|+||||+...
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCCCC
Confidence            999999999999999999998754

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.6e-32  Score=225.33  Aligned_cols=187  Identities=25%  Similarity=0.399  Sum_probs=149.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..|+||||+. ++|.+++....  .+++..+..++.|++.|+.+||++|++||||+|+||+
T Consensus        59 ~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil  132 (254)
T cd05083          59 KNLVRLLGVILH------NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL  132 (254)
T ss_pred             CCcCeEEEEEcC------CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence            799999999865      44799999997 69999997643  4789999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||++......  ......+..|+|||.+.+ ..++.++|+||+||++++|++ |++||.+.+.......
T Consensus       133 i~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  209 (254)
T cd05083         133 VSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC  209 (254)
T ss_pred             EcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            999999999999998764432  122334567999998854 458899999999999999997 9999977654433222


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +.+..                          ..   ...+..+..+++++++||..+|.+|||+++++.
T Consensus       210 ~~~~~--------------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         210 VEKGY--------------------------RM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HhCCC--------------------------CC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            21100                          00   011346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.5e-32  Score=225.63  Aligned_cols=189  Identities=24%  Similarity=0.386  Sum_probs=151.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..|+||||+. ++|.+++...  ..++...+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~  134 (260)
T cd05067          61 PRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL  134 (260)
T ss_pred             cCeeeEEEEEcc------CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence            799999998743      56899999996 6999988653  46899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++||||+||+++++++ |++||.+.+.....
T Consensus       135 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  213 (260)
T cd05067         135 VSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI  213 (260)
T ss_pred             EcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            99999999999999876542221  112334567999998854 457899999999999999998 99999877655544


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                             ......+.++.+++.+||..||++|||++++++
T Consensus       214 ~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         214 QNLERGYRM-----------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            433211110                             011245678999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-32  Score=229.27  Aligned_cols=205  Identities=21%  Similarity=0.266  Sum_probs=149.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++....   .+.+|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus        66 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~  141 (283)
T cd05080          66 ENIVKYKGCCSEQG---GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD  141 (283)
T ss_pred             CCEeeEEEEEecCC---CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc
Confidence            79999999886531   156899999997 599999876 4599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||++........    .....++..|+|||.+.. ..++.++|||||||++++|++|..||.......  .
T Consensus       142 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~  218 (283)
T cd05080         142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--E  218 (283)
T ss_pred             CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--h
Confidence            999999999999876543221    122344567999998854 457899999999999999999999985443211  0


Q ss_pred             HHHH-HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .... ..+......       .........   ..   ......+..+++++.+||+.||++|||++++++
T Consensus       219 ~~~~~~~~~~~~~~-------~~~~~~~~~---~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         219 EMIGPKQGQMTVVR-------LIELLERGM---RL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcccccccchhh-------hhhhhhcCC---CC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1110 000000000       000000000   00   112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.7e-32  Score=225.61  Aligned_cols=191  Identities=25%  Similarity=0.362  Sum_probs=146.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++....    +..|+||||+. ++|.+++.+. ..++...+..++.|++.||.|||+.|++||||+|+||++
T Consensus        56 ~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili  131 (262)
T cd05058          56 PNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML  131 (262)
T ss_pred             CCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence            79999999775431    56899999996 6999999764 456778888999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  152 (277)
                      +.++.++|+|||++.......     ......++..|+|||.+.. ..++.++|||||||++++|++ |.+||...+...
T Consensus       132 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~  210 (262)
T cd05058         132 DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD  210 (262)
T ss_pred             cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999987543221     1112344667999998854 458899999999999999998 566776554433


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+... ..                         ...   ....+..+.+++.+||..+|++||++.+++.
T Consensus       211 ~~~~~~~~-~~-------------------------~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         211 ITVYLLQG-RR-------------------------LLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHhcC-CC-------------------------CCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22221110 00                         000   0134678999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.8e-32  Score=228.69  Aligned_cols=197  Identities=23%  Similarity=0.360  Sum_probs=150.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------ALSEEHCQYFLYQILRGLKYIHSANVLH   68 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qll~al~~LH~~~i~H   68 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.+..           .+++..+..++.|++.||+|||+.|++|
T Consensus        79 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H  153 (296)
T cd05095          79 PNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH  153 (296)
T ss_pred             CCcceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            7999999999887     78999999996 69999987642           3667789999999999999999999999


Q ss_pred             cCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc--CCC
Q 023764           69 RDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKP  143 (277)
Q Consensus        69 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~  143 (277)
                      +||||+||+++.++.++|+|||++........   ......+..|++||..... .++.++|+||+||++|+|++  |..
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~  232 (296)
T cd05095         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQ  232 (296)
T ss_pred             ccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999875433221   1122335679999987554 58999999999999999997  778


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ||...+..+.+....+....                   ...   .......+..++.+.+|+..||+.||.+|||+.++
T Consensus       233 p~~~~~~~~~~~~~~~~~~~-------------------~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         233 PYSQLSDEQVIENTGEFFRD-------------------QGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             CccccChHHHHHHHHHHHhh-------------------ccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            88766554443322211100                   000   00001112456789999999999999999999998


Q ss_pred             hc
Q 023764          224 LA  225 (277)
Q Consensus       224 l~  225 (277)
                      ++
T Consensus       291 ~~  292 (296)
T cd05095         291 HA  292 (296)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.7e-32  Score=225.55  Aligned_cols=195  Identities=17%  Similarity=0.255  Sum_probs=149.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++.+.+.     ...|+||||+. |+|.+++.+.    ..++...+..++.|++.||+|||+.+++||||||+|
T Consensus        55 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~n  129 (268)
T cd05086          55 PNILQCLGQCVEA-----IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRN  129 (268)
T ss_pred             cchhheEEEecCC-----CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccce
Confidence            7999999999887     78999999997 6999998753    346677888999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCC------CCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           76 LLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      |+++.++.++|+|||++......   .......++..|+|||++...      ..++.++||||+||++++|++ |..||
T Consensus       130 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  209 (268)
T cd05086         130 CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY  209 (268)
T ss_pred             EEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence            99999999999999987542211   112334677889999987421      234678999999999999986 67788


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+....+..+......                     ....   +......++.+.+++..|+ .+|++|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~---------------------~~~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         210 SHLSDREVLNHVIKDQQV---------------------KLFK---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCHHHHHHHHHhhccc---------------------ccCC---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            776665544443321110                     0000   1111246778999999999 68999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-32  Score=225.02  Aligned_cols=185  Identities=18%  Similarity=0.258  Sum_probs=145.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      +..|+||||++ ++|.+++.+.+ .++...+..++.|++.||+|||++|++||||||+||++
T Consensus        61 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill  134 (259)
T cd05037          61 KHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV  134 (259)
T ss_pred             cchhheeeEEec------CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE
Confidence            799999998865      34589999997 69999998765 78999999999999999999999999999999999999


Q ss_pred             ecCC-------CeEEeeccceeeccCCCcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q 023764           79 NANC-------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  149 (277)
Q Consensus        79 ~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  149 (277)
                      +.++       .++|+|||++.....   .....++..|+|||.+... ..++.++|+||+||++++|++ |..||...+
T Consensus       135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         135 ARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             ecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            9887       799999999876543   2233456779999998654 357899999999999999998 577776554


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..........    .                   ...        .......+.++|.+||..||.+|||+.++++
T Consensus       212 ~~~~~~~~~~----~-------------------~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         212 SSEKERFYQD----Q-------------------HRL--------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chhHHHHHhc----C-------------------CCC--------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2221111100    0                   000        0011267899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.4e-32  Score=245.62  Aligned_cols=188  Identities=24%  Similarity=0.425  Sum_probs=161.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------QALSEEHCQYFLYQILRGLKYIHSAN   65 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------------~~l~~~~~~~i~~qll~al~~LH~~~   65 (277)
                      ||||+|++++..+     +-+|+|+|||. |||.++++..              ++++..+...|+.||+.|++||-++.
T Consensus       549 ~nIVrLlGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~  623 (774)
T KOG1026|consen  549 PNIVRLLGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH  623 (774)
T ss_pred             CCeEEEEEEEccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc
Confidence            8999999999998     88999999998 8999999742              23888999999999999999999999


Q ss_pred             ceecCCCCCcEEEecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-C
Q 023764           66 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  141 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g  141 (277)
                      +|||||-..|+||+++-.+||+|||+++.....+..   ....-..+|||||.+..+ .|+.++||||+||++||+++ |
T Consensus       624 FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG  702 (774)
T KOG1026|consen  624 FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYG  702 (774)
T ss_pred             ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccc
Confidence            999999999999999999999999999876554321   233456789999999755 59999999999999999986 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      ..||.+..+.+.++.+.+-                             .+-+...+-+.++.+||..|++.+|++|||++
T Consensus       703 ~QPy~glSn~EVIe~i~~g-----------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~  753 (774)
T KOG1026|consen  703 KQPYYGLSNQEVIECIRAG-----------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFK  753 (774)
T ss_pred             cCcccccchHHHHHHHHcC-----------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence            9999999998888776541                             11222235788999999999999999999999


Q ss_pred             HH
Q 023764          222 DA  223 (277)
Q Consensus       222 el  223 (277)
                      ||
T Consensus       754 eI  755 (774)
T KOG1026|consen  754 EI  755 (774)
T ss_pred             HH
Confidence            87

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8e-32  Score=251.41  Aligned_cols=88  Identities=27%  Similarity=0.557  Sum_probs=82.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +++|+||||+. ++|.+++...+.+++..++.++.||+.||+|||.+||+||||||+||+++
T Consensus        64 p~Iv~~~~~~~~~-----~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~  138 (669)
T cd05610          64 PFIVHLYYSLQSA-----NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS  138 (669)
T ss_pred             CCcCeEEEEEEEC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc
Confidence            7999999999876     89999999995 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeecccee
Q 023764           80 ANCDLKICDFGLAR   93 (277)
Q Consensus        80 ~~~~~~l~dfg~~~   93 (277)
                      .++.++|+|||+++
T Consensus       139 ~~g~vkL~DFGls~  152 (669)
T cd05610         139 NEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCEEEEeCCCCc
Confidence            99999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-31  Score=222.91  Aligned_cols=191  Identities=25%  Similarity=0.430  Sum_probs=150.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++...     +..++||||++ ++|.+++..    ...+++..+..++.|++.|+.+||+.|++|+||+|+|
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~n  136 (267)
T cd08224          62 PNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPAN  136 (267)
T ss_pred             CCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhh
Confidence            6899999999887     88999999997 599998864    2458999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH--H
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV--H  152 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~  152 (277)
                      |+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||......  .
T Consensus       137 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T cd08224         137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS  215 (267)
T ss_pred             EEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH
Confidence            999999999999999987554322 2233467888999998854 45789999999999999999999999654311  1


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+...                          ...+.  ..+..+..++++|.+||..+|++|||+.++++
T Consensus       216 ~~~~~~~~--------------------------~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         216 LCKKIEKC--------------------------DYPPL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHhhhhcC--------------------------CCCCC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            11111000                          00000  01145678999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=1.3e-31  Score=219.87  Aligned_cols=197  Identities=39%  Similarity=0.696  Sum_probs=160.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+...     ...++++|++++ +|.+++.....++...+..++.+++.++.+||+.|++|+||+|.||+++
T Consensus        47 ~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~  121 (244)
T smart00220       47 PNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD  121 (244)
T ss_pred             CcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC
Confidence            6888999998876     889999999986 9999998766689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++++|||.+.............++..|++||.+.. ..++.++|+||+|++++++++|..||..............
T Consensus       122 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~  200 (244)
T smart00220      122 EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG  200 (244)
T ss_pred             CCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            999999999999987765544455677888999998854 4478899999999999999999999977433322222111


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ....                          ........++.++.+++.+||..||++||++.++++||||
T Consensus       201 ~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      201 KPKP--------------------------PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ccCC--------------------------CCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            1000                          0001111167789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=6.6e-33  Score=248.82  Aligned_cols=196  Identities=29%  Similarity=0.400  Sum_probs=151.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~---l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      ||||++++.-.+.     .+.||..|+|..+|.++++.. ..   ...-..+.++.|++.||++||+.+|+|||+||.||
T Consensus       563 ~NviRyyc~E~d~-----qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNI  637 (903)
T KOG1027|consen  563 PNVIRYYCSEQDR-----QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNI  637 (903)
T ss_pred             CceEEEEeeccCC-----ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceE
Confidence            8999999999888     999999999999999999874 11   11134578899999999999999999999999999


Q ss_pred             EEec---C--CCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC-CCCCC
Q 023764           77 LLNA---N--CDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP  146 (277)
Q Consensus        77 l~~~---~--~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~  146 (277)
                      ||+.   +  .+++|+|||+++.....    .......||.+|+|||++.... -+.++||||+||++|+.++| .+||.
T Consensus       638 LI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFG  716 (903)
T KOG1027|consen  638 LISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFG  716 (903)
T ss_pred             EEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCC
Confidence            9976   3  46899999999876544    2345667999999999997654 47799999999999998875 99995


Q ss_pred             CCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +....+.  -|..                   .        ...+-...+....+++|||.+||..||.+||||.++|.|
T Consensus       717 d~~~R~~--NIl~-------------------~--------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  717 DSLERQA--NILT-------------------G--------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             chHHhhh--hhhc-------------------C--------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            5432210  0000                   0        000111111222279999999999999999999999999


Q ss_pred             CCCCC
Q 023764          227 PYLGS  231 (277)
Q Consensus       227 p~f~~  231 (277)
                      |+|=.
T Consensus       768 PlFW~  772 (903)
T KOG1027|consen  768 PLFWD  772 (903)
T ss_pred             CccCC
Confidence            99943

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=1.1e-31  Score=251.09  Aligned_cols=192  Identities=24%  Similarity=0.368  Sum_probs=148.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------QALSEEHCQYFLYQILRGLKYIHSANVLH   68 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------~~l~~~~~~~i~~qll~al~~LH~~~i~H   68 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...           ..++...+..++.|++.||+|||++||+|
T Consensus        62 PNIVkl~~v~~d~-----~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIH  136 (932)
T PRK13184         62 PGIVPVYSICSDG-----DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLH  136 (932)
T ss_pred             cCcCeEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            8999999999887     88999999997 5999988631           23556678899999999999999999999


Q ss_pred             cCCCCCcEEEecCCCeEEeeccceeeccCC-------------------CcccccccccccCChhhhhCCCCCCcchhHH
Q 023764           69 RDLKPSNLLLNANCDLKICDFGLARVTSET-------------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  129 (277)
Q Consensus        69 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  129 (277)
                      |||||+||+++.++.++|+|||++......                   .......||+.|+|||.+.+ ..++.++|||
T Consensus       137 RDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIW  215 (932)
T PRK13184        137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIY  215 (932)
T ss_pred             cCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHH
Confidence            999999999999999999999998755110                   01112468999999998854 4579999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHh
Q 023764          130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  209 (277)
Q Consensus       130 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  209 (277)
                      |+||++++|++|..||.+.........  .....|..                         ......+++.+.+++.+|
T Consensus       216 SLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~~-------------------------~~p~~~iP~~L~~LI~rc  268 (932)
T PRK13184        216 ALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPIE-------------------------VAPYREIPPFLSQIAMKA  268 (932)
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChhh-------------------------ccccccCCHHHHHHHHHH
Confidence            999999999999999976443221111  00001000                         001125678899999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q 023764          210 LTFDPRQRITVEDALA  225 (277)
Q Consensus       210 L~~dP~~R~t~~ell~  225 (277)
                      |..||++|++..+.+.
T Consensus       269 L~~DP~kR~ss~eeLl  284 (932)
T PRK13184        269 LAVDPAERYSSVQELK  284 (932)
T ss_pred             ccCChhhCcCHHHHHH
Confidence            9999999988665554

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=2.1e-31  Score=226.31  Aligned_cols=201  Identities=17%  Similarity=0.195  Sum_probs=148.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      +||++++++...... .....|+++|++..++.+.+......++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus        83 ~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         83 LGIPKYYGCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG  161 (294)
T ss_pred             CCCCcEEEeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence            467777766543311 1124578899988888888776666788899999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC--------CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           81 NCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      ++.++|+|||+++.....        .......||+.|+|||+..+ ..++.++||||+||++++|++|..||.+.....
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            999999999998754321        11223468999999998854 458999999999999999999999998763322


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ......+.                 .+..+...   .  ....+..++.+.+++..|+..+|.+||+.+++++
T Consensus       241 ~~~~~~~~-----------------~~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        241 NLIHAAKC-----------------DFIKRLHE---G--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhHH-----------------HHHHHhhh---h--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            21111110                 00000000   0  0112355788999999999999999999999865

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.98  E-value=2.3e-31  Score=221.97  Aligned_cols=189  Identities=26%  Similarity=0.420  Sum_probs=150.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      ...|++|||++ ++|.+++.+.  ..++...+..++.|++.||.+||+.|++|+||+|+||+
T Consensus        61 ~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~  134 (260)
T cd05073          61 DKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL  134 (260)
T ss_pred             CCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence            689999988865      45799999996 6999999763  45788899999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++|+||+||+++++++ |..||.+.+.....
T Consensus       135 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~  213 (260)
T cd05073         135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI  213 (260)
T ss_pred             EcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999876543221  112234567999998854 457889999999999999998 99999876655443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             ....+..+.++.+++.+||+.||++||++.++++
T Consensus       214 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         214 RALERGYR-----------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHhCCCC-----------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            33221100                             0111356778999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1.8e-32  Score=261.07  Aligned_cols=201  Identities=17%  Similarity=0.225  Sum_probs=144.8

Q ss_pred             CceeeeeccccCCCCCC--CCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRES--FNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      +||+++++.|......+  ...++.++|+++++|.+++... ..+++..++.+++||+.||.|||++||+||||||+|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL  112 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV  112 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence            37888888884432211  1468889999999999999753 56999999999999999999999999999999999999


Q ss_pred             EecCC-------------------CeEEeeccceeeccCCC-----------------cccccccccccCChhhhhCCCC
Q 023764           78 LNANC-------------------DLKICDFGLARVTSETD-----------------FMTEYVVTRWYRAPELLLNSSD  121 (277)
Q Consensus        78 ~~~~~-------------------~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~~  121 (277)
                      ++..|                   .+|++|||+++......                 ......+|+.|+|||++.+. .
T Consensus       113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~  191 (793)
T PLN00181        113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS-S  191 (793)
T ss_pred             EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC-C
Confidence            96544                   45556666554321100                 00113578889999998654 5


Q ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChh
Q 023764          122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS  201 (277)
Q Consensus       122 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (277)
                      ++.++||||+||++|||++|.+|+.....  ....+.... .|+                            ......+.
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~----------------------------~~~~~~~~  240 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPP----------------------------QILLNWPK  240 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cCh----------------------------hhhhcCHH
Confidence            89999999999999999998887643211  111111100 000                            00011345


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          202 AIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       202 ~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+++.+||+.||.+|||+.++++||||....
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            67899999999999999999999999998753

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.98  E-value=1.9e-31  Score=224.72  Aligned_cols=191  Identities=23%  Similarity=0.347  Sum_probs=150.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++...+    ...++++||++ ++|.+++...        ..+++..+..++.|++.||+|||++|++|+||
T Consensus        68 ~ni~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di  143 (280)
T cd05043          68 QNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDI  143 (280)
T ss_pred             CCCCeEEEEEecCC----CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence            79999999876531    67899999997 6999998653        45889999999999999999999999999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPG  147 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  147 (277)
                      +|.||+++.++.++++|||+++.......   .....++..|+|||.+.+ ..++.++||||+||+++++++ |++||..
T Consensus       144 ~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         144 AARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             CHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence            99999999999999999999875432211   112334567999998854 447899999999999999998 9999977


Q ss_pred             CChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.......+... ..                           + ......++++++++.+||..||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~-~~---------------------------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         223 IDPFEMAAYLKDG-YR---------------------------L-AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCHHHHHHHHHcC-CC---------------------------C-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6544322221110 00                           0 011235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=1.6e-31  Score=225.83  Aligned_cols=208  Identities=23%  Similarity=0.363  Sum_probs=151.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.+   ....|+||||++ ++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        66 ~~i~~~~~~~~~~~---~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~  142 (284)
T cd05079          66 ENIVKYKGICTEDG---GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV  142 (284)
T ss_pred             CCeeeeeeEEecCC---CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence            79999999887642   267899999996 6999998765 358999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++........    .....++..|+|||.+.+. .++.++||||+||++++|+++..|+.....    
T Consensus       143 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~----  217 (284)
T cd05079         143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT----  217 (284)
T ss_pred             cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc----
Confidence            9999999999999876543221    1234456779999988654 578999999999999999998766532211    


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                       ...+..+........   ..........      .........+..+.+|+.+||+.||.+|||+.+++..
T Consensus       218 -~~~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         218 -LFLKMIGPTHGQMTV---TRLVRVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -hhhhhcccccccccH---HHHHHHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             111111111110000   0000000000      0111224578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.98  E-value=2.5e-31  Score=234.29  Aligned_cols=156  Identities=26%  Similarity=0.341  Sum_probs=120.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhC
Q 023764           42 LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN  118 (277)
Q Consensus        42 l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~  118 (277)
                      ++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+
T Consensus       236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  315 (401)
T cd05107         236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN  315 (401)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence            5667788899999999999999999999999999999999999999999987543221   1123356778999998854


Q ss_pred             CCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCC
Q 023764          119 SSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  197 (277)
Q Consensus       119 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (277)
                       ..++.++||||+||++++|++ |..||......+...........+                            ...+.
T Consensus       316 -~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~----------------------------~~p~~  366 (401)
T cd05107         316 -NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM----------------------------AKPAH  366 (401)
T ss_pred             -CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC----------------------------CCCCC
Confidence             447899999999999999997 889997655433322221110000                            01124


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          198 VHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       198 ~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+.++.+|+.+|+..+|.+||++++++..
T Consensus       367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            67889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-33  Score=223.51  Aligned_cols=204  Identities=25%  Similarity=0.410  Sum_probs=164.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-----SNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~   74 (277)
                      ||||++|++....     ++.+|.||+|+-+|..+.+     ++..+++.....|..-.+.||.||-+. .|+|||+||+
T Consensus       123 p~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPS  197 (361)
T KOG1006|consen  123 PNIVKFYGALFSE-----GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPS  197 (361)
T ss_pred             cHHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChh
Confidence            8999999998887     8999999999987765543     346799999999999999999999864 7999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCh-HH
Q 023764           75 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDH-VH  152 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~  152 (277)
                      |||++..|.+||||||.+....++.-.+.-.|-..|||||.+..... |..++|+||||+.++|+.||..|+.+.+. .+
T Consensus       198 NILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe  277 (361)
T KOG1006|consen  198 NILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE  277 (361)
T ss_pred             heEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH
Confidence            99999999999999999976655544445567778999999866554 88999999999999999999999977654 23


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ++..++  .|.|+....                      ...--+.+..++.||..||.+|-+.||...+++.+||+...
T Consensus       278 ql~~Vv--~gdpp~l~~----------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  278 QLCQVV--IGDPPILLF----------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHH--cCCCCeecC----------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            333332  233332110                      00001468889999999999999999999999999999876


Q ss_pred             C
Q 023764          233 H  233 (277)
Q Consensus       233 ~  233 (277)
                      .
T Consensus       334 ~  334 (361)
T KOG1006|consen  334 A  334 (361)
T ss_pred             h
Confidence            4

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.1e-31  Score=223.38  Aligned_cols=189  Identities=25%  Similarity=0.326  Sum_probs=149.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      ...++||||+. |+|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||++
T Consensus        69 ~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~  142 (279)
T cd05057          69 PHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV  142 (279)
T ss_pred             CCcceEEEEEec------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE
Confidence            799999998864      56899999996 6999998764 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||.+.........   ....++..|+|||.+.. ..++.++|+||+||+++++++ |..||.+....+..
T Consensus       143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  221 (279)
T cd05057         143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP  221 (279)
T ss_pred             cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999998765432211   11223467999998854 457899999999999999998 99999876554433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.. ....                            ...+..+.++.+++.+||..||.+|||+.++++
T Consensus       222 ~~~~~-~~~~----------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         222 DLLEK-GERL----------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHhC-CCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            32221 0000                            011235678999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=1.9e-31  Score=231.34  Aligned_cols=193  Identities=25%  Similarity=0.412  Sum_probs=147.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------------------------------
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------------------------------   39 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------------------------   39 (277)
                      |||+++++++....    +.+|+||||++ |+|.+++...                                        
T Consensus        71 ~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (343)
T cd05103          71 LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQS  146 (343)
T ss_pred             ccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccc
Confidence            79999999886541    57899999997 6999988642                                        


Q ss_pred             ---------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccce
Q 023764           40 ---------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   92 (277)
Q Consensus        40 ---------------------------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~   92 (277)
                                                 ..++...+..++.|++.||+|||++|++||||||.||+++.++.++|+|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~  226 (343)
T cd05103         147 SASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA  226 (343)
T ss_pred             cccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccc
Confidence                                       13677788899999999999999999999999999999999999999999998


Q ss_pred             eeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHh
Q 023764           93 RVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAE  168 (277)
Q Consensus        93 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  168 (277)
                      .......   ......++..|+|||.+.. ..++.++||||+||++++|++ |..||.+................     
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  300 (343)
T cd05103         227 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----  300 (343)
T ss_pred             cccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-----
Confidence            7543221   1112234567999998854 458899999999999999996 99999765432222111110000     


Q ss_pred             hhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          169 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                                          ..   .....++++.+++..||+.||.+|||+.++++|
T Consensus       301 --------------------~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 --------------------MR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --------------------CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                00   001246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=3.4e-31  Score=223.66  Aligned_cols=208  Identities=20%  Similarity=0.345  Sum_probs=148.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...+   ...+|+||||++ ++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        65 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili  141 (284)
T cd05081          65 DNIVKYKGVCYSAG---RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV  141 (284)
T ss_pred             CCeeEEEEEEccCC---CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE
Confidence            79999999875432   157899999996 6999998764 468999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++........    .....++..|+|||.+.+ ..++.++||||+||++++|++|..++......   
T Consensus       142 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---  217 (284)
T cd05081         142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---  217 (284)
T ss_pred             CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---
Confidence            9999999999999876543221    111223446999998854 45889999999999999999988766433211   


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                        .....+......  ...............      ....+..+.++.+|+.+||..+|++|||+.+++.
T Consensus       218 --~~~~~~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         218 --FMRMMGNDKQGQ--MIVYHLIELLKNNGR------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             --hhhhcccccccc--cchHHHHHHHhcCCc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              111111100000  000000000000000      0112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=3.1e-31  Score=226.14  Aligned_cols=190  Identities=22%  Similarity=0.289  Sum_probs=148.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      ...++++||+. |+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus        69 ~niv~~~~~~~~------~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill  142 (303)
T cd05110          69 PHLVRLLGVCLS------PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV  142 (303)
T ss_pred             CCcccEEEEEcC------CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee
Confidence            799999998865      34679999997 69999987653 68999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.+||+|||++........   .....++..|+|||.+.+ ..++.++||||+||++++|++ |..||.+.......
T Consensus       143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~  221 (303)
T cd05110         143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP  221 (303)
T ss_pred             cCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999976443221   122334668999998854 458899999999999999986 88999765433322


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      . +......+                            ...+..+.++++++.+|+..||++|||++++++.
T Consensus       222 ~-~~~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         222 D-LLEKGERL----------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             H-HHHCCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 11110000                            0112356789999999999999999999998773

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=218.69  Aligned_cols=202  Identities=24%  Similarity=0.482  Sum_probs=163.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.+|.|+.+|...     ..+++|.||+. |+|--.++..+.++++.++.+...|+.||.|||++||++||+|..|++++
T Consensus       311 pflvglhscfqte-----srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld  385 (593)
T KOG0695|consen  311 PFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD  385 (593)
T ss_pred             CeEEehhhhhccc-----ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence            6789999999987     89999999996 68877788888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceee-ccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC--CCChHHHHHH
Q 023764           80 ANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP--GRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~--~~~~~~~~~~  156 (277)
                      ..|.+||.|+|.++. .......++++|||.|.|||++. +..|+.++|.|+|||+++||+.|+.||+  +.++.+    
T Consensus       386 aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d----  460 (593)
T KOG0695|consen  386 AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD----  460 (593)
T ss_pred             cCCceeecccchhhcCCCCCcccccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc----
Confidence            999999999999975 34456678899999999999985 4569999999999999999999999995  222111    


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHPYLG  230 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~f~  230 (277)
                                       .+...|..++.-.....+   ...+|..+..+++..|.+||.+|..      .+++-.|+||.
T Consensus       461 -----------------~ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  461 -----------------MNTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             -----------------cchhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence                             011111111110000000   1145667888999999999999985      78999999998


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      .+
T Consensus       521 ~i  522 (593)
T KOG0695|consen  521 SI  522 (593)
T ss_pred             hC
Confidence            65

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-32  Score=227.59  Aligned_cols=203  Identities=26%  Similarity=0.494  Sum_probs=160.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~nil   77 (277)
                      |-|||+||+|..++    +.+|.|+|||+| +|.-+++.++.+++.+++.|+.||+.||.||.+..  |+|-|+||.|||
T Consensus       527 pRIVKlYDyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL  602 (775)
T KOG1151|consen  527 PRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL  602 (775)
T ss_pred             ceeeeeeeeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence            67999999998763    789999999987 88888888889999999999999999999999874  999999999999


Q ss_pred             Ee---cCCCeEEeeccceeeccCC--------CcccccccccccCChhhhhCC---CCCCcchhHHHHHHHHHHHHcCCC
Q 023764           78 LN---ANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        78 ~~---~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      +.   ..|.+||.|||+++.+.+.        +......||.+|++||.+.-+   ...+.++||||+|||+|..+.|+.
T Consensus       603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK  682 (775)
T KOG1151|consen  603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK  682 (775)
T ss_pred             EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence            83   4588999999999876543        233456799999999998543   346889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ||...- .+  +.|.+..........               .++      .-|-+++++++||++||.+.-+.|..+.++
T Consensus       683 PFGhnq-sQ--QdILqeNTIlkAtEV---------------qFP------~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  683 PFGHNQ-SQ--QDILQENTILKATEV---------------QFP------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             CCCCch-hH--HHHHhhhchhcceec---------------cCC------CCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            995332 11  112211111000000               000      114689999999999999999999999999


Q ss_pred             hcCCCCCC
Q 023764          224 LAHPYLGS  231 (277)
Q Consensus       224 l~hp~f~~  231 (277)
                      ..||||..
T Consensus       739 A~dpyllP  746 (775)
T KOG1151|consen  739 ACDPYLLP  746 (775)
T ss_pred             ccCccccc
Confidence            99999975

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=241.14  Aligned_cols=204  Identities=24%  Similarity=0.441  Sum_probs=166.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||+++++++|.-....+.+.++||||||+ |+.-|++++  ..++.+..+..|++.++.|+.+||.+.++|||||-.|||
T Consensus        76 pnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL  155 (953)
T KOG0587|consen   76 PNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL  155 (953)
T ss_pred             CCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence            89999999997655555588999999997 688888875  357999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           78 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      ++.+|.+||+|||.+.... ......+..|||.|||||++.+..    .|+..+|+||||++..||..|.+|+.+.... 
T Consensus       156 LT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-  234 (953)
T KOG0587|consen  156 LTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-  234 (953)
T ss_pred             EeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-
Confidence            9999999999999986544 345667889999999999986543    3677899999999999999999998655432 


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                        +.+......|+..                       + ......+..+.+||..||.+|-.+||+..++|.|||+..
T Consensus       235 --raLF~IpRNPPPk-----------------------L-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  235 --RALFLIPRNPPPK-----------------------L-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             --hhhccCCCCCCcc-----------------------c-cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence              2222222222211                       1 112246778999999999999999999999999999983

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=229.25  Aligned_cols=202  Identities=23%  Similarity=0.362  Sum_probs=150.9

Q ss_pred             CceeeeeccccCCCCCCCC-cEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSAN---VLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~-~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~---i~H~di~~   73 (277)
                      ||||+|++|+.+.     + +.+||+|||. |+|.+.+....  .+++..+.+|+.+++.||+|||...   |+|||||+
T Consensus       131 ~Nlv~LlGyC~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs  205 (361)
T KOG1187|consen  131 PNLVKLLGYCLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS  205 (361)
T ss_pred             cCcccEEEEEecC-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH
Confidence            8999999999987     6 5999999997 79999998764  8999999999999999999999964   99999999


Q ss_pred             CcEEEecCCCeEEeeccceeeccC-CCccccc-ccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           74 SNLLLNANCDLKICDFGLARVTSE-TDFMTEY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        74 ~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      .|||++.+...||+|||+++.... ....... .||..|++||.... +..+.++||||+||+++|+++|+.+.+.....
T Consensus       206 sNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~  284 (361)
T KOG1187|consen  206 SNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPR  284 (361)
T ss_pred             HHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence            999999999999999999966554 3333333 89999999998854 55899999999999999999999887643211


Q ss_pred             --H-HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCccc-ccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          152 --H-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-EKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       152 --~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                        . ........+...          ....       .....+. ..++  ..-..+..+...|++.+|.+||+..+++.
T Consensus       285 ~~~~l~~w~~~~~~~~----------~~~e-------iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  285 GELSLVEWAKPLLEEG----------KLRE-------IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccccHHHHHHHHHHCc----------chhh-------eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence              1 111111111110          0000       0111111 1111  01123677889999999999999998744

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=2.7e-30  Score=216.79  Aligned_cols=195  Identities=22%  Similarity=0.362  Sum_probs=148.3

Q ss_pred             CceeeeeccccCCCCCC-CCcEEEEeecCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQRES-FNDVYIAYELMD-TDLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++......+ ..-.++++||+. |+|.+++...      ..++...+..++.|++.|++|||++|++|||||
T Consensus        61 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  140 (273)
T cd05074          61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLA  140 (273)
T ss_pred             CCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccc
Confidence            79999999887643211 123578899986 6888876432      247889999999999999999999999999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  148 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  148 (277)
                      |+||+++.++.++++|||++........   .....+++.|++||.+.. ..++.++||||+||++++|++ |.+||.+.
T Consensus       141 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             hhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999876543221   122234567999998854 447889999999999999998 88999766


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +.......+.+. ..                            ....+..+..+.+++.+||..+|++|||+.+++.
T Consensus       220 ~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         220 ENSEIYNYLIKG-NR----------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CHHHHHHHHHcC-Cc----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            554333322210 00                            0011346678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=233.26  Aligned_cols=190  Identities=24%  Similarity=0.374  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+++++....     .-+|||||+|. |+|.+++++++. ++..+...++++.+.||+|||+++++||||-..|+|+
T Consensus       221 ~NVVr~yGVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~  295 (474)
T KOG0194|consen  221 PNVVRFYGVAVLE-----EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY  295 (474)
T ss_pred             CCEEEEEEEEcCC-----CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee
Confidence            8999999999988     77999999996 699999999874 9999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCccc-ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      +.++.+||+|||+++......... ..--+..|+|||.+... .|+.++||||+||++||+.+ |..||.+....+..++
T Consensus       296 ~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k  374 (474)
T KOG0194|consen  296 SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK  374 (474)
T ss_pred             cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH
Confidence            999999999999987665332222 22345679999999654 69999999999999999987 8889999998887777


Q ss_pred             HHHHhC-CCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          157 LIELIG-TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       157 i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +..... .+..                             +..+..+..++.+|+..||++|||+.++.+
T Consensus       375 I~~~~~r~~~~-----------------------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  375 IVKNGYRMPIP-----------------------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHhcCccCCCC-----------------------------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            743211 1110                             145667888999999999999999988755

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1e-30  Score=242.61  Aligned_cols=185  Identities=32%  Similarity=0.510  Sum_probs=137.7

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeec-
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-   95 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l-~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~-   95 (277)
                      ..+||-||||+. .+.++++.+... .....++++.||++||.|+|+.|+|||||||.||+++.++.+||+|||++... 
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            568999999996 555566554433 46788999999999999999999999999999999999999999999998641 


Q ss_pred             -----------------c-CCCcccccccccccCChhhhhCCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           96 -----------------S-ETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        96 -----------------~-~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                                       + .....+...||..|+|||++.+..  .|+.|+|+||||+|++||+.   ||...  .+ ..
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--ME-Ra  822 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--ME-RA  822 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HH-HH
Confidence                             0 112445678999999999997766  69999999999999999974   46432  11 11


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .+...+..+.-.                     .+ ...+...-+.-+.+|+.||+.||++||||.|+|++.||-.
T Consensus       823 ~iL~~LR~g~iP---------------------~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  823 SILTNLRKGSIP---------------------EP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHHHhcccCCCC---------------------CC-cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            111111111100                     00 0011122234678999999999999999999999999964

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=3e-30  Score=217.52  Aligned_cols=207  Identities=23%  Similarity=0.364  Sum_probs=149.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...+   ....|+||||+. ++|.+++.... .++...+..++.|++.||++||++|++|+||+|.||++
T Consensus        66 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~  142 (284)
T cd05038          66 ENIVKYKGVCEKPG---GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV  142 (284)
T ss_pred             CChheEEeeeecCC---CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence            79999999887642   267999999996 69999997654 58999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||.+........    .....++..|++||.+... .++.++|+||+||++++|++|..||.......  
T Consensus       143 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--  219 (284)
T cd05038         143 ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEF--  219 (284)
T ss_pred             cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchh--
Confidence            9999999999999876653211    1112345569999988544 57899999999999999999999885432211  


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                         ....+.....   ................      ......+.++.+|+.+||+.||.+|||+.++++
T Consensus       220 ---~~~~~~~~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         220 ---LRMIGIAQGQ---MIVTRLLELLKEGERL------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ---cccccccccc---ccHHHHHHHHHcCCcC------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               0000000000   0000000001000000      011234578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-30  Score=239.92  Aligned_cols=190  Identities=25%  Similarity=0.400  Sum_probs=159.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      ||||+++++..+.     ...+|++|||. |+|..+|++.       ..++......++.||+.|..||+++++|||||.
T Consensus       755 pNiv~liGv~l~~-----~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLA  829 (1025)
T KOG1095|consen  755 PNIVSLIGVCLDS-----GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLA  829 (1025)
T ss_pred             cceeeEEEeecCC-----CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchh
Confidence            8999999999997     88999999996 7999999875       358999999999999999999999999999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCCCccc---ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  148 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  148 (277)
                      ..|+|++....+||+|||+|+.+.......   ...-...|||||.+.. +.++.++|||||||++||+++ |..||++.
T Consensus       830 aRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~  908 (1025)
T KOG1095|consen  830 ARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSR  908 (1025)
T ss_pred             hhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999998544332111   1233567999999965 569999999999999999987 99999999


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ++.+.+....+-..-++                             .+..+..+-++|..|++.+|++||++..+++
T Consensus       909 ~n~~v~~~~~~ggRL~~-----------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  909 SNFEVLLDVLEGGRLDP-----------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             chHHHHHHHHhCCccCC-----------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            98887765544221111                             0134567889999999999999999999887

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.1e-29  Score=199.67  Aligned_cols=166  Identities=23%  Similarity=0.323  Sum_probs=126.7

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCccccccccc
Q 023764           30 TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR  108 (277)
Q Consensus        30 ~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  108 (277)
                      |+|.+++.++ ..+++..++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            6899999874 56999999999999999999999998      999999999999999  99987665432    26789


Q ss_pred             ccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCccc
Q 023764          109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ  187 (277)
Q Consensus       109 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (277)
                      .|+|||++.+ ..++.++||||+||++|+|++|..||...... .....+..........                   .
T Consensus        69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------~  128 (176)
T smart00750       69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR-------------------D  128 (176)
T ss_pred             cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc-------------------c
Confidence            9999999865 45899999999999999999999999654332 2222222111110000                   0


Q ss_pred             CCcccccCCCCCh--hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          188 RQSFTEKFPNVHP--SAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       188 ~~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ..    ....++.  .++++|.+||..||.+|||+.+++.|+|+..
T Consensus       129 ~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 RS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            00    0001222  6899999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=226.74  Aligned_cols=193  Identities=22%  Similarity=0.361  Sum_probs=151.5

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||+=+.+++..+     .. .||+-+|+| +|..++.-. ..|.+...+.|+.|++.|+.|||.++|+|||+|..||++.
T Consensus       449 NIlLFMG~~~~p-----~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~  522 (678)
T KOG0193|consen  449 NILLFMGACMNP-----PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH  522 (678)
T ss_pred             hheeeehhhcCC-----ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc
Confidence            788888898776     44 999999987 899988643 4699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeec---cCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~---~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +++++||+|||++...   ....-.....++..|||||++..  ..+|++.+||||+||++|||++|..||.... .+++
T Consensus       523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqI  601 (678)
T KOG0193|consen  523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQI  601 (678)
T ss_pred             cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhhe
Confidence            9999999999998642   22333445578888999999853  3458999999999999999999999998433 3322


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      -.++   |..                     +-.+.......+-+.++++|+..|+.+++++||+..+||.
T Consensus       602 ifmV---GrG---------------------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  602 IFMV---GRG---------------------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             EEEe---ccc---------------------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            1111   111                     0011122222345568999999999999999999988877

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.2e-29  Score=225.35  Aligned_cols=212  Identities=19%  Similarity=0.292  Sum_probs=143.6

Q ss_pred             eeeeeccccCCCC---CCCCcEEEEeecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHH
Q 023764            3 VVAIRDIIPPPQR---ESFNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLYQI   54 (277)
Q Consensus         3 iv~l~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~ql   54 (277)
                      ++++++++.....   ...+..++||||++ ++|.+++...                        ..++...++.++.|+
T Consensus       239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql  318 (507)
T PLN03224        239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV  318 (507)
T ss_pred             hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence            4566666654221   11256899999997 5898887632                        123567788999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccc--cccccccCChhhhhCCCC-----------
Q 023764           55 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE--YVVTRWYRAPELLLNSSD-----------  121 (277)
Q Consensus        55 l~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~-----------  121 (277)
                      +.||.|||+.+++||||||+||+++.++.++|+|||++...........  ..+++.|+|||.+.....           
T Consensus       319 ~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~  398 (507)
T PLN03224        319 LTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAA  398 (507)
T ss_pred             HHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhh
Confidence            9999999999999999999999999999999999999865443322222  234789999998753221           


Q ss_pred             --------C--CcchhHHHHHHHHHHHHcCCC-CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCc
Q 023764          122 --------Y--TAAIDVWSVGCIFMELMDRKP-LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS  190 (277)
Q Consensus       122 --------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (277)
                              +  ....|+||+||++++|++|.. ||.+......   ..+..        ......+..+..     ....
T Consensus       399 ~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~--------~~~~~~~r~~~~-----~~~~  462 (507)
T PLN03224        399 LLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY--------DNDLNRWRMYKG-----QKYD  462 (507)
T ss_pred             hhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc--------cchHHHHHhhcc-----cCCC
Confidence                    1  124799999999999999875 6643221110   00000        000000000000     0011


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCC---CCCCCHHHHhcCCCCCC
Q 023764          191 FTEKFPNVHPSAIDLVEKMLTFDP---RQRITVEDALAHPYLGS  231 (277)
Q Consensus       191 ~~~~~~~~~~~~~~li~~~L~~dP---~~R~t~~ell~hp~f~~  231 (277)
                      + ..++..++.++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       463 ~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            1 1345678899999999999876   68999999999999964

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=227.37  Aligned_cols=188  Identities=23%  Similarity=0.402  Sum_probs=156.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+|.+++.+      .-.+||||++. |.|..+++.++ .++......+++||+.||.|||+.+++||||-..|||+
T Consensus       451 phIikLIGv~~e------~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV  524 (974)
T KOG4257|consen  451 PHIIKLIGVCVE------QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV  524 (974)
T ss_pred             cchhheeeeeec------cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee
Confidence            899999999987      66899999998 89999998764 68888999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccc--cccccCChhhhhCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYV--VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~  155 (277)
                      ....++||+|||+++...+........  -+.-|||||.+ +...++.++|||.|||.+||++ .|..||.|..+.+.+.
T Consensus       525 sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~  603 (974)
T KOG4257|consen  525 SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG  603 (974)
T ss_pred             cCcceeeecccchhhhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence            999999999999999877654333223  34569999987 4556999999999999999987 5999998887776555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      .+.+--..                             ...|+.++.+-.|+.+|+.+||.+||++.++.
T Consensus       604 ~iEnGeRl-----------------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  604 HIENGERL-----------------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             EecCCCCC-----------------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            44321111                             12246788899999999999999999977654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=6.5e-30  Score=214.44  Aligned_cols=224  Identities=28%  Similarity=0.465  Sum_probs=162.2

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ||+++.+++...     +.+.+|+||++. +..++..+   ++...++.+++.++.||+++|..||+||||||.|++.+.
T Consensus        96 ni~~~~~~~rnn-----d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~  167 (418)
T KOG1167|consen   96 NIIKLNGCFRNN-----DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR  167 (418)
T ss_pred             hhhcchhhhccC-----CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc
Confidence            788999999887     899999999986 67777654   678899999999999999999999999999999999975


Q ss_pred             -CCCeEEeeccceeec----------c-------C----C------------------------CcccccccccccCChh
Q 023764           81 -NCDLKICDFGLARVT----------S-------E----T------------------------DFMTEYVVTRWYRAPE  114 (277)
Q Consensus        81 -~~~~~l~dfg~~~~~----------~-------~----~------------------------~~~~~~~~~~~~~aPE  114 (277)
                       .+.-.|+|||++...          +       .    .                        .......||++|+|||
T Consensus       168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE  247 (418)
T KOG1167|consen  168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE  247 (418)
T ss_pred             ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence             467899999998510          0       0    0                        0001235899999999


Q ss_pred             hhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCChHhhhhhhhh-----------HHHHhhh
Q 023764          115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-GRDHVHQLRLLIELIGTPSEAELGFLNEN-----------AKKYICQ  182 (277)
Q Consensus       115 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-----------~~~~~~~  182 (277)
                      ++.+.+.-+.++||||.|||+..++++..||. ..++.+.+..+....|.-.-.....+...           ..+....
T Consensus       248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~  327 (418)
T KOG1167|consen  248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN  327 (418)
T ss_pred             HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence            99988888999999999999999999998874 55666666666655543222211111000           0000000


Q ss_pred             CCcc------c-CC---cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          183 LPRY------Q-RQ---SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       183 ~~~~------~-~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +...      . +.   .........+..+.||+.+||+.||.+|.||+++|.||||....
T Consensus       328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            0000      0 00   11111223455899999999999999999999999999999644

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-30  Score=225.52  Aligned_cols=148  Identities=27%  Similarity=0.402  Sum_probs=129.6

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      ||||++.++-.+... .....-.+|||||. |+|...+++.   ..+++.+...++..+..|+.|||++||+||||||.|
T Consensus        71 ~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~N  150 (732)
T KOG4250|consen   71 PNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGN  150 (732)
T ss_pred             hhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Confidence            799999999877641 11256789999996 7999999753   469999999999999999999999999999999999


Q ss_pred             EEE--ecCCC--eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           76 LLL--NANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        76 il~--~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      |++  +.+|+  .||+|||.|+...++....+.+||+.|.+||++.+.+.|+..+|.||+||++|+.+||..||-..
T Consensus       151 Ivl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  151 IVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             EEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            987  44454  59999999999999989999999999999999976677999999999999999999999999543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=192.09  Aligned_cols=154  Identities=29%  Similarity=0.485  Sum_probs=129.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~n   75 (277)
                      |.+|++++.+...     .+++|.||.|+.+|..+.    .+++.++|...-+|+..++.|+.|||++ .++|||+||.|
T Consensus       105 Pf~V~FyGa~~re-----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsN  179 (282)
T KOG0984|consen  105 PFTVHFYGALFRE-----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSN  179 (282)
T ss_pred             CeEEEeehhhhcc-----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcce
Confidence            6789999988776     899999999998886654    4567899999999999999999999986 89999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC---CCCCcchhHHHHHHHHHHHHcCCCCCCCC-ChH
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGR-DHV  151 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~  151 (277)
                      ||++.+|++|+||||.+....++.-.+-..|-..|||||.+...   ..|+.++||||||+.+.||.+++.||+.. +..
T Consensus       180 iLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF  259 (282)
T KOG0984|consen  180 ILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF  259 (282)
T ss_pred             EEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence            99999999999999999876655433434566779999987432   35889999999999999999999999755 455


Q ss_pred             HHHHHHHH
Q 023764          152 HQLRLLIE  159 (277)
Q Consensus       152 ~~~~~i~~  159 (277)
                      +++..+++
T Consensus       260 ~qLkqvVe  267 (282)
T KOG0984|consen  260 QQLKQVVE  267 (282)
T ss_pred             HHHHHHhc
Confidence            56665554

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=213.28  Aligned_cols=196  Identities=22%  Similarity=0.332  Sum_probs=157.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||+|++++..+     +-+++|+|||+ |+|.+++.++  .....+...+|+.||+.|++||.+.+++|||+.+.|+|
T Consensus       595 PNIveLvGVC~~D-----ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcL  669 (807)
T KOG1094|consen  595 PNIVELLGVCVQD-----DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCL  669 (807)
T ss_pred             CCeeEEEeeeecC-----CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcccccccee
Confidence            8999999999988     88999999998 8999999887  33455667789999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHH--cCCCCCCCCChHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVH  152 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~  152 (277)
                      ++.++.+||+|||.++-....+.   ....+.+.+|||+|.+.-+ .++.++|+|++|+.+||++  |...||....+.+
T Consensus       670 v~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~  748 (807)
T KOG1094|consen  670 VDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ  748 (807)
T ss_pred             ecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence            99999999999999985543321   1233456789999998765 4999999999999999974  7889998777776


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      ..+..-++...+...                      -.....+-.+..+.++|..|+..|-.+|||.+++.
T Consensus       749 vven~~~~~~~~~~~----------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  749 VVENAGEFFRDQGRQ----------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             HHHhhhhhcCCCCcc----------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            665555444333221                      11111223456788999999999999999999983

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=212.83  Aligned_cols=187  Identities=23%  Similarity=0.388  Sum_probs=154.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||+|+|+++++..     .-+|||+|||. |+|.++++...  .++.-...+++.||..|++||..+++||||+-..|+|
T Consensus       323 pNLVqLLGVCT~E-----pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCL  397 (1157)
T KOG4278|consen  323 PNLVQLLGVCTHE-----PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  397 (1157)
T ss_pred             ccHHHHhhhhccC-----CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcc
Confidence            8999999999987     78999999996 89999998653  4666677889999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCccccccc---ccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~---~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      ++++..+|++|||+++.+...... ...|   ..-|.|||.+. ...++.++|||+|||++||+.| |-.||+|-+..+.
T Consensus       398 VgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV  475 (1157)
T KOG4278|consen  398 VGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  475 (1157)
T ss_pred             ccccceEEeeccchhhhhcCCcee-cccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Confidence            999999999999999987655322 1222   34599999884 4558999999999999999986 8899999988777


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      +..+.+-..-                             +.-.+.++.+.+||+.|++|+|..||+.+|+
T Consensus       476 Y~LLEkgyRM-----------------------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  476 YGLLEKGYRM-----------------------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHhccccc-----------------------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            6655431100                             0112567788999999999999999999887

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-29  Score=222.35  Aligned_cols=190  Identities=23%  Similarity=0.361  Sum_probs=165.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||++|-++.+-.     +-+.||+|||+ |+|..+++++ +.|+..+..-+++-|+.|++||-+.|+|||||-..|||+
T Consensus       690 PNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  690 PNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV  764 (996)
T ss_pred             CcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee
Confidence            8999999999887     88999999998 7999999876 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-ccccccc---ccccCChhhhhCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETD-FMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~---~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~  153 (277)
                      +.+-.+|++|||+++...+.. ...+..|   ..+|.|||.+.. +.++.++||||+|+++||.+ .|..||.+.++.+.
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            999999999999999875543 2222222   467999999854 55999999999999999976 59999999999999


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +..+.+-.+-|+.                             .+.+..+-+|+..|+++|-..||+..+|++
T Consensus       844 IkaIe~gyRLPpP-----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  844 IKAIEQGYRLPPP-----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHhccCCCCC-----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            8888876665553                             256778999999999999999999999887

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=2.7e-27  Score=230.72  Aligned_cols=197  Identities=19%  Similarity=0.288  Sum_probs=140.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH---SANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH---~~~i~H~di~~~ni   76 (277)
                      ||||++++++.+.     +..|+||||++ |+|.+++..   +++..+..++.|++.|++|||   +.+++|||+||+||
T Consensus       743 pnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Ni  814 (968)
T PLN00113        743 PNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI  814 (968)
T ss_pred             CCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhE
Confidence            8999999999887     78899999997 699999863   889999999999999999999   66999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 023764           77 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-VHQLR  155 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~  155 (277)
                      +++.++..++. +|.......   .....+++.|+|||++.. ..++.++||||+||++|||++|+.||..... .....
T Consensus       815 l~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~  889 (968)
T PLN00113        815 IIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV  889 (968)
T ss_pred             EECCCCceEEE-ecccccccc---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHH
Confidence            99988887765 554432221   123367889999998854 4589999999999999999999999853211 00111


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC---CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF---PNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...........         ..       ...........   +....++.+++.+|++.||++|||++++++.
T Consensus       890 ~~~~~~~~~~~---------~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        890 EWARYCYSDCH---------LD-------MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHhcCccc---------hh-------heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11110000000         00       00000000000   0112357889999999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1e-26  Score=214.35  Aligned_cols=190  Identities=28%  Similarity=0.469  Sum_probs=152.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+.++++++.+     +.+++|+||+. |+|.+++++++                .++......+++||+.|++||++
T Consensus       362 ~niv~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~  436 (609)
T KOG0200|consen  362 PNIVNLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS  436 (609)
T ss_pred             cchhhheeeeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh
Confidence            7999999999886     88999999997 89999998765                38889999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCccc--ccc--cccccCChhhhhCCCCCCcchhHHHHHHHHHHHH
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYV--VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  139 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll  139 (277)
                      ..++|||+-..|||++.+..+|++|||+++.........  ...  -...|||||.+.. ..|+.++||||+|+++||++
T Consensus       437 ~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~Eif  515 (609)
T KOG0200|consen  437 VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIF  515 (609)
T ss_pred             CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHh
Confidence            999999999999999999999999999998654433221  112  2445999999965 66999999999999999998


Q ss_pred             c-CCCCCCCCC-hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC
Q 023764          140 D-RKPLFPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  217 (277)
Q Consensus       140 ~-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  217 (277)
                      + |..||++-. ..+.+..+.+ ....                            +.....+.++.++++.|++.+|++|
T Consensus       516 sLG~~PYp~~~~~~~l~~~l~~-G~r~----------------------------~~P~~c~~eiY~iM~~CW~~~p~~R  566 (609)
T KOG0200|consen  516 TLGGTPYPGIPPTEELLEFLKE-GNRM----------------------------EQPEHCSDEIYDLMKSCWNADPEDR  566 (609)
T ss_pred             hCCCCCCCCCCcHHHHHHHHhc-CCCC----------------------------CCCCCCCHHHHHHHHHHhCCCcccC
Confidence            6 889998744 3333222211 1110                            0111457889999999999999999


Q ss_pred             CCHHHHhc
Q 023764          218 ITVEDALA  225 (277)
Q Consensus       218 ~t~~ell~  225 (277)
                      |+..++..
T Consensus       567 P~F~~~~~  574 (609)
T KOG0200|consen  567 PTFSECVE  574 (609)
T ss_pred             CCHHHHHH
Confidence            99888754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-28  Score=212.90  Aligned_cols=201  Identities=27%  Similarity=0.431  Sum_probs=162.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||.+++-|.-.     ..+++.||||+ |+|.+...-.+++++.++.++.+..+.|++|||+.|=+|||||-.||+++
T Consensus        72 ~nivay~gsylr~-----dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt  146 (829)
T KOG0576|consen   72 PNIVAYFGSYLRR-----DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT  146 (829)
T ss_pred             cChHHHHhhhhhh-----cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec
Confidence            7999999999877     88999999998 59999888889999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhh--hCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELL--LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~--~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ..|.+|+.|||.+...+.. ....++.||++|||||+-  .+.+.|...+|||++|+...|+-.-++|.........+..
T Consensus       147 d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L  226 (829)
T KOG0576|consen  147 DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL  226 (829)
T ss_pred             ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH
Confidence            9999999999998654432 345678999999999984  3345589999999999999998777777544433333322


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +.+..-.|+-                        + +.-...++.+-+|++.+|.++|+||||++.+|.|||+..
T Consensus       227 mTkS~~qpp~------------------------l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  227 MTKSGFQPPT------------------------L-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             hhccCCCCCc------------------------c-cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            2222111111                        1 111245778899999999999999999999999999975

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.1e-28  Score=219.19  Aligned_cols=209  Identities=28%  Similarity=0.394  Sum_probs=159.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ||++..++.+.+.     ...+-+||||+++|+.++...+.++...+-.++.|++.|++|+|+.|+.|||+|++|+++..
T Consensus       381 ~~~~e~l~~~~~~-----~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~  455 (601)
T KOG0590|consen  381 PNIIETLDIVQEI-----DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE  455 (601)
T ss_pred             CchhhhHHHHhhc-----ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec
Confidence            4565556665554     33444499999999999998778999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC-----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           81 NCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      +|.+|++|||.+....-.     ......+|+..|+|||++.+...-.+..||||.|+++..|++|+.||.-....+..-
T Consensus       456 ~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~  535 (601)
T KOG0590|consen  456 NGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF  535 (601)
T ss_pred             CCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch
Confidence            999999999998654322     234456889999999999776655778999999999999999999995433222110


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                         .                ...+.  ...............++...+.+|.+||++||.+|.|+++|++.+||+.+...
T Consensus       536 ---~----------------~~~~~--~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  536 ---K----------------TNNYS--DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ---h----------------hhccc--cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence               0                00000  00000111122233567788999999999999999999999999999987643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=206.76  Aligned_cols=140  Identities=24%  Similarity=0.437  Sum_probs=128.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+|++++|.++     +.+||+||--+ | +|+++|+-++++++.+++.|++|++.|+++||+.||+|||||-+|+.+
T Consensus       629 ~NIlKlLdfFEdd-----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv  703 (772)
T KOG1152|consen  629 ENILKLLDFFEDD-----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV  703 (772)
T ss_pred             cchhhhhheeecC-----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE
Confidence            7999999999998     99999999986 4 999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      +.+|.+||+|||.+..... ..+..+.||..|+|||++.+.+..+..-|||+||+++|.++....||.
T Consensus       704 d~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999998865543 356788999999999999777767899999999999999998888875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-26  Score=205.27  Aligned_cols=195  Identities=22%  Similarity=0.337  Sum_probs=160.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||+|+||+++.+      .-..+|||++. |+|.+.+.+  ...|-......++.||+.|+.||.++++||||+-..|++
T Consensus       171 ~hliRLyGvVl~------qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll  244 (1039)
T KOG0199|consen  171 PHLIRLYGVVLD------QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL  244 (1039)
T ss_pred             cceeEEeeeecc------chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence            799999999987      45679999997 799999987  356888888999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCccccccc----ccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVV----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  152 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~----~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  152 (277)
                      +-..-.+||+|||+.+..+..+..+...+    ...|+|||.+. ...++.++|+|++||.+|||++ |.-||.|....+
T Consensus       245 lasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q  323 (1039)
T KOG0199|consen  245 LASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ  323 (1039)
T ss_pred             ecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence            98888999999999998877654443322    34599999995 4569999999999999999986 889999998888


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ++..+-+...-                             ..-+..+.++.+++..|+..+|.+|||+..|.+.-+...
T Consensus       324 IL~~iD~~erL-----------------------------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  324 ILKNIDAGERL-----------------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHhccccccC-----------------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            77765421111                             011245678999999999999999999999875544443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=5.3e-25  Score=176.32  Aligned_cols=161  Identities=37%  Similarity=0.685  Sum_probs=140.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     ...++++|+++ ++|.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||++
T Consensus        51 ~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~  125 (215)
T cd00180          51 PNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL  125 (215)
T ss_pred             CCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE
Confidence            6899999999887     88999999998 6999999875 478999999999999999999999999999999999999


Q ss_pred             ec-CCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NA-NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +. ++.++|+|||.+....... ......+...|++||........+.+.|+|++|++++++                  
T Consensus       126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------  187 (215)
T cd00180         126 DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------  187 (215)
T ss_pred             eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------
Confidence            99 8999999999987665432 123355778899999885543578999999999999998                  


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                                                                 ..+.+++.+|++.||++||+++++++|+
T Consensus       188 -------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                                       1467899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-24  Score=184.68  Aligned_cols=212  Identities=22%  Similarity=0.244  Sum_probs=150.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---------NVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---------~i~H~d   70 (277)
                      |||++++.+-.-.+ ...-.++||++|-+ |+|.+++.. ..+++....+++..+++||+|||+.         .|+|||
T Consensus       264 ~nIl~Fi~~ekr~t-~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD  341 (534)
T KOG3653|consen  264 ENILQFIGAEKRGT-ADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD  341 (534)
T ss_pred             hhHHHhhchhccCC-ccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence            56777766654421 11257999999986 899999987 4589999999999999999999973         499999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCC-----cchhHHHHHHHHHHHHcCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYT-----AAIDVWSVGCIFMELMDRK  142 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g~  142 (277)
                      ||..|||+..|+++-|+|||++......   ......+||.+|||||++.+.-++.     .+.||||+|.+++||+++.
T Consensus       342 lkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  342 LKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             ccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            9999999999999999999999765432   2233478999999999997655544     4699999999999999877


Q ss_pred             CCCC-CCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          143 PLFP-GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       143 ~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      ..+. +....-++..-.+....|+.+.+..+--    --+..|.++.....-   ..-..+++.+..|++.|++.|.||.
T Consensus       422 ~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV----~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  422 TDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV----RKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             ccccCCCCCcccCchhHHhcCCCCHHHHHHHHH----hhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhH
Confidence            6654 3333333333334444555443322210    001111111111000   1234589999999999999999974

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-25  Score=177.51  Aligned_cols=200  Identities=23%  Similarity=0.356  Sum_probs=144.2

Q ss_pred             ceeeeeccc-cCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            2 QVVAIRDII-PPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         2 niv~l~~~~-~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||+.-|++. ...     +.+++++||++ |+|..-+... .+-+...+.++.|+++|+.|+|+.++||||||.+||||-
T Consensus        82 hIi~tY~vaFqt~-----d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif  155 (378)
T KOG1345|consen   82 HIIDTYEVAFQTS-----DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF  155 (378)
T ss_pred             hhhHHHHHHhhcC-----ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence            455555543 333     78889999998 8999888764 478899999999999999999999999999999999994


Q ss_pred             c--CCCeEEeeccceeeccCCCcccccccccccCChhhhhCC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           80 A--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        80 ~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      .  ..++||||||.+...+..  ....-.+..|.+||.....    -...+..|||++|++++.+++|++||......  
T Consensus       156 ~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--  231 (378)
T KOG1345|consen  156 DADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--  231 (378)
T ss_pred             cCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--
Confidence            3  347999999999876643  2222345568888876422    12467899999999999999999999532211  


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDALAHPYLG  230 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~ell~hp~f~  230 (277)
                               .++...+..+          .. ......++.|...++.+..+.++-|..+|++|   -+++.....-|..
T Consensus       232 ---------d~~Y~~~~~w----------~~-rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  232 ---------DKPYWEWEQW----------LK-RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             ---------CchHHHHHHH----------hc-ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence                     1111111111          11 11123455666788899999999999999999   5666666666664


Q ss_pred             C
Q 023764          231 S  231 (277)
Q Consensus       231 ~  231 (277)
                      .
T Consensus       292 ~  292 (378)
T KOG1345|consen  292 K  292 (378)
T ss_pred             h
Confidence            3

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.91  E-value=1.9e-23  Score=169.72  Aligned_cols=142  Identities=37%  Similarity=0.683  Sum_probs=124.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..++++|++++ +|.+++..... +++..+..++.|++.++.+||++|++|+|++|.||++
T Consensus        57 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v  131 (225)
T smart00221       57 PNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL  131 (225)
T ss_pred             CChhhheeeeecC-----CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            6889999988776     889999999986 99999987766 8999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      +.++.++|+|||.+.......  ......++..|++||.+.....++.++|+|++|+++++|++|+.||.+
T Consensus       132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999999999987765442  334556788899999874344577899999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=4.8e-24  Score=191.83  Aligned_cols=189  Identities=23%  Similarity=0.323  Sum_probs=151.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||++|+++...+      .+-||++||+ |+|.++++.+ .++-......|.+||+.|+.|||+++++||||-..|||+
T Consensus       758 pnl~RLLgvc~~s------~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV  831 (1177)
T KOG1025|consen  758 PNLLRLLGVCMLS------TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV  831 (1177)
T ss_pred             chHHHHhhhcccc------hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence            7999999999875      3789999997 7999999865 578888999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccc---cccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYV---VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ..-..+|+.|||+++............   ..+-|||-|.+.. ..|+.++||||+||.+||++| |..|+.+....++-
T Consensus       832 ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~  910 (1177)
T KOG1025|consen  832 KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP  910 (1177)
T ss_pred             cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh
Confidence            999999999999998776554332222   2455888888754 559999999999999999986 99999877655543


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.. ..+                      .      ..-|.-+-++--++.+|+..|+..||+++++..
T Consensus       911 dlle~-geR----------------------L------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  911 DLLEK-GER----------------------L------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHhc-ccc----------------------C------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            33221 100                      0      112345668889999999999999999988754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.2e-23  Score=175.40  Aligned_cols=197  Identities=19%  Similarity=0.280  Sum_probs=140.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--------~i~H~di   71 (277)
                      +||..+.+.=..+ +.....++||++|-+ |+|+|++.. ..++.+...+++..++.||+|||..        .|.||||
T Consensus       265 ENILgFIaaD~~~-~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl  342 (513)
T KOG2052|consen  265 ENILGFIAADNKD-NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL  342 (513)
T ss_pred             chhhhhhhccccC-CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence            4666555544332 244568999999997 899999987 6799999999999999999999963        3999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCC-----CcccccccccccCChhhhhCCCCC-----CcchhHHHHHHHHHHHHcC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~-----~~~~DiwslG~il~~ll~g  141 (277)
                      |..||++..+|.+-|+|+|++......     ...+..+||.+|||||++...-..     =..+||||+|.++||+..+
T Consensus       343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999765443     245667899999999999654321     1368999999999998732


Q ss_pred             ----------CCCCCCCChH----HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCC--hhHHHH
Q 023764          142 ----------KPLFPGRDHV----HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDL  205 (277)
Q Consensus       142 ----------~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l  205 (277)
                                .+||.+....    +.+++++-.                        +..++.++..+...+  ..+..+
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv------------------------~~~RP~ipnrW~s~~~l~~m~kl  478 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCV------------------------QKLRPNIPNRWKSDPALRVMAKL  478 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceee------------------------cccCCCCCcccccCHHHHHHHHH
Confidence                      4566443221    112211110                        001111222221111  235678


Q ss_pred             HHHhcCCCCCCCCCHHHH
Q 023764          206 VEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       206 i~~~L~~dP~~R~t~~el  223 (277)
                      |+.|+..||..|.||--+
T Consensus       479 MkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  479 MKECWYANPAARLTALRI  496 (513)
T ss_pred             HHHhhcCCchhhhHHHHH
Confidence            999999999999997554

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.88  E-value=6e-22  Score=165.46  Aligned_cols=191  Identities=18%  Similarity=0.270  Sum_probs=147.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHH-----hC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-----SN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-----~~---~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      ||+..+.++..++.    ..-++++.+++ |+|..++.     +.   ..++..+...++.|+..|++|||++|++|.||
T Consensus       347 ~nll~V~~V~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi  422 (563)
T KOG1024|consen  347 PNLLSVLGVSIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI  422 (563)
T ss_pred             CCccceeEEEeecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence            68888888877653    56688999998 89999997     21   24677778889999999999999999999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPG  147 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  147 (277)
                      -..|.+|++.-++||+|=.+++..-..+   .....-.+..||+||.+.+. .|+.++|+|||||++|||++ |+.|+..
T Consensus       423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~Pyae  501 (563)
T KOG1024|consen  423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAE  501 (563)
T ss_pred             hhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence            9999999999999999998887432221   11222335669999999654 59999999999999999986 8899876


Q ss_pred             CChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      -+..+....+.+-                       -+...+      -+.++++-.++..|+..+|++||+.+++..
T Consensus       502 IDPfEm~~ylkdG-----------------------yRlaQP------~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  502 IDPFEMEHYLKDG-----------------------YRLAQP------FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cCHHHHHHHHhcc-----------------------ceecCC------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            6655544333221                       111111      146778999999999999999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.8e-22  Score=165.70  Aligned_cols=196  Identities=22%  Similarity=0.330  Sum_probs=144.2

Q ss_pred             CceeeeeccccCCCC----------------------CCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQR----------------------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL   58 (277)
Q Consensus         1 pniv~l~~~~~~~~~----------------------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al   58 (277)
                      ||||++..+|.++..                      .....+|+||.....+|.+++-.+ ..+....+-++.|+++|+
T Consensus       276 PNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav  354 (598)
T KOG4158|consen  276 PNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAV  354 (598)
T ss_pred             CCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHH
Confidence            899999999876421                      122469999999999999999874 467788888999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEe--cC--CCeEEeeccceeeccCCC-------cccccccccccCChhhhhCCCC-----C
Q 023764           59 KYIHSANVLHRDLKPSNLLLN--AN--CDLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNSSD-----Y  122 (277)
Q Consensus        59 ~~LH~~~i~H~di~~~nil~~--~~--~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~-----~  122 (277)
                      .|||++|+.|||+|.+||++.  .+  ..+.++|||++-......       ......|.-..||||+......     .
T Consensus       355 ~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvn  434 (598)
T KOG4158|consen  355 THLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVN  434 (598)
T ss_pred             HHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeec
Confidence            999999999999999999993  33  347999999985433211       1123346677899998743211     1


Q ss_pred             CcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhH
Q 023764          123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA  202 (277)
Q Consensus       123 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (277)
                      -.++|.|+.|.+.||+++...||.+......                            ....++...++.....+++.+
T Consensus       435 y~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------------~~r~Yqe~qLPalp~~vpp~~  486 (598)
T KOG4158|consen  435 YEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------------DTRTYQESQLPALPSRVPPVA  486 (598)
T ss_pred             cchhhhhhhhhhHHHHhccCCcccccchhee----------------------------chhhhhhhhCCCCcccCChHH
Confidence            2478999999999999999999976432110                            000122222333334678899


Q ss_pred             HHHHHHhcCCCCCCCCC---HHHHhc
Q 023764          203 IDLVEKMLTFDPRQRIT---VEDALA  225 (277)
Q Consensus       203 ~~li~~~L~~dP~~R~t---~~ell~  225 (277)
                      ++++..+|+.||+||++   |..+++
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999999   456665

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.9e-23  Score=181.99  Aligned_cols=187  Identities=22%  Similarity=0.431  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |.+++++-.|..+     +++|+++++.. |+|...+.+...+++...+.+...++.|++++|+.|++|||+|++||+++
T Consensus        57 ~f~v~lhyafqt~-----~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld  131 (612)
T KOG0603|consen   57 PFLVKLHYAFQTD-----GKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL  131 (612)
T ss_pred             Cceeeeeeeeccc-----cchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec
Confidence            5789999999998     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+++.|||+++..-..+..   +|+.-|||||+..   ....++|.||+|++.++|++|..||.+    +....|.+
T Consensus       132 ~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~  201 (612)
T KOG0603|consen  132 LEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK  201 (612)
T ss_pred             ccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence            9999999999998765544322   8999999999985   367899999999999999999999977    44444443


Q ss_pred             H-hCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCC
Q 023764          160 L-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~~  233 (277)
                      . .+.|.                               .++..+++++..++..+|.+|.-     +.++++|+||+.+.
T Consensus       202 ~~~~~p~-------------------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  202 AELEMPR-------------------------------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             hccCCch-------------------------------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence            1 11111                               35678999999999999999986     57999999998763

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=187.26  Aligned_cols=192  Identities=23%  Similarity=0.381  Sum_probs=140.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ||.+.+..+...+     ...|+|-+|...+|.|.+..++-+..-+.+.|+.|++.||..+|+.||+|||||.+|||++.
T Consensus        81 pn~lPfqk~~~t~-----kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS  155 (1431)
T KOG1240|consen   81 PNCLPFQKVLVTD-----KAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS  155 (1431)
T ss_pred             CcccchHHHHHhh-----HHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee
Confidence            5666666665444     67899999999999999998887888999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC--------cccccccccccCChhhhhCCC----------CCCcchhHHHHHHHHHHHHc-C
Q 023764           81 NCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMD-R  141 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~-g  141 (277)
                      =..+.|+||...++..-+.        .+.+...-..|.|||.+....          ..+++-||||+||+++|+++ |
T Consensus       156 WNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg  235 (1431)
T KOG1240|consen  156 WNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG  235 (1431)
T ss_pred             echhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC
Confidence            9999999998765432221        112222334599999986522          15678999999999999975 7


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      .+||.-       ..+.+.-.-. ...                   ....-+..  -+...+.+|..|++.||++|.+|+
T Consensus       236 ~PlF~L-------SQL~aYr~~~-~~~-------------------~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAe  286 (1431)
T KOG1240|consen  236 RPLFTL-------SQLLAYRSGN-ADD-------------------PEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAE  286 (1431)
T ss_pred             CCcccH-------HHHHhHhccC-ccC-------------------HHHHHHhC--cCccHHHHHHHHHccCchhccCHH
Confidence            998821       1111110000 000                   00000111  133689999999999999999999


Q ss_pred             HHhcC
Q 023764          222 DALAH  226 (277)
Q Consensus       222 ell~h  226 (277)
                      +.|+-
T Consensus       287 dyL~~  291 (1431)
T KOG1240|consen  287 DYLQK  291 (1431)
T ss_pred             HHHHh
Confidence            99985

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=1.4e-21  Score=161.88  Aligned_cols=162  Identities=20%  Similarity=0.283  Sum_probs=110.4

Q ss_pred             cEEEEeecCcccHHHHHHh---CC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccce
Q 023764           20 DVYIAYELMDTDLHQIIRS---NQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   92 (277)
Q Consensus        20 ~~~lv~e~~~~~L~~~l~~---~~----~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~   92 (277)
                      +.+++|+.+.++|.+++.-   ..    .+.......+..|++..+++||+.|++|+||+|+|++++.+|.+.|+||+..
T Consensus       113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            4588999999999888652   11    1233344566799999999999999999999999999999999999999988


Q ss_pred             eeccCCCcccccccccccCChhhhhCC-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Q 023764           93 RVTSETDFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS  165 (277)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  165 (277)
                      ...+.....  ...+..|.+||.....       -.++.+.|.|+||+++|.|+||..||........            
T Consensus       193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~------------  258 (288)
T PF14531_consen  193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD------------  258 (288)
T ss_dssp             EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST------------
T ss_pred             eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc------------
Confidence            766654322  3445779999987442       2368899999999999999999999954321100            


Q ss_pred             hHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC
Q 023764          166 EAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  217 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  217 (277)
                                           ....+..+. +++..+++||++||++||.+|
T Consensus       259 ---------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  259 ---------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ---------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                                 000334444 788899999999999999988

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=2.7e-20  Score=158.63  Aligned_cols=208  Identities=31%  Similarity=0.525  Sum_probs=159.1

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||+++++++...     +..+++++++. +++.+++....   .++...+..++.|++.++.++|+.|++|||+||+||+
T Consensus        59 ~i~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil  133 (384)
T COG0515          59 NIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL  133 (384)
T ss_pred             ceeeEEEEEecC-----CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence            689999999554     55899999997 58887777664   7999999999999999999999999999999999999


Q ss_pred             EecCC-CeEEeeccceeeccCCC-------cccccccccccCChhhhhCC--CCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           78 LNANC-DLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        78 ~~~~~-~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      ++..+ .++++|||.+.......       ......++..|++||.+...  .......|+||+|++++++++|..||..
T Consensus       134 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~  213 (384)
T COG0515         134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG  213 (384)
T ss_pred             ecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99988 69999999987554332       34667899999999998653  4678999999999999999999999876


Q ss_pred             CCh---HHHHHHHHHHhCCC-ChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          148 RDH---VHQLRLLIELIGTP-SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       148 ~~~---~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ...   .............+ ...                  .......   ......+.+++.+++..+|..|.+..+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~  272 (384)
T COG0515         214 EKNSSATSQTLKIILELPTPSLAS------------------PLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSD  272 (384)
T ss_pred             CCccccHHHHHHHHHhcCCccccc------------------ccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence            654   22222222222211 000                  0000000   1223578899999999999999999999


Q ss_pred             hcCCCCCCCCCC
Q 023764          224 LAHPYLGSLHDI  235 (277)
Q Consensus       224 l~hp~f~~~~~~  235 (277)
                      ..+++.......
T Consensus       273 ~~~~~~~~~~~~  284 (384)
T COG0515         273 LSHDLLAHLKLK  284 (384)
T ss_pred             hhchHhhCcccc
Confidence            988777665443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=5.2e-19  Score=152.03  Aligned_cols=194  Identities=18%  Similarity=0.155  Sum_probs=141.4

Q ss_pred             ceeeeecccc-CCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            2 QVVAIRDIIP-PPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         2 niv~l~~~~~-~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ++.++++... ..     ..-|+||++++.+|.++....  +.++...+.+++.|++.+|++||+.|++||||||.|+++
T Consensus        81 ~~~~~~~~G~~~~-----~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~  155 (322)
T KOG1164|consen   81 HFPKLLDHGRSTE-----DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVV  155 (322)
T ss_pred             CCCEEEEeccCCC-----ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeee
Confidence            5677777774 33     678999999999999988654  579999999999999999999999999999999999999


Q ss_pred             ecC-----CCeEEeecccee--eccCCC--------c-ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCC
Q 023764           79 NAN-----CDLKICDFGLAR--VTSETD--------F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  142 (277)
Q Consensus        79 ~~~-----~~~~l~dfg~~~--~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  142 (277)
                      +..     ..+.+.|||+++  ......        . .....||..|+++.+..+. ..+++.|+||++.++.+++.|.
T Consensus       156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~  234 (322)
T KOG1164|consen  156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGS  234 (322)
T ss_pred             cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCC
Confidence            765     358999999998  321110        1 1234599999999987544 4799999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||.+........+..+......                         ........+..+.++...+-..+...+|....
T Consensus       235 LPW~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~  289 (322)
T KOG1164|consen  235 LPWEALEMTDLKSKFEKDPRKLL-------------------------TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEK  289 (322)
T ss_pred             CCCccccccchHHHHHHHhhhhc-------------------------cccccCCChHHHHHHHHHhhccCCcCCCCHHH
Confidence            99966553332222221100000                         00011123456677777777788888888666


Q ss_pred             HhcC
Q 023764          223 ALAH  226 (277)
Q Consensus       223 ll~h  226 (277)
                      +...
T Consensus       290 ~~~~  293 (322)
T KOG1164|consen  290 LAEL  293 (322)
T ss_pred             HHHH
Confidence            5443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=3.6e-20  Score=160.46  Aligned_cols=175  Identities=26%  Similarity=0.459  Sum_probs=131.7

Q ss_pred             CcEEEEeecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           19 NDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        19 ~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      ..+||.|++|. .+|.+++..+.   ..+......++.|+..|++|   +|.+|+|+||.||++..+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            46899999997 79999997543   36677889999999999999   9999999999999999999999999999865


Q ss_pred             ccCCC-------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCh
Q 023764           95 TSETD-------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSE  166 (277)
Q Consensus        95 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~  166 (277)
                      .....       ..+...||..||+||.+.+ ..|+.++||||||+|++|++.- ...|      +.++....       
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d-------  471 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF------ERIATLTD-------  471 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhh-------
Confidence            54433       4456789999999999964 5699999999999999999862 1111      11111100       


Q ss_pred             HhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          167 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                                         .....+++.+-.-.+.-.+|+..||...|.+||++.+.--|+|.
T Consensus       472 -------------------~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  472 -------------------IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             -------------------hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                               00111111111223456789999999999999988887777764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=1.6e-19  Score=167.03  Aligned_cols=151  Identities=29%  Similarity=0.487  Sum_probs=123.4

Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCC---------------Cc-ccccccccccCChhhhh
Q 023764           54 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---------------DF-MTEYVVTRWYRAPELLL  117 (277)
Q Consensus        54 ll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~---------------~~-~~~~~~~~~~~aPE~~~  117 (277)
                      ++.+++|||+-||+|||+||+|.+|+.-|.+|+.|||+++.....               .. -...+||+.|.|||++.
T Consensus       152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            378899999999999999999999999999999999998653211               01 12348999999999987


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCC
Q 023764          118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  197 (277)
Q Consensus       118 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (277)
                      ..+ |+..+|.|++|+|+|+.+-|+.||.+....+.....+.....                           +.+.-..
T Consensus       232 rqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~---------------------------wpE~dea  283 (1205)
T KOG0606|consen  232 RQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---------------------------WPEEDEA  283 (1205)
T ss_pred             hhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc---------------------------ccccCcC
Confidence            654 999999999999999999999999998887776665543221                           1122335


Q ss_pred             CChhHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCC
Q 023764          198 VHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  232 (277)
Q Consensus       198 ~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~f~~~  232 (277)
                      ++++++++|..+|+.+|..|.-   +-++.+|+||+.+
T Consensus       284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            7889999999999999999984   6788999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.77  E-value=4.2e-18  Score=136.67  Aligned_cols=185  Identities=16%  Similarity=0.265  Sum_probs=141.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~n   75 (277)
                      |||..+++.+..+     .++.++..||+ |+|..++.....  .+..++.+++..+++|++|||+..  |.--.+....
T Consensus       247 pnilpvlgacnsp-----pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h  321 (448)
T KOG0195|consen  247 PNILPVLGACNSP-----PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH  321 (448)
T ss_pred             CchhhhhhhccCC-----CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence            8999999999888     89999999998 799999987654  577889999999999999999985  4344677888


Q ss_pred             EEEecCCCeEEe--eccceeeccCCCcccccccccccCChhhhhCCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           76 LLLNANCDLKIC--DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        76 il~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      ++++++.+.+|.  |--++...      .....+|.|++||.+.+...  .-.++|+||++++++|+.|...||.+.+..
T Consensus       322 vmidedltarismad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm  395 (448)
T KOG0195|consen  322 VMIDEDLTARISMADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM  395 (448)
T ss_pred             EEecchhhhheecccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence            999988766554  32222111      12245788999999976443  246899999999999999999999877765


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      +--.++.-. |.                           -..+.|+++..+..|+.-|+..||.+||..+.++
T Consensus       396 ecgmkiale-gl---------------------------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  396 ECGMKIALE-GL---------------------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             hhhhhhhhc-cc---------------------------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            533332211 00                           0123467888999999999999999999987653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=1.6e-17  Score=131.10  Aligned_cols=157  Identities=20%  Similarity=0.288  Sum_probs=123.3

Q ss_pred             eeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC
Q 023764            3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN   81 (277)
Q Consensus         3 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~   81 (277)
                      |..+..+.++.     +.-.+|||+++++|.++..- .++++...+.-++-|++.-++|+|.++++||||||+|+|.+-.
T Consensus        73 iP~i~~y~~e~-----~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg  147 (341)
T KOG1163|consen   73 IPHIRHYGTEK-----DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG  147 (341)
T ss_pred             Cchhhhhcccc-----ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc
Confidence            55666666665     77789999999988887653 3679999999999999999999999999999999999998643


Q ss_pred             ---CCeEEeeccceeeccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-
Q 023764           82 ---CDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-  149 (277)
Q Consensus        82 ---~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  149 (277)
                         ..+.++|||+++..-+..        ......||..|++-....+.. -+.+.|+=|+|.++.++.-|..||.+.. 
T Consensus       148 rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  148 RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccch
Confidence               568999999997644332        223457899999887765433 5788999999999999999999998764 


Q ss_pred             --hHHHHHHHHHHhCCCC
Q 023764          150 --HVHQLRLLIELIGTPS  165 (277)
Q Consensus       150 --~~~~~~~i~~~~~~~~  165 (277)
                        ..+-.++|.+...+.+
T Consensus       227 ~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  227 ATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             hhHHHHHHHHHHhhcCCC
Confidence              3445666666544433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=1.5e-17  Score=146.46  Aligned_cols=201  Identities=23%  Similarity=0.292  Sum_probs=147.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANV-LHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i-~H~di~~~nil   77 (277)
                      .|+.++++...+.     ...++|.+||. |+|.+.+.. ...++......+++.++.|+.|||...| .|+.++..|.+
T Consensus         7 ~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    7 DNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL   81 (484)
T ss_pred             hhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence            4888999999887     89999999998 899999987 3467788888999999999999999876 99999999999


Q ss_pred             EecCCCeEEeeccceeeccC---CCcccccccccccCChhhhhCCC--C----CCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           78 LNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSS--D----YTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~--~----~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      ++....+|+.|||+......   ............|.|||.+....  .    .+.+.||||+|++++|+++...||+..
T Consensus        82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~  161 (484)
T KOG1023|consen   82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR  161 (484)
T ss_pred             eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence            99999999999999876532   11112223455699999985531  1    366799999999999999999999754


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .......+++..+..                  ......++.....- ...+++..+++.|+..+|.+||+++.+-.
T Consensus       162 ~~~~~~~eii~~~~~------------------~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  162 NLVEDPDEIILRVKK------------------GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccCChHHHHHHHHh------------------cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            322211222221100                  00000111111110 34457899999999999999999988744

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.71  E-value=1.9e-16  Score=130.36  Aligned_cols=150  Identities=18%  Similarity=0.294  Sum_probs=121.3

Q ss_pred             CcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCC-----CeEEeeccce
Q 023764           19 NDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-----DLKICDFGLA   92 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~-----~~~l~dfg~~   92 (277)
                      .+=.||+|+++++|.|+..= .+.|+.+.+..++.|++.-++++|++.+|+|||||+|+||+..+     .+.++|||++
T Consensus        97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            45568999999988887763 46799999999999999999999999999999999999997543     4899999999


Q ss_pred             eeccCCCc--------ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHHHHHh
Q 023764           93 RVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR---DHVHQLRLLIELI  161 (277)
Q Consensus        93 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~  161 (277)
                      +..-++.+        ..+..||.+||+--...+.. -+++.|.=|||-++.+.|-|..||.|.   ++.+-+++|-+..
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            76554432        23456899999988776554 588999999999999999999999765   5666777777665


Q ss_pred             CCCChHhh
Q 023764          162 GTPSEAEL  169 (277)
Q Consensus       162 ~~~~~~~~  169 (277)
                      ...+...+
T Consensus       256 r~T~i~~L  263 (449)
T KOG1165|consen  256 RSTPIEVL  263 (449)
T ss_pred             ccCCHHHH
Confidence            54444433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=4.2e-18  Score=155.98  Aligned_cols=201  Identities=25%  Similarity=0.391  Sum_probs=158.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII-RSNQ-ALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l-~~~~-~l~~~~~~~i~~qll~al~~LH-~~~i~H~di~~~ni   76 (277)
                      +|++++++....+     +..++++++.. +++++.+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.
T Consensus        81 ~n~~~~~~~~~~~-----~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~  155 (601)
T KOG0590|consen   81 SNTVHMIEPSSSP-----RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNS  155 (601)
T ss_pred             ccccccCCccCCC-----cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccc
Confidence            4778888888777     88999999986 5888888 5554 6788889999999999999999 99999999999999


Q ss_pred             EEecCC-CeEEeeccceeeccC----CCccccccc-ccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           77 LLNANC-DLKICDFGLARVTSE----TDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        77 l~~~~~-~~~l~dfg~~~~~~~----~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      +++..+ .+++.|||++.....    .......+| ++.|+|||...+....+...|+||+|+++..+++|..|+.....
T Consensus       156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            999999 999999999975443    233445677 99999999987655678999999999999999999999854432


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ....                        +..... .....-...+..++....+++.++|..+|..|.+.+++-.++|+.
T Consensus       236 ~~~~------------------------~~~~~~-~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~  290 (601)
T KOG0590|consen  236 KDGR------------------------YSSWKS-NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLS  290 (601)
T ss_pred             cccc------------------------ceeecc-cccccccCccccCChhhhhcccccccCCchhcccccccccccccc
Confidence            2200                        000000 000111223346788899999999999999999999999999999


Q ss_pred             C
Q 023764          231 S  231 (277)
Q Consensus       231 ~  231 (277)
                      .
T Consensus       291 ~  291 (601)
T KOG0590|consen  291 S  291 (601)
T ss_pred             c
Confidence            8

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=3.2e-16  Score=123.94  Aligned_cols=132  Identities=14%  Similarity=0.069  Sum_probs=94.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL-KPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di-~~~nil~   78 (277)
                      |+|++++++         +..|++|||+.| +|.+.+..      . ...++.|++.+|+++|++||+|||| ||+||++
T Consensus        62 ~~vP~ll~~---------~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv  125 (218)
T PRK12274         62 PRTPRLLHW---------DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV  125 (218)
T ss_pred             CCCCEEEEE---------cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE
Confidence            356666663         346999999976 67544321      1 1357789999999999999999999 7999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc--------------cccccccccCChhhhhCCCCCC-cchhHHHHHHHHHHHHcCCC
Q 023764           79 NANCDLKICDFGLARVTSETDFM--------------TEYVVTRWYRAPELLLNSSDYT-AAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~  143 (277)
                      +.+|.++|+|||++.........              ....+++.++.|+...-....+ .+.+.++.|+-+|.++|+..
T Consensus       126 ~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~  205 (218)
T PRK12274        126 QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV  205 (218)
T ss_pred             cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC
Confidence            99999999999999755433210              0112466778887542222223 45677788999999999998


Q ss_pred             CCCCC
Q 023764          144 LFPGR  148 (277)
Q Consensus       144 pf~~~  148 (277)
                      ++.+.
T Consensus       206 ~~~~~  210 (218)
T PRK12274        206 LHWED  210 (218)
T ss_pred             Ccccc
Confidence            87544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.66  E-value=1.1e-16  Score=128.99  Aligned_cols=117  Identities=16%  Similarity=0.296  Sum_probs=84.9

Q ss_pred             CceeeeeccccCCCCCC---CCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRES---FNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~---~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |+|..+.+++.+.....   .+..++||||++| +|.++.    .++++    ...+++.++..+|+.|++|||++|.|+
T Consensus        95 ~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Ni  166 (232)
T PRK10359         95 EGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNF  166 (232)
T ss_pred             CCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHE
Confidence            57777777766542211   2568999999987 887773    23332    456999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHH
Q 023764           77 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  138 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~l  138 (277)
                      +++.+| ++++|||......+.....           ..+.. ..+..++|+||||+.+..+
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhHH-----------HHHHH-hHhcccccccceeEeehHH
Confidence            999998 9999999876443221111           02222 3366899999999988754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=7.8e-16  Score=126.70  Aligned_cols=199  Identities=20%  Similarity=0.215  Sum_probs=140.9

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCC
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   74 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~   74 (277)
                      ||++.+.|++++..++-..+.+++|||. |++.+++++.    ..+.....++|+.||+.||.|||+..  |+|+++...
T Consensus       128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~  207 (458)
T KOG1266|consen  128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD  207 (458)
T ss_pred             HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence            7899999999987766688999999997 7999998753    46888899999999999999999986  999999999


Q ss_pred             cEEEecCCCeEEeeccce--eecc---CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC-CC
Q 023764           75 NLLLNANCDLKICDFGLA--RVTS---ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-GR  148 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~--~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~  148 (277)
                      .|++..+|.+|++.-...  ....   .........+-++|.+||.-. ....+-++|||++|....+|..+..--. +.
T Consensus       208 tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnse  286 (458)
T KOG1266|consen  208 TIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSE  286 (458)
T ss_pred             heeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence            999999998887743221  1111   011112234567788998542 2335678999999999999976653211 11


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      +....-..+..                                 ..+..-+..-++++.+||+-.|..||++++++.||.
T Consensus       287 S~~~~ee~ia~---------------------------------~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  287 SKVEVEENIAN---------------------------------VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             ceeehhhhhhh---------------------------------heeeccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence            10000000000                                 000111223467899999999999999999999998


Q ss_pred             CCCCCC
Q 023764          229 LGSLHD  234 (277)
Q Consensus       229 f~~~~~  234 (277)
                      .-.++.
T Consensus       334 lfeVhs  339 (458)
T KOG1266|consen  334 LFEVHS  339 (458)
T ss_pred             eeecch
Confidence            877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.58  E-value=3.6e-15  Score=118.30  Aligned_cols=75  Identities=19%  Similarity=0.286  Sum_probs=64.5

Q ss_pred             EEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           21 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        21 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~L-H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      .+|||||++| ++.....+.+.++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++|+|||++....
T Consensus        92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            3899999986 5555444457899999999999999999999 799999999999999998 5789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=5e-15  Score=139.34  Aligned_cols=124  Identities=23%  Similarity=0.337  Sum_probs=108.5

Q ss_pred             CcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec-------CCCeEEeecc
Q 023764           19 NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-------NCDLKICDFG   90 (277)
Q Consensus        19 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~-------~~~~~l~dfg   90 (277)
                      +..+||+||.+ |+|.+++...+.+++..+..++.|++.-+++||..+|||+||||+|+++..       ..-++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            66799999997 899999998899999999999999999999999999999999999999942       3458999999


Q ss_pred             cee---eccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           91 LAR---VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        91 ~~~---~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      .+.   ...+...+...++|-.+-++|+..+ .+.+..+|.|.++.+++.||.|+.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            985   3344456677788999999998854 569999999999999999998863

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.58  E-value=5.8e-15  Score=127.50  Aligned_cols=93  Identities=24%  Similarity=0.333  Sum_probs=71.4

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEecCCCeEEeeccceeecc
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL-KPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di-~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      +..|+||||++| +|.. +..   ..   ...++.|++.||.+||++||+|||| ||+||+++.++.++|+|||+++...
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            457999999975 6752 211   11   1467899999999999999999999 9999999999999999999998654


Q ss_pred             CCCc---------ccccccccccCChhhhhC
Q 023764           97 ETDF---------MTEYVVTRWYRAPELLLN  118 (277)
Q Consensus        97 ~~~~---------~~~~~~~~~~~aPE~~~~  118 (277)
                      ....         .....++..|.+||.+..
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3321         123456777899998743

>PRK10345 hypothetical protein; Provisional

Probab=99.56  E-value=1.3e-14  Score=116.31  Aligned_cols=85  Identities=19%  Similarity=0.278  Sum_probs=68.0

Q ss_pred             CceeeeeccccCCCCCCCCcEE-EEeecCc---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVY-IAYELMD---TDLHQIIRSNQALSEEHCQYFLYQILRGL-KYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~-lv~e~~~---~~L~~~l~~~~~l~~~~~~~i~~qll~al-~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.++.  +.+.+| +|+||++   ++|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|
T Consensus        61 ~nIvr~yg~~et~~--g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~N  135 (210)
T PRK10345         61 SGIPRYYGTVETDC--GTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQN  135 (210)
T ss_pred             cccceeeEEEEeCC--CCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence            79999999998752  223444 7899965   699999976 457666  35688888887 99999999999999999


Q ss_pred             EEEec----CCCeEEeecc
Q 023764           76 LLLNA----NCDLKICDFG   90 (277)
Q Consensus        76 il~~~----~~~~~l~dfg   90 (277)
                      |+++.    ++.++|+|++
T Consensus       136 ILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        136 ILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEeccCCCCCcEEEEECC
Confidence            99974    3479999954

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.56  E-value=1.5e-14  Score=115.00  Aligned_cols=76  Identities=20%  Similarity=0.245  Sum_probs=64.5

Q ss_pred             EEEEeecCccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCCCeEEeeccceeeccC
Q 023764           21 VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE   97 (277)
Q Consensus        21 ~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~   97 (277)
                      .|+||||++|. +.........++...+..++.|++.++.++|. .||+||||||+||+++ ++.++|+|||++.....
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            38999999863 43332344678889999999999999999999 9999999999999999 88999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=3.4e-14  Score=125.58  Aligned_cols=194  Identities=26%  Similarity=0.250  Sum_probs=150.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR----GLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qll~----al~~LH~~~i~H~di~~~n   75 (277)
                      +|.++.+..+...     +..|+-+|+|+.+|..+...... ++....+..+.+...    ||.++|+.+++|.|++|.|
T Consensus       178 ~~~v~~~~~~e~~-----~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~  252 (524)
T KOG0601|consen  178 ENPVRDSPAWEGS-----GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPAN  252 (524)
T ss_pred             ccccccCcccccC-----CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhh
Confidence            3556655566555     89999999999999999887655 888899999999999    9999999999999999999


Q ss_pred             EEEecC-CCeEEeeccceeeccCCCccc------ccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           76 LLLNAN-CDLKICDFGLARVTSETDFMT------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        76 il~~~~-~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      |+...+ ..++++|||+...++......      ...+...|++||...  +.++...|++++|.++.+-.++..++..+
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCC
Confidence            999999 889999999998877654221      125677899999874  34799999999999999988887666433


Q ss_pred             --ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          149 --DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       149 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                        +...+.+.+                               ..-.+.....+.++...+..|++.+|..|+++..+++|
T Consensus       331 ~~~~W~~~r~~-------------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  331 KNSSWSQLRQG-------------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             CCCCccccccc-------------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence              111111100                               00112223456667779999999999999999999999


Q ss_pred             CCCCCC
Q 023764          227 PYLGSL  232 (277)
Q Consensus       227 p~f~~~  232 (277)
                      +++..-
T Consensus       380 ~~i~s~  385 (524)
T KOG0601|consen  380 NVIHSK  385 (524)
T ss_pred             ccccch
Confidence            999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=1.2e-13  Score=128.78  Aligned_cols=186  Identities=25%  Similarity=0.374  Sum_probs=148.8

Q ss_pred             CcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccC
Q 023764           19 NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE   97 (277)
Q Consensus        19 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~   97 (277)
                      ...++|++|++ ++|...+.+.+..+.+.++..+..+..++++||...+.|+|++|.|.+...+|..++.+||.....+.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            56899999996 59999999888899899999999999999999999999999999999999999999999973321100


Q ss_pred             ----------C----------------------CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           98 ----------T----------------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        98 ----------~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                                .                      .......+++.|.+||...+.. .+..+|.|+.|+++++.++|.+||
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCC
Confidence                      0                      0112345789999999986654 788999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH---H
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE---D  222 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---e  222 (277)
                      ......+..+-+...                           ..++.......+..+.+++...|..+|.+|..+.   +
T Consensus      1036 na~tpq~~f~ni~~~---------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR---------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred             CCcchhhhhhccccC---------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence            877665554333221                           1122233335678899999999999999999987   8


Q ss_pred             HhcCCCCCCC
Q 023764          223 ALAHPYLGSL  232 (277)
Q Consensus       223 ll~hp~f~~~  232 (277)
                      +-.|+||+..
T Consensus      1089 ~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1089 VKGHPFFQDV 1098 (1205)
T ss_pred             cccCCccCCC
Confidence            9999999865

>smart00090 RIO RIO-like kinase

Probab=99.40  E-value=4.8e-13  Score=109.74  Aligned_cols=76  Identities=17%  Similarity=0.196  Sum_probs=64.7

Q ss_pred             cEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           20 DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        20 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~-i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      ..|+||||++| +|.........++...+..++.|++.++.+||+.| ++|+||||+||+++ ++.++|+|||.+...+
T Consensus       122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            45899999987 56655544456777778899999999999999999 99999999999999 8899999999876544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.35  E-value=3e-12  Score=103.32  Aligned_cols=71  Identities=31%  Similarity=0.462  Sum_probs=62.8

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      +..++||||++| +|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        72 ~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         72 ENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            667999999975 89998865432    7788999999999999999999999999999999 78899999998765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=1.4e-11  Score=110.58  Aligned_cols=129  Identities=20%  Similarity=0.398  Sum_probs=100.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~~i~H~di~~~nil~~   79 (277)
                      |||+++++.+..+     +++|||+|.+. .|..++++   ++...+...++||+.||.||| +.+++|+++...+|+++
T Consensus        69 P~Il~yL~t~e~~-----~~~ylvTErV~-Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn  139 (690)
T KOG1243|consen   69 PNILSYLDTTEEE-----GTLYLVTERVR-PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN  139 (690)
T ss_pred             chhhhhhhhhccc-----CceEEEeeccc-cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc
Confidence            8999999999988     89999999987 34445544   337788889999999999997 67899999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  141 (277)
                      ..|..||++|..+....... .......--.|..|+...   +-....|.|.|||++++++.|
T Consensus       140 ~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~---~s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  140 ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID---PSEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC---ccccchhhhhHHHHHHHHhCc
Confidence            99999999998875443322 122222333466676442   123568999999999999988

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.30  E-value=9.5e-12  Score=102.26  Aligned_cols=69  Identities=29%  Similarity=0.422  Sum_probs=59.1

Q ss_pred             EEEEeecCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           21 VYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        21 ~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      .++|||+++|  +|.+++.. ..+++..    +.|++.++.+||++||+|+||||.||+++.++.++|+|||.+..
T Consensus       121 ~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        121 ADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             eeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            4699999975  88888765 4566543    57899999999999999999999999999999999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.28  E-value=7.8e-12  Score=99.98  Aligned_cols=68  Identities=28%  Similarity=0.487  Sum_probs=59.1

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      +..++||||++| +|.+.+.....       .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            456899999975 88888765321       7899999999999999999999999999999 88999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.27  E-value=1.1e-11  Score=113.83  Aligned_cols=80  Identities=23%  Similarity=0.338  Sum_probs=65.1

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ||+....+....     +..++||||++| +|.+++.        ....++.|++.++.+||+.|++|||+||.||++ .
T Consensus       397 ~i~~p~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~  462 (535)
T PRK09605        397 GVPTPVIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-R  462 (535)
T ss_pred             CCCeeEEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-E
Confidence            444444444343     557899999974 8988875        356789999999999999999999999999999 6


Q ss_pred             CCCeEEeeccceeec
Q 023764           81 NCDLKICDFGLARVT   95 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~   95 (277)
                      ++.++|+|||+++..
T Consensus       463 ~~~~~liDFGla~~~  477 (535)
T PRK09605        463 DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCcEEEEeCcccccC
Confidence            788999999998654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.20  E-value=2.9e-11  Score=96.71  Aligned_cols=72  Identities=22%  Similarity=0.276  Sum_probs=60.2

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      +..++||||++| +|......      .....++.+++.++.++|..|++|+||+|.||+++.++.++|+|||.+....
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            455899999986 67654321      3456788999999999999999999999999999999999999999985544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=6.8e-12  Score=112.93  Aligned_cols=157  Identities=22%  Similarity=0.321  Sum_probs=112.9

Q ss_pred             HHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCCCeEEeeccceeeccCCCc----------ccccccccccCChhhhh
Q 023764           49 YFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLL  117 (277)
Q Consensus        49 ~i~~qll~al~~LH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~  117 (277)
                      .=+.++..|+.++|.. ++||++|.|++|.++..|..||+.|+++.....+..          .........|.|||.+.
T Consensus       103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3345667899999976 899999999999999999999999998754433111          01112355699999986


Q ss_pred             CCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC
Q 023764          118 NSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  196 (277)
Q Consensus       118 ~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (277)
                      . ...+.++|++|+||++|.+. .|+..+.+.........-....+.+..                          ..-.
T Consensus       183 ~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~--------------------------~~s~  235 (700)
T KOG2137|consen  183 G-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAF--------------------------GYSN  235 (700)
T ss_pred             c-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccc--------------------------cccc
Confidence            5 45789999999999999988 666666544333222211111111000                          0003


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       197 ~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+++++++=|.++|..++..||++..++..|||+..
T Consensus       236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            578899999999999999999999999999999864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.12  E-value=1.5e-10  Score=91.59  Aligned_cols=76  Identities=21%  Similarity=0.266  Sum_probs=59.1

Q ss_pred             CcEEEEeecCcc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           19 NDVYIAYELMDT-DLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~-~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      ...++||||+++ ++. ..+... ... ..+..++.+++.++.++|. .|++|+|++|+||+++ ++.++++|||.+...
T Consensus        88 ~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119          88 NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            346899999986 221 111111 111 6778899999999999999 9999999999999999 899999999998654


Q ss_pred             cC
Q 023764           96 SE   97 (277)
Q Consensus        96 ~~   97 (277)
                      ..
T Consensus       165 ~~  166 (187)
T cd05119         165 DH  166 (187)
T ss_pred             cC
Confidence            43

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.08  E-value=3.9e-10  Score=89.13  Aligned_cols=78  Identities=18%  Similarity=0.294  Sum_probs=60.7

Q ss_pred             CcEEEEeecCccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           19 NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        19 ~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qll~al~~L-H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      +.-+|||||++++ +..-..+...++......+..|++.++..| |+.|++|+|+++.||++. ++.+.++|||.+....
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            3458999999863 322222334566667788889999999988 899999999999999997 4689999999886655


Q ss_pred             C
Q 023764           97 E   97 (277)
Q Consensus        97 ~   97 (277)
                      .
T Consensus       176 h  176 (197)
T cd05146         176 H  176 (197)
T ss_pred             C
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.05  E-value=5.1e-10  Score=84.71  Aligned_cols=80  Identities=25%  Similarity=0.293  Sum_probs=66.3

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEE
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---NVLHRDLKPSNLL   77 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---~i~H~di~~~nil   77 (277)
                      ++++++.+....     +..|++|||++| .+..+       +......++.+++.+++.+|..   +++|+|++|.||+
T Consensus        54 ~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil  121 (155)
T cd05120          54 PVPKVLASGESD-----GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL  121 (155)
T ss_pred             CCCeEEEEcCCC-----CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEE
Confidence            566777777655     778999999976 45433       5567778899999999999985   6999999999999


Q ss_pred             EecCCCeEEeecccee
Q 023764           78 LNANCDLKICDFGLAR   93 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~   93 (277)
                      ++..+.++++|||.+.
T Consensus       122 ~~~~~~~~l~Df~~~~  137 (155)
T cd05120         122 VDDGKILGIIDWEYAG  137 (155)
T ss_pred             EECCcEEEEEeccccc
Confidence            9998999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=2e-08  Score=86.31  Aligned_cols=191  Identities=12%  Similarity=0.155  Sum_probs=126.8

Q ss_pred             cEEEEeecCcc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccc
Q 023764           20 DVYIAYELMDT--DLHQIIRS------NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   91 (277)
Q Consensus        20 ~~~lv~e~~~~--~L~~~l~~------~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~   91 (277)
                      .+-+.|..+.|  .+..++..      .....+....++.+.++.+.+-||.+|..-+|+.++|++++.++.+.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            36788888865  45555532      24578889999999999999999999999999999999999999999998665


Q ss_pred             eeeccCCCcccccccccccCChhhhh-C---CCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCh
Q 023764           92 ARVTSETDFMTEYVVTRWYRAPELLL-N---SSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSE  166 (277)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~aPE~~~-~---~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~  166 (277)
                      -............+|...|++||.-. +   +-..+...|.|.||+++++++.| ++||.|--..       .-...|-+
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~-------~~ap~p~E  236 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI-------SDAPNPLE  236 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc-------CCCCCcch
Confidence            55444444455567899999999752 1   11246789999999999998865 9999654210       00011111


Q ss_pred             HhhhhhhhhHHHHhh---hCCcccCCcccccCCCCChhHHHHHHHhcCCC--CCCCCCHHH
Q 023764          167 AELGFLNENAKKYIC---QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD--PRQRITVED  222 (277)
Q Consensus       167 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--P~~R~t~~e  222 (277)
                      ..+.     ...|..   +...+...+.+--+.-+++++..+..+|+..-  +.-|||++.
T Consensus       237 ~~Ia-----~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         237 TDIA-----HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hhhh-----cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1111     111111   11122222222223346788888888888643  457999653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.97  E-value=3.6e-09  Score=88.11  Aligned_cols=75  Identities=17%  Similarity=0.266  Sum_probs=64.4

Q ss_pred             CcEEEEeecCcc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec-------CCCeEEe
Q 023764           19 NDVYIAYELMDT--DLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-------NCDLKIC   87 (277)
Q Consensus        19 ~~~~lv~e~~~~--~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~-------~~~~~l~   87 (277)
                      ...|||||++++  +|.+++..  ....+......++.++...+.-||.+||+|+|+++.||+++.       ++.+.++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            567899999986  79998864  245667788899999999999999999999999999999975       4679999


Q ss_pred             ecccee
Q 023764           88 DFGLAR   93 (277)
Q Consensus        88 dfg~~~   93 (277)
                      ||+.+.
T Consensus       188 Dl~r~~  193 (268)
T PRK15123        188 DLHRAQ  193 (268)
T ss_pred             ECCccc
Confidence            999774

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=4.8e-09  Score=84.35  Aligned_cols=76  Identities=24%  Similarity=0.420  Sum_probs=67.6

Q ss_pred             CcEEEEeecCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCC---CeEEeecccee
Q 023764           19 NDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLAR   93 (277)
Q Consensus        19 ~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~---~~~l~dfg~~~   93 (277)
                      ...|+|||++++  +|.+++......+......++.++...+.-||.+||+|+|+++.|||++.++   .+.++||+.++
T Consensus        90 ~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen   90 YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            456999999986  7999998755577888899999999999999999999999999999999887   89999998775


Q ss_pred             e
Q 023764           94 V   94 (277)
Q Consensus        94 ~   94 (277)
                      .
T Consensus       170 ~  170 (206)
T PF06293_consen  170 F  170 (206)
T ss_pred             e
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.93  E-value=5.5e-10  Score=99.23  Aligned_cols=178  Identities=23%  Similarity=0.259  Sum_probs=125.6

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC-CCeEEeeccceeecc
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTS   96 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~   96 (277)
                      .+.|+=-|||.+ ++...+.-...++++..+++..|++.++.++|+..++|+|++|.||++..+ +..+++|||......
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            667889999964 444333333458889999999999999999999999999999999999876 778999998875322


Q ss_pred             CCCcccccccccccC-ChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhh
Q 023764           97 ETDFMTEYVVTRWYR-APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN  175 (277)
Q Consensus        97 ~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  175 (277)
                      -.  ........++. ..|.+.....+..+.|++|+|.-+.+.++|.+.-........++                    
T Consensus       419 ~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~--------------------  476 (524)
T KOG0601|consen  419 FS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR--------------------  476 (524)
T ss_pred             ee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee--------------------
Confidence            11  01112222333 35556566678999999999999999998876543322111100                    


Q ss_pred             HHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          176 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                                   .......+....++..+.+.|+..++..|+++.++..|.-|..
T Consensus       477 -------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  477 -------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                         0011112233456788999999999999999999988886654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.3e-09  Score=81.01  Aligned_cols=70  Identities=24%  Similarity=0.422  Sum_probs=55.7

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      +...|+|||.+| .|.+.+...   .    ..++..+-.-+.-||.+||+|+|+.++|+.++..+ +.++|||++....
T Consensus        72 ~~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          72 DNGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CCCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            456799999987 677788765   2    34455555667789999999999999999997765 9999999986443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.91  E-value=4.2e-08  Score=86.30  Aligned_cols=172  Identities=18%  Similarity=0.247  Sum_probs=123.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc--ccHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRS---------------NQALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~---------------~~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      +|||++.++|...+ .+...+++|++|.+  ++|.++.-.               +...++...+.++.|+..||.++|+
T Consensus       333 ~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs  411 (655)
T KOG3741|consen  333 TNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS  411 (655)
T ss_pred             Cceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh
Confidence            69999999998543 33378999999997  478776521               2347789999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      .|+.-+-+.+.+|+++++.+++|...|.........           .+|  +.    --.+-|.=.||.+++.|.||..
T Consensus       412 sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~~~--le----~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  412 SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------TEP--LE----SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------Ccc--hh----HHhhhhHHHHHHHHHHHhhccc
Confidence            999999999999999999888888777655444332           111  21    1234588899999999999863


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      --...+..+..                                   .+..+.+.++.++++++.-+...+++. -++.++
T Consensus       475 ns~~~d~~~~s-----------------------------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~l  518 (655)
T KOG3741|consen  475 NSNRTDSTQSS-----------------------------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDL  518 (655)
T ss_pred             ccccccchHHH-----------------------------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHH
Confidence            21111111100                                   011222467788899999888888876 777887


Q ss_pred             hcC
Q 023764          224 LAH  226 (277)
Q Consensus       224 l~h  226 (277)
                      +.+
T Consensus       519 lp~  521 (655)
T KOG3741|consen  519 LPM  521 (655)
T ss_pred             HHH
Confidence            764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.78  E-value=3.1e-08  Score=76.20  Aligned_cols=77  Identities=26%  Similarity=0.374  Sum_probs=61.1

Q ss_pred             CcEEEEeecCcc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCC---eEEeeccc
Q 023764           19 NDVYIAYELMDT--DLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGL   91 (277)
Q Consensus        19 ~~~~lv~e~~~~--~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~---~~l~dfg~   91 (277)
                      +.-.|+||+++|  ++.+++.+..  ..+......++.++-+.+.-||.++++|+|+..+||++..++.   +.++|||+
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence            445799999998  8999887642  2333333678888889999999999999999999999966543   58999999


Q ss_pred             eeec
Q 023764           92 ARVT   95 (277)
Q Consensus        92 ~~~~   95 (277)
                      +...
T Consensus       163 s~~s  166 (229)
T KOG3087|consen  163 SSVS  166 (229)
T ss_pred             hhcc
Confidence            8654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.76  E-value=1.9e-08  Score=89.78  Aligned_cols=75  Identities=21%  Similarity=0.336  Sum_probs=57.3

Q ss_pred             CcEEEEeecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           19 NDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILR-GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qll~-al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      +..+|||||++| +|.++.... ...+   ...++.+++. .+..+|..|++|+|++|.||+++.+|.++++|||++...
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            346899999975 777765432 1222   2345555554 467899999999999999999999999999999998765


Q ss_pred             c
Q 023764           96 S   96 (277)
Q Consensus        96 ~   96 (277)
                      +
T Consensus       308 ~  308 (437)
T TIGR01982       308 S  308 (437)
T ss_pred             C
Confidence            4

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=1.6e-08  Score=79.58  Aligned_cols=73  Identities=30%  Similarity=0.430  Sum_probs=50.2

Q ss_pred             EEEEeecCc--c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           21 VYIAYELMD--T-DLHQIIRSNQALSEEHCQYFLYQILRGLKY-IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        21 ~~lv~e~~~--~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~-LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      -+|||||++  | .+..+ .. ..++.+....++.+++..+.. +|+.|++|+|+++.||+++.+ .+.++|||.+....
T Consensus        81 ~~ivME~I~~~G~~~~~l-~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRL-KD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TEEEEE--EETTEEGGCH-HH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             CEEEEEecCCCccchhhH-Hh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            379999998  6 34333 32 122245566778888885554 689999999999999999887 89999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.70  E-value=1.4e-08  Score=92.15  Aligned_cols=72  Identities=19%  Similarity=0.408  Sum_probs=53.5

Q ss_pred             CcEEEEeecCcc-cHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCC----CeEEe
Q 023764           19 NDVYIAYELMDT-DLHQI--IRSNQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC----DLKIC   87 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~--l~~~~----~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~----~~~l~   87 (277)
                      +..+|||||++| .+.++  +...+    .+.+..+..++.|++       ..|++|+|+||.||+++.+|    .++++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~ll  306 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIAL  306 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence            445799999986 77664  33333    244445555555554       59999999999999999888    99999


Q ss_pred             eccceeeccC
Q 023764           88 DFGLARVTSE   97 (277)
Q Consensus        88 dfg~~~~~~~   97 (277)
                      |||++...+.
T Consensus       307 DFGivg~l~~  316 (537)
T PRK04750        307 DFGIVGSLNK  316 (537)
T ss_pred             ecceEEECCH
Confidence            9999876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.64  E-value=3.9e-08  Score=76.29  Aligned_cols=64  Identities=28%  Similarity=0.342  Sum_probs=50.8

Q ss_pred             EEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEecCCCeEEeecccee
Q 023764           21 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV-----LHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        21 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i-----~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      -++|||+++| ++.+.        ......++.+++.+++.||..++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        66 ~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          66 GVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            4799999987 55432        11123456789999999999985     9999999999999 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK09902 hypothetical protein; Provisional

Probab=98.53  E-value=5.6e-07  Score=71.60  Aligned_cols=76  Identities=17%  Similarity=0.142  Sum_probs=65.5

Q ss_pred             CcEEEEeecCcc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCC--eEEeeccce
Q 023764           19 NDVYIAYELMDT--DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLA   92 (277)
Q Consensus        19 ~~~~lv~e~~~~--~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~   92 (277)
                      -.-+||+|-++|  +|.+++.+.  .+.+......++.++..+++-||..|+.|+|+-+.||+++.+|.  +.++||..+
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            568999999884  999998763  34577888899999999999999999999999999999987777  999999766


Q ss_pred             ee
Q 023764           93 RV   94 (277)
Q Consensus        93 ~~   94 (277)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            43

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=6.4e-07  Score=71.58  Aligned_cols=66  Identities=24%  Similarity=0.439  Sum_probs=50.6

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      ...+++|||++| .|.+...    +++.    +.-.+..++.-||+.|+.|+|++|.|++++.++ ++++|++..+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            455689999998 6665522    3332    335566788999999999999999999998654 9999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.22  E-value=2.6e-06  Score=81.73  Aligned_cols=191  Identities=17%  Similarity=0.241  Sum_probs=123.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC---cE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS---NL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~---ni   76 (277)
                      +|++.++.+-......+ --..+..++|.+ ++...+..-+..+.+..+.+..++++|++++|+....|.-+...   +.
T Consensus       242 ~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~  320 (1351)
T KOG1035|consen  242 DNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKES  320 (1351)
T ss_pred             ccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccccc
Confidence            35555555554431111 122334456654 78888888788999999999999999999999996555544444   33


Q ss_pred             EEecCCCeEEe--eccceeeccCCCcccccccccccCChhhhhCCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           77 LLNANCDLKIC--DFGLARVTSETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        77 l~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      .++.++.....  ||+................+..+-++|...... ......|+|++|.....+..|..+-.-.     
T Consensus       321 ~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~-----  395 (1351)
T KOG1035|consen  321 TVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS-----  395 (1351)
T ss_pred             ccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc-----
Confidence            33455555555  787776665554444445556677777663321 1234479999999999998776432100     


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCCh-hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP-SAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                       +....                                  ..+..+. ...+.+.+|+..++++|+++.+++.|+|.+.-
T Consensus       396 -~~~~~----------------------------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  396 -AVPVS----------------------------------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             -cchhh----------------------------------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence             00000                                  0111111 57789999999999999999999999998754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.18  E-value=2.6e-06  Score=69.78  Aligned_cols=82  Identities=22%  Similarity=0.330  Sum_probs=61.8

Q ss_pred             cCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeec
Q 023764           11 PPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF   89 (277)
Q Consensus        11 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~df   89 (277)
                      ..+.+-..+.-.+|||+++| .|...     +++.+....++..|++-+.-.-..|++|+|+++-||+++.+|.+.++||
T Consensus       172 ~VP~P~~~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDw  246 (304)
T COG0478         172 KVPKPIAWNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW  246 (304)
T ss_pred             CCCCccccccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeC
Confidence            33444455788999999998 44332     2235556667777777777777999999999999999999999999999


Q ss_pred             cceeeccC
Q 023764           90 GLARVTSE   97 (277)
Q Consensus        90 g~~~~~~~   97 (277)
                      ..+...+.
T Consensus       247 PQ~v~~~h  254 (304)
T COG0478         247 PQAVPISH  254 (304)
T ss_pred             cccccCCC
Confidence            77655443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.14  E-value=5.2e-06  Score=67.10  Aligned_cols=74  Identities=22%  Similarity=0.302  Sum_probs=52.9

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS----------------------------------   63 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~----------------------------------   63 (277)
                      +..|+|||+++| ++.+.+.. ..++......++.+++.+|..||+                                  
T Consensus        73 ~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          73 GTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             CCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            356899999986 55544321 345556666666666666666663                                  


Q ss_pred             ----------------------CCceecCCCCCcEEEec--CCCeEEeecccee
Q 023764           64 ----------------------ANVLHRDLKPSNLLLNA--NCDLKICDFGLAR   93 (277)
Q Consensus        64 ----------------------~~i~H~di~~~nil~~~--~~~~~l~dfg~~~   93 (277)
                                            ..++|+|+++.||+++.  ++.+.++||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                  23689999999999988  5668999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.79  E-value=3.2e-05  Score=62.76  Aligned_cols=78  Identities=18%  Similarity=0.297  Sum_probs=58.4

Q ss_pred             CCcEEEEeecCccc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           18 FNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        18 ~~~~~lv~e~~~~~--L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      +.+-.||||+++..  -.-.+. .-.++.+++..+..+++..+.-|-. .|++|+|++.-|||+. ++.+.++|+|.+..
T Consensus       138 ~~~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         138 FRNNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             ecCCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            34558999999743  111111 1234444777888899998888877 8999999999999999 88999999998865


Q ss_pred             ccC
Q 023764           95 TSE   97 (277)
Q Consensus        95 ~~~   97 (277)
                      ...
T Consensus       216 ~~h  218 (268)
T COG1718         216 IDH  218 (268)
T ss_pred             cCC
Confidence            553

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.71  E-value=0.00019  Score=64.08  Aligned_cols=91  Identities=19%  Similarity=0.182  Sum_probs=69.0

Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHH
Q 023764          124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  203 (277)
Q Consensus       124 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (277)
                      +++||||+|.++.++..|...+...........+.+....+......-...   .+.               -..+.-.+
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~---------------~~~d~~~~  171 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQ---------------LLADKKRL  171 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHH---------------HhhhHhHH
Confidence            599999999999999999988888888888888877765554432211111   000               12345678


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          204 DLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       204 ~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +++.+|+-..|..||...++..++-|...
T Consensus       172 ~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  172 PLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHhccCCccccccccchhHHhcCccHHHH
Confidence            89999999999999999999999999765

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.54  E-value=0.00027  Score=55.87  Aligned_cols=84  Identities=17%  Similarity=0.128  Sum_probs=64.2

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCc-ccHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCC
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQ---IIRSNQALSEEHCQYFLYQILRGLKYIHS---ANVLHRDLKPS   74 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~---~l~~~~~l~~~~~~~i~~qll~al~~LH~---~~i~H~di~~~   74 (277)
                      +++++++.+        ++ ++|+||.+ +++..   .+......++..+.+|+.+++..+++++.   ..+.-.|++++
T Consensus        21 ~~pk~lG~C--------G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~   91 (188)
T PF12260_consen   21 PFPKLLGSC--------GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPD   91 (188)
T ss_pred             CCCCeeeEC--------CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchH
Confidence            567778777        33 46889987 34431   11111235789999999999999999998   34777999999


Q ss_pred             cEEEecCCCeEEeeccceee
Q 023764           75 NLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~   94 (277)
                      |+-++.+|.+|++|...+..
T Consensus        92 nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   92 NFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HeEEeCCCcEEEEechhcch
Confidence            99999999999999986643

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.39  E-value=0.00068  Score=61.63  Aligned_cols=77  Identities=18%  Similarity=0.365  Sum_probs=54.6

Q ss_pred             CcEEEEeecCcc-cHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           19 NDVYIAYELMDT-DLHQI--IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~--l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      +.-.|+|||++| .+.+.  +++ ..++.+.+...+.++  -+..+-..|++|.|.+|-||+++.+|.+.+.|||.....
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            456899999998 66665  333 345533333322222  134444589999999999999999999999999998765


Q ss_pred             cCC
Q 023764           96 SET   98 (277)
Q Consensus        96 ~~~   98 (277)
                      ++.
T Consensus       316 ~~~  318 (517)
T COG0661         316 DPK  318 (517)
T ss_pred             CHH
Confidence            543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.34  E-value=0.001  Score=60.49  Aligned_cols=76  Identities=25%  Similarity=0.377  Sum_probs=51.8

Q ss_pred             CcEEEEeecCcc----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec----CCCeEEeecc
Q 023764           19 NDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA----NCDLKICDFG   90 (277)
Q Consensus        19 ~~~~lv~e~~~~----~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~----~~~~~l~dfg   90 (277)
                      ....|+||||+|    ++ +.+.+.+ ++...+...+.+..  ++.+=..|++|+|-+|-||++..    ++.+.+.|||
T Consensus       275 t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             cceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence            456899999987    45 4555543 44443333222221  23444678999999999999984    6789999999


Q ss_pred             ceeeccCC
Q 023764           91 LARVTSET   98 (277)
Q Consensus        91 ~~~~~~~~   98 (277)
                      +.....+.
T Consensus       351 l~~~is~~  358 (538)
T KOG1235|consen  351 LYAVISHK  358 (538)
T ss_pred             ccccccHH
Confidence            98766543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.09  E-value=0.0002  Score=71.22  Aligned_cols=126  Identities=17%  Similarity=0.156  Sum_probs=95.0

Q ss_pred             CcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC-C----ceecCCCCCcEEEecCCCeEEee
Q 023764           19 NDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSA-N----VLHRDLKPSNLLLNANCDLKICD   88 (277)
Q Consensus        19 ~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~-~----i~H~di~~~nil~~~~~~~~l~d   88 (277)
                      ...|.+++|+. |.+++.+.++    ..+....+.....+.+.+..-+|+. |    -+|+++++.|.++..+..+++++
T Consensus      1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred             hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence            56788999985 7899988765    3344445544444546666676654 1    68999999999999999999999


Q ss_pred             cccee-eccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           89 FGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        89 fg~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      +|+.+ ............+++.|+.|+...+ -.++.++|+|..|+-+|..-.|..+|
T Consensus      1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             cccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            99998 3333344556678888999987744 34777799999999999987777666

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.01  E-value=0.0033  Score=51.23  Aligned_cols=28  Identities=25%  Similarity=0.296  Sum_probs=25.0

Q ss_pred             CceecCCCCCcEEEecCCCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .++|+|+.|.|++++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.00  E-value=7.3e-05  Score=68.02  Aligned_cols=181  Identities=19%  Similarity=0.179  Sum_probs=113.8

Q ss_pred             CcEEEEeecCccc--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           19 NDVYIAYELMDTD--LHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        19 ~~~~lv~e~~~~~--L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      ....++++++++.  ....+. ....+..-+...+...-..+++++|+..=+|+|    ||+... +..+.++|+.....
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence            5677888888642  221111 111233334445556666789999998778888    655544 67899999887766


Q ss_pred             cCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhh
Q 023764           96 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN  175 (277)
Q Consensus        96 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  175 (277)
                      .......+..+++.++|||+.... .+....|.|++|+-..++.-|-+|-...-      .....+|.++.  ...+...
T Consensus       382 ~~~~~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~------~~~~~~g~~p~--s~~L~~~  452 (829)
T KOG0576|consen  382 TRTMKPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPP------AVLPMIGNGPN--SPMLTDK  452 (829)
T ss_pred             CcccccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCc------cccCCCCCCCC--ccccchh
Confidence            655456677899999999987544 47889999999987777777777653310      00001111110  0000000


Q ss_pred             HHHHhhhCCcccCCcccccCCCCChhH-HHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          176 AKKYICQLPRYQRQSFTEKFPNVHPSA-IDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                                       .   ..++.. +++...|+..-|..|++...++-|.+|+.+.
T Consensus       453 -----------------~---aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  453 -----------------S---AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             -----------------h---hcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence                             0   011111 2477899999999999999999999998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.94  E-value=0.0032  Score=51.84  Aligned_cols=29  Identities=21%  Similarity=0.187  Sum_probs=25.4

Q ss_pred             CceecCCCCCcEEEecCCCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .++|+|+.|.||+++.++...|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999987778899998653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.85  E-value=0.0092  Score=47.53  Aligned_cols=80  Identities=19%  Similarity=0.343  Sum_probs=57.4

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecC---cc----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELM---DT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~---~~----~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      +|.++++...++     -..-+|+|..   +|    +|.+++.. +.++. ....   .+-.-.++|-+++|+.+|++|.
T Consensus        78 ~i~r~~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~  147 (199)
T PF10707_consen   78 HIPRFYGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPH  147 (199)
T ss_pred             ccccEeEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcc
Confidence            578888988887     6678888876   23    78898865 45665 3333   3344566889999999999999


Q ss_pred             cEEEecCC----CeEEee-ccc
Q 023764           75 NLLLNANC----DLKICD-FGL   91 (277)
Q Consensus        75 nil~~~~~----~~~l~d-fg~   91 (277)
                      ||++....    .+.|+| ||.
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCC
Confidence            99995432    467776 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.71  E-value=0.002  Score=54.71  Aligned_cols=78  Identities=19%  Similarity=0.304  Sum_probs=57.2

Q ss_pred             CCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccc
Q 023764           13 PQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   91 (277)
Q Consensus        13 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~   91 (277)
                      +.+-+.+..++|||++.| .|.+.-.    +  ..+..+...+..-+.-|-.+|+||+|+.--||++..++.++++||..
T Consensus       175 PkpiD~~RH~Vvmelv~g~Pl~~v~~----v--~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  175 PKPIDHNRHCVVMELVDGYPLRQVRH----V--EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             CCcccccceeeHHHhhcccceeeeee----c--CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence            334455788999999987 6655421    1  12333445556667788999999999999999999999999999976


Q ss_pred             eeecc
Q 023764           92 ARVTS   96 (277)
Q Consensus        92 ~~~~~   96 (277)
                      ....+
T Consensus       249 mvS~s  253 (465)
T KOG2268|consen  249 MVSTS  253 (465)
T ss_pred             hhccC
Confidence            54433

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.55  E-value=0.0076  Score=51.99  Aligned_cols=106  Identities=17%  Similarity=0.305  Sum_probs=74.4

Q ss_pred             CcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCCCeEEeeccceeeccC
Q 023764           19 NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE   97 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~   97 (277)
                      -..|++|++-++.+.-.    .....+++..++++.+.-+.-+.+. .+-||++...||+++ +|.+.|+||-+++....
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            56788888888776533    2345678888999998877777766 589999999999999 99999999999985443


Q ss_pred             CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHH
Q 023764           98 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  135 (277)
Q Consensus        98 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il  135 (277)
                      .....    -...--|-.+.+.  -+..-+||-+.-.+
T Consensus       374 q~~is----y~rldhp~lF~G~--dd~QFeIYrlMr~l  405 (488)
T COG5072         374 QGIIS----YNRLDHPDLFNGV--DDYQFEIYRLMRRL  405 (488)
T ss_pred             Cceee----ccccCchhhhcCc--cceeeeHHHHHHHH
Confidence            32211    1123345555432  36677777765444

>PLN02876 acyl-CoA dehydrogenase

Probab=95.14  E-value=0.083  Score=51.56  Aligned_cols=31  Identities=23%  Similarity=0.485  Sum_probs=24.7

Q ss_pred             CceecCCCCCcEEEecC-CC-eEEeeccceeec
Q 023764           65 NVLHRDLKPSNLLLNAN-CD-LKICDFGLARVT   95 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~-~~-~~l~dfg~~~~~   95 (277)
                      .++|+|+++.|++++.+ +. ..|.||+.+...
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            49999999999999753 33 579999887543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.01  E-value=0.027  Score=46.11  Aligned_cols=30  Identities=33%  Similarity=0.458  Sum_probs=25.2

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .+++|+|+.+.|++++.++...++||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            358999999999999876656799998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.77  E-value=0.075  Score=45.30  Aligned_cols=29  Identities=24%  Similarity=0.423  Sum_probs=25.0

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .+++|+|+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.67  E-value=0.062  Score=45.90  Aligned_cols=30  Identities=33%  Similarity=0.526  Sum_probs=26.5

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .+++|+|+++.|++++.++...++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            579999999999999988877899998763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=94.65  E-value=0.071  Score=45.71  Aligned_cols=30  Identities=30%  Similarity=0.357  Sum_probs=25.7

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .|++|+|+++.||+++.+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999876656899998764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.28  E-value=0.067  Score=43.61  Aligned_cols=29  Identities=28%  Similarity=0.439  Sum_probs=25.5

Q ss_pred             CceecCCCCCcEEEec-CCCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNA-NCDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~-~~~~~l~dfg~~~   93 (277)
                      +++|+|+.+.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999998 5789999997653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.22  E-value=0.081  Score=44.80  Aligned_cols=30  Identities=30%  Similarity=0.386  Sum_probs=26.3

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .+++|+|++|.|++++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            469999999999999988777999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=93.73  E-value=0.045  Score=44.17  Aligned_cols=30  Identities=33%  Similarity=0.595  Sum_probs=20.7

Q ss_pred             CCceecCCCCCcEEEe-cCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLN-ANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~-~~~~~~l~dfg~~~   93 (277)
                      ..++|+|+.+.||+++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.41  E-value=0.15  Score=43.33  Aligned_cols=29  Identities=34%  Similarity=0.438  Sum_probs=25.4

Q ss_pred             CceecCCCCCcEEEecC----CCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNAN----CDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~----~~~~l~dfg~~~   93 (277)
                      +++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999875    889999997653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.27  E-value=0.16  Score=42.63  Aligned_cols=49  Identities=29%  Similarity=0.360  Sum_probs=37.0

Q ss_pred             HHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           46 HCQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        46 ~~~~i~~qll~al~~LH~~--~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      .....+..+-.++.-.+..  -++|+|+.|.|++.++.|.+.|+||.-+..
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444555555556666655  589999999999999999999999976643

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.18  E-value=0.088  Score=41.42  Aligned_cols=28  Identities=32%  Similarity=0.461  Sum_probs=24.7

Q ss_pred             ceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           66 VLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      .+|+|+.|.|++++++| ++++||+.+..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            69999999999998877 99999987754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.03  E-value=0.16  Score=43.84  Aligned_cols=28  Identities=36%  Similarity=0.644  Sum_probs=25.2

Q ss_pred             ceecCCCCCcEEEecCCC-eEEeecccee
Q 023764           66 VLHRDLKPSNLLLNANCD-LKICDFGLAR   93 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~-~~l~dfg~~~   93 (277)
                      ++|+|+.|.||+++.+.. +.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999885 8999998763

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.45  E-value=0.31  Score=38.73  Aligned_cols=30  Identities=27%  Similarity=0.455  Sum_probs=24.6

Q ss_pred             CCceecCCCCCcEEEecCC-----CeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANC-----DLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~-----~~~l~dfg~~~   93 (277)
                      ..++|||+.+.|+++..++     .+.++||+.+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            4589999999999997543     58999998764

subfamily of choline kinases

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.43  E-value=0.23  Score=42.50  Aligned_cols=29  Identities=21%  Similarity=0.238  Sum_probs=26.6

Q ss_pred             CceecCCCCCcEEEecCCCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      +++|+|+.+.|+++++++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            69999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.16  E-value=0.12  Score=42.76  Aligned_cols=29  Identities=31%  Similarity=0.441  Sum_probs=25.2

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            489999999999999877 78999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=91.88  E-value=0.15  Score=43.80  Aligned_cols=75  Identities=23%  Similarity=0.280  Sum_probs=44.3

Q ss_pred             EEEEeecCccc-----HHHHHHhCCCCCHHHHHHHHHHHHHHHH---HHH-hCCceecCCCCCcEEEecC----------
Q 023764           21 VYIAYELMDTD-----LHQIIRSNQALSEEHCQYFLYQILRGLK---YIH-SANVLHRDLKPSNLLLNAN----------   81 (277)
Q Consensus        21 ~~lv~e~~~~~-----L~~~l~~~~~l~~~~~~~i~~qll~al~---~LH-~~~i~H~di~~~nil~~~~----------   81 (277)
                      -.||++++-.+     +....+-+=.--.+-++.++.|++.-.-   .|- -.+++|-||||+|||+-+.          
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  325 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN  325 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence            35888887532     2222222111223567888888865431   222 3469999999999998432          


Q ss_pred             --------CCeEEeeccceeec
Q 023764           82 --------CDLKICDFGLARVT   95 (277)
Q Consensus        82 --------~~~~l~dfg~~~~~   95 (277)
                              -.++|-||.+++..
T Consensus       326 ~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  326 RNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             eEEEecccceeeecccCHHHhc
Confidence                    33566677766543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.82  E-value=0.12  Score=41.49  Aligned_cols=29  Identities=38%  Similarity=0.677  Sum_probs=20.6

Q ss_pred             CceecCCCCCcEEE-ecCCCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLL-NANCDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~-~~~~~~~l~dfg~~~   93 (277)
                      .+.|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=91.63  E-value=0.38  Score=38.37  Aligned_cols=57  Identities=30%  Similarity=0.422  Sum_probs=41.3

Q ss_pred             CcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccce
Q 023764           19 NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   92 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~   92 (277)
                      ...-||.||....-        .++.+.    +.+|++-+..+|+.||+-+|+++.|..     .-+|+|||.+
T Consensus       150 ~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  150 PIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            34567788776432        234444    456677788999999999999999976     3588999853

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.88  E-value=0.23  Score=40.22  Aligned_cols=37  Identities=30%  Similarity=0.405  Sum_probs=31.9

Q ss_pred             HHHHHHHHhC--CceecCCCCCcEEEecCCCeEEeeccc
Q 023764           55 LRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGL   91 (277)
Q Consensus        55 l~al~~LH~~--~i~H~di~~~nil~~~~~~~~l~dfg~   91 (277)
                      +.+|.-.|+.  +.+|+|..|+||+-+..|.+||.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            4667788843  699999999999999999999999764

The function of this family is unknown.

>PLN02236 choline kinase

Probab=90.87  E-value=0.37  Score=41.93  Aligned_cols=29  Identities=24%  Similarity=0.486  Sum_probs=25.1

Q ss_pred             CceecCCCCCcEEEec-CCCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNA-NCDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~-~~~~~l~dfg~~~   93 (277)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999976 4689999997764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=90.52  E-value=0.21  Score=42.00  Aligned_cols=31  Identities=26%  Similarity=0.541  Sum_probs=25.5

Q ss_pred             CceecCCCCCcEEEecCCC-eEEeeccceeec
Q 023764           65 NVLHRDLKPSNLLLNANCD-LKICDFGLARVT   95 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~-~~l~dfg~~~~~   95 (277)
                      .++|+|+++.||+++.++. ..|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987565 479999977543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=89.66  E-value=0.73  Score=40.34  Aligned_cols=76  Identities=18%  Similarity=0.249  Sum_probs=55.1

Q ss_pred             cEEEEeecCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           20 DVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        20 ~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      .-.|||+++++  --.-.+ +.-.++...+..+-.|++.-+.-|- .+++||.||+--|+|+- +|.+.++|.+.+....
T Consensus       238 ~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  238 NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEccccccCC
Confidence            45799999984  222222 3356777778777777777766664 56899999999999874 5689999998775444


Q ss_pred             C
Q 023764           97 E   97 (277)
Q Consensus        97 ~   97 (277)
                      .
T Consensus       316 H  316 (520)
T KOG2270|consen  316 H  316 (520)
T ss_pred             C
Confidence            3

>PRK11768 serine/threonine protein kinase; Provisional

Probab=89.37  E-value=0.57  Score=40.43  Aligned_cols=28  Identities=32%  Similarity=0.433  Sum_probs=23.4

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .+++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3689999999999995 4 57899998653

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=89.06  E-value=1  Score=42.51  Aligned_cols=82  Identities=18%  Similarity=0.172  Sum_probs=64.7

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||.++|++|..+     +.-.+++|+.+.  .|.+.-.. ...+.-+...+++||+.-..-|...|+.-.=+.++|+.++
T Consensus       181 ~iP~v~~~~~~~-----~~~i~Lle~~~~~~~l~~~w~~-~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~  254 (645)
T PRK14559        181 EIPKIHDAWQDG-----DLQVILLEDRSHWQPLLDLWQD-QTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVD  254 (645)
T ss_pred             cCcchheeecCC-----CCcEEEeCCCCCCchHHHHhhh-cCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeC
Confidence            489999999886     555788898863  66666554 2356788899999999999999999999999999999998


Q ss_pred             cCCCeEEeec
Q 023764           80 ANCDLKICDF   89 (277)
Q Consensus        80 ~~~~~~l~df   89 (277)
                      ++..+.|..|
T Consensus       255 ~~~~~~l~~l  264 (645)
T PRK14559        255 EDQTLGLQQL  264 (645)
T ss_pred             CCceehHhhh
Confidence            6555544443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=88.83  E-value=0.35  Score=41.43  Aligned_cols=33  Identities=24%  Similarity=0.494  Sum_probs=29.0

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceeeccC
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE   97 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~   97 (277)
                      .++|+|+++.|++++..+.+-++||+.+.....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999998899999998876543

>PRK06148 hypothetical protein; Provisional

Probab=88.79  E-value=0.64  Score=46.53  Aligned_cols=30  Identities=37%  Similarity=0.568  Sum_probs=25.4

Q ss_pred             CCceecCCCCCcEEEecCC--Ce-EEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANC--DL-KICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~--~~-~l~dfg~~~   93 (277)
                      .+++|+|+.+.||+++.++  .+ -|+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998875  44 599999774

>PRK06149 hypothetical protein; Provisional

Probab=88.72  E-value=0.55  Score=46.81  Aligned_cols=31  Identities=19%  Similarity=0.262  Sum_probs=25.1

Q ss_pred             hCCceecCCCCCcEEEecC--CC---eEEeecccee
Q 023764           63 SANVLHRDLKPSNLLLNAN--CD---LKICDFGLAR   93 (277)
Q Consensus        63 ~~~i~H~di~~~nil~~~~--~~---~~l~dfg~~~   93 (277)
                      ..|+||+|+++.||+++.+  +.   ..|+|||.+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            3579999999999999865  23   4899999764

>PHA03111 Ser/Thr kinase; Provisional

Probab=88.34  E-value=1.4  Score=38.06  Aligned_cols=60  Identities=25%  Similarity=0.231  Sum_probs=37.8

Q ss_pred             cEEEEeecCcc-----cHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHH----hCCceecCCCCCcEEEec
Q 023764           20 DVYIAYELMDT-----DLHQIIRSNQAL-SEEHCQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNA   80 (277)
Q Consensus        20 ~~~lv~e~~~~-----~L~~~l~~~~~l-~~~~~~~i~~qll~al~~LH----~~~i~H~di~~~nil~~~   80 (277)
                      .-.||++++-.     ++....+- |-. -.+-++.++.|++.-.-.+-    -.+++|-||||+|||+-.
T Consensus       249 GnIIIfPLArcSadkv~~~~~~e~-GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        249 GNIIIFPLARCSADKVTEENAAEL-GFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             CcEEEEehhhcccccCCHHHHHHc-CCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            34688888643     22223222 222 23567888899876543332    236999999999999843

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=88.07  E-value=0.79  Score=35.81  Aligned_cols=67  Identities=22%  Similarity=0.311  Sum_probs=45.4

Q ss_pred             EEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEecCCCeEEeeccceee
Q 023764           21 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK-PSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        21 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~-~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      -++.|||+.| .|.+.-...   +    +.-+..++++.--|-..||-|+.++ |...++..++.+.|+||..+..
T Consensus        87 ~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            4567999987 776654321   2    2223456666667788899999998 4444555555899999988763

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=86.55  E-value=1.2  Score=37.65  Aligned_cols=28  Identities=36%  Similarity=0.586  Sum_probs=23.3

Q ss_pred             ceecCCCCCcEEEecC--C---CeEEeecccee
Q 023764           66 VLHRDLKPSNLLLNAN--C---DLKICDFGLAR   93 (277)
Q Consensus        66 i~H~di~~~nil~~~~--~---~~~l~dfg~~~   93 (277)
                      ++|||++.+||++..+  |   .+.+.||..++
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeecccccc
Confidence            8999999999999654  3   58999997654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=85.55  E-value=1.6  Score=37.71  Aligned_cols=28  Identities=36%  Similarity=0.517  Sum_probs=24.5

Q ss_pred             ceecCCCCCcEEEec-CCCeEEeecccee
Q 023764           66 VLHRDLKPSNLLLNA-NCDLKICDFGLAR   93 (277)
Q Consensus        66 i~H~di~~~nil~~~-~~~~~l~dfg~~~   93 (277)
                      ++|+|+.+.||+++. ++.++++||..+.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4789999998764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=81.63  E-value=4.9  Score=35.92  Aligned_cols=60  Identities=17%  Similarity=0.246  Sum_probs=43.9

Q ss_pred             CcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEe
Q 023764           19 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY-IHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus        19 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~-LH~~~i~H~di~~~nil~~   79 (277)
                      .+..++-+|..| ++..++.. ...+++.++.++.-...|+-- |--.+++|.|++|.||++-
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ccceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            345677778877 88888865 446667777777766666543 4456899999999999984

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	277
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-85
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-85
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-85
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-85
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-85
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-85
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-85
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-85
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-85
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-85
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-85
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-85
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-85
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-84
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-84
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-84
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-84
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-84
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-84
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-83
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-83
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-83
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-83
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-82
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-76
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-76
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-76
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-75
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-75
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-70
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-70
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-70
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-70
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-70
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-70
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-70
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-70
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-70
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-70
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-70
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-70
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-70
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-70
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-70
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-70
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-70
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-70
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-70
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-70
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-70
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-70
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-70
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-70
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-70
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-70
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-70
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-70
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-70
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-70
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-70
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-70
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-70
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-70
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-70
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-70
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-69
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-69
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-69
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-69
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-69
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-69
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-69
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-69
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-69
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-69
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-69
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-69
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-69
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-69
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-69
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-69
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-69
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-69
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-69
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-69
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-69
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-68
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-68
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-68
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-66
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-66
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-62
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-62
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-62
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-55
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-55
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-55
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-55
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-54
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-54
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-54
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-54
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-54
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-54
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-54
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-54
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-54
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-54
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-54
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-54
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-54
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-54
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-54
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-54
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-54
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-54
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-54
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-54
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-54
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-54
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-54
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-53
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-53
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-53
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-53
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-53
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-53
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-52
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-50
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-50
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-50
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-50
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-49
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-45
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-42
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-41
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-41
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-41
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-41
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-41
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-41
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-41
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-41
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-41
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-41
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-41
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-41
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-40
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-40
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-40
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-40
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-40
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-40
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-40
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-40
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-40
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-40
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-40
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-40
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-40
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-40
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-40
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-40
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-40
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-40
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-40
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-40
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-40
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-40
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-40
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-40
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-40
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-39
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-39
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-39
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-39
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-39
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-39
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-39
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-39
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-39
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-39
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-39
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-39
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-39
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-38
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-38
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-38
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-38
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-38
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-38
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-38
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-38
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-38
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-38
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-38
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-38
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-38
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-38
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-38
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-36
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-36
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-36
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-35
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-34
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-34
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-31
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-30
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-30
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-30
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-29
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		7e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		8e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-27
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-27
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		8e-27
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		8e-27
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		8e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		8e-27
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-27
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-26
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-26
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-26
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-26
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-26
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-26
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-26
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-26
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-26
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-26
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-26
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-26
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-26
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-26
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-26
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-24
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-24
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-21
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-20
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-20
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-19
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-19
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-19
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-17
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-17
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-17
3soa_A	444	Full-Length Human Camkii Length = 444		8e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-13
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-13
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-13
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-06

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  312 bits (800), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPS 322
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  311 bits (797), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  311 bits (797), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 322
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 148
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 149 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 328
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 329 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 367

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 160
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 161 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 340
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 341 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 379

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 138
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 318
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 145
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 326 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 146
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 326
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 327 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 365

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 137
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 317
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 318 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 356

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  310 bits (794), Expect = 6e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL+++++  Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLKYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  309 bits (791), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 138
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+P + +L   +N  A
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 318
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  308 bits (789), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 143 HSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPS 322
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  307 bits (787), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  307 bits (787), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  307 bits (786), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  307 bits (786), Expect = 5e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  306 bits (783), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 147/279 (52%), Positives = 195/279 (69%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+ E V TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  306 bits (783), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 147/279 (52%), Positives = 195/279 (69%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 145
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+ E V TRWYRAPE++L
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 326 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  303 bits (777), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 147/279 (52%), Positives = 195/279 (69%), Gaps = 6/279 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKI DFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  303 bits (776), Expect = 7e-83,   Method: Compositional matrix adjust.
 Identities = 146/280 (52%), Positives = 193/280 (68%), Gaps = 6/280 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I DII  P  E   DVY+   LM  DL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 160
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 117
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 161 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 176
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 340
Query: 237 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 276
           DEP+  +PF FD E   L + ++KELI++E   F P YR 
Sbjct: 341 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS 380

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  302 bits (774), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 144/275 (52%), Positives = 197/275 (71%), Gaps = 6/275 (2%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           V+ IRDI+     E+  DVYI  +LM+TDL+++++S Q LS +H  YFLYQILRGLKYIH
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIH 161
Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLN 118
           SANVLHRDLKPSNLL+N  CDLKICDFGLAR+       T F+TE V TRWYRAPE++LN
Sbjct: 162 SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENAK 177
           S  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A+
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKAR 281
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
            Y+  LP   + ++ + FP     A+DL+++MLTF+P +RITVE+ALAHPYL   +D +D
Sbjct: 282 NYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTD 341
Query: 238 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           EPV   PF+F  E   L + ++KELI+QE   F P
Sbjct: 342 EPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  282 bits (722), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 143/285 (50%), Positives = 194/285 (68%), Gaps = 18/285 (6%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWY 110
           H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   MTEYV TRWY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAEL 169
           RAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 170 GFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
             + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 229 LGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 269
           L + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  282 bits (721), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 142/272 (52%), Positives = 190/272 (69%), Gaps = 9/272 (3%)
Query: 3   VVAIRDIIPP--PQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
           ++AI+DI+ P  P  E F  VY+  +LM++DLHQII S+Q L+ EH +YFLYQ+LRGLKY
Sbjct: 115 IIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPEL 115
           +HSA V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRWYRAPEL
Sbjct: 174 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-E 174
           +L+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++GTPS A +  +  E
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293
Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
             + YI  LP  Q   +   +P     A+ L+ +ML F+P  RI+   AL HP+L   HD
Sbjct: 294 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353
Query: 235 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 266
             DEP C  PF F F++ ALT  ++KE I  E
Sbjct: 354 PDDEPDCAPPFDFAFDREALTRERIKEAIVAE 385

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  281 bits (719), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 142/272 (52%), Positives = 190/272 (69%), Gaps = 9/272 (3%)
Query: 3   VVAIRDIIPP--PQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
           ++AI+DI+ P  P  E F  VY+  +LM++DLHQII S+Q L+ EH +YFLYQ+LRGLKY
Sbjct: 116 IIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPEL 115
           +HSA V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRWYRAPEL
Sbjct: 175 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-E 174
           +L+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++GTPS A +  +  E
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 294
Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
             + YI  LP  Q   +   +P     A+ L+ +ML F+P  RI+   AL HP+L   HD
Sbjct: 295 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354
Query: 235 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 266
             DEP C  PF F F++ ALT  ++KE I  E
Sbjct: 355 PDDEPDCAPPFDFAFDREALTRERIKEAIVAE 386

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  279 bits (714), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 142/285 (49%), Positives = 193/285 (67%), Gaps = 18/285 (6%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWY 110
           H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   MTE V TRWY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAEL 169
           RAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 170 GFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
             + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 229 LGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 269
           L + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  279 bits (713), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 141/285 (49%), Positives = 193/285 (67%), Gaps = 18/285 (6%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWY 110
           H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   M E+V TRWY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAEL 169
           RAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 170 GFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
             + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 229 LGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 269
           L + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  263 bits (671), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN+ 
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNAM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  262 bits (670), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 134/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   PF   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPFDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  262 bits (669), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWM 205
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  261 bits (668), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 152
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 210
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 269
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 270 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 330 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  261 bits (668), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  261 bits (668), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 152
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 210
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 269
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 270 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 330 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  261 bits (668), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 152
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 210
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 269
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 270 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 330 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  261 bits (668), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 151
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 209
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 268
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 269 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 328
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 329 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 163
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 221
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 280
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 281 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 340
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 341 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 160
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 218
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 277
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 278 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 338 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 205
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 160
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 218
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 277
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 278 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 338 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 159
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 217
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 276
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 277 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 336
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 337 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 150
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 208
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 267
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 268 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 327
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 328 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 360

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 139
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 197
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 256
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 257 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 316
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 317 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 349

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 159
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 217
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 276
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 277 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 336
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 337 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  261 bits (666), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 137
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 195
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 254
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 255 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 314
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 315 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 138
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 196
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 255
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 256 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 315
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 316 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 348

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 137
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 195
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 254
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 255 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 314
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 315 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 194
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 253
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  260 bits (665), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 194
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 253
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 254 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  260 bits (664), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI D+GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  259 bits (663), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWM 205
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+    E   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVP 357

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  259 bits (663), Expect = 9e-70,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 163
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  YV TRWYRAPE++LN  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAPEIMLNWM 221
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 280
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 281 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 340
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 341 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P    FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPTDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  + L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKY 136
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 194
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 253
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 254 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P    FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPRDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 176/273 (64%), Gaps = 8/273 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKYI
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 141
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMH 199
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKKY 179
           Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ Y
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARNY 258
Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 259 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 318
Query: 240 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           V   P    FE   L   + K L Y E ++F P
Sbjct: 319 VA-DPQDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI  FGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWM 205
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+    E   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSSESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT  V TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  258 bits (659), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 151
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 209
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 268
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 269 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 328
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 329 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  258 bits (658), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 128/271 (47%), Positives = 176/271 (64%), Gaps = 6/271 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P    E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 169
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 227
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 179
            Y   +D+WSVGCI  EL+  + LFPG DH++QL+ ++ L GTP  + +  + +  A+ Y
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNY 287
Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
           I  LP+  +++F + F   +P A+DL+EKML  D  +RIT  +ALAHPY    HD  DEP
Sbjct: 288 INSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDEP 347
Query: 240 VCMSPFSFDFEQHALTEGQMKELIYQEALAF 270
               P+   FE   L   + K L Y+E  +F
Sbjct: 348 ES-EPYDQSFESRQLEIEEWKRLTYEEVCSF 377

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWM 194
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 253
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 254 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  257 bits (657), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  257 bits (657), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  257 bits (657), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DF LAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  256 bits (653), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 175/274 (63%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 160
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M   V TRWYRAPE++LN  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIMLNWM 218
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 277
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 278 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 338 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  256 bits (653), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 175/274 (63%), Gaps = 8/274 (2%)
Query: 2   QVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            V+ + D+  P +  E FNDVY+   LM  DL+ I++S Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKY 140
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           IHSA+++HRDLKPSNL +N + +LKI DFGL R T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 178
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           PV   P+    E   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  253 bits (646), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 127/272 (46%), Positives = 175/272 (64%), Gaps = 6/272 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    E F++VY+   LM  DL+ I++  QALS+EH Q+ +YQ+LRGLKYI
Sbjct: 81  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYI 139
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+ +N +C+L+I DFGLAR   E   MT YV TRWYRAPE++LN   
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMH 197
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+ YI
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 257
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD  DEP 
Sbjct: 258 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPE 317
Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              P+    E    T  + KEL YQE L+F P
Sbjct: 318 A-EPYDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  249 bits (636), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 126/270 (46%), Positives = 174/270 (64%), Gaps = 6/270 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    E F++VY+   LM  DL+ I++S QALS+EH Q+ +YQ+LRGLKYI
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYI 147
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRWYRAPE++LN   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMH 205
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+ YI
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD  DEP 
Sbjct: 266 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPE 325
Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAF 270
              P+    E    T  + KEL YQE L+F
Sbjct: 326 A-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  247 bits (630), Expect = 7e-66,   Method: Compositional matrix adjust.
 Identities = 125/270 (46%), Positives = 173/270 (64%), Gaps = 6/270 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    E F++VY+   LM  DL+ I++  QALS+EH Q+ +YQ+LRGLKYI
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYI 147
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRWYRAPE++LN   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMH 205
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+ YI
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD  DEP 
Sbjct: 266 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPE 325
Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAF 270
              P+    E    T  + KEL YQE L+F
Sbjct: 326 A-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  234 bits (598), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 120/272 (44%), Positives = 163/272 (59%), Gaps = 6/272 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+GLKYI
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYI 160
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   
Sbjct: 161 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMH 218
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYI 180
           Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  LN+  AK YI
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D  +E  
Sbjct: 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE 338
Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              PF    E   LT  + K+ IY+E + F+P
Sbjct: 339 AQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 120/272 (44%), Positives = 163/272 (59%), Gaps = 6/272 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+GLKYI
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMH 200
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYI 180
           Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  LN+  AK YI
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D  +E  
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE 320
Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              PF    E   LT  + K+ IY+E + F+P
Sbjct: 321 AQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  233 bits (594), Expect = 8e-62,   Method: Compositional matrix adjust.
 Identities = 119/273 (43%), Positives = 170/273 (62%), Gaps = 8/273 (2%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P +  + F D Y+    M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YI
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYI 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H+A ++HRDLKP NL +N +C+LKI DFGLAR       M   VVTRWYRAPE++LN   
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWMR 202
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAKKYI 180
           YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GT P+E      ++ AK Y+
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP- 239
             LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD  DEP 
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322
Query: 240 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
           V     SFD     L E   K + Y+E L+F P
Sbjct: 323 VQKYDDSFDDVDRTLDE--WKRVTYKEVLSFKP 353

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  211 bits (538), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 115/282 (40%), Positives = 165/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 119/290 (41%), Positives = 166/290 (57%), Gaps = 27/290 (9%)
Query: 1   MQVVAIRDII-------PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 53
           M+VV  ++II       P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQ 134
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 113
           +L G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAP
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           E++L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 174 ENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVE 221
              + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V+
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 222 DALAHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
           +AL HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  211 bits (536), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 115/282 (40%), Positives = 165/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  210 bits (534), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 119/290 (41%), Positives = 166/290 (57%), Gaps = 27/290 (9%)
Query: 1   MQVVAIRDII-------PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 53
           M+VV  ++II       P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQ 134
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 113
           +L G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           E++L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 174 ENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVE 221
              + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V+
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 222 DALAHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
           +AL HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 141
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 200
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 321 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 360

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 180
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 360 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 399

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 143
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 323 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 143
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 323 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 135
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 180
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 360 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 399

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 136
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 316 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 169/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 136
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 316 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 164/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 143
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 323 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 115/282 (40%), Positives = 166/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 90  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 147
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 206
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 266
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 267 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 327 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 366

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 164/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 115/282 (40%), Positives = 166/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 79  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 136
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 256 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 316 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 118/290 (40%), Positives = 165/290 (56%), Gaps = 27/290 (9%)
Query: 1   MQVVAIRDII-------PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 53
           M+VV  ++II       P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQ 134
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 113
           +L G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAP
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           E++L    Y   +D+WSVG I  E++    LFPG DH+ Q   +IE +GTPS   +  L 
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 174 ENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVE 221
              + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V+
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 222 DALAHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
           +AL HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 164/282 (58%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 118/290 (40%), Positives = 165/290 (56%), Gaps = 27/290 (9%)
Query: 1   MQVVAIRDII-------PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 53
           M+VV  ++II       P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQ 134
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 113
           +L G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAP
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           E++L    Y   +D+WSVG I  E++    LFPG DH+ Q   +IE +GTPS   +  L 
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 174 ENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVE 221
              + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V+
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 222 DALAHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
           +AL HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 113/282 (40%), Positives = 168/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  207 bits (528), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 113/282 (40%), Positives = 168/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHL 135
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  207 bits (528), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 113/282 (40%), Positives = 168/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 230 GSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  207 bits (526), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 118/333 (35%), Positives = 174/333 (52%), Gaps = 61/333 (18%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            VV + DI+ P   E F+++Y+  E+ D+D  ++ R+   L+E H +  LY +L G+KY+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--------------ETDF------- 100
           HSA +LHRDLKP+N L+N +C +K+CDFGLAR                 E D        
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 101 -------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRK 142
                  +T +VVTRWYRAPEL+L   +YT AIDVWS+GCIF EL+           DR 
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 143 PLFPG--------------------RDHVHQLRLLIELIGTPSEAELGFL-NENAKKYIC 181
           PLFPG                    R +  QL ++  ++GTPSE ++  L  E+AK+YI 
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR 352
Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
             P+ +     E+FP     AI L+++ML F+P +RIT+ + LAHP+   +     E   
Sbjct: 353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNA 412
Query: 242 MSPFSFDF-EQHALTEGQMKELIYQEALAFNPE 273
                  F +   + E Q++    +E   ++PE
Sbjct: 413 TEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  207 bits (526), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 115/282 (40%), Positives = 168/282 (59%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L G+K++
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHL 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR  S    MT YVVTR+YRAPE++L    
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG- 199
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    + Y+ 
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P Y   +F E FP+ + PS           A DL+ KML  DP +RI+V++AL HPY+
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D ++    P  +     +  +HA+ E   KELIY+E +
Sbjct: 320 TVWYDPAEAEAPPPQIYDAQLEEREHAIEE--WKELIYKEVM 359

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  207 bits (526), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 115/284 (40%), Positives = 169/284 (59%), Gaps = 21/284 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR       MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y A +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    + Y+ 
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y    F E FP+ + PS           A DL+ KML  DP +RI+V++AL HPY+
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEALAF 270
              +D ++    P  +     +  +HA+ E   KELIY+E + +
Sbjct: 322 TVWYDPAEAEAPPPQIYDAQLEEREHAIEE--WKELIYKEVMDW 363

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  206 bits (524), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 118/283 (41%), Positives = 169/283 (59%), Gaps = 23/283 (8%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSS 120
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR T+ T FM E  VVTR+YRAPE++L   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP  A +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYV 260
Query: 181 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 229 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  205 bits (522), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 112/282 (39%), Positives = 163/282 (57%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 87  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 144
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  M  +VVTR+YRAPE++L    
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG- 203
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 263
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 264 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 324 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 363

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  204 bits (520), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 113/282 (40%), Positives = 163/282 (57%), Gaps = 21/282 (7%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT  VVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 182 QLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 230 GSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  204 bits (519), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 112/279 (40%), Positives = 166/279 (59%), Gaps = 24/279 (8%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 230 GSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +D +           D  +H + E   KELIY+E +
Sbjct: 322 NVWYDPA------XXXXXDEREHTIEE--WKELIYKEVM 352

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  204 bits (518), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 115/324 (35%), Positives = 176/324 (54%), Gaps = 53/324 (16%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+EEH +  LY +L G  +IH
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF--------------------- 100
            + ++HRDLKP+N LLN +C +K+CDFGLAR + SE D                      
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 101 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLFPGR 148
            +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLFPG 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 149 D-----------HVH------QLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQS 190
                        VH      QL ++  +IGTP+E +L  +N+    KYI   P  +  +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 250
             +K+P++    I+L+E ML F+P +RIT++ AL HPYL  +     E          F+
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD 386
Query: 251 Q-HALTEGQMKELIYQEALAFNPE 273
               L+E Q++ +  +E  +F+PE
Sbjct: 387 DWMVLSETQLRYIFLKEVQSFHPE 410

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  203 bits (517), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/283 (41%), Positives = 168/283 (59%), Gaps = 23/283 (8%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSS 120
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR T+ T FM E  VVTR+YRAPE++L   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 181 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 229 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  201 bits (511), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 111/279 (39%), Positives = 164/279 (58%), Gaps = 26/279 (9%)
Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 142
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 182 QLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 230 GSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 268
              +              D  +H + E   KELIY+E +
Sbjct: 322 NVWY--------XXXXXXDEREHTIEE--WKELIYKEVM 350

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 156/273 (57%), Gaps = 4/273 (1%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY 60
            ++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++   
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENAKKY 179
            +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP  E  + F + +A+ Y
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 180 I-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           +   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  D 
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 271
              +S   F F++       M ++   E   FN
Sbjct: 330 TEGLSE-RFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 156/273 (57%), Gaps = 4/273 (1%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY 60
            ++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++   
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENAKKY 179
            +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP  E  + F + +A+ Y
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 180 I-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
           +   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  D 
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329
Query: 239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 271
              +S   F F++       M ++   E   FN
Sbjct: 330 TEGLSE-RFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 116/331 (35%), Positives = 181/331 (54%), Gaps = 64/331 (19%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+E+H +  LY +L G K+IH
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH 148
Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF--------------------- 100
            + ++HRDLKP+N LLN +C +KICDFGLAR + S+ D                      
Sbjct: 149 ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKN 208
Query: 101 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLF 145
               +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLF
Sbjct: 209 LKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLF 268
Query: 146 PGR-------DH----VH------QLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQ 187
           PG        DH    VH      QL ++  +IGTP E +L  +  +   KYI   P   
Sbjct: 269 PGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRD 328
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG-----SLHDISDEPVCM 242
               ++K+ ++    IDL+E ML F+ ++RIT++ AL+HPYL      +L + S E + +
Sbjct: 329 GIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIIL 388
Query: 243 SPFSFDFEQHALTEGQMKELIYQEALAFNPE 273
            PF    +   L+E Q++ +  +E  +F+ +
Sbjct: 389 -PFD---DWMVLSETQLRYIFLKEIQSFHAD 415

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  193 bits (490), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 103/235 (43%), Positives = 145/235 (61%), Gaps = 20/235 (8%)
Query: 18  FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
            N VYI  E M+TDL  ++     L EEH + F+YQ+LRGLKYIHSANVLHRDLKP+NL 
Sbjct: 94  LNSVYIVQEYMETDLANVLEQGPLL-EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152
Query: 78  LNA-NCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           +N  +  LKI DFGLAR+     S    ++E +VT+WYR+P LLL+ ++YT AID+W+ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           CIF E++  K LF G   + Q++L++E I    E       E+ ++ +  +P Y R   T
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE-------EDRQELLSVIPVYIRNDMT 265
Query: 193 EK-------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
           E         P +   A+D +E++LTF P  R+T E+AL+HPY+       DEP+
Sbjct: 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  192 bits (487), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 169/290 (58%), Gaps = 47/290 (16%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           DVY+ ++ M+TDLH +IR+N  L   H QY +YQ+++ +KY+HS  +LHRD+KPSN+LLN
Sbjct: 85  DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN 143
Query: 80  ANCDLKICDFGLAR---------------VTSETD-------FMTEYVVTRWYRAPELLL 117
           A C +K+ DFGL+R               +   T+        +T+YV TRWYRAPE+LL
Sbjct: 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN---- 173
            S+ YT  ID+WS+GCI  E++  KP+FPG   ++QL  +I +I  PS  ++  +     
Sbjct: 204 GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFA 263
Query: 174 ----ENAKKYICQLPRYQRQSFTEKFPN----VHPS------AIDLVEKMLTFDPRQRIT 219
               E+ K+ +      +R  FT K+ N    ++P       A+DL++K+L F+P +RI+
Sbjct: 264 KTMIESLKEKVEIRQSNKRDIFT-KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322
Query: 220 VEDALAHPYLGSLHDISDEPVCMSPFSF---DFEQHALTEGQMKELIYQE 266
             DAL HP++   H+ ++EP C    +    D  +H++ +   + L+Y E
Sbjct: 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD--YRNLVYSE 370

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  177 bits (449), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 100/251 (39%), Positives = 141/251 (56%), Gaps = 12/251 (4%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKY 60
            +V + DII      +   + + +E +D DL Q +      ++  + + FL+Q+LRGL Y
Sbjct: 61  NIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 119
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T      VVT WYR P++LL S
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL-NENAK 177
           +DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L NE  K
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD-IS 236
            Y    P+Y+ ++     P +     DL+ K+L F+ R RI+ EDA+ HP+  SL + I 
Sbjct: 236 TY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293
Query: 237 DEPVCMSPFSF 247
             P   S F+ 
Sbjct: 294 KLPDTTSIFAL 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 125/212 (58%), Gaps = 2/212 (0%)
Query: 23  IAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           + +E M+ DL +++  N+  L +   + +LYQ+LRG+ + H   +LHRDLKP NLL+N++
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD 155
Query: 82  CDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             LK+ DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++ 
Sbjct: 156 GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP 200
            KPLFPG     QL  +  ++GTP+  E   + E           ++++ ++   P    
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ 275
Query: 201 SAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
             IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 125/212 (58%), Gaps = 2/212 (0%)
Query: 23  IAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           + +E M+ DL +++  N+  L +   + +LYQ+LRG+ + H   +LHRDLKP NLL+N++
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD 155
Query: 82  CDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             LK+ DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++ 
Sbjct: 156 GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP 200
            KPLFPG     QL  +  ++GTP+  E   + E           ++++ ++   P    
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ 275
Query: 201 SAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
             IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 70  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 243
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 244 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 70  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 243
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 244 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  163 bits (413), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  163 bits (413), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  163 bits (413), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 67  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 240
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +D DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 95/240 (39%), Positives = 131/240 (54%), Gaps = 28/240 (11%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKY 60
            +V + D+I   +R     + + +E +D DL +++      L     + FL Q+L G+ Y
Sbjct: 61  NIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 119
            H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+ S
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
             Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N+K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTP----------NSKNW 225
Query: 180 --ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL H Y 
Sbjct: 226 PNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 95/240 (39%), Positives = 131/240 (54%), Gaps = 28/240 (11%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKY 60
            +V + D+I   +R     + + +E +D DL +++      L     + FL Q+L G+ Y
Sbjct: 61  NIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 119
            H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+ S
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
             Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N+K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP----------NSKNW 225
Query: 180 --ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL H Y 
Sbjct: 226 PNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 67  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 240
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 94/240 (39%), Positives = 131/240 (54%), Gaps = 28/240 (11%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKY 60
            +V + D+I   +R     + + +E +D DL +++      L     + FL Q+L G+ Y
Sbjct: 61  NIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 119
            H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+ S
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
             Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N+K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP----------NSKNW 225
Query: 180 --ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL H Y 
Sbjct: 226 PNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 130/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 130/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 130/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 130/231 (56%), Gaps = 9/231 (3%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK 59
            +V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 118
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 91/238 (38%), Positives = 133/238 (55%), Gaps = 23/238 (9%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKY 60
            +V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+GL +
Sbjct: 62  NIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 119
            HS NVLHRDLKP NLL+N N +LK+ DFGLAR         +  VVT WYR P++L  +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 120 SDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
             Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +          
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW--------P 228
Query: 179 YICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            + +LP Y+         S     P ++ +  DL++ +L  +P QRI+ E+AL HPY 
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 142 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 319
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 320 TARLTPLEACAHSFFDELRD 339

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 119 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 179 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 239 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 296
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 297 TARLTPLEACAHSFFDELRD 316

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 326 TARLTPLEACAHSFFDELRD 345

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 150 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 327
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 328 TARLTPLEACAHSFFDELRD 347

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 152 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 329
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 330 TARLTPLEACAHSFFDELRD 349

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 193 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 370
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 371 TARLTPLEACAHSFFDELRD 390

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 127 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 304
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 305 TARLTPLEACAHSFFDELRD 324

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++    P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 90/238 (37%), Positives = 133/238 (55%), Gaps = 23/238 (9%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKY 60
            +V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+GL +
Sbjct: 62  NIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 119
            HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT WYR P++L  +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 120 SDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
             Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +          
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW--------P 228
Query: 179 YICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            + +LP Y+         S     P ++ +  DL++ +L  +P QRI+ E+AL HPY 
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 117/188 (62%), Gaps = 4/188 (2%)
Query: 48  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVV 106
           + ++YQ+LR L YIHS  + HRD+KP NLLL+     LK+ DFG A++    +     + 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 166
           +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +PLFPG   + QL  +I+++GTPS 
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 167 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 225
            ++  +N N  ++  + P+ +   F++ F P   P AIDL+ ++L + P  R+T  +AL 
Sbjct: 264 EQIKTMNPNYMEH--KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 226 HPYLGSLH 233
           HP+   L 
Sbjct: 322 HPFFDELR 329

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 142/232 (61%), Gaps = 6/232 (2%)
Query: 7   RDIIPPPQRESFNDVYIAY--ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA 64
           + +I  P +  + +V + Y  + +   L   IRS +++       ++YQ+ R + +IHS 
Sbjct: 101 KSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160
Query: 65  NVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYT 123
            + HRD+KP NLL+N+  + LK+CDFG A+    ++     + +R+YRAPEL+L +++YT
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYT 220
Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 183
            +ID+WS+GC+F EL+  KPLF G   + QL  +I+++GTP++ ++  +N +  +   + 
Sbjct: 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE--VRF 278
Query: 184 PRYQRQSFTEKFPNVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
           P  + + + +  P   PS AIDL+E++L ++P  RI   +A+AHP+   L +
Sbjct: 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 326 TARLTPLEACAHSFFDELRD 345

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 303
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 304 TARLTPLEACAHSFFDELRD 323

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 133 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 310
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 311 TARLTPLEACAHSFFDELRD 330

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 303
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 304 TARLTPLEACAHSFFDELRD 323

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 122 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 299
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 300 TARLTPLEACAHSFFDELRD 319

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 115 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 235 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 292
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 293 TARLTPLEACAHSFFDELRD 312

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 118 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 238 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 295
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 296 TARLTPLEACAHSFFDELRD 315

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 121/200 (60%), Gaps = 4/200 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 95
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 96  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 214
            +I+++GTP+  ++  +N N  ++    P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 215 RQRITVEDALAHPYLGSLHD 234
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/237 (38%), Positives = 136/237 (57%), Gaps = 16/237 (6%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+  + +
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRDV 247
Query: 181 CQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
             LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 248 A-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/237 (38%), Positives = 136/237 (57%), Gaps = 16/237 (6%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+  + +
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRDV 247
Query: 181 CQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
             LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 248 A-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 91/234 (38%), Positives = 135/234 (57%), Gaps = 16/234 (6%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+  + +
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRDV 247
Query: 181 CQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY 
Sbjct: 248 A-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 136/243 (55%), Gaps = 24/243 (9%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQIL 55
            +V + D+I      + N + + +E MD DL + + S       + L     +YF +Q+L
Sbjct: 64  NIVRLYDVI-----HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 114
           +GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA------E 168
           +L+ S  Y+ +ID+WS GCI  E++  KPLFPG +   QL+L+ +++GTP+E+      +
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 169 LGFLNENAKKYICQLPRYQRQSFT--EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
           L   N N ++   + PR  RQ      K P +  + +D +  +L  +P  R++ + AL H
Sbjct: 239 LPKYNPNIQQ---RPPRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 227 PYL 229
           P+ 
Sbjct: 295 PWF 297

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 126/220 (57%), Gaps = 3/220 (1%)
Query: 21  VYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +++ +E  D T LH++ R  + + E   +   +Q L+ + + H  N +HRD+KP N+L+ 
Sbjct: 77  LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136
Query: 80  ANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            +  +K+CDFG AR+ T  +D+  + V TRWYR+PELL+  + Y   +DVW++GC+F EL
Sbjct: 137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPN 197
           +   PL+PG+  V QL L+ + +G          + N      ++P  +     E KFPN
Sbjct: 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN 256
Query: 198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
           +   A+ L++  L  DP +R+T E  L HPY  ++ +I D
Sbjct: 257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 83/221 (37%), Positives = 121/221 (54%), Gaps = 16/221 (7%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +++ + ++ M+TDL  II+ N   L+  H + ++   L+GL+Y+H   +LHRDLKP+NLL
Sbjct: 85  SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 144
Query: 78  LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           L+ N  LK+ DFGLA+   S        VVTRWYRAPELL  +  Y   +D+W+VGCI  
Sbjct: 145 LDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 204
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFT--- 192
           EL+ R P  PG   + QL  + E +GTP+E +           +C LP Y   +SF    
Sbjct: 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW--------PDMCSLPDYVTFKSFPGIP 256
Query: 193 --EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
               F       +DL++ +  F+P  RIT   AL   Y  +
Sbjct: 257 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 84/230 (36%), Positives = 122/230 (53%), Gaps = 6/230 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 59
            VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS 194
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 195 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 250
Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 121/230 (52%), Gaps = 6/230 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 59
            VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 67  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+LL S
Sbjct: 127 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQS 186
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 242
Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 121/230 (52%), Gaps = 6/230 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 59
            VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 67  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+LL S
Sbjct: 127 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQS 186
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 242
Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 121/230 (52%), Gaps = 6/230 (2%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 59
            VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 67  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+LL S
Sbjct: 127 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQS 186
Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 242
Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 74/213 (34%), Positives = 119/213 (55%), Gaps = 7/213 (3%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ +E +D T L  +      L  +  Q +L+QI+ G+ + HS N++HRD+KP N+L++ 
Sbjct: 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ 159
Query: 81  NCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  +K+CDFG AR + +  +   + V TRWYRAPELL+    Y  A+DVW++GC+  E+ 
Sbjct: 160 SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 140 DRKPLFPGRDHVHQLRLLIELIGT--PSEAELGFLNENAKKYICQLPRY-QRQSFTEKFP 196
             +PLFPG   + QL  ++  +G   P   EL   N+N      +LP   +R+    ++P
Sbjct: 220 MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL--FNKNPVFAGVRLPEIKEREPLERRYP 277
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +    IDL +K L  DP +R    + L H + 
Sbjct: 278 KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 113/196 (57%), Gaps = 13/196 (6%)
Query: 48  QYFLYQILRGLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEY 104
           + FL+Q++R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 164
           + +R+YRAPEL+  +  YT A+D+WSVGCIF E+M  +P+F G +   QL  ++ ++G P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 165 SEAELGFLNENAKKYICQLPRYQRQS------FTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           S   L  LN +       +  Y  +       F++        A DL+  +L + P +R+
Sbjct: 252 SREVLRKLNPSHT----DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 219 TVEDALAHPYLGSLHD 234
              +AL HPY   LHD
Sbjct: 308 KPYEALCHPYFDELHD 323

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 117/228 (51%), Gaps = 32/228 (14%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +++ +E  + DL + +  N  +S    + FLYQ++ G+ + HS   LHRDLKP NLLL+ 
Sbjct: 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 81  NCD-----LKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           +       LKI DFGLAR         T  ++T WYR PE+LL S  Y+ ++D+WS+ CI
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
           + E++ + PLFPG   + QL  + E++G P        ++     +  LP ++     + 
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLP--------DDTTWPGVTALPDWK-----QS 274
Query: 195 FPNVHPSAIDLV-------------EKMLTFDPRQRITVEDALAHPYL 229
           FP      +  V               ML  DP +RI+ ++AL HPY 
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 12/229 (5%)
Query: 13  PQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           P       +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHR
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHR 149
Query: 70  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 124
           D+K +N+L+  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY  
Sbjct: 150 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGP 209
Query: 125 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 184
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 210 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 269
Query: 185 RYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 270 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 12/229 (5%)
Query: 13  PQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           P       +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHR
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHR 149
Query: 70  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 124
           D+K +N+L+  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY  
Sbjct: 150 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGP 209
Query: 125 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 184
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 210 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 269
Query: 185 RYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 270 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 12/229 (5%)
Query: 13  PQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           P       +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHR
Sbjct: 91  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHR 148
Query: 70  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 124
           D+K +N+L+  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY  
Sbjct: 149 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGP 208
Query: 125 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 184
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 209 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 268
Query: 185 RYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 269 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 116/221 (52%), Gaps = 12/221 (5%)
Query: 21  VYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHRD+K +N+L
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVL 157
Query: 78  LNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           +  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY   ID+W  G
Sbjct: 158 ITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAG 217
Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           CI  E+  R P+  G    HQL L+ +L G+ +      ++        +L + Q++   
Sbjct: 218 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 277
Query: 193 EKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 278 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/247 (34%), Positives = 129/247 (52%), Gaps = 42/247 (17%)
Query: 21  VYIAYELMDTDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           V++ ++  + DL  II+ ++A         L     +  LYQIL G+ Y+H+  VLHRDL
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154
Query: 72  KPSNLLLNA----NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYT 123
           KP+N+L+         +KI D G AR+ +        +   VVT WYRAPELLL +  YT
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 214
Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNE 174
            AID+W++GCIF EL+  +P+F  R          H  QL  +  ++G P++ +     E
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW----E 270
Query: 175 NAKK---YICQLPRYQRQSFTE----KFPNVH-----PSAIDLVEKMLTFDPRQRITVED 222
           + KK   +   +  ++R ++T     K+   H       A  L++K+LT DP +RIT E 
Sbjct: 271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330
Query: 223 ALAHPYL 229
           A+  PY 
Sbjct: 331 AMQDPYF 337

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 87  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 146
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 147 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 206
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 207 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 241
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 242 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 94  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 153
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 154 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 213
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 214 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 248
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 249 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 142 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 201
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 202 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 262 KVLGTDG------LNAYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 314
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 315 FLDKLLRYDHQERLTALEAMTHPYF 339

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 242 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 294
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 295 FLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 125/216 (57%), Gaps = 24/216 (11%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKIC 87
           +TD  Q+    Q L++   ++++Y++L+ L Y HS  ++HRD+KP N++++     L++ 
Sbjct: 119 NTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLI 175
Query: 88  DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFP 146
           D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+   ++  R+P F 
Sbjct: 176 DWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFH 235
Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKY-----------ICQLPRYQRQSF--TE 193
           G+D+  QL  + +++GT  E   G+L    KKY           + Q  R + ++F  +E
Sbjct: 236 GQDNYDQLVRIAKVLGT--EELYGYL----KKYHIDLDPHFNDILGQHSRKRWENFIHSE 289
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               V P A+DL++K+L +D +QR+T ++A+ HPY 
Sbjct: 290 NRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 243 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 295
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 296 FLDKLLRYDHQERLTALEAMTHPYF 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 125/216 (57%), Gaps = 24/216 (11%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKIC 87
           +TD  Q+    Q L++   ++++Y++L+ L Y HS  ++HRD+KP N++++     L++ 
Sbjct: 124 NTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLI 180
Query: 88  DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFP 146
           D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+   ++  R+P F 
Sbjct: 181 DWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFH 240
Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKY-----------ICQLPRYQRQSF--TE 193
           G+D+  QL  + +++GT  E   G+L    KKY           + Q  R + ++F  +E
Sbjct: 241 GQDNYDQLVRIAKVLGT--EELYGYL----KKYHIDLDPHFNDILGQHSRKRWENFIHSE 294
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               V P A+DL++K+L +D +QR+T ++A+ HPY 
Sbjct: 295 NRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 99
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 158
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 159 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 204
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 242 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 294
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 295 FLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 227 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 286
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 287 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 346
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++    +  +  F+                    E
Sbjct: 347 ILFICLSGYP--PFSEHRTQVSLKDQI----TSGKYNFI-------------------PE 381
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 382 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 31/216 (14%)
Query: 20  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 133
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I    +   P  P  +H  Q+ L  ++    +  +  F+                    E
Sbjct: 333 ILFICLSGYP--PFSEHRTQVSLKDQI----TSGKYNFI-------------------PE 367
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N+L++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 91  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 259
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 227 PYL 229
           PY 
Sbjct: 320 PYF 322

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 92  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 260
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 227 PYL 229
           PY 
Sbjct: 321 PYF 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 98  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 152
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 266
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 267 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 326
Query: 227 PYL 229
           PY 
Sbjct: 327 PYF 329

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 92  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 260
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 227 PYL 229
           PY 
Sbjct: 321 PYF 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 128/243 (52%), Gaps = 26/243 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYL 229
           PY 
Sbjct: 322 PYF 324

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 130/246 (52%), Gaps = 26/246 (10%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 62  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 180 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 227 PYLGSL 232
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 19  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 77  LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 186
             EL+   PL PG D   QL  +IEL+G PS+  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 187 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 224
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 225 AHPYL 229
            HP+L
Sbjct: 408 RHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 19  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 77  LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 186
             EL+   PL PG D   QL  +IEL+G PS+  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 187 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 224
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 225 AHPYL 229
            HP+L
Sbjct: 408 RHPWL 412

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            ++Y   EL D    +II+  +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL
Sbjct: 100 GELYTGGELFD----EIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G++    L+            E G       KY   LP+++        
Sbjct: 213 YILLSGTPPFYGKNEYDILK----------RVETG-------KYAFDLPQWR-------- 247
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 38/245 (15%)
Query: 19  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 77  LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 186
             EL+   PL PG D   QL  +IEL+G P +  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 187 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 224
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 225 AHPYL 229
            HP+L
Sbjct: 408 RHPWL 412

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            ++Y   EL D    +II+  +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL
Sbjct: 100 GELYTGGELFD----EIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G++    L+            E G       KY   LP+++        
Sbjct: 213 YILLSGTPPFYGKNEYDILK----------RVETG-------KYAFDLPQWR-------- 247
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            ++Y   EL D    +II+  +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL
Sbjct: 100 GELYTGGELFD----EIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G++    L+            E G       KY   LP+++        
Sbjct: 213 YILLSGTPPFYGKNEYDILK----------RVETG-------KYAFDLPQWR-------- 247
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 36/211 (17%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA- 80
           Y   EL D  +H++       +E      + Q+L G+ Y+H  N++HRDLKP NLLL + 
Sbjct: 118 YKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 81  --NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             +  +KI DFGL+ V      M E + T +Y APE+L     Y    DVWS+G I   L
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFIL 230
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 198
           +   P F G+     LR          + E G       KY    P ++         NV
Sbjct: 231 LAGYPPFGGQTDQEILR----------KVEKG-------KYTFDSPEWK---------NV 264
Query: 199 HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              A DL+++ML FD ++RI+ + AL HP++
Sbjct: 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  103 bits (258), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 128 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 182
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 240
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 241 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 276
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 277 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 129 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 183
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 241
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 242 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 277
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 278 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 218 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 253
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 254 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 111 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 165
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 223
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 224 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 259
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 260 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ES + +++ ++LM   +L   +    ALSE+  +  +  +L  + ++H+ N++HRDLKP 
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVW 129
           N+LL+ N  +++ DFG +      + + E   T  Y APE+L  S D     Y   +D+W
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 189
           + G I   L+   P F  R  +  LR+++E                  +Y    P +  +
Sbjct: 290 ACGVILFTLLAGSPPFWHRRQILMLRMIME-----------------GQYQFSSPEWDDR 332
Query: 190 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           S T K         DL+ ++L  DP  R+T E AL HP+ 
Sbjct: 333 SSTVK---------DLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            +VY   EL D      I S +  SE      + Q+L G+ Y H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLL 159
Query: 79  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            +   + +++I DFGL+     +    + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 218 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 253
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             V  SA DL+ K LT+ P  RI+  DAL H ++
Sbjct: 254 --VSESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 116/258 (44%), Gaps = 53/258 (20%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +VY   EL D     I+R  Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL 
Sbjct: 84  EVYRGGELFD---EIILR--QKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 138
Query: 80  ANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           +      +KI DFGL+        M E + T +Y APE+L     Y    DVWS G I  
Sbjct: 139 SKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILY 196
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
            L+   P F G+                ++ E+             L R ++  F+   P
Sbjct: 197 ILLCGYPPFGGQ----------------TDQEI-------------LKRVEKGKFSFDPP 227
Query: 197 N---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA 253
           +   V   A  LV+ MLT++P +RI+ E+AL HP++           C    + D  +HA
Sbjct: 228 DWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF--------CSQKHT-DVGKHA 278
Query: 254 LTE--GQMKELIYQEALA 269
           LT   G MK+    + LA
Sbjct: 279 LTGALGNMKKFQSSQKLA 296

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E    + I +EL+    +  I+ N  L    +H +   YQI + + ++HS  + H DLKP
Sbjct: 87  EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 74  SNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
            N+L                      N D+K+ DFG A  T + +  +  V TR YRAPE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPE 204
Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-------TPSEA 167
           ++L +  ++   DVWS+GCI +E      +FP  D    L ++  ++G         +  
Sbjct: 205 VIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263
Query: 168 ELGFLNE--------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 219
              F ++        +A +Y+ +  +  ++ F       H    DL++KML +DP +RIT
Sbjct: 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRIT 322
Query: 220 VEDALAHPYLGSL 232
           + +AL HP+   L
Sbjct: 323 LREALKHPFFDLL 335

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 79
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 80  A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 169
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275
Query: 170 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 222
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 330
Query: 223 ALAHPYLGSL 232
           AL HP+   L
Sbjct: 331 ALLHPFFAGL 340

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 116/253 (45%), Gaps = 40/253 (15%)
Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E    + I +EL+    +  I+ N  L    +H +   YQI + + ++HS  + H DLKP
Sbjct: 87  EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 74  SNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
            N+L                      N D+K+ DFG A  T + +  +  V  R YRAPE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPE 204
Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-------TPSEA 167
           ++L +  ++   DVWS+GCI +E      +FP  D    L ++  ++G         +  
Sbjct: 205 VIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263
Query: 168 ELGFLNE--------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 219
              F ++        +A +Y+ +  +  ++ F       H    DL++KML +DP +RIT
Sbjct: 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRIT 322
Query: 220 VEDALAHPYLGSL 232
           + +AL HP+   L
Sbjct: 323 LREALKHPFFDLL 335

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 79
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 167
Query: 80  A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 168 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 224
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 169
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 225 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 284
Query: 170 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 222
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 285 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 339
Query: 223 ALAHPYLGSL 232
           AL HP+   L
Sbjct: 340 ALLHPFFAGL 349

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 79
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 190
Query: 80  A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 191 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 247
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 169
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 248 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 307
Query: 170 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 222
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 308 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 362
Query: 223 ALAHPYLGSL 232
           AL HP+   L
Sbjct: 363 ALLHPFFAGL 372

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 42/216 (19%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +VY   EL D     I+R  Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL 
Sbjct: 101 EVYRGGELFD---EIILR--QKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 155
Query: 80  ANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           +      +KI DFGL+        M E + T +Y APE+L     Y    DVWS G I  
Sbjct: 156 SKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILY 213
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
            L+   P F G+                ++ E+             L R ++  F+   P
Sbjct: 214 ILLCGYPPFGGQ----------------TDQEI-------------LKRVEKGKFSFDPP 244
Query: 197 N---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +   V   A  LV+ MLT++P +RI+ E+AL HP++
Sbjct: 245 DWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 19  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 93  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 152
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 153 FLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 211
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 192
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 212 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 243
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 250
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 244 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 298
Query: 251 QHALTEGQMKEL 262
             +L     K L
Sbjct: 299 PSSLDPSNRKPL 310

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ ++L+   +L + I + +  SE    + ++QIL  + +IH  +++HRDLKP NLLL +
Sbjct: 106 YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLAS 165
Query: 81  NCD---LKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
            C    +K+ DFGLA  V  E      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 166 KCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDIWACGVI-- 222
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
                              L I L+G P      F +E+  K   Q+        + ++ 
Sbjct: 223 -------------------LYILLVGYPP-----FWDEDQHKLYQQIKAGAYDFPSPEWD 258
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            V P A +L+ +MLT +P +RIT + AL HP++
Sbjct: 259 TVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 19  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 89  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 148
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 149 FLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 207
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 192
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 208 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 239
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 250
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 240 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPXFSIA 294
Query: 251 QHALTEGQMKEL 262
             +L     K L
Sbjct: 295 PSSLDPSNRKPL 306

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 19  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 89  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 148
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 149 FLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 207
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 192
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 208 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 239
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 250
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 240 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 294
Query: 251 QHALTEGQMKEL 262
             +L     K L
Sbjct: 295 PSSLDPSNRKPL 306

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 19  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 111 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 170
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 171 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 229
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 192
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 230 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 261
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 250
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 262 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 316
Query: 251 QHALTEGQMKEL 262
             +L     K L
Sbjct: 317 PSSLDPSNRKPL 328

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 19  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 231
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 192
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 232 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 263
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 250
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 264 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318
Query: 251 QHALTEGQMKEL 262
             +L     K L
Sbjct: 319 PSSLDPSNRKPL 330

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L  +KY+
Sbjct: 78  IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 62  HSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y APE+L  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D WS+G I                       I L G P      F +EN  K
Sbjct: 193 KP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYDENDAK 225
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
              Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 226 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L  +KY+
Sbjct: 78  IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 62  HSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y APE+L  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D WS+G I                       I L G P      F +EN  K
Sbjct: 193 KP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYDENDAK 225
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
              Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 226 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L  +KY+
Sbjct: 78  IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 62  HSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y APE+L  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D WS+G I                       I L G P      F +EN  K
Sbjct: 193 KP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYDENDAK 225
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
              Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 226 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            +V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 66  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 61  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 179
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 180 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 213
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L  +KY+
Sbjct: 78  IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 62  HSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y APE+L  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D WS+G I                       I L G P      F +EN  K
Sbjct: 193 KP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYDENDAK 225
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
              Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 226 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 112/232 (48%), Gaps = 41/232 (17%)
Query: 19  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 87  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 147 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 205
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 192
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 206 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 237
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS 243
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++
Sbjct: 238 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLT 284

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 16  ESFND---VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 71
           E F+D    ++  EL++  +L + I+  +  SE    Y + +++  + ++H   V+HRDL
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 72  KPSNLLL---NANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           KP NLL    N N ++KI DFG AR+   +   +     T  Y APE LLN + Y  + D
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCD 191
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   ++  +  F   D        +E++    + +  F  E  K          
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK---------- 241
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP 244
                    NV   A DL++ +LT DP +R+ +     + +L     +S  P+ M+P
Sbjct: 242 ---------NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL-MTP 288

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            +V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 66  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 61  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 179
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 180 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 213
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            +V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 89  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 61  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 202
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 203 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 236
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            +V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 65  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 61  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 178
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 179 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 212
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 213 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 236 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 265
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 100/221 (45%), Gaps = 42/221 (19%)
Query: 21  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           VY+  ELM     L +I+R  +  SE    + L+ I + ++Y+HS  V+HRDLKPSN+L 
Sbjct: 96  VYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY 154
Query: 79  -----NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
                N  C L+ICDFG A+ + +E   +     T  + APE +L    Y    D+WS+G
Sbjct: 155 VDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLG 212
Query: 133 C-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
             ++  L    P   G               TP E                L R     F
Sbjct: 213 ILLYTMLAGYTPFANGPSD------------TPEEI---------------LTRIGSGKF 245
Query: 192 TEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           T    N   V  +A DLV KML  DP QR+T +  L HP++
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 100/221 (45%), Gaps = 42/221 (19%)
Query: 21  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           VY+  ELM     L +I+R  +  SE    + L+ I + ++Y+HS  V+HRDLKPSN+L 
Sbjct: 96  VYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY 154
Query: 79  -----NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
                N  C L+ICDFG A+ + +E   +     T  + APE +L    Y    D+WS+G
Sbjct: 155 VDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLG 212
Query: 133 C-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
             ++  L    P   G               TP E                L R     F
Sbjct: 213 ILLYTMLAGYTPFANGPSD------------TPEEI---------------LTRIGSGKF 245
Query: 192 TEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           T    N   V  +A DLV KML  DP QR+T +  L HP++
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 232 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 261
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 212
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 213 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 242
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 236 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 265
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 36/234 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            +VA+ DI   P     N +Y+  +L+   +L   I      +E+     + Q+L  + Y
Sbjct: 81  NIVALEDIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 61  IHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           +H   ++HRDLKP NLL    +    + I DFGL+++  + D M+    T  Y APE+L 
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+ A+D WS+G I                       I L G P      F +EN  
Sbjct: 196 QKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYDENDS 228
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E A  HP++  
Sbjct: 229 KLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAG 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 211
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 212 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 241
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 210
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 211 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 240
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 239
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 240 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 269
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 19  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 73
            DV+I  ELMDT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 123 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 130
           SN+L+NA   +K+CDFG++    ++   T     + Y APE +   LN   Y+   D+WS
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 243 LGITMIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 282
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
           F+ +F       +D   + L  + ++R T  + + HP+  +LH+
Sbjct: 283 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 318

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 209
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 210 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 239
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 232 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 261
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 40/210 (19%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I DFG 
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 92  ARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
           A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F   
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAG 237
Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
           +     + +I+L                              F EKF    P A DLVEK
Sbjct: 238 NEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDLVEK 267
Query: 209 MLTFDPRQRITVEDA------LAHPYLGSL 232
           +L  D  +R+  E+        AHP+  S+
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF 234
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +       +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEGLIFAKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  ++Y 
Sbjct: 74  HIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 128
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++     
Sbjct: 129 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
               +DVWS G I   ++ R+  F                    +  +  L +N    + 
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNISNGVY 229
Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
            LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 230 TLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 261

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 216
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F EKF    P A DL
Sbjct: 217 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 246
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  ++Y 
Sbjct: 75  HIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 129
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++     
Sbjct: 130 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
               +DVWS G I   ++ R+  F                    +  +  L +N    + 
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNISNGVY 230
Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
            LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 231 TLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  ++Y 
Sbjct: 65  HIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 119
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++     
Sbjct: 120 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
               +DVWS G I   ++ R+  F                    +  +  L +N    + 
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNISNGVY 220
Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
            LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 221 TLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 252

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  ++Y 
Sbjct: 69  HIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 123
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++     
Sbjct: 124 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
               +DVWS G I   ++ R+  F                    +  +  L +N    + 
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNISNGVY 224
Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
            LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 225 TLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 256

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 80  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + D+KI DFGLA ++  + +   +   T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 195
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 101 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 160
Query: 80  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + D+KI DFGLA ++  + +   +   T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 161 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 219
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 195
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 220 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 248
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 249 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            ++ + D+I  P      D+ +  E    +L   I   + ++E+  + F  QI+  ++Y 
Sbjct: 70  HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   ++HRDLKP NLLL+ N ++KI DFGL+ + ++ +F+     +  Y APE++     
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 122 YTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
               +DVWS G + ++ L+ R P     + +  L                F   N+  Y+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNL----------------FKKVNSCVYV 226
Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +P +           + P A  L+ +M+  DP QRIT+++    P+ 
Sbjct: 227 --MPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +       +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEGLIFAKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 80  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + D+KI DFGLA ++  + +       T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 195
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   V+HRDLKP NLLL +
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLAS 138
Query: 81  NCD---LKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
            C    +K+ DFGLA  V  +      +  T  Y +PE+L   + Y   +D+W+ G I  
Sbjct: 139 KCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA-YGKPVDIWACGVI-- 195
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
                              L I L+G P      F +E+  K   Q+        + ++ 
Sbjct: 196 -------------------LYILLVGYPP-----FWDEDQHKLYQQIKAGAYDFPSPEWD 231
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            V P A +L+ +MLT +P +RIT  +AL HP++
Sbjct: 232 TVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 80  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + D+KI DFGLA ++  + +       T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 195
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 107/220 (48%), Gaps = 40/220 (18%)
Query: 21  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           VY+  ELM     L +I+R  +  SE      L+ I + ++Y+H+  V+HRDLKPSN+L 
Sbjct: 91  VYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 79  ---NANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
              + N + ++ICDFG A+ + +E   +     T  + APE +L    Y AA D+WS+G 
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGV 208
Query: 134 -IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--AELGFLNENAKKYICQLPRYQRQS 190
            ++  L    P   G D             TP E  A +G     + K+          S
Sbjct: 209 LLYTMLTGYTPFANGPDD------------TPEEILARIG-----SGKF----------S 241
Query: 191 FTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  + N V  +A DLV KML  DP QR+T    L HP++
Sbjct: 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 115 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 174
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
            ++  +K+ DFG  A+V+ E       V T ++ APE +++   Y   +D+WS+G + +E
Sbjct: 175 TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIE 233
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE       Q  R  R S   +  +
Sbjct: 234 MIDGEP--------------------------PYFNEPP----LQAMRRIRDSLPPRVKD 263
Query: 198 VHPSAIDL---VEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQH 252
           +H  +  L   ++ ML  +P QR T ++ L HP+L     ++  P C+ P    +  H
Sbjct: 264 LHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFL----KLAGPPSCIVPLMRQYRHH 317

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +D+++  E +   +L   I  N  L E+  +    QIL G+ Y H   V+HRDLKP N+L
Sbjct: 89  SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148
Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           L+A+ + KI DFGL+ + S+ +F+     +  Y APE++         +D+WS G I   
Sbjct: 149 LDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           L+     F   DHV  L                       K IC    Y  Q        
Sbjct: 209 LLCGTLPFDD-DHVPTLF----------------------KKICDGIFYTPQY------- 238
Query: 198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           ++PS I L++ ML  DP +R T++D   H + 
Sbjct: 239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   V+HRDLKP NLLL +
Sbjct: 97  YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLAS 156
Query: 81  ---NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
                 +K+ DFGLA  V  E      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 157 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVI-- 213
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
                              L I L+G P      F +E+  +   Q+        + ++ 
Sbjct: 214 -------------------LYILLVGYPP-----FWDEDQHRLYQQIKAGAYDFPSPEWD 249
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 250 TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 21  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP N
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPEN 160
Query: 76  LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           +LL +   +  +K+ DFG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 161 VLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 219
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 220 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 254
Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 22  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP N+LL+ 
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
Query: 81  NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIF 135
           + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D+WS G I 
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F  R  +  LR+++                 +  Y    P +   S T K 
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMIM-----------------SGNYQFGSPEWDDYSDTVK- 261
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                   DLV + L   P++R T E+ALAHP+ 
Sbjct: 262 --------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 22  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP N+LL+ 
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 146
Query: 81  NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIF 135
           + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D+WS G I 
Sbjct: 147 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F  R  +  LR+++                 +  Y    P +   S T K 
Sbjct: 207 YTLLAGSPPFWHRKQMLMLRMIM-----------------SGNYQFGSPEWDDYSDTVK- 248
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                   DLV + L   P++R T E+ALAHP+ 
Sbjct: 249 --------DLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 186
           +WS+G I ++ L    P                           FL +  ++ +  +   
Sbjct: 200 MWSIGVITYILLSGASP---------------------------FLGDTKQETLANVSAV 232
Query: 187 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 83  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 198
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 199 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 232
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 83  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 198
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 199 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 232
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 45/257 (17%)
Query: 19  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 74
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 75  NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 245
Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-------- 184
           CI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP        
Sbjct: 246 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWNLKK 304
Query: 185 -----RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDPRQR 217
                R  +   T K  N+                 H  A      DL+ +ML +DP+ R
Sbjct: 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364
Query: 218 ITVEDALAHPYLGSLHD 234
           I    AL H +     D
Sbjct: 365 IQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 51/260 (19%)
Query: 19  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 74
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 75  NLLLNANCD-----LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+W
Sbjct: 189 NILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMW 242
Query: 130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP----- 184
           S+GCI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP     
Sbjct: 243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWN 301
Query: 185 --------RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDP 214
                   R  +   T K  N+                 H  A      DL+ +ML +DP
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 215 RQRITVEDALAHPYLGSLHD 234
           + RI    AL H +     D
Sbjct: 362 KTRIQPYYALQHSFFKKTAD 381

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 45/257 (17%)
Query: 19  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 74
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 110 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 169
Query: 75  NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 170 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 226
Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-------- 184
           CI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP        
Sbjct: 227 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWNLKK 285
Query: 185 -----RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDPRQR 217
                R  +   T K  N+                 H  A      DL+ +ML +DP+ R
Sbjct: 286 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 345
Query: 218 ITVEDALAHPYLGSLHD 234
           I    AL H +     D
Sbjct: 346 IQPYYALQHSFFKKTAD 362

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 127
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 78
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   ++HRDLKP NLLL  
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLAS 138
Query: 79  -NANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
            +    +K+ DFGLA  V  +      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDMWACGVI-- 195
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
                              L I L+G P      F +E+  +   Q+        + ++ 
Sbjct: 196 -------------------LYILLVGYPP-----FWDEDQHRLYQQIKAGAYDFPSPEWD 231
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 39/230 (16%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           ++++  E +       I S   L+EE        +L+ L Y+H+  V+HRD+K  ++LL 
Sbjct: 116 ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 80  ANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            +  +K+ DFG  A+++ +       V T ++ APE +++ S Y   +D+WS+G + +E+
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEM 234
Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 198
           +D +P +     V  ++ L                              R S   K  N 
Sbjct: 235 VDGEPPYFSDSPVQAMKRL------------------------------RDSPPPKLKNS 264
Query: 199 H---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 245
           H   P   D +E+ML  DP++R T ++ L HP+L      +  P C+ P 
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ----TGLPECLVPL 310

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 78
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   ++HRDLKP NLLL  
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLAS 138
Query: 79  -NANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
            +    +K+ DFGLA  V  +      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDMWACGVI-- 195
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
                              L I L+G P      F +E+  +   Q+        + ++ 
Sbjct: 196 -------------------LYILLVGYPP-----FWDEDQHRLYQQIKAGAYDFPSPEWD 231
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 89  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 237
Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
              +     + +I+L                              F   F    P A DL
Sbjct: 238 RAGNEYLIFQKIIKL---------------------------EYDFPAAF---FPKARDL 267
Query: 206 VEKMLTFDPRQRITVEDA------LAHPYLGSL 232
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 116/246 (47%), Gaps = 40/246 (16%)
Query: 23  IAYELMDTDLHQIIRSNQALSE--EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 79
           I++EL+       ++ N  L       ++  +Q+ + +K++H   + H DLKP N+L +N
Sbjct: 113 ISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVN 172
Query: 80  ANCDL------------------KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           ++ +L                  ++ DFG A  T + +  +  V TR YRAPE++L    
Sbjct: 173 SDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDHEHHSTIVSTRHYRAPEVILELG- 229
Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSE-------------A 167
           ++   DVWS+GCI  E      LF   D+   L ++  ++G  PS               
Sbjct: 230 WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRG 289
Query: 168 ELGF-LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
            L +  N +A +Y+ +  +  R+  T +    H    DL+E ML ++P +R+T+ +AL H
Sbjct: 290 RLDWDENTSAGRYVRENCKPLRRYLTSE-AEEHHQLFDLIESMLEYEPAKRLTLGEALQH 348
Query: 227 PYLGSL 232
           P+   L
Sbjct: 349 PFFARL 354

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 19  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 73
            DV+I  ELMDT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 130
           SN+L+NA   +K+CDFG++    +          + Y APE +   LN   Y+   D+WS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 199 LGITMIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 238
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
           F+ +F       +D   + L  + ++R T  + + HP+  +LH+
Sbjct: 239 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 274

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   V+HR+LKP NLLL +
Sbjct: 86  YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145
Query: 81  ---NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
                 +K+ DFGLA  V  E      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVI-- 202
Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
                              L I L+G P      F +E+  +   Q+        + ++ 
Sbjct: 203 -------------------LYILLVGYPP-----FWDEDQHRLYQQIKAGAYDFPSPEWD 238
Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +TE   T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 215
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 216 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 258
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 22  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP N+LL+ 
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
Query: 81  NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIF 135
           + ++K+ DFG +      + +     T  Y APE++      N   Y   +D+WS G I 
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             L+   P F  R  +  LR+++                 +  Y    P +   S T K 
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMIM-----------------SGNYQFGSPEWDDYSDTVK- 261
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                   DLV + L   P++R T E+ALAHP+ 
Sbjct: 262 --------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 38/219 (17%)
Query: 16  ESFNDVYIAYELM-DTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E  N VY+  E+  + ++++ +++  +  SE   ++F++QI+ G+ Y+HS  +LHRDL  
Sbjct: 81  EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140
Query: 74  SNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           SNLLL  N ++KI DFGLA   ++  E  +      T  Y +PE+   S+ +    DVWS
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRSA-HGLESDVWS 197
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +GC+F  L+  +P F      + L  ++                        L  Y+  S
Sbjct: 198 LGCMFYTLLIGRPPFDTDTVKNTLNKVV------------------------LADYEMPS 233
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           F      +   A DL+ ++L  +P  R+++   L HP++
Sbjct: 234 F------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 21  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           VY+  EL      L +I+R  +  SE      L+ I + ++Y+H+  V+HRDLKPSN+L 
Sbjct: 91  VYVVTELXKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 79  ---NANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
              + N + ++ICDFG A+ + +E   +     T  + APE +L    Y AA D+WS+G 
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VLERQGYDAACDIWSLGV 208
Query: 134 -IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--AELGFLNENAKKYICQLPRYQRQS 190
            ++  L    P   G D             TP E  A +G     + K+          S
Sbjct: 209 LLYTXLTGYTPFANGPDD------------TPEEILARIG-----SGKF----------S 241
Query: 191 FTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  + N V  +A DLV K L  DP QR+T    L HP++
Sbjct: 242 LSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 144 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 203
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 204 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 262
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 263 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 292
Query: 198 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 221 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 280
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 281 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 339
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 340 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 369
Query: 198 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLG 230
           +H   PS    ++++L  DP QR T  + L HP+L 
Sbjct: 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 123 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 231
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 232 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 274
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 275 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 309

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 115 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 223
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 224 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 266
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 267 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 114 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 222
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 223 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 265
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 266 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 300

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 113 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 221
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 222 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 264
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 265 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 217
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 218 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 260
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARVTS 96
           + +SE      + QIL G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R   
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 97  ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 156
               + E + T  Y APE +LN    T A D+W++G I   L+     F G D       
Sbjct: 186 HACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED------- 237
Query: 157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 216
                             N + Y+  + +       E F +V   A D ++ +L  +P +
Sbjct: 238 ------------------NQETYL-NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278
Query: 217 RITVEDALAHPYL 229
           R T E  L+H +L
Sbjct: 279 RPTAEICLSHSWL 291

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 108 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 216
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 217 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 259
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 260 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 294

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 99  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 158
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 159 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 217
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 218 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 247
Query: 198 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 248 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 101 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 160
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 161 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 219
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 220 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 249
Query: 198 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 250 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 286

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 261
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 262 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 304
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 215
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 216 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 258
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 16  ESFNDVYIAYELMDTD--LHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHRD 70
           E ++++YI  E  +    L +I+ +    +ALSE +    + Q++  L Y HS +V+H+D
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKD 149
Query: 71  LKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           LKP N+L    + +  +KI DFGLA +    +  T    T  Y APE+     D T   D
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCD 207
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +WS G +   L+     F G                        L E  +K   + P Y 
Sbjct: 208 IWSAGVVMYFLLTGCLPFTGTS----------------------LEEVQQKATYKEPNYA 245
Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                E  P + P A+DL+++MLT DP +R +    L H + 
Sbjct: 246 ----VECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 217
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 218 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 260
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 159 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 267
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 268 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 310
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 311 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 345

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 31/182 (17%)
Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVT 107
           + QIL G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 108 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA 167
            +Y APE+L     Y    DVWS G I   L+   P F G++    ++ +          
Sbjct: 212 AYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---------- 259
Query: 168 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                 E  K Y           F + + N+   A +L++ MLT+D  +R T E+AL   
Sbjct: 260 ------EKGKYYF---------DFND-WKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 228 YL 229
           ++
Sbjct: 304 WI 305

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 94  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 153
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 154 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 212
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 213 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 242
Query: 198 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 243 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 90  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 149
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 150 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 208
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 209 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 238
Query: 198 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 37/233 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            ++ +++I   P      ++ +  EL+   +L   I      SE      + QIL  + Y
Sbjct: 109 NIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 61  IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           +H   ++HRDLKP NLL      +  LKI DFGL+++      M     T  Y APE+L 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223
Query: 118 NSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
             + Y   +D+WSVG I ++ L   +P +  R      R ++                N 
Sbjct: 224 GCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------------NC 266
Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           + Y    P +   S   K         DLV K++  DP++R+T   AL HP++
Sbjct: 267 EYYFIS-PWWDEVSLNAK---------DLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   TE   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 77/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++  + + EE        +LRGL Y+   + ++HRD+KPS
Sbjct: 85  SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 144
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y APE  L  + Y+   D+WS+G  
Sbjct: 145 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLS 202
Query: 135 FMEL-MDRKPLFP 146
            +EL + R P+ P
Sbjct: 203 LVELAVGRYPIPP 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 19  NDVYIAYELMDT-DLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
            D++I  E      +  IIR  N+ L+E+     L   L+GL+Y+H    +HRD+K  N+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156
Query: 77  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           LLN     K+ DFG+A ++T         + T ++ APE ++    Y    D+WS+G   
Sbjct: 157 LLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVADIWSLGITA 215
Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
           +E+ + KP +     +H +R +  +   P                 + P     +FT   
Sbjct: 216 IEMAEGKPPYA---DIHPMRAIFMIPTNPPPT-------------FRKPELWSDNFT--- 256
Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
                   D V++ L   P QR T    L HP++ S   +S
Sbjct: 257 --------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 21  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP  
Sbjct: 103 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 162
Query: 76  LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           +LL +   +  +K+  FG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 221
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 222 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 256
Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 257 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 21  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP  
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160
Query: 76  LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           +LL +   +  +K+  FG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 219
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 220 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 254
Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 19  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 73
            DV+I  EL DT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 106 GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 165
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 130
           SN+L+NA   +K CDFG++    +          + Y APE +   LN   Y+   D+WS
Sbjct: 166 SNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 226 LGITXIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 265
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
           F+ +F       +D   + L  + ++R T  +   HP+  +LH+
Sbjct: 266 FSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFF-TLHE 301

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            +V + DI      ES    Y+  +L+   +L   I      +E+     + Q+L  +KY
Sbjct: 67  NIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 61  IHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           +H   ++HRDLKP NLL      N  + I DFGL+++  +   M+    T  Y APE+L 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAPEVLA 180
Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
               Y+ A+D WS+G I                       I L G P      F  E   
Sbjct: 181 QKP-YSKAVDCWSIGVI---------------------TYILLCGYPP-----FYEETES 213
Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           K   ++     +  +  + ++  SA D +  +L  DP +R T E AL+HP++
Sbjct: 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 220
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 221 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 250
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 251 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 94  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 153
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 154 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 211
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 212 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 241
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 242 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 76  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 135
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 136 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 193
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 194 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 223
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 224 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E +    L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
              +V T ++ APE++  S+ Y    D+WS+G   +EL   +P  P  D +H +R+L  +
Sbjct: 173 RNXFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLFLI 228
Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
              P  +      +++K +                        + VE  L  DPR R T 
Sbjct: 229 ---PKNSPPTLEGQHSKPF-----------------------KEFVEACLNKDPRFRPTA 262
Query: 221 EDALAHPYL 229
           ++ L H ++
Sbjct: 263 KELLKHKFI 271

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 21/185 (11%)
Query: 51  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-TEYVVTRW 109
           L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 169
           + APE++  S+ Y +  D+WS+G   +EL   +P  P  D +H +R+L  +        +
Sbjct: 186 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLV 241
Query: 170 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           G   ++ K++I         +   K P+  P+A +L+        + +  V+++    YL
Sbjct: 242 GDFTKSFKEFI--------DACLNKDPSFRPTAKELL--------KHKFIVKNSKKTSYL 285
Query: 230 GSLHD 234
             L D
Sbjct: 286 TELID 290

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 94  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 153
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 154 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 211
Query: 135 FMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
            +E+ + R P+  G   +    LL  ++  P                   P+     F+ 
Sbjct: 212 LVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP------------------PKLPSGVFSL 253
Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +F        D V K L  +P +R  ++  + H ++
Sbjct: 254 EFQ-------DFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +N +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +   P F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGMPPF-----------------------------EAHTYQETYRRISRVEFT- 228
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +  QR+T+ + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 228
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE  +    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-XIEGRXHDEKVDLWSLGV 199
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 74  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 133
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 134 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 191
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 192 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 221
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 222 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITSVSYDF 237
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 31/203 (15%)
Query: 34  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGL 91
           +I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGL
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 92  ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 151
           A   +  + +     T  + APE++ +        D+W++G +   L+     F G D +
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256
Query: 152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKML 210
             L                   +N K+  C         F E  F +V P A D ++ +L
Sbjct: 257 ETL-------------------QNVKR--CDW------EFDEDAFSSVSPEAKDFIKNLL 289
Query: 211 TFDPRQRITVEDALAHPYLGSLH 233
             +PR+R+TV DAL HP+L   H
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDH 312

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/136 (36%), Positives = 72/136 (52%), Gaps = 12/136 (8%)
Query: 21  VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SANVLHRD 70
           +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        VLHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 71  LKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           LKP+N+ L+   ++K+ DFGLAR+ + + DF  E+V T +Y +PE  +N   Y    D+W
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE-QMNRMSYNEKSDIW 200
Query: 130 SVGCIFMELMDRKPLF 145
           S+GC+  EL    P F
Sbjct: 201 SLGCLLYELCALMPPF 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 43  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFM 101
           +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 102 TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +    +   T  Y  PE ++    +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 220
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 221 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 250
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 251 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 43  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFM 101
           +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 102 TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 39/237 (16%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            ++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y
Sbjct: 69  NIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 61  IHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           +HS  + H DLKP N +LL+ N     +K+ DFG+A      +       T  + APE +
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-I 182
Query: 117 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 175
           +N        D+WS+G I ++ L    P                           FL E 
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLGET 215
Query: 176 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
            ++ +  +         E F N    A D + ++L  DP++R+T+  +L H ++ ++
Sbjct: 216 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 32/184 (17%)
Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-V 94
           +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  
Sbjct: 101 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 160
Query: 95  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 154
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 161 ISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-- 217
Query: 155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
             L ELI          + E       + PR            + P A  L+  +L  DP
Sbjct: 218 --LFELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDP 249
Query: 215 RQRI 218
           +QR+
Sbjct: 250 KQRL 253

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITSVSYDF 237
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITSVSYDF 237
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 30  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           TDL +  + N  L EE   Y   +ILRGL ++H   V+HRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 90  GL-ARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPL 144
           G+ A++         ++ T ++ APE++    +    Y    D+WS+G   +E+ +  P 
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 232
Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
            P  D +H +R L  +   P+                  PR + + +++KF +       
Sbjct: 233 -PLCD-MHPMRALFLIPRNPA------------------PRLKSKKWSKKFQS------- 265
Query: 205 LVEKMLTFDPRQRITVEDALAHPYL 229
            +E  L  +  QR   E  + HP++
Sbjct: 266 FIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 103 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 162
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 163 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 217
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 218 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 251

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +    +   T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 115/232 (49%), Gaps = 38/232 (16%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           VV + +++  P  +    +Y+ +EL++      + + + LSE+  +++   +++G++Y+H
Sbjct: 98  VVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH 154
Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSD 121
              ++HRD+KPSNLL+  +  +KI DFG++     +D  ++  V T  + APE L  +  
Sbjct: 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRK 214
Query: 122 Y--TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
                A+DVW++G                     + L   + G     +  F++E   + 
Sbjct: 215 IFSGKALDVWAMG---------------------VTLYCFVFG-----QCPFMDE---RI 245
Query: 180 ICQLPRYQRQS--FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +C   + + Q+  F ++ P++     DL+ +ML  +P  RI V +   HP++
Sbjct: 246 MCLHSKIKSQALEFPDQ-PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
           ELI          L E  +      PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI----------LMEEIR-----FPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITAVSYDF 237
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITAVSYDF 237
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E         I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+  + +T    T +Y APE +L    Y  + D WS+G I   L+   P          
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYP---------- 261
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   +  +Y+       FPN   S +      L+  
Sbjct: 262 ----------PFYSNHGLAISPGXKTRIRXGQYE-------FPNPEWSEVSEEVKXLIRN 304
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR T+ +   HP++     +   P+  S
Sbjct: 305 LLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTS 339

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI +FG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 196
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 197 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 226
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 227 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 69/122 (56%), Gaps = 3/122 (2%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L + I S+  LS +    F  QIL G+K+ H   ++HRD+KP N+L+++N  LKI DFG+
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 92  ARVTSETDFM-TEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           A+  SET    T +V+ T  Y +PE     +      D++S+G +  E++  +P F G  
Sbjct: 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGET 216
Query: 150 HV 151
            V
Sbjct: 217 AV 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI +FG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG +   + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 196
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 197 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 226
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 227 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++     ++++ ++      E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKP 136
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQDTYKRISRVEFT- 224
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +N +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +   P F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGMPPF-----------------------------EAHTYQETYRRISRVEFT- 228
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +  QR+T+ + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 17  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D   +Y+  E M   D+   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 17  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D   +Y+  E M   D+   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 75  N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITAVSYDF 237
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 20/143 (13%)
Query: 32  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 90  GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 135 FMELMDRKPLFPGRDHVHQLRLL 157
           F E++   P   G + V+ L+ L
Sbjct: 221 FFEMI--YPFSTGMERVNILKKL 241

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 21  VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SANVLHRD 70
           +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        VLHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 71  LKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           LKP+N+ L+   ++K+ DFGLAR+ + +T F   +V T +Y +PE  +N   Y    D+W
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIW 200
Query: 130 SVGCIFMELMDRKPLF 145
           S+GC+  EL    P F
Sbjct: 201 SLGCLLYELCALMPPF 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 21  VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SANVLHRD 70
           +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        VLHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 71  LKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           LKP+N+ L+   ++K+ DFGLAR+ + +T F   +V T +Y +PE  +N   Y    D+W
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIW 200
Query: 130 SVGCIFMELMDRKPLF 145
           S+GC+  EL    P F
Sbjct: 201 SLGCLLYELCALMPPF 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 20/143 (13%)
Query: 32  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 90  GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 135 FMELMDRKPLFPGRDHVHQLRLL 157
           F E++   P   G + V+ L+ L
Sbjct: 221 FFEMI--YPFSTGMERVNILKKL 241

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            ++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y
Sbjct: 90  NIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 61  IHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           +HS  + H DLKP N +LL+ N     +K+ DFG+A      +       T  + APE +
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-I 203
Query: 117 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 175
           +N        D+WS+G I ++ L    P                           FL E 
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLGET 236
Query: 176 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
            ++ +  +         E F N    A D + ++L  DP++R+ +  +L H ++ ++
Sbjct: 237 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAI 293

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 137 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 196
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 197 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 254
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 255 LVEMAVGRYPIPP 267

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            ++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y
Sbjct: 76  NIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 130
Query: 61  IHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           +HS  + H DLKP N +LL+ N     +K+ DFG+A      +       T  + APE +
Sbjct: 131 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-I 189
Query: 117 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 175
           +N        D+WS+G I ++ L    P                           FL E 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLGET 222
Query: 176 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            ++ +  +         E F N    A D + ++L  DP++R+ +  +L H ++
Sbjct: 223 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 16  ESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E   D+Y+  EL    +L + +   +   E      +  +L  + Y H  NV HRDLKP 
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135
Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N L    + +  LK+ DFGLA        M   V T +Y +P++L     Y    D WS 
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSA 193
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +   L+   P F                  P++ E+             + + +  +F
Sbjct: 194 GVMMYVLLCGYPPF----------------SAPTDXEV-------------MLKIREGTF 224
Query: 192 TEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           T  FP     NV P A  L+ ++LT  P+QRIT   AL H + 
Sbjct: 225 T--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 162 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 219
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 220 LVEMAVGRYPIPP 232

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 16  ESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E   D+Y+  EL    +L + +   +   E      +  +L  + Y H  NV HRDLKP 
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 152
Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N L    + +  LK+ DFGLA        M   V T +Y +P++L     Y    D WS 
Sbjct: 153 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSA 210
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +   L+   P F                  P++ E+             + + +  +F
Sbjct: 211 GVMMYVLLCGYPPF----------------SAPTDXEV-------------MLKIREGTF 241
Query: 192 TEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           T  FP     NV P A  L+ ++LT  P+QRIT   AL H + 
Sbjct: 242 T--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 282

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 176 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 91  LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 181 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 222

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 98
            + L E       +  L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207
Query: 99  DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP 143
           +    +V T ++ APE++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 208 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 18  FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           F+D    Y +++     ++++ ++      E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 194 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 161 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 202

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 78  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 137
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    + +   E+V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 138 NILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 195
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P  P
Sbjct: 196 LVEMAVGRYPRPP 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 102 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 161 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 17  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 74
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 135 FMEL-MDRKPLFP 146
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 97
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 105 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 164
Query: 98  TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 165 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 219
Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 220 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 253
Query: 218 I--TVEDA 223
           +    EDA
Sbjct: 254 LGGGSEDA 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 98
            + L E       +  L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 99  DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP 143
           +    +V T ++ APE++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 169 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 97
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 103 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 162
Query: 98  TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 163 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 217
Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 218 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 251
Query: 218 I--TVEDA 223
           +    EDA
Sbjct: 252 LGGGSEDA 259

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLAG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 97
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 104 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 163
Query: 98  TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 164 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 218
Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 219 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 252
Query: 218 I 218
           +
Sbjct: 253 L 253

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 80/147 (54%), Gaps = 3/147 (2%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A++T E    +E V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTP 164
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFGLA RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 33/199 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF---PGRDH 150
            T++    T    T +Y APE +L    Y  + D+WS+G I   L+   P F    G+  
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
              ++  I L       + GF N                    ++  V   A  L+  +L
Sbjct: 238 SPGMKRRIRL------GQYGFPN-------------------PEWSEVSEDAKQLIRLLL 272
Query: 211 TFDPRQRITVEDALAHPYL 229
             DP +R+T+   + HP++
Sbjct: 273 KTDPTERLTITQFMNHPWI 291

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 97
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302
Query: 98  TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 303 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 357
Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 358 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 391
Query: 218 I 218
           +
Sbjct: 392 L 392

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 97
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 246 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 305
Query: 98  TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 306 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 360
Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 361 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 394
Query: 218 I 218
           +
Sbjct: 395 L 395

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 33/199 (16%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF---PGRDH 150
            T++    T    T +Y APE +L    Y  + D+WS+G I   L+   P F    G+  
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 218
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
              ++  I L       + GF N                    ++  V   A  L+  +L
Sbjct: 219 SPGMKRRIRL------GQYGFPN-------------------PEWSEVSEDAKQLIRLLL 253
Query: 211 TFDPRQRITVEDALAHPYL 229
             DP +R+T+   + HP++
Sbjct: 254 KTDPTERLTITQFMNHPWI 272

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 42/235 (17%)
Query: 17  SFNDVYIAYELMDTDLHQIIRSNQ---ALSEEHCQYFLYQILR--------GLKYIHS-A 64
           ++++VYI YE M+ D   I++ ++    L + +  +   Q+++           YIH+  
Sbjct: 114 NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 65  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-----TRWYRAPELLLNS 119
           N+ HRD+KPSN+L++ N  +K+ DFG      E+++M +  +     T  +  PE   N 
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGSRGTYEFMPPEFFSNE 225
Query: 120 SDYTAA-IDVWSVG-CIFMELMDRKPLFPGRDHVHQLRL-LIELIGTPSEAELGF-LNEN 175
           S Y  A +D+WS+G C+++   +  P          L++ L+EL        + + L+ N
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPF--------SLKISLVELFNNIRTKNIEYPLDRN 277
Query: 176 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 230
              Y    P   ++S T     +    ID ++  L  +P +RIT EDAL H +L 
Sbjct: 278 HFLY----PLTNKKS-TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLXG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 92  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 211 TFDPRQRITVEDA 223
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 92  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 211 TFDPRQRITVEDA 223
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 92  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 211 TFDPRQRITVEDA 223
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 15  RESFNDVYIAYELMD----TDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLH 68
           RESF +    Y +MD     DL + I + + +   E+    +  QI   LK++H   +LH
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 69  RDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           RD+K  N+ L  +  +++ DFG+ARV + T +     + T +Y +PE+  N   Y    D
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSD 207
Query: 128 VWSVGCIFMELMDRKPLF 145
           +W++GC+  EL   K  F
Sbjct: 208 IWALGCVLYELCTLKHAF 225

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 27  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 86
           L   DL   +      +EE  +++L ++  GL ++HS  +++RDLKP N+LL+    +K+
Sbjct: 112 LRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKL 171
Query: 87  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
            DFGL++   + +     +  T  Y APE ++N   ++ + D WS G +  E++     F
Sbjct: 172 TDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230
Query: 146 PGRDHVHQLRLLIEL-IGTP 164
            G+D    + L+++  +G P
Sbjct: 231 QGKDRKETMTLILKAKLGMP 250

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 74/142 (52%), Gaps = 5/142 (3%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           N  ++   L   DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL
Sbjct: 93  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 152
Query: 79  NANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           + +  +KI DFG+ +     D  T E+  T  Y APE+LL    Y  ++D WS G +  E
Sbjct: 153 DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 211
Query: 138 LMDRKPLFPGRDH---VHQLRL 156
           ++  +  F G+D     H +R+
Sbjct: 212 MLIGQSPFHGQDEEELFHSIRM 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 92  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 211 TFDPRQRITVEDA 223
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 123 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 178
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 179 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 234
Query: 141 RKPLF 145
             P F
Sbjct: 235 GYPPF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 109 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQ 164
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 165 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 220
Query: 141 RKPLF 145
             P F
Sbjct: 221 GYPPF 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 143 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 198
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 199 GYIQVTDFGFAKRVKGATWTLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 254
Query: 141 RKPLF 145
             P F
Sbjct: 255 GYPPF 259

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +F D    + +MD     +L  ++R +Q       +++  ++   L+Y+HS ++++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           P N+LL+ N  +KI DFG A+   +  +      T  Y APE ++++  Y  +ID WS G
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFG 190
Query: 133 CIFMELM 139
            +  E++
Sbjct: 191 ILIYEML 197

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 20/143 (13%)
Query: 32  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 89
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HR+LKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 90  GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID +S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGII 220
Query: 135 FMELMDRKPLFPGRDHVHQLRLL 157
           F E +   P   G + V+ L+ L
Sbjct: 221 FFEXI--YPFSTGXERVNILKKL 241

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 5/111 (4%)
Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RV 94
           +R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++    +K+ DFG A RV
Sbjct: 133 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 192
Query: 95  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
              T  +     T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 193 KGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 27  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 86
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 87  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 146 PGRDHVHQLRLLIEL-IGTP 164
            G+D    + ++++  +G P
Sbjct: 227 QGKDRKETMTMILKAKLGMP 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            ++ +  +I  P      D ++  E +   +L   I  +  + E   +    QIL  + Y
Sbjct: 72  HIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
            H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+ +   +  Y APE++    
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRL 186
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAE-LGFLNENAKK 178
                +D+WS G I   L                     L GT P + E +  L +  + 
Sbjct: 187 YAGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKKIRG 225
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  +P Y  +S              L+  ML  DP +R T++D   H + 
Sbjct: 226 GVFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +++ DFGLA RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 19  NDVYIAYELMDT-DLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           N++ I  EL D  DL ++I+      + + E     +  Q+   L+++HS  V+HRD+KP
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164
Query: 74  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 223
Query: 133 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTP 164
           C+  E+   + P +  + +++ L   IE    P
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 27  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 86
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 87  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 146 PGRDHVHQLRLLIEL-IGTP 164
            G+D    + ++++  +G P
Sbjct: 227 QGKDRKETMTMILKAKLGMP 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 27  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 86
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 109 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 168
Query: 87  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 145
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 169 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227
Query: 146 PGRDHVHQLRLLIEL-IGTP 164
            G+D    + ++++  +G P
Sbjct: 228 QGKDRKETMTMILKAKLGMP 247

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 16  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           ES ND+ +  E +D      +II  +  L+E     F+ QI  G++++H   +LH DLKP
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 74  SNLL-LNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N+L +N +   +KI DFGLAR     + +     T  + APE++ N    +   D+WSV
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSV 274
Query: 132 GCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           G I +M L    P                           FL +N  + +  +   +   
Sbjct: 275 GVIAYMLLSGLSP---------------------------FLGDNDAETLNNILACRWDL 307
Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E+F ++   A + + K+L  +   RI+  +AL HP+L
Sbjct: 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     +E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 59/246 (23%)
Query: 41  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETD 99
           +LS +  + ++  + + LK IH   ++HRD+KPSN L N       + DFGLA+ T +T 
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 100 F-----------------------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
                                         +     T  +RAPE+L    + T AID+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 131 VGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC--QLPRYQ 187
            G IF+ L+  R P +   D +  L  ++ + G  S   +       K  +C  ++P   
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQD 290
Query: 188 RQSFTEKFPNVHPSAIDLVEKM------------------------LTFDPRQRITVEDA 223
            +   E+   +  S   L   +                        L  +P  RIT E+A
Sbjct: 291 LRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEA 350
Query: 224 LAHPYL 229
           L HP+ 
Sbjct: 351 LLHPFF 356

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 245
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 246 GVLIYEMAAGYPPF 259

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  ++  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 18  FNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
           ++ + + +E +   L++II  N       E  + +  +IL+ L Y+   ++ H DLKP N
Sbjct: 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167
Query: 76  LLLN-------------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWY 110
           +LL+                          +  +K+ DFG A  T ++D+    + TR Y
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQY 225
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEAEL 169
           RAPE++LN   +  + D+WS GC+  EL     LF   +H+  L ++  +I   P     
Sbjct: 226 RAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 170 GFLNENAKKYI----CQLPRYQRQSFTEKFPNV-----------HPSAIDLVEKMLTFDP 214
                N  KY+     +L   +  S      +V           H    D +  +L  DP
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 215 RQRITVEDALAHPYL 229
             R +  + L H +L
Sbjct: 345 TLRPSPAELLKHKFL 359

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 40/231 (17%)
Query: 2   QVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
            ++ +  +I  P      D ++  E +   +L   I  +  + E   +    QIL  + Y
Sbjct: 72  HIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
            H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++    
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 186
Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAE-LGFLNENAKK 178
                +D+WS G I   L                     L GT P + E +  L +  + 
Sbjct: 187 YAGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKKIRG 225
Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +  +P Y  +S              L+  ML  DP +R T++D   H + 
Sbjct: 226 GVFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 150
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 209
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTP 164
           +++ +P +   + +  L  LI   GTP
Sbjct: 210 MIEGEPPYLNENPLRAL-YLIATNGTP 235

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTP 164
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTP 164
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 143 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 198
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 199 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 254
Query: 141 RKPLF 145
             P F
Sbjct: 255 GYPPF 259

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 217
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NL+++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE+++ S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           N  ++   L   DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL
Sbjct: 92  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 79  NANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           + +  +KI DFG+ +     D  T  +  T  Y APE+LL    Y  ++D WS G +  E
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 210
Query: 138 LMDRKPLFPGRDH---VHQLRL 156
           ++  +  F G+D     H +R+
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRM 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 155 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 210
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 211 GVLIYEMAAGYPPF 224

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 117 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 172
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 173 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 228
Query: 141 RKPLF 145
             P F
Sbjct: 229 GYPPF 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 21  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           V I  EL++   L Q+++    L E+   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 80  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 131
           ++     +CDFG A V  + D + + ++T  Y        APE++L  S   A +DVWS 
Sbjct: 220 SDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 277
Query: 132 GCIFMELMD 140
            C+ + +++
Sbjct: 278 CCMMLHMLN 286

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T  Y AP ++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQ 382
Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
               Q +  I+              E  ++ + ++P    + ++E+F    P A  L  +
Sbjct: 383 SPFQQRKKKIK-------------REEVERLVKEVP----EEYSERF---SPQARSLCSQ 422
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
           +L  DP +R+           GS  ++ + P+
Sbjct: 423 LLCKDPAERLGCRG-------GSAREVKEHPL 447

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 29  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 88
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQ 382
Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
               Q +  I+              E  ++ + ++P    + ++E+F    P A  L  +
Sbjct: 383 SPFQQRKKKIK-------------REEVERLVKEVP----EEYSERF---SPQARSLCSQ 422
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
           +L  DP +R+           GS  ++ + P+
Sbjct: 423 LLCKDPAERLGCRG-------GSAREVKEHPL 447

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 143
Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 134
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 144 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 201
Query: 135 FMELM--DRKPLFPGRDHVHQLRLL 157
            ME++   R P +PG  +   +R L
Sbjct: 202 LMEIVTYGRIP-YPGMSNPEVIRAL 225

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 277 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 91  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 337 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
            E+  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 219 TVEDALAHPYLGSLHDISD 237
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 91  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 66/120 (55%), Gaps = 3/120 (2%)
Query: 27  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 86
           L+  DL   ++ N    EE  + F+ +++  L Y+ +  ++HRD+KP N+LL+ +  + I
Sbjct: 97  LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156
Query: 87  CDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELM-DRKP 143
            DF +A +      +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  R+P
Sbjct: 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 21  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           V I  EL++   L Q+++    L E+   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 80  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 131
           ++     +CDFG A V  + D + + ++T  Y        APE++L  S   A +DVWS 
Sbjct: 201 SDGSHAALCDFGHA-VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 258
Query: 132 GCIFMELMD 140
            C+ + +++
Sbjct: 259 CCMMLHMLN 267

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N+L++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 81  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 137 ELMDRKPLFPG 147
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 62/113 (54%), Gaps = 8/113 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  QI  G+ +I   N +HRDL+ +N+L++A+   KI DFGLARV  + ++         
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 108 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
            +W  APE  +N   +T   DVWS G + ME++   R P +PG  +   +R L
Sbjct: 349 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRAL 398

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 91  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 91  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 57/239 (23%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 72
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 73  PSNLLLNA-------------NCDLKICDFGLARV--TSETDFMTEY---VVTRWYRAPE 114
           P N+L++              N  + I DFGL +   + ++ F T       T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 115 LLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 168
           LL  S++       T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDE 259
Query: 169 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
           +  L++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 260 MKCLHDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 82  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
             +++ DFG A RV   T  +     T    APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 141 RKPLF 145
             P F
Sbjct: 234 GYPPF 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 34  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 93
           Q+ R    + +  C ++L +I   L ++H   +++RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 94  VTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +     +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 34  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 93
           Q+ R    + +  C ++L +I   L ++H   +++RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 94  VTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +     +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +++++  E +       + +   + E        + L+ L+++HS  V+HR++K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILL 150
Query: 79  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 209
Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTP 164
           +++ +P +   + +  L  LI   GTP
Sbjct: 210 MIEGEPPYLNENPLRAL-YLIATNGTP 235

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 16  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 74  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 342
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +   L+     F G +    LR +        ++    ++E+ K              
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK-------------- 388
Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                       D + K+L  DP  R+T+  AL HP+L
Sbjct: 389 ------------DFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 217
Query: 132 GCIFMELMDRKPLF 145
           G +  E+    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 19  NDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLK 72
            D +I  ELM T   +  +      +  + EE         ++ L ++  +  ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD---YTAAIDVW 129
           PSN+LL+ + ++K+CDFG++    ++   T     R Y APE +  S+    Y    DVW
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 130 SVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           S+G    EL   +  +P  + V  QL  +++  G P                 QL   + 
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP----------------QLSNSEE 255
Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           + F+       PS I+ V   LT D  +R   ++ L HP++
Sbjct: 256 REFS-------PSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 91  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 156 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 210
Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
                    +++G+    +     +N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 211 ---------DIVGSSDNPD-----QNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 253
Query: 210 LTFDPRQRITVE------DALAHPYLGSLH-DISDEPVCMSPFS 246
           L  DP++R+         D   HP+  ++  D+ ++   + PF 
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK 297

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 16  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 177
Query: 74  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 178 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 236
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +   L+     F G +    LR +        ++    ++E+ K              
Sbjct: 237 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK-------------- 282
Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                       D + K+L  DP  R+T+  AL HP+L
Sbjct: 283 ------------DFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 92  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 91  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 152 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 206
Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 207 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 249
Query: 210 LTFDPRQRITVE------DALAHPYLGSLH-DISDEPVCMSPFS 246
           L  DP++R+         D   HP+  ++  D+ ++   + PF 
Sbjct: 250 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK 293

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 107 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 91  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 167 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 221
Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 222 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSMSVKAASV--LKSF 264
Query: 210 LTFDPRQRITV------EDALAHPYLGSLH-DISDEPVCMSPF 245
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 265 LNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 307

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 91  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 253
Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 254 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 296
Query: 210 LTFDPRQRITVE------DALAHPYLGSLH-DISDEPVCMSPF 245
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 339

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 44/206 (21%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLK--ICDFGLAR--VTSETDFMT 102
            L Q   GL ++HS N++HRDLKP N+L+   NA+  +K  I DFGL +        F  
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 103 EYVV--TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
              V  T  + APE+L      + T  +D++S GC+F  ++       G+    Q  +L+
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                            A    C  P        EK  +V   A +L+EKM+  DP++R 
Sbjct: 243 ----------------GACSLDCLHP--------EKHEDV--IARELIEKMIAMDPQKRP 276
Query: 219 TVEDALAHPYLGSL-------HDISD 237
           + +  L HP+  SL        D+SD
Sbjct: 277 SAKHVLKHPFFWSLEKQLQFFQDVSD 302

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 219 TVEDALAHPYLGSLHDISD 237
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVAPLPDYKD 288

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 81  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 137 ELMDRKPLFPG 147
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 81  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 137 ELMDRKPLFPG 147
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 81  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 137 ELMDRKPLFPG 147
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 81  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 137 ELMDRKPLFPG 147
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 53/235 (22%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 72
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 73  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 114
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 115 LLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 172
           LL  S+    T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E+  L
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDEMKCL 277
Query: 173 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
           ++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 278 HDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 53/235 (22%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 72
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 73  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 114
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 115 LLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 172
           LL  S+    T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E+  L
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDEMKCL 277
Query: 173 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
           ++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 278 HDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 81  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 227
Query: 137 ELMDRKPLFPG 147
           E++  +P F G
Sbjct: 228 EVLTGEPPFTG 238

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 100
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 101 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 156
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 157 LIELIGT--PSEAELGFLNENAKKYI 180
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 89
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 90  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 100
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 101 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 156
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 157 LIELIGT--PSEAELGFLNENAKKYI 180
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 61/110 (55%), Gaps = 12/110 (10%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 109
           F  QI  G+ +I   N +HRDL+ +N+L++A+   KI DFGLARV ++          +W
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-------FPIKW 335
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
             APE  +N   +T   DVWS G + ME++   R P +PG  +   +R L
Sbjct: 336 -TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRAL 382

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 219 TVEDALAHPYLGSLHDISD 237
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 50/87 (57%), Gaps = 1/87 (1%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 112
           QI +G+ YIHS  ++HRDLKPSN+ L     +KI DFGL          T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 113 PELLLNSSDYTAAIDVWSVGCIFMELM 139
           PE  ++S DY   +D++++G I  EL+
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 219 TVEDALAHPYLGSLHDISD 237
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 100
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 101 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 156
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 157 LIELIGT--PSEAELGFLNENAKKYI 180
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 103 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 162
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 163 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 210
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 211 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 262
Query: 219 TVEDALAHPYLGSLHDISD 237
             ED    PY+  L D  D
Sbjct: 263 GHEDDELKPYVEPLPDYKD 281

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 21  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 77
           V + +E++  +L  +I+   ++ +   + +    Q+L GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 78  LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           +           +KI D G A    E    T  + TR YR+PE+LL +  +    D+WS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 132 GCIFMELMDRKPLF-PGRDHVH-----QLRLLIELIGT-PSEAELGFLNENAK------- 177
            C+  EL+    LF P   H +      +  +IEL+G  PS     +L  N K       
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-----YLLRNGKYTRTFFN 276
Query: 178 -----KYICQLPRYQRQS-FTEKFPNVHPSA---IDLVEKMLTFDPRQRITVEDALAHPY 228
                + I +L  +  +   TEK+      A    D +  ML  DPR+R      + HP+
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
Query: 229 L 229
           L
Sbjct: 337 L 337

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 56/108 (51%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +
Sbjct: 108 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 167
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
             +  +  Y APEL          +DVWS+G I   L+     F G++
Sbjct: 168 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 21  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 77
           V + +E++  +L  +I+   ++ +   + +    Q+L GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 78  LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           +           +KI D G A    E    T  + TR YR+PE+LL +  +    D+WS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 132 GCIFMELMDRKPLF-PGRDHVH-----QLRLLIELIGT-PSEAELGFLNENAK------- 177
            C+  EL+    LF P   H +      +  +IEL+G  PS     +L  N K       
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-----YLLRNGKYTRTFFN 276
Query: 178 -----KYICQLPRYQRQS-FTEKFPNVHPSA---IDLVEKMLTFDPRQRITVEDALAHPY 228
                + I +L  +  +   TEK+      A    D +  ML  DPR+R      + HP+
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
Query: 229 L 229
           L
Sbjct: 337 L 337

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 2/104 (1%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICD 88
           +L++ I +    SE+  ++F  Q+L G+ Y HS  + HRDLK  N LL+ +    LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161
Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           FG ++ +         V T  Y APE+LL         DVWS G
Sbjct: 162 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
             +     Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 218
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 219 TVEDALAHPYLGSLHDISD 237
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 10/153 (6%)
Query: 3   VVAIRDIIPPPQRESFNDV-YIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRG 57
           VV+ R++    Q+ + ND+  +A E  +  DL + +   +    L E   +  L  I   
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 58  LKYIHSANVLHRDLKPSNLLLNANCDL---KICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 146
            LL    YT  +D WS G +  E +   +P  P
Sbjct: 194 -LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 10/153 (6%)
Query: 3   VVAIRDIIPPPQRESFNDV-YIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRG 57
           VV+ R++    Q+ + ND+  +A E  +  DL + +   +    L E   +  L  I   
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 58  LKYIHSANVLHRDLKPSNLLLNANCDL---KICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APE
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 194
Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 146
            LL    YT  +D WS G +  E +   +P  P
Sbjct: 195 -LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 57/239 (23%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 72
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 73  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 114
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 115 LLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 168
           LL  S++       T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDE 259
Query: 169 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
           +  L++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 260 MKCLHDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
             +     Y APEL          +DVWS+G I   L+     F G++
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 98
           ++ L+E   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG++    +T
Sbjct: 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
Query: 99  -DFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 227
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
           +R+L+++  +     L        K+  +   + + +  +K P   PSA  L+E
Sbjct: 228 MRVLLKIAKSDPPTLL-----TPSKWSVEFRDFLKIAL-DKNPETRPSAAQLLE 275

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG
Sbjct: 101 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF--PGR 148
            + V + +        T  Y  PE ++    +   +D+W  G +  E +   P F  P  
Sbjct: 161 WS-VHAPSLRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218
Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
              H+  + ++L   P      FL++ +K                          DL+ K
Sbjct: 219 TETHRRIVNVDLKFPP------FLSDGSK--------------------------DLISK 246
Query: 209 MLTFDPRQRITVEDALAHPYLGS 231
           +L + P QR+ ++  + HP++ +
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 78
           Y+ +E M    +   I   +  +E      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 79  -NANCDLKICDFGLARVTS--------ETDFMTEYVVTRWYRAPELL----LNSSDYTAA 125
            N    +KICDFGL              T  +     +  Y APE++      +S Y   
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            D+WS+G I   L+   P F GR             G+    + G      +  + +  +
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGSDCGWDRGEACPACQNMLFESIQ 254
Query: 186 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +  F +K + ++  +A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG
Sbjct: 100 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF--PGR 148
            + V + +        T  Y  PE ++    +   +D+W  G +  E +   P F  P  
Sbjct: 160 WS-VHAPSLRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
              H+  + ++L   P      FL++ +K                          DL+ K
Sbjct: 218 TETHRRIVNVDLKFPP------FLSDGSK--------------------------DLISK 245
Query: 209 MLTFDPRQRITVEDALAHPYLGS 231
           +L + P QR+ ++  + HP++ +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 98
           ++ L+E   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG++    +T
Sbjct: 103 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 162
Query: 99  -DFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 219
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
           +R+L+++  +     L        K+  +   + + +  +K P   PSA  L+E
Sbjct: 220 MRVLLKIAKSDPPTLL-----TPSKWSVEFRDFLKIAL-DKNPETRPSAAQLLE 267

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 2/107 (1%)
Query: 44  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 103
           E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T 
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 104 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +  T  Y APE +L+   Y   +D W +G +  E++   P F  R+
Sbjct: 198 TFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 99
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKICDFG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 171
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 160 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 215 RQRITVEDALAHPYL 229
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 99
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKICDFG ++ +    
Sbjct: 111 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 170
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 171 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 209
Query: 160 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 210 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 261
Query: 215 RQRITVEDALAHPYL 229
            +RI++ +   H + 
Sbjct: 262 AKRISIPEIRNHEWF 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 56/108 (51%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+ + ++KI DFG +   +  + +
Sbjct: 111 MKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL 170
Query: 102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
             +  +  Y APEL          +DVWS+G I   L+     F G++
Sbjct: 171 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLAR-----VTSETDFMT 102
            + QI   L Y+H+  + HRD+KP N L + N   ++K+ DFGL++        E   MT
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 103 EYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 161
               T ++ APE+L  +++ Y    D WS G +   L+     FPG +    +  ++   
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-- 290
Query: 162 GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE 221
                          KK   + P Y   S         P A DL+  +L  +  +R    
Sbjct: 291 ---------------KKLCFENPNYNVLS---------PLARDLLSNLLNRNVDERFDAM 326
Query: 222 DALAHPYLGSLHD 234
            AL HP++    D
Sbjct: 327 RALQHPWISQFSD 339

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 6/112 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 108 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL 157
            +W  APE  +N   +T   DVWS G +  E++    + +PGR +   +  L
Sbjct: 175 IKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 6/126 (4%)
Query: 19  NDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 76
            DV+IA ELM T   ++ +  Q  + E         I++ L Y+     V+HRD+KPSN+
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 77  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVG 132
           LL+    +K+CDFG++    +            Y APE +        DY    DVWS+G
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 133 CIFMEL 138
              +EL
Sbjct: 217 ISLVEL 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 36/204 (17%)
Query: 47  CQYFLY--QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFM 101
           CQ   Y  Q++ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D  
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 102 TEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
                +  ++ PE+      ++   +D+WS G     +      F G D++++   L E 
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYK---LFEN 224
Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
           IG  S A  G                          +  P   DL++ ML ++P +R ++
Sbjct: 225 IGKGSYAIPG--------------------------DCGPPLSDLLKGMLEYEPAKRFSI 258
Query: 221 EDALAHPYLGSLHDISDEPVCMSP 244
                H +    H  ++ PV + P
Sbjct: 259 RQIRQHSWFRKKHPPAEAPVPIPP 282

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 90/186 (48%), Gaps = 29/186 (15%)
Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 93
           +   +  +E   Q ++ +I+  L+++H   +++RD+K  N+LL++N  + + DFGL++  
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH 152
           V  ET+   ++  T  Y AP+++    S +  A+D WS+G +  EL+     F       
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF------- 262
Query: 153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF 212
                        + E     E +++ +   P Y ++        +   A DL++++L  
Sbjct: 263 -----------TVDGEKNSQAEISRRILKSEPPYPQE--------MSALAKDLIQRLLMK 303
Query: 213 DPRQRI 218
           DP++R+
Sbjct: 304 DPKKRL 309

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%)
Query: 43  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 102
            E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + + 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD 170
Query: 103 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +     Y APEL          +DVWS+G I   L+     F G++
Sbjct: 171 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 211 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
            L  I  G+KY+ + N +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  +  
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGG 210
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               RW  APE  ++   +T+A DVWS G +  E+M
Sbjct: 211 KIPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVM 244

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 270 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 213 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 216 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+       R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 147
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 233 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 147
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 233 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             +W  APE + N   YT   DVWS G    EL
Sbjct: 226 PVKWM-APESIFNCV-YTFESDVWSYGIFLWEL 256

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 57/215 (26%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 93
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 94  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
            T+                         Y  + D+WS+G I   L+   P          
Sbjct: 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYP---------- 196
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 208
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 197 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 239
Query: 209 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 243
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 147
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 228 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 268

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 6/112 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 108 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL 157
            +W  APE  +N   +T   +VWS G +  E++    + +PGR +   +  L
Sbjct: 174 IKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 21  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 80  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 131
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 201 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 258
Query: 132 GCIFMELMD 140
            C+ + +++
Sbjct: 259 CCMMLHMLN 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 147
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 210 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 250

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  ++I DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 167 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 82  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 279
Query: 138 L 138
           +
Sbjct: 280 I 280

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 27/174 (15%)
Query: 47  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------- 99
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 100 ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 153
                   T  V T+ Y +PE +  +S Y+  +D++S+G I  EL     L+P    + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
           +R L ++        L F     +KY C+      Q      P   P AI+++E
Sbjct: 234 VRTLTDV------RNLKFPPLFTQKYPCEY--VMVQDMLSPSPMERPEAINIIE 279

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 109
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 110 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 21  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 80  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 131
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 185 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 242
Query: 132 GCIFMELMD 140
            C+ + +++
Sbjct: 243 CCMMLHMLN 251

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 17  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 77  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 133 CIFMEL 138
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 82  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 138 L 138
           +
Sbjct: 243 I 243

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 21  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 80  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 131
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 199 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 256
Query: 132 GCIFMELMD 140
            C+ + +++
Sbjct: 257 CCMMLHMLN 265

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 99
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKIC FG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHS 171
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
              + V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 160 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 215 RQRITVEDALAHPYL 229
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 17  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 77  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 133 CIFMEL 138
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 99
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKI DFG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHS 171
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 160 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 215 RQRITVEDALAHPYL 229
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 99
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKIC FG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHS 171
Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 160 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 214
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 215 RQRITVEDALAHPYL 229
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 22  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 78
           Y+ +E M    +   I   +  +E      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 79  -NANCDLKICDFGLARVTS--------ETDFMTEYVVTRWYRAPELL----LNSSDYTAA 125
            N    +KICDF L              T  +     +  Y APE++      +S Y   
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            D+WS+G I   L+   P F GR             G+    + G      +  + +  +
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGSDCGWDRGEACPACQNMLFESIQ 254
Query: 186 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +  F +K + ++  +A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 82  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 138 L 138
           +
Sbjct: 243 I 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 11/126 (8%)
Query: 17  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 77  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL+    +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 133 CIFMEL 138
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 11/126 (8%)
Query: 17  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 77  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL+    +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 133 CIFMEL 138
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 205
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 206 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 244
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 245 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS  ++HRD+KP N+LL+
Sbjct: 150 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 208
Query: 80  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 134
            +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 209 KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 268
Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGT---PSEAELGFLNENAKKYICQL 183
             E++     F     V     +++   +   P +AE   ++++AK  IC  
Sbjct: 269 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAE---ISKHAKNLICAF 317

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 293

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 61/122 (50%), Gaps = 4/122 (3%)
Query: 21  VYIAYELMDTD-LHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           ++I  E  D   L Q I  R  + L +        QI +G+ YIHS  +++RDLKPSN+ 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           L     +KI DFGL               T  Y +PE  ++S DY   +D++++G I  E
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAE 213
Query: 138 LM 139
           L+
Sbjct: 214 LL 215

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 295

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++   +    +
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 102 TE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
           T       +V T  + APE++     Y    D+WS G   +EL       P   +     
Sbjct: 173 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 230
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 206
           L++ L   P   E G  ++   K   +  R       +K P   P+A +L+
Sbjct: 231 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 260
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++ + +Y   E ++  DL   I+      E    ++  +I  GL ++H   +++RDLK  
Sbjct: 90  QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLD 149
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N++L++   +KI DFG+ +        T E+  T  Y APE++     Y  ++D W+ G 
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP-YGKSVDWWAYGV 208
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIE 159
           +  E++  +P F G D     + ++E
Sbjct: 209 LLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++   +    +
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 102 TE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
           T       +V T  + APE++     Y    D+WS G   +EL       P   +     
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 235
Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 206
           L++ L   P   E G  ++   K   +  R       +K P   P+A +L+
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 201
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 202 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 240
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 241 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 288

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 241
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 242 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 286

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 207 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 245

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 32  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNAN-------- 81
           L  II+SN Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 82  -----------------------------------------CDLKICDFGLARVTSETDF 100
                                                      +KI D G A    +   
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 249
Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQ 153
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF         RD  H 
Sbjct: 250 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH- 307
Query: 154 LRLLIELIG-TPSEAELG-------FLNENAKKYICQL-PRYQRQSFTEKFPNVHPSA-- 202
           + L+IEL+G  P +  +        F  +   K+I +L P    +   EK+      A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 203 -IDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             D +  ML   P +R T  + L HP+L S
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 82  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 138 L 138
           +
Sbjct: 243 I 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D 
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 205 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           ES  ++ + +E +   D+ + I ++   L+E     +++Q+   L+++HS N+ H D++P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 74  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N++     +  +KI +FG AR     D          Y APE+  +    TA  D+WS+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSL 189
Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +   L+    + P                        FL E  ++ I  +   +    
Sbjct: 190 GTLVYVLLS--GINP------------------------FLAETNQQIIENIMNAEYTFD 223
Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            E F  +   A+D V+++L  + + R+T  +AL HP+L
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 32  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNAN-------- 81
           L  II+SN Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+ N        
Sbjct: 116 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175
Query: 82  -----------------------------------------CDLKICDFGLARVTSETDF 100
                                                      +KI D G A    +   
Sbjct: 176 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 233
Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQ 153
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF         RD  H 
Sbjct: 234 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH- 291
Query: 154 LRLLIELIG-TPSEAELG-------FLNENAKKYICQL-PRYQRQSFTEKFPNVHPSA-- 202
           + L+IEL+G  P +  +        F  +   K+I +L P    +   EK+      A  
Sbjct: 292 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 351
Query: 203 -IDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             D +  ML   P +R T  + L HP+L S
Sbjct: 352 FTDFLLPMLELIPEKRATAAECLRHPWLNS 381

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +    D++ +    +
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             +W  APE + +   Y+   DVWS G +  E+
Sbjct: 264 PLKWM-APESIFDKI-YSTKSDVWSYGVLLWEI 294

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 63/128 (49%), Gaps = 11/128 (8%)
Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V I  E M+   L   +R N    +       L  I  G+KY+   N +HRDL   N+L+
Sbjct: 109 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 168
Query: 79  NANCDLKICDFGLARV----TSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N+N   K+ DFGL+R     TS+   T  +   +  RW  APE  +    +T+A DVWS 
Sbjct: 169 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AIQYRKFTSASDVWSY 226
Query: 132 GCIFMELM 139
           G +  E+M
Sbjct: 227 GIVMWEVM 234

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 431 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 22  YIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+ +E L    +   I+  +  +E      +  +   L ++H+  + HRDLKP N+L  +
Sbjct: 87  YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCES 146
Query: 81  N---CDLKICDF----GLARVTSETDFMTEYVVT----RWYRAPELLLNSSD----YTAA 125
                 +KICDF    G+    S T   T  + T      Y APE++   +D    Y   
Sbjct: 147 PEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKR 206
Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            D+WS+G +   ++   P F G              G     + G +    +  + +  +
Sbjct: 207 CDLWSLGVVLYIMLSGYPPFVGH------------CGADCGWDRGEVCRVCQNKLFESIQ 254
Query: 186 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +  F +K + ++   A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 175 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 100 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
              +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 171 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 13/113 (11%)
Query: 50  FLYQILRGLKYIHS---ANVLHRDLKPSNLLLN--------ANCDLKICDFGLARVTSET 98
           +  QI RG+ Y+H      ++HRDLK SN+L+         +N  LKI DFGLAR    T
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 151
             M+      W  APE++  +S ++   DVWS G +  EL+  +  F G D +
Sbjct: 170 TKMSAAGAYAWM-APEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 81  NCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A               V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 260
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 205 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
            L  I  G++Y+     +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  T  
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGG 208
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 209 KIPVRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++ S  +++RDLK  
Sbjct: 91  QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 209
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIE 159
           +  E++  +  F G D     + ++E
Sbjct: 210 LLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 182 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGLARV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 67/118 (56%), Gaps = 8/118 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 165
           + APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 230

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 18  FNDVYIAYELMDT-DLHQIIRSNQAL---SEEHCQYFLYQILRGLKYIHSAN---VLHRD 70
            N V +  E  +   L+ ++   + L   +  H   +  Q  +G+ Y+HS     ++HRD
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 71  LKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           LKP NLLL A    LKICDFG A        MT    +  + APE +   S+Y+   DV+
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVF 188
Query: 130 SVGCIFMELMDRKPLF 145
           S G I  E++ R+  F
Sbjct: 189 SWGIILWEVITRRKPF 204

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL  +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGL R+  + ++          +W
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 349 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 21  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 81  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 127
           +  LK+ DFG+A ++  +T  + +   V    Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 188 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 229
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 107/268 (39%), Gaps = 72/268 (26%)
Query: 32  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNA--------- 80
           L  II+SN Q L     +  + Q+L+GL Y+HS   ++H D+KP N+L+           
Sbjct: 126 LKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMA 185
Query: 81  -----------------------------------NCD---LKICDFGLARVTSETDFMT 102
                                              N D   +KI D G A    +    T
Sbjct: 186 AEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHK--HFT 243
Query: 103 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQLR 155
           E + TR YR+ E+L+ +  Y+   D+WS  C+  EL     LF         RD  H + 
Sbjct: 244 EDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDH-IA 301
Query: 156 LLIELIGT-PSEAELG------FLNENAK-KYICQL-PRYQRQSFTEKFPNVHPSA---I 203
            +IEL+G+ P    L       F N   + ++I +L P        EK+   H  A    
Sbjct: 302 HIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFT 361
Query: 204 DLVEKMLTFDPRQRITVEDALAHPYLGS 231
           D +  ML   P +R +  + L HP+L S
Sbjct: 362 DFLIPMLEMVPEKRASAGECLRHPWLNS 389

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 105
           F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR + S+++++      +
Sbjct: 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 106 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             +W  APE L     YT   DVWS G +  E+
Sbjct: 237 PVKW-MAPESLFEGI-YTIKSDVWSYGILLWEI 267

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++ S  +++RDLK  
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 530
Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIE 159
           +  E++  +  F G D     + ++E
Sbjct: 531 LLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 18  FNDVYIAYELMDT-DLHQIIRSNQAL---SEEHCQYFLYQILRGLKYIHSAN---VLHRD 70
            N V +  E  +   L+ ++   + L   +  H   +  Q  +G+ Y+HS     ++HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 71  LKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           LKP NLLL A    LKICDFG A        MT    +  + APE +   S+Y+   DV+
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVF 187
Query: 130 SVGCIFMELMDRKPLF 145
           S G I  E++ R+  F
Sbjct: 188 SWGIILWEVITRRKPF 203

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  APE +     +T+A DVWS G +  E+M
Sbjct: 196 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVM 228

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           + + L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K+CDFGL+R+ 
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 96  SETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + T   ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           + + L E       Y + +G+ Y+H+ N  ++HRDLK  NLL++    +K+CDFGL+R+ 
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 96  SETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +     ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 61
           V+A+  I+ PP  E    V + Y +   DL Q IRS Q   + +    F  Q+ RG++Y+
Sbjct: 84  VLALIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT------EYVVTRWYRAPEL 115
                +HRDL   N +L+ +  +K+ DFGLAR   + ++ +        +  +W      
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES- 199
Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDR 141
            L +  +T   DVWS G +  EL+ R
Sbjct: 200 -LQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + +           +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 210 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 242

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + +           +W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 172 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 16/107 (14%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-------------S 96
           F   I  G+ Y+HS N++HRDL   N L+  N ++ + DFGLAR+               
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 97  ETDFMTEYVVTR--WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 141
           + D    Y V    ++ APE ++N   Y   +DV+S G +  E++ R
Sbjct: 173 KPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 193 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 195 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 190 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 216 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 200 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 216
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 217 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 215

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 185 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------TSETDFMT 102
            L  I  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R         +ET  + 
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 103 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
             +  RW  APE +     +T+A D WS G +  E+M
Sbjct: 183 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVM 217

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  APE +     +T+A DVWS G +  E+M
Sbjct: 181 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVM 213

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 186 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 14/106 (13%)
Query: 47  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF------ 100
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 101 -MTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            M  Y      V T+ Y +PE  ++ ++Y+  +D++S+G I  EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 100
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR +  + D+
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 101 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  APE +     +T+A DVWS G +  E+M
Sbjct: 175 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVM 207

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR+  + +           +W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDH 150
             APE  L    +T   DVWS G +  EL+ +  + +PG ++
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HR+L+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 173 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 147
             APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 178 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 109
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 147
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 179 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 257 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 203 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 10/119 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 108
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 109 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 165
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 242

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSE---TDFMT 102
            L  I  G+KY+   N +HR L   N+L+N+N   K+ DFGL+R     TS+   T  + 
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 103 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
             +  RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 174 GKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 10/119 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 108
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 109 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 165
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 242

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI  G+ Y+HS + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + +  + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 146
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 104
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 129 MLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  APE +     +T+A DVWS G +  E++
Sbjct: 189 IPIRW-TAPEAIA-FRKFTSASDVWSYGIVMWEVV 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 564

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 113
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++T   +  V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 565

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMT 102
            L  I  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   E       T  + 
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 103 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
             +  RW  APE +     +T+A D WS G +  E+M
Sbjct: 181 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVM 215

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 6/105 (5%)
Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTS 96
           +N  LS     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 97  ETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +++++ +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 259

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 3/141 (2%)
Query: 16  ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E    +Y+  EL    L Q   +   +L E     +L   L  L ++HS  ++H D+KP+
Sbjct: 127 EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+ L      K+ DFGL                  Y APELL  S  Y  A DV+S+G  
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLT 244
Query: 135 FMELMDRKPLFPGRDHVHQLR 155
            +E+     L  G +   QLR
Sbjct: 245 ILEVACNMELPHGGEGWQQLR 265

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD     V    
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDR 189
Query: 109 -----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 190 DSPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 220

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI  G+ Y+H+ + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD     V    
Sbjct: 119 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDR 177
Query: 109 -----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 178 DSPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRW 109
           Q  +G+ Y+H+ N++HRD+K +N+ L+    +KI DFGLA V S    +  + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + +++ ++   DV+S G +  ELM
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 113
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++T      V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 200

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 92  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 202

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI  G+ Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 173
Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI  G+ Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 172
Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           F  QI  G+ Y+H+ + +HRDL   N+LL+ +  +KI DFGLA+   E      Y V   
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVRED 196
Query: 109 ------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                 WY APE L     Y A+ DVWS G    EL+
Sbjct: 197 GDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 80  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 134
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 135 FMELM 139
             E++
Sbjct: 268 LYEML 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 144 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 80  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 134
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 135 FMELM 139
             E++
Sbjct: 263 LYEML 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 21  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 80  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 134
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 135 FMELM 139
             E++
Sbjct: 268 LYEML 272

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
            L  +  G++Y+     +HRDL   N+L+++N   K+ DFGL+RV  E D    Y  T  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGG 214
Query: 108 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               RW  APE +   + +++A DVWS G +  E++
Sbjct: 215 KIPIRWT-APEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTR 108
           QI  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R    TD+        +  R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLF 145
           W   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 201 WM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTS 96
           +N   S     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 97  ETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +++++ +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTR 108
            L+Q+  G+KY+   N +HRDL   N+LL      KI DFGL++     D + T     +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           W   + APE  +N   +++  DVWS G    E +
Sbjct: 175 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 98
           + LS     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +++
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 99  DFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 140
           +++ +    +  +W  APE + +   YT   DVWS G +  E+  
Sbjct: 221 NYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 34/200 (17%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           +L++ ++ +    E+     + ++   L Y H   V+HRD+KP NLLL    +LKI DFG
Sbjct: 109 ELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168
Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
            + V + +        T  Y  PE ++    +   +D+W +G +  EL+   P F    H
Sbjct: 169 WS-VHAPSLRRKTMCGTLDYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226
Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS-AIDLVEKM 209
               R ++++                                 KFP   P+ A DL+ K+
Sbjct: 227 NETYRRIVKV-------------------------------DLKFPASVPTGAQDLISKL 255
Query: 210 LTFDPRQRITVEDALAHPYL 229
           L  +P +R+ +    AHP++
Sbjct: 256 LRHNPSERLPLAQVSAHPWV 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           +AL+      F +QI +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 100 FMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
              +     +  +W  A E L +   YT   DVWS G +  E++
Sbjct: 205 SXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 109
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 110 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 20/140 (14%)
Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFL---YQILRGLKYIHSAN--VLHRDLKPSNLLLNA 80
           EL    L + ++  ++     C   L   YQ  R ++++H     ++HRDLK  NLLL+ 
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 81  NCDLKICDFGLARVTS---------ETDFMTEYVVTR----WYRAPELLLNSSDYTAA-- 125
              +K+CDFG A   S         +   + E  +TR     YR PE++   S++     
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 126 IDVWSVGCIFMELMDRKPLF 145
            D+W++GCI   L  R+  F
Sbjct: 234 QDIWALGCILYLLCFRQHPF 253

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 108
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 178
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               WY APE  L+ + ++   DVWS G +  EL 
Sbjct: 179 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 6/104 (5%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 100 FMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
              +     +  +W  A E L +   YT   DVWS G +  E++
Sbjct: 205 SXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 113
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
           E L    + T   D++S G + +E++   P
Sbjct: 196 EAL--RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     E+   + 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKE 175
Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
                  WY APE  L  S ++ A DVWS G +  EL
Sbjct: 176 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 92  ARV--TSETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++     E  +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 13/94 (13%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 108
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 191
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 192 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 108
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 179
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               WY APE  L+ + ++   DVWS G +  EL 
Sbjct: 180 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 8/105 (7%)
Query: 40  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 99
           +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 100 FMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELM 139
               YV     R P   +         YT   DVWS G +  E++
Sbjct: 205 ---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 60/115 (52%), Gaps = 12/115 (10%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+ ++   E   +++  +I+  L ++H   +++RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 91  LAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           + +      VT+ T     +  T  Y APE +L    Y  A+D W++G +  E++
Sbjct: 170 MCKEGICNGVTTAT-----FCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 36  IRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 94
           +R N+  L  +    +  QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+
Sbjct: 109 VRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168
Query: 95  --TSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
               ET++  +   V  +W     +L     +T   DVWS G    ELM
Sbjct: 169 LDIDETEYHADGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELM 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HR+L   N+L+     +KI DFGL +V  +     EY   + 
Sbjct: 120 YTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKE 176
Query: 109 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
                  WY APE  L  S ++ A DVWS G +  EL
Sbjct: 177 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 211

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 113
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
           E L    + T   D++S G + +E++   P
Sbjct: 199 EAL--RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 104
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 224 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 255

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-----LARVTS 96
           L+E+   + L  I RGL+ IH+    HRDLKP+N+LL       + D G        V  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 97  ETDFMT--EYVVTRW---YRAPELLLNSSDYT--AAIDVWSVGCIFMELM 139
               +T  ++   R    YRAPEL    S        DVWS+GC+   +M
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 27  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 84
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HRDL   N+L+  N   
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181
Query: 85  KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 104
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 221
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 222 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 253

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTR 108
            L+Q+  G+KY+   N +HR+L   N+LL      KI DFGL++     D + T     +
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           W   + APE  +N   +++  DVWS G    E +
Sbjct: 501 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 27  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 84
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HRDL   N+L+  N   
Sbjct: 112 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 171
Query: 85  KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 172 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 104
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 216 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 247

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 210 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 124 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 184 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 123 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 183 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 118 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 178 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 125 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 185 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 117 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 177 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 208

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 126 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 186 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 108
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 52/109 (47%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I  +  L E    Y   Q++  + Y+   +++HRD+K  N+++  +  +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            A           +  T  Y APE+L+ +      +++WS+G     L+
Sbjct: 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 108
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 109 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 108
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 109 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 108
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 109 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 139
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 223

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 21  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A+V+HRDL   N L+
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLV 136
Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 194
Query: 136 MELMDRKPL 144
            E+     +
Sbjct: 195 WEVFSEGKI 203

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           D Y+  +L    L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++
Sbjct: 154 DYYVGGDL----LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 80  ANCDLKICDFG--LARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVG- 132
            N  +++ DFG  L  +   T   +  V T  Y +PE+L         Y    D WS+G 
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           C++  L    P +           L+E  G               K +    R+Q   F 
Sbjct: 270 CMYEMLYGETPFYA--------ESLVETYG---------------KIMNHKERFQ---FP 303
Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSLHDISDEPVCMSPF 245
            +  +V  +A DL+ +++     +  +  +ED   HP+   + D  +   C +P+
Sbjct: 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI-DWDNIRNCEAPY 357

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEY 104
            L  +  G++Y+     +HRDL   N+L+++N   K+ DFGL+RV      +        
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           +  RW  APE +   + +++A DVWS G +  E++
Sbjct: 216 IPIRWT-APEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 107
           F+  I  G++Y+ S N +HRDL   N +L  +  + + DFGL+R     D+  +   +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 108 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 141
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 202 PVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 101
           L++    +   QI  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+ 
Sbjct: 125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 102 T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
                  +  RW   PE ++    +T   DVWS+G +  E+
Sbjct: 185 RVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEI 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 27  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 84
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HR+L   N+L+  N   
Sbjct: 119 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVA 178
Query: 85  KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 179 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 255

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 255

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 249

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 197 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 246

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 248

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL--LNANCDLKICD 88
           DL   I     L E   + F  Q++  +++ HS  V+HRD+K  N+L  L   C  K+ D
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLID 183
Query: 89  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           FG   +  +  + T++  TR Y  PE +     +     VWS+G +  +++
Sbjct: 184 FGSGALLHDEPY-TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 108
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W     +  N   YT   DVW+ G +  E+
Sbjct: 242 WMPPESIFYNR--YTTESDVWAYGVVLWEI 269

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 108
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +  V R    
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDXXVVREPGQ 175
Query: 109 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 176 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 196 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 245

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 228 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 277

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 248

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 242

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 195 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 211 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 247

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 21  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 156
Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 157 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 214
Query: 136 MELMDRKPL 144
            E+     +
Sbjct: 215 WEVFSEGKI 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 187 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 223

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 21  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 136
Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 194
Query: 136 MELMDRKPL 144
            E+     +
Sbjct: 195 WEVFSEGKI 203

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 21  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134
Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 135 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 192
Query: 136 MELMDRKPL 144
            E+     +
Sbjct: 193 WEVFSEGKI 201

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---WYRA 112
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D      V +    Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 113 PELLLNSSDYTAAIDVWSVGCIFMELM 139
           PE  +     T   DV+S G +  E++
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVL 235

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 179 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 178 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 142 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 202 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 238

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 123 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 183 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 219

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 21  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 80  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139
Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 135
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 140 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 197
Query: 136 MELMDRKPL 144
            E+     +
Sbjct: 198 WEVFSEGKI 206

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 173 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 204 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 249

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 181 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           D Y+  +L    L  + +    L E+  ++++ +++  +  IH  + +HRD+KP N+LL+
Sbjct: 170 DYYVGGDL----LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 225
Query: 80  ANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG- 132
            N  +++ DFG     ++   +   V   T  Y +PE+L    D    Y    D WS+G 
Sbjct: 226 VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 285
Query: 133 CIFMELMDRKPLF 145
           C++  L    P +
Sbjct: 286 CMYEMLYGETPFY 298

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAK 171
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 191 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 240

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 8/123 (6%)
Query: 21  VYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  EL+   D    +R+  A L  +     +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 79  NANCDLKICDFGLARVTSETDFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
                LKI DFG++R  ++  +        V  +W  APE  LN   Y++  DVWS G +
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYGRYSSESDVWSFGIL 304
Query: 135 FME 137
             E
Sbjct: 305 LWE 307

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 20  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           D Y+  +L    L  + +    L E+  ++++ +++  +  IH  + +HRD+KP N+LL+
Sbjct: 154 DYYVGGDL----LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 209
Query: 80  ANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG- 132
            N  +++ DFG     ++   +   V   T  Y +PE+L    D    Y    D WS+G 
Sbjct: 210 VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 269
Query: 133 CIFMELMDRKPLF 145
           C++  L    P +
Sbjct: 270 CMYEMLYGETPFY 282

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 171 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWY 110
           +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET  +      RW 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW- 187
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             PE+L+ S  +++  D+W+ G +  E+
Sbjct: 188 SPPEVLMYSK-FSSKSDIWAFGVLMWEI 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +   + APE L  +  ++   DVW+ G +  E+
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 203

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAK 192
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRD 149
           +   + APE L  ++ ++   DVW+ G +  E+      P +PG D
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 174
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 175 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW---Y 110
           +  G+ Y+  A V+HRDL   N L+  N  +K+ DFG+ R   +  + T    T++   +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 171
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
            +PE + + S Y++  DVWS G +  E+     +
Sbjct: 172 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 4/130 (3%)
Query: 21  VYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           +Y+   L++  DL   +R    L+       + QI   L   H+A   HRD+KP N+L++
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 80  ANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           A+    + DFG+A  T++     +   V T +Y APE   + S  T   D++++ C+  E
Sbjct: 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVLYE 227
Query: 138 LMDRKPLFPG 147
            +   P + G
Sbjct: 228 CLTGSPPYQG 237

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 178
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +   + APE L  +  ++   DVW+ G +  E+
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 210

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 186
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 157
           +   + APE L   + ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 187 FPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 238

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 175
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRA 112
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E   T        T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 113 PELLLNSSDYTAAIDVWSVGCIFMELM 139
           PE  +     T   DV+S G +  E++
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVL 235

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           W  APE L +   +T + D+WS G +  E+
Sbjct: 199 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 175
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +   + APE L  +  ++   DVW+ G +  E+
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +   + APE L  +  ++   DVW+ G +  E+
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 108
           +I  G+ Y+++   +HRDL   N  +  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 159
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 242

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 7/118 (5%)
Query: 33  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 92
           H + R+  +L       +  QI + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+
Sbjct: 113 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 93  RVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 145
           R   + D+    V     +W  +PE  +N   +T A DVW       E++   ++P F
Sbjct: 173 RYIEDEDYYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 7/118 (5%)
Query: 33  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 92
           H + R+  +L       +  QI + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+
Sbjct: 97  HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 93  RVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 145
           R   + D+    V     +W  +PE  +N   +T A DVW       E++   ++P F
Sbjct: 157 RYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +   + APE L  +  ++   DVW+ G +  E+
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L   + ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 178 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 7/118 (5%)
Query: 33  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 92
           H + R+  +L       +  QI + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+
Sbjct: 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 93  RVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 145
           R   + D+    V     +W  +PE  +N   +T A DVW       E++   ++P F
Sbjct: 161 RYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 48  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 102
           QY L    QI  G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 114 QYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 103 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 174 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 210

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 10/124 (8%)
Query: 21  VYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  EL+   D    +R+  A L  +     +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 79  NANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
                LKI DFG++R     V + +  + + V  +W  APE  LN   Y++  DVWS G 
Sbjct: 247 TEKNVLKISDFGMSREEADGVXAASGGLRQ-VPVKWT-APE-ALNYGRYSSESDVWSFGI 303
Query: 134 IFME 137
           +  E
Sbjct: 304 LLWE 307

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 106
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++         + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 107 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 108
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 109 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 157
           +   + APE L   + ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 50  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVV 106
           +L++ + GLK  H   + HRD+K  N+LL  N    I DFGLA               V 
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 107 TRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDR 141
           TR Y APE+L  +     D    ID++++G +  EL  R
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWY 110
           +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW 
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 167
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             PE+L+ S  +++  D+W+ G +  E+
Sbjct: 168 SPPEVLMYSK-FSSKSDIWAFGVLMWEI 194

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 96
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 100 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 159
Query: 97  ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
            T    +  V   + APE L  ++ ++   DVWS G +  E+
Sbjct: 160 STQDTGKLPVK--WTAPEALREAA-FSTKSDVWSFGILLWEI 198

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWY 110
           +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW 
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 171
Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMEL 138
             PE+L+ S  +++  D+W+ G +  E+
Sbjct: 172 SPPEVLMYSK-FSSKSDIWAFGVLMWEI 198
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	277
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-178
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-173
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-172
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-169
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-168
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-168
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-167
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-165
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-162
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-160
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-157
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-156
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-141
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-140
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-138
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-136
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-125
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-106
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-92
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-91
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-91
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-90
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-90
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-90
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-88
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-87
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-86
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-76
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-53
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-50
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-50
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-50
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-50
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-49
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-48
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-46
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-45
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-44
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-44
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-43
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-42
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-41
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-41
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-41
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-41
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-41
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-40
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-40
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-40
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-40
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-40
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-40
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-40
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-39
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-39
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-39
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-39
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-39
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-39
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-39
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-38
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-38
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-38
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-38
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-38
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-37
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-36
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-34
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-33
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-32
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-31
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-30
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-29
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-28
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-27
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-27
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-25
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-22
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-06

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  493 bits (1271), Expect = e-178
 Identities = 149/278 (53%), Positives = 197/278 (70%), Gaps = 6/278 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYIH
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 145

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLLN 118
           SANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++LN
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAK 177
           S  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L  + N  A+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
            Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325

Query: 238 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           EP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 326 EPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  482 bits (1243), Expect = e-173
 Identities = 103/272 (37%), Positives = 153/272 (56%), Gaps = 4/272 (1%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 61
           ++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL  +
Sbjct: 91  ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL 150

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++    
Sbjct: 151 HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKG 210

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP   ++    + +A+ Y+
Sbjct: 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270

Query: 181 -CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
              L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  D  
Sbjct: 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT 330

Query: 240 VCMSPFSFDFEQHALTEGQMKELIYQEALAFN 271
                  F F++       M ++   E   FN
Sbjct: 331 EG-LSERFHFDESVTDVYDMHKIFTAEVERFN 361

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  477 bits (1230), Expect = e-172
 Identities = 140/284 (49%), Positives = 192/284 (67%), Gaps = 18/284 (6%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ I +I  P   E+FN+VYI  ELM TDLH++I + Q LS++H QYF+YQ LR +K +H
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLH 129

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWYR 111
            +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   M E+V TRWYR
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAELG 170
           APE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L 
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249

Query: 171 FL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPYL
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

Query: 230 GSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEALA 269
            + HD +DEP       S F FD  + ALT   +K+LI+ E  +
Sbjct: 310 QTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  471 bits (1214), Expect = e-169
 Identities = 117/277 (42%), Positives = 170/277 (61%), Gaps = 6/277 (2%)

Query: 3   VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    + F D Y+    M TDL ++++  + L E+  Q+ +YQ+L+GL+YI
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYI 144

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMR 202

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GTP    +  L ++ AK Y+
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD  DEP 
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
               +   F+    T  + K + Y+E L+F P  +  
Sbjct: 323 V-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLG 358

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  471 bits (1214), Expect = e-168
 Identities = 109/328 (33%), Positives = 171/328 (52%), Gaps = 53/328 (16%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+EEH +  LY +L G  +IH
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-----------------------ETD 99
            + ++HRDLKP+N LLN +C +K+CDFGLAR  +                          
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

Query: 100 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLFPG- 147
            +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLFPG 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266

Query: 148 ----------------RDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQS 190
                           + +  QL ++  +IGTP+E +L  +      KYI   P  +  +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 250
             +K+P++    I+L+E ML F+P +RIT++ AL HPYL  +     E          F+
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD 386

Query: 251 Q-HALTEGQMKELIYQEALAFNPEYRQQ 277
               L+E Q++ +  +E  +F+PE    
Sbjct: 387 DWMVLSETQLRYIFLKEVQSFHPELVIP 414

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  468 bits (1207), Expect = e-168
 Identities = 131/277 (47%), Positives = 177/277 (63%), Gaps = 6/277 (2%)

Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKYI
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 148

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMH 206

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ YI
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEPV
Sbjct: 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
              P+    E   L   + K L Y E ++F P    Q
Sbjct: 327 A-DPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  467 bits (1203), Expect = e-167
 Identities = 119/272 (43%), Positives = 163/272 (59%), Gaps = 6/272 (2%)

Query: 3   VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+GLKYI
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYI 142

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMH 200

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 180
           Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  L ++ AK YI
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D  +E  
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE 320

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              PF    E   LT  + K+ IY+E + F+P
Sbjct: 321 AQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  465 bits (1198), Expect = e-165
 Identities = 115/336 (34%), Positives = 172/336 (51%), Gaps = 61/336 (18%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           VV + DI+ P   E F+++Y+  E+ D+D  ++ R+   L+E H +  LY +L G+KY+H
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----------------------- 99
           SA +LHRDLKP+N L+N +C +K+CDFGLAR     +                       
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 100 -----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKP 143
                 +T +VVTRWYRAPEL+L   +YT AIDVWS+GCIF EL+           DR P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

Query: 144 LFPGRD--------------------HVHQLRLLIELIGTPSEAELGFL-NENAKKYICQ 182
           LFPG                      +  QL ++  ++GTPSE ++  L  E+AK+YI  
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353

Query: 183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCM 242
            P+ +     E+FP     AI L+++ML F+P +RIT+ + LAHP+   +     E    
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT 413

Query: 243 SPFSFDFE-QHALTEGQMKELIYQEALAFNPEYRQQ 277
                 F     + E Q++    +E   ++PE +  
Sbjct: 414 EKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQLP 449

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  453 bits (1168), Expect = e-162
 Identities = 102/315 (32%), Positives = 164/315 (52%), Gaps = 44/315 (13%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           +V + +++      +  DVY+ ++ M+TDLH +IR+   L   H QY +YQ+++ +KY+H
Sbjct: 71  IVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH 126

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARV----------------------TSETDF 100
           S  +LHRD+KPSN+LLNA C +K+ DFGL+R                         +   
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
           +T+YV TRWYRAPE+LL S+ YT  ID+WS+GCI  E++  KP+FPG   ++QL  +I +
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

Query: 161 IGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKF----------------PNVHPSAI 203
           I  PS  ++  + +  AK  I  L        + K                  + +  A+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 204 DLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA-LTEGQMKEL 262
           DL++K+L F+P +RI+  DAL HP++   H+ ++EP C    +     +   +    + L
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNL 366

Query: 263 IYQEALAFNPEYRQQ 277
           +Y E      E    
Sbjct: 367 VYSEISRRKRELISN 381

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  448 bits (1154), Expect = e-160
 Identities = 111/289 (38%), Positives = 161/289 (55%), Gaps = 17/289 (5%)

Query: 3   VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + ++  P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 143

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262

Query: 182 QLPRYQRQSFTEKFPNVH------------PSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

Query: 230 GSLHDISDEPVCM-SPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
              +D S+             ++   T  + KELIY+E +     +   
Sbjct: 323 NVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHHH 371

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  445 bits (1146), Expect = e-157
 Identities = 110/289 (38%), Positives = 166/289 (57%), Gaps = 17/289 (5%)

Query: 3   VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++++ ++  P    E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 180

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299

Query: 182 QLPRYQRQSFTEKFPNVH------------PSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             P+Y   +F + FP+                A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

Query: 230 GSLHDISDE-PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
              +D ++        +    ++   T  + KELIY+E +    + +  
Sbjct: 360 NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNG 408

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  435 bits (1122), Expect = e-156
 Identities = 103/252 (40%), Positives = 147/252 (58%), Gaps = 15/252 (5%)

Query: 3   VVAIRDIIPPPQR---------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 53
           +V + +I+ P               N VYI  E M+TDL  ++     L EEH + F+YQ
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFMYQ 128

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTS----ETDFMTEYVVTR 108
           +LRGLKYIHSANVLHRDLKP+NL +N  +  LKI DFGLAR+          ++E +VT+
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 168
           WYR+P LLL+ ++YT AID+W+ GCIF E++  K LF G   + Q++L++E I    E +
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 169 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
              L      YI        +  T+  P +   A+D +E++LTF P  R+T E+AL+HPY
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 229 LGSLHDISDEPV 240
           +       DEP+
Sbjct: 309 MSIYSFPMDEPI 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  400 bits (1031), Expect = e-141
 Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 16/280 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVY--IAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILR 56
           +V ++            D+Y  +  E +   LH+  R+      A      + FL+Q++R
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 57  GLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 113
            +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y+ +R+YRAP
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200

Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           EL+  +  YT A+D+WSVGCIF E+M  +P+F G +   QL  ++ ++G PS   L  LN
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260

Query: 174 -ENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
             +    +           F++        A DL+  +L + P +R+   +AL HPY   
Sbjct: 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320

Query: 232 LHDISDE-----PVCMSPFSFDFEQHALTEGQMKELIYQE 266
           LHD + +      +    F F   +  +     K  + ++
Sbjct: 321 LHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  399 bits (1026), Expect = e-140
 Identities = 82/283 (28%), Positives = 155/283 (54%), Gaps = 21/283 (7%)

Query: 11  PPPQRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANV 66
                     + +  E +   LH++++    S +++       ++YQ+ R + +IHS  +
Sbjct: 103 VIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162

Query: 67  LHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAA 125
            HRD+KP NLL+N+  + LK+CDFG A+    ++    Y+ +R+YRAPEL+L +++YT +
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
           ID+WS+GC+F EL+  KPLF G   + QL  +I+++GTP++ ++  +N +  +   + P 
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV--RFPT 280

Query: 186 YQRQSFTEKFPNVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP 244
            + + + +  P   PS AIDL+E++L ++P  RI   +A+AHP+   L +  +  V  + 
Sbjct: 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNS 340

Query: 245 -------------FSFDFEQHALTEGQMKELIYQEALAFNPEY 274
                        F+F   + ++  G +   I  +  + N ++
Sbjct: 341 NFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPNYKH 383

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  394 bits (1014), Expect = e-138
 Identities = 83/285 (29%), Positives = 150/285 (52%), Gaps = 12/285 (4%)

Query: 3   VVAIRDIIPPP-QRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRG 57
           +V +R       +++    + +  + +   ++++ R    + Q L   + + ++YQ+ R 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 58  LKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+YRAPEL+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
             ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++  +N N 
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288

Query: 177 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 235
            ++  + P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH +   L D 
Sbjct: 289 TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346

Query: 236 SDEP--VCMSPFSFDFEQHALTE-GQMKELIYQEALAFNPEYRQQ 277
           + +      +P  F+F    L+    +  ++              
Sbjct: 347 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 391

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  388 bits (1000), Expect = e-136
 Identities = 85/276 (30%), Positives = 148/276 (53%), Gaps = 13/276 (4%)

Query: 3   VVAIRDIIPPP-QRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRG 57
           VV ++        ++    + +  E +   +++  R      Q +     + ++YQ+LR 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 58  LKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           L YIHS  + HRD+KP NLLL+     LK+ DFG A++    +    Y+ +R+YRAPEL+
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELI 213

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
             +++YT  ID+WS GC+  ELM  +PLFPG   + QL  +I+++GTPS  ++  +N N 
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273

Query: 177 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD- 234
            ++  + P+ +   F++ F P   P AIDL+ ++L + P  R+T  +AL HP+   L   
Sbjct: 274 MEH--KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331

Query: 235 ---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEA 267
              + +       F++  E+ ++    +  L+ Q A
Sbjct: 332 EARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHA 367

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  358 bits (922), Expect = e-125
 Identities = 67/241 (27%), Positives = 131/241 (54%), Gaps = 14/241 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y H
Sbjct: 93  IITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 147

Query: 63  SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           S  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++   
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 122 YTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAE-LGFLN-ENAKK 178
           Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT    + +   N E   +
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267

Query: 179 YICQLPRYQRQSFTEKFPN-----VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 233
           +   L R+ R+ +     +     V P A+D ++K+L +D + R+T  +A+ HPY  ++ 
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327

Query: 234 D 234
            
Sbjct: 328 K 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  310 bits (796), Expect = e-106
 Identities = 75/253 (29%), Positives = 129/253 (50%), Gaps = 9/253 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDL-HQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + ++           +++ +E  D  + H++ R  + + E   +   +Q L+ + + 
Sbjct: 64  LVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           H  N +HRD+KP N+L+  +  +K+CDFG AR+ T  +D+  + V TRWYR+PELL+  +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 179
            Y   +DVW++GC+F EL+   PL+PG+  V QL L+ + +G         F        
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
           +        +    KFPN+   A+ L++  L  DP +R+T E  L HPY  ++ +I D  
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298

Query: 240 VCMS-PFSFDFEQ 251
                P    + Q
Sbjct: 299 KEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  285 bits (732), Expect = 2e-96
 Identities = 70/229 (30%), Positives = 119/229 (51%), Gaps = 8/229 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + ++            Y+ +E +D  +   +      L  +  Q +L+QI+ G+ + 
Sbjct: 86  LVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           HS N++HRD+KP N+L++ +  +K+CDFG AR   +  +   + V TRWYRAPELL+   
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y  A+DVW++GC+  E+   +PLFPG   + QL  ++  +G          N+N     
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260

Query: 181 CQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
            +LP  + R+    ++P +    IDL +K L  DP +R    + L H +
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  272 bits (699), Expect = 5e-92
 Identities = 87/229 (37%), Positives = 121/229 (52%), Gaps = 10/229 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + D+I      +   + + +E +D DL +++      L     + FL Q+L G+ Y 
Sbjct: 62  IVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+ S 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 179
            Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP+             KY
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--TELPKY 234

Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
                 Y+   +      +  S IDL+ KML  DP QRIT + AL H Y
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  272 bits (699), Expect = 1e-91
 Identities = 83/229 (36%), Positives = 122/229 (53%), Gaps = 8/229 (3%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL +
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S+
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 179
            Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +       +  + 
Sbjct: 196 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD--VSLPRG 252

Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
               P    +      P +  S   L+ +MLTF+P +RI+   AL H Y
Sbjct: 253 --AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  272 bits (698), Expect = 2e-91
 Identities = 86/253 (33%), Positives = 129/253 (50%), Gaps = 14/253 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 179
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +          + 
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD--VALPRQ 252

Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
                    Q   +   ++     DL+ K LTF+P +RI+   AL+HPY        D  
Sbjct: 253 --AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF------QDLE 304

Query: 240 VCMSPFSFDFEQH 252
            C           
Sbjct: 305 RCKENLDSHLPPS 317

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  271 bits (695), Expect = 5e-91
 Identities = 85/234 (36%), Positives = 132/234 (56%), Gaps = 11/234 (4%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V++ D+I      S   + + +E M+ DL +++      L +   + +LYQ+LRG+ + 
Sbjct: 81  IVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           H   +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT WYRAP++L+ S 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKK 178
            Y+ ++D+WS+GCIF E++  KPLFPG     QL  +  ++GTP+  E          K+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
                  ++++ ++   P      IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 256 R--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  269 bits (689), Expect = 5e-90
 Identities = 97/259 (37%), Positives = 142/259 (54%), Gaps = 15/259 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + DII      +   + + +E +D DL Q +      ++  + + FL+Q+LRGL Y 
Sbjct: 62  IVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++LL S+
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKK 178
           DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L+ E  K 
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL----HD 234
           Y    P+Y+ ++     P +     DL+ K+L F+ R RI+ EDA+ HP+  SL    H 
Sbjct: 237 Y--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294

Query: 235 ISDEPVCMSPFSFDFEQHA 253
           + D     +      ++ A
Sbjct: 295 LPDTTSIFALKEIQLQKEA 313

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  269 bits (690), Expect = 6e-90
 Identities = 78/230 (33%), Positives = 121/230 (52%), Gaps = 13/230 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           ++ + D          +++ + ++ M+TDL  II+  +  L+  H + ++   L+GL+Y+
Sbjct: 74  IIGLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           H   +LHRDLKP+NLLL+ N  LK+ DFGLA+   S     T  VVTRWYRAPELL  + 
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 188

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKK 178
            Y   +D+W+VGCI  EL+ R P  PG   + QL  + E +GTP+E +     +  +   
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
           +      +        F       +DL++ +  F+P  RIT   AL   Y
Sbjct: 249 F----KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  265 bits (679), Expect = 2e-88
 Identities = 75/238 (31%), Positives = 126/238 (52%), Gaps = 15/238 (6%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ ++ +I        + +++ +E  + DL + +  N  +S    + FLYQ++ G+ + H
Sbjct: 95  IIELKSVIH-----HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149

Query: 63  SANVLHRDLKPSNLLLNANCD-----LKICDFGLARV-TSETDFMTEYVVTRWYRAPELL 116
           S   LHRDLKP NLLL+ +       LKI DFGLAR         T  ++T WYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNEN 175
           L S  Y+ ++D+WS+ CI+ E++ + PLFPG   + QL  + E++G P +    G     
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV--TA 267

Query: 176 AKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
              +    P+++ ++        +    +DL+  ML  DP +RI+ ++AL HPY    
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  260 bits (668), Expect = 3e-87
 Identities = 90/241 (37%), Positives = 131/241 (54%), Gaps = 25/241 (10%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 61
           +V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+GL + 
Sbjct: 63  IVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 120
           HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT WYR P++L  + 
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 121 DYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKK 178
            Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +           
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM------- 230

Query: 179 YICQLPRY-------QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
              +LP Y          S     P ++ +  DL++ +L  +P QRI+ E+AL HPY   
Sbjct: 231 --TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

Query: 232 L 232
            
Sbjct: 289 F 289

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  262 bits (671), Expect = 6e-87
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 18/267 (6%)

Query: 3   VVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGL 58
           VV + +I      P       +Y+ ++  + DL  ++ +     +    +  +  +L GL
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 59  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYRAP 113
            YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT WYR P
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197

Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL 172
           ELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +        
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257

Query: 173 N-ENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           N E  +K   +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL H + 
Sbjct: 258 NYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

Query: 230 GSL---HDISDEPVCMSPFSFDFEQHA 253
            S     D+           F++    
Sbjct: 316 WSDPMPSDLKGMLSTHLTSMFEYLAPP 342

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  257 bits (660), Expect = 9e-86
 Identities = 79/250 (31%), Positives = 131/250 (52%), Gaps = 20/250 (8%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQILR 56
           +V + D+I      + N + + +E MD DL + + S       + L     +YF +Q+L+
Sbjct: 65  IVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 115
           GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT WYRAP++
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNE 174
           L+ S  Y+ +ID+WS GCI  E++  KPLFPG +   QL+L+ +++GTP+E+        
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV--T 237

Query: 175 NAKKYICQLPRYQRQSFTEKF-----PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              KY   + +   +   +         +  + +D +  +L  +P  R++ + AL HP+ 
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 230 GSLHDISDEP 239
              +  +   
Sbjct: 298 AEYYHHASMG 307

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  235 bits (601), Expect = 9e-76
 Identities = 80/263 (30%), Positives = 127/263 (48%), Gaps = 43/263 (16%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS---------NQALSEEHCQYFLYQ 53
           V++++ +           V++ ++  + DL  II+             L     +  LYQ
Sbjct: 80  VISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-----VTSETDFMTEY 104
           IL G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR     +    D     
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV- 195

Query: 105 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLR 155
           VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F  R          H  QL 
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255

Query: 156 LLIELIGTPSEAEL-GFLNENAKKYICQLPRYQRQSFT---------EKFPNVHPSAIDL 205
            +  ++G P++ +      +   ++   +  ++R ++T         +        A  L
Sbjct: 256 RIFNVMGFPADKDWEDI--KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313

Query: 206 VEKMLTFDPRQRITVEDALAHPY 228
           ++K+LT DP +RIT E A+  PY
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPY 336

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  178 bits (453), Expect = 2e-53
 Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 36/240 (15%)

Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 79
           + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+LL  
Sbjct: 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235

Query: 80  -ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
                +K+ DFG +    E   +  Y+ +R+YRAPE++L +  Y   ID+WS+GCI  EL
Sbjct: 236 QGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAEL 292

Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSE--------AELGFLNENA-------------- 176
           +   PL PG D   QL  +IEL+G PS+        A+    ++                
Sbjct: 293 LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSV 352

Query: 177 -------KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                  ++   + P   R+          P  +D +++ L +DP  R+T   AL HP+L
Sbjct: 353 VLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  169 bits (430), Expect = 1e-50
 Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 30/234 (12%)

Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN 79
           + +E++  +L  +I+    + +   + +    Q+L GL Y+H    ++H D+KP N+L+ 
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166

Query: 80  ANCD------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
                     +KI D G A      +  T  + TR YR+PE+LL +  +    D+WS  C
Sbjct: 167 IVDSPENLIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTAC 223

Query: 134 IFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSE--------AELGFLNENAKKY 179
           +  EL+    LF   +          +  +IEL+G                F +    + 
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283

Query: 180 ICQLPRYQRQSFTEKFPNV----HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           I +L  +  +    +             D +  ML  DPR+R      + HP+L
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  169 bits (431), Expect = 1e-50
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 43/247 (17%)

Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLL 78
           + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP N+LL
Sbjct: 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192

Query: 79  --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
                  +KI DFG +        + +Y+ +R+YR+PE+LL    Y  AID+WS+GCI +
Sbjct: 193 CNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILV 249

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSE--------AELGFLNENAKKY--------- 179
           E+   +PLF G + V Q+  ++E++G P          A   F       +         
Sbjct: 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGK 309

Query: 180 -----------------ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 222
                                P  +R   +      +    DL+ +ML +DP+ RI    
Sbjct: 310 REYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369

Query: 223 ALAHPYL 229
           AL H + 
Sbjct: 370 ALQHSFF 376

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  167 bits (426), Expect = 3e-50
 Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 38/242 (15%)

Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 79
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L   
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158

Query: 80  ------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
                              N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS--------------EA 167
           +    DVWS+GCI  E      LF   ++   L ++ +++G                 + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275

Query: 168 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
            L +   ++     +      +S+  +    H    DL+ +ML FDP QRIT+ +AL HP
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335

Query: 228 YL 229
           + 
Sbjct: 336 FF 337

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  167 bits (425), Expect = 4e-50
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 43/254 (16%)

Query: 15  RESF---NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHR 69
            E F     + I +EL+    +  I+ N       +H +   YQI + + ++HS  + H 
Sbjct: 83  LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT 142

Query: 70  DLKPSNLLLN-------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWY 110
           DLKP N+L                      N D+K+ DFG A  T + +  +  V TR Y
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHY 200

Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL- 169
           RAPE++L    ++   DVWS+GCI +E      +FP  D    L ++  ++G   +  + 
Sbjct: 201 RAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259

Query: 170 ----------GFLN----ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 215
                       L+     +A +Y+ +  +  ++    +    H    DL++KML +DP 
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE-HERLFDLIQKMLEYDPA 318

Query: 216 QRITVEDALAHPYL 229
           +RIT+ +AL HP+ 
Sbjct: 319 KRITLREALKHPFF 332

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  166 bits (422), Expect = 1e-49
 Identities = 57/250 (22%), Positives = 103/250 (41%), Gaps = 46/250 (18%)

Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 79
           + +E +   L++II  N       E  + +  +IL+ L Y+   ++ H DLKP N+LL+ 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 80  ------------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 115
                                    +  +K+ DFG A  T ++D+    + TR YRAPE+
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEV 230

Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--------- 166
           +LN   +  + D+WS GC+  EL     LF   +H+  L ++  +I    +         
Sbjct: 231 ILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT 289

Query: 167 AELGFLNENAKKYICQLP-------RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 219
               ++N++  K             ++ ++         H    D +  +L  DP  R +
Sbjct: 290 NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349

Query: 220 VEDALAHPYL 229
             + L H +L
Sbjct: 350 PAELLKHKFL 359

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  164 bits (415), Expect = 2e-48
 Identities = 32/232 (13%), Positives = 62/232 (26%), Gaps = 31/232 (13%)

Query: 6   IRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-------SNQALSEEHCQYFLYQILRGL 58
              + P     +  +  +       DL  +                        Q++R  
Sbjct: 148 FAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207

Query: 59  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL-L 117
             + S  ++H    P NL +  +  L + D                 V   Y   E L  
Sbjct: 208 ANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNA 265

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
           +++ +T A++ W +G     +      F       +       +  P    L F      
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF------ 319

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                               +      L+ + L FD R+R+   +A+  P  
Sbjct: 320 ---------------GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  161 bits (409), Expect = 4e-48
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
            +   +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N
Sbjct: 98  ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 157

Query: 76  LLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSD----------Y 122
            L+  +  LK+ DFG+A        +      V T  Y  PE + + S            
Sbjct: 158 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216

Query: 123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 182
           +   DVWS+GCI   +   K  F      +Q+  L  +I                 +  +
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAII--------------DPNHEIE 260

Query: 183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            P                   D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 FP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (408), Expect = 9e-47
 Identities = 57/241 (23%), Positives = 90/241 (37%), Gaps = 45/241 (18%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           +     YIA EL    L + +     A         L Q   GL ++HS N++HRDLKP 
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147

Query: 75  NLLL-----NANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPELLLNSSD--YT 123
           N+L+     +      I DFGL +            +    T  + APE+L        T
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207

Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 183
             +D++S GC+F  ++       G+    Q  +L+                 A       
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------------GACSL---- 247

Query: 184 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY-------LGSLHDIS 236
                        +    A +L+EKM+  DP++R + +  L HP+       L    D+S
Sbjct: 248 ------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVS 301

Query: 237 D 237
           D
Sbjct: 302 D 302

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  157 bits (400), Expect = 2e-46
 Identities = 54/276 (19%), Positives = 101/276 (36%), Gaps = 43/276 (15%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
            +   +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N
Sbjct: 79  ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 138

Query: 76  LLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSD----------Y 122
            L+  +  LK+ DFG+A        +      V T  Y  PE + + S            
Sbjct: 139 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197

Query: 123 TAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
           +   DVWS+GCI   +   K  F    + + +L  +I+                   +  
Sbjct: 198 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----------------PNHEI 240

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           + P                   D+++  L  DP+QRI++ + LAHPY+       ++   
Sbjct: 241 EFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289

Query: 242 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
            +     +    L        I + A      Y   
Sbjct: 290 GTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  156 bits (397), Expect = 2e-46
 Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 47/241 (19%)

Query: 7   RDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA 64
             + P    +  + ++I  E  +   L+ +I S N     +       QIL  L YIHS 
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135

Query: 65  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---------------DFMTEYVVTRW 109
            ++HRDLKP N+ ++ + ++KI DFGLA+    +               D +T  + T  
Sbjct: 136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM 195

Query: 110 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 169
           Y A E+L  +  Y   ID++S+G IF E++   P   G + V+ L+ L            
Sbjct: 196 YVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL------------ 241

Query: 170 GFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 228
                          R     F   F  N       ++  ++  DP +R      L   +
Sbjct: 242 ---------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286

Query: 229 L 229
           L
Sbjct: 287 L 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  155 bits (393), Expect = 1e-45
 Identities = 52/212 (24%), Positives = 74/212 (34%), Gaps = 34/212 (16%)

Query: 19  NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
             +Y+  EL    L Q       +L E     +L   L  L ++HS  ++H D+KP+N+ 
Sbjct: 130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           L      K+ DFGL                  Y APELL     Y  A DV+S+G   +E
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILE 247

Query: 138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
           +     L  G +   QLR                          +               
Sbjct: 248 VACNMELPHGGEGWQQLR--------------------QGYLPPEFT-----------AG 276

Query: 198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +      ++  ML  DP+ R T E  LA P L
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  156 bits (396), Expect = 2e-45
 Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 41/272 (15%)

Query: 19  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
             +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188

Query: 79  NANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSD----------YTAA 125
             +  LK+ DFG+A        +      V    Y  PE + + S            +  
Sbjct: 189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247

Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            DVWS+GCI   +   K  F    +       I                    +  + P 
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----------------PNHEIEFP- 290

Query: 186 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 245
                             D+++  L  DP+QRI++ + LAHPY+       ++    +  
Sbjct: 291 ----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340

Query: 246 SFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 277
              +    L        I + A      Y   
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 372

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (385), Expect = 7e-45
 Identities = 48/222 (21%), Positives = 79/222 (35%), Gaps = 38/222 (17%)

Query: 11  PPPQRESFNDVYIAYELMDT-DLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVL 67
               R     ++I  E  D   L Q I  R  + L +        QI +G+ YIHS  ++
Sbjct: 85  KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLI 144

Query: 68  HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 127
           +RDLKPSN+ L     +KI DFGL          T    T  Y +PE + +   Y   +D
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVD 203

Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           ++++G I  EL+             +       +                         +
Sbjct: 204 LYALGLILAELL--HVCDTA----FETSKFFTDL-------------------------R 232

Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               ++ F         L++K+L+  P  R    + L    +
Sbjct: 233 DGIISDIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  150 bits (380), Expect = 6e-44
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 39/234 (16%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +  +L  +  +
Sbjct: 86  IIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T  Y APE++  S +
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 200

Query: 122 -----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
                Y   +D+WS G I                     +   L G+P      F +   
Sbjct: 201 DNHPGYGKEVDMWSTGVI---------------------MYTLLAGSPP-----FWHRKQ 234

Query: 177 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              + ++       F      +   +  DLV + L   P++R T E+ALAHP+ 
Sbjct: 235 ML-MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  152 bits (386), Expect = 8e-44
 Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 33/218 (15%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
            D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271

Query: 78  LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVG 132
           L++   +C +KI DFG +++  ET  M     T  Y APE+L++     Y  A+D WS+G
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
            I                     L I L G P      F     +  +       + +F 
Sbjct: 332 VI---------------------LFICLSGYPP-----FSEHRTQVSLKDQITSGKYNFI 365

Query: 193 -EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            E +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  148 bits (376), Expect = 3e-43
 Identities = 73/235 (31%), Positives = 111/235 (47%), Gaps = 33/235 (14%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
            D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146

Query: 78  LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVG 132
           L++   +C +KI DFG +++  ET  M     T  Y APE+L++     Y  A+D WS+G
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF- 191
            I                     L I L G P      F     +  +       + +F 
Sbjct: 207 VI---------------------LFICLSGYPP-----FSEHRTQVSLKDQITSGKYNFI 240

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFS 246
            E +  V   A+DLV+K+L  DP+ R T E+AL HP+L            +S  +
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEEN 295

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  147 bits (374), Expect = 2e-42
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 49/237 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + D       ES + +++ ++LM   +L   +    ALSE+  +  +  +L  + ++
Sbjct: 162 IITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFL 216

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H+ N++HRDLKP N+LL+ N  +++ DFG +      + + E   T  Y APE+L  S D
Sbjct: 217 HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276

Query: 122 -----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGF 171
                Y   +D+W+ G I                     L   L G+P      +  +  
Sbjct: 277 ETHPGYGKEVDLWACGVI---------------------LFTLLAGSPPFWHRRQILM-L 314

Query: 172 LNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                 +Y           F+     +   +  DL+ ++L  DP  R+T E AL HP
Sbjct: 315 RMIMEGQY----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (373), Expect = 2e-42
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 37/222 (16%)

Query: 15  RESF---NDVYIAYELMDT-DLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLH 68
           RESF     +YI  +  +  DL + I  +      E+    +  QI   LK++H   +LH
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148

Query: 69  RDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAID 127
           RD+K  N+ L  +  +++ DFG+ARV + T  +    + T +Y +PE+  N   Y    D
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSD 207

Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           +W++GC+  EL   K  F      +    L+  I                     +    
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKN----LVLKI--------------ISGSFPPVS--- 246

Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                    +       LV ++   +PR R +V   L   ++
Sbjct: 247 --------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  143 bits (364), Expect = 1e-41
 Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 49/248 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y+
Sbjct: 70  IITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 62  HSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + APE ++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IV 183

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFL 172
           N        D+WS+G I                       I L G       ++ E    
Sbjct: 184 NYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGETKQET-LT 221

Query: 173 NENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           N +A  Y           F E+ F N    A D + ++L  DP++R+T+  +L H ++ +
Sbjct: 222 NISAVNY----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

Query: 232 LHDISDEP 239
           +   +   
Sbjct: 272 IRRRNVRG 279

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  143 bits (364), Expect = 3e-41
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 50/239 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DL-HQII-RSNQALSEEHCQYFLYQILRGLK 59
           V+ + ++      E+ +++ +  E     ++    +    + +SE      + QIL G+ 
Sbjct: 91  VINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 60  YIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           Y+H  N++H DLKP N+LL       D+KI DFG++R       + E + T  Y APE +
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE-I 204

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGF 171
           LN    T A D+W++G I                       + L  T         E  +
Sbjct: 205 LNYDPITTATDMWNIGII---------------------AYMLLTHTSPFVGEDNQET-Y 242

Query: 172 LNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           LN +               ++E+ F +V   A D ++ +L  +P +R T E  L+H +L
Sbjct: 243 LNISQVNV----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  143 bits (362), Expect = 5e-41
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 49/238 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+
Sbjct: 77  VITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 62  HSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           H+  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IV 190

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFL 172
           N        D+WS+G I                       I L G       ++ E    
Sbjct: 191 NYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGDTKQET-LA 228

Query: 173 NENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           N  +  Y           F  E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 229 NITSVSY----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  143 bits (362), Expect = 5e-41
 Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 49/241 (20%)

Query: 9   IIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSA 64
           +           +YI  +L    +L   +    +L       C +   QI   ++++HS 
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 65  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-------------MTEYVVTRWYR 111
            ++HRDLKPSN+    +  +K+ DFGL     + +               T  V T+ Y 
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 112 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 171
           +PE  ++ ++Y+  +D++S+G I  EL                     L    ++ E   
Sbjct: 244 SPE-QIHGNNYSHKVDIFSLGLILFEL---------------------LYSFSTQMERVR 281

Query: 172 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
           +  + +             F   F   +P    +V+ ML+  P +R    D + +    +
Sbjct: 282 IITDVRNLK----------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

Query: 232 L 232
           L
Sbjct: 332 L 332

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  141 bits (358), Expect = 7e-41
 Identities = 62/242 (25%), Positives = 94/242 (38%), Gaps = 39/242 (16%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + +       E   D+Y+  EL    +L + +   +   E      +  +L  + Y 
Sbjct: 68  IIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H  NV HRDLKP N L    + +  LK+ DFGLA        M   V T +Y +P++L  
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y    D WS G +                     + + L G P      F      +
Sbjct: 183 L--YGPECDEWSAGVM---------------------MYVLLCGYPP-----FSAPTDSE 214

Query: 179 YICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
            +    R    +F EK + NV P A  L+ ++LT  P+QRIT   AL H +       S 
Sbjct: 215 -VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273

Query: 238 EP 239
             
Sbjct: 274 RN 275

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  141 bits (358), Expect = 8e-41
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 38/230 (16%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + D I     +  +  Y+ ++L+   +L + I + +  SE    + + QIL  + Y 
Sbjct: 67  IVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 62  HSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L 
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLK 180

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+  +D+W+ G I                     L I L+G P      F +E+  +
Sbjct: 181 KDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQHR 214

Query: 179 YICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
              Q+       +    +  V P A  L++ MLT +P++RIT + AL  P
Sbjct: 215 LYAQIKAGAY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (360), Expect = 1e-40
 Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 49/238 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+
Sbjct: 76  VITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 62  HSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           HS  + H DLKP N++L         +KI DFGLA      +       T  + APE ++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IV 189

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFL 172
           N        D+WS+G I                       I L G       ++ E    
Sbjct: 190 NYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGDTKQET-LA 227

Query: 173 NENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           N +A  Y           F ++ F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 228 NVSAVNY----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  145 bits (368), Expect = 1e-40
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 34/219 (15%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E   + Y+  E     +L   I      +E      + Q+L G+ Y+H  N++HRDLKP 
Sbjct: 106 EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPE 165

Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           NLLL     +  +KI DFGL+ V      M E + T +Y APE+L     Y    DVWS+
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSI 223

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I   L+   P F G+                             + I +     + +F
Sbjct: 224 GVILFILLAGYPPFGGQTD---------------------------QEILRKVEKGKYTF 256

Query: 192 TEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               + NV   A DL+++ML FD ++RI+ + AL HP++
Sbjct: 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  145 bits (367), Expect = 1e-40
 Identities = 67/229 (29%), Positives = 98/229 (42%), Gaps = 34/229 (14%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E     Y+  E+    +L   I S +  SE      + Q+L G+ Y+H   ++HRDLKP 
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 155

Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           NLLL   + + +++I DFGL+     +  M + + T +Y APE+L     Y    DVWS 
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL--HGTYDEKCDVWST 213

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I                     L I L G P      F   N    I +     + +F
Sbjct: 214 GVI---------------------LYILLSGCP-----PFNGANEYD-ILKKVEKGKYTF 246

Query: 192 TEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
               +  V  SA DL+ KMLT+ P  RI+  DAL H ++ +        
Sbjct: 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  144 bits (365), Expect = 2e-40
 Identities = 63/260 (24%), Positives = 103/260 (39%), Gaps = 62/260 (23%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQ-------ALSEEHCQYFLYQILRGLKYIHSANVLH 68
            +   +YIA EL + +L  ++ S            E +    L QI  G+ ++HS  ++H
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138

Query: 69  RDLKPSNLLL-------------NANCDLKICDFGLARV-----TSETDFMTEYVVTRWY 110
           RDLKP N+L+               N  + I DFGL +      +S    +     T  +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198

Query: 111 RAPELLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 164
           RAPELL  S++       T +ID++S+GC+F  ++ +     G  +  +           
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----------- 247

Query: 165 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
                     N  + I  L   +         ++   A DL+ +M+  DP +R T    L
Sbjct: 248 ---------SNIIRGIFSLDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

Query: 225 AHPY-------LGSLHDISD 237
            HP        L  L  +SD
Sbjct: 295 RHPLFWPKSKKLEFLLKVSD 314

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  140 bits (356), Expect = 2e-40
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 52/238 (21%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-----TDLHQIIRSNQALSEEHCQYFLYQILRG 57
           ++ I ++      E ++++YI  E  +       +       +ALSE +    + Q++  
Sbjct: 82  IIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 58  LKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L Y HS +V+H+DLKP N+L    + +  +KI DFGLA +    +  T    T  Y APE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAEL 169
           +     D T   D+WS G +                     +   L G       S  E+
Sbjct: 197 VF--KRDVTFKCDIWSAGVV---------------------MYFLLTGCLPFTGTSLEEV 233

Query: 170 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                  K+           ++  +   + P A+DL+++MLT DP +R +    L H 
Sbjct: 234 -QQKATYKEP----------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (356), Expect = 2e-40
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 49/226 (21%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           +YI  +L    +L   +     +       C +   QI   ++++HS  ++HRDLKPSN+
Sbjct: 90  LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNI 149

Query: 77  LLNANCDLKICDFGLARVTSETDFM-------------TEYVVTRWYRAPELLLNSSDYT 123
               +  +K+ DFGL     + +               T  V T+ Y +PE +  +S Y+
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YS 208

Query: 124 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 183
             +D++S+G I  EL+   P     + V  L  +                          
Sbjct: 209 HKVDIFSLGLILFELL--YPFSTQMERVRTLTDV-------------------------- 240

Query: 184 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              +   F   F   +P    +V+ ML+  P +R    + + +   
Sbjct: 241 ---RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  142 bits (360), Expect = 2e-40
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 49/238 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+
Sbjct: 77  IITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 62  HSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 117
           H+  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IV 190

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFL 172
           N        D+WS+G I                       I L G       ++ E    
Sbjct: 191 NYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGDTKQET-LA 228

Query: 173 NENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           N  A  Y           F E+ F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 229 NITAVSY----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  141 bits (356), Expect = 3e-40
 Identities = 42/244 (17%), Positives = 83/244 (34%), Gaps = 27/244 (11%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRGL 58
           +V +  I    +  +     +  E      L+ ++        L E      L  ++ G+
Sbjct: 69  IVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 59  KYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
            ++    ++HR++KP N++     D     K+ DFG AR   + +       T  Y  P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 115 LLLNSSD-------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI--GTPS 165
           +   +         Y A +D+WS+G  F         F   +   + + ++  I  G PS
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 166 EAELGF--LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 223
            A  G          +   +P     S       +      ++  +L  D  +    +  
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 224 LAHP 227
            A  
Sbjct: 301 FAET 304

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  142 bits (359), Expect = 3e-40
 Identities = 62/241 (25%), Positives = 113/241 (46%), Gaps = 36/241 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + D I     +  +  Y+ ++L+   +L + I + +  SE    + + QIL  + Y 
Sbjct: 90  IVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 62  HSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L 
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLK 203

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+  +D+W+ G I                     L I L+G P      F +E+  +
Sbjct: 204 KDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQHR 237

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
              Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++ +   ++  
Sbjct: 238 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 297

Query: 239 P 239
            
Sbjct: 298 I 298

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  141 bits (357), Expect = 3e-40
 Identities = 51/237 (21%), Positives = 101/237 (42%), Gaps = 48/237 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLH-QIIRSNQALSEEHCQYFLYQILRGLKY 60
           ++ + +       ES  ++ + +E +   D+  +I  S   L+E     +++Q+   L++
Sbjct: 63  ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 61  IHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           +HS N+ H D++P N++     +  +KI +FG AR     D          Y APE +  
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQ 176

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFLN 173
               + A D+WS+G +                     + + L G       +  ++   N
Sbjct: 177 HDVVSTATDMWSLGTL---------------------VYVLLSGINPFLAETNQQI-IEN 214

Query: 174 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               +Y          +F E+ F  +   A+D V+++L  + + R+T  +AL HP+L
Sbjct: 215 IMNAEY----------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (353), Expect = 3e-40
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 46/231 (19%)

Query: 15  RESFND-----VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSA 64
            +   D     +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 65  N-----VLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLN 118
           +     VLHRDLKP+N+ L+   ++K+ DFGLAR+   +T F   +V T +Y +PE +  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
            S Y    D+WS+GC+  EL    P F       +L   I                  + 
Sbjct: 191 MS-YNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIR-----------------EG 231

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              ++P                   +++ +ML      R +VE+ L +P +
Sbjct: 232 KFRRIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  139 bits (353), Expect = 4e-40
 Identities = 70/217 (32%), Positives = 96/217 (44%), Gaps = 34/217 (15%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E  +  YI  EL    +L   I   +  SE      + Q+  G+ Y+H  N++HRDLKP 
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150

Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N+LL     +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS 
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSA 208

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I                     L I L GTP      F  +N    I +     + +F
Sbjct: 209 GVI---------------------LYILLSGTPP-----FYGKNEYD-ILKRVETGKYAF 241

Query: 192 TEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
               +  +   A DL+ KMLTF P  RIT    L HP
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  141 bits (358), Expect = 7e-40
 Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 43/235 (18%)

Query: 16  ESFNDVYIAYELMD-TDLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E   ++ +  E +   +L  +I   +  +SE     ++ Q   GLK++H  +++H D+KP
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177

Query: 74  SNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N++        +KI DFGLA   +  + +     T  + APE +++        D+W++
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAI 236

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFLNENAKKYICQLPRY 186
           G +                       + L G        + E    N     +       
Sbjct: 237 GVL---------------------GYVLLSGLSPFAGEDDLET-LQNVKRCDW------- 267

Query: 187 QRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
               F E  F +V P A D ++ +L  +PR+R+TV DAL HP+L   H      +
Sbjct: 268 ---EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  142 bits (361), Expect = 1e-39
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E     Y+  E  +  +L + I +     E      + QIL G+ Y+H  N++HRD+KP 
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175

Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N+LL   N+  ++KI DFGL+   S+   + + + T +Y APE+L     Y    DVWS 
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSC 233

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I   L+   P F G++     + +I+ +    + +  F                    
Sbjct: 234 GVIMYILLCGYPPFGGQND----QDIIKKV---EKGKYYFD------------------- 267

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
              + N+   A +L++ MLT+D  +R T E+AL   ++    +  ++ 
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  139 bits (352), Expect = 2e-39
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 37/232 (15%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ +++I      E+  ++ +  EL+   +L   I      SE      + QIL  + Y+
Sbjct: 110 IIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL      +  LKI DFGL+++      M     T  Y APE+L  
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
            + Y   +D+WSVG I                       I L G        F +E   +
Sbjct: 225 CA-YGPEVDMWSVGII---------------------TYILLCGFEP-----FYDERGDQ 257

Query: 179 YICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           ++ +        F    +  V  +A DLV K++  DP++R+T   AL HP++
Sbjct: 258 FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  142 bits (359), Expect = 3e-39
 Identities = 70/219 (31%), Positives = 98/219 (44%), Gaps = 34/219 (15%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E  +  YI  EL    +L   I   +  SE      + Q+  G+ Y+H  N++HRDLKP 
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150

Query: 75  NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N+LL     +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS 
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSA 208

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G I                     L I L GTP      F  +N    I +     + +F
Sbjct: 209 GVI---------------------LYILLSGTP-----PFYGKNEYD-ILKRVETGKYAF 241

Query: 192 TEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               +  +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  138 bits (350), Expect = 3e-39
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 34/201 (16%)

Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARV 94
             +    E+     + QI   L Y+H+  + HRD+KP N L   N + ++K+ DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 95  -----TSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGR 148
                  E   MT    T ++ APE+L  +++ Y    D WS G +   L+     FPG 
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
           +        I  +      +L F                       +  + P A DL+  
Sbjct: 280 ND----ADTISQV---LNKKLCFE-------------------NPNYNVLSPLARDLLSN 313

Query: 209 MLTFDPRQRITVEDALAHPYL 229
           +L  +  +R     AL HP++
Sbjct: 314 LLNRNVDERFDAMRALQHPWI 334

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  138 bits (349), Expect = 4e-39
 Identities = 61/258 (23%), Positives = 108/258 (41%), Gaps = 30/258 (11%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + ++            ++  EL++  +L + I+  +  SE    Y + +++  + ++
Sbjct: 68  IVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLL 117
           H   V+HRDLKP NLL    N N ++KI DFG AR    +   +     T  Y APE LL
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LL 181

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
           N + Y  + D+WS+G I   ++  +  F   D        +E++    + +  F  E   
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA-- 239

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
                            + NV   A DL++ +LT DP +R+ +     + +L     +S 
Sbjct: 240 -----------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282

Query: 238 EPVCMSPFSFDFEQHALT 255
            P+              T
Sbjct: 283 NPLMTPDILGSSGAAVHT 300

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  137 bits (348), Expect = 8e-39
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 35/244 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ ++D+      +    VY+  ELM   +L   I   +  SE      L+ I + ++Y+
Sbjct: 78  IITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 62  HSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELL 116
           H+  V+HRDLKPSN+L          ++ICDFG A+ + +E   +     T  + APE+L
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
                Y AA D+WS+G +   ++     F          +L   IG     +        
Sbjct: 193 ERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-ARIG---SGKFSLSGGY- 246

Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
                             + +V  +A DLV KML  DP QR+T    L HP++     + 
Sbjct: 247 ------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288

Query: 237 DEPV 240
              +
Sbjct: 289 QYQL 292

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  138 bits (350), Expect = 8e-39
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 43/224 (19%)

Query: 16  ESFNDVYIAYELMDT-DLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           ES ND+ +  E +D  +L  +II  +  L+E     F+ QI  G++++H   +LH DLKP
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215

Query: 74  SNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N+L        +KI DFGLAR     + +     T  + APE ++N    +   D+WSV
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSV 274

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFLNENAKKYICQLPRY 186
           G I                       + L G       ++AE    N  A ++       
Sbjct: 275 GVI---------------------AYMLLSGLSPFLGDNDAET-LNNILACRW------- 305

Query: 187 QRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                 ++ F ++   A + + K+L  +   RI+  +AL HP+L
Sbjct: 306 ---DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  137 bits (346), Expect = 1e-38
 Identities = 70/251 (27%), Positives = 109/251 (43%), Gaps = 35/251 (13%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170

Query: 75  NLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           NL LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GC
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 229

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I   L+  KP F                               KK    +P++       
Sbjct: 230 IMYTLLVGKPPFETSCLKETYL-------------------RIKKNEYSIPKH------- 263

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL--GSLHDISDEPVCMSPFSFDFEQ 251
               ++P A  L++KML  DP  R T+ + L   +   G +           P  F    
Sbjct: 264 ----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 319

Query: 252 HALTEGQMKEL 262
            +L     K L
Sbjct: 320 SSLDPSNRKPL 330

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 2e-38
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 36/224 (16%)

Query: 15  RESF---NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANV 66
             SF   N++ I  EL D  DL ++I    +  + + E     +  Q+   L+++HS  V
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157

Query: 67  LHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAA 125
           +HRD+KP+N+ + A   +K+ D GL R  +S+T      V T +Y +PE +  +  Y   
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFK 216

Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 185
            D+WS+GC+  E+   +  F G      L  L + I                   C  P 
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQ-----------------CDYPP 257

Query: 186 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                ++E+          LV   +  DP +R  V         
Sbjct: 258 LPSDHYSEEL-------RQLVNMCINPDPEKRPDVTYVYDVAKR 294

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  136 bits (345), Expect = 2e-38
 Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 30/239 (12%)

Query: 21  VYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           + I  E M+      +I  R +QA +E      +  I   ++++HS N+ HRD+KP NLL
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160

Query: 78  L---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
                 +  LK+ DFG A+ T++    T    T +Y APE+L     Y  + D+WS+G I
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK-YDKSCDMWSLGVI 218

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
              L+   P F           +   I      + GF N                     
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIR---LGQYGFPNPE------------------- 256

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA 253
           +  V   A  L+  +L  DP +R+T+   + HP++     +   P+  +    + + H 
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  136 bits (345), Expect = 3e-38
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 48/249 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDL-HQIIR---SNQALSEEHCQYFLYQILRG 57
           +V + +        S   +Y+ +E MD  DL  +I++   +    SE    +++ QIL  
Sbjct: 88  IVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 58  LKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAP 113
           L+Y H  N++HRD+KP  +LL     +  +K+  FG+A  +          V T  + AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 114 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           E ++    Y   +DVW  G I                     L I L G        F  
Sbjct: 203 E-VVKREPYGKPVDVWGCGVI---------------------LFILLSGCLP-----FYG 235

Query: 174 ENAKKY--ICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 230
              + +  I +  +Y       + + ++  SA DLV +ML  DP +RITV +AL HP+L 
Sbjct: 236 TKERLFEGIIKG-KY---KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

Query: 231 SLHDISDEP 239
                + + 
Sbjct: 292 ERDRYAYKI 300

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  136 bits (345), Expect = 6e-38
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)

Query: 19  NDVYIAYELMD--TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
             + I  E +D      +I  R +QA +E      +  I   ++Y+HS N+ HRD+KP N
Sbjct: 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191

Query: 76  LLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL      N  LK+ DFG A+ T+  + +T    T +Y APE+L     Y  + D+WS+G
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLG 250

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
            I   L+   P F     +     +   I      +  F N                   
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFPNPE----------------- 290

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 239
             +  V      L+  +L  +P QR+T+ + + HP++     +   P
Sbjct: 291 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  139 bits (351), Expect = 8e-38
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 43/224 (19%)

Query: 16  ESFNDVYIAYELMD-TDL-HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E  N++ + YE M   +L  ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283

Query: 74  SNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 342

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGFLNENAKKYICQLPRY 186
           G +                       I L G       ++ E    N  +  +       
Sbjct: 343 GVL---------------------SYILLSGLSPFGGENDDET-LRNVKSCDW------- 373

Query: 187 QRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              +     F  +     D + K+L  DP  R+T+  AL HP+L
Sbjct: 374 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  133 bits (337), Expect = 1e-37
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 35/240 (14%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  
Sbjct: 85  EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 144

Query: 75  NLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           NL LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GC
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 203

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           I   L+  KP F                               KK    +P++       
Sbjct: 204 IMYTLLVGKPPFETSCLKETYL-------------------RIKKNEYSIPKH------- 237

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL--GSLHDISDEPVCMSPFSFDFEQ 251
               ++P A  L++KML  DP  R T+ + L   +   G +           P  F    
Sbjct: 238 ----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  131 bits (333), Expect = 7e-37
 Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 45/235 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + DI      ES    Y+  +L+   +L   I      +E+     + Q+L  +KY+
Sbjct: 68  IVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL      N  + I DFGL+++  +   M+    T  Y APE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAPEVLAQ 181

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAELGFLNEN 175
              Y+ A+D WS+G I                       I L G P    E E     + 
Sbjct: 182 KP-YSKAVDCWSIGVI---------------------TYILLCGYPPFYEETESKLFEK- 218

Query: 176 AKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                 +   Y    F   F  ++  SA D +  +L  DP +R T E AL+HP++
Sbjct: 219 -----IKEGYY---EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (329), Expect = 1e-36
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 45/216 (20%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
             VY+  E      +++ ++      E+    ++ ++   L Y HS  V+HRD+KP NLL
Sbjct: 82  TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141

Query: 78  LNANCDLKICDFGLARVTSETDFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           L +  +LKI DFG +     +         +Y+       PE ++    +   +D+WS+G
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE-MIEGRMHDEKVDLWSLG 194

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
            +  E +  KP F    +    +                             R  R  F 
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYK-----------------------------RISRVEF- 224

Query: 193 EKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
             FP+ V   A DL+ ++L  +P QR  + + L HP
Sbjct: 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  133 bits (338), Expect = 1e-36
 Identities = 66/246 (26%), Positives = 102/246 (41%), Gaps = 45/246 (18%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + D I           Y+ ++L+   +L + I + +  SE    + + QIL  + + 
Sbjct: 72  IVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLL 117
           H   V+HR+LKP NLLL        +K+ DFGLA  V  E      +  T  Y +PE+L 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 118 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAELGFLNE 174
               Y   +D+W+ G I                     L I L+G P    E +     +
Sbjct: 187 KDP-YGKPVDLWACGVI---------------------LYILLVGYPPFWDEDQHRLYQQ 224

Query: 175 NAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 233
                  +   Y    F       V P A DL+ KMLT +P +RIT  +AL HP++    
Sbjct: 225 ------IKAGAY---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275

Query: 234 DISDEP 239
            ++   
Sbjct: 276 TVASCM 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 2e-36
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 44/220 (20%)

Query: 16  ESFNDVYIA--Y----ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           E  N VY+        E+       +    +  SE   ++F++QI+ G+ Y+HS  +LHR
Sbjct: 81  EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136

Query: 70  DLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 128
           DL  SNLLL  N ++KI DFGLA ++    +       T  Y +PE +   S +    DV
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGLESDV 195

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           WS+GC+F  L+  +P F      + L                              +   
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVKNTLN-----------------------------KVVL 226

Query: 189 QSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
             +  + P+ +   A DL+ ++L  +P  R+++   L HP
Sbjct: 227 ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  129 bits (326), Expect = 4e-36
 Identities = 45/235 (19%), Positives = 84/235 (35%), Gaps = 59/235 (25%)

Query: 19  NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           + + I  E  +   L   I    R      E   +  L Q+ RGL+YIHS +++H D+KP
Sbjct: 84  DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP 143

Query: 74  SNLLLNAN-------------------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           SN+ ++                        KI D G     S             + A E
Sbjct: 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE---EGDSRFLANE 200

Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 174
           +L  +  +    D++++    +     +PL    D  H++R                   
Sbjct: 201 VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR------------------- 241

Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +  + ++P    Q  +++F        +L++ M+  DP +R +    + H  L
Sbjct: 242 --QGRLPRIP----QVLSQEF-------TELLKVMIHPDPERRPSAMALVKHSVL 283

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (331), Expect = 6e-36
 Identities = 42/243 (17%), Positives = 83/243 (34%), Gaps = 27/243 (11%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRGL 58
           +V +  I    +  +     +  E      L+ ++        L E      L  ++ G+
Sbjct: 69  IVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 59  KYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
            ++    ++HR++KP N++     D     K+ DFG AR   + +       T  Y  P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 115 LLLNSSD-------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI--GTPS 165
           +   +         Y A +D+WS+G  F         F   +   + + ++  I  G PS
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 166 EAELGF--LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 223
            A  G          +   +P     S       +      ++  +L  D  +    +  
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 224 LAH 226
            A 
Sbjct: 301 FAE 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  130 bits (329), Expect = 7e-36
 Identities = 30/244 (12%), Positives = 67/244 (27%), Gaps = 54/244 (22%)

Query: 1   MQVVAIRDIIPPPQRESFNDVYIAYELMDTD-------LHQIIRSNQALSEEHCQYFLYQ 53
            Q   +  +    +       +  Y  M ++       L     ++++L          Q
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214

Query: 54  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 113
           ++R L  +H   ++H  L+P +++L+    + +  F                V+R +  P
Sbjct: 215 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGFEPP 271

Query: 114 ELL----------LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT 163
           EL              +  T + D W++G +   +            +     +      
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC-- 329

Query: 164 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 223
                                            N+      L+E  L +    R+    A
Sbjct: 330 --------------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQA 357

Query: 224 LAHP 227
           +  P
Sbjct: 358 METP 361

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (336), Expect = 2e-35
 Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 15/246 (6%)

Query: 3   VVAIRDIIPPPQRESFND-VYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRG 57
           VV+ R++    Q+ + ND   +A E  +  DL + +   +    L E   +  L  I   
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 58  LKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPE 114
           L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 174
           LL     YT  +D WS G +  E +     F       Q    +    +     +     
Sbjct: 194 LLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE-KSNEHIVVYDDLT 251

Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
            A K+   LP     S               ++ ML +  RQR T           +L  
Sbjct: 252 GAVKFSSVLPTPNHLSGILA-----GKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

Query: 235 ISDEPV 240
           I    +
Sbjct: 307 ILSLKL 312

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (325), Expect = 2e-35
 Identities = 46/198 (23%), Positives = 78/198 (39%), Gaps = 23/198 (11%)

Query: 37  RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
                +  +  +  +  +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG +   
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 96  SETDFMT-----EYVVTRWYRAPELLLNSSDY-TAAIDVWSVGCIFMELMDRKPLFPGRD 149
            +          E++       PE   N S Y  A +D+WS+G     +      F  + 
Sbjct: 203 VDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 209
            + +L   I          + +           L     +  T     +    ID ++  
Sbjct: 257 SLVELFNNI------RTKNIEY----PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306

Query: 210 LTFDPRQRITVEDALAHP 227
           L  +P +RIT EDAL H 
Sbjct: 307 LRKNPAERITSEDALKHE 324

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  125 bits (317), Expect = 8e-35
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 38/235 (16%)

Query: 19  NDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 73
            DV+I  ELMDT       Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138

Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE---LLLNSSDYTAAIDVWS 130
           SN+L+NA   +K+CDFG++    +          + Y APE     LN   Y+   D+WS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G   +EL   +  FP        + L +++  PS                  P+     
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS------------------PQLPADK 238

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 245
           F+ +F       +D   + L  + ++R T  + + HP+         +   ++ F
Sbjct: 239 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPF---FTLHESKGTDVASF 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (317), Expect = 2e-34
 Identities = 51/231 (22%), Positives = 79/231 (34%), Gaps = 44/231 (19%)

Query: 14  QRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLH 68
           +R + ++ ++         L   I         L+E+   + L  I RGL+ IH+    H
Sbjct: 98  ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157

Query: 69  RDLKPSNLLLNANCDLKICDFGLARV------TSETDFMTEYVVTR----WYRAPELLLN 118
           RDLKP+N+LL       + D G           S      +    +     YRAPEL   
Sbjct: 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217

Query: 119 SS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
            S        DVWS+GC+   +M  +  +           L                   
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---------------VQN 262

Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
           +  I Q PR+              +   L+  M+T DP QR  +   L+  
Sbjct: 263 QLSIPQSPRH------------SSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  123 bits (312), Expect = 8e-34
 Identities = 55/242 (22%), Positives = 91/242 (37%), Gaps = 34/242 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + +       E  +  Y+ +E M    +   I   +  +E      +  +   L ++
Sbjct: 73  VLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW--------Y 110
           H+  + HRDLKP N+L    N    +KICDF L          +               Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 111 RAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 166
            APE++   S+    Y    D+WS+G I   L+   P  P                 P+ 
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP--PFVGRCGSDCGWDRGEACPAC 245

Query: 167 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 225
             + F +    KY           F +K   ++  +A DL+ K+L  D +QR++    L 
Sbjct: 246 QNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

Query: 226 HP 227
           HP
Sbjct: 296 HP 297

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (310), Expect = 8e-34
 Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 44/202 (21%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG 
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW 160

Query: 92  ARVTSETDFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 146
           +         T     +Y+       PE ++    +   +D+W  G +  E +   P F 
Sbjct: 161 SVHAPSLRRRTMCGTLDYL------PPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDL 205
              H          I      +L                        KFP  +   + DL
Sbjct: 214 SPSHTE----THRRI---VNVDL------------------------KFPPFLSDGSKDL 242

Query: 206 VEKMLTFDPRQRITVEDALAHP 227
           + K+L + P QR+ ++  + HP
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHP 264

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  123 bits (311), Expect = 9e-34
 Identities = 54/234 (23%), Positives = 105/234 (44%), Gaps = 46/234 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYE------LMDTDLHQIIRSNQALSEEHCQYFLYQILR 56
           VV + +++  P  +    +Y+ +E      +M+      + + + LSE+  +++   +++
Sbjct: 98  VVKLVEVLDDPNEDH---LYMVFELVNQGPVME------VPTLKPLSEDQARFYFQDLIK 148

Query: 57  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPEL 115
           G++Y+H   ++HRD+KPSNLL+  +  +KI DFG++     +D +    V T  + APE 
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES 208

Query: 116 LLNSS-DYT-AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 173
           L  +   ++  A+DVW++G      +  +  F   + +  L   I               
Sbjct: 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI--------------- 252

Query: 174 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
              K    + P           P++     DL+ +ML  +P  RI V +   HP
Sbjct: 253 ---KSQALEFPDQ---------PDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (313), Expect = 3e-33
 Identities = 27/238 (11%), Positives = 62/238 (26%), Gaps = 47/238 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-------NQALSEEHCQYFLYQIL 55
              +  +    +       +  Y  M ++L             +++L          Q++
Sbjct: 162 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 221

Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAP 113
           R L  +H   ++H  L+P +++L+    + +  F        +               A 
Sbjct: 222 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAE 281

Query: 114 ELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 169
            +L     + +  T A D W++G     +            +     +            
Sbjct: 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-------- 333

Query: 170 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                                      N+      L+E  L +    R+    A+  P
Sbjct: 334 --------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (307), Expect = 6e-33
 Identities = 43/212 (20%), Positives = 84/212 (39%), Gaps = 35/212 (16%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG 90
           L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+++     +CDFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196

Query: 91  LARVTSE-----TDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
            A          +    +Y+  T  + APE+++      A +D+WS  C+ + +++    
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
           +       +  L +  I +                  ++P           P+  P    
Sbjct: 256 WT---QYFRGPLCL-KIASEPPPIR------------EIP-----------PSCAPLTAQ 288

Query: 205 LVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
            +++ L  +P  R +  +              
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  118 bits (298), Expect = 7e-32
 Identities = 52/241 (21%), Positives = 86/241 (35%), Gaps = 50/241 (20%)

Query: 19  NDVYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
             + I  E +D      +I  R +QA +E      +  I   ++Y+HS N+ HRD+KP N
Sbjct: 88  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147

Query: 76  LLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL      N  LK+ DFG                     A E       Y  + D+WS+G
Sbjct: 148 LLYTSKRPNAILKLTDFGF--------------------AKETTGEK--YDKSCDMWSLG 185

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
            I   L+   P F     +     +   I      +  F N                   
Sbjct: 186 VIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFPNPE----------------- 225

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQH 252
             +  V      L+  +L  +P QR+T+ + + HP++     +   P+  S    + ++ 
Sbjct: 226 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 283

Query: 253 A 253
            
Sbjct: 284 W 284

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  116 bits (292), Expect = 7e-31
 Identities = 45/229 (19%), Positives = 79/229 (34%), Gaps = 47/229 (20%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
           V+ + D       E+     +  E      DL   I     L E   + F  Q++  +++
Sbjct: 100 VIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154

Query: 61  IHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
            HS  V+HRD+K  N+L++      K+ DFG   +  +  +   +  TR Y  PE +   
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISRH 213

Query: 120 SDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
             +     VWS+G + +  +    P F     +                          +
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIP-FERDQEI-------------------------LE 247

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                P +           V P    L+ + L   P  R ++E+ L  P
Sbjct: 248 AELHFPAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  116 bits (292), Expect = 9e-31
 Identities = 54/265 (20%), Positives = 111/265 (41%), Gaps = 38/265 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+  ++Y 
Sbjct: 76  IVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +  +     Y APEL      
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
               +DVWS+G I   L+     F G  ++ +LR  +                   +   
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERV------------------LRGKY 231

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 241
           ++P Y           +     +L+++ L  +P +R T+E  +   ++ + H+  +    
Sbjct: 232 RIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPF 280

Query: 242 MSPFSFDFEQHALTEGQMKELIYQE 266
           + P     +Q  +    M  + Y +
Sbjct: 281 VEPELDISDQKRID--IMVGMGYSQ 303

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (291), Expect = 9e-31
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 32/217 (14%)

Query: 19  NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 76
            DV+IA ELM T   ++  R    + E         I++ L Y+     V+HRD+KPSN+
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156

Query: 77  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE----LLLNSSDYTAAIDVWSVG 132
           LL+    +K+CDFG++    +            Y APE          DY    DVWS+G
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
              +EL   +  +          +L +++                     LP +    F+
Sbjct: 217 ISLVELATGQFPYKNCKTD--FEVLTKVLQEEPP---------------LLPGHMG--FS 257

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             F          V+  LT D R+R      L H ++
Sbjct: 258 GDF-------QSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 1e-30
 Identities = 48/227 (21%), Positives = 95/227 (41%), Gaps = 18/227 (7%)

Query: 19  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 76
            ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163

Query: 77  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           L+N+  ++K+CDFG++    ++   + +V TR Y +PE  L  + Y+   D+WS+G   +
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ----SFT 192
           E+   +   P  D      +    +   +           +         +         
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 193 EKFPNVHP----------SAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +   N  P             D V K L  +P +R  ++  + H ++
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (289), Expect = 2e-30
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 19  NDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK 72
            D +I  ELM T   +  +      +  + EE         ++ L ++     ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVW 129
           PSN+LL+ + ++K+CDFG++    ++   T     R Y APE +    +   Y    DVW
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213

Query: 130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 189
           S+G    EL   +  +P  + V      +             +  +  +    L   + +
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQV-------------VKGDPPQ----LSNSEER 256

Query: 190 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            F+  F       I+ V   LT D  +R   ++ L HP++
Sbjct: 257 EFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFI 289

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  114 bits (287), Expect = 5e-30
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 30/212 (14%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
            +  D+ +  E    +L   I   + ++E+  + F  QI+  ++Y H   ++HRDLKP N
Sbjct: 79  TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPEN 138

Query: 76  LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           LLL+ N ++KI DFGL+ + ++ +F+     +  Y APE++         +DVWS G + 
Sbjct: 139 LLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198

Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
             ++  +  F   + +  L   +                     +  +P +         
Sbjct: 199 YVMLVGRLPFDD-EFIPNLFKKV------------------NSCVYVMPDF--------- 230

Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
             + P A  L+ +M+  DP QRIT+++    P
Sbjct: 231 --LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  113 bits (285), Expect = 6e-30
 Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 45/228 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
           V+ + D       E  +   +  E  +   DL   I    AL EE  + F +Q+L  +++
Sbjct: 110 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 61  IHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
            H+  VLHRD+K  N+L++ N  +LK+ DFG   +  +T +   +  TR Y  PE +   
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYH 223

Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
             +  +  VWS+G +  +++     F   + + + ++                       
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV----------------------- 260

Query: 180 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                +            V      L+   L   P  R T E+   HP
Sbjct: 261 --FFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  113 bits (285), Expect = 9e-30
 Identities = 54/248 (21%), Positives = 93/248 (37%), Gaps = 55/248 (22%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQII--RSNQALSEEHCQYFLYQILR 56
           +V         + ES         L +      +  +    S   LS +      YQ  R
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 57  GLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARV---------TSETDFMTEYV 105
            ++++H     ++HRDLK  NLLL+    +K+CDFG A           +++   + E  
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 106 VTR----WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 159
           +TR     YR PE+  L ++       D+W++GCI   L  R+  F              
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED------------ 255

Query: 160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 219
                  A+L  +N    KY   +P +  Q               L+  ML  +P +R++
Sbjct: 256 ------GAKLRIVN---GKY--SIPPHDTQY---------TVFHSLIRAMLQVNPEERLS 295

Query: 220 VEDALAHP 227
           + + +   
Sbjct: 296 IAEVVHQL 303

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  115 bits (288), Expect = 9e-30
 Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 73/279 (26%)

Query: 23  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN 79
           + +E++   L + I  +  Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181

Query: 80  AN-------------------------------------------------CDLKICDFG 90
            N                                                   +KI D G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241

Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD- 149
            A    +    TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF     
Sbjct: 242 NACWVHKHF--TEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSG 298

Query: 150 -----HVHQLRLLIELIGTP-------SEAELGFLNENAK-KYICQLPRYQRQSFTEKFP 196
                    + L+IEL+G          +    F  +    K+I +L  +       +  
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 197 NV----HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 231
                      D +  ML   P +R T  + L HP+L S
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  112 bits (281), Expect = 2e-29
 Identities = 40/215 (18%), Positives = 86/215 (40%), Gaps = 34/215 (15%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSN 75
             + +  ELM +  L   ++  + +  +  + +  QIL+GL+++H+    ++HRDLK  N
Sbjct: 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 161

Query: 76  LLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           + +      +KI D GLA +   + F    + T  + APE+      Y  ++DV++ G  
Sbjct: 162 IFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMC 218

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
            +E+   +  +    +  Q+       G    +         K                 
Sbjct: 219 MLEMATSEYPYSECQNAAQI-YRRVTSGVKPASFDKVAIPEVK----------------- 260

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                    +++E  +  +  +R +++D L H + 
Sbjct: 261 ---------EIIEGCIRQNKDERYSIKDLLNHAFF 286

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  110 bits (278), Expect = 3e-29
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 36/226 (15%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ +  +I      +  D ++  E +   +L   I  +  + E   +    QIL  + Y 
Sbjct: 73  IIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++     
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
               +D+WS G I   L+     F   +HV  L   I                  +  + 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKI------------------RGGVF 228

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
            +P Y           ++ S   L+  ML  DP +R T++D   H 
Sbjct: 229 YIPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHE 263

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (278), Expect = 4e-29
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 33/204 (16%)

Query: 32  LHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKIC 87
           L  ++RS       +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N  +  LKI 
Sbjct: 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165

Query: 88  DFGLARVTSETDFMTEYVV-TRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLF 145
           DFG ++  +  +  TE    T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
                       +  +G               K   ++P            ++   A   
Sbjct: 226 YELGEPQA---AMFKVGM-------------FKVHPEIP-----------ESMSAEAKAF 258

Query: 206 VEKMLTFDPRQRITVEDALAHPYL 229
           + K    DP +R    D L   +L
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFL 282

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  112 bits (281), Expect = 5e-29
 Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 29/216 (13%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
            +   + I  E     +L++ I +    SE+  ++F  Q+L G+ Y HS  + HRDLK  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145

Query: 75  NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           N LL  +    LKICDFG ++ +         V T  Y APE+LL         DVWS G
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205

Query: 133 CI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
              ++ L+   P F   +     R  I+ I                     +P   R S 
Sbjct: 206 VTLYVMLVGAYP-FEDPEEPRDYRKTIQRI---------------LSVKYSIPDDIRIS- 248

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                   P    L+ ++   DP  RI++ +   H 
Sbjct: 249 --------PECCHLISRIFVADPATRISIPEIKTHS 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (276), Expect = 6e-29
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 34/197 (17%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V 
Sbjct: 96  IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155

Query: 96  SETDFMTEYVVTRW-----YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
                  E ++ +      Y APELL     +   +DVWS G +   ++  +   P    
Sbjct: 156 --RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQP 211

Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
               +   +                           +++++   +  +  + + L+ K+L
Sbjct: 212 SDSCQEYSD-------------------------WKEKKTYLNPWKKIDSAPLALLHKIL 246

Query: 211 TFDPRQRITVEDALAHP 227
             +P  RIT+ D     
Sbjct: 247 VENPSARITIPDIKKDR 263

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (278), Expect = 6e-29
 Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 34/207 (16%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SET 98
                   +  Q++ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165

Query: 99  DFMTEYVVTRWYRAPELLLNSSDYT-AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 157
           D       +  ++ PE+      ++   +D+WS G     +      F G D++++L   
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFEN 224

Query: 158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
           I                   K    +P               P   DL++ ML ++P +R
Sbjct: 225 I------------------GKGSYAIPGD-----------CGPPLSDLLKGMLEYEPAKR 255

Query: 218 ITVEDALAHPYLGSLHDISDEPVCMSP 244
            ++     H +    H  ++ PV + P
Sbjct: 256 FSIRQIRQHSWFRKKHPPAEAPVPIPP 282

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  110 bits (276), Expect = 2e-28
 Identities = 43/216 (19%), Positives = 80/216 (37%), Gaps = 38/216 (17%)

Query: 16  ESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           E+     +  E   +  DL   I  +  L E    Y   Q++  + Y+   +++HRD+K 
Sbjct: 99  ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKD 158

Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
            N+++  +  +K+ DFG A           +  T  Y APE+L+ +      +++WS+G 
Sbjct: 159 ENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
               L+  +  F   +                EA +              P         
Sbjct: 219 TLYTLVFEENPFCELEET-------------VEAAI------------HPPYL------- 246

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
               V    + LV  +L   P +R T+E  +  P++
Sbjct: 247 ----VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (274), Expect = 3e-28
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 34/197 (17%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V 
Sbjct: 96  IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155

Query: 96  SETDFMTEYVVTRW-----YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
                  E ++ +      Y APELL     +   +DVWS G +   ++  +   P    
Sbjct: 156 --RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQP 211

Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 210
               +   +                           +++++   +  +  + + L+ K+L
Sbjct: 212 SDSCQEYSD-------------------------WKEKKTYLNPWKKIDSAPLALLHKIL 246

Query: 211 TFDPRQRITVEDALAHP 227
             +P  RIT+ D     
Sbjct: 247 VENPSARITIPDIKKDR 263

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (268), Expect = 1e-27
 Identities = 36/204 (17%), Positives = 76/204 (37%), Gaps = 31/204 (15%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + I  +  +   L+  + +++     +       Q  RG+ Y+H+ +++HRDLK +N+ L
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153

Query: 79  NANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGC 133
           + +  +KI DFGLA      S +    +   +  + APE++       Y+   DV++ G 
Sbjct: 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  ELM  +  +                    +  +  +                   ++
Sbjct: 214 VLYELMTGQLPYSNI--------------NNRDQIIEMVGRG----------SLSPDLSK 249

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQR 217
              N       L+ + L     +R
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDER 273

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  107 bits (269), Expect = 7e-27
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 31/213 (14%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
            + +D+++  E +   +L   I  N  L E+  +    QIL G+ Y H   V+HRDLKP 
Sbjct: 86  STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++         +D+WS G I
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
              L+     F   DHV  L   I                     I   P+Y        
Sbjct: 206 LYALLCGTLPFDD-DHVPTLFKKI------------------CDGIFYTPQY-------- 238

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
              ++PS I L++ ML  DP +R T++D   H 
Sbjct: 239 ---LNPSVISLLKHMLQVDPMKRATIKDIREHE 268

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (264), Expect = 2e-26
 Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 30/205 (14%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++ N    EE  + F+ +++  L Y+ +  ++HRD+KP N+LL+ +  + I DF 
Sbjct: 101 DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160

Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGR 148
           +A +      +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  +  +  R
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

Query: 149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 208
                 + ++          + +            P                  + L++K
Sbjct: 221 SS-TSSKEIVHTF---ETTVVTY------------P-----------SAWSQEMVSLLKK 253

Query: 209 MLTFDPRQRI-TVEDALAHPYLGSL 232
           +L  +P QR   + D    PY+  +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMNDI 278

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 2e-26
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 41/218 (18%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           +++++  E +     TD    + +   + E        + L+ L+++HS  V+HRD+K  
Sbjct: 90  DELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145

Query: 75  NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N+LL  +  +K+ DFG  A++T E    +  V T ++ APE++     Y   +D+WS+G 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGI 204

Query: 134 IFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           + +E+++ +P  P  +  + LR   LI   GTP       L    K              
Sbjct: 205 MAIEMIEGEP--PYLN-ENPLRALYLIATNGTPE------LQNPEK-------------L 242

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +  F        D + + L  D  +R + ++ L H +L
Sbjct: 243 SAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFL 273

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (260), Expect = 2e-26
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 54/209 (25%)

Query: 36  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 95
           IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+V 
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 96  SETDFMT---------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 146
           S               +YV      +PELL        + D+W++GCI  +L+   P F 
Sbjct: 181 SPESKQARANSFVGTAQYV------SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDL 205
             +      L+ + I                +Y               FP    P A DL
Sbjct: 234 AGNE----YLIFQKI-------------IKLEY--------------DFPEKFFPKARDL 262

Query: 206 VEKMLTFDPRQRIT------VEDALAHPY 228
           VEK+L  D  +R+            AHP+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (260), Expect = 3e-26
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 41/218 (18%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
            ++++  E +     TD    I S   L+EE        +L+ L Y+H+  V+HRD+K  
Sbjct: 115 EELWVLMEFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170

Query: 75  NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           ++LL  +  +K+ DFG  A+++ +       V T ++ APE++   S Y   +D+WS+G 
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGI 229

Query: 134 IFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           + +E++D +P  P       ++    +     P       L  + K              
Sbjct: 230 MVIEMVDGEP--PYFS-DSPVQAMKRLRDSPPPK------LKNSHK-------------V 267

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +           D +E+ML  DP++R T ++ L HP+L
Sbjct: 268 SPVL-------RDFLERMLVRDPQERATAQELLDHPFL 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 5e-26
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           + +++  E       TDL +  +    L EE   Y   +ILRGL ++H   V+HRD+K  
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158

Query: 75  NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVW 129
           N+LL  N ++K+ DFG+ A++         ++ T ++ APE++       + Y    D+W
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218

Query: 130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 189
           S+G   +E+ +  P  P  D +H +R L  +   P+                  PR + +
Sbjct: 219 SLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNPA------------------PRLKSK 257

Query: 190 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            +++KF          +E  L  +  QR   E  + HP++
Sbjct: 258 KWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFI 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 5e-26
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 39/218 (17%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
            D++I  E       +D+ ++   N+ L+E+     L   L+GL+Y+H    +HRD+K  
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154

Query: 75  NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N+LLN     K+ DFG+  ++T         + T ++ APE++     Y    D+WS+G 
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGI 213

Query: 134 IFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
             +E+ + KP  P  D +H +R   +I     P+        +                +
Sbjct: 214 TAIEMAEGKP--PYAD-IHPMRAIFMIPTNPPPT------FRKPEL-------------W 251

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           ++ F        D V++ L   P QR T    L HP++
Sbjct: 252 SDNF-------TDFVKQCLVKSPEQRATATQLLQHPFV 282

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (258), Expect = 1e-25
 Identities = 47/243 (19%), Positives = 85/243 (34%), Gaps = 36/243 (14%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           N++++    M      DL         ++E    Y L  +L+ L YIH    +HR +K S
Sbjct: 99  NELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS 157

Query: 75  NLLLNANCDLKICDFGLA--------RVTSETDFMTEYVVTRWYRAPELLL-NSSDYTAA 125
           ++L++ +  + +              R     DF    V    + +PE+L  N   Y A 
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217

Query: 126 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE--------LIGTPSEAELGFLNENAK 177
            D++SVG    EL +    F     +   ++L+E        L+ T +          ++
Sbjct: 218 SDIYSVGITACELANGHVPF---KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAI-----------DLVEKMLTFDPRQRITVEDALAH 226
                       + T +  N    +              VE+ L  +P  R +    L H
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334

Query: 227 PYL 229
            + 
Sbjct: 335 SFF 337

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  102 bits (255), Expect = 1e-25
 Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 18/144 (12%)

Query: 21  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +    E +    L  II+S            F   I  G+ Y+HS N++HRDL   N L+
Sbjct: 82  LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141

Query: 79  NANCDLKICDFGLARVTSETDF---------------MTEYVVTRWYRAPELLLNSSDYT 123
             N ++ + DFGLAR+  +                      V   ++ APE++   S Y 
Sbjct: 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YD 200

Query: 124 AAIDVWSVGCIFMELMDRKPLFPG 147
             +DV+S G +  E++ R    P 
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPD 224

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  100 bits (250), Expect = 3e-25
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 15/138 (10%)

Query: 22  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN---VLHRDLKPSNLL 77
            +  E      L++++   + +  +    +  QI RG+ Y+H      ++HRDLK SN+L
Sbjct: 82  CLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140

Query: 78  LN--------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           +         +N  LKI DFGLAR    T  M+      W  APE ++ +S ++   DVW
Sbjct: 141 ILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE-VIRASMFSKGSDVW 198

Query: 130 SVGCIFMELMDRKPLFPG 147
           S G +  EL+  +  F G
Sbjct: 199 SYGVLLWELLTGEVPFRG 216

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 4e-25
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 37/254 (14%)

Query: 19  NDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +  ++  E        ++  ++  L E       +  L+GL Y+HS N++HRD+K  N+L
Sbjct: 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 78  LNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCI 134
           L+    +K+ DFG  + +     F    V T ++ APE++L      Y   +DVWS+G  
Sbjct: 187 LSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
            +EL +RKP  P   +++ +  L   I             N        P  Q   ++E 
Sbjct: 243 CIELAERKP--P-LFNMNAMSALY-HIAQ-----------NES------PALQSGHWSEY 281

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD-EPVCMSPFSFDFEQHA 253
           F        + V+  L   P+ R T E  L H ++      +    +         E   
Sbjct: 282 F-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 334

Query: 254 LTEGQMKELIYQEA 267
           L   +MK++++QEA
Sbjct: 335 LQYRKMKKILFQEA 348

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  100 bits (251), Expect = 5e-25
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 11/139 (7%)

Query: 17  SFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSAN---VLHR 69
             N V +  E  +   L+ ++   +     +  H   +  Q  +G+ Y+HS     ++HR
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 70  DLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 128
           DLKP NLLL A    LKICDFG A        MT    +  + APE +   S+Y+   DV
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE-VFEGSNYSEKCDV 186

Query: 129 WSVGCIFMELMDRKPLFPG 147
           +S G I  E++ R+  F  
Sbjct: 187 FSWGIILWEVITRRKPFDE 205

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (250), Expect = 5e-25
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 8/129 (6%)

Query: 26  ELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN 79
           E +    L++++  + A   L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173

Query: 80  ANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
               +K+CDFGL+R+ + T         T  + APE +L         DV+S G I  EL
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWEL 232

Query: 139 MDRKPLFPG 147
              +  +  
Sbjct: 233 ATLQQPWGN 241

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (250), Expect = 6e-25
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 30/212 (14%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           +++   + +    +  L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161

Query: 86  ICDFGLARVTSETDFMTE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           I DFG++   +    +T       +V T  + APE++     Y    D+WS G   +EL 
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221

Query: 140 DRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 197
                +        ++  +L      PS        E  KKY                  
Sbjct: 222 TGAAPY---HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY----------G------- 261

Query: 198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              S   ++   L  DP +R T  + L H + 
Sbjct: 262 --KSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 98.9 bits (247), Expect = 1e-24
 Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 12/132 (9%)

Query: 26  ELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--- 78
           E +   DL+  +      +        +  I  G++Y+ + N  ++HRDL+  N+ L   
Sbjct: 101 EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160

Query: 79  --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIF 135
             NA    K+ DFGL++ +  +  ++  +    + APE +    + YT   D +S   I 
Sbjct: 161 DENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218

Query: 136 MELMDRKPLFPG 147
             ++  +  F  
Sbjct: 219 YTILTGEGPFDE 230

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 48/222 (21%), Positives = 96/222 (43%), Gaps = 42/222 (18%)

Query: 19  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
             ++I  E         +  ++  ++ L+E   Q    Q+L  L ++HS  ++HRDLK  
Sbjct: 89  GKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG 146

Query: 75  NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVW 129
           N+L+    D+++ DFG+ A+          ++ T ++ APE+++      + Y    D+W
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206

Query: 130 SVGCIFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           S+G   +E+   +P  P  + ++ +R  L I     P+      L   +K          
Sbjct: 207 SLGITLIEMAQIEP--PHHE-LNPMRVLLKIAKSDPPT------LLTPSK---------- 247

Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              ++ +F        D ++  L  +P  R +    L HP++
Sbjct: 248 ---WSVEF-------RDFLKIALDKNPETRPSAAQLLEHPFV 279

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (252), Expect = 3e-24
 Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 36/210 (17%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           ++    ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++
Sbjct: 271 DIR-YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

Query: 86  ICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           I D GLA         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  
Sbjct: 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP 388

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAI 203
           F  R    + + L + +          L +                    +P    P++ 
Sbjct: 389 FRARGEKVENKELKQRV----------LEQA-----------------VTYPDKFSPASK 421

Query: 204 DLVEKMLTFDPRQRI-----TVEDALAHPY 228
           D  E +L  DP +R+     + +    HP 
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 97.4 bits (243), Expect = 8e-24
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 17/142 (11%)

Query: 22  YIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
            I   L     L+ ++R     L     +    +I++G+ Y+H+  +LH+DLK  N+  +
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164

Query: 80  ANCDLKICDFGLARVTSETDFMTEY----VVTRWYR--APELLLNSSD--------YTAA 125
            N  + I DFGL  ++             +   W    APE++   S         ++  
Sbjct: 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223

Query: 126 IDVWSVGCIFMELMDRKPLFPG 147
            DV+++G I+ EL  R+  F  
Sbjct: 224 SDVFALGTIWYELHAREWPFKT 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.1 bits (244), Expect = 8e-24
 Identities = 33/230 (14%), Positives = 63/230 (27%), Gaps = 57/230 (24%)

Query: 19  NDVYIAYELMD-TDLHQIIR-----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           N   +  EL     L   I        + + +     F  ++L  ++ +H   ++H D+K
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK 199

Query: 73  PSNLLLN-----------ANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAPELLLN 118
           P N +L             +  L + D G +   ++  +    T    T  ++  E+L N
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              +   ID + V      ++    +                            NE  + 
Sbjct: 260 KP-WNYQIDYFGVAATVYCMLFGTYMK-------------------------VKNEGGEC 293

Query: 179 YICQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                  R        +F             ML       +   D L   
Sbjct: 294 KPEGLFRRLPHLDMWNEF----------FHVMLNIPDCHHLPSLDLLRQK 333

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 97.0 bits (242), Expect = 2e-23
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 52/226 (23%)

Query: 17  SFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168

Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDV 128
           P NLL++    +++ DFG A RV   T  +    E +      APE++L+   Y  A+D 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEIILS-KGYNKAVDW 221

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           W++G +  E+    P F     +     + E I          ++               
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ----IYEKI----------VSGKV------------ 255

Query: 189 QSFTEKFP-NVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
                +FP +      DL+  +L  D  +R       V D   H +
Sbjct: 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.4 bits (245), Expect = 2e-23
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 35/204 (17%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 91  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 150
           LA   S+       V T  Y APE+L     Y ++ D +S+GC+  +L+     F     
Sbjct: 338 LACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-- 394

Query: 151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKM 209
                       T  + E+        +    +          + P +  P    L+E +
Sbjct: 395 -----------KTKDKHEI-------DRMTLTMA--------VELPDSFSPELRSLLEGL 428

Query: 210 LTFDPRQRI-----TVEDALAHPY 228
           L  D  +R+       ++    P+
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPF 452

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 94.2 bits (235), Expect = 4e-23
 Identities = 21/129 (16%), Positives = 45/129 (34%), Gaps = 11/129 (8%)

Query: 26  ELMDT-DLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNA 80
             M    L+ ++       + +     F   + RG+ ++H+    +    L   +++++ 
Sbjct: 89  HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148

Query: 81  NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMEL 138
           +   +I    +         M       W  APE L          + D+WS   +  EL
Sbjct: 149 DMTARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTNRRSADMWSFAVLLWEL 204

Query: 139 MDRKPLFPG 147
           + R+  F  
Sbjct: 205 VTREVPFAD 213

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 97.2 bits (242), Expect = 6e-23
 Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 10/167 (5%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V I + +    R      YI  E +    L +     Q L       +L +IL  L Y+
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYL 198

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HS  +++ DLKP N++L     LK+ D G     +   ++     T  ++APE++     
Sbjct: 199 HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP- 253

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 168
            T A D+++VG     L    P   G  +V  L     ++ T     
Sbjct: 254 -TVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYG 298

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 34/196 (17%)

Query: 39  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 98
                E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E 
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339

Query: 99  DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 158
             +   V T  Y APE++ N   YT + D W++GC+  E++  +  F  R    +   + 
Sbjct: 340 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

Query: 159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQR 217
            L+                               E++     P A  L  ++L  DP +R
Sbjct: 399 RLV----------KEVP-----------------EEYSERFSPQARSLCSQLLCKDPAER 431

Query: 218 I-----TVEDALAHPY 228
           +     +  +   HP 
Sbjct: 432 LGCRGGSAREVKEHPL 447

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 94.3 bits (235), Expect = 7e-23
 Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 19/128 (14%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNANCD 83
           L+  ++    L    C   +  I  GL ++H           + HRDLK  N+L+  N  
Sbjct: 93  LYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151

Query: 84  LKICDFGLARVTSETDFMTEYVV-----TRWYRAPELL-----LNSSDYTAAIDVWSVGC 133
             I D GLA + S++    +        T+ Y APE+L     ++  D    +D+W+ G 
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211

Query: 134 IFMELMDR 141
           +  E+  R
Sbjct: 212 VLWEVARR 219

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 43/205 (20%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 91  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           + +     + M     T        Y APE+LL    Y  ++D WS G +  E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 204
           F G+D       L   I            +N        PR+           +   A D
Sbjct: 218 FHGQDE----EELFHSI----------RMDNPF-----YPRW-----------LEKEAKD 247

Query: 205 LVEKMLTFDPRQRI-TVEDALAHPY 228
           L+ K+   +P +R+    D   HP 
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPL 272

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.5 bits (233), Expect = 2e-22
 Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 31/189 (16%)

Query: 42  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 100
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+  ++T     
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175

Query: 101 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 160
              +V T ++ APE++  S  Y +  D+WS+G   +EL   +P  P  + +H +++L   
Sbjct: 176 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEP--PHSE-LHPMKVL--- 228

Query: 161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 220
                     FL          +P+    +    +        + VE  L  +P  R T 
Sbjct: 229 ----------FL----------IPKNNPPTLEGNYS---KPLKEFVEACLNKEPSFRPTA 265

Query: 221 EDALAHPYL 229
           ++ L H ++
Sbjct: 266 KELLKHKFI 274

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.1 bits (232), Expect = 3e-22
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 4/129 (3%)

Query: 22  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
           Y+   L++  DL  ++R    L+       + QI   L   H+A   HRD+KP N+L++A
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169

Query: 81  NCDLKICDFGLARVTSETDF-MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           +    + DFG+A  T++         V T +Y APE     S  T   D++++ C+  E 
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYEC 228

Query: 139 MDRKPLFPG 147
           +   P + G
Sbjct: 229 LTGSPPYQG 237

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 92.9 bits (231), Expect = 4e-22
 Identities = 33/128 (25%), Positives = 49/128 (38%), Gaps = 19/128 (14%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--------VLHRDLKPSNLLLNANCD 83
           L+  ++S   L  +      Y  + GL ++H+          + HRDLK  N+L+  N  
Sbjct: 122 LYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180

Query: 84  LKICDFGLARV-----TSETDFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGC 133
             I D GLA                 V T+ Y  PE+L      N        D++S G 
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

Query: 134 IFMELMDR 141
           I  E+  R
Sbjct: 241 ILWEVARR 248

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.2 bits (230), Expect = 5e-22
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 50/225 (22%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +F D    + +MD     +L  ++R +Q       +++  ++   L+Y+HS ++++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133

Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDV 128
           P N+LL+ N  +KI DFG A  V   T  +    +Y+      APE++     Y  +ID 
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDW 186

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           WS G +  E++     F   +         E I     AEL F            P +  
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNT----MKTYEKI---LNAELRF------------PPF-- 225

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
                     +    DL+ +++T D  QR+       ED   HP+
Sbjct: 226 ---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 35/205 (17%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 92  A-RVTSETDFMTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPLF 145
             ++  +    +   V T  Y +PE+L         Y    D WS+G    E++  +  F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 205
                V         I                     +   +R  F  +  +V  +A DL
Sbjct: 282 YAESLVE----TYGKI---------------------MNHKERFQFPTQVTDVSENAKDL 316

Query: 206 VEKMLTFDPRQRITVEDAL---AHP 227
           + +++      R+          HP
Sbjct: 317 IRRLIC-SREHRLGQNGIEDFKKHP 340

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.8 bits (226), Expect = 1e-21
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 9/148 (6%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V++ D       E  +  Y+  E ++   L + I S+  LS +    F  QIL G+K+ 
Sbjct: 73  IVSMID-----VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVV-TRWYRAPELLLNS 119
           H   ++HRD+KP N+L+++N  LKI DFG+A+  SET    T +V+ T  Y +PE     
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-G 186

Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPG 147
                  D++S+G +  E++  +P F G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNG 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 91.1 bits (227), Expect = 2e-21
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 54/215 (25%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           EL      Q+ R      E+   ++L +I   L ++H   +++RDLKP N++LN    +K
Sbjct: 107 ELF----MQLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

Query: 86  ICDFGLARVTSETDFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 138
           + DFGL + +     +T       EY+      APE+L+  S +  A+D WS+G +  ++
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYM------APEILMR-SGHNRAVDWWSLGALMYDM 214

Query: 139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 198
           +   P F G +     +  I+ I          L          LP Y           +
Sbjct: 215 LTGAPPFTGENR----KKTIDKI----------LKCKLN-----LPPY-----------L 244

Query: 199 HPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
              A DL++K+L  +   R+        +  AHP+
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.7 bits (226), Expect = 2e-21
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 52/214 (24%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           EL     H  +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +K
Sbjct: 91  ELF---FH--LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145

Query: 86  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           I DFGL +     + +++    +       Y APE+L + +DY  A+D W +G +  E+M
Sbjct: 146 ITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
             +  F  +DH      L ELI          L E  +      PR            + 
Sbjct: 200 CGRLPFYNQDH----ERLFELI----------LMEEIR-----FPRT-----------LS 229

Query: 200 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
           P A  L+  +L  DP+QR+       ++ + H +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 90.7 bits (226), Expect = 2e-21
 Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 49/198 (24%)

Query: 43  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 102
           +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

Query: 103 -------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 155
                  EY+      APE++     +T + D WS G +  E++     F G+D     +
Sbjct: 184 YSFCGTVEYM------APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----K 232

Query: 156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 215
             + +I          L          +P++           + P A  L+  +   +P 
Sbjct: 233 ETMTMI----------LKAKLG-----MPQF-----------LSPEAQSLLRMLFKRNPA 266

Query: 216 QRI-----TVEDALAHPY 228
            R+      VE+   H +
Sbjct: 267 NRLGAGPDGVEEIKRHSF 284

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 37/208 (17%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 91
           L  + +  + +  E  +++L +I+  +  +H    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 92  A-RVTSETDFMTEYVV-TRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMDRKP 143
             ++ ++    +   V T  Y +PE+L        +  Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 203
            F               I                     +   +  S       V   A 
Sbjct: 269 PFYADSTAE----TYGKI---------------------VHYKEHLSLPLVDEGVPEEAR 303

Query: 204 DLVEKMLTFDPRQRITVEDAL---AHPY 228
           D ++++L   P  R+    A     HP+
Sbjct: 304 DFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 53/215 (24%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           +LM      I +S +   E   +++  +I+  L ++H   +++RDLK  N+LL+     K
Sbjct: 110 DLM----FHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

Query: 86  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           + DFG+ +     + +   V T        Y APE+L     Y  A+D W++G +  E++
Sbjct: 165 LADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
                F   +       L E I          LN+         P +           +H
Sbjct: 219 CGHAPFEAENE----DDLFEAI----------LNDEVV-----YPTW-----------LH 248

Query: 200 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 228
             A  +++  +T +P  R+           L HP+
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.0 bits (224), Expect = 5e-21
 Identities = 45/211 (21%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           EL       + +  +  +E   Q ++ +I+  L+++H   +++RD+K  N+LL++N  + 
Sbjct: 145 ELF----THLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199

Query: 86  ICDFGLAR--VTSETDFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRK 142
           + DFGL++  V  ET+   ++  T  Y AP+++    S +  A+D WS+G +  EL+   
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA 202
             F      +    +   I    ++E  +            P+            +   A
Sbjct: 260 SPFTVDGEKNSQAEISRRI---LKSEPPY------------PQE-----------MSALA 293

Query: 203 IDLVEKMLTFDPRQRI-----TVEDALAHPY 228
            DL++++L  DP++R+       ++   H +
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 89.1 bits (221), Expect = 9e-21
 Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 19/128 (14%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNANCD 83
           L   +     ++ E           GL ++H           + HRDLK  N+L+  N  
Sbjct: 127 LFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185

Query: 84  LKICDFGLARVTSETDFMTEYVV-----TRWYRAPELLLNSS-----DYTAAIDVWSVGC 133
             I D GLA          +        T+ Y APE+L +S      +     D++++G 
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

Query: 134 IFMELMDR 141
           +F E+  R
Sbjct: 246 VFWEIARR 253

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.2 bits (222), Expect = 9e-21
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 52/214 (24%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           +LM    + I +  +   E H  ++  +I  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 107 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

Query: 86  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           I DFG+ +     + + + V T+       Y APE++     Y  ++D W+ G +  E++
Sbjct: 162 IADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 215

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
             +  F G D       L + I          +  N        P+            + 
Sbjct: 216 AGQAPFEGEDE----DELFQSI----------MEHNVA-----YPKS-----------MS 245

Query: 200 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
             A+ + + ++T  P +R+        D   H +
Sbjct: 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 6/132 (4%)

Query: 21  VYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
            YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150

Query: 80  ANCDLKICDFGLAR-VTSETDFMTE--YVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           A   +K+ DFG+AR +    + +T+   V+ T  Y +PE         A  DV+S+GC+ 
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVL 209

Query: 136 MELMDRKPLFPG 147
            E++  +P F G
Sbjct: 210 YEVLTGEPPFTG 221

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 88.6 bits (220), Expect = 1e-20
 Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 18/155 (11%)

Query: 32  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA----------NVLHRDLKPSNLLLNAN 81
           L   +++N  +S     +    + RGL Y+H             + HRD+K  N+LL  N
Sbjct: 109 LSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

Query: 82  CDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCI 134
               I DFGLA               V TR Y APE+L        D    ID++++G +
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 169
             EL  R     G    + L    E+   PS  ++
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 43/210 (20%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDL 84
           EL     H  +   +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +
Sbjct: 234 ELF---FH--LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288

Query: 85  KICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 143
           KI DFGL +    +   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  + 
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 203
            F  +DH      L ELI          L E  +      PR            + P A 
Sbjct: 348 PFYNQDH----EKLFELI----------LMEEIR-----FPRT-----------LGPEAK 377

Query: 204 DLVEKMLTFDPRQRI-----TVEDALAHPY 228
            L+  +L  DP+QR+       ++ + H +
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 51/213 (23%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           EL     H  ++  +   E   +++  +I   L Y+HS N+++RDLKP N+LL++   + 
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179

Query: 86  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           + DFGL +     + +     T        Y APE+L     Y   +D W +G +  E++
Sbjct: 180 LTDFGLCK-----ENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
              P F  R+       + + I          LN+  +     L              + 
Sbjct: 234 YGLPPFYSRNT----AEMYDNI----------LNKPLQ-----LKPN-----------IT 263

Query: 200 PSAIDLVEKMLTFDPRQRI----TVEDALAHPY 228
            SA  L+E +L  D  +R+       +  +H +
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 52/214 (24%)

Query: 26  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 85
           +LM    + I +  +   E H  ++  +I  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 428 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482

Query: 86  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           I DFG+ +     + + + V T+       Y APE++     Y  ++D W+ G +  E++
Sbjct: 483 IADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 536

Query: 140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
             +  F G D       L + I          +  N        P+            + 
Sbjct: 537 AGQAPFEGEDE----DELFQSI----------MEHNVA-----YPKS-----------MS 566

Query: 200 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 228
             A+ + + ++T  P +R+        D   H +
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 6e-20
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 17  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +F D    Y +M+     DL  ++  N  + E+  +++  +++  L  IHS   +HRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 73  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVV-TRWYRAPELLLN---SSDYTAAID 127
           P N+LL+ +  LK+ DFG   ++  E     +  V T  Y +PE+L +      Y    D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 128 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
            WSVG    E+                     L+G        F  ++      ++  ++
Sbjct: 256 WWSVGVFLYEM---------------------LVGDTP-----FYADSLVGTYSKIMNHK 289

Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHP 227
                    ++   A +L+   LT D   R+    VE+   H 
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHL 331

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.5 bits (215), Expect = 7e-20
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 91  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           + +     + +     T        Y APE+L    DY  ++D W++G +  E+M  +  
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 145 FPGRDHVHQLR-----LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
           F                L ++I          L +  +     +PR            + 
Sbjct: 210 FDIVGSSDNPDQNTEDYLFQVI----------LEKQIR-----IPRS-----------LS 243

Query: 200 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 228
             A  +++  L  DP++R+         D   HP+
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 31  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 90
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 91  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 144
           + +     + +     T        Y APE+L    DY  ++D W++G +  E+M  +  
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 145 FPGRDHVHQLR-----LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 199
           F                L ++I          L +  +     +PR            + 
Sbjct: 253 FDIVGSSDNPDQNTEDYLFQVI----------LEKQIR-----IPRS-----------LS 286

Query: 200 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 228
             A  +++  L  DP++R+         D   HP+
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 12/127 (9%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
             +  E+ +   L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL 
Sbjct: 92  WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 151

Query: 80  ANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 132
                KI DFGL++     +    Y          +WY APE  +N   +++  DVWS G
Sbjct: 152 TQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFG 207

Query: 133 CIFMELM 139
            +  E  
Sbjct: 208 VLMWEAF 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  EL     L   +R +Q          +  Q+  G+ Y+ S   +HRDL   NLLL
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
                +KI DFGL R   + D    YV+         W  APE  L +  ++ A D W  
Sbjct: 155 ATRDLVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWC-APE-SLKTRTFSHASDTWMF 210

Query: 132 GCIFMELM 139
           G    E+ 
Sbjct: 211 GVTLWEMF 218

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V +  +LM    L   +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
                +KI DFGLA++    +   EY         +W  A E  +    YT   DVWS G
Sbjct: 151 KTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYG 206

Query: 133 CIFMELM 139
               ELM
Sbjct: 207 VTVWELM 213

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E +    L   ++ ++  +       +  QI +G++Y+ +   +HRDL   N+L+
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
                +KI DFGL +V  +      + V         WY APE L  S  ++ A DVWS 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIFWY-APESLTESK-FSVASDVWSF 203

Query: 132 GCIFMELM 139
           G +  EL 
Sbjct: 204 GVVLYELF 211

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E + +  L   ++ ++A L       +  QI +G++Y+ S   +HRDL   N+L+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
            +   +KI DFGLA++         YVV         WY APE L ++  ++   DVWS 
Sbjct: 161 ESEAHVKIADFGLAKLLPLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSF 216

Query: 132 GCIFMELM 139
           G +  EL 
Sbjct: 217 GVVLYELF 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E +    L   ++ ++  +       +  QI +G++Y+ +   +HRDL   N+L+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
                +KI DFGL +V  +      Y V         WY APE L  S  ++ A DVWS 
Sbjct: 179 ENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-APESLTESK-FSVASDVWSF 234

Query: 132 GCIFMELM 139
           G +  EL 
Sbjct: 235 GVVLYELF 242

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.7 bits (200), Expect = 4e-18
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 18/138 (13%)

Query: 21  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  E +    L   +RS+ + L         Y +  G+ ++ S   +HRDL   N L+
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
           + +  +K+ DFG+ R   +     +YV +       +W  APE+      Y++  DVW+ 
Sbjct: 138 DRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APEVFHYFK-YSSKSDVWAF 191

Query: 132 GCIFMELMD--RKPLFPG 147
           G +  E+    + P +  
Sbjct: 192 GILMWEVFSLGKMP-YDL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.7 bits (200), Expect = 5e-18
 Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 6/122 (4%)

Query: 21  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   +RS     L  +    F   +   ++Y+   N +HRDL   N+L
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           ++ +   K+ DFGL +  S T    +  V +W  APE L     ++   DVWS G +  E
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFGILLWE 206

Query: 138 LM 139
           + 
Sbjct: 207 IY 208

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 80.8 bits (200), Expect = 6e-18
 Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E + +  L + +  N+  ++ +    +  QI +G+ Y+ S   +HRDL   N+L+
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
            +   +KI DFGL +          Y V         WY APE L+ S  +  A DVWS 
Sbjct: 160 ESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY-APECLMQSK-FYIASDVWSF 215

Query: 132 GCIFMELM 139
           G    EL+
Sbjct: 216 GVTLHELL 223

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.0 bits (200), Expect = 6e-18
 Identities = 47/245 (19%), Positives = 89/245 (36%), Gaps = 42/245 (17%)

Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSA---------NVLHRDLKPSNLLLNANCDLKICD 88
           S             + + RGL Y+H+           + HRDL   N+L+  +    I D
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 89  FGLARVTSETDF---------MTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGC 133
           FGL+   +                 V T  Y APE+L  +            +D++++G 
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN--ENAKKYICQLPRYQRQSF 191
           I+ E+  R       + V + ++         + E+G     E+ +  + +    QR  F
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQM-------AFQTEVGNHPTFEDMQVLVSR--EKQRPKF 274

Query: 192 TEKFPNVHPSAIDLVEKMLTF----DPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSF 247
            E +   +  A+  +++ +      D   R+T + A     +  L  I +    +SP + 
Sbjct: 275 PEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEE--RMAELMMIWERNKSVSPTAH 331

Query: 248 DFEQH 252
               H
Sbjct: 332 HHHHH 336

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.4 bits (199), Expect = 8e-18
 Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E+     LH+ +   +  +   +    L+Q+  G+KY+   N +HRDL   N+LL
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 143

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
                 KI DFGL++     D  + Y          +WY APE  +N   +++  DVWS 
Sbjct: 144 VNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSY 199

Query: 132 GCIFMELM 139
           G    E +
Sbjct: 200 GVTMWEAL 207

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.6 bits (197), Expect = 9e-18
 Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 15/128 (11%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E M+   L   +R+ +   + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
             N  +K+ DFG+ R   +     +Y  +       +W  +PE+   S  Y++  DVWS 
Sbjct: 138 GENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPEVFSFSR-YSSKSDVWSF 191

Query: 132 GCIFMELM 139
           G +  E+ 
Sbjct: 192 GVLMWEVF 199

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 81.1 bits (201), Expect = 9e-18
 Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 21  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           +YI  EL+   D    +R+    L  +     +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT----RWYRAPELLLNSSDYTAAIDVWSVGCI 134
                LKI DFG++R  ++  +     +     +W  APE L     Y++  DVWS G +
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSESDVWSFGIL 304

Query: 135 FMELM 139
             E  
Sbjct: 305 LWETF 309

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 21  VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   ++    + L          QI  G+ Y+   N +HRDL+ +N+L
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 134
           +  N   K+ DFGLAR+  + ++          +W  APE       +T   DVWS G +
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGIL 453

Query: 135 FMELM 139
             EL 
Sbjct: 454 LTELT 458

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 21  VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   ++    + L          QI  G+ Y+   N +HRDL+ +N+L
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 134
           +  N   K+ DFGLAR+  + ++          +W  APE       +T   DVWS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGIL 370

Query: 135 FMELM 139
             EL 
Sbjct: 371 LTELT 375

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 79.6 bits (197), Expect = 1e-17
 Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V+I  EL    +L   ++  +  L       + YQ+   L Y+ S   +HRD+   N+L+
Sbjct: 90  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 149

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
           ++N  +K+ DFGL+R   ++     Y          +W  APE  +N   +T+A DVW  
Sbjct: 150 SSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMF 203

Query: 132 GCIFMELM 139
           G    E++
Sbjct: 204 GVCMWEIL 211

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 80.1 bits (198), Expect = 2e-17
 Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 14/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  + +    L   +R ++  L  +    +  QI +G+ Y+    ++HR+L   N+LL
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
            +   +++ DFG+A +    D   + ++        +W  A E +     YT   DVWS 
Sbjct: 149 KSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWM-ALESIHFGK-YTHQSDVWSY 203

Query: 132 GCIFMELM 139
           G    ELM
Sbjct: 204 GVTVWELM 211

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 41/139 (29%), Positives = 61/139 (43%), Gaps = 19/139 (13%)

Query: 21  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
            YI  E M   +L   +R    Q +S     Y   QI   ++Y+   N +HRDL   N L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 130
           +  N  +K+ DFGL+R+    D    Y          +W  APE L  +  ++   DVW+
Sbjct: 144 VGENHLVKVADFGLSRLM-TGD---TYTAHAGAKFPIKWT-APESLAYNK-FSIKSDVWA 197

Query: 131 VGCIFMELMD--RKPLFPG 147
            G +  E+      P +PG
Sbjct: 198 FGVLLWEIATYGMSP-YPG 215

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 6/127 (4%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           E    +YI  E M    L   +RS     L  +    F   +   ++Y+   N +HRDL 
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
             N+L++ +   K+ DFGL +  S T    +  V +W  APE L     ++   DVWS G
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFG 373

Query: 133 CIFMELM 139
            +  E+ 
Sbjct: 374 ILLWEIY 380

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.8 bits (195), Expect = 2e-17
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 15/128 (11%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           ++I  E M    L   +R  +     +        +   ++Y+ S   LHRDL   N L+
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
           N    +K+ DFGL+R   +     EY  +       RW   PE+L+ S  +++  D+W+ 
Sbjct: 154 NDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLMYSK-FSSKSDIWAF 207

Query: 132 GCIFMELM 139
           G +  E+ 
Sbjct: 208 GVLMWEIY 215

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 36/129 (27%), Positives = 57/129 (44%), Gaps = 16/129 (12%)

Query: 21  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
            YI  E M   +L   +R    Q +S     Y   QI   ++Y+   N +HR+L   N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 130
           +  N  +K+ DFGL+R+ +       Y          +W  APE  L  + ++   DVW+
Sbjct: 351 VGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWA 404

Query: 131 VGCIFMELM 139
            G +  E+ 
Sbjct: 405 FGVLLWEIA 413

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + +  E+     LH+ +   +  +   +    L+Q+  G+KY+   N +HR+L   N+LL
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
                 KI DFGL++     D  + Y          +WY APE  +N   +++  DVWS 
Sbjct: 470 VNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSY 525

Query: 132 GCIFMELM 139
           G    E +
Sbjct: 526 GVTMWEAL 533

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.9 bits (195), Expect = 4e-17
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V +  +LM    L   +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
                +KI DFGLA++    +   EY         +W  A E  +    YT   DVWS G
Sbjct: 151 KTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYG 206

Query: 133 CIFMELM 139
               ELM
Sbjct: 207 VTVWELM 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 43/129 (33%), Positives = 63/129 (48%), Gaps = 16/129 (12%)

Query: 21  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M    L   ++S+            F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 130
           ++A+   KI DFGLARV  +     EY          +W  APE +   S +T   DVWS
Sbjct: 317 VSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWT-APEAINFGS-FTIKSDVWS 370

Query: 131 VGCIFMELM 139
            G + ME++
Sbjct: 371 FGILLMEIV 379

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.1 bits (193), Expect = 6e-17
 Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 13/127 (10%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 79
           + +  E +    L   +  +  +       F  QI  G+ Y+H+ + +HRDL   N+LL+
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168

Query: 80  ANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 132
            +  +KI DFGLA+   E      Y V         WY APE L     +  A DVWS G
Sbjct: 169 NDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-APECLKEYK-FYYASDVWSFG 224

Query: 133 CIFMELM 139
               EL+
Sbjct: 225 VTLYELL 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 44/127 (34%), Positives = 63/127 (49%), Gaps = 11/127 (8%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           + I  E M+   L + +R      S       L  I  G+KY+ + N +HRDL   N+L+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           N+N   K+ DFGL+RV  E D    Y  +      RW  APE +     +T+A DVWS G
Sbjct: 181 NSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT-APEAISYRK-FTSASDVWSFG 237

Query: 133 CIFMELM 139
            +  E+M
Sbjct: 238 IVMWEVM 244

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.6 bits (192), Expect = 7e-17
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 8/125 (6%)

Query: 21  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +YI  E M+   L   +++     L+         QI  G+ +I   N +HRDL+ +N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           ++     KI DFGLAR+  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-APE-AINYGTFTIKSDVWSFGIL 199

Query: 135 FMELM 139
             E++
Sbjct: 200 LTEIV 204

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.6 bits (192), Expect = 7e-17
 Identities = 34/128 (26%), Positives = 57/128 (44%), Gaps = 15/128 (11%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            +I  EL    +L   +  N+  L       +  QI + + Y+ S N +HRD+   N+L+
Sbjct: 87  TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV 146

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
            +   +K+ DFGL+R   + D    Y          +W  +PE  +N   +T A DVW  
Sbjct: 147 ASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMF 200

Query: 132 GCIFMELM 139
                E++
Sbjct: 201 AVCMWEIL 208

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 43/127 (33%), Positives = 60/127 (47%), Gaps = 11/127 (8%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V I  E M+   L   +R + A  +       L  I  G+KY+     +HRDL   N+L+
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           N+N   K+ DFGL RV  E D    Y         RW  +PE  +    +T+A DVWS G
Sbjct: 181 NSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWT-SPE-AIAYRKFTSASDVWSYG 237

Query: 133 CIFMELM 139
            +  E+M
Sbjct: 238 IVLWEVM 244

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
           V+I  EL    +L   ++  +  L       + YQ+   L Y+ S   +HRD+   N+L+
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 131
           ++N  +K+ DFGL+R   ++     Y          +W  APE  +N   +T+A DVW  
Sbjct: 525 SSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMF 578

Query: 132 GCIFMELM 139
           G    E++
Sbjct: 579 GVCMWEIL 586

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 16/142 (11%)

Query: 21  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
             +  E +    L   ++ N+  ++         Q+   + ++    ++H ++   N+LL
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146

Query: 79  NANCDL--------KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
               D         K+ D G++      D + E +   W   PE + N  +   A D WS
Sbjct: 147 IREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPECIENPKNLNLATDKWS 203

Query: 131 VGCIFMELMD--RKPLFPGRDH 150
            G    E+     KP     D 
Sbjct: 204 FGTTLWEICSGGDKP-LSALDS 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 11/127 (8%)

Query: 21  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
             I  E M+   L   +R++    +       L  +  G++Y+     +HRDL   N+L+
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           ++N   K+ DFGL+RV  E D    Y  T      RW  APE  +    +++A DVWS G
Sbjct: 185 DSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFG 241

Query: 133 CIFMELM 139
            +  E++
Sbjct: 242 VVMWEVL 248

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.5 bits (189), Expect = 2e-16
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)

Query: 21  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
            ++    M   DL Q IRS  +  + +    F  Q+ RG++Y+     +HRDL   N +L
Sbjct: 98  PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           + +  +K+ DFGLAR   + ++ +           +W  A E L     +T   DVWS G
Sbjct: 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQTYR-FTTKSDVWSFG 215

Query: 133 CIFMELMD--RKPLFPGRDHVHQLRLLIE 159
            +  EL+     P +   D       L +
Sbjct: 216 VLLWELLTRGAPP-YRHIDPFDLTHFLAQ 243

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.7 bits (186), Expect = 6e-16
 Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 12/122 (9%)

Query: 25  YELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 84
              ++ +          L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 85  KICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFME 137
           KICDFGLAR   +     +YV         +W  APE + +   YT   DVWS G +  E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 138 LM 139
           + 
Sbjct: 288 IF 289

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 73.8 bits (182), Expect = 2e-15
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 21  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
             +    M   DL   IR+     + +    F  Q+ +G+KY+ S   +HRDL   N +L
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           +    +K+ DFGLAR   + ++ + +  T      +W  A E L     +T   DVWS G
Sbjct: 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFG 219

Query: 133 CIFMELMDR--KPLFPGRDHVHQLRLLIE 159
            +  ELM R   P +P  +       L++
Sbjct: 220 VLLWELMTRGAPP-YPDVNTFDITVYLLQ 247

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 21  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 78
             +    M   DL   IR+     + +    F  Q+ +G+K++ S   +HRDL   N +L
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225

Query: 79  NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 132
           +    +K+ DFGLAR   + +F + +  T      +W  A E L     +T   DVWS G
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFG 283

Query: 133 CIFMELMDR--KPLFPGRDHVHQLRLLIE 159
            +  ELM R   P +P  +       L++
Sbjct: 284 VLLWELMTRGAPP-YPDVNTFDITVYLLQ 311

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.1 bits (180), Expect = 3e-15
 Identities = 42/109 (38%), Positives = 51/109 (46%), Gaps = 12/109 (11%)

Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 97
              AL  E    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 98  TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                 YVV        +W  APE + N   YT   DVWS G    EL 
Sbjct: 198 DS---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELF 241

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 72.6 bits (179), Expect = 5e-15
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 10/100 (10%)

Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-----Y 110
            G+ ++H  + +HRD+K +N+LL+     KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 111 RAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD 149
            APE L    + T   D++S G + +E++     +   R+
Sbjct: 202 MAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.7 bits (179), Expect = 6e-15
 Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 12/114 (10%)

Query: 33  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 92
                +N   S     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 93  RVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
           R          Y+V        +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 212 RDIMNDS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIF 260

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 72.0 bits (177), Expect = 8e-15
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 22/161 (13%)

Query: 15  RESFNDVYIAYELMDT-DLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVL 67
           +       +    M   DLH  + ++        L  +    F+  I  G++Y+ S N +
Sbjct: 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159

Query: 68  HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSS 120
           HRDL   N +L  +  + + DFGL+R     D    Y          +W  A E L ++ 
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPVKWL-ALESLADNL 215

Query: 121 DYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 159
            YT   DVW+ G    E+M R   P + G ++      LI 
Sbjct: 216 -YTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLIG 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 71.9 bits (177), Expect = 9e-15
 Identities = 38/154 (24%), Positives = 63/154 (40%), Gaps = 22/154 (14%)

Query: 22  YIAYELMDT-DLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
            +    M   DLH  +  +      + +  +    F+  I  G++Y+ + N LHRDL   
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAID 127
           N +L  +  + + DFGL++     D    Y          +W  A E L +   YT+  D
Sbjct: 177 NCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAKMPVKWI-AIESLADRV-YTSKSD 231

Query: 128 VWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 159
           VW+ G    E+  R   P +PG  +      L+ 
Sbjct: 232 VWAFGVTMWEIATRGMTP-YPGVQNHEMYDYLLH 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 12/109 (11%)

Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 97
               L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 98  TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 12/109 (11%)

Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 97
               L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 98  TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                 YVV        +W  APE L     YT   DVWS G +  E+ 
Sbjct: 225 DS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIF 268

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 23/137 (16%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------YFLYQILRGLKYIHSANVLHR 69
             +  ELM   DL   +RS +     +                +I  G+ Y+++   +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162

Query: 70  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 122
           DL   N ++  +  +KI DFG+ R   ETD+   Y          RW  +PE L +   +
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKDGV-F 217

Query: 123 TAAIDVWSVGCIFMELM 139
           T   DVWS G +  E+ 
Sbjct: 218 TTYSDVWSFGVVLWEIA 234

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.5 bits (173), Expect = 4e-14
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 21  VYIAYELMDT-DLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS 63
           +Y+  E     +L + +R+                 + ++ +      YQ+ RG++Y+ S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 64  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 116
              +HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 277

Query: 117 LNSSDYTAAIDVWSVGCIFMELM 139
            +   YT   DVWS G +  E+ 
Sbjct: 278 FDRV-YTHQSDVWSFGVLMWEIF 299

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 69.5 bits (171), Expect = 5e-14
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 29/143 (20%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 63
           + + +      DLH+ +      S+                    + + QI  G++Y+ S
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 64  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 116
            +V+H+DL   N+L+    ++KI D GL R     D    Y +        RW  APE +
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAI 202

Query: 117 LNSSDYTAAIDVWSVGCIFMELM 139
           +    ++   D+WS G +  E+ 
Sbjct: 203 MYGK-FSIDSDIWSYGVVLWEVF 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.6 bits (171), Expect = 7e-14
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 21  VYIAYELMDT-DLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS 63
           +Y+  E     +L + +R+                 + ++ +      YQ+ RG++Y+ S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 64  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 116
              +HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 231

Query: 117 LNSSDYTAAIDVWSVGCIFMELM 139
            +   YT   DVWS G +  E+ 
Sbjct: 232 FDRV-YTHQSDVWSFGVLMWEIF 253

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 69.7 bits (171), Expect = 7e-14
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT- 107
              YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D    Y  T 
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YYKKTT 251

Query: 108 ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
                 +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 252 NGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIF 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.8 bits (169), Expect = 8e-14
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 29/143 (20%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 63
           + + +E M   DL++ +R++   +                     +   QI  G+ Y+ S
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 64  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 116
            + +HRDL   N L+ AN  +KI DFG++R    TD+   Y V        RW   PE +
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWM-PPESI 207

Query: 117 LNSSDYTAAIDVWSVGCIFMELM 139
           +    +T   DVWS G I  E+ 
Sbjct: 208 MYRK-FTTESDVWSFGVILWEIF 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 28/142 (19%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQ---------------YFLYQILRGLKYIHSA 64
           + + +E M   DL++ +RS+   ++                       Q+  G+ Y+   
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 65  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLL 117
           + +HRDL   N L+     +KI DFG++R    TD+   Y V        RW   PE +L
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPESIL 233

Query: 118 NSSDYTAAIDVWSVGCIFMELM 139
               +T   DVWS G +  E+ 
Sbjct: 234 YRK-FTTESDVWSFGVVLWEIF 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 38  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 97
             +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 98  TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 139
            D    YV         +W  A E L +   YT   DVWS G +  E++
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 56  RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW--- 109
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++    D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 110 --YRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIE 159
             + APE L  +   +   DV+  G + +EL+  ++     R       +L++
Sbjct: 199 IGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.1 bits (167), Expect = 2e-13
 Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 32/143 (22%)

Query: 21  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 63
           +Y+A E     +L   +R ++ L  +                   +F   + RG+ Y+  
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 64  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 116
              +HRDL   N+L+  N   KI DFGL+R     +    YV         RW  A E L
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLSR---GQE---VYVKKTMGRLPVRWM-AIESL 213

Query: 117 LNSSDYTAAIDVWSVGCIFMELM 139
             S  YT   DVWS G +  E++
Sbjct: 214 NYSV-YTTNSDVWSYGVLLWEIV 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 67.2 bits (165), Expect = 4e-13
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 19/106 (17%)

Query: 56  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-----Y 110
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 111 RAPE-----LLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDH 150
             PE      L   S      DV+S G +  E++  R  +      
Sbjct: 208 IDPEYFIKGRLTEKS------DVYSFGVVLFEVLCARSAIVQSLPR 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 66.6 bits (163), Expect = 7e-13
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 21  VYIAYELMDT-DLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
            +I  ELM   DL   +R          +L+     +    I  G +Y+   + +HRD+ 
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167

Query: 73  PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 122
             N LL         KI DFG+AR      +   Y          +W   PE  +    +
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFMEGI-F 222

Query: 123 TAAIDVWSVGCIFMELM 139
           T+  D WS G +  E+ 
Sbjct: 223 TSKTDTWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 21  VYIAYELMDT-DLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
            +I  ELM   DL   +R          +L+     +    I  G +Y+   + +HRD+ 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208

Query: 73  PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 122
             N LL         KI DFG+AR      +   Y          +W   PE  +    +
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWM-PPEAFMEGI-F 263

Query: 123 TAAIDVWSVGCIFMELM 139
           T+  D WS G +  E+ 
Sbjct: 264 TSKTDTWSFGVLLWEIF 280

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 2e-12
 Identities = 36/227 (15%), Positives = 69/227 (30%), Gaps = 27/227 (11%)

Query: 11  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHR 69
             P     + ++I  E     +       +  S    +  L+Q+   L    ++    HR
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186

Query: 70  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 129
           DL   N+LL      K+      + ++                  L ++  DYT +    
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLER 233

Query: 130 SVGCIFMELMDRKPLFPGRDHVHQL---RLLIELIGTPSEAELGFLNENAKKYICQ---- 182
               +F ++   + LF G D  +Q    RL+ +           + N     Y+      
Sbjct: 234 DGIVVFCDVSMDEDLFTG-DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292

Query: 183 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              ++ +  T     +     +    ML F      +  D L    L
Sbjct: 293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 29/91 (31%), Positives = 39/91 (42%), Gaps = 12/91 (13%)

Query: 49  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT- 107
               Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D    Y    
Sbjct: 178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADG 234

Query: 108 ------RWYRAPELLLNSSDYTAAIDVWSVG 132
                 RW   PE +  +  YT   DVW+ G
Sbjct: 235 NDAIPIRWM-PPESIFYNR-YTTESDVWAYG 263

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.5 bits (152), Expect = 1e-11
 Identities = 23/217 (10%), Positives = 51/217 (23%), Gaps = 60/217 (27%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V  + D++      +     +  E +    L ++  +  + S       +  +       
Sbjct: 93  VARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAA 145

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H A V      PS + ++ + D+ +                                  D
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPATM---------------------------PD 178

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI-ELIGTPSEAELGFLNENAKKYI 180
                D+  +G     L+  +   P       L     +  G P E              
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-------------- 224

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
              P            ++      +  + +  D   R
Sbjct: 225 ---PADID-------RDIPFQISAVAARSVQGDGGIR 251

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 7e-10
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 2/74 (2%)

Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-A 80
           ++  E +  DL +I   N    +        ++L  L+YIH    +H D+K +NLLL   
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 81  NCD-LKICDFGLAR 93
           N D + + D+GL+ 
Sbjct: 188 NPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLN-ANCD-LKICDFGLAR 93
           +IL  L+YIH    +H D+K SNLLLN  N D + + D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 16/46 (34%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKIC---DFGLAR 93
           Q++  ++Y+HS N+++RD+KP N L+    N   ++    DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 11/72 (15%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 26  ELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD 83
             +   L   +  +    LSE        ++L  L+++H    +H ++   N+ ++    
Sbjct: 138 PSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197

Query: 84  LKI--CDFGLAR 93
            ++    +G A 
Sbjct: 198 SQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.5 bits (116), Expect = 6e-07
 Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 22  YIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
            +  EL+   L  +    ++  S +       Q++  ++YIHS N +HRD+KP N L+  
Sbjct: 81  VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140

Query: 81  NCD---LKICDFGLAR 93
                 + I DFGLA+
Sbjct: 141 GKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.5 bits (116), Expect = 8e-07
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)

Query: 53  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLK-----ICDFGLAR 93
           Q+L  ++ IH  ++++RD+KP N L+            + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 21/76 (27%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 22  YIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 80
            +  +L+   L  +    ++ LS +       Q++  ++++HS + LHRD+KP N L+  
Sbjct: 79  VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 81  NCD---LKICDFGLAR 93
                 + I DFGLA+
Sbjct: 139 GRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	277
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.82
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.64
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.42
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.21
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.66
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.43
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.39
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.36
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.62
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.57
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.86
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.67
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.18
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.09
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	92.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.22
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	91.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	89.63
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.22
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	87.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	86.03
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	85.97
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.21
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	82.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.03

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-60  Score=413.39  Aligned_cols=273  Identities=51%  Similarity=0.921  Sum_probs=243.5

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.... ....+++|||||||+|+|.+++.+++.+++..++.+++||+.||+|||++||+||||||+|||++
T Consensus       113 pnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~  192 (398)
T 4b99_A          113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN  192 (398)
T ss_dssp             TTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC
Confidence            89999999997653 33447899999999999999999989999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-----CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .+|.+||+|||+++....     .....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l  272 (398)
T 4b99_A          193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL  272 (398)
T ss_dssp             TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred             CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999975432     223456789999999999877777899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+....+.|+...+... ......+....+.....++...++.+|++++|||.+||++||++|||++|+|+||||+..+
T Consensus       273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            999999999998776554 3445556667777777788889999999999999999999999999999999999999999


Q ss_pred             CCCCCCcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChh
Q 023764          234 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE  273 (277)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (277)
                      ++.+++.+..++++.++...++..+++++++.++.+|+++
T Consensus       353 ~p~~~p~~~~~~~~~~~~~~~~~~~~k~~i~~ei~~~~~~  392 (398)
T 4b99_A          353 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHAR  392 (398)
T ss_dssp             CGGGSCCCSSCCCCHHHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCccccCCCCCCCCccchhhcCHHHHHHHHHHHHHHHHHH
Confidence            9999998999999999999999999999999999998874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.3e-55  Score=362.46  Aligned_cols=196  Identities=25%  Similarity=0.492  Sum_probs=163.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ||||+++++|.++     +.+|+|||||+|+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus        73 pnIv~~~~~~~~~-----~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~  147 (275)
T 3hyh_A           73 PHIIKLYDVIKSK-----DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE  147 (275)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC
Confidence            8999999999987     89999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL  160 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  160 (277)
                      +|.+||+|||+++.........+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+...
T Consensus       148 ~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~  227 (275)
T 3hyh_A          148 HLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG  227 (275)
T ss_dssp             TCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence            99999999999987766666667899999999999976655578999999999999999999999988766655554331


Q ss_pred             hCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .  +                            .....+|+++++||++||+.||++|||++|+++||||+.
T Consensus       228 ~--~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 V--Y----------------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             C--C----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             C--C----------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            1  0                            011257899999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-53  Score=360.61  Aligned_cols=197  Identities=30%  Similarity=0.515  Sum_probs=173.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +++|||||||. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        92 pnIv~l~~~~~~~-----~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~  166 (311)
T 4aw0_A           92 PFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN  166 (311)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc
Confidence            8999999999988     89999999996 69999999989999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .+|.+||+|||+++.....   ....+.+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus       167 ~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  245 (311)
T 4aw0_A          167 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK  245 (311)
T ss_dssp             TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999876432   345567899999999999654 589999999999999999999999999887777766


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED------ALAHPYLG  230 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------ll~hp~f~  230 (277)
                      +.+..-.                              ....+|+++++||++||++||++|||++|      +++||||+
T Consensus       246 i~~~~~~------------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~  295 (311)
T 4aw0_A          246 IIKLEYD------------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE  295 (311)
T ss_dssp             HHHTCCC------------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred             HHcCCCC------------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence            6541100                              01257889999999999999999999987      58999998


Q ss_pred             CCC
Q 023764          231 SLH  233 (277)
Q Consensus       231 ~~~  233 (277)
                      ++.
T Consensus       296 ~id  298 (311)
T 4aw0_A          296 SVT  298 (311)
T ss_dssp             TCC
T ss_pred             CCC
Confidence            753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.3e-53  Score=361.26  Aligned_cols=199  Identities=25%  Similarity=0.504  Sum_probs=173.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +++|||||||+ |+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       131 pnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~  204 (346)
T 4fih_A          131 ENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT  204 (346)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC
Confidence            8999999999988     89999999997 699999876 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++..... ....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus       205 ~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~  283 (346)
T 4fih_A          205 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR  283 (346)
T ss_dssp             TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            9999999999999876543 44567899999999999854 558999999999999999999999999888777766654


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..... .                          ....+.+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       284 ~~~~~-~--------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          284 DNLPP-R--------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HSSCC-C--------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cCCCC-C--------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            32110 0                          111235789999999999999999999999999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-51  Score=365.08  Aligned_cols=275  Identities=40%  Similarity=0.782  Sum_probs=235.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.......++++|+||||++++|.+++.....+++..++.+++||+.||+|||++||+||||||+||+++.
T Consensus        85 ~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~  164 (432)
T 3n9x_A           85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ  164 (432)
T ss_dssp             TTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred             CCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC
Confidence            79999999998876556688999999999999999998888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC-----------------------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD-----------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  137 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~  137 (277)
                      ++.+||+|||+++......                       .....++|+.|+|||++.....++.++||||+||++++
T Consensus       165 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e  244 (432)
T 3n9x_A          165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE  244 (432)
T ss_dssp             TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence            9999999999998654321                       23566889999999997666779999999999999999


Q ss_pred             HHc-----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCChHhhhhh-hhhHHHHhhhCCcccC
Q 023764          138 LMD-----------RKPLFPGRD-----------------HVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQR  188 (277)
Q Consensus       138 ll~-----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  188 (277)
                      |++           |.++|.+.+                 ...++..+.+.+|.|+...+..+ ......+....+....
T Consensus       245 ll~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  324 (432)
T 3n9x_A          245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP  324 (432)
T ss_dssp             HHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred             HHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC
Confidence            997           566666654                 46789999999999999888776 4556677777777777


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCcCCCCCCcchhh-hhcCHHHHHHHHHHHH
Q 023764          189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQ-HALTEGQMKELIYQEA  267 (277)
Q Consensus       189 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  267 (277)
                      ..+...++.+++++++||++||+.||++|||++|+|+||||+.++....++.+..++...++. ..++..+++++++.|+
T Consensus       325 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  404 (432)
T 3n9x_A          325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEV  404 (432)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHH
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHH
Confidence            778888899999999999999999999999999999999999999888887776666665544 5789999999999999


Q ss_pred             HhhChhhh
Q 023764          268 LAFNPEYR  275 (277)
Q Consensus       268 ~~~~~~~~  275 (277)
                      .+|+|+.+
T Consensus       405 ~~~~~~~~  412 (432)
T 3n9x_A          405 QSFHPELV  412 (432)
T ss_dssp             HHHCTTCC
T ss_pred             HHhCcccc
Confidence            99999764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.4e-53  Score=355.58  Aligned_cols=196  Identities=23%  Similarity=0.458  Sum_probs=171.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +.+|||||||+ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus        86 pnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~  160 (304)
T 3ubd_A           86 PFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD  160 (304)
T ss_dssp             TTEECEEEEEEET-----TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc
Confidence            8999999999987     89999999997 69999999989999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++.... .....+.+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+.
T Consensus       161 ~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~  239 (304)
T 3ubd_A          161 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL  239 (304)
T ss_dssp             TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEecccccceeccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence            999999999999986543 334556789999999999865 458999999999999999999999999988877766665


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      +..  +                            .....+|+++++||++||+.||++|||     ++|+++||||+.+
T Consensus       240 ~~~--~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          240 KAK--L----------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HCC--C----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCC--C----------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            311  0                            011257899999999999999999998     5899999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6e-51  Score=365.11  Aligned_cols=275  Identities=41%  Similarity=0.804  Sum_probs=234.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.....+..+.+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       112 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  191 (458)
T 3rp9_A          112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ  191 (458)
T ss_dssp             TTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred             CCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC
Confidence            79999999998766566689999999999999999998888999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC----------------------------cccccccccccCChhhhhCCCCCCcchhHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD----------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  132 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  132 (277)
                      ++.+||+|||+++......                            .....+||+.|+|||++.....++.++||||||
T Consensus       192 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG  271 (458)
T 3rp9_A          192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG  271 (458)
T ss_dssp             TCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred             CCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHH
Confidence            9999999999997654221                            234457899999999876666799999999999


Q ss_pred             HHHHHHHc-----------CCCCCCCCC--------------------hHHHHHHHHHHhCCCChHhhhhh-hhhHHHHh
Q 023764          133 CIFMELMD-----------RKPLFPGRD--------------------HVHQLRLLIELIGTPSEAELGFL-NENAKKYI  180 (277)
Q Consensus       133 ~il~~ll~-----------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~  180 (277)
                      |++|+|++           |.++|++.+                    ..+++..+.+.+|.|+...+..+ ......+.
T Consensus       272 ~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~  351 (458)
T 3rp9_A          272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI  351 (458)
T ss_dssp             HHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHH
T ss_pred             HHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHH
Confidence            99999998           788887765                    36788999999999999888776 45566677


Q ss_pred             hhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCcCCCCCCcch-hhhhcCHHHH
Q 023764          181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF-EQHALTEGQM  259 (277)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  259 (277)
                      ...+......+...++..++++++||++||++||++|||++|+|+||||+.++....++.+..+....+ +...++..++
T Consensus       352 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~  431 (458)
T 3rp9_A          352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQL  431 (458)
T ss_dssp             TTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHH
T ss_pred             HhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHH
Confidence            777777778888899999999999999999999999999999999999999988777766655555544 3467899999


Q ss_pred             HHHHHHHHHhhChhhh
Q 023764          260 KELIYQEALAFNPEYR  275 (277)
Q Consensus       260 ~~~~~~~~~~~~~~~~  275 (277)
                      ++.++.++..|+|+..
T Consensus       432 ~~~~~~e~~~~~~~~~  447 (458)
T 3rp9_A          432 RYAFVKEIQRYHPEIQ  447 (458)
T ss_dssp             HHHHHHHHTTTCTTCC
T ss_pred             HHHHHHHHHHhCcccc
Confidence            9999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.6e-52  Score=362.49  Aligned_cols=199  Identities=25%  Similarity=0.512  Sum_probs=173.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.+.     +++|||||||+ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       208 pnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~  281 (423)
T 4fie_A          208 ENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT  281 (423)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred             CCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence            8999999999987     89999999997 699999876 5699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||++...... ......+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus       282 ~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~  360 (423)
T 4fie_A          282 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR  360 (423)
T ss_dssp             TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            9999999999999876543 44567899999999999854 558999999999999999999999999888777766654


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .... +                          .....+.+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       361 ~~~~-~--------------------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          361 DNLP-P--------------------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HSCC-C--------------------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cCCC-C--------------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            3110 0                          0122346899999999999999999999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-50  Score=353.17  Aligned_cols=270  Identities=43%  Similarity=0.830  Sum_probs=231.8

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... ...+.++|+||||++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        84 pnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~  162 (367)
T 1cm8_A           84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN  162 (367)
T ss_dssp             TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             cCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence            89999999998753 344567899999999999999987 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||+++.....  .....+|+.|+|||++.+...++.++||||+||++++|++|++||.+.+...++..+.+
T Consensus       163 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  240 (367)
T 1cm8_A          163 EDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  240 (367)
T ss_dssp             TTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999999876543  34567899999999997756789999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.|+...+..+ ......+....+......+...++..++++++||.+||+.||.+|||++++|+||||+.++++..+
T Consensus       241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~  320 (367)
T 1cm8_A          241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE  320 (367)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred             hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC
Confidence            9999999877666 455667778888888888888889999999999999999999999999999999999999988877


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChhh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  274 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (277)
                      +.+. +++..++....+.++|+++++.++++|+|..
T Consensus       321 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (367)
T 1cm8_A          321 PQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR  355 (367)
T ss_dssp             -CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred             CCCC-CCCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence            7654 6777778888999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.6e-52  Score=353.52  Aligned_cols=203  Identities=24%  Similarity=0.383  Sum_probs=171.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +.+|||||||+ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus       110 pnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~  184 (336)
T 4g3f_A          110 PRIVPLYGAVREG-----PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS  184 (336)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe
Confidence            8999999999987     89999999997 69999999888999999999999999999999999999999999999999


Q ss_pred             cCC-CeEEeeccceeeccCCC------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           80 ANC-DLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        80 ~~~-~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      .+| .+||+|||+++......      .....+||+.|||||++.+ ..|+.++||||+||++|+|++|++||.+.+...
T Consensus       185 ~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~  263 (336)
T 4g3f_A          185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP  263 (336)
T ss_dssp             TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred             CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence            998 59999999998654322      1234579999999999965 458999999999999999999999998776554


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---------
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA---------  223 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el---------  223 (277)
                      .+..+...                           ..++.+..+.+++++++||.+||++||.+|||+.|+         
T Consensus       264 ~~~~i~~~---------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          264 LCLKIASE---------------------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             CHHHHHHS---------------------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcC---------------------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            44444321                           111223446789999999999999999999999997         


Q ss_pred             ----hcCCCCCCCCCCC
Q 023764          224 ----LAHPYLGSLHDIS  236 (277)
Q Consensus       224 ----l~hp~f~~~~~~~  236 (277)
                          ++|||+...+++.
T Consensus       317 ~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          317 EVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             HTTSSCSCSSSSCCCCC
T ss_pred             hhhhccCCCcCCCCCCC
Confidence                6799999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.4e-52  Score=358.17  Aligned_cols=196  Identities=25%  Similarity=0.444  Sum_probs=170.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||+++++|.++     +.+|||||||+ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        83 pnIV~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL  157 (350)
T 4b9d_A           83 PNIVQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF  157 (350)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEE
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE
Confidence            8999999999987     89999999997 6999999754  45799999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.+|.+||+|||+++..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..
T Consensus       158 l~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~  236 (350)
T 4b9d_A          158 LTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK  236 (350)
T ss_dssp             ECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            999999999999999866543 22345689999999999865 4589999999999999999999999999888777666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +.....                             ....+.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       237 i~~~~~-----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          237 IISGSF-----------------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHcCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            654211                             1122367899999999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-51  Score=346.28  Aligned_cols=200  Identities=21%  Similarity=0.372  Sum_probs=165.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~nil   77 (277)
                      ||||+++++|.+.. .+.+.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||
T Consensus        85 pnIV~~~~~~~~~~-~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NIL  163 (290)
T 3fpq_A           85 PNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF  163 (290)
T ss_dssp             TTBCCEEEEEEEEE-TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEE
T ss_pred             CCCCcEEEEEeecc-CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhee
Confidence            89999999997531 12267999999997 699999998889999999999999999999999999  999999999999


Q ss_pred             Eec-CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++. +|.+||+|||+|+.... ....+.+||+.|||||++.+  .|+.++|||||||++|+|++|++||.+......+..
T Consensus       164 l~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~  240 (290)
T 3fpq_A          164 ITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  240 (290)
T ss_dssp             ESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             EECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH
Confidence            974 79999999999975433 34456789999999998853  489999999999999999999999987665544333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .+.....|.                           ...+..++++++||.+||+.||++|||++|+|+||||+.
T Consensus       241 ~i~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          241 RVTSGVKPA---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHTTTCCCG---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHcCCCCC---------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            222111110                           111246789999999999999999999999999999975

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-51  Score=357.95  Aligned_cols=224  Identities=29%  Similarity=0.499  Sum_probs=174.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.+.     +++|+|||||+ |+|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        80 ~nIv~l~~~~~~~-----~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~  151 (361)
T 4f9c_A           80 DNVMGVKYCFRKN-----DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN  151 (361)
T ss_dssp             TTBCCCSEEEEET-----TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             CCCceEEEEEEEC-----CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe
Confidence            8999999999987     89999999997 69999984   599999999999999999999999999999999999998


Q ss_pred             cC-CCeEEeeccceeeccCCC-----------------------------cccccccccccCChhhhhCCCCCCcchhHH
Q 023764           80 AN-CDLKICDFGLARVTSETD-----------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVW  129 (277)
Q Consensus        80 ~~-~~~~l~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  129 (277)
                      .+ +.+||+|||+|+......                             ...+.+||+.|+|||++.+...++.++|||
T Consensus       152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW  231 (361)
T 4f9c_A          152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW  231 (361)
T ss_dssp             TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred             CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence            77 799999999997543221                             123457999999999997766789999999


Q ss_pred             HHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCChHhhhhhh-------------------hhHHHHhhhCCccc--
Q 023764          130 SVGCIFMELMDRKPLFP-GRDHVHQLRLLIELIGTPSEAELGFLN-------------------ENAKKYICQLPRYQ--  187 (277)
Q Consensus       130 slG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~--  187 (277)
                      |+||++|+|++|++||. +.+..+++..+....|++.........                   ..........+...  
T Consensus       232 SlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~  311 (361)
T 4f9c_A          232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD  311 (361)
T ss_dssp             HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred             hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence            99999999999999984 667788899999888865443221110                   00000000001000  


Q ss_pred             ---CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          188 ---RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       188 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                         .....+.++.+|++++|||++||++||++|+||+|+|+||||+++
T Consensus       312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             ----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence               011123456789999999999999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-50  Score=355.36  Aligned_cols=272  Identities=38%  Similarity=0.731  Sum_probs=220.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++...+   ..++|+|||||+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus        69 ~niv~l~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~  144 (388)
T 3oz6_A           69 ENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA  144 (388)
T ss_dssp             TTBCCEEEEEECTT---SSCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred             CCCCeeeeEEecCC---CCEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC
Confidence            79999999997642   268999999999999999987 57999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccC----------------------CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSE----------------------TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  138 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~l  138 (277)
                      ++.+||+|||+++....                      .......+||+.|+|||++.+...++.++||||+||++++|
T Consensus       145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  224 (388)
T 3oz6_A          145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI  224 (388)
T ss_dssp             TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence            99999999999976432                      11234457999999999997766789999999999999999


Q ss_pred             HcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhh-HHHHhhhCCccc---CCcccccC-------------CCCChh
Q 023764          139 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYICQLPRYQ---RQSFTEKF-------------PNVHPS  201 (277)
Q Consensus       139 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~-------------~~~~~~  201 (277)
                      ++|++||.+.+...++..+....+.|+...+...... ...+....+...   .......+             +..+++
T Consensus       225 l~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (388)
T 3oz6_A          225 LCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE  304 (388)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHH
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHH
Confidence            9999999999999999999999999998766443211 111111111110   11111111             267899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCcCCCCCCcchh-hhhcCHHHHHHHHHHHHHhhChhhhc
Q 023764          202 AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE-QHALTEGQMKELIYQEALAFNPEYRQ  276 (277)
Q Consensus       202 ~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (277)
                      +++||++||+.||++|||++++|+||||+.++++..++.+...+...++ ....+.++++++++.++.+++++.++
T Consensus       305 ~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (388)
T 3oz6_A          305 ALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRELIS  380 (388)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhhhhhh
Confidence            9999999999999999999999999999999999888888887777665 45788999999999999999887764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.7e-50  Score=351.06  Aligned_cols=270  Identities=48%  Similarity=0.886  Sum_probs=226.1

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+..+.+|+|||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        88 pnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~  166 (367)
T 2fst_X           88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN  166 (367)
T ss_dssp             TTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC
Confidence            79999999997652 234477999999999999998876 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||+++.....  .....+|+.|+|||++.+...++.++||||+||++++|++|.+||.+.+...++..+.+
T Consensus       167 ~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          167 EDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             TTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999999765533  34567899999999987656789999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.|+...+..+ ......+....+......+...++..++++++||++||+.||++|||++++|+||||+.+.++.++
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~  324 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  324 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC
Confidence            9999999887766 445666777777777778888889999999999999999999999999999999999999988877


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChhh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  274 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (277)
                      +.+. +++...+...+..++++++++.++.+|+|..
T Consensus       325 ~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          325 PVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             CCCC-CCCGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred             CCCC-CCCcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence            7654 7778878888999999999999999998864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-49  Score=345.92  Aligned_cols=274  Identities=54%  Similarity=1.004  Sum_probs=236.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.....+....+|+||||++++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus        85 ~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~  163 (364)
T 3qyz_A           85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT  163 (364)
T ss_dssp             TTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred             CCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence            79999999998765555578999999999999999976 56999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.++|+|||++.......    ......||+.|+|||++.+...++.++||||+||++++|++|.+||.+.+..+.+..
T Consensus       164 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  243 (364)
T 3qyz_A          164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH  243 (364)
T ss_dssp             TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred             CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            9999999999998654332    234557899999999987766689999999999999999999999999999999999


Q ss_pred             HHHHhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      +....+.|+...+... ......+....+......+...++.+++++++||.+||+.||++|||++++|+||||+...++
T Consensus       244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence            9999999998877665 344555666666666667778888999999999999999999999999999999999999888


Q ss_pred             CCCCcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChhhh
Q 023764          236 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR  275 (277)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (277)
                      ..++....++.++.+...++.++++++++.++..|+|.+|
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  363 (364)
T 3qyz_A          324 SDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR  363 (364)
T ss_dssp             GGSCCCSSCCCCC-----CCHHHHHHHHHHHTGGGCC---
T ss_pred             ccccCCCCcCCcccccccCCHHHHHHHHHHHHHHhhhhcC
Confidence            8888888899998888899999999999999999999886

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.2e-50  Score=359.13  Aligned_cols=271  Identities=41%  Similarity=0.745  Sum_probs=217.7

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+..+++|+||||++++|.+.+..  .+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus       121 pnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~  198 (464)
T 3ttj_A          121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  198 (464)
T ss_dssp             TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence            89999999998754 245578999999999999888864  499999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||+++...........+||+.|+|||++.+. .++.++||||+||++++|++|++||.+.+..+++..+.+
T Consensus       199 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          199 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999999877766556677899999999999654 589999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCC------------ChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..|.|....+..+......+....+......+...++..            ++++++||++||++||++|||++|+|+||
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence            999999988888777777777777776666666665543            67899999999999999999999999999


Q ss_pred             CCCCCCCCCCCCc-CCCCCCcchhhhhcCHHHHHHHHHHHHHhhChhh
Q 023764          228 YLGSLHDISDEPV-CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  274 (277)
Q Consensus       228 ~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (277)
                      ||+.+.++.+... ....+....+....+..+++++++.+++.++...
T Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  405 (464)
T 3ttj_A          358 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKT  405 (464)
T ss_dssp             TTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC-----
T ss_pred             hhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhhcc
Confidence            9998876554322 2234555667778899999999999998876544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-47  Score=333.98  Aligned_cols=268  Identities=45%  Similarity=0.819  Sum_probs=229.5

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... ......+|+||||++++|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus       101 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~  178 (371)
T 4exu_A          101 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN  178 (371)
T ss_dssp             TTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC
Confidence            79999999998763 22233569999999999998875  4599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....+++.|+|||++.+...++.++|||||||++++|++|..||.+.+..+.+..+..
T Consensus       179 ~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  256 (371)
T 4exu_A          179 EDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  256 (371)
T ss_dssp             TTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999999999765543  34557899999999987656789999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhh-hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+....+..+. .....+....+......+...++..++++++||++||+.||.+|||++++|+||||+.+..+..+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  336 (371)
T 4exu_A          257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  336 (371)
T ss_dssp             HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccc
Confidence            99999888776653 34455666666666677777888999999999999999999999999999999999999887777


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      .....+++...+....+.+++++.++.++.+|.|
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          337 TEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             CCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             cccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            7667777777777889999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-48  Score=357.53  Aligned_cols=196  Identities=27%  Similarity=0.449  Sum_probs=169.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +++|||||||. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       252 P~IV~l~~~f~~~-----~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld  326 (689)
T 3v5w_A          252 PFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD  326 (689)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             CCEeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe
Confidence            8999999999998     99999999996 69999999989999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH---HHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH---QLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~  156 (277)
                      .+|.+||+|||+|....... ..+.+||+.|+|||++.++..|+.++|+|||||++|+|++|.+||.+.+...   ....
T Consensus       327 ~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~  405 (689)
T 3v5w_A          327 EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  405 (689)
T ss_dssp             TTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH
T ss_pred             CCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence            99999999999998765543 4567999999999999665669999999999999999999999997643221   1111


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~  231 (277)
                      +..  ..                            ....+.+|+++++||.+||+.||.+|++     ++|+++||||+.
T Consensus       406 i~~--~~----------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          406 TLT--MA----------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHH--CC----------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             hcC--CC----------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            111  00                            0112368999999999999999999998     899999999997


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      +
T Consensus       456 i  456 (689)
T 3v5w_A          456 L  456 (689)
T ss_dssp             C
T ss_pred             C
Confidence            6

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-47  Score=334.01  Aligned_cols=268  Identities=41%  Similarity=0.748  Sum_probs=211.2

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+...++|+||||++++|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        84 pniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~  161 (371)
T 2xrw_A           84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  161 (371)
T ss_dssp             TTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCccceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence            89999999998753 23446899999999999999986  4599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||++.............+++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+....+..+.+
T Consensus       162 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  240 (371)
T 2xrw_A          162 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  240 (371)
T ss_dssp             TTSCEEECCCCC----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred             CCCCEEEEEeecccccccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999987665544556789999999999865 4589999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCC------------ChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..+.|....+..+......+....+.+....+...++..            +.++++||++||+.||++|||++++|+||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            999998887776666666666666655555444444332            56799999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcCC-CCCCcchhhhhcCHHHHHHHHHHHHHhhC
Q 023764          228 YLGSLHDISDEPVCM-SPFSFDFEQHALTEGQMKELIYQEALAFN  271 (277)
Q Consensus       228 ~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (277)
                      ||+.+.++....... .......++...+.++|+++++.++..++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 2xrw_A          321 YINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE  365 (371)
T ss_dssp             HHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred             chhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence            999887654332222 22334456667899999999999998875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-47  Score=350.61  Aligned_cols=205  Identities=26%  Similarity=0.428  Sum_probs=179.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+++++|.++     +++|||||||+ |+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       214 pnIv~l~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill  288 (573)
T 3uto_A          214 PTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF  288 (573)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccc
Confidence            8999999999988     99999999996 699999864 4679999999999999999999999999999999999999


Q ss_pred             ecC--CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +.+  +.+||+|||+++...........+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus       289 ~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~  367 (573)
T 3uto_A          289 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN  367 (573)
T ss_dssp             SSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             cCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            754  8999999999998877766777899999999999865 4589999999999999999999999999888877766


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      +......++                          ...++.+|+++++||++||+.||.+|||++|+|+||||+....+.
T Consensus       368 i~~~~~~~~--------------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          368 VKSCDWNMD--------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHTTCCCCC--------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            654222111                          123457899999999999999999999999999999999876544


Q ss_pred             C
Q 023764          237 D  237 (277)
Q Consensus       237 ~  237 (277)
                      .
T Consensus       422 ~  422 (573)
T 3uto_A          422 R  422 (573)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=326.67  Aligned_cols=268  Identities=45%  Similarity=0.817  Sum_probs=226.7

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .....++|+||||++++|.+++.  ..+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        83 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~  160 (353)
T 3coi_A           83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN  160 (353)
T ss_dssp             TTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred             CCcccHhheEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC
Confidence            79999999998752 12224579999999999988875  3599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++......  .....+++.|+|||++.+...++.++||||+||++++|++|..||.+.+..+.+..+.+
T Consensus       161 ~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~  238 (353)
T 3coi_A          161 EDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  238 (353)
T ss_dssp             TTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred             CCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999998765433  33457899999999987656689999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhh-hhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.++...+..+. .....+....+......+....+..++++++||.+||+.||.+|||++++++||||+.+..+..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence            99999887766653 33445556666666666777778899999999999999999999999999999999998877766


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +....+++...+...++.+++++.++.++.+|.|
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          319 TEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             CCCSSCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             ccCCCCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            6666777777778889999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2e-46  Score=319.63  Aligned_cols=228  Identities=37%  Similarity=0.727  Sum_probs=194.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++++|.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        79 p~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~  153 (311)
T 3niz_A           79 PNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN  153 (311)
T ss_dssp             TTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC
Confidence            8999999999887     899999999999999988765 4599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|..||.+....+....+.
T Consensus       154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  233 (311)
T 3niz_A          154 SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF  233 (311)
T ss_dssp             TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred             CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999999999876533 233455789999999998766678999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...+.+....+.....................+....+..++++++||++||+.||++|||++++++||||+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            999988877665543332222222333344456667788999999999999999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.8e-46  Score=320.59  Aligned_cols=268  Identities=51%  Similarity=0.919  Sum_probs=221.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.....+..+..|+||||++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        69 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~  147 (353)
T 2b9h_A           69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS  147 (353)
T ss_dssp             TTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC
Confidence            79999999988765555588999999999999999987 57999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCC-----------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           81 NCDLKICDFGLARVTSETD-----------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      ++.++|+|||++.......           ......|++.|+|||++.....++.++|||||||++++|++|.+||.+.+
T Consensus       148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999997654321           12234689999999998766678999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChHhhhh-h-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGF-L-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      .......+....+.|....... . ......+....+......+...++.+++++++||.+||+.||++|||++++++||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            9999999999888876432211 1 2233445555666666667777889999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcC----CCCCCcchhhhhcCHHHHHHHHHHHHHh
Q 023764          228 YLGSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEALA  269 (277)
Q Consensus       228 ~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (277)
                      ||+....+...+..    ...++++.....++..++++++++++++
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (353)
T 2b9h_A          308 YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS  353 (353)
T ss_dssp             GGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHTC
T ss_pred             cccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHhhC
Confidence            99998776554322    2234556677789999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=318.13  Aligned_cols=195  Identities=19%  Similarity=0.318  Sum_probs=158.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++..      +.+|||||||+ |+|.+++... +++++..+..|+.|++.||+|||++||+||||||+|||+
T Consensus        92 pNIV~l~g~~~~------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl  165 (307)
T 3omv_A           92 VNILLFMGYMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL  165 (307)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE
T ss_pred             CCEeeEEEEEEC------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE
Confidence            899999998754      56899999997 6999999764 579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.+||+|||+|+.....   ......+||+.|||||++...  ..|+.++|||||||++|||++|+.||.+.+....
T Consensus       166 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~  245 (307)
T 3omv_A          166 HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ  245 (307)
T ss_dssp             ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred             CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH
Confidence            99999999999999765432   233456899999999998642  3589999999999999999999999988776665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +..++.....+                        .......+..++++.+||.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~------------------------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          246 IIFMVGRGYAS------------------------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHTTCCC------------------------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HHHHHhcCCCC------------------------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            55444321111                        1122334567889999999999999999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-47  Score=324.13  Aligned_cols=201  Identities=24%  Similarity=0.411  Sum_probs=149.9

Q ss_pred             CceeeeeccccCCCC-------CCCCcEEEEeecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023764            1 MQVVAIRDIIPPPQR-------ESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~-------~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qll~al~~LH~~~i~H~   69 (277)
                      ||||+++++|.+.+.       .....+|+|||||. |+|.+++...+.   .+...++.++.||+.||+|||++||+||
T Consensus        63 pnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHR  142 (299)
T 4g31_A           63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR  142 (299)
T ss_dssp             TTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccc
Confidence            899999999976421       11235899999996 699999987654   4456788999999999999999999999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCC-------------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHH
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETD-------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  136 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~  136 (277)
                      ||||+|||++.+|.+||+|||+++......             .....+||+.|||||++.+ ..|+.++|||||||++|
T Consensus       143 DlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvily  221 (299)
T 4g31_A          143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILF  221 (299)
T ss_dssp             CCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHH
T ss_pred             cCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHH
Confidence            999999999999999999999997654321             1234579999999999865 56899999999999999


Q ss_pred             HHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC
Q 023764          137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  216 (277)
Q Consensus       137 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  216 (277)
                      +|++   ||.+..  +....+.......                          ++..++..++.+++||++||+.||++
T Consensus       222 ell~---Pf~~~~--~~~~~~~~~~~~~--------------------------~p~~~~~~~~~~~~li~~~L~~dP~~  270 (299)
T 4g31_A          222 ELLY---PFSTQM--ERVRTLTDVRNLK--------------------------FPPLFTQKYPCEYVMVQDMLSPSPME  270 (299)
T ss_dssp             HHHS---CCSSHH--HHHHHHHHHHTTC--------------------------CCHHHHHHCHHHHHHHHHHTCSSGGG
T ss_pred             HHcc---CCCCcc--HHHHHHHHHhcCC--------------------------CCCCCcccCHHHHHHHHHHcCCChhH
Confidence            9996   675432  2222222211111                          01111234567889999999999999


Q ss_pred             CCCHHHHhcCCCCCCCC
Q 023764          217 RITVEDALAHPYLGSLH  233 (277)
Q Consensus       217 R~t~~ell~hp~f~~~~  233 (277)
                      |||+.++++||||+.+.
T Consensus       271 Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          271 RPEAINIIENAVFEDLD  287 (299)
T ss_dssp             SCCHHHHHTSGGGCCC-
T ss_pred             CcCHHHHhcCHhhCCCC
Confidence            99999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=317.91  Aligned_cols=232  Identities=39%  Similarity=0.740  Sum_probs=194.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus        60 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~  134 (324)
T 3mtl_A           60 ANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN  134 (324)
T ss_dssp             TTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred             CCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence            7999999999887     889999999999999998875 4599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|.+||.+.+..+....+.
T Consensus       135 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  214 (324)
T 3mtl_A          135 ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF  214 (324)
T ss_dssp             TTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999765433 233455789999999998776678999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      ...+.|....+..............+...........+.+++++++||.+||+.||.+|||++|+|+||||.++.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          215 RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             HHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence            9999998877765544333333344444445556667789999999999999999999999999999999998865433

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-45  Score=319.86  Aligned_cols=270  Identities=38%  Similarity=0.712  Sum_probs=212.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++........+.+|+||||++|+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             TTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             cCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc
Confidence            899999999965433334789999999999999988765 4799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.............+++.|+|||++.+...++.++||||+||++++|++|..||.+.+.......+.+
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  248 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE  248 (362)
T ss_dssp             TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999999998665555556678899999999987656689999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhh-hHHHHh-hhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNE-NAKKYI-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      ..+.|.......... ....+. ..........+....+..++.+.+||.+||+.||.+|||++++++||||+.+.++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            999998876654432 222222 222233334455667788999999999999999999999999999999999876554


Q ss_pred             CCcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhC
Q 023764          238 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFN  271 (277)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (277)
                      .... ....+.+.....+..++++++..++.+++
T Consensus       329 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          329 LTEG-LSERFHFDESVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             GTTT-CCCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred             cccc-cccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence            3321 22234455677888999999999998875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-45  Score=324.61  Aligned_cols=262  Identities=31%  Similarity=0.596  Sum_probs=208.1

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++...+. .+...+|+||||+++++.+.+.    ....+++..++.++.|++.||+|||++||+||||||+|
T Consensus        92 ~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N  171 (394)
T 4e7w_A           92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN  171 (394)
T ss_dssp             TTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHH
Confidence            899999999976432 2224588999999987766554    35679999999999999999999999999999999999


Q ss_pred             EEEe-cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           76 LLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        76 il~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      |+++ .++.+||+|||+++............+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+
T Consensus       172 ill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l  251 (394)
T 4e7w_A          172 LLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL  251 (394)
T ss_dssp             EEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999 789999999999987766555667788999999999876666899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+.+..+.|+...+...+.....  ...+.....++...++ ..++++++||.+||+.||.+|||+.++++||||+.++
T Consensus       252 ~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          252 VEIIKVLGTPSREQIKTMNPNYME--HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHHHHHCCCCHHHHHHHCGGGSS--SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHHHHHhCCCCHHHHHhhChhhhh--hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            999999999998876654432211  1233333344444443 4899999999999999999999999999999999987


Q ss_pred             CCCCCC----cCCCCCCcchhhhhcCHHHHHHHHH
Q 023764          234 DISDEP----VCMSPFSFDFEQHALTEGQMKELIY  264 (277)
Q Consensus       234 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  264 (277)
                      ......    .....+++..++.....+.+..++.
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (394)
T 4e7w_A          330 TGEARMPNGRELPPLFNWTKEELSVRPDLISRLVP  364 (394)
T ss_dssp             SSCCCCTTSSCCCCSCCCCHHHHHTCGGGHHHHSC
T ss_pred             cccccCCCCCCCCCcCCCCHHHhhcCHHHHHhhcc
Confidence            654432    2233455555555555444444443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-46  Score=315.46  Aligned_cols=195  Identities=22%  Similarity=0.370  Sum_probs=164.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------QALSEEHCQYFLYQILRGLKYIHSANV   66 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------~~l~~~~~~~i~~qll~al~~LH~~~i   66 (277)
                      ||||++++++.++     +.+|||||||+ |+|.+++.+.             ..+++..+..++.|++.||+|||+++|
T Consensus        75 pnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i  149 (299)
T 4asz_A           75 EHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF  149 (299)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCccEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            8999999999987     88999999997 7999999764             369999999999999999999999999


Q ss_pred             eecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CC
Q 023764           67 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  142 (277)
Q Consensus        67 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  142 (277)
                      +||||||+|||++.++.+||+|||+++......   ......||+.|||||++.+. .++.++||||+||++|||+| |+
T Consensus       150 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~  228 (299)
T 4asz_A          150 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGK  228 (299)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999997654332   22335689999999999654 59999999999999999998 89


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||.+.+..+.+..+.+-. .+                            ...+..++++.+||.+||+.||++|||+++
T Consensus       229 ~Pf~~~~~~~~~~~i~~~~-~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~  279 (299)
T 4asz_A          229 QPWYQLSNNEVIECITQGR-VL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKG  279 (299)
T ss_dssp             CTTTTSCHHHHHHHHHHTC-CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHcCC-CC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            9999888777666554311 00                            111357889999999999999999999999


Q ss_pred             HhcCCCCCCC
Q 023764          223 ALAHPYLGSL  232 (277)
Q Consensus       223 ll~hp~f~~~  232 (277)
                      +  ++|++.+
T Consensus       280 i--~~~L~~~  287 (299)
T 4asz_A          280 I--HTLLQNL  287 (299)
T ss_dssp             H--HHHHHHH
T ss_pred             H--HHHHHHH
Confidence            9  4466554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=311.25  Aligned_cols=228  Identities=37%  Similarity=0.630  Sum_probs=190.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..........+|+||||++++|.+++.....  +++..++.++.|++.||+|||++||+||||||+||++
T Consensus        74 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV  153 (308)
T ss_dssp             TTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE
T ss_pred             CCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            89999999998764333347999999999999999987654  9999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++.............+|+.|+|||++.+. .++.++|||||||++++|++|.+||.+.+.......+.
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          154 TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999999876655556667899999999998654 48999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +..+.++...+.......   ....+...........+.++.++.+||.+||+.||++|||+.++|+||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHhCCCChhhccchhhcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            999988876553221100   01122223334556667899999999999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=314.89  Aligned_cols=191  Identities=23%  Similarity=0.366  Sum_probs=155.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---------------QALSEEHCQYFLYQILRGLKYIHSA   64 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------------~~l~~~~~~~i~~qll~al~~LH~~   64 (277)
                      ||||++++++.++     +.+|||||||+ |+|.+++.+.               +++++..+..++.|++.||+|||++
T Consensus       103 pnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~  177 (329)
T 4aoj_A          103 QHIVRFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL  177 (329)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            8999999999987     88999999997 6999999753               3589999999999999999999999


Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  140 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  140 (277)
                      +|+||||||+|||++.++.+||+|||+++......   ......||+.|||||++.+ ..++.++|||||||++|||+| 
T Consensus       178 ~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~  256 (329)
T 4aoj_A          178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTY  256 (329)
T ss_dssp             TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcC
Confidence            99999999999999999999999999998654332   2334678999999999864 458999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 023764          141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  220 (277)
Q Consensus       141 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  220 (277)
                      |+.||.+.+..+.+..+.+-. .+                            ...+..++++.+||.+||+.||++|||+
T Consensus       257 G~~Pf~~~~~~~~~~~i~~g~-~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~  307 (329)
T 4aoj_A          257 GKQPWYQLSNTEAIDCITQGR-EL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSI  307 (329)
T ss_dssp             SCCTTCSSCHHHHHHHHHHTC-CC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHcCC-CC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCH
Confidence            899999888777665554311 10                            0112578899999999999999999999


Q ss_pred             HHHhcC
Q 023764          221 EDALAH  226 (277)
Q Consensus       221 ~ell~h  226 (277)
                      +|++++
T Consensus       308 ~ei~~~  313 (329)
T 4aoj_A          308 KDVHAR  313 (329)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7e-45  Score=312.25  Aligned_cols=201  Identities=22%  Similarity=0.398  Sum_probs=175.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        74 pnIv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~  148 (328)
T 3fe3_A           74 PNIVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD  148 (328)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCEeeEEEEEEEC-----CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc
Confidence            8999999999887     89999999996 69999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||++............+||+.|+|||++.+....+.++||||+||++++|++|..||.+.+.......+..
T Consensus       149 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  228 (328)
T 3fe3_A          149 ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR  228 (328)
T ss_dssp             TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999999998766665667778999999999997766556899999999999999999999998877665555443


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      ....                              ....+++++.+||++||+.||.+|||++++++||||+......
T Consensus       229 ~~~~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  275 (328)
T 3fe3_A          229 GKYR------------------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED  275 (328)
T ss_dssp             CCCC------------------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred             CCCC------------------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence            1100                              0124688999999999999999999999999999999876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-45  Score=307.64  Aligned_cols=225  Identities=39%  Similarity=0.709  Sum_probs=185.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++++|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        60 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  134 (288)
T 1ob3_A           60 SNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN  134 (288)
T ss_dssp             TTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCEeeeeeEEccC-----CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence            8999999999887     889999999999999999864 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.+||+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|.+||.+.+..+....+.
T Consensus       135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  214 (288)
T 1ob3_A          135 REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF  214 (288)
T ss_dssp             TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998765432 223445789999999998766668999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ...+.+....+...... ..+...........+....+.+++++++||++||+.||++|||++++++||||+.
T Consensus       215 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          215 RILGTPNSKNWPNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             HHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHCCCChhhchhhhcc-cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            98888776554432211 1111122222333445556678999999999999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.1e-45  Score=311.26  Aligned_cols=232  Identities=34%  Similarity=0.678  Sum_probs=187.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||+++++++.+.     +.+|+||||++++|.+++...      ..+++..++.++.|++.||.|||++||+||||||+
T Consensus        63 p~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~  137 (317)
T 2pmi_A           63 ENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ  137 (317)
T ss_dssp             TTBCCEEEEECCT-----TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             CCcceEEEEEEEC-----CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChH
Confidence            8999999999887     899999999999999998753      35899999999999999999999999999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           75 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      ||+++.++.+||+|||++...... .......+++.|+|||++.+...++.++|||||||++++|++|..||.+.+....
T Consensus       138 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  217 (317)
T 2pmi_A          138 NLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ  217 (317)
T ss_dssp             GEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999999876533 2344567899999999997656689999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc-----cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-----TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      ...+.+..+.+....+...... ..+...........+     ......++.++++||.+||+.||++|||++++++|||
T Consensus       218 ~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          218 LKLIFDIMGTPNESLWPSVTKL-PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             HHHHHHHHCSCCTTTCGGGGGC-TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHHhCCCChhHhhhhhhh-hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence            9999999998877655433211 001001111111111     1122357889999999999999999999999999999


Q ss_pred             CCCCCCCCCC
Q 023764          229 LGSLHDISDE  238 (277)
Q Consensus       229 f~~~~~~~~~  238 (277)
                      |+........
T Consensus       297 f~~~~~~~~~  306 (317)
T 2pmi_A          297 FAEYYHHASM  306 (317)
T ss_dssp             GGGGCC----
T ss_pred             hhcccchhhc
Confidence            9988765443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-45  Score=311.95  Aligned_cols=191  Identities=19%  Similarity=0.333  Sum_probs=162.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      ||||++++++.++     +.+|||||||+ |+|.+++...                ..+++..+..++.|++.||+|||+
T Consensus        89 pNIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  163 (308)
T 4gt4_A           89 PNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS  163 (308)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCcceEEEEC-----CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            8999999999887     88999999997 7999999653                358999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      ++|+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++... .++.++||||+||++|||+|
T Consensus       164 ~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t  242 (308)
T 4gt4_A          164 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFS  242 (308)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHh
Confidence            99999999999999999999999999999765332   223456789999999998654 59999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+.+..+....+......                             ...+..++++.+|+.+||+.||++|||
T Consensus       243 ~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs  293 (308)
T 4gt4_A          243 YGLQPYCGYSNQDVVEMIRNRQVL-----------------------------PCPDDCPAWVYALMIECWNEFPSRRPR  293 (308)
T ss_dssp             TTCCTTTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCcccchHHHHHHHHHHcCCChhHCcC
Confidence             89999988877665554321111                             111356789999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +++++++
T Consensus       294 ~~ei~~~  300 (308)
T 4gt4_A          294 FKDIHSR  300 (308)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-44  Score=305.93  Aligned_cols=226  Identities=38%  Similarity=0.726  Sum_probs=186.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+++++.+.+.. ++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~  135 (292)
T 3o0g_A           61 KNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN  135 (292)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCEeeEEeEEEeC-----CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence            7999999999887     89999999999988887765 57899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++...... .......+|+.|+|||++.+...++.++||||+||++++|++|..| |.+.+....+..+
T Consensus       136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i  215 (292)
T 3o0g_A          136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  215 (292)
T ss_dssp             TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            9999999999999876533 3344567899999999997666689999999999999999977666 6777888889999


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ....+.+....+........ + ...+.. .........+.++.++++||++||+.||++|||++|+++||||+.+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          216 FRLLGTPTEEQWPSMTKLPD-Y-KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHCCCCTTTCTTGGGSTT-C-CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             HHHhCCCChhhhhhhccccc-c-cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            99999888765544322100 0 001111 11223445567899999999999999999999999999999999754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-45  Score=317.13  Aligned_cols=193  Identities=25%  Similarity=0.407  Sum_probs=159.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      ||||++++++..++    +.+|||||||+ |+|.+++++.                ..+++..+..++.||+.||+|||+
T Consensus       128 pnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~  203 (353)
T 4ase_A          128 LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  203 (353)
T ss_dssp             TTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh
Confidence            79999999987641    67899999997 7999999753                348999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      ++|+||||||+|||++.++.+||+|||+++......   ......||+.|||||++.+. .|+.++||||+||++|||++
T Consensus       204 ~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t  282 (353)
T 4ase_A          204 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS  282 (353)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTT
T ss_pred             CCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHh
Confidence            999999999999999999999999999998654332   23345789999999999654 59999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+.+....+...+.....+.                            ..+..++++.+||.+||+.||++|||
T Consensus       283 ~G~~Pf~~~~~~~~~~~~i~~g~~~~----------------------------~p~~~~~~~~~li~~c~~~dP~~RPt  334 (353)
T 4ase_A          283 LGASPYPGVKIDEEFCRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPT  334 (353)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCcChhHCcC
Confidence             9999988765444433333211111                            11246889999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      ++++++|
T Consensus       335 ~~eil~~  341 (353)
T 4ase_A          335 FSELVEH  341 (353)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.5e-44  Score=310.32  Aligned_cols=200  Identities=28%  Similarity=0.485  Sum_probs=174.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        75 pnIv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~  149 (361)
T 2yab_A           75 PNIITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL  149 (361)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             cCCCcEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence            8999999999887     89999999995 79999999888999999999999999999999999999999999999998


Q ss_pred             cCC----CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++    .++|+|||++............+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+......
T Consensus       150 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~  228 (361)
T 2yab_A          150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (361)
T ss_dssp             CTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            776    799999999988766655667789999999999854 458999999999999999999999999887776666


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+.......+                          ...++.+++++++||++||..||.+|||++++++||||+..
T Consensus       229 ~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          229 NITAVSYDFD--------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHTTCCCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHhcCCCCC--------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            5543211111                          12234678899999999999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-44  Score=318.88  Aligned_cols=235  Identities=34%  Similarity=0.673  Sum_probs=192.5

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++..... .+...+++||||++++|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus       107 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N  186 (420)
T 1j1b_A          107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN  186 (420)
T ss_dssp             TTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred             CCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence            799999999865321 1224578999999988877664    35679999999999999999999999999999999999


Q ss_pred             EEEecC-CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           76 LLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        76 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      |+++.+ +.+||+|||+++............+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++
T Consensus       187 ILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l  266 (420)
T 1j1b_A          187 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL  266 (420)
T ss_dssp             EEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999965 5689999999987665555566788999999999876656899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+.+..+.|....+...+.....+  ..+......+...+ +..++++++||++||+.||.+|||+.|+++||||+.++
T Consensus       267 ~~i~~~lg~p~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          267 VEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHHHHCSCCHHHHHHHCSCCCCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHHhCCCCHHHHHhhChhhhhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            9999999999987765443221111  22233333344333 46789999999999999999999999999999999887


Q ss_pred             CCCC
Q 023764          234 DISD  237 (277)
Q Consensus       234 ~~~~  237 (277)
                      ++..
T Consensus       345 ~~~~  348 (420)
T 1j1b_A          345 DPNV  348 (420)
T ss_dssp             CTTC
T ss_pred             cccc
Confidence            6544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-44  Score=313.97  Aligned_cols=232  Identities=32%  Similarity=0.690  Sum_probs=191.9

Q ss_pred             CceeeeeccccCCCC---------------------------------CCCCcEEEEeecCcccHHHHHH----hCCCCC
Q 023764            1 MQVVAIRDIIPPPQR---------------------------------ESFNDVYIAYELMDTDLHQIIR----SNQALS   43 (277)
Q Consensus         1 pniv~l~~~~~~~~~---------------------------------~~~~~~~lv~e~~~~~L~~~l~----~~~~l~   43 (277)
                      |||+++++++...+.                                 .+...+|+||||++++|.+.+.    .++.++
T Consensus        60 pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~  139 (383)
T 3eb0_A           60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIP  139 (383)
T ss_dssp             TTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCC
T ss_pred             CCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCC
Confidence            799999999865421                                 2235689999999998777665    457899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCC
Q 023764           44 EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY  122 (277)
Q Consensus        44 ~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  122 (277)
                      +..++.++.|++.||+|||++||+||||||+||+++ .++.++|+|||++.............+++.|+|||++.+...+
T Consensus       140 ~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  219 (383)
T 3eb0_A          140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY  219 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCC
Confidence            999999999999999999999999999999999998 5889999999999877666666677889999999998766668


Q ss_pred             CcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChh
Q 023764          123 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPS  201 (277)
Q Consensus       123 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  201 (277)
                      +.++||||+||++++|++|.+||.+.+..+.+..+.+..+.|+...+...+.....  ...+......+...++ ..+++
T Consensus       220 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  297 (383)
T 3eb0_A          220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE--VRFPTLKAKDWRKILPEGTPSL  297 (383)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC----CCCCCCCCCCHHHHSCTTCCHH
T ss_pred             CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc--ccCCccCcccHHhhCCCCCCHH
Confidence            99999999999999999999999999999999999999999998766544332211  1223333334444444 47889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          202 AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       202 ~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +++||.+||+.||.+|||+.|+++||||+.+++
T Consensus       298 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            999999999999999999999999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-44  Score=309.59  Aligned_cols=226  Identities=33%  Similarity=0.669  Sum_probs=180.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~-   79 (277)
                      |||+++++++.+.     +.+|+||||++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++ 
T Consensus        93 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~  167 (329)
T 3gbz_A           93 RNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV  167 (329)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC
T ss_pred             CCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEec
Confidence            7999999999887     8999999999999999999988999999999999999999999999999999999999995 


Q ss_pred             ----cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ----ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ----~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                          .++.++|+|||++...... .......+++.|+|||++.+...++.++|||||||++++|++|.+||.+.+..+.+
T Consensus       168 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  247 (329)
T 3gbz_A          168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL  247 (329)
T ss_dssp             -----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence                4455999999999765432 23345577999999999976666899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ..+.+..+.|....+...... ..+....+......+....+ .+++++++||.+||+.||.+|||++++|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTAL-PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             HHHHHHhCCCchhhhhhhhhh-hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            999999988887655432211 01111122222222222221 268899999999999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=301.81  Aligned_cols=232  Identities=32%  Similarity=0.665  Sum_probs=183.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+++ +|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        62 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~  136 (311)
T 4agu_A           62 PNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT  136 (311)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCccchhheeecC-----CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence            7999999999887     889999999985 7888888778899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|.+||.+.+..+....+.
T Consensus       137 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  216 (311)
T 4agu_A          137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR  216 (311)
T ss_dssp             TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999876533 333456789999999999776678999999999999999999999999999999988888


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      +..+.....................+.. ........++.+++++.+||++||+.||.+|||++++++||||+++.+..+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            8888776654333222111100111111 112234456788999999999999999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=305.86  Aligned_cols=229  Identities=34%  Similarity=0.654  Sum_probs=190.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        72 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  146 (346)
T 1ua2_A           72 PNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD  146 (346)
T ss_dssp             TTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCCCeEEEEEeeC-----CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc
Confidence            7999999999887     889999999999999998765 4689999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++||||+||++++|++|.+||.+.+..+.+..+.
T Consensus       147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~  226 (346)
T 1ua2_A          147 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF  226 (346)
T ss_dssp             TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9999999999999765433 334456789999999998766668999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      +..+.+....+........ + ......+..+....++..+.++++||++||+.||.+|||++++++||||+....+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          227 ETLGTPTEEQWPDMCSLPD-Y-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             HHHCCCCTTTSSSTTSSTT-C-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             HHcCCCChhhhhhhccCcc-c-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            9988887765543211100 0 01111222334445567889999999999999999999999999999998865443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=309.99  Aligned_cols=196  Identities=21%  Similarity=0.407  Sum_probs=166.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        84 p~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  158 (353)
T 3txo_A           84 PFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD  158 (353)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC
Confidence            7999999999987     89999999997 59999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||++.... ........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.
T Consensus       159 ~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  237 (353)
T 3txo_A          159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  237 (353)
T ss_dssp             TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999997533 22344566899999999998654 48999999999999999999999999888777766665


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~f~~~  232 (277)
                      .....                              ....+++++++||++||+.||.+||++      +++++||||+.+
T Consensus       238 ~~~~~------------------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          238 NDEVV------------------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             cCCCC------------------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            41100                              012478899999999999999999998      899999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-43  Score=302.59  Aligned_cols=196  Identities=27%  Similarity=0.473  Sum_probs=170.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        65 p~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~  139 (337)
T 1o6l_A           65 PFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD  139 (337)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC
Confidence            8999999999987     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.++|+|||++.... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus       140 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  218 (337)
T 1o6l_A          140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999997533 3334556789999999999854 458999999999999999999999998877666555443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ....                              .....+++++++||.+||+.||.+||     +++++++||||+.+
T Consensus       219 ~~~~------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          219 MEEI------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HCCC------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            2100                              00125788999999999999999999     89999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.1e-43  Score=310.59  Aligned_cols=224  Identities=33%  Similarity=0.628  Sum_probs=183.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +++|+||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||++
T Consensus       159 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl  233 (429)
T 3kvw_A          159 MNVIHMLENFTFR-----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL  233 (429)
T ss_dssp             SCBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred             cCEEEEEeecccC-----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence            6999999999887     8999999999999999998764  49999999999999999999999999999999999999


Q ss_pred             ecCCC--eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +.++.  +||+|||++......  .....+|+.|+|||++.+. .++.++|||||||++++|++|.+||.+.+..+.+..
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~  310 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC  310 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99887  999999999765543  3456889999999998754 489999999999999999999999999999999999


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhC--Ccc---------------------------cCCcccccC-CCCChhHHHHH
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQL--PRY---------------------------QRQSFTEKF-PNVHPSAIDLV  206 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~~-~~~~~~~~~li  206 (277)
                      +.+..+.|+...+....... .+....  +.+                           ....+...+ ...++++++||
T Consensus       311 i~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli  389 (429)
T 3kvw_A          311 MIELLGMPSQKLLDASKRAK-NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL  389 (429)
T ss_dssp             HHHHHCCCCHHHHHTBTTHH-HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred             HHHHcCCCCHHHHHhhhhhh-hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence            99999999987654432221 111110  000                           000111111 23478899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          207 EKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       207 ~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ++||++||++|||++|+|+||||+...
T Consensus       390 ~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          390 KQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             HHHCCCChhhCCCHHHHhCChhhccCC
Confidence            999999999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=298.93  Aligned_cols=200  Identities=30%  Similarity=0.485  Sum_probs=173.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        74 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~  148 (326)
T 2y0a_A           74 PNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL  148 (326)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred             CCCCcEEEEEEeC-----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe
Confidence            8999999999887     89999999996 69999998888899999999999999999999999999999999999998


Q ss_pred             cCC----CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++    .++|+|||++.............|++.|+|||++.. ..++.++||||+||++++|++|..||.+........
T Consensus       149 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  227 (326)
T 2y0a_A          149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  227 (326)
T ss_dssp             CSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             cCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            877    799999999987765555566789999999999854 458999999999999999999999998887766655


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+.......+                          ...++..+..+++||++||+.||.+|||++++++||||+..
T Consensus       228 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          228 NVSAVNYEFE--------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHTCCCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHhcCCCcC--------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            5543221111                          12234678899999999999999999999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.6e-45  Score=312.49  Aligned_cols=197  Identities=26%  Similarity=0.491  Sum_probs=168.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.++     +.+|+||||++|+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus        69 pnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~  143 (336)
T 3h4j_B           69 PHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD  143 (336)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT
T ss_pred             CCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC
Confidence            8999999999987     88999999999999999988889999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 023764           81 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL  160 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  160 (277)
                      ++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.........    
T Consensus       144 ~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----  219 (336)
T 3h4j_B          144 NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----  219 (336)
T ss_dssp             TCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----
T ss_pred             CCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----
Confidence            9999999999998776666666778999999999986554447899999999999999999999976432111000    


Q ss_pred             hCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          161 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                                                .........+.+++++++||++||+.||.+|||++++++||||+.-
T Consensus       220 --------------------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          220 --------------------------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             --------------------------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             --------------------------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                                      0000011123578899999999999999999999999999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=298.26  Aligned_cols=194  Identities=24%  Similarity=0.470  Sum_probs=170.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        66 p~Iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~  140 (318)
T 1fot_A           66 PFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD  140 (318)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred             CCCceEeEEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc
Confidence            8999999999887     89999999997 59999999988999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+||+|||++......  ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus       141 ~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  217 (318)
T 1fot_A          141 KNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN  217 (318)
T ss_dssp             TTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             CCCCEEEeecCcceecCCc--cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999999999876543  345689999999999854 4589999999999999999999999988877666655543


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ...                              ...+.+++++++||++||+.||++|+     +++++++||||+.+
T Consensus       218 ~~~------------------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          218 AEL------------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             CCC------------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCC------------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            110                              01125788999999999999999999     89999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.4e-43  Score=302.66  Aligned_cols=237  Identities=33%  Similarity=0.590  Sum_probs=191.8

Q ss_pred             CceeeeeccccCCCC--CCCCcEEEEeecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQR--ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIH--SANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH--~~~i~H~di~   72 (277)
                      |||+++++++.....  .....+|+||||++++|.+.+.    ....+++..+..++.|++.||.|||  ++||+|||||
T Consensus        79 ~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlk  158 (360)
T 3e3p_A           79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIK  158 (360)
T ss_dssp             TTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCC
T ss_pred             CCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCC
Confidence            899999999976421  1113488999999988766554    4567999999999999999999999  9999999999


Q ss_pred             CCcEEEec-CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           73 PSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        73 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      |+||+++. ++.++|+|||++.............+++.|+|||++.+...++.++||||+||++++|++|.+||.+.+..
T Consensus       159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  238 (360)
T 3e3p_A          159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA  238 (360)
T ss_dssp             GGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence            99999997 89999999999987766655566788999999999876666899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP----NVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..+..+....+.++...+..+........  ........+...++    ..++++++||.+||+.||.+|||+.++|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVD--LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGG--GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhcc--ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            99999999999998876655432211111  11111122233333    3578899999999999999999999999999


Q ss_pred             CCCCCCCCCCCC
Q 023764          228 YLGSLHDISDEP  239 (277)
Q Consensus       228 ~f~~~~~~~~~~  239 (277)
                      ||+....+....
T Consensus       317 ~f~~~~~~~~~~  328 (360)
T 3e3p_A          317 YFDELHDPATKL  328 (360)
T ss_dssp             GGGGGGCTTCCC
T ss_pred             cccccCCccccC
Confidence            999987765543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.3e-43  Score=303.16  Aligned_cols=237  Identities=33%  Similarity=0.570  Sum_probs=183.9

Q ss_pred             CceeeeeccccCCCC---CCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++.....   ...+.+|+||||++++|.+.+... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus        76 ~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  155 (351)
T 3mi9_A           76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV  155 (351)
T ss_dssp             TTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHE
Confidence            799999999976421   112679999999999998888764 5799999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccC-----CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.++|+|||++.....     ........+++.|+|||++.+...++.++||||+||++++|++|.+||.+.+..
T Consensus       156 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  235 (351)
T 3mi9_A          156 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  235 (351)
T ss_dssp             EECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999999999999999976542     223345578999999999876666899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .....+....+.++...+...........................  ..++++++||.+||+.||++|||++|+|+||||
T Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  315 (351)
T 3mi9_A          236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  315 (351)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence            999999998888776554433211100000000000000000000  136789999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 023764          230 GSLHDISD  237 (277)
Q Consensus       230 ~~~~~~~~  237 (277)
                      .....++.
T Consensus       316 ~~~~~~~~  323 (351)
T 3mi9_A          316 WSDPMPSD  323 (351)
T ss_dssp             GSSSCCCC
T ss_pred             CCCCCccc
Confidence            87655443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-42  Score=297.20  Aligned_cols=232  Identities=36%  Similarity=0.643  Sum_probs=191.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++........+.+|+||||++|+|.+++....  .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        74 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili  153 (326)
T 1blx_A           74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV  153 (326)
T ss_dssp             TTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             CCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE
Confidence            7999999998732222237899999999999999998753  49999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++.............+++.|+|||++.+. .++.++|||||||++++|++|..||.+.+....+..+.
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (326)
T 1blx_A          154 TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  232 (326)
T ss_dssp             CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            99999999999999766544445566789999999998654 58999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      +..+.+....+........   ...............+.++..+++||.+||+.||.+|||+.++++||||+.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             HHcCCCCcccCccccccch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            9888887665432211000   11111222334555678899999999999999999999999999999999876543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3e-43  Score=303.89  Aligned_cols=196  Identities=25%  Similarity=0.441  Sum_probs=170.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        78 p~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~  152 (345)
T 1xjd_A           78 PFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD  152 (345)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CCCCcEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC
Confidence            8999999999987     89999999996 69999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.++|+|||++..... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus       153 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  231 (345)
T 1xjd_A          153 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  231 (345)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999975432 233456789999999999865 458999999999999999999999999887766655543


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-ell~hp~f~~~  232 (277)
                      ..  .+                            .....+++++++||.+||+.||++|||+. ++++||||+.+
T Consensus       232 ~~--~~----------------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          232 MD--NP----------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HC--CC----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             hC--CC----------------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            21  00                            00124788999999999999999999998 99999999976

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.8e-43  Score=306.11  Aligned_cols=205  Identities=23%  Similarity=0.445  Sum_probs=164.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++++++|.+.     +.+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus       113 p~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~  187 (396)
T 4dc2_A          113 PFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD  187 (396)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CCcCeeEEEEEEC-----CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC
Confidence            8999999999987     89999999996 59999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeec-cCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++.. .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........  
T Consensus       188 ~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--  264 (396)
T 4dc2_A          188 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--  264 (396)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------
T ss_pred             CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--
Confidence            9999999999999753 33344566789999999999865 4589999999999999999999999965432111000  


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~f~~~  232 (277)
                           ....   .+   .........        ...+.+++++++||++||+.||.+||++      +++++||||+.+
T Consensus       265 -----~~~~---~~---~~~i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          265 -----NTED---YL---FQVILEKQI--------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             -----CCHH---HH---HHHHHHCCC--------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             -----hhHH---HH---HHHHhcccc--------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence                 0000   00   000000000        1112578899999999999999999995      899999999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=300.89  Aligned_cols=201  Identities=23%  Similarity=0.433  Sum_probs=174.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        61 pnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~  135 (321)
T 1tki_A           61 RNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY  135 (321)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE
Confidence            8999999999887     89999999997 5999999765 479999999999999999999999999999999999999


Q ss_pred             ec--CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +.  ++.++|+|||++.............+++.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......
T Consensus       136 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  214 (321)
T 1tki_A          136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN  214 (321)
T ss_dssp             SSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             ccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence            87  78999999999988766655566789999999999854 4478999999999999999999999998887776666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +.......+.                          ..++.++.++++||.+||+.||.+|||+.++|+||||+...
T Consensus       215 i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          215 IMNAEYTFDE--------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHTCCCCCH--------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHcCCCCCCh--------------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            6543222221                          22346788999999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.8e-43  Score=301.90  Aligned_cols=196  Identities=21%  Similarity=0.411  Sum_probs=170.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        81 p~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~  155 (353)
T 2i0e_A           81 PFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD  155 (353)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CEEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc
Confidence            7999999999887     89999999996 59999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.++|+|||++.... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.
T Consensus       156 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  234 (353)
T 2i0e_A          156 SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  234 (353)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            99999999999997633 2334556789999999999854 458999999999999999999999999887776666555


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ...-.                              ..+.+++++++||++||+.||.+||+     ++++++||||+.+
T Consensus       235 ~~~~~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          235 EHNVA------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HCCCC------------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             hCCCC------------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            31100                              01257889999999999999999994     7999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=305.95  Aligned_cols=233  Identities=33%  Similarity=0.604  Sum_probs=176.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++....   .+.+|+||||++++|.+++...         ..+++..++.++.||+.||+|||++||+||||
T Consensus        78 pniv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dl  154 (405)
T 3rgf_A           78 PNVISLQKVFLSHA---DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL  154 (405)
T ss_dssp             TTBCCCCEEEEETT---TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             CCeeeEeeEEecCC---CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCc
Confidence            89999999995421   1789999999999999888632         24999999999999999999999999999999


Q ss_pred             CCCcEEE----ecCCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           72 KPSNLLL----NANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        72 ~~~nil~----~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      ||+||++    +.++.+||+|||++......    .......||+.|+|||++.+...++.++||||+||++|+|++|.+
T Consensus       155 kp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  234 (405)
T 3rgf_A          155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP  234 (405)
T ss_dssp             CGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCC
Confidence            9999999    67789999999999765432    233456789999999999776668999999999999999999999


Q ss_pred             CCCCCCh---------HHHHHHHHHHhCCCChHhhhhhhhh--HHHHhhhCCcc--cCCc----ccccCCCCChhHHHHH
Q 023764          144 LFPGRDH---------VHQLRLLIELIGTPSEAELGFLNEN--AKKYICQLPRY--QRQS----FTEKFPNVHPSAIDLV  206 (277)
Q Consensus       144 pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~li  206 (277)
                      ||.+...         .+++..+.+.++.|+...|..+...  ...........  ....    ........++.+.+||
T Consensus       235 pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll  314 (405)
T 3rgf_A          235 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL  314 (405)
T ss_dssp             TTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHH
T ss_pred             CCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHH
Confidence            9976654         5788999999999988766554221  11111111110  0000    1112224478899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          207 EKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       207 ~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      ++||+.||.+|||++|+|+||||.....+.
T Consensus       315 ~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          315 QKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             HHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            999999999999999999999998765443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=296.33  Aligned_cols=238  Identities=43%  Similarity=0.760  Sum_probs=188.5

Q ss_pred             CceeeeeccccCCCC---------CCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQR---------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~---------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++..++.         ...+..|+||||++|+|.+++.. +.+++..++.++.|++.||+|||++|++||||
T Consensus        68 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  146 (320)
T 2i6l_A           68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDL  146 (320)
T ss_dssp             TTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred             CCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence            799999999865321         23378999999999999999865 67999999999999999999999999999999


Q ss_pred             CCCcEEEe-cCCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           72 KPSNLLLN-ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        72 ~~~nil~~-~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      ||+||+++ .++.++|+|||++......    .......+++.|+|||.+.....++.++|||||||++++|++|..||.
T Consensus       147 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence            99999997 4678999999998765322    223345678899999998766678999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +.+.......+.+....+..............+..........++....+.++.++++||++||+.||.+|||++++++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            99988888888887777666554443322222222222233344556667899999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCC
Q 023764          227 PYLGSLHDISDEP  239 (277)
Q Consensus       227 p~f~~~~~~~~~~  239 (277)
                      |||+....+..+|
T Consensus       307 p~~~~~~~p~~~~  319 (320)
T 2i6l_A          307 PYMSIYSFPMDEP  319 (320)
T ss_dssp             HHHHTTCC-----
T ss_pred             cccccccCccCCC
Confidence            9999876555443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-42  Score=292.52  Aligned_cols=199  Identities=21%  Similarity=0.419  Sum_probs=169.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        77 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~  150 (297)
T 3fxz_A           77 PNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  150 (297)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCCCeEeEEEEEC-----CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence            8999999999887     88999999995 6999999874 699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  229 (297)
T 3fxz_A          151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (297)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998765543 234456799999999998654 58999999999999999999999998877666555443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .......                           ...+.++..+++||.+||+.||.+|||++++++||||+...
T Consensus       230 ~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          230 TNGTPEL---------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHCSCCC---------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             hCCCCCC---------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            3211100                           01124678899999999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=307.52  Aligned_cols=200  Identities=30%  Similarity=0.482  Sum_probs=171.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||+. |+|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        70 pnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~  144 (444)
T 3soa_A           70 PNIVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA  144 (444)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred             cCCCeEEEEEEEC-----CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence            8999999999887     89999999996 59999999989999999999999999999999999999999999999998


Q ss_pred             ---cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ---ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ---~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                         .++.+||+|||++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+......
T Consensus       145 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~  223 (444)
T 3soa_A          145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ  223 (444)
T ss_dssp             BSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence               4678999999999765543 23345689999999999854 458999999999999999999999998888776666


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+.......+                          ...++.+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus       224 ~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          224 QIKAGAYDFP--------------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHhCCCCCC--------------------------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            5544221111                          12235678999999999999999999999999999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-42  Score=300.74  Aligned_cols=222  Identities=25%  Similarity=0.423  Sum_probs=178.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     ++.|+||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||++
T Consensus        96 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  170 (360)
T 3llt_A           96 NNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL  170 (360)
T ss_dssp             GGBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCeecccceeeEC-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE
Confidence            7999999999887     8999999999999999998754  59999999999999999999999999999999999999


Q ss_pred             ec-------------------------CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHH
Q 023764           79 NA-------------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  133 (277)
Q Consensus        79 ~~-------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  133 (277)
                      +.                         ++.++|+|||++......  .....+|+.|+|||++.+. .++.++||||+||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~  247 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGC  247 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCC-CCCCccchHHHHH
Confidence            65                         789999999999875543  3456789999999998654 5899999999999


Q ss_pred             HHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcc----cCC------------cccccCCC
Q 023764          134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY----QRQ------------SFTEKFPN  197 (277)
Q Consensus       134 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~------------~~~~~~~~  197 (277)
                      ++|+|++|..||.+.+..+.+..+....+.++.....................    +..            ..+.....
T Consensus       248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  327 (360)
T 3llt_A          248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII  327 (360)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred             HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence            99999999999999999999999998888877765433221111000000000    000            00000012


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          198 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       198 ~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      .++.+.+||.+||+.||.+|||++++|+||||+
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            347788999999999999999999999999995

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.6e-43  Score=303.43  Aligned_cols=204  Identities=27%  Similarity=0.431  Sum_probs=154.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        76 pniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~  150 (361)
T 3uc3_A           76 PNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD  150 (361)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC
T ss_pred             CCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence            8999999999887     89999999996 69999998888899999999999999999999999999999999999998


Q ss_pred             cCCC--eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.  +||+|||++.............||+.|+|||++.+....+.++||||+||++|+|++|..||.+.........+
T Consensus       151 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~  230 (361)
T 3uc3_A          151 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT  230 (361)
T ss_dssp             SSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH
T ss_pred             CCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence            7665  99999999875544444556689999999999976654455699999999999999999999765443222222


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...+....                       ..+ .....+++++++||++||+.||.+|||++++++||||....
T Consensus       231 ~~~~~~~~-----------------------~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          231 IQRILSVK-----------------------YSI-PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHTTC-----------------------CCC-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHhcCC-----------------------CCC-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            22110000                       000 01125788999999999999999999999999999997643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-42  Score=302.17  Aligned_cols=200  Identities=29%  Similarity=0.503  Sum_probs=171.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||+. ++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        88 pnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~  162 (362)
T 2bdw_A           88 PNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA  162 (362)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred             CCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence            8999999999887     89999999997 59999998888899999999999999999999999999999999999997


Q ss_pred             cC---CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 AN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .+   +.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......
T Consensus       163 ~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~  241 (362)
T 2bdw_A          163 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  241 (362)
T ss_dssp             CSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            65   4599999999987766555566789999999999854 4589999999999999999999999988877665555


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +.......+                          ...++.+++++++||.+||+.||.+|||+.++|+||||...
T Consensus       242 i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          242 IKAGAYDYP--------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHTCCCCC--------------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHhCCCCCC--------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            443211111                          11223578899999999999999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-42  Score=298.91  Aligned_cols=194  Identities=23%  Similarity=0.409  Sum_probs=170.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus       101 p~iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~  175 (350)
T 1rdq_E          101 PFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID  175 (350)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC
Confidence            8999999999987     89999999995 69999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.++|+|||++......  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       176 ~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~  252 (350)
T 1rdq_E          176 QQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS  252 (350)
T ss_dssp             TTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEEcccccceeccCC--cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999876543  345689999999999865 4589999999999999999999999988877666655543


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ...                              ...+.+++++++||++||+.||.+||+     ++++++||||+.+
T Consensus       253 ~~~------------------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          253 GKV------------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CCC------------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCC------------------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            100                              001257889999999999999999998     9999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-42  Score=297.84  Aligned_cols=226  Identities=31%  Similarity=0.638  Sum_probs=182.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||+++ +|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus        84 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~  158 (331)
T 4aaa_A           84 ENLVNLLEVCKKK-----KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS  158 (331)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCEeeEEEEeecC-----CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc
Confidence            7999999999887     889999999986 6666767677899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...++.++|||||||++++|++|.+||.+.+.......+.
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  238 (331)
T 4aaa_A          159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM  238 (331)
T ss_dssp             TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9999999999999765432 233456789999999999765568999999999999999999999999999999999998


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcc-cCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ...+.........+...........+.. .........+.+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            8888877654443332211111111111 122344556788999999999999999999999999999999976

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-42  Score=310.05  Aligned_cols=197  Identities=29%  Similarity=0.511  Sum_probs=173.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        76 pnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~  150 (476)
T 2y94_A           76 PHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD  150 (476)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe
Confidence            8999999999887     89999999995 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||++............+|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus       151 ~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  230 (476)
T 2y94_A          151 AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD  230 (476)
T ss_dssp             TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT
T ss_pred             cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence            99999999999998877666666778999999999997655457899999999999999999999988776665555432


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ....                              ....+++++++||++||+.||.+|||++++++||||+..
T Consensus       231 ~~~~------------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          231 GIFY------------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TCCC------------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCcC------------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            1100                              012468899999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-42  Score=298.63  Aligned_cols=205  Identities=23%  Similarity=0.443  Sum_probs=163.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        70 p~iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~  144 (345)
T 3a8x_A           70 PFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD  144 (345)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CccCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence            8999999999887     89999999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.++|+|||++.... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...........  
T Consensus       145 ~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--  221 (345)
T 3a8x_A          145 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--  221 (345)
T ss_dssp             TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------
T ss_pred             CCCCEEEEeccccccccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--
Confidence            99999999999997533 2334556789999999999865 4589999999999999999999999965322110000  


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~f~~~  232 (277)
                           ...   ..+   .........        ...+.++.++++||++||+.||.+|||+      +++++||||+.+
T Consensus       222 -----~~~---~~~---~~~i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          222 -----NTE---DYL---FQVILEKQI--------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             ------CH---HHH---HHHHHHCCC--------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             -----ccH---HHH---HHHHHcCCC--------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence                 000   000   000000000        0112578899999999999999999995      899999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-42  Score=301.18  Aligned_cols=196  Identities=23%  Similarity=0.449  Sum_probs=170.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        99 p~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~  173 (373)
T 2r5t_A           99 PFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD  173 (373)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCCCCEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence            7999999999987     89999999996 59999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+.
T Consensus       174 ~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  252 (373)
T 2r5t_A          174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL  252 (373)
T ss_dssp             TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred             CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            99999999999997533 2334556789999999999864 458999999999999999999999999887776666554


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~f~~~  232 (277)
                      ...-                              ...+.++.++++||++||+.||.+||++    .++++||||+.+
T Consensus       253 ~~~~------------------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          253 NKPL------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HSCC------------------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             hccc------------------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            3100                              1113678899999999999999999996    699999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-42  Score=295.39  Aligned_cols=208  Identities=26%  Similarity=0.480  Sum_probs=148.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     ++.|+||||++ ++|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        66 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~  140 (325)
T 3kn6_A           66 PNIVKLHEVFHDQ-----LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT  140 (325)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred             CCeeEEEEEEEcC-----CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe
Confidence            8999999999887     89999999996 59999999989999999999999999999999999999999999999998


Q ss_pred             cCC---CeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH--
Q 023764           80 ANC---DLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ--  153 (277)
Q Consensus        80 ~~~---~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--  153 (277)
                      .++   .++|+|||++...... .......+++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+....  
T Consensus       141 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  219 (325)
T 3kn6_A          141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT  219 (325)
T ss_dssp             C----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC
T ss_pred             cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc
Confidence            766   7999999999765433 23445678999999999854 4589999999999999999999999976543211  


Q ss_pred             -HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          154 -LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       154 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                       ...+...+..                      .........++.+++++++||++||+.||.+|||++++++||||+..
T Consensus       220 ~~~~~~~~i~~----------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          220 SAVEIMKKIKK----------------------GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             CHHHHHHHHTT----------------------TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             cHHHHHHHHHc----------------------CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence             0011111100                      00001112223578899999999999999999999999999999976


Q ss_pred             CCCC
Q 023764          233 HDIS  236 (277)
Q Consensus       233 ~~~~  236 (277)
                      ...+
T Consensus       278 ~~~~  281 (325)
T 3kn6_A          278 SQLS  281 (325)
T ss_dssp             CCCC
T ss_pred             ccCC
Confidence            5443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.7e-42  Score=299.57  Aligned_cols=200  Identities=24%  Similarity=0.452  Sum_probs=168.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++++++|.+.     +.+|+||||+. |+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus        75 p~Iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~  149 (384)
T 4fr4_A           75 PFLVNLWYSFQDE-----EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD  149 (384)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCCCcEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC
Confidence            8999999999987     89999999995 69999999988999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .+|.++|+|||++............+||+.|+|||++..  ...++.++|||||||++|+|++|..||.+..........
T Consensus       150 ~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~  229 (384)
T 4fr4_A          150 EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV  229 (384)
T ss_dssp             TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH
T ss_pred             CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence            999999999999988766666677889999999999854  234789999999999999999999999754322111111


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~ell~hp~f~~~  232 (277)
                      .....                   ..        ....+.+++++.+||.+||+.||.+||+ ++++++||||+.+
T Consensus       230 ~~~~~-------------------~~--------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          230 HTFET-------------------TV--------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHH-------------------CC--------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHhh-------------------cc--------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            10000                   00        0111357889999999999999999998 9999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-42  Score=307.08  Aligned_cols=202  Identities=22%  Similarity=0.420  Sum_probs=172.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +++|+|||||. |+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus       134 p~Iv~l~~~~~~~-----~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl  208 (437)
T 4aw2_A          134 KWITTLHYAFQDD-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM  208 (437)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCEEEEEEEEeeC-----CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE
Confidence            7999999999987     89999999995 699999987 4789999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhh----CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +.+|.+||+|||++........  ....+||+.|+|||++.    +...++.++||||+||++|+|++|.+||.+.+..+
T Consensus       209 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~  288 (437)
T 4aw2_A          209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  288 (437)
T ss_dssp             CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence            9999999999999976554322  23468999999999986    24458999999999999999999999999988877


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLG  230 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~  230 (277)
                      ....+......                         ..++...+.+++++++||++||+.+|++  |++++|+++||||+
T Consensus       289 ~~~~i~~~~~~-------------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          289 TYGKIMNHKER-------------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HHHHHHTHHHH-------------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             HHHhhhhcccc-------------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            77766532100                         1112223468999999999999999988  99999999999998


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      .+
T Consensus       344 ~i  345 (437)
T 4aw2_A          344 GI  345 (437)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-42  Score=304.43  Aligned_cols=200  Identities=24%  Similarity=0.357  Sum_probs=170.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus       129 p~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~  202 (410)
T 3v8s_A          129 PWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD  202 (410)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC
Confidence            8999999999987     89999999995 699999876 5699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .+|.+||+|||++.......  .....+||+.|+|||++.+...   ++.++|||||||++|+|++|.+||.+.+.....
T Consensus       203 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  282 (410)
T 3v8s_A          203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY  282 (410)
T ss_dssp             TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH
Confidence            99999999999998765443  2346789999999999865432   678999999999999999999999988877777


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~f~~~  232 (277)
                      ..+........                 .         ...+.+++++++||++||+.+|.+  |++++++++||||+.+
T Consensus       283 ~~i~~~~~~~~-----------------~---------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          283 SKIMNHKNSLT-----------------F---------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHTHHHHCC-----------------C---------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHhcccccc-----------------C---------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            76654210000                 0         011357899999999999999988  9999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.7e-42  Score=287.07  Aligned_cols=201  Identities=29%  Similarity=0.464  Sum_probs=174.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~-   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||++ 
T Consensus        66 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~  140 (277)
T 3f3z_A           66 PNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL  140 (277)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             CCEeeEEEEEecC-----CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEe
Confidence            7999999999887     88999999996 5999999888889999999999999999999999999999999999999 


Q ss_pred             --ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                        +.++.++|+|||++.............+++.|+|||++.+  .++.++||||+||++++|++|..||.+.+.......
T Consensus       141 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  218 (277)
T 3f3z_A          141 TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK  218 (277)
T ss_dssp             SSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence              7889999999999987766666667789999999999853  389999999999999999999999998887776666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +.+.....+..                          .+..+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       219 ~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          219 IREGTFTFPEK--------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHCCCCCCHH--------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             HHhCCCCCCch--------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            55432222221                          12357889999999999999999999999999999987543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.6e-42  Score=293.34  Aligned_cols=196  Identities=24%  Similarity=0.461  Sum_probs=166.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +++|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        81 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~  155 (327)
T 3a62_A           81 PFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN  155 (327)
T ss_dssp             TTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC
T ss_pred             CCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC
Confidence            8999999999887     89999999996 69999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  234 (327)
T 3a62_A          156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL  234 (327)
T ss_dssp             TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999999999875432 223445678999999999865 458999999999999999999999999887766665554


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ....                              ...+.+++++++||.+||+.||.+||     +++++++||||+.+
T Consensus       235 ~~~~------------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          235 KCKL------------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HTCC------------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             hCCC------------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            3110                              01135788999999999999999999     89999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-41  Score=290.63  Aligned_cols=201  Identities=28%  Similarity=0.487  Sum_probs=173.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        75 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~  149 (321)
T 2a2a_A           75 HNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL  149 (321)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             CCcceEEEEEecC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence            8999999999887     89999999996 69999999888899999999999999999999999999999999999999


Q ss_pred             cCC----CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++    .++|+|||++.............+++.|+|||++.+ ..++.++|||||||++++|++|..||.+.+......
T Consensus       150 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  228 (321)
T 2a2a_A          150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (321)
T ss_dssp             CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            887    799999999987766555566779999999999854 458999999999999999999999998887666555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .+.......+                          ....+..+..+++||++||+.||++|||++++++||||+...
T Consensus       229 ~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          229 NITSVSYDFD--------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHTTCCCCC--------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHhcccccC--------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            5443211111                          112246788999999999999999999999999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-41  Score=295.92  Aligned_cols=200  Identities=28%  Similarity=0.553  Sum_probs=172.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus       160 p~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          160 PHIITLIDSYESS-----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD  234 (365)
T ss_dssp             TTBCCEEEEEEBS-----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCEeEEEEEEeeC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            7999999999887     89999999997 59999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .+|.++|+|||++.............|++.|+|||++.+     ...++.++|||||||++|+|++|..||.+.+.....
T Consensus       235 ~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  314 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML  314 (365)
T ss_dssp             TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999987766555666789999999999853     234788999999999999999999999887766655


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ..+......+..                          ..++..+..+.+||.+||+.||++|||++++++||||+.
T Consensus       315 ~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          315 RMIMEGQYQFSS--------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHTCCCCCH--------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHhCCCCCCC--------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            555432211111                          112357888999999999999999999999999999973

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.4e-42  Score=305.60  Aligned_cols=196  Identities=27%  Similarity=0.476  Sum_probs=168.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||++ |+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||++
T Consensus       208 ~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll  282 (446)
T 4ejn_A          208 PFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML  282 (446)
T ss_dssp             TTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE
T ss_pred             CeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE
Confidence            7999999999887     88999999997 5999999888899999999999999999999998 999999999999999


Q ss_pred             ecCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||++.... ........+||+.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+
T Consensus       283 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  361 (446)
T 4ejn_A          283 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  361 (446)
T ss_dssp             CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999999987533 2234456789999999999865 45899999999999999999999999888776665554


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ......                              ..+.+++++.+||.+||+.||.+||     |++++++||||+.+
T Consensus       362 ~~~~~~------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          362 LMEEIR------------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHCCCC------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhCCCC------------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            431100                              1125788999999999999999999     99999999999976

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=298.13  Aligned_cols=201  Identities=26%  Similarity=0.467  Sum_probs=171.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||++
T Consensus       108 pnIv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll  182 (387)
T 1kob_A          108 PKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC  182 (387)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             cCCCeEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEE
Confidence            8999999999887     89999999996 69999987653 79999999999999999999999999999999999999


Q ss_pred             ec--CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +.  ++.++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......
T Consensus       183 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~  261 (387)
T 1kob_A          183 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN  261 (387)
T ss_dssp             SSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             ecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            74  57799999999988766555556689999999999854 4589999999999999999999999988876665554


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +......                          .....++.+++++++||.+||+.||.+|||++++++||||+...
T Consensus       262 i~~~~~~--------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          262 VKRCDWE--------------------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHCCCC--------------------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHhCCCC--------------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            4331100                          01123346889999999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.4e-42  Score=300.42  Aligned_cols=232  Identities=19%  Similarity=0.277  Sum_probs=165.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        86 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIl  160 (389)
T 3gni_B           86 PNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL  160 (389)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCcEeEEEEEC-----CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8999999999987     89999999997 6999999875  67999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCC--------CcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           78 LNANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      ++.++.++|+|||.+......        .......+++.|+|||++.+. ..++.++|||||||++++|++|..||.+.
T Consensus       161 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             ECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             EcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999987643221        122334788899999998653 45899999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCC--------CChHhhhhhhhh-----HHH---HhhhCCcccCCcccccCCCCChhHHHHHHHhcCC
Q 023764          149 DHVHQLRLLIELIGT--------PSEAELGFLNEN-----AKK---YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  212 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~--------~~~~~~~~~~~~-----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  212 (277)
                      +.......+......        +...........     ...   .....+.............+++++++||++||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  320 (389)
T 3gni_B          241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR  320 (389)
T ss_dssp             CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred             CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence            655544333221100        000000000000     000   0000000011111123346789999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          213 DPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       213 dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      ||++|||++++|+||||+.+.....
T Consensus       321 dP~~Rpta~ell~hp~f~~~~~~~~  345 (389)
T 3gni_B          321 NPDARPSASTLLNHSFFKQIKRRAS  345 (389)
T ss_dssp             CTTTSCCHHHHTTSGGGGGC---CC
T ss_pred             CcccCCCHHHHhcCHHHHHHhhcch
Confidence            9999999999999999998765443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-41  Score=297.39  Aligned_cols=223  Identities=29%  Similarity=0.564  Sum_probs=178.5

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEE
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH--SANVLHRDLKPSNLL   77 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH--~~~i~H~di~~~nil   77 (277)
                      ||+++++++...     +++|+||||++++|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+||+
T Consensus       117 ~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIl  191 (382)
T 2vx3_A          117 YIVHLKRHFMFR-----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL  191 (382)
T ss_dssp             GBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEE
T ss_pred             eEEEeeeeeccC-----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEE
Confidence            589999999887     899999999999999999875  46999999999999999999999  579999999999999


Q ss_pred             Ee--cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           78 LN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        78 ~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      ++  .++.+||+|||++......  .....+|+.|+|||++.+. .++.++|||||||++++|++|.+||.+.+..+.+.
T Consensus       192 l~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~  268 (382)
T 2vx3_A          192 LCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN  268 (382)
T ss_dssp             ESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            95  4788999999999876543  3456889999999998654 58999999999999999999999999999999999


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCccc--------------C---CcccccC-----------CC-------CCh
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQ--------------R---QSFTEKF-----------PN-------VHP  200 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~---~~~~~~~-----------~~-------~~~  200 (277)
                      .+.+..+.|+...+..... ...+....+...              .   ..+...+           ..       .++
T Consensus       269 ~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (382)
T 2vx3_A          269 KIVEVLGIPPAHILDQAPK-ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL  347 (382)
T ss_dssp             HHHHHHCSCCHHHHTTCTT-HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHH
T ss_pred             HHHHHhCCCCHHHHHhhHH-HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhH
Confidence            9999999988765543222 122222221100              0   0000000           00       013


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          201 SAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       201 ~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ++++||++||++||++|||++++|+||||+...
T Consensus       348 ~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          348 KFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             HHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            789999999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=292.38  Aligned_cols=193  Identities=27%  Similarity=0.317  Sum_probs=159.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus       117 ~~iv~l~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~  191 (311)
T 3p1a_A          117 PCCVRLEQAWEEG-----GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG  191 (311)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CcEEEEEEEEEeC-----CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence            7999999999887     899999999999999988764 4699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||++.............||+.|+|||++.+  .++.++||||+||++++|++|..+|.+.....   .+..
T Consensus       192 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~  266 (311)
T 3p1a_A          192 PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ  266 (311)
T ss_dssp             GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT
T ss_pred             CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc
Confidence            999999999999987766555556679999999998864  48999999999999999999977665432211   1110


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                        +..                          .....+.+++++.+||.+||+.||++|||++++++||||+.
T Consensus       267 --~~~--------------------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          267 --GYL--------------------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             --TCC--------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             --cCC--------------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence              000                          01122367889999999999999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.4e-42  Score=296.46  Aligned_cols=205  Identities=29%  Similarity=0.491  Sum_probs=167.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. |+|.+.+...+.+++..+..++.|++.||+|||++||+||||||+||++.
T Consensus        76 p~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~  150 (342)
T 2qr7_A           76 PNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV  150 (342)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred             CCcCeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence            8999999999887     89999999996 69999999888999999999999999999999999999999999999984


Q ss_pred             cC----CCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hH
Q 023764           80 AN----CDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---HV  151 (277)
Q Consensus        80 ~~----~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~  151 (277)
                      .+    +.+||+|||++...... ......++|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..   ..
T Consensus       151 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  229 (342)
T 2qr7_A          151 DESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE  229 (342)
T ss_dssp             SSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH
T ss_pred             cCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH
Confidence            33    35999999999865433 334566889999999998643 47899999999999999999999997532   22


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .....+...  .                        .......++.+++++++||++||..||++|||++++++||||..
T Consensus       230 ~~~~~i~~~--~------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          230 EILARIGSG--K------------------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHHHC--C------------------------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHccC--C------------------------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            222222210  0                        00011223568899999999999999999999999999999987


Q ss_pred             CCCCCC
Q 023764          232 LHDISD  237 (277)
Q Consensus       232 ~~~~~~  237 (277)
                      +.....
T Consensus       284 ~~~~~~  289 (342)
T 2qr7_A          284 WDQLPQ  289 (342)
T ss_dssp             GGGSCC
T ss_pred             cccccc
Confidence            654443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1e-41  Score=292.03  Aligned_cols=201  Identities=26%  Similarity=0.399  Sum_probs=166.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        65 pnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~  139 (323)
T 3tki_A           65 ENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  139 (323)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCCCeEEEEEecC-----CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence            7999999999887     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++......   .......|++.|+|||++.+...++.++|||||||++++|++|..||.+.........
T Consensus       140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  219 (323)
T 3tki_A          140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  219 (323)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred             CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            9999999999999754322   2234567899999999997665457899999999999999999999976544321111


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ......                           .....+..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       220 ~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          220 DWKEKK---------------------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHTTC---------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHhccc---------------------------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            110000                           00011235788999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-41  Score=291.62  Aligned_cols=201  Identities=28%  Similarity=0.473  Sum_probs=167.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +.+|+||||+. ++|.+++...  +.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        89 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl  163 (327)
T 3lm5_A           89 PRVINLHEVYENT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL  163 (327)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             CCEEEEEEEEEeC-----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence            7999999999887     88999999997 5999988653  67999999999999999999999999999999999999


Q ss_pred             Eec---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           78 LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++.   ++.++|+|||++.............+++.|+|||++.. ..++.++|||||||++++|++|..||.+.+.....
T Consensus       164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  242 (327)
T 3lm5_A          164 LSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY  242 (327)
T ss_dssp             ESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence            987   78999999999987766555566789999999999854 45899999999999999999999999888777666


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+.......+                          ...++.+++.+++||.+||+.||.+|||++++|+||||+.+.
T Consensus       243 ~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          243 LNISQVNVDYS--------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HHHHHTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HHHHhcccccC--------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            55544322211                          123346788999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=301.38  Aligned_cols=201  Identities=21%  Similarity=0.352  Sum_probs=169.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus       121 p~Iv~l~~~~~~~-----~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl  195 (412)
T 2vd5_A          121 RWITQLHFAFQDE-----NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL  195 (412)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCeeeEEEEEeeC-----CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence            7999999999987     89999999995 7999999874 479999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhC------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      +.+|.+||+|||++........  ....+||+.|+|||++..      ...++.++|+|||||++|+|++|.+||.+.+.
T Consensus       196 d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  275 (412)
T 2vd5_A          196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST  275 (412)
T ss_dssp             CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence            9999999999999987654332  234689999999999863      34589999999999999999999999998887


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCC
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDALAHP  227 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~ell~hp  227 (277)
                      .+....+......                         ..++...+.+++++++||++||+ +|.+|   ++++++++||
T Consensus       276 ~~~~~~i~~~~~~-------------------------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          276 AETYGKIVHYKEH-------------------------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHHHHHHHTHHHH-------------------------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             HHHHHHHHhcccC-------------------------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            7776666532100                         00111123678999999999999 99998   5999999999


Q ss_pred             CCCCC
Q 023764          228 YLGSL  232 (277)
Q Consensus       228 ~f~~~  232 (277)
                      ||+.+
T Consensus       330 ff~~i  334 (412)
T 2vd5_A          330 FFFGL  334 (412)
T ss_dssp             GGTTC
T ss_pred             CcCCC
Confidence            99875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-41  Score=316.23  Aligned_cols=196  Identities=21%  Similarity=0.415  Sum_probs=172.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++++++|.+.     +.+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       402 ~~i~~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~  476 (674)
T 3pfq_A          402 PFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD  476 (674)
T ss_dssp             TTBCCEEEECBCS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC
T ss_pred             CeEEEEEEEEEeC-----CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc
Confidence            7899999999887     89999999996 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeecc-CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||++.... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.
T Consensus       477 ~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  555 (674)
T 3pfq_A          477 SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  555 (674)
T ss_dssp             SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            99999999999998633 3334556789999999999854 458999999999999999999999999988777766665


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~f~~~  232 (277)
                      .....                              ..+.+++++++||++||+.||.+|+++     +++++||||+.+
T Consensus       556 ~~~~~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          556 EHNVA------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             SSCCC------------------------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             hCCCC------------------------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            31100                              112578999999999999999999997     999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-41  Score=283.52  Aligned_cols=203  Identities=29%  Similarity=0.502  Sum_probs=173.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+. ++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~  139 (284)
T 3kk8_A           65 PNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA  139 (284)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred             CCcCeEEEEEEcC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence            7999999999887     88999999996 59999998888899999999999999999999999999999999999997


Q ss_pred             cCCC---eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.   ++|+|||.+.............+++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......
T Consensus       140 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  218 (284)
T 3kk8_A          140 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  218 (284)
T ss_dssp             SSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH
Confidence            6655   99999999987776655566789999999999854 4589999999999999999999999988877665555


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      +.......+                          ...++.+++++.+||.+||+.||++|||++++++||||+.....
T Consensus       219 ~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          219 IKAGAYDYP--------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHHTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHhccccCC--------------------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            443211111                          11234678899999999999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=293.39  Aligned_cols=201  Identities=30%  Similarity=0.492  Sum_probs=158.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..+     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       108 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~  182 (349)
T 2w4o_A          108 PNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA  182 (349)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred             CCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence            7999999999887     88999999996 69999999888899999999999999999999999999999999999997


Q ss_pred             c---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-HHH
Q 023764           80 A---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH-QLR  155 (277)
Q Consensus        80 ~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~  155 (277)
                      .   ++.++|+|||++.............|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ...
T Consensus       183 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  261 (349)
T 2w4o_A          183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR  261 (349)
T ss_dssp             SSSTTCCEEECCCC----------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH
T ss_pred             cCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH
Confidence            5   88999999999987665544556789999999999865 458999999999999999999999997765544 222


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .+.....                          ......++.++.++++||++||+.||++|||+.++++||||....
T Consensus       262 ~i~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          262 RILNCEY--------------------------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHTTCC--------------------------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHhCCC--------------------------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            2221100                          011122346788999999999999999999999999999998743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-41  Score=306.57  Aligned_cols=199  Identities=33%  Similarity=0.572  Sum_probs=172.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+|||||. |+|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        96 pniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  170 (494)
T 3lij_A           96 PNIMKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE  170 (494)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred             CCCCeEEEEEEeC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEe
Confidence            8999999999887     89999999996 59999998888899999999999999999999999999999999999997


Q ss_pred             c---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 A---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .   ++.+||+|||++.............||+.|+|||++.  ..++.++||||+||++|+|++|.+||.+.+..+....
T Consensus       171 ~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  248 (494)
T 3lij_A          171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK  248 (494)
T ss_dssp             CSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            6   4559999999998877666666778999999999884  3489999999999999999999999998887776666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +.......+                          ...++.+++.+++||++||+.||.+|||+.++|+||||+..
T Consensus       249 i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          249 VEKGKYTFD--------------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHTCCCCC--------------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHhCCCCCC--------------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            544221111                          12234678999999999999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.1e-42  Score=301.54  Aligned_cols=205  Identities=28%  Similarity=0.468  Sum_probs=158.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||++++++|.... .+.+++|+||||++ |+|.+++...+  .+++..++.++.|++.||.|||++||+||||||+||+
T Consensus       115 p~iv~l~~~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil  193 (400)
T 1nxk_A          115 PHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL  193 (400)
T ss_dssp             TTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCcceEeEEEeecc-cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEE
Confidence            79999999986511 11278999999996 69999998753  5999999999999999999999999999999999999


Q ss_pred             Eec---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH--
Q 023764           78 LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH--  152 (277)
Q Consensus        78 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--  152 (277)
                      ++.   ++.+||+|||++............+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.....  
T Consensus       194 l~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  272 (400)
T 1nxk_A          194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_dssp             ESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred             EecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence            987   7899999999998766555556778999999999885 4558999999999999999999999997654321  


Q ss_pred             --HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          153 --QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       153 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                        ....+..  +.                      +  ......++.++.++++||++||+.||.+|||++++++||||.
T Consensus       273 ~~~~~~i~~--~~----------------------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          273 PGMKTRIRM--GQ----------------------Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             CSHHHHHHH--TC----------------------C--CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHHHHc--Cc----------------------c--cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence              1111110  00                      0  000112346889999999999999999999999999999998


Q ss_pred             CCC
Q 023764          231 SLH  233 (277)
Q Consensus       231 ~~~  233 (277)
                      ...
T Consensus       327 ~~~  329 (400)
T 1nxk_A          327 QST  329 (400)
T ss_dssp             TTT
T ss_pred             CCC
Confidence            644

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-41  Score=306.59  Aligned_cols=201  Identities=28%  Similarity=0.487  Sum_probs=175.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+|||||+ |+|.+.+.+.+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       106 pniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          106 PNIIKLFDVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE  180 (504)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred             CCCCeEEEEEEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEe
Confidence            8999999999887     89999999996 59999998888899999999999999999999999999999999999998


Q ss_pred             cCC---CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++   .++|+|||++.............||+.|+|||++.  ..++.++||||+||++|+|++|.+||.+.+.......
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  258 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK  258 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            776   69999999998877665666778999999999985  3489999999999999999999999999887776666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +.......+.                          ..++.+++++++||++||+.||.+|||++++|+||||+....
T Consensus       259 i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          259 VEKGKYYFDF--------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHCCCCCCH--------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             HHcCCCCCCc--------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            5542211111                          122467889999999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.3e-42  Score=297.75  Aligned_cols=200  Identities=28%  Similarity=0.437  Sum_probs=171.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus       146 pnIv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  220 (373)
T 2x4f_A          146 ANLIQLYDAFESK-----NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC  220 (373)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence            8999999999887     88999999996 5999888654 469999999999999999999999999999999999999


Q ss_pred             --ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                        +.++.++|+|||++.............|++.|+|||++.. ..++.++|||||||++++|++|..||.+.+....+..
T Consensus       221 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  299 (373)
T 2x4f_A          221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN  299 (373)
T ss_dssp             EETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             ecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence              4567899999999988766655566689999999998854 4589999999999999999999999998887776666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      +......++                          ...++.+++++++||.+||+.||.+|||++++++||||+..
T Consensus       300 i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          300 ILACRWDLE--------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHTCCCSC--------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHhccCCCC--------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            554211111                          12335688999999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.2e-41  Score=288.44  Aligned_cols=225  Identities=30%  Similarity=0.562  Sum_probs=179.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      +||+++++++...     +++|+||||++++|.+++...+  .+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        77 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  151 (339)
T 1z57_A           77 FRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF  151 (339)
T ss_dssp             TCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             eeeEeeecccccC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE
Confidence            4689999999887     8999999999999999998765  68999999999999999999999999999999999999


Q ss_pred             ec-------------------CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHH
Q 023764           79 NA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  139 (277)
Q Consensus        79 ~~-------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll  139 (277)
                      +.                   ++.++|+|||++......  .....+++.|+|||++.+ ..++.++|||||||++++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~  228 (339)
T 1z57_A          152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYY  228 (339)
T ss_dssp             SCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHH
T ss_pred             eccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHH
Confidence            87                   678999999999875543  345678999999999864 45899999999999999999


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhH---------------HHHhhhCCcccCCcccccCCCCChhHHH
Q 023764          140 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA---------------KKYICQLPRYQRQSFTEKFPNVHPSAID  204 (277)
Q Consensus       140 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (277)
                      +|..||.+.+..+....+....+..+...+.......               ..+....... ........+..++++.+
T Consensus       229 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             HSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHH
Confidence            9999999999988888888888877765443221100               0000000000 00000111123567899


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          205 LVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       205 li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ||.+||+.||.+|||++|+++||||+.++.
T Consensus       308 li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence            999999999999999999999999998653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-41  Score=307.09  Aligned_cols=201  Identities=32%  Similarity=0.579  Sum_probs=170.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+.+.+.+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        81 pniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~  155 (486)
T 3mwu_A           81 PNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE  155 (486)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEES
T ss_pred             CCcCeEEEEEEcC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence            8999999999887     89999999996 59999998888999999999999999999999999999999999999994


Q ss_pred             ---cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ---ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                         .++.+||+|||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus       156 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  233 (486)
T 3mwu_A          156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR  233 (486)
T ss_dssp             SSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               456799999999977665555566789999999999854  489999999999999999999999998887776665


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +........                          ...++.+|+++++||++||+.||.+|||+.++|+||||+....
T Consensus       234 i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          234 VETGKYAFD--------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             HHHTCCCSC--------------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             HHhCCCCCC--------------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            544211111                          1122357889999999999999999999999999999987643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-41  Score=288.48  Aligned_cols=227  Identities=28%  Similarity=0.573  Sum_probs=174.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++.   ....|+||||++ ++|.+++..   +++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        91 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~  164 (330)
T 3nsz_A           91 PNIITLADIVKDPV---SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID  164 (330)
T ss_dssp             TTBCCEEEEEECTT---TCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             CCEEEeeeeeccCC---CCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc
Confidence            79999999998742   178999999997 588888753   89999999999999999999999999999999999999


Q ss_pred             cCC-CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHH
Q 023764           80 ANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-GRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i  157 (277)
                      .++ .++|+|||++.............+++.|+|||++.+...++.++|||||||++++|++|..||. +.+....+..+
T Consensus       165 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~  244 (330)
T 3nsz_A          165 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  244 (330)
T ss_dssp             TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence            777 7999999999877665556667889999999999765678999999999999999999999984 55666666666


Q ss_pred             HHHhCCCChHhhhhh-hh-hHHHHhhhCCcccCCcccccC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          158 IELIGTPSEAELGFL-NE-NAKKYICQLPRYQRQSFTEKF-----PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ....+.+........ .. ....+...........+....     +.+++++++||.+||+.||.+|||++++|+||||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            666554322111000 00 000000001111111111111     23789999999999999999999999999999999


Q ss_pred             CCC
Q 023764          231 SLH  233 (277)
Q Consensus       231 ~~~  233 (277)
                      .+.
T Consensus       325 ~~~  327 (330)
T 3nsz_A          325 TVV  327 (330)
T ss_dssp             TCC
T ss_pred             hhc
Confidence            865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-41  Score=292.60  Aligned_cols=199  Identities=31%  Similarity=0.494  Sum_probs=163.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.++     +.+|+||||++ ++|.+.+.+.    ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus        86 pnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N  160 (351)
T 3c0i_A           86 PHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC  160 (351)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence            8999999999887     89999999997 6998877542    358999999999999999999999999999999999


Q ss_pred             EEEecCCC---eEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           76 LLLNANCD---LKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        76 il~~~~~~---~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      |+++.++.   ++|+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.. .
T Consensus       161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~  238 (351)
T 3c0i_A          161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-E  238 (351)
T ss_dssp             EEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-H
T ss_pred             eEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-H
Confidence            99976654   9999999998765543 2345679999999999864 458999999999999999999999997743 2


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .....+.......                          ....++.++.++++||++||+.||++|||+.++++||||+.
T Consensus       239 ~~~~~i~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          239 RLFEGIIKGKYKM--------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHHHHTCCCC--------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHcCCCCC--------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            2222222211111                          11223467889999999999999999999999999999986


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      .
T Consensus       293 ~  293 (351)
T 3c0i_A          293 R  293 (351)
T ss_dssp             H
T ss_pred             C
Confidence            4

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.1e-42  Score=307.92  Aligned_cols=201  Identities=31%  Similarity=0.527  Sum_probs=174.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~-   78 (277)
                      |||+++++++.+.     +.+|+||||+. ++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||++ 
T Consensus        86 pniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  160 (484)
T 3nyv_A           86 PNIMKLYEFFEDK-----GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLE  160 (484)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CCCCcEEEEEEeC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEe
Confidence            8999999999887     89999999996 6999999988999999999999999999999999999999999999999 


Q ss_pred             --ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                        +.++.++|+|||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+....
T Consensus       161 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  238 (484)
T 3nyv_A          161 SKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK  238 (484)
T ss_dssp             SSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence              5678999999999987666555566789999999999864  489999999999999999999999998887776666


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +........                          ...++.+++++++||++||+.||.+|||++++|+||||+....
T Consensus       239 i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          239 VEKGKYTFE--------------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHCCCCCC--------------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHcCCCCCC--------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            544211111                          1122357889999999999999999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-41  Score=289.51  Aligned_cols=218  Identities=24%  Similarity=0.371  Sum_probs=157.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        71 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~  145 (316)
T 2ac3_A           71 RNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE  145 (316)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred             CCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence            7999999999887     89999999997 69999998888899999999999999999999999999999999999998


Q ss_pred             cCCC---eEEeeccceeeccCC--------CcccccccccccCChhhhhCC----CCCCcchhHHHHHHHHHHHHcCCCC
Q 023764           80 ANCD---LKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPL  144 (277)
Q Consensus        80 ~~~~---~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~p  144 (277)
                      .++.   ++|+|||++......        .......|++.|+|||++...    ..++.++||||+||++++|++|..|
T Consensus       146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p  225 (316)
T 2ac3_A          146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP  225 (316)
T ss_dssp             CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence            8766   999999998654321        112344689999999998541    3368899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      |.+....+.....    ..........+   ........    .......++.+++++++||++||+.||.+|||+++++
T Consensus       226 f~~~~~~~~~~~~----~~~~~~~~~~~---~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          226 FVGRCGSDCGWDR----GEACPACQNML---FESIQEGK----YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             CCCCCCSCSCC--------CCHHHHHHH---HHHHHHCC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             Ccccccccccccc----cccchhHHHHH---HHHHhccC----cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence            9765421100000    00000000000   00000000    0001112246788999999999999999999999999


Q ss_pred             cCCCCCCCCC
Q 023764          225 AHPYLGSLHD  234 (277)
Q Consensus       225 ~hp~f~~~~~  234 (277)
                      +||||+....
T Consensus       295 ~hp~~~~~~~  304 (316)
T 2ac3_A          295 QHPWVQGCAP  304 (316)
T ss_dssp             HSTTCC----
T ss_pred             cChhhcCCCC
Confidence            9999997643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.6e-41  Score=283.34  Aligned_cols=203  Identities=27%  Similarity=0.506  Sum_probs=173.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++..+..+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        84 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  158 (298)
T 1phk_A           84 PNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD  158 (298)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCEeeeeeeeccC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc
Confidence            7999999999887     89999999997 69999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhh-----CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||++.............+++.|+|||++.     ....++.++|||||||++++|++|..||.+.+.....
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  238 (298)
T 1phk_A          159 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML  238 (298)
T ss_dssp             TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence            99999999999998776655556678899999999985     2345789999999999999999999999887766555


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+.......+                          ....+.++..+.+||.+||+.||.+|||++++++||||+....
T Consensus       239 ~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          239 RMIMSGNYQFG--------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             HHHHHTCCCCC--------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             HHHhcCCcccC--------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            54443211111                          0112356789999999999999999999999999999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-41  Score=281.79  Aligned_cols=197  Identities=29%  Similarity=0.477  Sum_probs=158.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+.+..    ...+++..+..++.|++.||+|||++||+||||||+|
T Consensus        80 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N  154 (285)
T 3is5_A           80 PNIIKIFEVFEDY-----HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN  154 (285)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred             chHHhHHHheecC-----CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHH
Confidence            8999999999887     88999999997 599888853    3679999999999999999999999999999999999


Q ss_pred             EEE---ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           76 LLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        76 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      |++   +.++.++|+|||++.............+++.|+|||++.  ..++.++|||||||++++|++|..||.+.+...
T Consensus       155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~  232 (285)
T 3is5_A          155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE  232 (285)
T ss_dssp             EEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH
Confidence            999   556889999999998766555556678899999999884  347899999999999999999999998876555


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ....+....                           .........+++++++||.+||+.||++|||++++++||||+.
T Consensus       233 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          233 VQQKATYKE---------------------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHCC---------------------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHhhhccCC---------------------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            443322210                           0111112246889999999999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.5e-41  Score=284.79  Aligned_cols=199  Identities=28%  Similarity=0.450  Sum_probs=154.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~n   75 (277)
                      |||+++++++.+.     ++.|+||||++|+|.+++.    ....+++..+..++.|++.||+|||++ |++||||||+|
T Consensus        66 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~N  140 (290)
T 3fme_A           66 PFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN  140 (290)
T ss_dssp             TTBCCEEEEEECS-----SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGG
T ss_pred             CeEEEEeeeeecc-----CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence            7999999999887     8899999999998877765    356899999999999999999999998 99999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhh---hCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-H
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-V  151 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~  151 (277)
                      |+++.++.++|+|||++.............+++.|+|||.+   .....++.++||||+||++++|++|..||.+... .
T Consensus       141 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  220 (290)
T 3fme_A          141 VLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF  220 (290)
T ss_dssp             CEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH
T ss_pred             EEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH
Confidence            99999999999999999876655545556789999999997   3445588999999999999999999999976433 2


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .......... .+                           ......+++++.+||.+||+.||++|||++++++||||+.
T Consensus       221 ~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          221 QQLKQVVEEP-SP---------------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHSC-CC---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHhccC-CC---------------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            2222222110 00                           0111357889999999999999999999999999999986


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      .
T Consensus       273 ~  273 (290)
T 3fme_A          273 H  273 (290)
T ss_dssp             H
T ss_pred             C
Confidence            4

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-41  Score=288.77  Aligned_cols=213  Identities=18%  Similarity=0.261  Sum_probs=148.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--------~i~H~di   71 (277)
                      ||||++++++.++.. ....+|||||||+ |+|.+++.. .+++++.+.+++.|++.||+|||++        +|+||||
T Consensus        57 pNIv~l~g~~~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDl  134 (303)
T 3hmm_A           57 ENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL  134 (303)
T ss_dssp             TTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCC
T ss_pred             CCCCcEEEEEEecCC-CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccC
Confidence            899999999986521 1146899999997 699999987 4699999999999999999999987        9999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCC-----CCCcchhHHHHHHHHHHHHcC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g  141 (277)
                      ||+|||++.++.+||+|||+++......     .....+||+.|+|||++.+..     .++.++||||+||++|||++|
T Consensus       135 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg  214 (303)
T 3hmm_A          135 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  214 (303)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHC
Confidence            9999999999999999999998654432     123457999999999986432     256799999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC--CCCChhHHHHHHHhcCCCCCCCCC
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                      .+||......+....- .....+....       .......  ...++.++...  ...+..+.+|+.+||+.||++|||
T Consensus       215 ~~~~~~~~~~~~p~~~-~~~~~~~~~~-------~~~~~~~--~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt  284 (303)
T 3hmm_A          215 CSIGGIHEDYQLPYYD-LVPSDPSVEE-------MRKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT  284 (303)
T ss_dssp             BCBTTBCCCCCCTTTT-TSCSSCCHHH-------HHHHHTT--SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred             CCCCCccccccccchh-cccccchHHH-------HHHHHhc--ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC
Confidence            8877433211000000 0000000000       0000000  00001111111  112346789999999999999999


Q ss_pred             HHHHhc
Q 023764          220 VEDALA  225 (277)
Q Consensus       220 ~~ell~  225 (277)
                      +.++++
T Consensus       285 ~~ei~~  290 (303)
T 3hmm_A          285 ALRIKK  290 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.3e-41  Score=287.47  Aligned_cols=192  Identities=21%  Similarity=0.378  Sum_probs=165.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ | +|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        89 ~~Iv~~~~~~~~~-----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  163 (335)
T 3dls_A           89 ANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI  163 (335)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCEeeEEEEEeeC-----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE
Confidence            8999999999887     89999999985 5 999999998899999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+....      .
T Consensus       164 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~  237 (335)
T 3dls_A          164 AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V  237 (335)
T ss_dssp             CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T
T ss_pred             cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H
Confidence            9999999999999988776665666789999999999976554588999999999999999999999542110      0


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                                                    .........+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       238 ------------------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          238 ------------------------------EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ------------------------------TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ------------------------------hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                                          000011124688999999999999999999999999999998743

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-41  Score=308.12  Aligned_cols=197  Identities=28%  Similarity=0.486  Sum_probs=166.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+||+
T Consensus       244 p~Iv~l~~~~~~~-----~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL  318 (576)
T 2acx_A          244 RFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL  318 (576)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCEeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence            7999999999887     89999999995 69999998754  4999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---HHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV---HQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~  154 (277)
                      ++.+|.+||+|||++............+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+....   ..+
T Consensus       319 ld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i  397 (576)
T 2acx_A          319 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV  397 (576)
T ss_dssp             ECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH
T ss_pred             EeCCCCeEEEecccceecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH
Confidence            99999999999999988766555566789999999999865 45899999999999999999999999865421   111


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  229 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f  229 (277)
                      .......                      +    .   ...+.+++++++||++||+.||.+||     |++++++||||
T Consensus       398 ~~~i~~~----------------------~----~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF  448 (576)
T 2acx_A          398 ERLVKEV----------------------P----E---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF  448 (576)
T ss_dssp             HHHHHHC----------------------C----C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred             HHHhhcc----------------------c----c---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence            1111100                      0    0   11135789999999999999999999     89999999999


Q ss_pred             CCC
Q 023764          230 GSL  232 (277)
Q Consensus       230 ~~~  232 (277)
                      +.+
T Consensus       449 ~~i  451 (576)
T 2acx_A          449 KKL  451 (576)
T ss_dssp             TTC
T ss_pred             ccC
Confidence            975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-40  Score=284.24  Aligned_cols=199  Identities=27%  Similarity=0.496  Sum_probs=167.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus       102 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            7999999999887     88999999996 589998865 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......||+.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+.
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~  254 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR  254 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            9999999999998766543 23345679999999999854 458999999999999999999999998877665554443


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..... .                          ......+++.+++||.+||+.||++|||++++++||||....
T Consensus       255 ~~~~~-~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          255 DSPPP-K--------------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HSSCC-C--------------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             cCCCC-C--------------------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            21100 0                          001124678899999999999999999999999999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.5e-41  Score=294.52  Aligned_cols=226  Identities=28%  Similarity=0.466  Sum_probs=173.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil   77 (277)
                      |||+++++++...+..+ .++|+||||++++|.+.+...  ..+++..++.++.||+.||+|||++ ||+||||||+||+
T Consensus       101 ~~iv~~~~~~~~~~~~~-~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIl  179 (397)
T 1wak_A          101 EMVVQLLDDFKISGVNG-THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL  179 (397)
T ss_dssp             GGBCCEEEEEEEEETTE-EEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEE
T ss_pred             ceeeeeecceeecCCCC-ceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHee
Confidence            57999999997432111 789999999999888887654  5699999999999999999999998 9999999999999


Q ss_pred             EecCC-------------------------------------------------CeEEeeccceeeccCCCccccccccc
Q 023764           78 LNANC-------------------------------------------------DLKICDFGLARVTSETDFMTEYVVTR  108 (277)
Q Consensus        78 ~~~~~-------------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~  108 (277)
                      ++.++                                                 .++|+|||++......  .....+|+
T Consensus       180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~  257 (397)
T 1wak_A          180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR  257 (397)
T ss_dssp             ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCG
T ss_pred             EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCC
Confidence            98775                                                 7999999999876543  34567899


Q ss_pred             ccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhh
Q 023764          109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSEAELGFLNENAKKYICQ  182 (277)
Q Consensus       109 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  182 (277)
                      .|+|||++.+. .++.++|||||||++|+|++|..||.+.+      ....+..+.+..+.++...+....... .+...
T Consensus       258 ~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~  335 (397)
T 1wak_A          258 QYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK-EFFTK  335 (397)
T ss_dssp             GGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG-GTBCT
T ss_pred             cccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc-cccCC
Confidence            99999999764 48999999999999999999999997655      566788888888888765442211110 00000


Q ss_pred             CCcccCC------c----cccc---CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          183 LPRYQRQ------S----FTEK---FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       183 ~~~~~~~------~----~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .......      .    +...   ....+.++++||.+||+.||++|||++++|+||||++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000000      0    0000   0123457899999999999999999999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.7e-41  Score=280.90  Aligned_cols=196  Identities=25%  Similarity=0.418  Sum_probs=165.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        69 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~  143 (279)
T 3fdn_A           69 PNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG  143 (279)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC
T ss_pred             CCCcchhheEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc
Confidence            7999999999887     88999999997 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++...... ......+++.|+|||.+.+ ..++.++||||+||++++|++|..||.+.+.......+..
T Consensus       144 ~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  221 (279)
T 3fdn_A          144 SAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR  221 (279)
T ss_dssp             TTSCEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh
Confidence            9999999999988654433 2345578999999999854 4578999999999999999999999988776665554433


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ....                              .....+.++++||.+||+.||.+|||++++++||||+...
T Consensus       222 ~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          222 VEFT------------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             TCCC------------------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             CCCC------------------------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            1111                              1124678899999999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=285.08  Aligned_cols=198  Identities=25%  Similarity=0.504  Sum_probs=161.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+..   .+.+|+||||++ ++|.+++. .+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        96 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  171 (298)
T 2zv2_A           96 PNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG  171 (298)
T ss_dssp             TTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence            79999999998642   178999999997 57776543 46799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+...  ++.++|||||||++++|++|..||.+.........
T Consensus       172 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  251 (298)
T 2zv2_A          172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK  251 (298)
T ss_dssp             TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence            9999999999999876543 23345678999999999855432  37789999999999999999999987765444333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      +......                      .      ...+.+++++++||.+||+.||++|||++++++||||+
T Consensus       252 ~~~~~~~----------------------~------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          252 IKSQALE----------------------F------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHCCCC----------------------C------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HhcccCC----------------------C------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            3221000                      0      11246788999999999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-40  Score=284.26  Aligned_cols=222  Identities=29%  Similarity=0.555  Sum_probs=176.9

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-   78 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~-   78 (277)
                      +++.+++++...     +++|+||||+++++.+.+....  .+++..+..++.|++.||+|||++||+||||||+||++ 
T Consensus        83 ~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~  157 (355)
T 2eu9_A           83 LCVLMSDWFNFH-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFV  157 (355)
T ss_dssp             CBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEES
T ss_pred             eEEEeeeeeeeC-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence            488888888887     8999999999999988887653  69999999999999999999999999999999999999 


Q ss_pred             ------------------ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           79 ------------------NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        79 ------------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                                        +.++.++|+|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             CCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHh
Confidence                              67889999999999875543  345678999999999865 458999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhH---------------HHHhh-hCCcccCCcccccCCCCChhHHH
Q 023764          141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA---------------KKYIC-QLPRYQRQSFTEKFPNVHPSAID  204 (277)
Q Consensus       141 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  204 (277)
                      |..||.+.+.......+.+..+.++...+.......               ..+.. ......  .........+.++.+
T Consensus       235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~  312 (355)
T 2eu9_A          235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK--SYMLQDSLEHVQLFD  312 (355)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG--GGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccc--ccccccchhHHHHHH
Confidence            999999999988888888888887775543221100               00000 000000  000001122457899


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          205 LVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       205 li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ||++||+.||++|||++++++||||+.+.
T Consensus       313 li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          313 LMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             HHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            99999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.6e-41  Score=280.76  Aligned_cols=197  Identities=26%  Similarity=0.440  Sum_probs=159.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        71 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  145 (276)
T 2h6d_A           71 PHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD  145 (276)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC
T ss_pred             CCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC
Confidence            7999999999887     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++.............+++.|+|||.+.+....+.++||||+||++++|++|..||.+.........+..
T Consensus       146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  225 (276)
T 2h6d_A          146 AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG  225 (276)
T ss_dssp             TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            99999999999998766554445667899999999986554446899999999999999999999987765554443322


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ...                              .....++..+.++|.+||+.||.+|||++++++||||+..
T Consensus       226 ~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          226 GVF------------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             CCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             Ccc------------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            100                              0112467889999999999999999999999999999764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-40  Score=279.05  Aligned_cols=197  Identities=23%  Similarity=0.444  Sum_probs=168.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++
T Consensus        74 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  148 (284)
T 2vgo_A           74 PNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG  148 (284)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             CCEeeEEEEEEcC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc
Confidence            7999999999887     89999999996 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++|+|||++...... ......+++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+..
T Consensus       149 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  226 (284)
T 2vgo_A          149 YKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN  226 (284)
T ss_dssp             TTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             CCCCEEEecccccccCccc-ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc
Confidence            9999999999998765443 2345678999999999864 4579999999999999999999999987776554443332


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ...                              ...+.++.++++||.+||+.||.+|||++++++||||+....
T Consensus       227 ~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          227 VDL------------------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             TCC------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             ccc------------------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            100                              011357889999999999999999999999999999987543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-40  Score=286.48  Aligned_cols=196  Identities=26%  Similarity=0.403  Sum_probs=166.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||+.|+|.+++. ....+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       114 pniv~~~~~~~~~-----~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  188 (348)
T 1u5q_A          114 PNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS  188 (348)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred             CCEeeEEEEEEEC-----CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence            8999999999887     8999999999999988885 456799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.+||+|||++......   ....|++.|+|||++..  ...++.++|||||||++++|++|..||.+.+.......+
T Consensus       189 ~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  265 (348)
T 1u5q_A          189 EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  265 (348)
T ss_dssp             TTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999999999998765432   34578999999999853  455889999999999999999999999887766554443


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .... .+.                           ......+..+++||.+||+.||++|||++++++||||...
T Consensus       266 ~~~~-~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          266 AQNE-SPA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHSC-CCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HhcC-CCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            3211 000                           0113567889999999999999999999999999999763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-40  Score=285.01  Aligned_cols=203  Identities=31%  Similarity=0.466  Sum_probs=171.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       101 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~  175 (335)
T 2owb_A          101 QHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN  175 (335)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             CCCCeEEEEEecC-----CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc
Confidence            7999999999887     89999999997 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||++.+. .++.++|||||||++++|++|..||.+.........+.
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  254 (335)
T 2owb_A          176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK  254 (335)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh
Confidence            9999999999999865432 234456789999999998654 47899999999999999999999998776555443332


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ....                              .....+++.+.+||++||+.||++|||++++++||||.....+...
T Consensus       255 ~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~  304 (335)
T 2owb_A          255 KNEY------------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  304 (335)
T ss_dssp             HTCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             cCCC------------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccC
Confidence            2100                              0112567889999999999999999999999999999887655544


Q ss_pred             C
Q 023764          239 P  239 (277)
Q Consensus       239 ~  239 (277)
                      +
T Consensus       305 ~  305 (335)
T 2owb_A          305 P  305 (335)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=286.04  Aligned_cols=199  Identities=26%  Similarity=0.396  Sum_probs=158.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.+.     +.+|+|||+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++ 
T Consensus        69 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-  142 (343)
T 3dbq_A           69 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-  142 (343)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-
T ss_pred             CceEEEeeeEeeC-----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-
Confidence            7999999999887     8999999988899999999989999999999999999999999999999999999999997 


Q ss_pred             CCCeEEeeccceeeccCCC---cccccccccccCChhhhhC----------CCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           81 NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN----------SSDYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      ++.+||+|||++.......   ......||+.|+|||++.+          ...++.++|||||||++++|++|..||.+
T Consensus       143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            6789999999997654332   2335679999999999853          24578999999999999999999999976


Q ss_pred             CChHH-HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          148 RDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       148 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..... ....+.   ....                         ........+.++.+||.+||+.||.+|||+.++++|
T Consensus       223 ~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          223 IINQISKLHAII---DPNH-------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCSHHHHHHHHH---CTTS-------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHHHHHh---cCCc-------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            43321 111111   1000                         001112346789999999999999999999999999


Q ss_pred             CCCCCCC
Q 023764          227 PYLGSLH  233 (277)
Q Consensus       227 p~f~~~~  233 (277)
                      |||+...
T Consensus       275 p~~~~~~  281 (343)
T 3dbq_A          275 PYVQIQT  281 (343)
T ss_dssp             HHHHSCC
T ss_pred             ccccccC
Confidence            9998644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-40  Score=278.60  Aligned_cols=202  Identities=27%  Similarity=0.487  Sum_probs=167.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.+...+++..+..++.|++.||.|||++|++||||+|+||+++
T Consensus        68 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~  142 (283)
T 3bhy_A           68 PNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL  142 (283)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred             CCeeehhheecCC-----CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe
Confidence            7999999999887     88999999996 69999998878899999999999999999999999999999999999998


Q ss_pred             cCC----CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++    .++|+|||.+.............+++.|+|||++.. ..++.++||||+||++++|++|..||.+.+......
T Consensus       143 ~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  221 (283)
T 3bhy_A          143 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLT  221 (283)
T ss_dssp             CSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             cCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH
Confidence            877    899999999987665544556678999999999854 458999999999999999999999998877665554


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .+.......+                          ....+..+..+++||.+||+.||++|||+.++++||||+..+.
T Consensus       222 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          222 NISAVNYDFD--------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHTTCCCCC--------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HhHhcccCCc--------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            4432111111                          1223467889999999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.6e-41  Score=288.36  Aligned_cols=203  Identities=24%  Similarity=0.438  Sum_probs=164.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----------------------------------------C
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----------------------------------------N   39 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----------------------------------------~   39 (277)
                      |||+++++++.+.     +..|+||||++ |+|.+++..                                        .
T Consensus        88 pniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (345)
T 3hko_A           88 PNIARLYEVYEDE-----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD  162 (345)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred             CCcceeehhhccC-----CeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence            8999999999887     89999999995 699998852                                        1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCC--CeEEeeccceeeccCCC-----cccccccccccCC
Q 023764           40 QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARVTSETD-----FMTEYVVTRWYRA  112 (277)
Q Consensus        40 ~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~a  112 (277)
                      ..+++..++.++.|++.||+|||++||+||||||+||+++.++  .++|+|||++.......     ......+++.|+|
T Consensus       163 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          163 FVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            1246788899999999999999999999999999999998776  89999999998654321     2345678999999


Q ss_pred             hhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc
Q 023764          113 PELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF  191 (277)
Q Consensus       113 PE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (277)
                      ||++.+. ..++.++|||||||++++|++|..||.+.+..+....+.........                         
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------  297 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------  297 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------
Confidence            9998642 45889999999999999999999999988877766655542211111                         


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       192 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                       ...+.+++++++||.+||+.||.+|||+.++++||||+.+.+
T Consensus       298 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          298 -PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             -GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             -cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence             112346889999999999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.2e-40  Score=289.69  Aligned_cols=199  Identities=25%  Similarity=0.403  Sum_probs=159.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++...     +.+|+|||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++ 
T Consensus       116 ~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-  189 (390)
T 2zmd_A          116 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-  189 (390)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-
T ss_pred             CeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-
Confidence            7999999999887     7899999987889999999988999999999999999999999999999999999999995 


Q ss_pred             CCCeEEeeccceeeccCCC---cccccccccccCChhhhhCC----------CCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           81 NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      ++.+||+|||++.......   ......||+.|+|||++.+.          ..++.++|||||||++|+|++|..||.+
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            6899999999997654322   23456799999999998641          3588999999999999999999999976


Q ss_pred             CChH-HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          148 RDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       148 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .... ..+..+..   ...                      ..   ......+.++.+||.+||+.||.+|||+.++++|
T Consensus       270 ~~~~~~~~~~~~~---~~~----------------------~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          270 IINQISKLHAIID---PNH----------------------EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCHHHHHHHHHC---TTS----------------------CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHHHHHHhC---ccc----------------------cC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            5432 22221111   000                      00   0111346789999999999999999999999999


Q ss_pred             CCCCCCC
Q 023764          227 PYLGSLH  233 (277)
Q Consensus       227 p~f~~~~  233 (277)
                      |||+...
T Consensus       322 p~~~~~~  328 (390)
T 2zmd_A          322 PYVQIQT  328 (390)
T ss_dssp             HHHHSCC
T ss_pred             cCccccC
Confidence            9998654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.7e-40  Score=278.42  Aligned_cols=203  Identities=31%  Similarity=0.469  Sum_probs=171.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        75 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  149 (294)
T 2rku_A           75 QHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN  149 (294)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCEeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc
Confidence            7999999999887     88999999997 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++...... .......+++.|+|||.+.+ ..++.++||||+||++++|++|..||.+....+....+.
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  228 (294)
T 2rku_A          150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK  228 (294)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            9999999999999865432 23445678999999999854 457899999999999999999999998776554433322


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ...                              ......+++.+.+||.+||+.||++|||++++++||||.+...+...
T Consensus       229 ~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~  278 (294)
T 2rku_A          229 KNE------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  278 (294)
T ss_dssp             TTC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             hcc------------------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCC
Confidence            100                              01112567889999999999999999999999999999886655443


Q ss_pred             C
Q 023764          239 P  239 (277)
Q Consensus       239 ~  239 (277)
                      +
T Consensus       279 ~  279 (294)
T 2rku_A          279 P  279 (294)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4e-40  Score=298.74  Aligned_cols=196  Identities=25%  Similarity=0.449  Sum_probs=164.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.+.     +++|+||||+. |+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       245 p~Iv~l~~~~~~~-----~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~N  319 (543)
T 3c4z_A          245 RFIVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN  319 (543)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCEeeEEEEEeeC-----CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHH
Confidence            7999999999887     88999999996 6999998763    469999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCc-ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh----
Q 023764           76 LLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH----  150 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----  150 (277)
                      |+++.+|.+||+|||++........ ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.    
T Consensus       320 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~  398 (543)
T 3c4z_A          320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN  398 (543)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred             EEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence            9999999999999999987654432 334589999999999865 4589999999999999999999999976532    


Q ss_pred             HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhc
Q 023764          151 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALA  225 (277)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~  225 (277)
                      ......+...                      ..        ...+.+++++++||++||+.||.+||+     ++++++
T Consensus       399 ~~~~~~i~~~----------------------~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          399 KELKQRVLEQ----------------------AV--------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHHHHC----------------------CC--------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHHHhhc----------------------cc--------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            2222222110                      00        011357889999999999999999996     589999


Q ss_pred             CCCCCCC
Q 023764          226 HPYLGSL  232 (277)
Q Consensus       226 hp~f~~~  232 (277)
                      ||||+.+
T Consensus       449 Hpff~~i  455 (543)
T 3c4z_A          449 HPLFRDI  455 (543)
T ss_dssp             SGGGTTC
T ss_pred             CccccCC
Confidence            9999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.1e-41  Score=298.07  Aligned_cols=200  Identities=35%  Similarity=0.649  Sum_probs=156.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..      +++|+||||+. ++|.+++..++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus       200 pniv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~  273 (419)
T 3i6u_A          200 PCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS  273 (419)
T ss_dssp             TTBCCCCEEEES------SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CCEeeEEEEEec------CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence            899999999854      56899999996 59999998888999999999999999999999999999999999999996


Q ss_pred             cC---CCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 AN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .+   +.+||+|||++.............||+.|+|||++..  ...++.++||||+||++++|++|.+||.+......+
T Consensus       274 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~  353 (419)
T 3i6u_A          274 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  353 (419)
T ss_dssp             SSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred             cCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence            54   4599999999987766555566789999999999853  345788999999999999999999999765433222


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .........                         ......++.+++.+++||.+||+.||.+|||++++|+||||+.
T Consensus       354 ~~~i~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          354 KDQITSGKY-------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHHHHTTCC-------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHhcCCC-------------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            221111100                         1112333567889999999999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.1e-40  Score=286.94  Aligned_cols=232  Identities=25%  Similarity=0.423  Sum_probs=175.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil   77 (277)
                      |||+++++++...+.. ...+++|||+++++|.+++...  ..+++..+..++.||+.||+|||++ ||+||||||+||+
T Consensus        86 ~~i~~~~~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           86 NHILKLLDHFNHKGPN-GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL  164 (373)
T ss_dssp             TTBCCCCEEEEEEETT-EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred             chHHHHHHHhhccCCC-CceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence            6999999999865221 1489999999999999999864  4599999999999999999999998 9999999999999


Q ss_pred             EecC------CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--
Q 023764           78 LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD--  149 (277)
Q Consensus        78 ~~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--  149 (277)
                      ++.+      +.++|+|||++......  .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+  
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             EeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence            9543      47999999999876543  3455789999999999754 48999999999999999999999997654  


Q ss_pred             ----hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCC------cc----cc---cCCCCChhHHHHHHHhcCC
Q 023764          150 ----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ------SF----TE---KFPNVHPSAIDLVEKMLTF  212 (277)
Q Consensus       150 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----~~---~~~~~~~~~~~li~~~L~~  212 (277)
                          ....+..+.+..+.++...+..... ...+..........      ..    ..   ..+..+.++++||++||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKY-TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTT-HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccch-hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence                5667788888888887754432211 11111100000000      00    00   0113456789999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          213 DPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       213 dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      ||.+|||++++++||||+.......
T Consensus       321 dP~~Rpt~~ell~hp~f~~~~~~~~  345 (373)
T 1q8y_A          321 DPRKRADAGGLVNHPWLKDTLGMEE  345 (373)
T ss_dssp             STTTCBCHHHHHTCGGGTTCTTCTT
T ss_pred             CccccCCHHHHhhChhhhcccCccc
Confidence            9999999999999999998755443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.2e-40  Score=275.52  Aligned_cols=192  Identities=22%  Similarity=0.288  Sum_probs=156.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.++     +..|+||||++ ++|.+++...    +.+++..+..++.|++.||.|||++||+||||||+|
T Consensus        71 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N  145 (289)
T 1x8b_A           71 SHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN  145 (289)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHH
Confidence            8999999999887     89999999996 5999999764    679999999999999999999999999999999999


Q ss_pred             EEEecC-------------------CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHH
Q 023764           76 LLLNAN-------------------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  136 (277)
Q Consensus        76 il~~~~-------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~  136 (277)
                      |+++.+                   +.++|+|||.+.......   ...+++.|+|||++.+...++.++|||||||+++
T Consensus       146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~  222 (289)
T 1x8b_A          146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVV  222 (289)
T ss_dssp             EEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHH
Confidence            999844                   479999999998765432   3458999999999976555678999999999999


Q ss_pred             HHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCC
Q 023764          137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  216 (277)
Q Consensus       137 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  216 (277)
                      +|++|.+++......   ..+..                             .......+.+++++.+||.+||+.||.+
T Consensus       223 ~l~~~~~~~~~~~~~---~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~  270 (289)
T 1x8b_A          223 CAAGAEPLPRNGDQW---HEIRQ-----------------------------GRLPRIPQVLSQEFTELLKVMIHPDPER  270 (289)
T ss_dssp             HHTTCCCCCSSSHHH---HHHHT-----------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred             HHhcCCCCCcchhHH---HHHHc-----------------------------CCCCCCCcccCHHHHHHHHHHhCCCccc
Confidence            999999877543221   11110                             0111222367889999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q 023764          217 RITVEDALAHPYLGSL  232 (277)
Q Consensus       217 R~t~~ell~hp~f~~~  232 (277)
                      |||+.++++||||...
T Consensus       271 Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          271 RPSAMALVKHSVLLSA  286 (289)
T ss_dssp             SCCHHHHHTCTTC---
T ss_pred             CCCHHHHhhChHhhhh
Confidence            9999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-40  Score=286.86  Aligned_cols=201  Identities=20%  Similarity=0.372  Sum_probs=163.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus       119 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  193 (355)
T 1vzo_A          119 PFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD  193 (355)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            7999999999887     88999999997 59999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC--CcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.++|+|||++......  .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........
T Consensus       194 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  273 (355)
T 1vzo_A          194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE  273 (355)
T ss_dssp             TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred             CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH
Confidence            9999999999999765332  223445789999999998643 3478999999999999999999999975432111111


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~  231 (277)
                      +....                  ....        ....+.++..+++||.+||+.||.+||     |++++++||||+.
T Consensus       274 ~~~~~------------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          274 ISRRI------------------LKSE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             HHHHH------------------HHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHH------------------hccC--------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            11100                  0000        011235788899999999999999999     9999999999997


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      +
T Consensus       328 ~  328 (355)
T 1vzo_A          328 I  328 (355)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.6e-40  Score=275.72  Aligned_cols=200  Identities=27%  Similarity=0.424  Sum_probs=164.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~  139 (276)
T 2yex_A           65 ENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  139 (276)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCceeeeeEEEcC-----CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc
Confidence            7999999999887     88999999997 59999998878899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH-HH
Q 023764           80 ANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ-LR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~  155 (277)
                      .++.++|+|||.+......   .......+++.|+|||.+.+....+.++||||+||++++|++|..||.+...... ..
T Consensus       140 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  219 (276)
T 2yex_A          140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  219 (276)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH
T ss_pred             cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            9999999999998754322   2234567899999999986554457899999999999999999999976543221 11


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      .+...                            .......+.+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus       220 ~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          220 DWKEK----------------------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHTT----------------------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             Hhhhc----------------------------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            11100                            000011235788999999999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.3e-40  Score=280.63  Aligned_cols=201  Identities=34%  Similarity=0.628  Sum_probs=164.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++..      ++.|+||||++ ++|.+++..++.+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        75 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~  148 (322)
T 2ycf_A           75 PCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS  148 (322)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             CCCceEeeEEcC------CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence            799999999865      34899999996 59999998888999999999999999999999999999999999999998


Q ss_pred             cCCC---eEEeeccceeeccCCCcccccccccccCChhhhh--CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.   ++|+|||++.............+++.|+|||++.  +...++.++|||||||++++|++|..||.+......+
T Consensus       149 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (322)
T 2ycf_A          149 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  228 (322)
T ss_dssp             SSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred             cCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence            7654   9999999998776554445567899999999974  3455789999999999999999999999765432222


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .........                         .......+.++..+.+||.+||+.||.+|||++++++||||+..
T Consensus       229 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          229 KDQITSGKY-------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHHHHTCC-------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HHHHHhCcc-------------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            111111100                         01122234678899999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.7e-40  Score=279.76  Aligned_cols=200  Identities=30%  Similarity=0.496  Sum_probs=169.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~-   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||++ 
T Consensus        66 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~  140 (304)
T 2jam_A           66 ENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL  140 (304)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred             CCeeehhhhcccC-----CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence            7999999999887     89999999996 6999999888889999999999999999999999999999999999999 


Q ss_pred             --ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                        +.++.++|+|||++...... ......+++.|+|||++.+ ..++.++||||+||++++|++|..||.+.........
T Consensus       141 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  218 (304)
T 2jam_A          141 TPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK  218 (304)
T ss_dssp             SSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             cCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence              77899999999998754432 2344568999999999854 4589999999999999999999999988776665555


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +.+.....                          .....+.+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       219 i~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          219 IKEGYYEF--------------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHCCCCC--------------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHcCCCCC--------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            44311110                          0122346788999999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-39  Score=275.20  Aligned_cols=200  Identities=21%  Similarity=0.375  Sum_probs=162.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~nil   77 (277)
                      |||+++++++..... +.+.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.|  ++||||||+||+
T Consensus        85 ~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil  163 (290)
T 1t4h_A           85 PNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF  163 (290)
T ss_dssp             TTBCCEEEEEEEESS-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred             CCeeeeeeeeccccC-CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEE
Confidence            799999999875322 2277999999996 599999998888999999999999999999999999  999999999999


Q ss_pred             Ee-cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++ .++.++|+|||++...... ......+++.|+|||++.+  .++.++||||+||++++|++|..||.+.........
T Consensus       164 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  240 (290)
T 1t4h_A          164 ITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  240 (290)
T ss_dssp             ESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             EECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH
Confidence            97 7899999999998654433 2345578999999998853  489999999999999999999999987655443332


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .......+                           .......++++.+||.+||+.||.+|||++++++||||+.
T Consensus       241 ~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          241 RVTSGVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHTTTCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHhccCCc---------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            22111110                           0111245678999999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.3e-42  Score=299.34  Aligned_cols=177  Identities=17%  Similarity=0.241  Sum_probs=145.4

Q ss_pred             cEEEEeecCcccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccce
Q 023764           20 DVYIAYELMDTDLHQIIRSNQALSE-------EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   92 (277)
Q Consensus        20 ~~~lv~e~~~~~L~~~l~~~~~l~~-------~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~   92 (277)
                      ..|+||||++|+|.+++...+.+++       ..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus       174 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a  253 (377)
T 3byv_A          174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL  253 (377)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence            3899999999999999987655555       788889999999999999999999999999999999999999999999


Q ss_pred             eeccCCCcccccccccccCChhhhhCC----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Q 023764           93 RVTSETDFMTEYVVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG  162 (277)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  162 (277)
                      ...+.  ......| +.|+|||++.+.          ..++.++|||||||++|+|++|..||.+.+.....        
T Consensus       254 ~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~--------  322 (377)
T 3byv_A          254 VRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS--------  322 (377)
T ss_dssp             EETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS--------
T ss_pred             eecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch--------
Confidence            86543  2345567 999999998654          25899999999999999999999999654321100        


Q ss_pred             CCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          163 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                                                .......+.+++++++||.+||+.||.+|||+.++++||||+.+.
T Consensus       323 --------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          323 --------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             --------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             --------------------------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence                                      001112257789999999999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=276.32  Aligned_cols=206  Identities=21%  Similarity=0.391  Sum_probs=166.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++....   .+..|+||||++++|.+++..  ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        66 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~  142 (305)
T 2wtk_C           66 KNVIQLVDVLYNEE---KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL  142 (305)
T ss_dssp             TTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCeeEEEEEEEcCC---CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE
Confidence            79999999985431   178999999999888888875  3579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++......   .......+++.|+|||++.+.. ..+.++|||||||++++|++|..||.+.+.....
T Consensus       143 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  222 (305)
T 2wtk_C          143 TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF  222 (305)
T ss_dssp             CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Confidence            99999999999999765422   2334556899999999986432 2377999999999999999999999887665544


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+....                              ....+..++.+.+||.+||+.||.+|||++++++||||+....
T Consensus       223 ~~i~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          223 ENIGKGS------------------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHCC------------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHhcCC------------------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            4432210                              0111256789999999999999999999999999999998765


Q ss_pred             CCCCC
Q 023764          235 ISDEP  239 (277)
Q Consensus       235 ~~~~~  239 (277)
                      ....+
T Consensus       273 ~~~~~  277 (305)
T 2wtk_C          273 PAEAP  277 (305)
T ss_dssp             C-CCC
T ss_pred             CcCCC
Confidence            55443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=276.33  Aligned_cols=197  Identities=29%  Similarity=0.508  Sum_probs=142.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        71 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili  145 (278)
T 3cok_A           71 PSILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL  145 (278)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred             CCeEeEEEEEccC-----CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            7999999999887     88999999996 6999999875 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++||||+||++++|++|..||...........+
T Consensus       146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  224 (278)
T 3cok_A          146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV  224 (278)
T ss_dssp             CTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C
T ss_pred             cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH
Confidence            99999999999999765432 22334578999999998854 45789999999999999999999999765432221110


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..                        .   .   ......++.++++||.+||+.||++|||++++++||||....
T Consensus       225 ~~------------------------~---~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          225 VL------------------------A---D---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             CS------------------------S---C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             hh------------------------c---c---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            00                        0   0   011124688999999999999999999999999999998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.9e-40  Score=278.42  Aligned_cols=209  Identities=22%  Similarity=0.398  Sum_probs=160.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------NQALSEEHCQYFLYQILRGLKYIHSANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--------~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di   71 (277)
                      |||+++++++...     +..|+||||++ ++|.+++..        .+.+++..+..++.|++.||.|||++|++||||
T Consensus        73 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl  147 (303)
T 2vwi_A           73 PNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV  147 (303)
T ss_dssp             TTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             CCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8999999999887     88999999996 699999873        456999999999999999999999999999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCC------CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSET------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      +|+||+++.++.++|+|||++......      .......+++.|+|||++.....++.++|||||||++++|++|..||
T Consensus       148 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  227 (303)
T 2vwi_A          148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY  227 (303)
T ss_dssp             SGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999998654322      12234578999999999865445799999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+............  +.+...                  ............++.++++||.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          228 HKYPPMKVLMLTLQ--NDPPSL------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTSCGGGHHHHHHT--SSCCCT------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCchhhHHHHHhc--cCCCcc------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            87665443322211  111000                  0000112233567889999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 023764          226 HPYLGSLHD  234 (277)
Q Consensus       226 hp~f~~~~~  234 (277)
                      ||||+....
T Consensus       288 h~~~~~~~~  296 (303)
T 2vwi_A          288 HKFFQKAKN  296 (303)
T ss_dssp             STTC-----
T ss_pred             ChhhhcCCC
Confidence            999998654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.9e-40  Score=275.57  Aligned_cols=200  Identities=33%  Similarity=0.582  Sum_probs=168.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||+. ++|.+.+.+.+.+++..+..++.|++.||.+||++|++|+||+|+||+++
T Consensus        81 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~  155 (287)
T 2wei_A           81 PNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE  155 (287)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CCccEEEEEEeCC-----CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence            7999999999887     88999999996 69999998878899999999999999999999999999999999999996


Q ss_pred             cC---CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 AN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .+   +.++|+|||++.............+++.|+|||.+.+  .++.++|||||||++++|++|..||.+.+.......
T Consensus       156 ~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (287)
T 2wei_A          156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR  233 (287)
T ss_dssp             CSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            54   4699999999877665554556678999999998853  389999999999999999999999988776655544


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +........                          ...++.+++++.+||++||+.||.+|||++++++||||+...
T Consensus       234 ~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          234 VETGKYAFD--------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHCCCCCC--------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHcCCCCCC--------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            433111000                          112246788999999999999999999999999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.6e-39  Score=273.17  Aligned_cols=201  Identities=22%  Similarity=0.404  Sum_probs=161.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        76 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~  150 (302)
T 2j7t_A           76 PYIVKLLGAYYHD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM  150 (302)
T ss_dssp             TTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             CCEeeeeeeeeeC-----CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence            8999999999887     88999999996 589888765 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhh----CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++...... .......+++.|+|||++.    ....++.++|||||||++++|++|..||.+.+....
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  230 (302)
T 2j7t_A          151 TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV  230 (302)
T ss_dssp             CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            99999999999987532211 1223457899999999984    345588999999999999999999999988776554


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...+...... .                          ......++..+.+||.+||+.||.+|||++++++||||+...
T Consensus       231 ~~~~~~~~~~-~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          231 LLKIAKSDPP-T--------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHHSCCC-C--------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHhccCCc-c--------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            4433321100 0                          001124678899999999999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.8e-40  Score=279.17  Aligned_cols=206  Identities=22%  Similarity=0.376  Sum_probs=163.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++......+ ...|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        72 p~iv~~~~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~  150 (311)
T 3ork_A           72 PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS  150 (311)
T ss_dssp             TTBCCEEEEEEEEETTE-EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred             CCcceEEEeeeccCCCC-cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence            89999999997752211 35699999996 69999998888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||++.......    ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+......
T Consensus       151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  229 (311)
T 3ork_A          151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY  229 (311)
T ss_dssp             TTSCEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999997654321    22335689999999998654 58999999999999999999999998877665544


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ........+                          .....+.++.++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       230 ~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          230 QHVREDPIP--------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HHHHCCCCC--------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             HHhcCCCCC--------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            433321111                          11223467889999999999999999999999999999986543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.4e-40  Score=283.67  Aligned_cols=224  Identities=21%  Similarity=0.357  Sum_probs=164.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+||++
T Consensus        91 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~  165 (360)
T 3eqc_A           91 PYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV  165 (360)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred             CCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE
Confidence            7999999999887     88999999996 59999999888899999999999999999999996 99999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.++|+|||++...... ......+++.|+|||++.+ ..++.++||||+||++++|++|..||.+.+.......+.
T Consensus       166 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  243 (360)
T 3eqc_A          166 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG  243 (360)
T ss_dssp             CTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC
T ss_pred             CCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            99999999999998654322 2334578999999999865 458999999999999999999999998876555433221


Q ss_pred             HHhCC-CChHhhhhh--hhh-------------HHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          159 ELIGT-PSEAELGFL--NEN-------------AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       159 ~~~~~-~~~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      ..... +........  ...             .............  .......++.++++||++||+.||.+|||+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  321 (360)
T 3eqc_A          244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ  321 (360)
T ss_dssp             ------------------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             ccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHH
Confidence            11100 000000000  000             0000000000000  00111246889999999999999999999999


Q ss_pred             HhcCCCCCCCC
Q 023764          223 ALAHPYLGSLH  233 (277)
Q Consensus       223 ll~hp~f~~~~  233 (277)
                      +++||||+...
T Consensus       322 ll~hp~~~~~~  332 (360)
T 3eqc_A          322 LMVHAFIKRSD  332 (360)
T ss_dssp             HHTSHHHHHHH
T ss_pred             HhhChHhhcch
Confidence            99999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.2e-39  Score=274.12  Aligned_cols=181  Identities=25%  Similarity=0.464  Sum_probs=142.0

Q ss_pred             cEEEEeecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           20 DVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        20 ~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      .+|+||||++ ++|.+++.....   .++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus       135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            4899999997 599999987643   566678999999999999999999999999999999999999999999999876


Q ss_pred             cCCC-------------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Q 023764           96 SETD-------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG  162 (277)
Q Consensus        96 ~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  162 (277)
                      ....             ......||+.|+|||++.+. .++.++||||+||++++|++|..|+..     ....+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~  288 (332)
T 3qd2_B          215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRN  288 (332)
T ss_dssp             SCC--------------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHT
T ss_pred             ccchhhccccccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhc
Confidence            5431             22345789999999998654 589999999999999999998766411     1111111100


Q ss_pred             CCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          163 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .                          ..+...+..++++++||.+||+.||.+|||++++++||||+++
T Consensus       289 ~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          289 L--------------------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             T--------------------------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             c--------------------------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            0                          0111112346678999999999999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.2e-40  Score=287.94  Aligned_cols=192  Identities=16%  Similarity=0.155  Sum_probs=147.3

Q ss_pred             CcEEEEeecCcccHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccc
Q 023764           19 NDVYIAYELMDTDLHQIIRSN-QALSEEHC------QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   91 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~------~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~   91 (277)
                      +++|+||||++++|.+++... ..++...+      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+
T Consensus       161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~  240 (371)
T 3q60_A          161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA  240 (371)
T ss_dssp             EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecce
Confidence            458999999999999999864 33454555      67779999999999999999999999999999999999999999


Q ss_pred             eeeccCCCcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHhhh
Q 023764           92 ARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG  170 (277)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  170 (277)
                      +...+..  .....+++.|+|||++.+. ..++.++||||+||++|+|++|..||.+......             ..+.
T Consensus       241 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~  305 (371)
T 3q60_A          241 LWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK-------------GSWK  305 (371)
T ss_dssp             EEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-------------TCCC
T ss_pred             eeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-------------cchh
Confidence            9876543  2245667999999998541 4589999999999999999999999976532100             0000


Q ss_pred             hhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          171 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                             .... .............+.+++.+.+||.+||+.||++|||++++++||||+.+.
T Consensus       306 -------~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          306 -------RPSL-RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             -------BCCT-TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             -------hhhh-hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence                   0000 000000111122347889999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=271.98  Aligned_cols=200  Identities=28%  Similarity=0.462  Sum_probs=165.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++. ....+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        84 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~  158 (314)
T 3com_A           84 PHVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL  158 (314)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCCccEEEEEEeC-----CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence            7999999999887     88999999997 59999987 45789999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++|||||||++++|++|..||.+.........+
T Consensus       159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  237 (314)
T 3com_A          159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI  237 (314)
T ss_dssp             CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999999765543 22345578999999999854 45899999999999999999999999876654433322


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...  .++                   .      ......++.++.+||.+||..||.+|||+.++++||||+...
T Consensus       238 ~~~--~~~-------------------~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          238 PTN--PPP-------------------T------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHS--CCC-------------------C------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             hcC--CCc-------------------c------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            110  000                   0      001123578899999999999999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=274.03  Aligned_cols=201  Identities=25%  Similarity=0.399  Sum_probs=154.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||+++.+..+... .+.+++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus        84 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~  158 (318)
T 2dyl_A           84 PYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL  158 (318)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE
T ss_pred             CceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE
Confidence            7999999999887     89999999998777666654 56799999999999999999999995 99999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhh----CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~  153 (277)
                      +.++.++|+|||++.............+++.|+|||++.    ....++.++||||+||++++|++|..||.+.. ....
T Consensus       159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  238 (318)
T 2dyl_A          159 DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV  238 (318)
T ss_dssp             CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH
Confidence            999999999999997665554455567899999999984    23457889999999999999999999997643 3333


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +..+...  .+                         ........+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       239 ~~~~~~~--~~-------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          239 LTKVLQE--EP-------------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             HHHHHHS--CC-------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHhcc--CC-------------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            3322221  00                         00011135788999999999999999999999999999998754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-39  Score=280.50  Aligned_cols=215  Identities=25%  Similarity=0.378  Sum_probs=166.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQI------IRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~--~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~d   70 (277)
                      |||+++++++.+.     +..|+||||+++ +|.++      +..  ...+++..+..++.|++.||.|||+ +|++|||
T Consensus       103 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d  177 (348)
T 2pml_X          103 EYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD  177 (348)
T ss_dssp             TTBCCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred             CCcceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence            7999999999887     899999999975 99988      665  5779999999999999999999999 9999999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCc-chhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |+|+||+++.++.++|+|||.+...... ......+++.|+|||++.+...++. ++||||+||++++|++|..||.+..
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999876543 3455678999999999866534555 9999999999999999999998776


Q ss_pred             h-HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 023764          150 H-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  228 (277)
Q Consensus       150 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  228 (277)
                      . ......+.......+.....        +   .............+.+++++.+||.+||+.||.+|||++++++|||
T Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          257 SLVELFNNIRTKNIEYPLDRNH--------F---LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             CSHHHHHHHTSCCCCCCCSSSS--------S---TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             cHHHHHHHHhccCcCCccchhh--------h---hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            5 44433332211000000000        0   0000001111222568899999999999999999999999999999


Q ss_pred             CCCC
Q 023764          229 LGSL  232 (277)
Q Consensus       229 f~~~  232 (277)
                      |+..
T Consensus       326 f~~~  329 (348)
T 2pml_X          326 LADT  329 (348)
T ss_dssp             GTTC
T ss_pred             ccCC
Confidence            9874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=273.86  Aligned_cols=204  Identities=24%  Similarity=0.412  Sum_probs=159.0

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++..... ...+.+|+||||++ ++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||
T Consensus        81 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI  160 (326)
T 2x7f_A           81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV  160 (326)
T ss_dssp             TTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred             CCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHE
Confidence            799999999976431 11378999999997 5999999864  5699999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.++|+|||++...... .......+++.|+|||++..    ...++.++|||||||++++|++|..||.+....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  240 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  240 (326)
T ss_dssp             EECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             EEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence            9999999999999998765432 22344578999999999852    345789999999999999999999999877655


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .....+.... .+                           ....+.++..+++||.+||..||.+|||++++++||||+.
T Consensus       241 ~~~~~~~~~~-~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          241 RALFLIPRNP-AP---------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             HHHHHHHHSC-CC---------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             HHHHHhhcCc-cc---------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            4433322110 00                           0112357889999999999999999999999999999986


Q ss_pred             C
Q 023764          232 L  232 (277)
Q Consensus       232 ~  232 (277)
                      .
T Consensus       293 ~  293 (326)
T 2x7f_A          293 Q  293 (326)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.3e-40  Score=282.00  Aligned_cols=209  Identities=27%  Similarity=0.413  Sum_probs=142.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.... .+.+.+|+||||++ |+|.+++...+  .+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        82 ~~i~~~~~~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIl  160 (336)
T 3fhr_A           82 PHIVCILDVYENMH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL  160 (336)
T ss_dssp             TTBCCEEEEEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CChHHHHHHHhhcc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            79999999997621 11266999999996 59999998764  6999999999999999999999999999999999999


Q ss_pred             Eec---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           78 LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++.   ++.++|+|||++...... ......+++.|+|||++.. ..++.++||||+||++++|++|..||.+.......
T Consensus       161 l~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  238 (336)
T 3fhr_A          161 YTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS  238 (336)
T ss_dssp             ESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             EEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh
Confidence            976   455999999999765543 2345678999999998843 45789999999999999999999999765433221


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      .........                      .........+..+++++++||.+||+.||.+|||++++++||||+....
T Consensus       239 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          239 PGMKRRIRL----------------------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             ----------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             hhHHHhhhc----------------------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            111110000                      0000011223467889999999999999999999999999999987544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-38  Score=269.31  Aligned_cols=196  Identities=26%  Similarity=0.408  Sum_probs=165.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        80 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  153 (303)
T 3a7i_A           80 PYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS  153 (303)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence            7999999999887     88999999997 599998865 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++++|++|..||.+.........+.
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  232 (303)
T 3a7i_A          154 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP  232 (303)
T ss_dssp             TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence            99999999999997765432 2345578999999999854 458899999999999999999999998766554433322


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ..  .                           .......++..+.+||.+||+.||.+|||++++++||||...
T Consensus       233 ~~--~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          233 KN--N---------------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HS--C---------------------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             cC--C---------------------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            10  0                           011223578899999999999999999999999999999763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=267.18  Aligned_cols=201  Identities=26%  Similarity=0.424  Sum_probs=160.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...   ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        79 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  153 (295)
T 2clq_A           79 KNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV  153 (295)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence            7999999999887     88999999996 6999999865   2467899999999999999999999999999999999


Q ss_pred             EEec-CCCeEEeeccceeeccCC-CcccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           77 LLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        77 l~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +++. ++.++|+|||++...... .......+++.|+|||++.+. ..++.++|||||||++++|++|..||.+......
T Consensus       154 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  233 (295)
T 2clq_A          154 LINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA  233 (295)
T ss_dssp             EEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH
T ss_pred             EEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH
Confidence            9988 899999999999765432 223455789999999998643 2378999999999999999999999965443322


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..........                           .....+.+++++.+||.+||+.||++|||++++++||||+...
T Consensus       234 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          234 AMFKVGMFKV---------------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHHHCC---------------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHhhccccc---------------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            1111110000                           0112235788999999999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-39  Score=274.82  Aligned_cols=191  Identities=27%  Similarity=0.455  Sum_probs=163.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..+     +..|+|||++.  ++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus       108 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  182 (320)
T 3a99_A          108 SGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI  182 (320)
T ss_dssp             CSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCceEEEEEEecC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE
Confidence            7999999999887     88999999996  6999999988889999999999999999999999999999999999999


Q ss_pred             e-cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 N-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      + .++.++|+|||++....... .....+++.|+|||++......+.++|||||||++++|++|..||.+...      +
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~  255 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I  255 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred             eCCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------h
Confidence            9 77899999999998765432 34557899999999987655457899999999999999999999954311      0


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..  +.                            ....+.+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       256 ~~--~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          256 IR--GQ----------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HH--CC----------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             hc--cc----------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            00  00                            001135788999999999999999999999999999998764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=286.61  Aligned_cols=200  Identities=28%  Similarity=0.383  Sum_probs=151.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.+.     +..|+|||||+|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        78 pnIv~l~~~~~~~-----~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~  152 (432)
T 3p23_A           78 PNVIRYFCTEKDR-----QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS  152 (432)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEEC
T ss_pred             CCcCeEEEEEecC-----CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEe
Confidence            8999999999887     8899999999999999998653 456667789999999999999999999999999999994


Q ss_pred             c-----CCCeEEeeccceeeccCC----CcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 023764           80 A-----NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMD-RKPLFPG  147 (277)
Q Consensus        80 ~-----~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~  147 (277)
                      .     ...++|+|||++......    .......||+.|+|||++.+  ...++.++||||+||++++|++ |.+||.+
T Consensus       153 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             CCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             cCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            3     235789999999765433    22344679999999999864  3446789999999999999999 9999965


Q ss_pred             CChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ....... .+   .+.....                       ........+..+++||.+||+.||.+|||++++++||
T Consensus       233 ~~~~~~~-~~---~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          233 SLQRQAN-IL---LGACSLD-----------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             TTTHHHH-HH---TTCCCCT-----------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             hhHHHHH-HH---hccCCcc-----------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            4433211 11   1110000                       0000012345689999999999999999999999999


Q ss_pred             CCCCC
Q 023764          228 YLGSL  232 (277)
Q Consensus       228 ~f~~~  232 (277)
                      ||..+
T Consensus       286 ~f~~~  290 (432)
T 3p23_A          286 FFWSL  290 (432)
T ss_dssp             TTCCH
T ss_pred             cccCh
Confidence            99864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-38  Score=270.04  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=156.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++...     +.+|+|||+.+++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++ 
T Consensus        88 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-  161 (313)
T 3cek_A           88 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-  161 (313)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-
T ss_pred             CceEEEEEEeecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-
Confidence            7999999999887     8899999988899999999988999999999999999999999999999999999999996 


Q ss_pred             CCCeEEeeccceeeccCCC---cccccccccccCChhhhhCC----------CCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 023764           81 NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMDRKPLFPG  147 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~  147 (277)
                      ++.++|+|||++.......   ......+++.|+|||.+.+.          ..++.++|||||||++++|++|..||.+
T Consensus       162 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            4899999999987654322   22345789999999998541          3578899999999999999999999976


Q ss_pred             CChHH-HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          148 RDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       148 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..... ....+.   ...                         .........+.++.+||.+||+.||.+|||++++++|
T Consensus       242 ~~~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          242 IINQISKLHAII---DPN-------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CCSHHHHHHHHH---CTT-------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHHH---hcc-------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            54322 111111   000                         0001112346789999999999999999999999999


Q ss_pred             CCCCCCCC
Q 023764          227 PYLGSLHD  234 (277)
Q Consensus       227 p~f~~~~~  234 (277)
                      |||+....
T Consensus       294 ~~~~~~~~  301 (313)
T 3cek_A          294 PYVQIQTH  301 (313)
T ss_dssp             HHHHCC--
T ss_pred             ccccCCCC
Confidence            99987543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.4e-39  Score=275.85  Aligned_cols=203  Identities=26%  Similarity=0.430  Sum_probs=145.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-----~~~l~~~~~~~i~~qll~al~~LH~~-~i~H~di~~~   74 (277)
                      |||+++++++...     +..|+||||++++|.+++..     ...+++..+..++.|++.||.|||+. |++||||||+
T Consensus        81 ~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~  155 (327)
T 3aln_A           81 PYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS  155 (327)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGG
T ss_pred             CcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHH
Confidence            7999999999887     89999999999999888863     57799999999999999999999999 9999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhh---CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           75 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL---NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      ||+++.++.+||+|||++.............+++.|+|||++.   ....++.++|||||||++++|++|..||.+....
T Consensus       156 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (327)
T 3aln_A          156 NILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV  235 (327)
T ss_dssp             GEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---
T ss_pred             HEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH
Confidence            9999999999999999997765544444557899999999983   2345789999999999999999999999764321


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc-cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ..  .+.                       .........+ ....+..++++.+||.+||+.||.+|||++++++||||.
T Consensus       236 ~~--~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          236 FD--QLT-----------------------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             ------C-----------------------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             HH--HHH-----------------------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            10  000                       0000000111 112245788999999999999999999999999999998


Q ss_pred             CCC
Q 023764          231 SLH  233 (277)
Q Consensus       231 ~~~  233 (277)
                      ...
T Consensus       291 ~~~  293 (327)
T 3aln_A          291 MYE  293 (327)
T ss_dssp             HHH
T ss_pred             HhH
Confidence            654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=277.56  Aligned_cols=217  Identities=17%  Similarity=0.274  Sum_probs=161.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++....   ....|+||||++ ++|.+++....   .+++..+..++.|++.||+|||++||+||||||+||
T Consensus        67 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  143 (319)
T 4euu_A           67 KNIVKLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI  143 (319)
T ss_dssp             TTBCCEEEEEECTT---TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCcceEEEEeecCC---CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            79999999997652   158899999996 69999998653   399999999999999999999999999999999999


Q ss_pred             EE----ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhC-------CCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           77 LL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-------SSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        77 l~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      ++    +.++.+||+|||++.............+++.|+|||++..       ...++.++||||+||++++|++|..||
T Consensus       144 ll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  223 (319)
T 4euu_A          144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (319)
T ss_dssp             EEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred             EEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            98    6777899999999988766655566789999999999852       355889999999999999999999999


Q ss_pred             CCCCh----HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccC-Cc-ccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          146 PGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QS-FTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       146 ~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                      .....    ...+..+...  .|+. .+........    ....+.. .+ .......++..+.+||++||+.||++|||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~--~p~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s  296 (319)
T 4euu_A          224 RPFEGPRRNKEVMYKIITG--KPSG-AISGVQKAEN----GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG  296 (319)
T ss_dssp             ECTTCGGGCHHHHHHHHHH--CCTT-CCEEEECSTT----CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred             CCCCccchhHHHHHHHhcC--CCcc-cchhhhcccC----CccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence            64432    2333333221  1111 1100000000    0000000 00 00111134567899999999999999999


Q ss_pred             HHHHhcCC
Q 023764          220 VEDALAHP  227 (277)
Q Consensus       220 ~~ell~hp  227 (277)
                      ++|+|+||
T Consensus       297 ~~ell~h~  304 (319)
T 4euu_A          297 FDQFFAET  304 (319)
T ss_dssp             HHHHHHHH
T ss_pred             HHHhhhcc
Confidence            99999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-38  Score=269.14  Aligned_cols=202  Identities=26%  Similarity=0.393  Sum_probs=159.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        71 p~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~  145 (294)
T 4eqm_A           71 QNIVSMIDVDEED-----DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID  145 (294)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCCceEEEeeeeC-----CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            8999999999887     89999999996 59999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++.......  ......|++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+........
T Consensus       146 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~  224 (294)
T 4eqm_A          146 SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH  224 (294)
T ss_dssp             TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred             CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999987554332  23345689999999998654 4799999999999999999999999887765543332


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ...  ..+                       .......+.+++.+.++|.+||+.||.+||+..+.+.+.|.+-..
T Consensus       225 ~~~--~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          225 IQD--SVP-----------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HSS--CCC-----------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hhc--cCC-----------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            211  000                       011223356888999999999999999999666666666655443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.8e-38  Score=269.04  Aligned_cols=197  Identities=25%  Similarity=0.410  Sum_probs=154.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~   74 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++.+.+.   +++..+..++.|++.||+|||++|  |+||||||+
T Consensus        94 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~  168 (309)
T 3p86_A           94 PNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP  168 (309)
T ss_dssp             TTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGG
T ss_pred             CCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChh
Confidence            8999999999887     78999999996 599999987654   999999999999999999999999  999999999


Q ss_pred             cEEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           75 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        75 nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      ||+++.++.++|+|||++...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       169 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  247 (309)
T 3p86_A          169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV  247 (309)
T ss_dssp             GEEECTTCCEEECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred             hEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999999754433 22345678999999999865 4579999999999999999999999988776655


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYLGS  231 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~f~~  231 (277)
                      ...+......                            ......+++++.+||.+||+.||.+|||++++++  .++++.
T Consensus       248 ~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          248 VAAVGFKCKR----------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHSCCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            4443221111                            0112367889999999999999999999999987  455544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.2e-39  Score=284.49  Aligned_cols=201  Identities=28%  Similarity=0.412  Sum_probs=150.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALS-------EEHCQYFLYQILRGLKYIHSANVLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~-------~~~~~~i~~qll~al~~LH~~~i~H~di~~   73 (277)
                      |||+++++++.+.     +.+|+|||||+|+|.+++.......       +..+..++.|++.||+|||++||+||||||
T Consensus        69 pnIv~~~~~~~~~-----~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp  143 (434)
T 2rio_A           69 PNVIRYYCSETTD-----RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP  143 (434)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CCcCeEEEEEecC-----CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence            8999999999887     8999999999999999998764332       224567999999999999999999999999


Q ss_pred             CcEEEecC-------------CCeEEeeccceeeccCCC-----cccccccccccCChhhhhC------CCCCCcchhHH
Q 023764           74 SNLLLNAN-------------CDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLN------SSDYTAAIDVW  129 (277)
Q Consensus        74 ~nil~~~~-------------~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~------~~~~~~~~Diw  129 (277)
                      +||+++.+             +.++|+|||++.......     ......||+.|+|||++.+      ...++.++|||
T Consensus       144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw  223 (434)
T 2rio_A          144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF  223 (434)
T ss_dssp             GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred             HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence            99999754             479999999998765432     1234579999999999864      24578999999


Q ss_pred             HHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHH
Q 023764          130 SVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  208 (277)
Q Consensus       130 slG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  208 (277)
                      |+||++++|++ |..||.+.....  ..+.......                   +..  .  ....+.+++++++||.+
T Consensus       224 SlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~-------------------~~~--~--~~~~~~~~~~~~~li~~  278 (434)
T 2rio_A          224 SMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL-------------------DEM--K--CLHDRSLIAEATDLISQ  278 (434)
T ss_dssp             HHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCC-------------------CCC--T--TCCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCc-------------------ccc--c--ccccccchHHHHHHHHH
Confidence            99999999998 999997654332  1111100000                   000  0  00001245689999999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCC
Q 023764          209 MLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       209 ~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ||+.||.+|||+.++++||||..
T Consensus       279 ~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          279 MIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HhhCChhhCCCHHHHHhCCccCC
Confidence            99999999999999999999964

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.6e-38  Score=274.85  Aligned_cols=191  Identities=26%  Similarity=0.405  Sum_probs=157.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +.+|+||||++ |+|.+++...+                .++...+..++.|++.||+|||+
T Consensus       147 pnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  221 (370)
T 2psq_A          147 KNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  221 (370)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            8999999999887     88999999997 59999998653                47899999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +||+||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       222 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt  300 (370)
T 2psq_A          222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT  300 (370)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHc
Confidence            999999999999999999999999999998655432   2233456788999999865 458999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+....+....+....                             ........+.++.+||.+||+.||.+|||
T Consensus       301 ~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  351 (370)
T 2psq_A          301 LGGSPYPGIPVEELFKLLKEGH-----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPT  351 (370)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence             999998766544333322110                             00112357789999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +.+++++
T Consensus       352 ~~ell~~  358 (370)
T 2psq_A          352 FKQLVED  358 (370)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999863

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-37  Score=263.45  Aligned_cols=194  Identities=13%  Similarity=0.163  Sum_probs=158.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        66 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  140 (298)
T 1csn_A           66 TGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG  140 (298)
T ss_dssp             TTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred             CCCCeEEeecCCC-----ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence            6899999999876     8999999999889999998754 599999999999999999999999999999999999998


Q ss_pred             cCCC-----eEEeeccceeeccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           80 ANCD-----LKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        80 ~~~~-----~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      .++.     ++|+|||++.......        ......|++.|+|||++.+ ..++.++|||||||++++|++|..||.
T Consensus       141 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~  219 (298)
T 1csn_A          141 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ  219 (298)
T ss_dssp             CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             cCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence            7776     9999999998655432        1345578999999999854 458999999999999999999999998


Q ss_pred             CCC---hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          147 GRD---HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       147 ~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      +.+   .......+......                         .......+.+++++.+|+.+||+.||++|||++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l  274 (298)
T 1csn_A          220 GLKAATNKQKYERIGEKKQS-------------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL  274 (298)
T ss_dssp             SCCSCCHHHHHHHHHHHHHH-------------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             hhhccccHHHHHHHHhhccC-------------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence            743   23333333221111                         11223334678899999999999999999999998


Q ss_pred             hc
Q 023764          224 LA  225 (277)
Q Consensus       224 l~  225 (277)
                      ++
T Consensus       275 ~~  276 (298)
T 1csn_A          275 QG  276 (298)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=271.50  Aligned_cols=200  Identities=14%  Similarity=0.132  Sum_probs=157.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++.... .+.+..|+||||++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus       108 ~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          108 LGIPLFYGSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY  186 (345)
T ss_dssp             CCCCCEEEEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred             cCcceeeccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence            79999999998721 11288999999998899999988778999999999999999999999999999999999999998


Q ss_pred             CC--CeEEeeccceeeccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-C
Q 023764           81 NC--DLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-D  149 (277)
Q Consensus        81 ~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~  149 (277)
                      ++  .++|+|||++.......        ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+. .
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            87  99999999997653221        12445789999999998654 5899999999999999999999999642 2


Q ss_pred             hHHHHHHH-HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          150 HVHQLRLL-IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       150 ~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ........ .......+..                       .....+  .++.++.+||.+||..||++|||++++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          266 DPVAVQTAKTNLLDELPQS-----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             CHHHHHHHHHHHHHTTTHH-----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccHHHHHHHHhhcccccHH-----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22222111 1111111110                       111112  67889999999999999999999999877

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-38  Score=267.34  Aligned_cols=192  Identities=23%  Similarity=0.399  Sum_probs=156.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeec-Cc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYEL-MD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+|||+ +. ++|.+++..++.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        98 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  172 (312)
T 2iwi_A           98 PGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI  172 (312)
T ss_dssp             SSBCCEEEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE
T ss_pred             CCeeeEEEEEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE
Confidence            7999999999887     889999998 54 6999999988889999999999999999999999999999999999999


Q ss_pred             e-cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 N-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      + .++.++|+|||++....... .....+++.|+|||++.+....+.++|||||||++++|++|+.||.+...      +
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~  245 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------I  245 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred             eCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------H
Confidence            9 78999999999998765432 34567899999999987655445689999999999999999999964311      1


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..                      ..        ....+.++.++++||.+||+.||++|||++++++||||+...+
T Consensus       246 ~~----------------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          246 LE----------------------AE--------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HH----------------------TC--------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             hh----------------------hc--------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            00                      00        0111357889999999999999999999999999999997543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.7e-38  Score=263.38  Aligned_cols=200  Identities=30%  Similarity=0.451  Sum_probs=161.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSAN-----VLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~~-----i~H~d   70 (277)
                      |||+++++++.+..   .+.+|+||||++ ++|.+++...    ..+++..+..++.|++.||+|||+.|     ++|||
T Consensus        65 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~d  141 (279)
T 2w5a_A           65 PNIVRYYDRIIDRT---NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD  141 (279)
T ss_dssp             TTBCCEEEEEEEGG---GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCC
T ss_pred             CCCCeEEEEEecCC---CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEec
Confidence            79999999885431   178999999997 5999998753    34999999999999999999999999     99999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+. .++.++|||||||++++|++|..||.+.+
T Consensus       142 l~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             CSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence            99999999999999999999987654332 22345689999999998654 58999999999999999999999998876


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .......+.....                             ......++.++.++|.+||+.||.+|||++++++|+|+
T Consensus       221 ~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          221 QKELAGKIREGKF-----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             HHHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHhhccc-----------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            6554444332100                             01112578899999999999999999999999999999


Q ss_pred             CCCC
Q 023764          230 GSLH  233 (277)
Q Consensus       230 ~~~~  233 (277)
                      ..-.
T Consensus       272 ~~~~  275 (279)
T 2w5a_A          272 LEHH  275 (279)
T ss_dssp             CGGG
T ss_pred             hhhc
Confidence            8643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=268.56  Aligned_cols=190  Identities=21%  Similarity=0.310  Sum_probs=157.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+.||+||||||+||++
T Consensus       110 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  184 (325)
T 3kul_A          110 PNIIRLEGVVTRG-----RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV  184 (325)
T ss_dssp             TTBCCEEEEECGG-----GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCCCcEEEEEEeC-----CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE
Confidence            8999999999887     88999999996 5999999754 579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++.......    ......+++.|+|||++.+. .++.++|||||||++++|++ |..||.+......
T Consensus       185 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  263 (325)
T 3kul_A          185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV  263 (325)
T ss_dssp             CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred             CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999998654432    12223456789999998644 48999999999999999998 9999988877665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+......+                             .....++++.+||.+||..||.+|||++++++
T Consensus       264 ~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          264 ISSVEEGYRLP-----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCC-----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            55543321111                             11357889999999999999999999999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=272.86  Aligned_cols=191  Identities=26%  Similarity=0.408  Sum_probs=160.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +.+|+||||++ |+|.+++....                .+++..+..++.|++.||+|||+
T Consensus       135 pnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  209 (382)
T 3tt0_A          135 KNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS  209 (382)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            8999999999887     88999999996 59999998753                49999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +||+||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+ ..++.++|||||||++++|++
T Consensus       210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt  288 (382)
T 3tt0_A          210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT  288 (382)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHh
Confidence            999999999999999999999999999997654432   2334456788999999865 458999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+.+..+....+.....                             .......++++.+||.+||+.||++|||
T Consensus       289 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps  339 (382)
T 3tt0_A          289 LGGSPYPGVPVEELFKLLKEGHR-----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPT  339 (382)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTTCC-----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcC
Confidence             9999988776554443332110                             0111357889999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +++++++
T Consensus       340 ~~ell~~  346 (382)
T 3tt0_A          340 FKQLVED  346 (382)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999885

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.6e-38  Score=260.96  Aligned_cols=191  Identities=20%  Similarity=0.332  Sum_probs=158.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++... +.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~  139 (269)
T 4hcu_A           65 PKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV  139 (269)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEeeEEEEEecC-----CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE
Confidence            8999999999887     88999999996 5999999764 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++.......  ......+++.|+|||.+... .++.++||||+||++++|++ |..||.+........
T Consensus       140 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~  218 (269)
T 4hcu_A          140 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE  218 (269)
T ss_dssp             CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999987544321  22334567789999998654 48999999999999999999 999998877766555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+......                             ......++.+.+++.+||+.||.+|||++++++|
T Consensus       219 ~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          219 DISTGFRL-----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCccC-----------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            44321110                             0112467889999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.1e-38  Score=271.93  Aligned_cols=193  Identities=25%  Similarity=0.413  Sum_probs=157.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC--------------------------------------
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--------------------------------------   41 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------------------------------   41 (277)
                      |||+++++++.+++    +.+|+||||++ |+|.+++.....                                      
T Consensus        86 pniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (359)
T 3vhe_A           86 LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQS  161 (359)
T ss_dssp             TTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------
T ss_pred             cceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccc
Confidence            79999999998752    55899999997 599999986543                                      


Q ss_pred             ----------------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           42 ----------------------------LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        42 ----------------------------l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                                                  +++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  241 (359)
T 3vhe_A          162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR  241 (359)
T ss_dssp             ----------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             ccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEecccee
Confidence                                        8999999999999999999999999999999999999999999999999997


Q ss_pred             eccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhh
Q 023764           94 VTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAEL  169 (277)
Q Consensus        94 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  169 (277)
                      ......   ......+++.|+|||++.+ ..++.++|||||||++++|++ |..||.+................+     
T Consensus       242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----  315 (359)
T 3vhe_A          242 DIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----  315 (359)
T ss_dssp             CTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----
T ss_pred             eecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----
Confidence            654332   2334567889999999865 458999999999999999998 999998776544433333221111     


Q ss_pred             hhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          170 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                                             ......++++.++|.+||+.||.+|||++++++|
T Consensus       316 -----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 -----------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                   1112467899999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-37  Score=266.16  Aligned_cols=193  Identities=16%  Similarity=0.218  Sum_probs=156.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus        65 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~  139 (330)
T 2izr_A           65 DGIPQVYYFGPCG-----KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG  139 (330)
T ss_dssp             TTSCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCCCEEEEEEecC-----CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence            7999999999887     88999999998899999986 36799999999999999999999999999999999999999


Q ss_pred             cCCC-----eEEeeccceeeccCCCc--------ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           80 ANCD-----LKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        80 ~~~~-----~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      .++.     ++|+|||++........        .....||+.|+|||++.+ ..++.++|||||||++++|++|..||.
T Consensus       140 ~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~  218 (330)
T 2izr_A          140 RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQ  218 (330)
T ss_dssp             CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence            8877     99999999986544321        245678999999999865 458999999999999999999999998


Q ss_pred             CCChH---HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          147 GRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       147 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      +.+..   ..+..+.......+                         ........+ ++.+||..||+.||.+||+++++
T Consensus       219 ~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l  272 (330)
T 2izr_A          219 GLKADTLKERYQKIGDTKRATP-------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYL  272 (330)
T ss_dssp             TCCCSSHHHHHHHHHHHHHHSC-------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             ccccccHHHHHHHHHhhhccCC-------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence            75432   22333222111000                         011112233 89999999999999999999887


Q ss_pred             hc
Q 023764          224 LA  225 (277)
Q Consensus       224 l~  225 (277)
                      ++
T Consensus       273 ~~  274 (330)
T 2izr_A          273 RK  274 (330)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=274.77  Aligned_cols=195  Identities=20%  Similarity=0.271  Sum_probs=160.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++...     +..|+||||+. |+|.+++...       ..+++..+..++.|++.||+|||++||+|||||
T Consensus       134 pnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  208 (367)
T 3l9p_A          134 QNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA  208 (367)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCCCeEEEEEecC-----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            8999999999887     78899999995 6999999764       358999999999999999999999999999999


Q ss_pred             CCcEEEecCC---CeEEeeccceeeccC---CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           73 PSNLLLNANC---DLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        73 ~~nil~~~~~---~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      |+||+++.+|   .+||+|||++.....   ........+++.|+|||++.+. .++.++|||||||++++|++ |..||
T Consensus       209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf  287 (367)
T 3l9p_A          209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY  287 (367)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999998555   499999999974322   1223345678899999998654 48999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+..+....+......                             ......+..+.+||.+||+.||.+|||++++++
T Consensus       288 ~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~  338 (367)
T 3l9p_A          288 PSKSNQEVLEFVTSGGRM-----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE  338 (367)
T ss_dssp             TTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCC-----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            888776655544321111                             111256788999999999999999999999999


Q ss_pred             CCCCC
Q 023764          226 HPYLG  230 (277)
Q Consensus       226 hp~f~  230 (277)
                      +.++-
T Consensus       339 ~l~~~  343 (367)
T 3l9p_A          339 RIEYC  343 (367)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87664

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.8e-38  Score=272.12  Aligned_cols=202  Identities=17%  Similarity=0.150  Sum_probs=156.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.... .+....|+||||++++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus       108 ~~iv~~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          108 LGVPKYWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             CCSCCEEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred             CCCCeEEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence            79999999987642 122568999999988999999876 6799999999999999999999999999999999999999


Q ss_pred             --cCCCeEEeeccceeeccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           80 --ANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        80 --~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                        .++.++|+|||++.......        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence              88999999999997654321        1133458999999999865 458999999999999999999999997543


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..............          ......           ....+  +..+.++.+|+..||..||.+|||++++++
T Consensus       266 ~~~~~~~~~~~~~~----------~~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          266 KDPKYVRDSKIRYR----------ENIASL-----------MDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TCHHHHHHHHHHHH----------HCHHHH-----------HHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHHhh----------hhHHHH-----------HHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22221111111000          000000           00111  357889999999999999999999998876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9e-38  Score=260.27  Aligned_cols=191  Identities=19%  Similarity=0.305  Sum_probs=158.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus        63 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~  137 (268)
T 3sxs_A           63 PKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV  137 (268)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE
T ss_pred             CCEeeEEEEEccC-----CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE
Confidence            8999999999887     88999999996 6899999765 359999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++........  .....+++.|+|||.+.+. .++.++||||+||++++|++ |..||.+........
T Consensus       138 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  216 (268)
T 3sxs_A          138 DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL  216 (268)
T ss_dssp             CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH
Confidence            9999999999999986654422  2233456779999998654 47899999999999999998 999998877665544


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+......                             ......++.+.++|.+||+.||.+|||+++++++
T Consensus       217 ~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          217 KVSQGHRL-----------------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHTTCCC-----------------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCC-----------------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43321100                             0112457889999999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.6e-38  Score=268.48  Aligned_cols=202  Identities=24%  Similarity=0.367  Sum_probs=150.4

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCc-ccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSNQ------ALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++..... ......|+||||+. ++|.+++....      .+++..+..++.|++.||+|||++||+|||||
T Consensus        85 ~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dik  164 (323)
T 3qup_A           85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLA  164 (323)
T ss_dssp             TTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Confidence            799999999987521 11123499999997 59999986432      59999999999999999999999999999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  148 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  148 (277)
                      |+||+++.++.++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++++|++ |..||.+.
T Consensus       165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999976543321   2233457789999998654 48999999999999999999 99999887


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-------HH
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-------VE  221 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~  221 (277)
                      +.......+.....                             ....+..++++.+||.+||+.||.+|||       ++
T Consensus       244 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          244 ENAEIYNYLIGGNR-----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             CGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ChHHHHHHHhcCCC-----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            76555444332110                             1112357889999999999999999999       78


Q ss_pred             HHhcCCCCCCC
Q 023764          222 DALAHPYLGSL  232 (277)
Q Consensus       222 ell~hp~f~~~  232 (277)
                      ++++|+|+...
T Consensus       295 ~~l~~~~~~~~  305 (323)
T 3qup_A          295 NILGHLSVLST  305 (323)
T ss_dssp             HHHHC------
T ss_pred             HHHHHhhhcCC
Confidence            89999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.7e-38  Score=264.30  Aligned_cols=203  Identities=27%  Similarity=0.384  Sum_probs=151.3

Q ss_pred             CceeeeeccccCCC--------CCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 023764            1 MQVVAIRDIIPPPQ--------RESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~--------~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~d   70 (277)
                      |||+++++++.+..        ....+..|+||||++ ++|.+++... ..+++..+..++.|++.||+|||++|++|||
T Consensus        62 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d  141 (303)
T 1zy4_A           62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRD  141 (303)
T ss_dssp             TTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             hHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            79999999886531        122378999999996 5999999854 4688899999999999999999999999999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCC---------------CcccccccccccCChhhhhCCCCCCcchhHHHHHHHH
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSET---------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  135 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il  135 (277)
                      |||+||+++.++.++|+|||++......               .......+++.|+|||++.+...++.++||||+||++
T Consensus       142 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  221 (303)
T 1zy4_A          142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF  221 (303)
T ss_dssp             CCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHH
T ss_pred             CCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHH
Confidence            9999999999999999999998754321               1233456899999999987665689999999999999


Q ss_pred             HHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCC
Q 023764          136 MELMDRKPLFPGRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  214 (277)
Q Consensus       136 ~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  214 (277)
                      ++|++   ||..... ......+....                          ........+..+..+++||++||+.||
T Consensus       222 ~~l~~---p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp  272 (303)
T 1zy4_A          222 FEMIY---PFSTGMERVNILKKLRSVS--------------------------IEFPPDFDDNKMKVEKKIIRLLIDHDP  272 (303)
T ss_dssp             HHHHS---CCSSHHHHHHHHHHHHSTT--------------------------CCCCTTCCTTTSHHHHHHHHHHTCSSG
T ss_pred             HHHHh---ccCCchhHHHHHHhccccc--------------------------cccCccccccchHHHHHHHHHHHhcCc
Confidence            99998   4432211 11111111000                          000011123456789999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 023764          215 RQRITVEDALAHPYLGSL  232 (277)
Q Consensus       215 ~~R~t~~ell~hp~f~~~  232 (277)
                      .+|||++++++||||+..
T Consensus       273 ~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          273 NKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             GGSCCHHHHHHSSCSCCC
T ss_pred             ccCcCHHHHhCCCCcCCC
Confidence            999999999999999763

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1e-37  Score=261.98  Aligned_cols=191  Identities=18%  Similarity=0.294  Sum_probs=159.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        79 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili  153 (283)
T 3gen_A           79 EKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV  153 (283)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred             CCEeeEEEEEecC-----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE
Confidence            7999999999887     88999999996 699999976 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++.......  ......+++.|+|||.+.+. .++.++||||+||++++|++ |..||.+.+......
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~  232 (283)
T 3gen_A          154 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE  232 (283)
T ss_dssp             CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH
Confidence            999999999999987544321  12233456789999998654 48999999999999999998 999998877666555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+.......                             .....++.+.+||.+||+.||.+|||++++++|
T Consensus       233 ~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          233 HIAQGLRLY-----------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHTTCCCC-----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHhcccCCC-----------------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            443321110                             112457889999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.7e-38  Score=269.01  Aligned_cols=191  Identities=25%  Similarity=0.326  Sum_probs=156.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++.+.+                .+++..+..++.|++.||.|||+
T Consensus        86 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  160 (327)
T 1fvr_A           86 PNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  160 (327)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CchhhhceeeeeC-----CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            7999999999887     88999999996 59999998754                69999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CC
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  142 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  142 (277)
                      +||+||||||+||+++.++.++|+|||++.............+++.|+|||.+.. ..++.++|||||||++++|++ |.
T Consensus       161 ~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~  239 (327)
T 1fvr_A          161 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGG  239 (327)
T ss_dssp             TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCC
Confidence            9999999999999999999999999999875433333344456788999999864 447899999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      .||.+.+.......+....                             .......+++++.+||.+||+.||.+|||+++
T Consensus       240 ~pf~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  290 (327)
T 1fvr_A          240 TPYCGMTCAELYEKLPQGY-----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  290 (327)
T ss_dssp             CTTTTCCHHHHHHHGGGTC-----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCcHHHHHHHhhcCC-----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9998776554433321100                             00112357889999999999999999999999


Q ss_pred             HhcC
Q 023764          223 ALAH  226 (277)
Q Consensus       223 ll~h  226 (277)
                      ++++
T Consensus       291 ll~~  294 (327)
T 1fvr_A          291 ILVS  294 (327)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-37  Score=264.71  Aligned_cols=191  Identities=24%  Similarity=0.362  Sum_probs=157.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA------------------------LSEEHCQYFLYQIL   55 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------------------l~~~~~~~i~~qll   55 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.....                        +++..+..++.|++
T Consensus        86 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  160 (314)
T 2ivs_A           86 PHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS  160 (314)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHH
T ss_pred             CceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHH
Confidence            8999999999887     88999999997 699999987543                        89999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHH
Q 023764           56 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  132 (277)
Q Consensus        56 ~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  132 (277)
                      .||.|||++|++||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++||||+|
T Consensus       161 ~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG  239 (314)
T 2ivs_A          161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFG  239 (314)
T ss_dssp             HHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHH
T ss_pred             HHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHH
Confidence            99999999999999999999999999999999999998664432   1233456788999999865 4489999999999


Q ss_pred             HHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcC
Q 023764          133 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       133 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  211 (277)
                      |++++|++ |..||.+.........+....                             .....+.+++++.+||.+||+
T Consensus       240 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~  290 (314)
T 2ivs_A          240 VLLWEIVTLGGNPYPGIPPERLFNLLKTGH-----------------------------RMERPDNCSEEMYRLMLQCWK  290 (314)
T ss_dssp             HHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-----------------------------cCCCCccCCHHHHHHHHHHcc
Confidence            99999999 999998766544333222100                             011123578899999999999


Q ss_pred             CCCCCCCCHHHHhcC
Q 023764          212 FDPRQRITVEDALAH  226 (277)
Q Consensus       212 ~dP~~R~t~~ell~h  226 (277)
                      .||.+|||+++++++
T Consensus       291 ~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          291 QEPDKRPVFADISKD  305 (314)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-37  Score=261.36  Aligned_cols=189  Identities=25%  Similarity=0.405  Sum_probs=146.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+      +..|+||||++ ++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        76 ~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  149 (281)
T 1mp8_A           76 PHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV  149 (281)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CccceEEEEEcc------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE
Confidence            899999999854      66899999997 59999998654 69999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++........  .....+++.|+|||++... .++.++||||+||++++|++ |..||.+....+...
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~  228 (281)
T 1mp8_A          150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG  228 (281)
T ss_dssp             EETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CCCCCEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH
Confidence            9999999999999976544321  2234567789999998644 58999999999999999996 999998776555444


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+....                             .....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       229 ~i~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          229 RIENGE-----------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             HHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCC-----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            332110                             00122467889999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=267.38  Aligned_cols=193  Identities=25%  Similarity=0.377  Sum_probs=157.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------------------ALSEEHCQYFLYQILR   56 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------~l~~~~~~~i~~qll~   56 (277)
                      |||+++++++...     +..|+||||++ |+|.+++....                       .+++..+..++.|++.
T Consensus       109 p~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  183 (344)
T 1rjb_A          109 ENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK  183 (344)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred             CCeeeEEEEEeeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHH
Confidence            8999999999887     88999999996 59999998653                       2789999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHH
Q 023764           57 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  133 (277)
Q Consensus        57 al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  133 (277)
                      ||+|||++||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++|||||||
T Consensus       184 aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~  262 (344)
T 1rjb_A          184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGI  262 (344)
T ss_dssp             HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHH
T ss_pred             HHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHH
Confidence            9999999999999999999999999999999999997654332   12334567889999998654 4899999999999


Q ss_pred             HHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCC
Q 023764          134 IFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  212 (277)
Q Consensus       134 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  212 (277)
                      ++++|++ |..||.+.........+......+                            ......++++.+||.+||+.
T Consensus       263 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~  314 (344)
T 1rjb_A          263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAF  314 (344)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCC
Confidence            9999998 999998766444333332211000                            11124678999999999999


Q ss_pred             CCCCCCCHHHHhcCC
Q 023764          213 DPRQRITVEDALAHP  227 (277)
Q Consensus       213 dP~~R~t~~ell~hp  227 (277)
                      ||.+|||+.+++++.
T Consensus       315 dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          315 DSRKRPSFPNLTSFL  329 (344)
T ss_dssp             SGGGSCCHHHHHHHH
T ss_pred             CchhCcCHHHHHHHH
Confidence            999999999998853

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-37  Score=262.14  Aligned_cols=192  Identities=27%  Similarity=0.373  Sum_probs=158.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------ALSEEHCQYFLYQILRGLKYI   61 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~~~~~i~~qll~al~~L   61 (277)
                      |||+++++++.+.     +..|+||||++ |+|.+++....                  .+++..+..++.|++.||.||
T Consensus        87 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  161 (313)
T 1t46_A           87 MNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL  161 (313)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCeeeEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            8999999999887     88999999996 59999998654                  489999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHH
Q 023764           62 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  138 (277)
Q Consensus        62 H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~l  138 (277)
                      |++|++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++++|
T Consensus       162 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el  240 (313)
T 1t46_A          162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWEL  240 (313)
T ss_dssp             HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             HHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999976554322   2234567889999998654 589999999999999999


Q ss_pred             Hc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC
Q 023764          139 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  217 (277)
Q Consensus       139 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  217 (277)
                      ++ |..||.+................+                            ...+..+.++.+||.+||+.||.+|
T Consensus       241 lt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~R  292 (313)
T 1t46_A          241 FSLGSSPYPGMPVDSKFYKMIKEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKR  292 (313)
T ss_dssp             HTTTCCSSTTCCSSHHHHHHHHHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCCcccchhHHHHHhccCCCC----------------------------CCcccCCHHHHHHHHHHcCCCchhC
Confidence            98 999998766544333333221110                            0113567899999999999999999


Q ss_pred             CCHHHHhcC
Q 023764          218 ITVEDALAH  226 (277)
Q Consensus       218 ~t~~ell~h  226 (277)
                      ||+++++++
T Consensus       293 ps~~ell~~  301 (313)
T 1t46_A          293 PTFKQIVQL  301 (313)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-37  Score=261.97  Aligned_cols=187  Identities=14%  Similarity=0.241  Sum_probs=152.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +..|+||||++ ++|.+++...+. +++..+..++.|++.||.|||++||+||||||+||++
T Consensus        72 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  146 (289)
T 4fvq_A           72 KHLVLNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL  146 (289)
T ss_dssp             TTBCCEEEEECCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             CCEeEEEEEEEeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEE
Confidence            8999999999887     78899999997 699999987654 9999999999999999999999999999999999999


Q ss_pred             ecCCC--------eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCC
Q 023764           79 NANCD--------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRD  149 (277)
Q Consensus        79 ~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~  149 (277)
                      +.++.        ++|+|||++......   ....+++.|+|||++.+...++.++||||+||++++|++| .+||....
T Consensus       147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          147 IREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             EECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            98887        999999998644322   3346788999999997646689999999999999999995 45554444


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .......... .                              ....+..++++.+||.+||+.||.+|||++++++|
T Consensus       224 ~~~~~~~~~~-~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          224 SQRKLQFYED-R------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHHHHHHT-T------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHhhc-c------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3332221111 0                              01112456789999999999999999999999884

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-37  Score=265.68  Aligned_cols=190  Identities=22%  Similarity=0.303  Sum_probs=153.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      +..|+||||+. |+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        75 ~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~  148 (325)
T 3kex_A           75 AHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL  148 (325)
T ss_dssp             TTBCCEEEEECB------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE
T ss_pred             CCcCeEEEEEcC------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE
Confidence            799999999853      67899999997 6999999875 579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.......   ......++..|+|||.+.+. .++.++||||+||++|+|++ |..||.+.......
T Consensus       149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  227 (325)
T 3kex_A          149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP  227 (325)
T ss_dssp             SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred             CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence            999999999999997654332   23345677789999998654 48999999999999999999 99999876654443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+.... .                            .......+.++.++|.+||+.||.+|||+.+++++
T Consensus       228 ~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          228 DLLEKGE-R----------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHTTC-B----------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHcCC-C----------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322110 0                            01112356788999999999999999999999886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-37  Score=266.31  Aligned_cols=190  Identities=22%  Similarity=0.310  Sum_probs=157.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLYQIL   55 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~qll   55 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...                        ..+++..+..++.|++
T Consensus       110 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  184 (343)
T 1luf_A          110 PNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA  184 (343)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred             CCEEEEEEEEccC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHH
Confidence            8999999999887     88999999997 5999999864                        5699999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHH
Q 023764           56 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  132 (277)
Q Consensus        56 ~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  132 (277)
                      .||.|||++||+||||||+||+++.++.++|+|||++......   .......+++.|+|||++... .++.++||||||
T Consensus       185 ~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG  263 (343)
T 1luf_A          185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYG  263 (343)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred             HHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHH
Confidence            9999999999999999999999999999999999998754322   122344678889999998654 489999999999


Q ss_pred             HHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcC
Q 023764          133 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       133 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  211 (277)
                      |++|+|++ |..||.+.+.......+....                             .....+..++++.+||++||+
T Consensus       264 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~  314 (343)
T 1luf_A          264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-----------------------------ILACPENCPLELYNLMRLCWS  314 (343)
T ss_dssp             HHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCcCCCCChHHHHHHHhCCC-----------------------------cCCCCCCCCHHHHHHHHHHcc
Confidence            99999998 999998877655444332210                             001113567899999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 023764          212 FDPRQRITVEDALA  225 (277)
Q Consensus       212 ~dP~~R~t~~ell~  225 (277)
                      .||.+|||+.++++
T Consensus       315 ~~p~~Rps~~~~~~  328 (343)
T 1luf_A          315 KLPADRPSFCSIHR  328 (343)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999999976

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=262.16  Aligned_cols=197  Identities=25%  Similarity=0.405  Sum_probs=156.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        67 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~  141 (310)
T 3s95_A           67 PNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV  141 (310)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             cCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence            8999999999887     88999999996 599999987 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---------------cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           79 NANCDLKICDFGLARVTSETDFM---------------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      +.++.++|+|||++.........               ....||+.|+|||++.+ ..++.++||||+||++++|++|..
T Consensus       142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~  220 (310)
T 3s95_A          142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVN  220 (310)
T ss_dssp             CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred             CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCC
Confidence            99999999999999765433211               14578999999999864 558999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ||........              ...   .......          .....+..++.+.+||.+||+.||++|||++++
T Consensus       221 ~~~~~~~~~~--------------~~~---~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  273 (310)
T 3s95_A          221 ADPDYLPRTM--------------DFG---LNVRGFL----------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL  273 (310)
T ss_dssp             SSTTTSCBCT--------------TSS---BCHHHHH----------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCcchhhhHH--------------HHh---hhhhccc----------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9864321100              000   0000000          001124577899999999999999999999999


Q ss_pred             hcCCCCCCC
Q 023764          224 LAHPYLGSL  232 (277)
Q Consensus       224 l~hp~f~~~  232 (277)
                      ++  +++.+
T Consensus       274 ~~--~L~~l  280 (310)
T 3s95_A          274 EH--WLETL  280 (310)
T ss_dssp             HH--HHHHH
T ss_pred             HH--HHHHH
Confidence            87  55544

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.5e-38  Score=267.22  Aligned_cols=214  Identities=21%  Similarity=0.272  Sum_probs=156.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------Cceec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA----------NVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~----------~i~H~   69 (277)
                      |||+++++++...... ..++|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.          ||+||
T Consensus        78 pniv~~~~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~  155 (322)
T 3soc_A           78 ENILQFIGAEKRGTSV-DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR  155 (322)
T ss_dssp             TTBCCEEEEEEEECSS-SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS
T ss_pred             CCchhhcceeccCCCC-CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC
Confidence            8999999999874211 256899999996 599999987 4599999999999999999999999          99999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCC----CCCCcchhHHHHHHHHHHHHcCC
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRK  142 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~  142 (277)
                      ||||+||+++.++.+||+|||++.......   ......+|+.|+|||++.+.    ..++.++||||+||++|+|++|+
T Consensus       156 Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~  235 (322)
T 3soc_A          156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC  235 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             CCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence            999999999999999999999997654432   23345789999999998653    23456789999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITV  220 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~  220 (277)
                      .||.+................+....+...       ..  .......+...++  ..+.++.+||.+||+.||++|||+
T Consensus       236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (322)
T 3soc_A          236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEV-------VV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA  306 (322)
T ss_dssp             TTSSSCCCCCCCTTHHHHCSSCCHHHHHHH-------HT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCcchhccchhhhhccCCchhhhhhh-------hh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence            999765432222112222222222211110       00  0000111111111  123459999999999999999999


Q ss_pred             HHHhc
Q 023764          221 EDALA  225 (277)
Q Consensus       221 ~ell~  225 (277)
                      +++++
T Consensus       307 ~ell~  311 (322)
T 3soc_A          307 GCVGE  311 (322)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-36  Score=256.76  Aligned_cols=195  Identities=21%  Similarity=0.335  Sum_probs=149.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||++++++...      +..++||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        80 ~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~  153 (289)
T 3og7_A           80 VNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL  153 (289)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CcEEEEEeeccC------CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            799999996543      66899999997 6999998643 569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccC---CCcccccccccccCChhhhh--CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++.....   ........+++.|+|||++.  ....++.++|||||||++++|++|..||.+......
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  233 (289)
T 3og7_A          154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ  233 (289)
T ss_dssp             ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH
T ss_pred             CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH
Confidence            9999999999999875432   22234457899999999985  234578899999999999999999999988776665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..........++                        .........++.+++||.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          234 IIEMVGRGSLSP------------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHTSCCC------------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccccCc------------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            554443322111                        122233467889999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.8e-37  Score=269.02  Aligned_cols=190  Identities=23%  Similarity=0.372  Sum_probs=155.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||++ |+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus       172 pniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~  246 (377)
T 3cbl_A          172 PNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV  246 (377)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE
Confidence            8999999999887     78999999996 6999999765 469999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcc---cccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.+||+|||++.........   ....++..|+|||++... .++.++|||||||++++|++ |..||.+.+.....
T Consensus       247 ~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~  325 (377)
T 3cbl_A          247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR  325 (377)
T ss_dssp             CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH
T ss_pred             cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999865433211   122356779999998644 48999999999999999998 99999887765544


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+... ..+                            ......++++.+||.+||+.||.+|||++++++
T Consensus       326 ~~~~~~-~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          326 EFVEKG-GRL----------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHTT-CCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcC-CCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            333211 000                            011246788999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-37  Score=263.70  Aligned_cols=190  Identities=23%  Similarity=0.304  Sum_probs=154.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.      ..++|+|++. |+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        77 ~~iv~~~~~~~~~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll  150 (327)
T 3poz_A           77 PHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV  150 (327)
T ss_dssp             TTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEeEEEEEEecC------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE
Confidence            8999999999763      4788999986 699999886 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.+||+|||++........   .....+++.|+|||.+.+ ..++.++|||||||++++|++ |..||.+.......
T Consensus       151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  229 (327)
T 3poz_A          151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence            9999999999999976544322   223345778999999865 458999999999999999999 99999876654433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+.....                             ....+..+.++.+++.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          230 SILEKGER-----------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTTCC-----------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            32221100                             01123567889999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-36  Score=262.05  Aligned_cols=191  Identities=26%  Similarity=0.423  Sum_probs=158.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++....                .+++..+..++.|++.||+|||+
T Consensus       101 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  175 (334)
T 2pvf_A          101 KNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  175 (334)
T ss_dssp             TTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            8999999999887     88999999996 59999998654                38999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCc---ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +||+||||||+||+++.++.++|+|||++........   .....+++.|+|||++.+. .++.++||||+||++++|++
T Consensus       176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt  254 (334)
T 2pvf_A          176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT  254 (334)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHT
T ss_pred             CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999986654321   2234567889999998654 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+....+....+.....                             .......+.++.+||.+||+.||.+|||
T Consensus       255 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps  305 (334)
T 2pvf_A          255 LGGSPYPGIPVEELFKLLKEGHR-----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPT  305 (334)
T ss_dssp             TSCCSSTTCCHHHHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCcCcCCHHHHHHHHhcCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcC
Confidence             9999988766554443332110                             0112357789999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      +++++++
T Consensus       306 ~~ell~~  312 (334)
T 2pvf_A          306 FKQLVED  312 (334)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-36  Score=256.15  Aligned_cols=189  Identities=21%  Similarity=0.306  Sum_probs=156.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++ ..     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        78 ~~i~~~~~~~-~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~  151 (291)
T 1xbb_A           78 PYIVRMIGIC-EA-----ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV  151 (291)
T ss_dssp             TTBCCEEEEE-ES-----SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             CCEEEEEEEE-CC-----CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe
Confidence            7999999999 33     67899999997 69999999988899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      .++.++|+|||++........    .....+++.|+|||.+... .++.++|||||||++++|++ |..||.+.+.....
T Consensus       152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  230 (291)
T 1xbb_A          152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT  230 (291)
T ss_dssp             ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999986654322    1223456789999998644 47899999999999999999 99999887765544


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+... ..                            ....+..++++.++|.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~-~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          231 AMLEKG-ER----------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHTT-CC----------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcC-CC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333211 00                            0112357889999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-37  Score=254.26  Aligned_cols=191  Identities=20%  Similarity=0.319  Sum_probs=157.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +..|+||||++ ++|.+++.+. +.+++..+..++.|++.||.+||++|++|+||||+||++
T Consensus        63 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili  137 (267)
T 3t9t_A           63 PKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV  137 (267)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred             CCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence            7999999999887     78999999996 6999999875 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++.......  ......++..|+|||++... .++.++||||+||++++|++ |..||.+.+......
T Consensus       138 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  216 (267)
T 3t9t_A          138 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE  216 (267)
T ss_dssp             CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CCCCCEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH
Confidence            999999999999987543321  12234567789999998644 47999999999999999999 899998877665544


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+......                             ......+..+.+++.+||+.||.+|||+++++++
T Consensus       217 ~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          217 DISTGFRL-----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCcC-----------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43321000                             0112467889999999999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.7e-37  Score=266.37  Aligned_cols=190  Identities=22%  Similarity=0.342  Sum_probs=146.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +.+|+||||++ ++|.+++.+.+ .+++..+..++.|++.||+|||++||+||||||+||++
T Consensus       106 ~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  180 (373)
T 2qol_A          106 PNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI  180 (373)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE
Confidence            8999999999887     88999999995 69999998754 69999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.+||+|||++........    .....++..|+|||.+... .++.++|||||||++++|++ |..||.+.+..+.
T Consensus       181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~  259 (373)
T 2qol_A          181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV  259 (373)
T ss_dssp             CTTCCEEECCC----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred             cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999976543311    1122346789999998654 58999999999999999997 9999987776554


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+......                             ......+..+.+||.+||+.||.+|||++++++
T Consensus       260 ~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          260 IKAVDEGYRL-----------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHTTEEC-----------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCC-----------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            4433221100                             011246778999999999999999999998876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-36  Score=253.96  Aligned_cols=190  Identities=26%  Similarity=0.367  Sum_probs=148.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN---VLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~---i~H~di~~~ni   76 (277)
                      |||+++++++...     +..|+||||++ ++|.+++. .+.+++..+..++.|++.||.|||++|   ++||||||+||
T Consensus        66 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Ni  139 (271)
T 3dtc_A           66 PNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI  139 (271)
T ss_dssp             TTBCCEEEEECCC-------CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGE
T ss_pred             CCEeeEEEEEecC-----CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHE
Confidence            7999999999887     88999999996 68988885 467999999999999999999999999   89999999999


Q ss_pred             EEec--------CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 023764           77 LLNA--------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  148 (277)
Q Consensus        77 l~~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  148 (277)
                      +++.        ++.++|+|||++....... .....+++.|+|||.+.+. .++.++||||+||++++|++|..||.+.
T Consensus       140 l~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~  217 (271)
T 3dtc_A          140 LILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGI  217 (271)
T ss_dssp             EESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             EEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9985        7789999999997655432 2345789999999998654 5899999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          149 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +.......+.....                            ........++.+.++|.+||+.||.+|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          218 DGLAVAYGVAMNKL----------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHTSCC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHhhhcCCC----------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            65544333221100                            001123567899999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-36  Score=260.14  Aligned_cols=191  Identities=23%  Similarity=0.346  Sum_probs=152.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...     +..|+||||++ ++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus       106 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~  180 (333)
T 1mqb_A          106 HNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV  180 (333)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCCCcEEEEEecC-----CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE
Confidence            7999999999887     88999999997 5999999765 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++.......    ......+++.|+|||++... .++.++|||||||++++|++ |..||.+.+..+.
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~  259 (333)
T 1mqb_A          181 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV  259 (333)
T ss_dssp             CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999997654321    11223456789999998654 58999999999999999998 9999987776555


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...+......                             ......+..+.++|.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          260 MKAINDGFRL-----------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHTTCCC-----------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHCCCcC-----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4443321110                             0112567889999999999999999999998874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.6e-37  Score=256.48  Aligned_cols=190  Identities=23%  Similarity=0.331  Sum_probs=152.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+      +..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        73 ~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~  146 (281)
T 3cc6_A           73 PHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV  146 (281)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             CCcceEEEEEcC------CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence            899999999865      45699999997 6999999764 469999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.++|+|||++.......  ......+++.|+|||++.. ..++.++|||||||++++|++ |..||..........
T Consensus       147 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~  225 (281)
T 3cc6_A          147 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG  225 (281)
T ss_dssp             EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred             CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence            999999999999987654332  1233456778999999864 458999999999999999998 999997666554443


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+......                             ......++.+.++|.+||+.||.+|||+++++++
T Consensus       226 ~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          226 VLEKGDRL-----------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            33221100                             0112467889999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.2e-37  Score=260.17  Aligned_cols=193  Identities=25%  Similarity=0.413  Sum_probs=157.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA----------------LSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----------------l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+++++++..++    +.+|+||||++ ++|.+++.....                +++..+..++.|++.||.|||+
T Consensus        91 p~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  166 (316)
T 2xir_A           91 LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  166 (316)
T ss_dssp             TTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeeeEEEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh
Confidence            79999999987652    56899999997 599999987654                8999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +|++||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++||||+||++++|++
T Consensus       167 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHh
Confidence            999999999999999999999999999997654332   12344578889999998654 48999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |..||.+................+                            ......++.+.++|.+||+.||.+|||
T Consensus       246 ~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps  297 (316)
T 2xir_A          246 LGASPYPGVKIDEEFCRRLKEGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPT  297 (316)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCcccchhHHHHHHhccCccC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence             999998765433332222211110                            111246789999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      ++++++|
T Consensus       298 ~~ell~~  304 (316)
T 2xir_A          298 FSELVEH  304 (316)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.3e-36  Score=254.16  Aligned_cols=181  Identities=18%  Similarity=0.207  Sum_probs=145.8

Q ss_pred             CcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ecCCCeEEeeccceee
Q 023764           19 NDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARV   94 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~   94 (277)
                      +..|+||||++++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||++   +.++.++|+|||++..
T Consensus        78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            78899999998899999974 4679999999999999999999999999999999999999   4889999999999986


Q ss_pred             ccCCCc--------ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCC
Q 023764           95 TSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH---VHQLRLLIELIGT  163 (277)
Q Consensus        95 ~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~  163 (277)
                      ......        .....+++.|+|||.+.+ ..++.++||||+||++++|++|..||.+...   ......+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            554322        245578999999999865 4589999999999999999999999976432   1222222211100


Q ss_pred             CChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          164 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                                               .+.....+.+++++.+||.+||+.||.+|||++++++
T Consensus       237 -------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 -------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                     0111223467889999999999999999999999876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.7e-37  Score=259.68  Aligned_cols=196  Identities=20%  Similarity=0.287  Sum_probs=150.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR------SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~------~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~   73 (277)
                      |||+++++++.+....+....|+||||+. ++|.+++.      ....+++..+..++.|++.||.|||++|++||||||
T Consensus        96 ~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp  175 (313)
T 3brb_A           96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA  175 (313)
T ss_dssp             TTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSG
T ss_pred             CCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence            79999999998764333356799999997 59999984      335699999999999999999999999999999999


Q ss_pred             CcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q 023764           74 SNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  149 (277)
Q Consensus        74 ~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  149 (277)
                      +||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|||||||++++|++ |.+||.+..
T Consensus       176 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            99999999999999999987654332   1233456788999999865 458999999999999999999 999998776


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .......+.....                             ....+.+++++.+||.+||..||.+|||+++++++
T Consensus       255 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          255 NHEMYDYLLHGHR-----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             GGGHHHHHHTTCC-----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCC-----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5544443322100                             01123577899999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-36  Score=259.63  Aligned_cols=191  Identities=24%  Similarity=0.387  Sum_probs=158.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~~i~H~   69 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++...          ..+++..+..++.|++.||.|||++||+||
T Consensus        88 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  162 (322)
T 1p4o_A           88 HHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR  162 (322)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             CCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            7999999999887     88999999997 5999998752          457999999999999999999999999999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      ||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++|||||||++++|++ |..||
T Consensus       163 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~  241 (322)
T 1p4o_A          163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY  241 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             CCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCcc
Confidence            999999999999999999999987554322   12334567889999998654 48999999999999999999 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+.......+....                             .....+..+..+.+||.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~  292 (322)
T 1p4o_A          242 QGLSNEQVLRFVMEGG-----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  292 (322)
T ss_dssp             TTSCHHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHcCC-----------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            8877655544433210                             01112357889999999999999999999999998


Q ss_pred             C
Q 023764          226 H  226 (277)
Q Consensus       226 h  226 (277)
                      +
T Consensus       293 ~  293 (322)
T 1p4o_A          293 S  293 (322)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-36  Score=256.11  Aligned_cols=190  Identities=24%  Similarity=0.380  Sum_probs=157.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        69 ~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil  143 (288)
T 3kfa_A           69 PNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  143 (288)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEE
T ss_pred             CCEeeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEE
Confidence            7999999999887     88999999997 6999999864  45999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||++.......  ......+++.|+|||.+.+. .++.++||||+||++++|++ |..||.+.+.....
T Consensus       144 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~  222 (288)
T 3kfa_A          144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  222 (288)
T ss_dssp             ECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987654332  22334567789999998654 48999999999999999999 99999877654443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             ....+.+++.+.+||.+||..||.+|||++++++
T Consensus       223 ~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          223 ELLEKDYR-----------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCC-----------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            33322100                             0112357889999999999999999999999965

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-36  Score=261.73  Aligned_cols=191  Identities=23%  Similarity=0.317  Sum_probs=156.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------------NQALSEEHCQYFLYQILRGLKYIHSAN   65 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--------------~~~l~~~~~~~i~~qll~al~~LH~~~   65 (277)
                      |||+++++++...     +.+|+||||++ |+|.+++..              ...+++..+..++.|++.||.|||++|
T Consensus       110 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  184 (333)
T 2i1m_A          110 ENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN  184 (333)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            8999999999887     88999999996 599999875              245899999999999999999999999


Q ss_pred             ceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-C
Q 023764           66 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  141 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g  141 (277)
                      |+||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++|||||||++++|++ |
T Consensus       185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g  263 (333)
T 2i1m_A          185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLG  263 (333)
T ss_dssp             EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTS
T ss_pred             cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999997654332   12334567889999998654 48999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  221 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  221 (277)
                      ..||.+.........+......+                            ......+..+.+||.+||+.||.+|||+.
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~  315 (333)
T 2i1m_A          264 LNPYPGILVNSKFYKLVKDGYQM----------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQ  315 (333)
T ss_dssp             CCSSTTCCSSHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCcccchhHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence            99998766544433333221110                            01124578899999999999999999999


Q ss_pred             HHhc
Q 023764          222 DALA  225 (277)
Q Consensus       222 ell~  225 (277)
                      ++++
T Consensus       316 ~l~~  319 (333)
T 2i1m_A          316 QICS  319 (333)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9976

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.9e-36  Score=253.59  Aligned_cols=181  Identities=18%  Similarity=0.207  Sum_probs=146.4

Q ss_pred             CcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ecCCCeEEeeccceee
Q 023764           19 NDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARV   94 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~   94 (277)
                      +..|+||||++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            78899999998899999985 4679999999999999999999999999999999999999   7889999999999986


Q ss_pred             ccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCC
Q 023764           95 TSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV---HQLRLLIELIGT  163 (277)
Q Consensus        95 ~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~  163 (277)
                      .....        ......+++.|+|||.+.+ ..++.++||||+||++++|++|+.||.+.+..   .....+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            55432        1235578999999999865 45899999999999999999999999764322   112221111000


Q ss_pred             CChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          164 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                                               .+.....+.+++++.+||.+||+.||++|||++++++
T Consensus       237 -------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 -------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                     1112223467889999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-36  Score=257.97  Aligned_cols=192  Identities=25%  Similarity=0.369  Sum_probs=149.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++...     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++
T Consensus        94 p~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~  168 (309)
T 2h34_A           94 PHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS  168 (309)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc
Confidence            8999999999887     89999999997 59999999888899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.++|+|||++.......  ......+++.|+|||.+.+ ..++.++|||||||++++|++|..||.+.+...... .
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~  246 (309)
T 2h34_A          169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-H  246 (309)
T ss_dssp             TTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-H
T ss_pred             CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-H
Confidence            99999999999987654332  2334578999999998854 457899999999999999999999997765432211 1


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhc
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-TVEDALA  225 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~~ell~  225 (277)
                      ...  .                        ........+.+++++.++|.+||+.||.+|| |++++++
T Consensus       247 ~~~--~------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          247 INQ--A------------------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHS--C------------------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             hcc--C------------------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            110  0                        0111223356888999999999999999999 7887765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.3e-36  Score=250.05  Aligned_cols=190  Identities=15%  Similarity=0.255  Sum_probs=156.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~n   75 (277)
                      |||+++++++.+..   .+..|+||||++ ++|.+++....  .+++..+..++.|++.||.|||++|  ++||||||+|
T Consensus        67 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~N  143 (271)
T 3kmu_A           67 PNVLPVLGACQSPP---APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS  143 (271)
T ss_dssp             TTEECEEEEECTTT---SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGG
T ss_pred             CchhheEEEEccCC---CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccce
Confidence            89999999997652   267899999997 59999998765  4899999999999999999999999  9999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      |+++.++.++++|||++.....    ....+++.|+|||.+.+...  ++.++||||+||++++|++|..||.+.+....
T Consensus       144 il~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  219 (271)
T 3kmu_A          144 VMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI  219 (271)
T ss_dssp             EEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred             EEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence            9999999999999988654332    34577899999999865432  23379999999999999999999988776665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+......+                            ...+.+++++.++|.+||+.||.+|||++++++
T Consensus       220 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          220 GMKVALEGLRP----------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            44443211111                            112357889999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.3e-37  Score=262.11  Aligned_cols=196  Identities=20%  Similarity=0.282  Sum_probs=159.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------ALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qll~al~~LH~~~i~H~di~   72 (277)
                      |||+++++++...     +..|+||||++ ++|.+++....       .+++..+..++.|++.||.|||++|++|||||
T Consensus        93 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk  167 (327)
T 2yfx_A           93 QNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA  167 (327)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence            8999999999887     78899999995 69999998753       48999999999999999999999999999999


Q ss_pred             CCcEEEec---CCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 023764           73 PSNLLLNA---NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  145 (277)
Q Consensus        73 ~~nil~~~---~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  145 (277)
                      |+||+++.   +..++|+|||++.......   ......+++.|+|||.+.+. .++.++|||||||++++|++ |..||
T Consensus       168 p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~  246 (327)
T 2yfx_A          168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY  246 (327)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             HhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999984   4469999999986543221   22344678899999998654 48999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.........+.....                             ....+..+..+.+||.+||+.||.+|||++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  297 (327)
T 2yfx_A          247 PSKSNQEVLEFVTSGGR-----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE  297 (327)
T ss_dssp             TTCCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCHHHHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            87766554443322100                             0111356789999999999999999999999999


Q ss_pred             CCCCCC
Q 023764          226 HPYLGS  231 (277)
Q Consensus       226 hp~f~~  231 (277)
                      +.|+-.
T Consensus       298 ~l~~~~  303 (327)
T 2yfx_A          298 RIEYCT  303 (327)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            987643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.5e-37  Score=259.31  Aligned_cols=189  Identities=26%  Similarity=0.421  Sum_probs=145.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.... .+.+.+|+||||++ ++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        71 ~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil  149 (299)
T 3m2w_A           71 PHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL  149 (299)
T ss_dssp             TTBCCEEEEEEEEE-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCchhHHhhhhhhc-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence            79999999987611 11278999999997 59999998764  6999999999999999999999999999999999999


Q ss_pred             Eec---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           78 LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++.   ++.++|+|||++.....                      ..++.++||||+||++++|++|..||.+.......
T Consensus       150 ~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  207 (299)
T 3m2w_A          150 YTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  207 (299)
T ss_dssp             ESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred             EecCCCCCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence            988   78899999998864331                      23678999999999999999999999765432211


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ..+...                      ...............+++++++||.+||+.||.+|||++++++||||+....
T Consensus       208 ~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          208 PGMKTR----------------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             CCSCCS----------------------SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             HHHHHH----------------------HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            000000                      0000000011122467899999999999999999999999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-36  Score=254.58  Aligned_cols=191  Identities=20%  Similarity=0.288  Sum_probs=157.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++..      +..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        70 ~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili  143 (287)
T 1u59_A           70 PYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL  143 (287)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCEeEEEEEecC------CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE
Confidence            899999999943      66999999997 5999999654 569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++........    .....+++.|+|||++.+. .++.++||||+||++++|++ |..||.+....+.
T Consensus       144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  222 (287)
T 1u59_A          144 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV  222 (287)
T ss_dssp             EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred             cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9999999999999987654321    2233457889999998643 48899999999999999998 9999988776554


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ...+....                             .....+..++++.++|.+||+.||.+|||+.+++++.
T Consensus       223 ~~~i~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          223 MAFIEQGK-----------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCC-----------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            44332210                             0111236788999999999999999999999998863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-36  Score=269.49  Aligned_cols=189  Identities=22%  Similarity=0.355  Sum_probs=153.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++....    +.+|+||||++ |+|.+++.+.+.  +++..+..++.|++.||+|||++|++||||||+||+
T Consensus       246 ~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil  321 (450)
T 1k9a_A          246 SNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL  321 (450)
T ss_dssp             TTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             CCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence            89999999986641    57999999996 599999987543  799999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.+||+|||+++.....  .....++..|+|||++... .++.++|||||||++++|++ |..||.+.+..+....
T Consensus       322 l~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~  398 (450)
T 1k9a_A          322 VSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  398 (450)
T ss_dssp             ECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH
T ss_pred             ECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999999865432  2233567889999998654 58999999999999999998 9999987665544433


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +.....                             ....+..++++.+||.+||+.||.+|||+.++++
T Consensus       399 i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          399 VEKGYK-----------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            321100                             0111357889999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.4e-37  Score=262.84  Aligned_cols=195  Identities=23%  Similarity=0.369  Sum_probs=138.7

Q ss_pred             CceeeeeccccCCC---CCCCCcEEEEeecCcccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCC
Q 023764            1 MQVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~l~~---~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~   72 (277)
                      |||+++++++....   ..+.+.+|+||||++|+|.+++..   .+.+++..+..++.|++.||.|||+.|  |+|||||
T Consensus        86 ~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dik  165 (337)
T 3ll6_A           86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLK  165 (337)
T ss_dssp             TTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCC
T ss_pred             CChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCC
Confidence            79999999984321   122367999999999999998864   567999999999999999999999999  9999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCCCc-------------ccccccccccCChhhhh--CCCCCCcchhHHHHHHHHHH
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSETDF-------------MTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFME  137 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~il~~  137 (277)
                      |+||+++.++.++|+|||++........             .....+++.|+|||++.  ....++.++|||||||++++
T Consensus       166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e  245 (337)
T 3ll6_A          166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL  245 (337)
T ss_dssp             GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred             cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence            9999999999999999999976544321             11445899999999873  23457889999999999999


Q ss_pred             HHcCCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC
Q 023764          138 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  217 (277)
Q Consensus       138 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  217 (277)
                      |++|..||.+.........   ...                             .......+..+.+||++||+.||.+|
T Consensus       246 l~~g~~p~~~~~~~~~~~~---~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R  293 (337)
T 3ll6_A          246 LCFRQHPFEDGAKLRIVNG---KYS-----------------------------IPPHDTQYTVFHSLIRAMLQVNPEER  293 (337)
T ss_dssp             HHHSSCCC---------------CC-----------------------------CCTTCCSSGGGHHHHHHHSCSSGGGS
T ss_pred             HHhCCCCCcchhHHHhhcC---ccc-----------------------------CCcccccchHHHHHHHHHccCChhhC
Confidence            9999999965433221110   000                             01112456779999999999999999


Q ss_pred             CCHHHHhcCC
Q 023764          218 ITVEDALAHP  227 (277)
Q Consensus       218 ~t~~ell~hp  227 (277)
                      ||+++++++-
T Consensus       294 ps~~e~l~~l  303 (337)
T 3ll6_A          294 LSIAEVVHQL  303 (337)
T ss_dssp             CCHHHHHHHH
T ss_pred             cCHHHHHHHH
Confidence            9999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-36  Score=260.24  Aligned_cols=207  Identities=23%  Similarity=0.320  Sum_probs=155.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++...     +..|+||||++ ++|.+++....    .+++..+..++.|++.||+|||++|++||||||+|
T Consensus        95 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N  169 (321)
T 2qkw_B           95 PHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSIN  169 (321)
T ss_dssp             TTBCCEEEECCCT-----TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTT
T ss_pred             CCEeeEEEEEcCC-----CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHH
Confidence            8999999999887     88999999997 69999886543    58999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           76 LLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      |+++.++.++|+|||++......   .......|++.|+|||++.+. .++.++|||||||++++|++|+.||.+.....
T Consensus       170 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~  248 (321)
T 2qkw_B          170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE  248 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred             EEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence            99999999999999999764432   223345689999999998654 48999999999999999999999997553221


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcc-cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ......          +.  ...  .............. ....+..+..+.+++.+||+.||++|||+++++++.
T Consensus       249 ~~~~~~----------~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          249 MVNLAE----------WA--VES--HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CCCHHH----------HT--HHH--HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHH----------Hh--hhc--cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            100000          00  000  00000001001111 111123456789999999999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-36  Score=254.48  Aligned_cols=191  Identities=23%  Similarity=0.338  Sum_probs=152.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++....    +..|+||||+++ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        86 ~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~  161 (298)
T 3f66_A           86 PNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML  161 (298)
T ss_dssp             TTBCCCCEEECCSS----SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEeeeeeEEEcCC----CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence            79999999865431    678999999975 999999764 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  152 (277)
                      +.++.++|+|||++.......     ......+++.|+|||.+.+. .++.++||||+||++++|++ |.+||.+.+...
T Consensus       162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~  240 (298)
T 3f66_A          162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  240 (298)
T ss_dssp             CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred             CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence            999999999999997554321     22334567889999998654 58999999999999999999 677776665544


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+......                             ......+..+.++|.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          241 ITVYLLQGRRL-----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33333221100                             011246788999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=258.66  Aligned_cols=189  Identities=23%  Similarity=0.315  Sum_probs=149.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...      ..++|+|++. |+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        77 p~iv~~~~~~~~~------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~  150 (327)
T 3lzb_A           77 PHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV  150 (327)
T ss_dssp             TTBCCCCEEEESS------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCeeEEEEEEecC------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE
Confidence            8999999999764      4788899886 6999998764 579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.......
T Consensus       151 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  229 (327)
T 3lzb_A          151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             EETTEEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            999999999999997654332   12233457789999998654 58999999999999999999 99999877655443


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             ....+..+.++.+||++||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          230 SILEKGER-----------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHTTCC-----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            33221110                             0112357789999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=260.64  Aligned_cols=197  Identities=8%  Similarity=0.118  Sum_probs=151.4

Q ss_pred             eeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            3 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         3 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      ++++++++...    .+..|+||||++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus       119 i~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          119 IPTCMGFGVHQ----DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CCCCCEEEEET----TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred             ccchhhccccC----CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence            33455555442    1789999999988999999976  78999999999999999999999999999999999999999


Q ss_pred             CC--CeEEeeccceeeccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-
Q 023764           81 NC--DLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-  149 (277)
Q Consensus        81 ~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  149 (277)
                      ++  .++|+|||++.......        ......+++.|+|||++.+ ..++.++|||||||++++|++|..||.+.. 
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            98  89999999997544321        1234578999999999865 458999999999999999999999997653 


Q ss_pred             hHHHHHHHHH-HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          150 HVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       150 ~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+..... ....+.                   ....  .......+++++.+||.+||+.||.+|||++++++
T Consensus       274 ~~~~~~~~~~~~~~~~~-------------------~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          274 NTEDIMKQKQKFVDKPG-------------------PFVG--PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             CHHHHHHHHHHHHHSCC-------------------CEEC--TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHhccCChh-------------------hhhh--hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            2222222211 111100                   0000  00111256889999999999999999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-36  Score=256.15  Aligned_cols=191  Identities=21%  Similarity=0.315  Sum_probs=153.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.     +.+|+||||++ ++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        89 ~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~  163 (319)
T 2y4i_B           89 ENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY  163 (319)
T ss_dssp             TTBCCCCEEEECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE
T ss_pred             CCEeEEEEEEecC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE
Confidence            7999999999887     88999999996 69999998754 69999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccC------CCcccccccccccCChhhhhC--------CCCCCcchhHHHHHHHHHHHHcCCCC
Q 023764           79 NANCDLKICDFGLARVTSE------TDFMTEYVVTRWYRAPELLLN--------SSDYTAAIDVWSVGCIFMELMDRKPL  144 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~------~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~p  144 (277)
                      + ++.++|+|||++.....      ........+++.|+|||++..        ...++.++|||||||++++|++|..|
T Consensus       164 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  242 (319)
T 2y4i_B          164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP  242 (319)
T ss_dssp             C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            8 68999999998765421      122334468899999999854        23478899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          145 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                      |.+.........+.... .+                           ......++.++.++|.+||..||.+|||+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~  294 (319)
T 2y4i_B          243 FKTQPAEAIIWQMGTGM-KP---------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLM  294 (319)
T ss_dssp             SSSCCHHHHHHHHHTTC-CC---------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             CCCCCHHHHHHHhccCC-CC---------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            98776655443332110 00                           001124678899999999999999999999998


Q ss_pred             c
Q 023764          225 A  225 (277)
Q Consensus       225 ~  225 (277)
                      +
T Consensus       295 ~  295 (319)
T 2y4i_B          295 D  295 (319)
T ss_dssp             H
T ss_pred             H
Confidence            7

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-36  Score=269.90  Aligned_cols=189  Identities=26%  Similarity=0.421  Sum_probs=156.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +.+|+||||+. |+|.+++...  ..++...+..++.|++.||+|||++||+||||||+||+
T Consensus       243 ~~iv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil  316 (454)
T 1qcf_A          243 DKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL  316 (454)
T ss_dssp             TTBCCEEEEECS------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred             CCEeeEEEEEeC------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence            899999999863      66899999996 6999999754  36899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.+||+|||+++......  ......++..|+|||++... .++.++|||||||++++|++ |..||.+.+..+..
T Consensus       317 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~  395 (454)
T 1qcf_A          317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI  395 (454)
T ss_dssp             ECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997654321  11233456789999998644 58999999999999999999 99999988776665


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......+                             .....++++.+||.+||+.||.+|||++++++
T Consensus       396 ~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          396 RALERGYRMP-----------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            5543311111                             11256789999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-36  Score=252.08  Aligned_cols=196  Identities=25%  Similarity=0.325  Sum_probs=157.9

Q ss_pred             CceeeeeccccCCC-----------CCCCCcEEEEeecCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023764            1 MQVVAIRDIIPPPQ-----------RESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANV   66 (277)
Q Consensus         1 pniv~l~~~~~~~~-----------~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i   66 (277)
                      |||+++++++....           ....+.+|+||||+++ +|.+++...  ..+++..+..++.|++.||.|||++|+
T Consensus        64 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  143 (284)
T 2a19_B           64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL  143 (284)
T ss_dssp             TTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            79999999885410           0112668999999985 999999754  579999999999999999999999999


Q ss_pred             eecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           67 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        67 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      +|+||||+||+++.++.++|+|||++.............+++.|+|||.+.+ ..++.++|||||||++++|++|..||.
T Consensus       144 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          144 INRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             ECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             eeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            9999999999999999999999999987766555556678999999999865 458999999999999999999998873


Q ss_pred             CCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          147 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...  .....+.                             ..   ...+.++..+++||.+||+.||.+|||+.+++++
T Consensus       223 ~~~--~~~~~~~-----------------------------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~  268 (284)
T 2a19_B          223 ETS--KFFTDLR-----------------------------DG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRT  268 (284)
T ss_dssp             HHH--HHHHHHH-----------------------------TT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHH--HHHHHhh-----------------------------cc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            210  0000000                             00   0113467889999999999999999999999998


Q ss_pred             CCCCC
Q 023764          227 PYLGS  231 (277)
Q Consensus       227 p~f~~  231 (277)
                      .+.-.
T Consensus       269 l~~~~  273 (284)
T 2a19_B          269 LTVWK  273 (284)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            76543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-36  Score=256.73  Aligned_cols=208  Identities=19%  Similarity=0.315  Sum_probs=151.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...+.   +++|+||||++ ++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        71 ~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~  147 (295)
T 3ugc_A           71 DNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV  147 (295)
T ss_dssp             TTBCCEEEEECHHHH---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEeeEEEEEecCCC---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE
Confidence            799999999865421   56899999996 69999998754 59999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.......    ......++..|+|||.+.+. .++.++||||+||++++|++|..||......   
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---  223 (295)
T 3ugc_A          148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE---  223 (295)
T ss_dssp             EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---
T ss_pred             cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH---
Confidence            999999999999997654332    22234567779999998654 4899999999999999999999988543211   


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                        .....+.........  ............      ....+..++++.+||.+||+.||.+|||++++++
T Consensus       224 --~~~~~~~~~~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          224 --FMRMIGNDKQGQMIV--FHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             --HHHHHCTTCCTHHHH--HHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --HHhhhcCccccchhH--HHHHHHHhccCc------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              112222211111100  000011111111      1112357889999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-36  Score=252.85  Aligned_cols=191  Identities=26%  Similarity=0.361  Sum_probs=151.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+..    +..|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        82 ~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili  157 (298)
T 3pls_A           82 PNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML  157 (298)
T ss_dssp             TTBCCCCEEECCSS----SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCeeeEEEEEecCC----CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence            79999999998751    34499999995 799999987 4578999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~  152 (277)
                      +.++.++|+|||++......     .......+++.|+|||.+.+ ..++.++||||+||++++|++| .+||.+.+...
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~  236 (298)
T 3pls_A          158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD  236 (298)
T ss_dssp             CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred             cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence            99999999999998754322     22234567889999999854 4589999999999999999995 55555544433


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ....+......                             ......+..+.+||.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          237 LTHFLAQGRRL-----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCCCC-----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            33222211100                             111246788999999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-36  Score=272.02  Aligned_cols=190  Identities=23%  Similarity=0.388  Sum_probs=157.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++...     +.+|+||||+. |+|.+++.+.  ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus       276 pniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl  350 (495)
T 1opk_A          276 PNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL  350 (495)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            8999999999887     88999999997 6999999864  45899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.+||+|||+++.......  .....++..|+|||++... .++.++|||||||++++|++ |..||.+.+.....
T Consensus       351 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~  429 (495)
T 1opk_A          351 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  429 (495)
T ss_dssp             ECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987544321  1223456789999998654 48999999999999999998 99999887655444


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             .......++.+.+||.+||+.||.+|||++++++
T Consensus       430 ~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          430 ELLEKDYR-----------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            33221100                             0111356789999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.7e-36  Score=251.92  Aligned_cols=189  Identities=23%  Similarity=0.389  Sum_probs=155.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +..|+||||++ ++|.+++....  .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        68 ~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil  141 (279)
T 1qpc_A           68 QRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL  141 (279)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             cCcceEEEEEcC------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence            799999999864      56899999996 69999987543  6999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.++|+|||++........  .....++..|+|||.+.. ..++.++|||||||++++|++ |..||.+.+..+..
T Consensus       142 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  220 (279)
T 1qpc_A          142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI  220 (279)
T ss_dssp             ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             EcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            99999999999999987654321  223456778999999864 447899999999999999999 99999887766554


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+.....                             .......+.++.+|+.+||..||++|||++++++
T Consensus       221 ~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          221 QNLERGYR-----------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcccC-----------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            44322100                             0111356789999999999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-36  Score=253.32  Aligned_cols=189  Identities=21%  Similarity=0.342  Sum_probs=147.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++....    +.+|+||||++ ++|.+++.+.+.  +++..+..++.|++.||.|||++|++||||||+||+
T Consensus        74 ~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil  149 (278)
T 1byg_A           74 SNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL  149 (278)
T ss_dssp             TTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEeeEEEEEEcCC----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEE
Confidence            79999999976541    57899999997 499999986543  899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++|+|||++......  .....+++.|+|||.+.+ ..++.++|||||||++++|++ |..||.+....+....
T Consensus       150 ~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  226 (278)
T 1byg_A          150 VSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  226 (278)
T ss_dssp             ECTTSCEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred             EeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999998765433  223456888999999865 458999999999999999998 9999977654433322


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      +...                             ......+..++.+.++|.+||+.||.+|||+.++++
T Consensus       227 ~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          227 VEKG-----------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HTTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcC-----------------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            2110                             001112357889999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-36  Score=263.13  Aligned_cols=192  Identities=22%  Similarity=0.333  Sum_probs=145.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++....    +..|+||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus       150 pnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  225 (373)
T 3c1x_A          150 PNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML  225 (373)
T ss_dssp             TTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE
Confidence            89999999865431    67899999997 5999999865 458999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 023764           79 NANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  152 (277)
                      +.++.+||+|||++.......     ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+
T Consensus       226 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~  304 (373)
T 3c1x_A          226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  304 (373)
T ss_dssp             CTTCCEEECCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred             CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence            999999999999997543321     1223456778999999865 458999999999999999999 788887665443


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ....+.... .                            ....+..+..+.++|.+||+.||.+|||+++++++
T Consensus       305 ~~~~~~~~~-~----------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          305 ITVYLLQGR-R----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHTTC-C----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCC-C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332222100 0                            00112467889999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.8e-36  Score=277.81  Aligned_cols=189  Identities=21%  Similarity=0.303  Sum_probs=155.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++..      +.+|+||||+. |+|.+++..++.+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus       430 pnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~  503 (635)
T 4fl3_A          430 PYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV  503 (635)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCEeeEEEEEec------CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe
Confidence            899999999854      56899999997 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      .++.+||+|||+++......    ......+++.|+|||++.. ..++.++|||||||++++|++ |..||.+.+..+..
T Consensus       504 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~  582 (635)
T 4fl3_A          504 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT  582 (635)
T ss_dssp             ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999997654332    1223345778999999865 458999999999999999998 99999888776655


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..+......                             ......++++.+||.+||+.||++|||++++++
T Consensus       583 ~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          583 AMLEKGERM-----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            544321100                             111357889999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-36  Score=257.20  Aligned_cols=204  Identities=22%  Similarity=0.330  Sum_probs=155.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++..   ...+++..+..++.|++.||.|||++|++||||||+||
T Consensus        90 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni  164 (307)
T 2nru_A           90 ENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI  164 (307)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             CCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHE
Confidence            8999999999887     88999999995 699999873   35699999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           77 LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +++.++.++|+|||++.......   ......+++.|+|||.+.+  .++.++|||||||++++|++|.+||.+......
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            99999999999999987654422   1234568999999998853  378999999999999999999999976554332


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ...+.+........        ...+.       ........+..+..+.+++.+||+.||.+|||+++++++
T Consensus       243 ~~~~~~~~~~~~~~--------~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          243 LLDIKEEIEDEEKT--------IEDYI-------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             TTHHHHHHHTTSCC--------HHHHS-------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHhhhhhhh--------hhhhc-------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22222211110000        00000       000111111234678999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.1e-36  Score=254.92  Aligned_cols=201  Identities=21%  Similarity=0.293  Sum_probs=150.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH--------SANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH--------~~~i~H~di   71 (277)
                      |||+++++++.... ...+.+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||        +.||+||||
T Consensus        62 ~niv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl  139 (301)
T 3q4u_A           62 ENILGFIASDMTSR-HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL  139 (301)
T ss_dssp             TTBCCEEEEEEEEE-TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCC
T ss_pred             cCeeeEEEeecccc-CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCC
Confidence            79999999976532 12267999999997 599999965 57999999999999999999999        999999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCCc-----ccccccccccCChhhhhCCCC-----CCcchhHHHHHHHHHHHHcC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g  141 (277)
                      ||+||+++.++.+||+|||++........     .....||+.|+|||++.+...     ++.++||||+||++|+|++|
T Consensus       140 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          140 KSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            99999999999999999999976544322     233478999999999865432     34689999999999999999


Q ss_pred             ----------CCCCCCCCh----HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHH
Q 023764          142 ----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  207 (277)
Q Consensus       142 ----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  207 (277)
                                ..||.+...    ...........+..                      ...+........++++.+||.
T Consensus       220 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~  277 (301)
T 3q4u_A          220 MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR----------------------PNIPNRWFSDPTLTSLAKLMK  277 (301)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC----------------------CCCCGGGGGSHHHHHHHHHHH
T ss_pred             hcCccccccccccccccCCCCcchhhhhHHHhccCCC----------------------CCCChhhccCccHHHHHHHHH
Confidence                      788854321    11111111100000                      000000001124567999999


Q ss_pred             HhcCCCCCCCCCHHHHhc
Q 023764          208 KMLTFDPRQRITVEDALA  225 (277)
Q Consensus       208 ~~L~~dP~~R~t~~ell~  225 (277)
                      +||+.||.+|||++++++
T Consensus       278 ~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          278 ECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHCCSSGGGSCCHHHHHH
T ss_pred             HHhhcChhhCCCHHHHHH
Confidence            999999999999999975

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-36  Score=259.87  Aligned_cols=206  Identities=21%  Similarity=0.290  Sum_probs=154.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYIHSA---NVLHRDLK   72 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qll~al~~LH~~---~i~H~di~   72 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++....    .+++..+..++.|++.||+|||++   ||+|||||
T Consensus        87 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  161 (326)
T 3uim_A           87 RNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK  161 (326)
T ss_dssp             TTBCCCCEEECCS-----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred             CCccceEEEEecC-----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence            7999999999887     88899999996 59999998653    499999999999999999999999   99999999


Q ss_pred             CCcEEEecCCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-
Q 023764           73 PSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-  149 (277)
Q Consensus        73 ~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  149 (277)
                      |+||+++.++.++|+|||++......  .......|++.|+|||++.+. .++.++||||+||++++|++|..||.... 
T Consensus       162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (326)
T 3uim_A          162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL  240 (326)
T ss_dssp             GGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred             hhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCccccccc
Confidence            99999999999999999999865433  223345589999999998654 48999999999999999999999995210 


Q ss_pred             ----hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 023764          150 ----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  224 (277)
Q Consensus       150 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  224 (277)
                          .......+.......                 ........... ...+..+..+.+++.+||+.||.+|||+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  303 (326)
T 3uim_A          241 ANDDDVMLLDWVKGLLKEK-----------------KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV  303 (326)
T ss_dssp             TTTSCSBHHHHHTTTTSSC-----------------CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred             ccccchhHHHHHHHHhhch-----------------hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHH
Confidence                000000000000000                 00000000000 01112346789999999999999999999999


Q ss_pred             cCCCC
Q 023764          225 AHPYL  229 (277)
Q Consensus       225 ~hp~f  229 (277)
                      +|-.-
T Consensus       304 ~~L~~  308 (326)
T 3uim_A          304 RMLEG  308 (326)
T ss_dssp             HHHHT
T ss_pred             HHhcC
Confidence            97643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-35  Score=251.66  Aligned_cols=207  Identities=22%  Similarity=0.356  Sum_probs=155.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+.+   .+.+|+||||++ ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        83 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~  159 (302)
T 4e5w_A           83 ENIVKYKGICTEDG---GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV  159 (302)
T ss_dssp             TTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCeeeeeeEEecCC---CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE
Confidence            79999999997752   267999999996 599999954 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.......    ......++..|+|||.+.+. .++.++||||+||++++|++|..|+...     .
T Consensus       160 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~-----~  233 (302)
T 4e5w_A          160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSP-----M  233 (302)
T ss_dssp             EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSH-----H
T ss_pred             cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcch-----h
Confidence            999999999999998765432    22345677889999998654 4789999999999999999999886322     1


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .......+........   ..........      ......+.+++++.+||.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          234 ALFLKMIGPTHGQMTV---TRLVNTLKEG------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHCSCCGGGHH---HHHHHHHHTT------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hHHhhccCCcccccCH---HHHHHHHhcc------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222222322221110   0000001000      011122467889999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.8e-35  Score=248.78  Aligned_cols=188  Identities=19%  Similarity=0.330  Sum_probs=151.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~ni   76 (277)
                      |||+++++++.+.     .  ++||||+. ++|.+.+.+. ..+++..+..++.|++.||+|||++|  ++||||||+||
T Consensus        83 ~~i~~~~~~~~~~-----~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Ni  155 (287)
T 4f0f_A           83 PNIVKLYGLMHNP-----P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI  155 (287)
T ss_dssp             TTBCCEEEEETTT-----T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGE
T ss_pred             CCchhhheeecCC-----C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceE
Confidence            7999999999764     2  79999997 6998888654 47999999999999999999999999  99999999999


Q ss_pred             EEecCCC-----eEEeeccceeeccCCCcccccccccccCChhhhhC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 023764           77 LLNANCD-----LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  150 (277)
Q Consensus        77 l~~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  150 (277)
                      +++.++.     ++|+|||++......  .....+++.|+|||++.. ...++.++||||+||++++|++|..||.+...
T Consensus       156 l~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          156 FLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             EESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            9988776     999999998754432  345678999999998842 33468899999999999999999999976543


Q ss_pred             HHH--HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          151 VHQ--LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       151 ~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...  ...+.. .+.                           .....+..++++.+||.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          234 GKIKFINMIRE-EGL---------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CHHHHHHHHHH-SCC---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHhc-cCC---------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            322  111111 000                           01122357889999999999999999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.3e-36  Score=257.30  Aligned_cols=208  Identities=20%  Similarity=0.298  Sum_probs=155.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++....   .+.+|+||||++ ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        84 ~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~  160 (327)
T 3lxl_A           84 DFIVKYRGVSYGPG---RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV  160 (327)
T ss_dssp             TTBCCEEEEEECSS---SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CceeEEEEEEecCC---CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE
Confidence            79999999987532   277999999995 699999976 3569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++.......    ......+++.|+|||++.+. .++.++|||||||++++|++|..||........ 
T Consensus       161 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-  238 (327)
T 3lxl_A          161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-  238 (327)
T ss_dssp             EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-
T ss_pred             CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhh-
Confidence            999999999999998765432    22334577889999998654 478999999999999999999999865432211 


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                          ........  ...... ........      ......+.+++++.+||.+||+.||.+|||+++++++
T Consensus       239 ----~~~~~~~~--~~~~~~-~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          239 ----RMMGCERD--VPALSR-LLELLEEG------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ----HHCC------CCHHHH-HHHHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----hhcccccc--cccHHH-HHHHhhcc------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                00000000  000000 00000000      0111224678899999999999999999999999653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-37  Score=271.91  Aligned_cols=177  Identities=16%  Similarity=0.232  Sum_probs=146.4

Q ss_pred             CcEEEEeecCcccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccc
Q 023764           19 NDVYIAYELMDTDLHQIIRS-------NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   91 (277)
Q Consensus        19 ~~~~lv~e~~~~~L~~~l~~-------~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~   91 (277)
                      ..++++|++++++|.++++.       .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus       178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred             cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence            46899999999999998851       24477888999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCcccccccccccCChhhhh---------CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Q 023764           92 ARVTSETDFMTEYVVTRWYRAPELLL---------NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG  162 (277)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  162 (277)
                      +...+..  ....+| +.|+|||++.         ....++.++|||||||++|+|++|+.||.+.+......       
T Consensus       258 a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-------  327 (413)
T 3dzo_A          258 LVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-------  327 (413)
T ss_dssp             CEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-------
T ss_pred             eeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-------
Confidence            8876544  345567 9999999984         33447889999999999999999999996653211000       


Q ss_pred             CCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          163 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                                                 ......+.+++++++||.+||+.||++|||+.++++||||+.+
T Consensus       328 ---------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          328 ---------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             ---------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ---------------------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence                                       0011223678899999999999999999999999999999865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=260.53  Aligned_cols=221  Identities=19%  Similarity=0.244  Sum_probs=153.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---------NVLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---------~i~H~d   70 (277)
                      |||+++++.+......+...+|+||||++ |+|.+++... ..++..+..++.|++.||+|||+.         ||+|||
T Consensus        67 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~D  145 (336)
T 3g2f_A           67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD  145 (336)
T ss_dssp             TTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSS
T ss_pred             cchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecc
Confidence            79999998654433333367899999996 6999999774 458899999999999999999999         999999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCC---------CcccccccccccCChhhhhCC------CCCCcchhHHHHHHHH
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSET---------DFMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIF  135 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~il  135 (277)
                      |||+||+++.++.+||+|||++......         .......||+.|+|||++.+.      ..++.++|||||||++
T Consensus       146 ikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il  225 (336)
T 3g2f_A          146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY  225 (336)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHH
Confidence            9999999999999999999999765432         122345689999999998642      2355789999999999


Q ss_pred             HHHHcCCCCCC-CCChHHHHHHHHH-HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC---CCChhHHHHHHHhc
Q 023764          136 MELMDRKPLFP-GRDHVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP---NVHPSAIDLVEKML  210 (277)
Q Consensus       136 ~~ll~g~~pf~-~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L  210 (277)
                      |+|++|..||. +.........+.. ....+........       ...  ......+...++   ..++++.+||.+||
T Consensus       226 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl  296 (336)
T 3g2f_A          226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL-------VSR--EKQRPKFPEAWKENSLAVRSLKETIEDCW  296 (336)
T ss_dssp             HHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHH-------HTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHS
T ss_pred             HHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhh-------hcc--cccCCCCCcccccccchHHHHHHHHHHHh
Confidence            99999976653 3221111111111 1112221111100       000  001111111111   13457999999999


Q ss_pred             CCCCCCCCCHHHHhc------CCCCCC
Q 023764          211 TFDPRQRITVEDALA------HPYLGS  231 (277)
Q Consensus       211 ~~dP~~R~t~~ell~------hp~f~~  231 (277)
                      +.||++|||++++++      ++|-++
T Consensus       297 ~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          297 DQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             cCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            999999999999954      666654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6e-36  Score=251.94  Aligned_cols=190  Identities=21%  Similarity=0.297  Sum_probs=154.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++...      ..++||||+. ++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus        81 ~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili  154 (291)
T 1u46_A           81 RNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL  154 (291)
T ss_dssp             TTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             CCcccEEEEEccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence            7999999999764      3799999997 6999998764 569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.++|+|||++........    .....++..|+|||++... .++.++|||||||++++|++ |..||.+.+....
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  233 (291)
T 1u46_A          155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI  233 (291)
T ss_dssp             EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH
Confidence            9999999999999977654321    2234567789999998654 47899999999999999999 9999988776655


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+......+                            ...+.++.++.++|.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          234 LHKIDKEGERL----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHTSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCC----------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            44433211000                            112357889999999999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-35  Score=250.32  Aligned_cols=187  Identities=28%  Similarity=0.418  Sum_probs=144.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHS---ANVLHRDLKP   73 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~---~~i~H~di~~   73 (277)
                      |||+++++++.+       ..|+||||++ ++|.+++....   .++...+..++.|++.||+|||+   +||+||||||
T Consensus        61 p~iv~~~~~~~~-------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp  133 (307)
T 2eva_A           61 PNIVKLYGACLN-------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP  133 (307)
T ss_dssp             TTBCCEEEBCTT-------TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred             CCcCeEEEEEcC-------CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence            899999998863       3699999996 59999998764   37899999999999999999999   8999999999


Q ss_pred             CcEEEecCCC-eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           74 SNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        74 ~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      +||+++.++. +||+|||++......  .....|++.|+|||++.+ ..++.++|||||||++++|++|..||.......
T Consensus       134 ~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  210 (307)
T 2eva_A          134 PNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA  210 (307)
T ss_dssp             GGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH
T ss_pred             hHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH
Confidence            9999999887 799999998755433  234468999999999854 458999999999999999999999997543221


Q ss_pred             H-HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          153 Q-LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       153 ~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      . ...... .+                           ......+.++..+.+||.+||+.||.+|||++++++
T Consensus       211 ~~~~~~~~-~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          211 FRIMWAVH-NG---------------------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHH-TT---------------------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHh-cC---------------------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1 100000 00                           011122467889999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.2e-37  Score=281.03  Aligned_cols=255  Identities=23%  Similarity=0.281  Sum_probs=176.0

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.... ....+..|+||||++ |+|.+++....   .+++..++.++.|++.||+|||+.||+||||||+|
T Consensus        72 pnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~N  151 (676)
T 3qa8_A           72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN  151 (676)
T ss_dssp             TTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTT
T ss_pred             CCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence            89999999987622 122378899999995 69999998754   59999999999999999999999999999999999


Q ss_pred             EEEecCCC---eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH
Q 023764           76 LLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  152 (277)
Q Consensus        76 il~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  152 (277)
                      |+++.++.   ++|+|||.+.............+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.....
T Consensus       152 ILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~  230 (676)
T 3qa8_A          152 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV  230 (676)
T ss_dssp             EEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH
T ss_pred             eEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99997765   89999999988766655666789999999999854 458999999999999999999999997765432


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccC--CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR--QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      .+......   ...........     ......+..  .......+.+++.+.+||.+||.+||.+|||++++++||||+
T Consensus       231 ~~~~~i~~---~~~~~~~~~~~-----l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          231 QWHGKVRE---KSNEHIVVYDD-----LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             HSSTTCC---------CCSCCC-----CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             hhhhhhhc---ccchhhhhhhh-----hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence            21110000   00000000000     000000000  001112234567899999999999999999999999999998


Q ss_pred             CCCCCCCCCcC-------CCCCCcchhhhhcCHHHHHHHHHH
Q 023764          231 SLHDISDEPVC-------MSPFSFDFEQHALTEGQMKELIYQ  265 (277)
Q Consensus       231 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  265 (277)
                      .+.+.......       .....+ ......+...+++.+..
T Consensus       303 ~l~~iL~~kil~~f~~~~~~~~~~-~i~~~~tl~~l~~~i~~  343 (676)
T 3qa8_A          303 ALDSILSLKLLSVMNMVSGRVHTY-PVTENENLQNLKSWLQQ  343 (676)
T ss_dssp             HHHHHHCCCEEECCCSSSSCCCEE-ECCTTCCHHHHHHHHHT
T ss_pred             HHHHHHhcccccccccccccccee-ecCCCccHHHHHHHHHH
Confidence            76433222210       011111 23345566677776654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=271.66  Aligned_cols=215  Identities=17%  Similarity=0.297  Sum_probs=157.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++....   ..+.|+||||++ |+|.+++....   .+++..+..++.|++.||+|||++||+||||||+||
T Consensus        67 pnIv~~~~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  143 (396)
T 4eut_A           67 KNIVKLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI  143 (396)
T ss_dssp             TTBCCEEEEEECTT---TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCeEEEeeccCC---CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence            89999999997752   157899999996 69999997643   399999999999999999999999999999999999


Q ss_pred             EE----ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCC-------CCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           77 LL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        77 l~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      ++    +.++.+||+|||++.............|++.|+|||++.+.       ..++.++||||+||++|+|++|..||
T Consensus       144 ll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf  223 (396)
T 4eut_A          144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (396)
T ss_dssp             EEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred             EEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            98    66777999999999877665555667899999999998531       34678999999999999999999999


Q ss_pred             CCCC----hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccC--CcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          146 PGRD----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR--QSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       146 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                      .+..    ..+.+..+..  +.|+. .+........    ....+..  .........++..+.++|++||++||++|||
T Consensus       224 ~~~~~~~~~~~~~~~~~~--~~p~~-~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s  296 (396)
T 4eut_A          224 RPFEGPRRNKEVMYKIIT--GKPSG-AISGVQKAEN----GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG  296 (396)
T ss_dssp             ECTTCTTTCHHHHHHHHH--SCCTT-CCEEEECSTT----CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred             CCCCcccchHHHHHHHhc--CCCcc-cchhheeccC----CCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence            6432    2333333322  22221 1110000000    0000000  0000111234567899999999999999999


Q ss_pred             HHHHhc
Q 023764          220 VEDALA  225 (277)
Q Consensus       220 ~~ell~  225 (277)
                      ++++++
T Consensus       297 ~~e~l~  302 (396)
T 4eut_A          297 FDQFFA  302 (396)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999855

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-35  Score=265.93  Aligned_cols=195  Identities=27%  Similarity=0.392  Sum_probs=154.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +.+|+||||++ |+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus       239 p~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil  312 (452)
T 1fmk_A          239 EKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  312 (452)
T ss_dssp             TTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence            899999999864      56899999996 6999999743  56999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.+||+|||++.......  ......++..|+|||++... .++.++|||||||++++|++ |..||.+....+..
T Consensus       313 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~  391 (452)
T 1fmk_A          313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  391 (452)
T ss_dssp             ECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             ECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997654332  12233456789999998654 58999999999999999999 99999888766655


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYLGS  231 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~f~~  231 (277)
                      ..+......                             ...+..++.+.+||.+||+.||++|||++++++  ..++..
T Consensus       392 ~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          392 DQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            443321100                             111356788999999999999999999999987  355544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.6e-35  Score=249.61  Aligned_cols=192  Identities=27%  Similarity=0.429  Sum_probs=144.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++...     +..|+||||+++ +|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus        92 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N  166 (310)
T 2wqm_A           92 PNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN  166 (310)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             CCEeeEEEEEEcC-----CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHH
Confidence            7999999999887     899999999975 99998864    4679999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHH
Q 023764           76 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-VHQ  153 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~  153 (277)
                      |+++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|||||||++++|++|..||.+... ...
T Consensus       167 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  245 (310)
T 2wqm_A          167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS  245 (310)
T ss_dssp             EEECTTSCEEECCC------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred             EEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence            999999999999999987654332 2334578999999999854 4589999999999999999999999975432 111


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ..........+                           ......++.++.+||.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          246 LCKKIEQCDYP---------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHTTCSC---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcccCC---------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11111110000                           0011357889999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-35  Score=265.00  Aligned_cols=193  Identities=17%  Similarity=0.210  Sum_probs=152.6

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL--   78 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~--   78 (277)
                      +|+.+..++...     +..||||||++++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+  
T Consensus        64 ~i~~i~~~~~~~-----~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~  138 (483)
T 3sv0_A           64 GIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL  138 (483)
T ss_dssp             TCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC
T ss_pred             CCCeEEEEEeeC-----CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEec
Confidence            455555555554     78899999999999999985 4679999999999999999999999999999999999999  


Q ss_pred             -ecCCCeEEeeccceeeccCCCc--------ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           79 -NANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        79 -~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                       +.++.++|+|||++........        .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             GGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             CCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence             5889999999999987654322        225678999999999865 458999999999999999999999998754


Q ss_pred             h---HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          150 H---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       150 ~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .   ...+..+......                         .........++.++.+||.+||+.||.+||+++++++
T Consensus       218 ~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          218 AGTKKQKYEKISEKKVA-------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             CSSHHHHHHHHHHHHHH-------------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             chhHHHHHHHHhhcccc-------------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3   2222222221100                         1111222367889999999999999999999887665

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-35  Score=253.48  Aligned_cols=199  Identities=22%  Similarity=0.296  Sum_probs=148.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--------~i~H~di   71 (277)
                      |||+++++++.... ...+.+|+||||++ |+|.+++.. ..+++..+..++.|++.||.|||++        ||+||||
T Consensus        91 ~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di  168 (337)
T 3mdy_A           91 ENILGFIAADIKGT-GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL  168 (337)
T ss_dssp             TTBCCEEEEEEESC-GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred             CCeeeEEEEEccCC-CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence            79999999987642 12267999999996 599999976 4699999999999999999999999        9999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCCc-----ccccccccccCChhhhhCCCCCCc------chhHHHHHHHHHHHHc
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSDYTA------AIDVWSVGCIFMELMD  140 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~------~~DiwslG~il~~ll~  140 (277)
                      ||+||+++.++.+||+|||++........     .....||+.|+|||++.+.. ...      ++|||||||++|+|++
T Consensus       169 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~t  247 (337)
T 3mdy_A          169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVAR  247 (337)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred             chHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHh
Confidence            99999999999999999999976543321     22457899999999986543 333      3999999999999999


Q ss_pred             C----------CCCCCCCCh----HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccc--cCCCCChhHHH
Q 023764          141 R----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE--KFPNVHPSAID  204 (277)
Q Consensus       141 g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  204 (277)
                      |          ..||.....    ...........                       .. ......  .....+.++.+
T Consensus       248 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~-~~~~~~~~~~~~~~~~l~~  303 (337)
T 3mdy_A          248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK-----------------------KL-RPSFPNRWSSDECLRQMGK  303 (337)
T ss_dssp             TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS-----------------------CC-CCCCCGGGGGSHHHHHHHH
T ss_pred             ccCcccccccccccHhhhcCCCCchhhhHHHHhhh-----------------------cc-CccccccchhhHHHHHHHH
Confidence            9          566643221    11111111000                       00 000000  01134567999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcC
Q 023764          205 LVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       205 li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ||.+||+.||.+|||+++++++
T Consensus       304 li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          304 LMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHhhhhChhhCCCHHHHHHH
Confidence            9999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=271.56  Aligned_cols=189  Identities=20%  Similarity=0.294  Sum_probs=152.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++..      +.+|+||||++ |+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus       396 pniv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl  469 (613)
T 2ozo_A          396 PYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL  469 (613)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEeeEEEEecc------CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE
Confidence            899999999865      45899999997 5999999754 569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.+||+|||+++.......    .....+++.|+|||++.. ..++.++|||||||++++|++ |..||.+.+..+.
T Consensus       470 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~  548 (613)
T 2ozo_A          470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV  548 (613)
T ss_dssp             EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH
T ss_pred             cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            9999999999999976543211    122334678999999864 458999999999999999998 9999988877665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+.....                             ....+..++++.+||.+||+.||.+|||++++++
T Consensus       549 ~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          549 MAFIEQGKR-----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            544432100                             0111357889999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-35  Score=253.06  Aligned_cols=206  Identities=21%  Similarity=0.302  Sum_probs=155.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.+   .+.+|+||||++ ++|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus        93 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~  168 (318)
T 3lxp_A           93 EHIIKYKGCCEDAG---AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD  168 (318)
T ss_dssp             TTBCCEEEEEEETT---TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cchhhEEEEEecCC---CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc
Confidence            79999999998742   278999999997 5999999764 599999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++.++|+|||++.......    ......++..|+|||++.+. .++.++|||||||++++|++|..||......    
T Consensus       169 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----  243 (318)
T 3lxp_A          169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTK----  243 (318)
T ss_dssp             TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----
T ss_pred             CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchh----
Confidence            99999999999998765432    22344577889999998654 4789999999999999999999998643221    


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                       .....+........   ..........      ........++.++.+||++||+.||.+|||++++++
T Consensus       244 -~~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          244 -FLELIGIAQGQMTV---LRLTELLERG------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             -HHHHHCSCCHHHHH---HHHHHHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hhhhhcccccchhH---HHHHHHHhcc------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             11111111111000   0000001100      011122357889999999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.1e-35  Score=271.38  Aligned_cols=189  Identities=25%  Similarity=0.409  Sum_probs=154.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.+      +..|+||||++ |+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus       451 pnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl  524 (656)
T 2j0j_A          451 PHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV  524 (656)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCCeEEEEEec------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE
Confidence            899999999854      56899999997 69999998654 69999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc--ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.+||+|||++........  .....+++.|+|||++... .++.++||||+||++++|++ |..||.+....+...
T Consensus       525 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~  603 (656)
T 2j0j_A          525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG  603 (656)
T ss_dssp             EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9999999999999976544321  2234567789999998654 58999999999999999996 999998887766555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+......                             ...+..++.+.+||.+||+.||.+|||+.++++
T Consensus       604 ~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          604 RIENGERL-----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCC-----------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            44331111                             112357889999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=256.54  Aligned_cols=185  Identities=16%  Similarity=0.203  Sum_probs=148.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   74 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~   74 (277)
                      |||+++++++...     +..|+||||++ |+|.+++..     ...+++..+..++.|++.||+|||++||+||||||+
T Consensus       127 ~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~  201 (365)
T 3e7e_A          127 HMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD  201 (365)
T ss_dssp             GGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred             hhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHH
Confidence            6899999999887     88999999996 699999973     467999999999999999999999999999999999


Q ss_pred             cEEEec-----------CCCeEEeeccceeecc---CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           75 NLLLNA-----------NCDLKICDFGLARVTS---ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        75 nil~~~-----------~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      ||+++.           ++.+||+|||++....   ........+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus       202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt  280 (365)
T 3e7e_A          202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLF  280 (365)
T ss_dssp             GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHH
T ss_pred             HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHh
Confidence            999998           8999999999997543   22334556799999999998654 48999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 023764          141 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  220 (277)
Q Consensus       141 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  220 (277)
                      |+.||.......                                ......+. .. ..+..+.+++.+||..+|.+|++.
T Consensus       281 g~~pf~~~~~~~--------------------------------~~~~~~~~-~~-~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          281 GTYMKVKNEGGE--------------------------------CKPEGLFR-RL-PHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             SSCCCEEEETTE--------------------------------EEECSCCT-TC-SSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             CCCccccCCCCc--------------------------------eeechhcc-cc-CcHHHHHHHHHHHcCCCCCCcchH
Confidence            999984332100                                00000000 00 134578899999999999999765


Q ss_pred             HHHhc
Q 023764          221 EDALA  225 (277)
Q Consensus       221 ~ell~  225 (277)
                      .+.+.
T Consensus       327 ~~~l~  331 (365)
T 3e7e_A          327 LDLLR  331 (365)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44444

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=253.32  Aligned_cols=198  Identities=24%  Similarity=0.341  Sum_probs=150.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||+++++++.... ...+..|+||||+.+ +|.+++..    ...+++..+..++.|++.||.|||++|++||||||+|
T Consensus        86 ~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~N  164 (317)
T 2buj_A           86 PNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN  164 (317)
T ss_dssp             TTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence            79999999997421 112689999999974 99998875    4679999999999999999999999999999999999


Q ss_pred             EEEecCCCeEEeeccceeeccCCC----------cccccccccccCChhhhhCCC--CCCcchhHHHHHHHHHHHHcCCC
Q 023764           76 LLLNANCDLKICDFGLARVTSETD----------FMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        76 il~~~~~~~~l~dfg~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      |+++.++.++|+|||.+.......          ......+++.|+|||++....  .++.++|||||||++++|++|..
T Consensus       165 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  244 (317)
T 2buj_A          165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG  244 (317)
T ss_dssp             EEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred             EEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999886543211          012335689999999885432  25889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          144 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      ||......          +. .          .........      .....+..+.++.+||.+||+.||.+|||++++
T Consensus       245 p~~~~~~~----------~~-~----------~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  297 (317)
T 2buj_A          245 PYDMVFQK----------GD-S----------VALAVQNQL------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL  297 (317)
T ss_dssp             TTHHHHHT----------TS-C----------HHHHHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             Chhhhhcc----------cc-h----------hhHHhhccC------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            99421000          00 0          000000000      001124678899999999999999999999999


Q ss_pred             hcC
Q 023764          224 LAH  226 (277)
Q Consensus       224 l~h  226 (277)
                      +++
T Consensus       298 l~~  300 (317)
T 2buj_A          298 LSQ  300 (317)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.4e-35  Score=267.52  Aligned_cols=195  Identities=27%  Similarity=0.391  Sum_probs=158.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++..      +.+||||||+. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus       322 pniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl  395 (535)
T 2h8h_A          322 EKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  395 (535)
T ss_dssp             TTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence            799999999865      56899999996 6999999743  56999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      ++.++.+||+|||++.......  ......++..|+|||++... .++.++|||||||++++|++ |..||.+....+..
T Consensus       396 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~  474 (535)
T 2h8h_A          396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  474 (535)
T ss_dssp             ECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987554321  11223456789999998654 58999999999999999999 99999888766655


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC--CCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH--PYLGS  231 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h--p~f~~  231 (277)
                      ..+......                             ...+..+..+.+||.+||+.||++|||++++++.  .+|..
T Consensus       475 ~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          475 DQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            443321100                             1113567889999999999999999999999873  45543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-34  Score=248.17  Aligned_cols=200  Identities=18%  Similarity=0.264  Sum_probs=151.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH--------SANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH--------~~~i~H~di   71 (277)
                      |||+++++++..... ....+|+||||+++ +|.+++.+ ..+++..+..++.|++.||.|||        +.||+||||
T Consensus        96 ~ni~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl  173 (342)
T 1b6c_B           96 ENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL  173 (342)
T ss_dssp             TTBCCEEEEEECCCS-SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred             CcEEEEEeeecccCC-ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence            799999999987521 12389999999974 99999987 46999999999999999999999        899999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCC-----CcchhHHHHHHHHHHHHcC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~-----~~~~DiwslG~il~~ll~g  141 (277)
                      ||+||+++.++.++|+|||++.......     ......+++.|+|||++.+....     +.++|||||||++|+|++|
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            9999999999999999999997655432     22445789999999998654322     2689999999999999999


Q ss_pred             ----------CCCCCCCCh----HHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC--CCCChhHHHH
Q 023764          142 ----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDL  205 (277)
Q Consensus       142 ----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  205 (277)
                                ..||.....    ...+........                        ....+...+  ...+..+.+|
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~~l  309 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK------------------------LRPNIPNRWQSCEALRVMAKI  309 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC------------------------CCCCCCGGGGTSHHHHHHHHH
T ss_pred             cCcCCcccccccCccccCcCcccHHHHHHHHHHHH------------------------hCCCCcccccchhHHHHHHHH
Confidence                      677754421    111111110000                        000011110  1234578999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcC
Q 023764          206 VEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       206 i~~~L~~dP~~R~t~~ell~h  226 (277)
                      |.+||+.||++|||++++++|
T Consensus       310 i~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          310 MRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHHH
Confidence            999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-34  Score=247.15  Aligned_cols=208  Identities=19%  Similarity=0.291  Sum_probs=153.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++....   .+.+|+||||++ ++|.+++.+. ..+++..+..++.|++.||.+||++|++||||||+||++
T Consensus       102 ~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli  178 (326)
T 2w1i_A          102 DNIVKYKGVCYSAG---RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV  178 (326)
T ss_dssp             TTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             CCeeeEEEEEEecC---CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence            79999999987652   157899999996 5999999876 469999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      +.++.++|+|||++........    .....++..|+|||.+.+. .++.++|||||||++++|++|..||....     
T Consensus       179 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~-----  252 (326)
T 2w1i_A          179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP-----  252 (326)
T ss_dssp             EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----
T ss_pred             cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH-----
Confidence            9999999999999987654321    2234567779999998654 47899999999999999999999885321     


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .......+........  .............      ....+..+.++.+||++||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          253 AEFMRMIGNDKQGQMI--VFHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHCTTCCTHHH--HHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhccccchhhh--HHHHHHHhhcCCC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1112222222211100  0000011111000      0112357889999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-35  Score=255.97  Aligned_cols=177  Identities=17%  Similarity=0.206  Sum_probs=134.6

Q ss_pred             CcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEecCC--------------
Q 023764           19 NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNANC--------------   82 (277)
Q Consensus        19 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~~i~H~di~~~nil~~~~~--------------   82 (277)
                      +.+|+||||+. |++.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+|||++.++              
T Consensus       135 ~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~  213 (336)
T 2vuw_A          135 DQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST  213 (336)
T ss_dssp             TCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEE
T ss_pred             CeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcccc
Confidence            88999999995 555555543 67899999999999999999999 99999999999999999887              


Q ss_pred             ------CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHH-HHHHHcCCCCCCCCChHH-HH
Q 023764           83 ------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVH-QL  154 (277)
Q Consensus        83 ------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~  154 (277)
                            .+||+|||+++.....    ...||+.|+|||++.+.  .+.++||||+|++ .++++.|..||.+..... ..
T Consensus       214 ~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~  287 (336)
T 2vuw_A          214 IPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLT  287 (336)
T ss_dssp             EECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHH
T ss_pred             ccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC--CccceehhhhhCCCCcccccccCCCcchhhhhHHH
Confidence                  8999999999876543    45899999999998643  3889999998777 677888999883321100 11


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh-cCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL-AHPYLG  230 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell-~hp~f~  230 (277)
                      ..+...                       ............+.+++++++||++||++|     |++++| +||||+
T Consensus       288 ~~~~~~-----------------------~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          288 DKMLKQ-----------------------MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHT-----------------------CCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             Hhhhhh-----------------------hccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            111110                       001111111222346788999999999977     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=2.2e-33  Score=262.58  Aligned_cols=187  Identities=26%  Similarity=0.374  Sum_probs=147.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++......+....||||||++ ++|.+++..  .+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus       139 p~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~  216 (681)
T 2pzi_A          139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT  216 (681)
T ss_dssp             TTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe
Confidence            89999999998763222223799999997 589887764  799999999999999999999999999999999999998


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+ .+||+|||++......   ....||+.|+|||++.+.  .+.++|||||||++++|++|.+||.+....        
T Consensus       217 ~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------  282 (681)
T 2pzi_A          217 EE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------  282 (681)
T ss_dssp             SS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------
T ss_pred             CC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc--------
Confidence            75 8999999999876543   455789999999998643  488999999999999999999888542110        


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                        +.+..                      ..    ....++.+.+||.+||+.||.+||+..+++.|+|+..
T Consensus       283 --~~~~~----------------------~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 --GLPED----------------------DP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --SCCTT----------------------CH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --ccccc----------------------cc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence              00000                      00    0013567899999999999999999988888888753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=5.9e-32  Score=227.56  Aligned_cols=167  Identities=13%  Similarity=0.066  Sum_probs=132.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     +..|+||||++ ++|.+++..+  .....+..++.|++.||+|||++||+||||||+||+++
T Consensus        91 p~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~  163 (286)
T 3uqc_A           91 PGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS  163 (286)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE
T ss_pred             CCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc
Confidence            7999999999887     88999999997 5999999653  46667889999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.++|++++                   |++        .++.++|||||||++|+|++|+.||.+.+....+...  
T Consensus       164 ~~g~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--  214 (286)
T 3uqc_A          164 IDGDVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--  214 (286)
T ss_dssp             TTSCEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--
T ss_pred             CCCCEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--
Confidence            99999998443                   333        2689999999999999999999999765432100000  


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                                           ...............+.+++++.+||.+||+.||++| |+.++++
T Consensus       215 ---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          215 ---------------------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             ---------------------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ---------------------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                                 0000001112223446789999999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.5e-31  Score=244.62  Aligned_cols=133  Identities=17%  Similarity=0.205  Sum_probs=101.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +.+||||||++| +|.+++..++++++.   .|+.||+.||+|+|++||+||||||+|||++
T Consensus       302 ~~i~~~~~~~ed~-----~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~  373 (569)
T 4azs_A          302 FDAPAVLAHGENA-----QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD  373 (569)
T ss_dssp             CCCCCEEEEEECS-----SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC
T ss_pred             CCeeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC
Confidence            7999999999998     999999999975 999999998889865   4789999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCC
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  143 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  143 (277)
                      .+|.+||+|||+++..... ....+.+||+.|+|||++.+  .+..++|+||+|++.+.+.++..
T Consensus       374 ~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          374 ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence            9999999999999865443 34456789999999999854  36788999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.82  E-value=1.1e-21  Score=178.42  Aligned_cols=130  Identities=20%  Similarity=0.305  Sum_probs=104.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++..+....     ++.|+||||++ ++|.+++.+        +..++.|++.||+|||++||+||||||+||+++
T Consensus       399 ~nIv~~~~~~~~~-----~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~  465 (540)
T 3en9_A          399 FGIPAPYIFDVDL-----DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD  465 (540)
T ss_dssp             GTCCCCCEEEEET-----TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES
T ss_pred             CCcCceEEEEEeC-----CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC
Confidence            7899444444344     56699999996 799999875        668999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCc--------ccccccccccCChhhhhCC-CCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           80 ANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                      .  .+||+|||+++.......        .....||+.|+|||++... ..|+..+|+||.++-..+.+.++.+|
T Consensus       466 ~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          466 K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            8  999999999987765321        2356799999999998541 23678889999988887777665554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.64  E-value=4.1e-17  Score=136.55  Aligned_cols=79  Identities=24%  Similarity=0.253  Sum_probs=66.0

Q ss_pred             CcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccC
Q 023764           19 NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE   97 (277)
Q Consensus        19 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~   97 (277)
                      +..|+||||++ ++|.+ +.      ......++.|++.||.+||++||+||||||+||+++ ++.++|+|||++...  
T Consensus       173 ~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~--  242 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV--  242 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET--
T ss_pred             cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC--
Confidence            56799999996 58987 32      133557999999999999999999999999999999 999999999998643  


Q ss_pred             CCcccccccccccCChhhhh
Q 023764           98 TDFMTEYVVTRWYRAPELLL  117 (277)
Q Consensus        98 ~~~~~~~~~~~~~~aPE~~~  117 (277)
                                ..+.|||.+.
T Consensus       243 ----------~~~~a~e~l~  252 (282)
T 1zar_A          243 ----------GEEGWREILE  252 (282)
T ss_dssp             ----------TSTTHHHHHH
T ss_pred             ----------CCCCHHHHHH
Confidence                      3467888773

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.42  E-value=1.2e-13  Score=113.84  Aligned_cols=73  Identities=19%  Similarity=0.284  Sum_probs=61.3

Q ss_pred             CcEEEEeecCcc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEecCCCeEEeeccc
Q 023764           19 NDVYIAYELMDT------DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGL   91 (277)
Q Consensus        19 ~~~~lv~e~~~~------~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~~i~H~di~~~nil~~~~~~~~l~dfg~   91 (277)
                      +..||||||+++      +|.+....   .++..+..++.|++.|+.+|| ++||+||||||.||+++.  .++|+|||+
T Consensus       141 ~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~  215 (258)
T 1zth_A          141 MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQ  215 (258)
T ss_dssp             ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTT
T ss_pred             CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcc
Confidence            456899999963      67776433   235577889999999999999 999999999999999988  899999999


Q ss_pred             eeecc
Q 023764           92 ARVTS   96 (277)
Q Consensus        92 ~~~~~   96 (277)
                      +....
T Consensus       216 a~~~~  220 (258)
T 1zth_A          216 AVTLR  220 (258)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            97653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.21  E-value=4.1e-12  Score=109.80  Aligned_cols=70  Identities=17%  Similarity=0.211  Sum_probs=56.6

Q ss_pred             EEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCC----------eEEeec
Q 023764           21 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----------LKICDF   89 (277)
Q Consensus        21 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~----------~~l~df   89 (277)
                      .+|||||++| +|.++.      +......++.|++.++.+||++||+||||||.|||++.+|.          +.|+||
T Consensus       186 ~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~  259 (397)
T 4gyi_A          186 HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXF  259 (397)
T ss_dssp             TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCC
T ss_pred             ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEe
Confidence            4799999986 665432      12345678899999999999999999999999999988763          889999


Q ss_pred             cceeecc
Q 023764           90 GLARVTS   96 (277)
Q Consensus        90 g~~~~~~   96 (277)
                      +.+....
T Consensus       260 ~Q~V~~~  266 (397)
T 4gyi_A          260 PQMVSMD  266 (397)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9776544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.66  E-value=3.4e-08  Score=81.04  Aligned_cols=82  Identities=15%  Similarity=0.085  Sum_probs=63.2

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-----------------   63 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-----------------   63 (277)
                      ++++++++..+.     +..|+|||+++| +|.+...     +......++.++..++..||+                 
T Consensus        71 ~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~  140 (263)
T 3tm0_A           71 PVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA  140 (263)
T ss_dssp             CCCCEEEEEEET-----TEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred             CCCeEEEEEecC-----CceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence            466777777665     788999999987 7776521     222344778899999999998                 


Q ss_pred             ------------------------------------------CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ------------------------------------------ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ------------------------------------------~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                                                                .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                                      448999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.43  E-value=4.2e-07  Score=74.07  Aligned_cols=78  Identities=15%  Similarity=0.195  Sum_probs=56.8

Q ss_pred             eeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------
Q 023764            3 VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN----------------   65 (277)
Q Consensus         3 iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~----------------   65 (277)
                      +++++++....     +..|+|||+++| +| + .   ...+.   ..++.++...+..||+..                
T Consensus        77 vP~~~~~~~~~-----~~~~~v~e~i~G~~l-~-~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~  143 (264)
T 1nd4_A           77 CAAVLDVVTEA-----GRDWLLLGEVPGQDL-L-S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER  143 (264)
T ss_dssp             BCCEEEEEECS-----SCEEEEEECCSSEET-T-T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred             CCeEEEeccCC-----CCCEEEEEecCCccc-C-c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence            55667766554     678999999986 66 3 1   11222   255677777777777643                


Q ss_pred             ------------------------------------------ceecCCCCCcEEEecCCCeEEeecccee
Q 023764           66 ------------------------------------------VLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        66 ------------------------------------------i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                                                                ++|+|++|.||+++.++.+.|+||+.+.
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                                      9999999999999877666799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.39  E-value=5.5e-07  Score=77.34  Aligned_cols=90  Identities=16%  Similarity=0.262  Sum_probs=67.8

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-----------------   63 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-----------------   63 (277)
                      ++++++.+..+..  ..+..|+|||+++| .+.+.  ....++......++.++..+|..||+                 
T Consensus        99 pvP~~~~~~~~~~--~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~  174 (359)
T 3dxp_A           99 PVAKMYALCEDES--VIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY  174 (359)
T ss_dssp             CCCCEEEEECCTT--TTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred             CCCcEEEECCCCC--ccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence            3566777665531  11457999999987 44331  11347888888999999999999997                 


Q ss_pred             -----------------------------------------CCceecCCCCCcEEEecCCC--eEEeeccceeec
Q 023764           64 -----------------------------------------ANVLHRDLKPSNLLLNANCD--LKICDFGLARVT   95 (277)
Q Consensus        64 -----------------------------------------~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~   95 (277)
                                                               .+++|+|+++.||+++.++.  +.++||+.+...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                                     35899999999999987753  689999988643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.36  E-value=2.4e-07  Score=77.79  Aligned_cols=124  Identities=16%  Similarity=0.204  Sum_probs=79.9

Q ss_pred             cEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 023764           20 DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-----------------------------------   63 (277)
Q Consensus        20 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-----------------------------------   63 (277)
                      ..|+||++++| ++.+...  ..++.++...++.|+...+..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            45899999987 5654333  347777888888888888888886                                   


Q ss_pred             -----------------------CCceecCCCCCcEEEec--CCCeEEeeccceeeccCCCcccccccccccCChhhhh-
Q 023764           64 -----------------------ANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-  117 (277)
Q Consensus        64 -----------------------~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-  117 (277)
                                             ..++|+|+++.||+++.  .+.+.++||+.+.................-..|+... 
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                   13799999999999998  4567899999886543211000000000001222110 


Q ss_pred             ---CCCC---------CCcchhHHHHHHHHHHHHcCCCCC
Q 023764          118 ---NSSD---------YTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus       118 ---~~~~---------~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                         ..+.         ...-.+.|++|.+++.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0000         112368999999999999998766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.02  E-value=0.0001  Score=57.95  Aligned_cols=97  Identities=20%  Similarity=0.165  Sum_probs=64.2

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCccccccccc
Q 023764           31 DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR  108 (277)
Q Consensus        31 ~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  108 (277)
                      +|.+++.. +.++++++++.+++|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            79999875 4689999999999999998877632 2212334457899999999888764 1111           1122


Q ss_pred             ccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC
Q 023764          109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus       109 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  141 (277)
                      .+.+||...  ...+.+.=|+|||+++|.-+--
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhc
Confidence            355777652  2357888999999999987753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.59  E-value=0.00018  Score=58.76  Aligned_cols=83  Identities=18%  Similarity=0.303  Sum_probs=56.4

Q ss_pred             eeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------
Q 023764            3 VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-----------------   64 (277)
Q Consensus         3 iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-----------------   64 (277)
                      |.+++.+..+.     +..|+|||+++| ++.+.....    ......+..++...|..||..                 
T Consensus        82 VP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~  152 (272)
T 4gkh_A           82 LPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQ  152 (272)
T ss_dssp             CCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHH
T ss_pred             cCeEEEEEEEC-----CeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhh
Confidence            45666666665     778999999987 666554331    122234445555555555531                 


Q ss_pred             -----------------------------------------CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           65 -----------------------------------------NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        65 -----------------------------------------~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                                                               .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          153 AQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                                     168999999999999877778999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.57  E-value=0.0004  Score=58.07  Aligned_cols=31  Identities=39%  Similarity=0.659  Sum_probs=25.5

Q ss_pred             CceecCCCCCcEEEec---CCCe-EEeeccceeec
Q 023764           65 NVLHRDLKPSNLLLNA---NCDL-KICDFGLARVT   95 (277)
Q Consensus        65 ~i~H~di~~~nil~~~---~~~~-~l~dfg~~~~~   95 (277)
                      .++|+|+++.||+++.   ++.+ .|+||+.+...
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            3599999999999987   4665 89999987654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.67  E-value=0.0014  Score=55.80  Aligned_cols=31  Identities=16%  Similarity=0.269  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      ..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644578999988754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.18  E-value=0.0088  Score=50.20  Aligned_cols=30  Identities=27%  Similarity=0.394  Sum_probs=27.0

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.09  E-value=0.021  Score=49.79  Aligned_cols=34  Identities=12%  Similarity=0.304  Sum_probs=28.8

Q ss_pred             HhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           62 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        62 H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      +...++|+|+++.||+++.++ +.++||+.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            456799999999999998876 9999999886543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.61  E-value=0.075  Score=43.86  Aligned_cols=30  Identities=20%  Similarity=0.248  Sum_probs=25.3

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      .++|+|+.+.||+ ..++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            3899999999999 66778999999877543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=92.74  E-value=0.06  Score=45.11  Aligned_cols=33  Identities=27%  Similarity=0.425  Sum_probs=27.6

Q ss_pred             CCceecCCCCCcEEEecC----CCeEEeeccceeecc
Q 023764           64 ANVLHRDLKPSNLLLNAN----CDLKICDFGLARVTS   96 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~----~~~~l~dfg~~~~~~   96 (277)
                      ..++|+|+++.||+++.+    +.+.++||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999874    678999999876543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.47  E-value=0.043  Score=45.68  Aligned_cols=30  Identities=27%  Similarity=0.293  Sum_probs=25.6

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      +++|+|+++.||+++.++.+.++||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            699999999999998876568999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.22  E-value=0.13  Score=42.79  Aligned_cols=29  Identities=28%  Similarity=0.302  Sum_probs=24.7

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      ..++|+|+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999998 4 799999987654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=91.20  E-value=0.17  Score=42.58  Aligned_cols=32  Identities=19%  Similarity=0.320  Sum_probs=27.6

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeec
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVT   95 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~   95 (277)
                      .+++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35999999999999998888999999876543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=89.63  E-value=0.36  Score=41.41  Aligned_cols=31  Identities=19%  Similarity=0.371  Sum_probs=25.8

Q ss_pred             hCCceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           63 SANVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        63 ~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      ...++|+|+++.||+++.+ .+.++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            3579999999999999876 489999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.22  E-value=0.41  Score=40.61  Aligned_cols=29  Identities=28%  Similarity=0.595  Sum_probs=24.0

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      +++|+|+++.||+++.++ +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999997654 89999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=87.07  E-value=0.3  Score=42.62  Aligned_cols=29  Identities=34%  Similarity=0.486  Sum_probs=23.4

Q ss_pred             CceecCCCCCcEEEecC----------------------------CCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNAN----------------------------CDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~----------------------------~~~~l~dfg~~~   93 (277)
                      .++|+|+.+.||+++.+                            +.+.++||..+.
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            48999999999999875                            678889987664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=86.03  E-value=0.45  Score=40.78  Aligned_cols=29  Identities=28%  Similarity=0.457  Sum_probs=25.7

Q ss_pred             CceecCCCCCcEEEecC----CCeEEeecccee
Q 023764           65 NVLHRDLKPSNLLLNAN----CDLKICDFGLAR   93 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~----~~~~l~dfg~~~   93 (277)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            48999999999999876    789999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=85.97  E-value=0.42  Score=42.10  Aligned_cols=15  Identities=33%  Similarity=0.401  Sum_probs=14.0

Q ss_pred             CceecCCCCCcEEEe
Q 023764           65 NVLHRDLKPSNLLLN   79 (277)
Q Consensus        65 ~i~H~di~~~nil~~   79 (277)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            489999999999998

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.99  E-value=2.7  Score=32.76  Aligned_cols=99  Identities=16%  Similarity=0.174  Sum_probs=66.6

Q ss_pred             CcEEEEeecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeecc
Q 023764           19 NDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   96 (277)
Q Consensus        19 ~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~   96 (277)
                      +.+.+.++.-+ + ++..+    ..++.....+++.+|+....++++  =+|--++|+|++++.++.+++.-.|+...  
T Consensus        57 D~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~~~p~i~~RGik~~--  128 (215)
T 4ann_A           57 DSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRDGLPIAKTRGLQNV--  128 (215)
T ss_dssp             SEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTTSCEEESCCEETTT--
T ss_pred             cEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCCCCEEEEEccCccC--
Confidence            55666666654 2 55553    337888999999999887644433  46778999999999999999887665321  


Q ss_pred             CCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 023764           97 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  145 (277)
Q Consensus        97 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  145 (277)
                                    ++|.      ..+...-.-++=|++..++.++..|
T Consensus       129 --------------l~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          129 --------------VDPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             --------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             --------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence                          1221      1233333445778888899988777

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.03  E-value=0.88  Score=39.17  Aligned_cols=29  Identities=28%  Similarity=0.448  Sum_probs=24.3

Q ss_pred             ceecCCCCCcEEE------ecCCCeEEeeccceee
Q 023764           66 VLHRDLKPSNLLL------NANCDLKICDFGLARV   94 (277)
Q Consensus        66 i~H~di~~~nil~------~~~~~~~l~dfg~~~~   94 (277)
                      ++|+|+.+.||++      +.++.+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3457799999987753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	277
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-76
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-68
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-66
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-59
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-54
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-53
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-49
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-48
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-47
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-34
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-30
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-28
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-27
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-27
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-26
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-25
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (598), Expect = 1e-76
 Identities = 146/278 (52%), Positives = 193/278 (69%), Gaps = 6/278 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 62
           ++ I DII  P  E   DVY+   LM  DL++++++   LS +H  YFLYQILRGLKYIH
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 126

Query: 63  SANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPELLLN 118
           SANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++LN
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAK 177
           S  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A+
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
            Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D SD
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306

Query: 238 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 275
           EP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 307 EPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 344

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-68
 Identities = 117/272 (43%), Positives = 170/272 (62%), Gaps = 6/272 (2%)

Query: 3   VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    + F D Y+    M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YI
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYI 137

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           H+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMR 195

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAKKYI 180
           YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GT P+E      ++ AK Y+
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD  DEP 
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
               +   F+    T  + K + Y+E L+F P
Sbjct: 316 V-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 4e-66
 Identities = 130/272 (47%), Positives = 174/272 (63%), Gaps = 6/272 (2%)

Query: 3   VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           V+ + D+  P    E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKYI
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYI 137

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 121
           HSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH 195

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKYI 180
           Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L    +E+A+ YI
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 240
             L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEPV
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 315

Query: 241 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 272
              P+   FE   L   + K L Y E ++F P
Sbjct: 316 A-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-60
 Identities = 83/272 (30%), Positives = 149/272 (54%), Gaps = 13/272 (4%)

Query: 3   VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRG 57
           +V +R       +++    + +  + +   ++++     R+ Q L   + + ++YQ+ R 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 58  LKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+YRAPEL+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
             ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++  +N N 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 177 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD- 234
            ++  + P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH +   L D 
Sbjct: 255 TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 235 ---ISDEPVCMSPFSFDFEQHALTEGQMKELI 263
              + +     + F+F  ++ +        LI
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPPLATILI 344

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-59
 Identities = 109/282 (38%), Positives = 163/282 (57%), Gaps = 17/282 (6%)

Query: 1   MQVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 59
             ++++ ++  P    E F DVY+  ELMD +L Q+I+       E   Y LYQ+L G+K
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGIK 133

Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 119
           ++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 120 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 179
             Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y
Sbjct: 194 G-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 180 ICQLPRYQRQSFTEKFPN------------VHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
           +   P+Y   +F + FP+                A DL+ KML  DP +RI+V+DAL HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312

Query: 228 YLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEAL 268
           Y+   +D ++        +    ++   T  + KELIY+E +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-56
 Identities = 78/228 (34%), Positives = 119/228 (52%), Gaps = 6/228 (2%)

Query: 19  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +++ + ++ M+TD    I  ++  L+  H + ++   L+GL+Y+H   +LHRDLKP+NLL
Sbjct: 73  SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 132

Query: 78  LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           L+ N  LK+ DFGLA+   S     T  VVTRWYRAPELL  +  Y   +D+W+VGCI  
Sbjct: 133 LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
           EL+ R P  PG   + QL  + E +GTP+E +  + +  +         +        F 
Sbjct: 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ--WPDMCSLPDYVTFKSFPGIPLHHIFS 250

Query: 197 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP 244
                 +DL++ +  F+P  RIT   AL   Y  +       P C  P
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG--PTPGCQLP 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-54
 Identities = 83/232 (35%), Positives = 126/232 (54%), Gaps = 6/232 (2%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 60
           VV + D+    + +    + + +E +  D   +        +  E  +  ++Q+LRGL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 61  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 180
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +      +     
Sbjct: 192 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED---WPRDVALPR 247

Query: 181 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
                   Q   +   ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 7e-54
 Identities = 77/245 (31%), Positives = 120/245 (48%), Gaps = 8/245 (3%)

Query: 1   MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLK 59
           + ++ I      P       +Y+ ++  + DL  +        +    +  +  +L GL 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPE 114
           YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT WYR PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 115 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 174
           LLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++ 
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 175 NAKKYICQLPRYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
                  +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S 
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311

Query: 233 HDISD 237
              SD
Sbjct: 312 PMPSD 316

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-53
 Identities = 57/243 (23%), Positives = 107/243 (44%), Gaps = 23/243 (9%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +V            S  ++ I  E MD   L Q+++    + E+        +++GL Y+
Sbjct: 66  IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 62  HSAN-VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
              + ++HRD+KPSN+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGT 178

Query: 121 DYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLLIELIGTPSE-----------AE 168
            Y+   D+WS+G   +E+   +   P  D    +L    ++ G  +E             
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 169 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS--AIDLVEKMLTFDPRQRITVEDALAH 226
              ++      I +L  Y       K P+   S    D V K L  +P +R  ++  + H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298

Query: 227 PYL 229
            ++
Sbjct: 299 AFI 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-53
 Identities = 82/222 (36%), Positives = 126/222 (56%), Gaps = 4/222 (1%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
            + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL + HS  VLHRDLKP
Sbjct: 71  HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130

Query: 74  SNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
            NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+D+WS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           CIF E++ R+ LFPG   + QL  +   +GTP E        +   Y    P++ RQ F+
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG-VTSMPDYKPSFPKWARQDFS 249

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
           +  P +      L+ +ML +DP +RI+ + ALAHP+   +  
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  171 bits (435), Expect = 6e-53
 Identities = 83/215 (38%), Positives = 109/215 (50%), Gaps = 2/215 (0%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
                V +   L       +      L     + FL Q+L G+ Y H   VLHRDLKP N
Sbjct: 71  TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130

Query: 76  LLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           LL+N   +LKI DFGLAR         T  +VT WYRAP++L+ S  Y+  ID+WSVGCI
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
           F E+++  PLFPG     QL  +  ++GTP+      + E   KY      Y+   +   
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE-LPKYDPNFTVYEPLPWESF 249

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              +  S IDL+ KML  DP QRIT + AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 6e-51
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 31/215 (14%)

Query: 19  NDVYIAYELMDTDLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           N  Y+  E          I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLL
Sbjct: 76  NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 135

Query: 78  LNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           L+   +LKI DFGLA V    +    + +   T  Y APELL     +   +DVWS G +
Sbjct: 136 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 195

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
              ++  +  +       Q     +                           +++++   
Sbjct: 196 LTAMLAGELPWDQPSDSCQEYSDWK---------------------------EKKTYLNP 228

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
           +  +  + + L+ K+L  +P  RIT+ D     + 
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (419), Expect = 2e-50
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+    ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP 
Sbjct: 80  ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 139

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVW 129
           N+LL+ + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D+W
Sbjct: 140 NILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199

Query: 130 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 189
           S G I   L+   P F  R  +  LR+++                               
Sbjct: 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG------------------------ 235

Query: 190 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             + ++ +   +  DLV + L   P++R T E+ALAHP+ 
Sbjct: 236 --SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 4e-50
 Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 35/253 (13%)

Query: 19  NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +  ++  E    +    +    + L E       +  L+GL Y+HS N++HRD+K  N+L
Sbjct: 88  HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 78  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIF 135
           L+    +K+ DFG A + +       +V T ++ APE++L   +  Y   +DVWS+G   
Sbjct: 148 LSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204

Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
           +EL +RKP     + +  L  +                             Q +S   + 
Sbjct: 205 IELAERKPPLFNMNAMSALYHIA----------------------------QNESPALQS 236

Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD-EPVCMSPFSFDFEQHAL 254
            +      + V+  L   P+ R T E  L H ++      +    +         E   L
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296

Query: 255 TEGQMKELIYQEA 267
              +MK++++QEA
Sbjct: 297 QYRKMKKILFQEA 309

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-49
 Identities = 80/222 (36%), Positives = 114/222 (51%), Gaps = 3/222 (1%)

Query: 15  RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
                   +               N  L  E  + FL+Q+L+GL + HS NVLHRDLKP 
Sbjct: 71  HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130

Query: 75  NLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           NLL+N N +LK+ +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GC
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190

Query: 134 IFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           IF EL    +PLFPG D   QL+ +  L+GTP+E +   + +    Y          S  
Sbjct: 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDYKPYPMYPATTSLV 249

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 234
              P ++ +  DL++ +L  +P QRI+ E+AL HPY      
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 2e-49
 Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 33/215 (15%)

Query: 16  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
                VY+  E      +++ ++      E+    ++ ++   L Y HS  V+HRD+KP 
Sbjct: 76  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 135

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           NLLL +  +LKI DFG +     +   T    T  Y  PE++     +   +D+WS+G +
Sbjct: 136 NLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRM-HDEKVDLWSLGVL 193

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
             E +  KP F    +    + +  +  T                               
Sbjct: 194 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----------------------------- 224

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-48
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 34/218 (15%)

Query: 19  NDVYIAYELMDTDL--HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           N+++I  E          ++   + L+E   Q    Q L  L Y+H   ++HRDLK  N+
Sbjct: 82  NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141

Query: 77  LLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSV 131
           L   + D+K+ DFG++   T        ++ T ++ APE+++  +     Y    DVWS+
Sbjct: 142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G   +E+ + +P     + +  L  + +                      + P       
Sbjct: 202 GITLIEMAEIEPPHHELNPMRVLLKIAK---------------------SEPPTL----- 235

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             +      +  D ++K L  +   R T    L HP++
Sbjct: 236 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  160 bits (406), Expect = 4e-48
 Identities = 65/240 (27%), Positives = 133/240 (55%), Gaps = 16/240 (6%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           ++ + DI+   +        + +E ++ TD  Q+ ++   L++   ++++Y+IL+ L Y 
Sbjct: 92  IITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 145

Query: 62  HSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 120
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 121 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAK 177
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT    +    +  E   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 178 KYICQLPRYQRQSF-----TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 232
           ++   L R+ R+ +     +E    V P A+D ++K+L +D + R+T  +A+ HPY  ++
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (407), Expect = 6e-48
 Identities = 53/241 (21%), Positives = 92/241 (38%), Gaps = 36/241 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKY 60
           +V + D       E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL +
Sbjct: 85  LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139

Query: 61  IHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           +H  N +H DLKP N++     + +LK+ DFGL         +     T  + APE+   
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
                   D+WSVG +   L+     F G +    LR +        +            
Sbjct: 200 KP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------------ 246

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
                           F  +     D + K+L  DP  R+T+  AL HP+L   +    +
Sbjct: 247 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292

Query: 239 P 239
            
Sbjct: 293 S 293

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-47
 Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 41/225 (18%)

Query: 16  ESFNDVYIAYELMD-TDLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SAN 65
            +   +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        
Sbjct: 75  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134

Query: 66  VLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTA 124
           VLHRDLKP+N+ L+   ++K+ DFGLAR +  +T F   +V T +Y +PE +   S Y  
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNE 193

Query: 125 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 184
             D+WS+GC+  EL    P F           + E                         
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------------------------- 228

Query: 185 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                 F            +++ +ML      R +VE+ L +P +
Sbjct: 229 ----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 7e-47
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 30/256 (11%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII--RSNQALSEEHCQYFLYQILRGLK 59
           +V I D+           + I  E +D  +L   I  R +QA +E      +  I   ++
Sbjct: 67  IVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 60  YIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 116
           Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 184

Query: 117 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 176
           L    Y  + D+WS+G I   L+   P F     +     +   I               
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--------------- 229

Query: 177 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 236
           +    + P         ++  V      L+  +L  +P QR+T+ + + HP++     + 
Sbjct: 230 RMGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282

Query: 237 DEPVCMSPFSFDFEQH 252
             P+  S    + ++ 
Sbjct: 283 QTPLHTSRVLKEDKER 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-46
 Identities = 54/266 (20%), Positives = 108/266 (40%), Gaps = 32/266 (12%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           ES  ++ + +E +   D+ + I ++   L+E     +++Q+   L+++HS N+ H D++P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130

Query: 74  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N++     +  +KI +FG AR     D          Y APE+  +    + A D+WS+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSL 189

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +   L+     F    +   +  ++    T  E                         
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------------------------- 224

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQ 251
            E F  +   A+D V+++L  + + R+T  +AL HP+L    +     V +         
Sbjct: 225 -EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV-IRTLKHRRYY 282

Query: 252 HALTEGQMKELIYQEALAFNPEYRQQ 277
           H L +  +  ++    ++     R Q
Sbjct: 283 HTLIKKDLNMVVSAARISCGGAIRSQ 308

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-46
 Identities = 45/215 (20%), Positives = 93/215 (43%), Gaps = 29/215 (13%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
              +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146

Query: 76  LLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           +LL  +  +K+ DFG    +T E    +  V T ++ APE++   + Y   +D+WS+G +
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM 205

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
            +E+++ +P +   + +  L  LI   GTP                            + 
Sbjct: 206 AIEMIEGEPPYLNENPLRALY-LIATNGTPEL--------------------------QN 238

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
              +     D + + L  D  +R + ++ L H +L
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 3e-46
 Identities = 56/248 (22%), Positives = 104/248 (41%), Gaps = 36/248 (14%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY 60
           ++ + D       E   ++ +  E +   +L   I +    +SE     ++ Q   GLK+
Sbjct: 88  LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 61  IHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           +H  +++H D+KP N++        +KI DFGLA   +  + +     T  + APE +++
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVD 201

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
                   D+W++G +   L+     F G D +  L+ +        E            
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------------ 249

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 238
                         + F +V P A D ++ +L  +PR+R+TV DAL HP+L   H     
Sbjct: 250 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295

Query: 239 PVCMSPFS 246
            +  S ++
Sbjct: 296 RIPSSRYN 303

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 9e-45
 Identities = 40/215 (18%), Positives = 87/215 (40%), Gaps = 34/215 (15%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSN 75
             + +  ELM +  L   ++  + +  +  + +  QIL+GL+++H+    ++HRDLK  N
Sbjct: 85  KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 144

Query: 76  LLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           + +      +KI D GLA +     F    + T  + APE+      Y  ++DV++ G  
Sbjct: 145 IFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMC 201

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
            +E+   +  +    +  Q+   +     P+  +                          
Sbjct: 202 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-------------------------- 235

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                P   +++E  +  +  +R +++D L H + 
Sbjct: 236 -KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 2e-44
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 36/231 (15%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
           +VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L  +KY+
Sbjct: 69  IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123

Query: 62  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP NLL    + +  + I DFGL+++      ++    T  Y APE+L  
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
              Y+ A+D WS+G I   L+   P F   +       +++                   
Sbjct: 184 KP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------ 230

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
                           + ++  SA D +  ++  DP +R T E AL HP++
Sbjct: 231 --------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-42
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)

Query: 3   VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 61
            V +         +    +Y         +L + IR   +  E   +++  +I+  L+Y+
Sbjct: 70  FVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 62  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLN 118
           H   ++HRDLKP N+LLN +  ++I DFG A+V    S+      +V T  Y +PELL  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 119 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 178
            S    + D+W++GCI  +L+   P F   +     + +I+L     E            
Sbjct: 185 KS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE------------ 231

Query: 179 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA------LAHPYLGSL 232
                                P A DLVEK+L  D  +R+  E+        AHP+  S+
Sbjct: 232 ------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-42
 Identities = 40/218 (18%), Positives = 85/218 (38%), Gaps = 31/218 (14%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
            +   + I  +  + + L+  +   +             Q  +G+ Y+H+ +++HRDLK 
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKS 132

Query: 74  SNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLL--NSSDYTAAIDV 128
           +N+ L+ +  +KI DFGLA V S    +    +   +  + APE++   + + Y+   DV
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           ++ G +  ELM  +  +   ++  Q+  ++                           Y  
Sbjct: 193 YAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------------------GYLS 228

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
              ++   N   +   L+ + L     +R      LA 
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-40
 Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 40/214 (18%)

Query: 19  NDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           +   +  E  +   DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+
Sbjct: 82  DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 141

Query: 77  LLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 135
           L++ N  +LK+ DFG   +  +T   T++  TR Y  PE +     +  +  VWS+G + 
Sbjct: 142 LIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

Query: 136 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 195
            +++     F   + + + ++                                       
Sbjct: 201 YDMVCGDIPFEHDEEIIRGQVFFR------------------------------------ 224

Query: 196 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             V      L+   L   P  R T E+   HP++
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-39
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 32/219 (14%)

Query: 16  ESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           E+  DV +  EL+    L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 83  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142

Query: 75  NLLLN----ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           N++L         +KI DFGLA      +       T  + APE++ N        D+WS
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWS 201

Query: 131 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           +G I   L+     F G      L  +  +     +                        
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------------------------ 237

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
             E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 238 --EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-38
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 34/217 (15%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++  +++   E ++  DL   I+S          ++  +I+ GL+++HS  +++RDLK  
Sbjct: 73  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 132

Query: 75  NLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           N+LL+ +  +KI DFG+ +           +  T  Y APE+LL    Y  ++D WS G 
Sbjct: 133 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGV 191

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
           +  E++  +  F G+D                                      R     
Sbjct: 192 LLYEMLIGQSPFHGQDEEELF------------------------------HSIRMDNPF 221

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYL 229
               +   A DL+ K+   +P +R+ V  D   HP  
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (338), Expect = 9e-38
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 34/220 (15%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
            + + +    +LM+  DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+
Sbjct: 77  HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+
Sbjct: 137 NILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
             +L+     F       +  +                            R       E 
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEID---------------------------RMTLTMAVEL 228

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYL 229
             +  P    L+E +L  D  +R+       ++    P+ 
Sbjct: 229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 7e-35
 Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 34/214 (15%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           E    +YI  E M    L   +RS     L  +    F   +   ++Y+   N +HRDL 
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 130

Query: 73  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
             N+L++ +   K+ DFGL +  S T       +   + APE L     ++   DVWS G
Sbjct: 131 ARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFG 187

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
            +  E+     +   R  +  +   +E                 K Y    P        
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRVE-----------------KGYKMDAP-------- 222

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                  P+  ++++     D   R +       
Sbjct: 223 ---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 4e-34
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 19  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           + +    E  +   L   +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137

Query: 78  LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 136
           L+ +  +KI DFGL +   S+   M  +  T  Y APE+L + +DY  A+D W +G +  
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMY 196

Query: 137 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 196
           E+M  +  F  +DH                               + P            
Sbjct: 197 EMMCGRLPFYNQDHERLFE-------------------LILMEEIRFP-----------R 226

Query: 197 NVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 229
            + P A  L+  +L  DP+QR+       ++ + H + 
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 6e-34
 Identities = 35/223 (15%), Positives = 85/223 (38%), Gaps = 35/223 (15%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           ++   +++  + ++  +L   +   +  +E   Q ++ +I+  L+++H   +++RD+K  
Sbjct: 99  QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 158

Query: 75  NLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           N+LL++N  + + DFGL++                  +     +    S +  A+D WS+
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218

Query: 132 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
           G +  EL+     F      +    +   I                              
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------------------------- 253

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 229
                 +   A DL++++L  DP++R+       ++   H + 
Sbjct: 254 -PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  121 bits (303), Expect = 2e-33
 Identities = 43/219 (19%), Positives = 82/219 (37%), Gaps = 32/219 (14%)

Query: 14  QRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 72
           +  +    YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+K
Sbjct: 79  ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 138

Query: 73  PSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDV 128
           P+N++++A   +K+ DFG+AR  +++          + T  Y +PE     S   A  DV
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 197

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           +S+GC+  E++  +P F G   V      +     P                        
Sbjct: 198 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---------------------- 235

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 227
                +   +      +V K L  +P  R      +   
Sbjct: 236 ----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-32
 Identities = 52/225 (23%), Positives = 78/225 (34%), Gaps = 38/225 (16%)

Query: 17  SFNDVYIAYELMD---TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
           S   +YI  E M            + + L          QI  G+ Y+   N +HRDL+ 
Sbjct: 82  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 141

Query: 74  SNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
           +N+L+  N   K+ DFGLAR+  + ++           + APE  L    +T   DVWS 
Sbjct: 142 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSF 200

Query: 132 GCIFMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           G +  EL    +  +PG  +   L  +      P                          
Sbjct: 201 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP------------------------ 236

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYLGSLH 233
                P    S  DL+ +    +P +R T E   A    Y  S  
Sbjct: 237 -----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  119 bits (299), Expect = 3e-32
 Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 28/237 (11%)

Query: 18  FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNL 76
              +       +         ++ +   + +    Q+L GL Y+H    ++H D+KP N+
Sbjct: 98  HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157

Query: 77  LLNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
           L+           +KI D G A    E       + TR YR+PE+LL +  +    D+WS
Sbjct: 158 LMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQTREYRSPEVLLGA-PWGCGADIWS 214

Query: 131 VGCIFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSEAEL--------GFLNENA 176
             C+  EL+    LF   +          +  +IEL+G      L         F +   
Sbjct: 215 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274

Query: 177 KKYICQLPRYQRQSFTEK----FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 229
            + I +L  +  +    +      +      D +  ML  DPR+R      + HP+L
Sbjct: 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (295), Expect = 6e-32
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           +    +++  + ++  +L  ++R +Q       +++  ++   L+Y+HS ++++RDLKP 
Sbjct: 74  QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 133

Query: 75  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           N+LL+ N  +KI DFG A+   +         T  Y APE ++++  Y  +ID WS G +
Sbjct: 134 NILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGIL 190

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
             E++     F   + +     ++        AEL F                       
Sbjct: 191 IYEMLAGYTPFYDSNTMKTYEKIL-------NAELRFP---------------------- 221

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 229
            P  +    DL+ +++T D  QR+       ED   HP+ 
Sbjct: 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (293), Expect = 2e-31
 Identities = 42/213 (19%), Positives = 77/213 (36%), Gaps = 38/213 (17%)

Query: 22  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 81
            +   +   ++   +R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

Query: 82  CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 141
             +++ DFG A+             T    APE++L+   Y  A+D W++G +  E+   
Sbjct: 178 GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAG 234

Query: 142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS 201
            P F     +                                             +    
Sbjct: 235 YPPFFADQPIQIY------------------------------EKIVSGKVRFPSHFSSD 264

Query: 202 AIDLVEKMLTFDPRQRI-----TVEDALAHPYL 229
             DL+  +L  D  +R       V D   H + 
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-31
 Identities = 48/239 (20%), Positives = 79/239 (33%), Gaps = 57/239 (23%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQ-----------------------ALSEEHCQYFL 51
                +Y+ +E     DL   +RS +                        L+ E    F 
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170

Query: 52  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTR 108
           YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR               +  
Sbjct: 171 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230

Query: 109 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEA 167
            + APE L     YT   DVWS G +  E+       +PG         LI+        
Sbjct: 231 KWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-------- 281

Query: 168 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                      +    P                    +++    FD R+R +  +  + 
Sbjct: 282 ---------NGFKMDQP-----------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 5e-31
 Identities = 46/230 (20%), Positives = 84/230 (36%), Gaps = 43/230 (18%)

Query: 18  FNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
                +  E+ +   L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+
Sbjct: 79  AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 138

Query: 77  LLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL      KI DFGL++     +      T       + APE +     +++  DVWS G
Sbjct: 139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFG 197

Query: 133 CIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
            +  E     +  + G        +L                   K      P       
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLE------------------KGERMGCP------- 232

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLHDISDE 238
                       DL+    T+D   R     VE  L + Y    +D+ +E
Sbjct: 233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY----YDVVNE 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-30
 Identities = 43/241 (17%), Positives = 83/241 (34%), Gaps = 33/241 (13%)

Query: 17  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVL 67
           ++  +++  +  +   L   +     ++ E           GL ++H           + 
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130

Query: 68  HRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-- 120
           HRDLK  N+L+  N    I D GLA                 V T+ Y APE+L +S   
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190

Query: 121 ---DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 177
              +     D++++G +F E+  R  +  G    +QL     +   PS  E+       +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEM-------R 242

Query: 178 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 237
           K +C+           +          ++ +    +   R+T            L  +S 
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT-----LSQLSQ 297

Query: 238 E 238
           +
Sbjct: 298 Q 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 8e-30
 Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 40/220 (18%)

Query: 19  NDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
             + +  E+     LH+ +    + +   +    L+Q+  G+KY+   N +HRDL   N+
Sbjct: 81  EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140

Query: 77  LLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           LL      KI DFGL++     D      +       + APE + N   +++  DVWS G
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYG 199

Query: 133 CIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 191
               E +   +  +        +  +                             ++   
Sbjct: 200 VTMWEALSYGQKPYKKMKGPEVMAFI-----------------------------EQGKR 230

Query: 192 TEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPY 228
            E  P   P    L+     +    R     VE  +   Y
Sbjct: 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 9e-30
 Identities = 47/223 (21%), Positives = 78/223 (34%), Gaps = 41/223 (18%)

Query: 19  NDVYIAYELMDTDL---HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
             +YI  E M+           S   L+         QI  G+ +I   N +HRDL+ +N
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139

Query: 76  LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           +L++     KI DFGLAR+  + ++           + APE + N   +T   DVWS G 
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 198

Query: 134 IFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
           +  E++   +  +PG  +   ++ L                             +R    
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNL-----------------------------ERGYRM 229

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 235
            +  N       L+       P  R T +   +      L D 
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV-----LEDF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-29
 Identities = 36/212 (16%), Positives = 66/212 (31%), Gaps = 34/212 (16%)

Query: 19  NDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
             + +  EL    + L ++ +            +  Q+  G+ Y+ S   +HRDL   NL
Sbjct: 83  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142

Query: 77  LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           LL     +KI DFGL R   + D    M E+    +       L +  ++ A D W  G 
Sbjct: 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202

Query: 134 IFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
              E+    +  + G +    L  + +                                 
Sbjct: 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------------------------- 234

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
            +  +      +++ +     P  R T     
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-29
 Identities = 46/199 (23%), Positives = 68/199 (34%), Gaps = 29/199 (14%)

Query: 28  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 87
            D        +   LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI 
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169

Query: 88  DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 147
           DFGL+R        T   +   + A E  LN S YT   DVWS G +  E++        
Sbjct: 170 DFGLSRGQEVYVKKTMGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228

Query: 148 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 207
                +L                       + + Q  R       EK  N      DL+ 
Sbjct: 229 GMTCAELY----------------------EKLPQGYRL------EKPLNCDDEVYDLMR 260

Query: 208 KMLTFDPRQRITVEDALAH 226
           +     P +R +    L  
Sbjct: 261 QCWREKPYERPSFAQILVS 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 2e-28
 Identities = 36/216 (16%), Positives = 70/216 (32%), Gaps = 35/216 (16%)

Query: 16  ESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
                ++I  E M     L+ +         +        +   ++Y+ S   LHRDL  
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 128

Query: 74  SNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 131
            N L+N    +K+ DFGL+R   + ++           +  PE+L+ S  +++  D+W+ 
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAF 187

Query: 132 GCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 190
           G +  E+    K  +    +                             I Q  R  R  
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEH-----------------------IAQGLRLYRP- 223

Query: 191 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                         ++         +R T +  L++
Sbjct: 224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (267), Expect = 4e-28
 Identities = 36/215 (16%), Positives = 64/215 (29%), Gaps = 34/215 (15%)

Query: 14  QRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
                    +++  + T           LS         Q+  G+ Y+     +HRDL  
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168

Query: 74  SNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWS 130
            N L+  N  +KI DFGL+R     D+        +   +  PE +  +  YT   DVW+
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWA 227

Query: 131 VGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 189
            G +  E+       + G  H   +  + +                              
Sbjct: 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-----------------------------G 258

Query: 190 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
           +      N      +L+    +  P  R +     
Sbjct: 259 NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 7e-28
 Identities = 39/212 (18%), Positives = 70/212 (33%), Gaps = 33/212 (15%)

Query: 19  NDVYIAYELMDT-DLHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
             + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N 
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132

Query: 77  LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           L+  N  +K+ DFG+ R   +      T       + +PE+  + S Y++  DVWS G +
Sbjct: 133 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVL 191

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
             E+     +        ++   I                    +    PR         
Sbjct: 192 MWEVFSEGKIPYENRSNSEVVEDIS-----------------TGFRLYKPR--------- 225

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                     ++       P  R      L  
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-27
 Identities = 46/257 (17%), Positives = 86/257 (33%), Gaps = 41/257 (15%)

Query: 19  NDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           + V +  +LM     L  +      +  ++   +  QI +G+ Y+    ++HRDL   N+
Sbjct: 83  STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142

Query: 77  LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 133
           L+     +KI DFGLA++    +         V   + A E +L+   YT   DVWS G 
Sbjct: 143 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGV 201

Query: 134 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 193
              ELM             ++  ++E                            +     
Sbjct: 202 TVWELMTFGSKPYDGIPASEISSILE----------------------------KGERLP 233

Query: 194 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH-------PYLGSLHDISDEPVCMSPFS 246
           + P        ++ K    D   R    + +         P    +    +     SP  
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 293

Query: 247 FDFEQHALTEGQMKELI 263
            +F +  + E  M +++
Sbjct: 294 SNFYRALMDEEDMDDVV 310

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 4e-27
 Identities = 44/212 (20%), Positives = 79/212 (37%), Gaps = 33/212 (15%)

Query: 19  NDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
           N V+I  EL         +     +L       + YQ+   L Y+ S   +HRD+   N+
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139

Query: 77  LLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
           L+++N  +K+ DFGL+R   ++ +   ++  +   + APE + N   +T+A DVW  G  
Sbjct: 140 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVC 198

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
             E++            + +   I                            +       
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRI----------------------------ENGERLPM 230

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
            PN  P+   L+ K   +DP +R    +  A 
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (259), Expect = 6e-27
 Identities = 33/225 (14%), Positives = 65/225 (28%), Gaps = 38/225 (16%)

Query: 19  NDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 77
           +   +  EL+   L  +    ++  S +       Q++  ++YIHS N +HRD+KP N L
Sbjct: 76  DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 135

Query: 78  ---LNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAI 126
                    + I DFGLA+   +                 T  Y +    L   + +   
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRD 194

Query: 127 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 186
           D+ S+G + M        + G     + +                      KY     + 
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQ----------------------KYERISEKK 232

Query: 187 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPY 228
                              +    +     +     +     + +
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  103 bits (258), Expect = 8e-27
 Identities = 41/210 (19%), Positives = 70/210 (33%), Gaps = 32/210 (15%)

Query: 19  NDVYIAYELMD---TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 75
              YI  E M       +    + Q +S     Y   QI   ++Y+   N +HRDL   N
Sbjct: 86  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145

Query: 76  LLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 134
            L+  N  +K+ DFGL+R +T +T                  L  + ++   DVW+ G +
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205

Query: 135 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 194
             E+            + Q+  L+E                 K Y  + P          
Sbjct: 206 LWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRMERP---------- 238

Query: 195 FPNVHPSAIDLVEKMLTFDPRQRITVEDAL 224
                    +L+     ++P  R +  +  
Sbjct: 239 -EGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-26
 Identities = 46/232 (19%), Positives = 83/232 (35%), Gaps = 50/232 (21%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGL 58
           +    + +  E     +L   +RS +                 L+ EH   + +Q+ +G+
Sbjct: 88  KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147

Query: 59  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPEL 115
           +++ S   +HRDL   N+LL+    +KICDFGLAR   +        +  +   + APE 
Sbjct: 148 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 207

Query: 116 LLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 174
           + +   YT   DVWS G +  E+       +PG     +    ++               
Sbjct: 208 IFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------- 251

Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
             +    + P               P     +      +P QR T  + + H
Sbjct: 252 --EGTRMRAP-----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (256), Expect = 2e-26
 Identities = 39/219 (17%), Positives = 68/219 (31%), Gaps = 37/219 (16%)

Query: 16  ESFNDVYIAYELMDTDLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 73
                V I  E M+         +++   +       L  I  G+KY+   N +HRDL  
Sbjct: 97  TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156

Query: 74  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDV 128
            N+L+N+N   K+ DFGL+R   +      Y      + P             +T+A DV
Sbjct: 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV 216

Query: 129 WSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 187
           WS G +  E+M   +  +    +   +  + +    P                       
Sbjct: 217 WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP--------------------- 255

Query: 188 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                    +   +   L+      D   R      +  
Sbjct: 256 --------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (253), Expect = 5e-26
 Identities = 29/216 (13%), Positives = 63/216 (29%), Gaps = 37/216 (17%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 74
           +      +  +L+   L  ++    +  S +       Q+L  ++ IH  ++++RD+KP 
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130

Query: 75  NLLLNANC-----DLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSD 121
           N L+          + + DFG+ +   +                 T  Y +    L   +
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-RE 189

Query: 122 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 181
            +   D+ ++G +FM  +     + G                           N +KY  
Sbjct: 190 QSRRDDLEALGHVFMYFLRGSLPWQGLKAA----------------------TNKQKYER 227

Query: 182 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 217
              + Q     E            +           
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 5e-26
 Identities = 46/237 (19%), Positives = 80/237 (33%), Gaps = 41/237 (17%)

Query: 19  NDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 76
             + I  E M        +   +   S       L  I  G+KY+ + N +HRDL   N+
Sbjct: 82  KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141

Query: 77  LLNANCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 132
           L+N+N   K+ DFGL+RV  +    T   +   +   + APE +      +A+ DVWS G
Sbjct: 142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFG 200

Query: 133 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 192
            +  E+M            H++   I                                  
Sbjct: 201 IVMWEVMTYGERPYWELSNHEVMKAI----------------------------NDGFRL 232

Query: 193 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF 249
               +   +   L+ +    +  +R    D ++      L  +   P  +   + DF
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI-----LDKLIRAPDSLKTLA-DF 283

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 4e-25
 Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 51/232 (21%)

Query: 16  ESFNDVYIAYELMD-TDLHQIIR----------------SNQALSEEHCQYFLYQILRGL 58
                +Y+  E     +L + ++                  + LS +      YQ+ RG+
Sbjct: 89  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148

Query: 59  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAPEL 115
           +Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +     +   + APE 
Sbjct: 149 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208

Query: 116 LLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 174
           L +   YT   DVWS G +  E+       +PG                          E
Sbjct: 209 LFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------------------VE 244

Query: 175 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
              K + +  R       +K  N       ++       P QR T +  +  
Sbjct: 245 ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 6e-25
 Identities = 53/230 (23%), Positives = 78/230 (33%), Gaps = 54/230 (23%)

Query: 19  NDVYIAYELMD-TDLHQIIRSNQ------------------ALSEEHCQYFLYQILRGLK 59
               +  E     DL   +R  +                  AL  E    F YQ+ +G+ 
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159

Query: 60  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELL 116
           ++ S N +HRDL   N+LL      KICDFGLAR     S         +   + APE +
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219

Query: 117 LNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 175
            N   YT   DVWS G    EL       +PG     +   +I                 
Sbjct: 220 FNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI----------------- 261

Query: 176 AKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDAL 224
                       ++ F    P +      D+++     DP +R T +  +
Sbjct: 262 ------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 3e-24
 Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 45/223 (20%)

Query: 19  NDVYIAYELMD-TDLHQIIRSNQ----------ALSEEHCQYFLYQILRGLKYIHSANVL 67
               +  ELM   DL   +RS +            S         +I  G+ Y+++   +
Sbjct: 96  QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155

Query: 68  HRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTA 124
           HRDL   N ++  +  +KI DFG+ R   ETD+     + ++   + +PE L +   +T 
Sbjct: 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTT 214

Query: 125 AIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 183
             DVWS G +  E+    +  + G  +   LR ++E                        
Sbjct: 215 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------------------------ 250

Query: 184 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                    +K  N      +L+     ++P+ R +  + ++ 
Sbjct: 251 -----GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 6e-24
 Identities = 41/218 (18%), Positives = 72/218 (33%), Gaps = 36/218 (16%)

Query: 16  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ--YFLYQILRGLKYIHSANVLHRDLKP 73
            S     +    M     +    N+  +        F  Q+ +G+K++ S   +HRDL  
Sbjct: 99  RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 158

Query: 74  SNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSDYTAAIDV 128
            N +L+    +K+ DFGLAR   + +F      T   +   + A E L     +T   DV
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDV 217

Query: 129 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 188
           WS G +  ELM R        +   +                        Y+ Q  R  +
Sbjct: 218 WSFGVLLWELMTRGAPPYPDVNTFDIT----------------------VYLLQGRRLLQ 255

Query: 189 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 226
                          +++ K        R +  + ++ 
Sbjct: 256 PE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 1e-15
 Identities = 21/133 (15%), Positives = 44/133 (33%), Gaps = 20/133 (15%)

Query: 10  IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 69
           +  P+  ++    +  EL+D      +R       E+    L  IL  +   +   ++H 
Sbjct: 74  LAVPKVYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVAKFYHRGIVHG 127

Query: 70  DLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTA 124
           DL   N+L++    + I DF  +    E             +  ++           Y  
Sbjct: 128 DLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRT 178

Query: 125 AIDVWSVGCIFME 137
             D+ S     ++
Sbjct: 179 EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	277
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.61
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.15
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.26
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.23
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.68
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.59

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=364.34  Aligned_cols=268  Identities=44%  Similarity=0.841  Sum_probs=226.8

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|...+ .....++|+||||++++|..++.. +++++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        77 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~  155 (346)
T d1cm8a_          77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN  155 (346)
T ss_dssp             TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc
Confidence            89999999998753 233457899999998888888765 6799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++++|||++......  .....+++.|+|||++.+...++.++||||+||++++|++|++||.+.+....+..+..
T Consensus       156 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  233 (346)
T d1cm8a_         156 EDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  233 (346)
T ss_dssp             TTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence            9999999999999876644  45678999999999998777789999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.++...+... ......+....+......+....+..++++++||++||+.||++|||++|+|+||||+.+.+..++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~  313 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE  313 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc
Confidence            9999998877665 344555666677777777888888999999999999999999999999999999999999877776


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhCh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  272 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (277)
                      +.. ..++..++....+.++++++++.|+++|+|
T Consensus       314 ~~~-~~~~~~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         314 PQV-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             -CC-CCCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred             ccC-CCCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence            654 345555666678899999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-52  Score=356.31  Aligned_cols=274  Identities=53%  Similarity=0.994  Sum_probs=231.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   80 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~   80 (277)
                      |||+++++++..+......++|+++++++|+|.+++.. +++++..++.++.|++.||+|||++||+||||||+||+++.
T Consensus        66 p~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~  144 (345)
T d1pmea_          66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT  144 (345)
T ss_dssp             TTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred             CCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence            89999999998765444467888888888999999976 47999999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           81 NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        81 ~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++.+||+|||++......    .......|++.|+|||++.....++.++||||+||++++|++|+.||.+.+..+....
T Consensus       145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~  224 (345)
T d1pmea_         145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH  224 (345)
T ss_dssp             TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH
Confidence            999999999999764332    2345567899999999986666789999999999999999999999999999999999


Q ss_pred             HHHHhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      .....+.+........ ...........+.....++...++++|+++++||.+||+.||.+|||++|+|+||||+....+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence            9888888887655333 334455555666666677788889999999999999999999999999999999999999888


Q ss_pred             CCCCcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChhhh
Q 023764          236 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR  275 (277)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (277)
                      .+++....++.++.+...++..+++++++++...++|.+|
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~~~  344 (345)
T d1pmea_         305 SDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR  344 (345)
T ss_dssp             GGSCCCSSCC--------CCHHHHHHHHHHHSGGGSTTTC
T ss_pred             ccCccccCccCCChhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence            8888878888888888899999999999999999999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=348.26  Aligned_cols=228  Identities=33%  Similarity=0.621  Sum_probs=191.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~-~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +++|+||||+++++.. +...+..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        60 pnIv~~~~~~~~~-----~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~  134 (299)
T d1ua2a_          60 PNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD  134 (299)
T ss_dssp             TTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCEeEEEeeeccC-----CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec
Confidence            8999999999988     8899999999875444 444557799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.+||+|||++...... ......+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..+++..+.
T Consensus       135 ~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~  214 (299)
T d1ua2a_         135 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF  214 (299)
T ss_dssp             TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence            9999999999999765543 334456799999999998777778999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      +..++|....+.......  ...........++...++..++++++||++||+.||++||||+|+|+||||+....+
T Consensus       215 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         215 ETLGTPTEEQWPDMCSLP--DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             HHHCCCCTTTSSSTTSST--TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             HhcCCCChhhccchhccc--hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            999998876543321110  011122233344556677889999999999999999999999999999999875543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=347.33  Aligned_cols=269  Identities=48%  Similarity=0.901  Sum_probs=230.0

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.... .++.+.+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        77 ~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~  155 (348)
T d2gfsa1          77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN  155 (348)
T ss_dssp             TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc
Confidence            79999999997653 234356777777777899999865 5799999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.++++|||.+......  .....|++.|+|||...+...++.++||||+||++|+|++|.+||.+.+.......+..
T Consensus       156 ~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~  233 (348)
T d2gfsa1         156 EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  233 (348)
T ss_dssp             TTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999998765433  44567899999999987777789999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhh-hhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 023764          160 LIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE  238 (277)
Q Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~  238 (277)
                      ..+.+........ ......+...........+...++.+++++++||++||+.||.+|||++|+|+||||+.+.++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~  313 (348)
T d2gfsa1         234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  313 (348)
T ss_dssp             HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred             hcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence            9998888766555 344455556666666777778888999999999999999999999999999999999999988887


Q ss_pred             CcCCCCCCcchhhhhcCHHHHHHHHHHHHHhhChh
Q 023764          239 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE  273 (277)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (277)
                      +. ..+++..++....+.++++++++.++.+|+|-
T Consensus       314 ~~-~~~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         314 PV-ADPYDQSFESRDLLIDEWKSLTYDEVISFVPP  347 (348)
T ss_dssp             CC-CCCCCCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred             CC-CCCCCCcccchhcCHHHHHHHHHHHhhccCCC
Confidence            75 45778888999999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=342.10  Aligned_cols=199  Identities=27%  Similarity=0.415  Sum_probs=167.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        63 pnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~  137 (271)
T d1nvra_          63 ENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  137 (271)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             CCEeeEeeeeccC-----ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence            8999999999987     89999999997 69999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .++.+||+|||+++.....   ......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.........
T Consensus       138 ~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~  217 (271)
T d1nvra_         138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  217 (271)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred             CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999865432   2345668999999999997665457889999999999999999999976553322221


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .....                           .......+.+|+++++||++||+.||++|||++|+++||||+.
T Consensus       218 ~~~~~---------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         218 DWKEK---------------------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHTT---------------------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHhcC---------------------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            11100                           0011112357889999999999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=340.04  Aligned_cols=194  Identities=25%  Similarity=0.419  Sum_probs=169.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        66 pnIv~~~~~~~~~-----~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~  140 (263)
T d2j4za1          66 PNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG  140 (263)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec
Confidence            8999999999987     89999999997 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.+||+|||++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+....+.+
T Consensus       141 ~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  218 (263)
T d2j4za1         141 SAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR  218 (263)
T ss_dssp             TTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             CCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999765543 2345689999999999965 4589999999999999999999999988877666555432


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ...                              ...+.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       219 ~~~------------------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         219 VEF------------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             TCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CCC------------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            100                              011247889999999999999999999999999999964

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-50  Score=339.73  Aligned_cols=199  Identities=28%  Similarity=0.521  Sum_probs=160.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||++.
T Consensus        67 pnIv~l~~~~~~~-----~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~  141 (307)
T d1a06a_          67 PNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY  141 (307)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence            8999999999987     89999999997 69999999988999999999999999999999999999999999999994


Q ss_pred             ---cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ---ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                         .++.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......
T Consensus       142 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~  220 (307)
T d1a06a_         142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ  220 (307)
T ss_dssp             SSSTTCCEEECCC------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               578999999999987766666667789999999999865 4589999999999999999999999998877766655


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +......+                          .....+.+|+++++||++||+.||++|||++|+++||||++
T Consensus       221 i~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         221 ILKAEYEF--------------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHTTCCCC--------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HhccCCCC--------------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            54321111                          11233578999999999999999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-50  Score=335.61  Aligned_cols=197  Identities=22%  Similarity=0.436  Sum_probs=169.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +++|+|||||+ |+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        77 pnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~  150 (293)
T d1yhwa1          77 PNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  150 (293)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC
Confidence            8999999999987     89999999997 599998876 5699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||++...... ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+....+..+.
T Consensus       151 ~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~  229 (293)
T d1yhwa1         151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (293)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCcEeeccchhheeeccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999876543 34456689999999999965 458999999999999999999999998888776665554


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      .... +..                          ...+.+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       230 ~~~~-~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         230 TNGT-PEL--------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHCS-CCC--------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             hCCC-CCC--------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            3211 110                          111357889999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-50  Score=336.63  Aligned_cols=229  Identities=37%  Similarity=0.725  Sum_probs=196.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+++++|.++     +++|+||||+++++.+.+..  .+.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        61 p~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~  135 (298)
T d1gz8a_          61 PNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI  135 (298)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CcEEEeccccccc-----cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee
Confidence            8999999999987     89999999999887776643  3579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.++.+||+|||.++..... .......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+..+
T Consensus       136 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i  215 (298)
T d1gz8a_         136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI  215 (298)
T ss_dssp             CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH
Confidence            99999999999999766543 34556689999999999877776789999999999999999999999999999999999


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  235 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~  235 (277)
                      ....+.+....+..... ...+....+...........+.+|+++++||++||+.||++|||++|+|+||||+.+..+
T Consensus       216 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         216 FRTLGTPDEVVWPGVTS-MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             HHHHCCCCTTTSTTGGG-STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             HHhcCCCchhhcccccc-ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            99998888765544322 222333344445555666778899999999999999999999999999999999987654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=340.27  Aligned_cols=266  Identities=41%  Similarity=0.756  Sum_probs=207.9

Q ss_pred             CceeeeeccccCCCC-CCCCcEEEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|...+. +..+++|+|||||.+++.+.+.  ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        76 pnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~  153 (355)
T d2b1pa1          76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  153 (355)
T ss_dssp             TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence            899999999986542 3448999999999998887774  5699999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .++.++++|||+++............+|+.|+|||++.+ ..++.++||||+||++++|++|++||.+.+.......+..
T Consensus       154 ~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~  232 (355)
T d2b1pa1         154 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  232 (355)
T ss_dssp             TTCCEEECCCCC---------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccceeeechhhhhccccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999987777666677789999999999865 4589999999999999999999999999999999999999


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC------------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFDPRQRITVEDALAHP  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  227 (277)
                      ..+.+....+.........+....+..........++            ..++++++||++||+.||++||||+|+|+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             HHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             hccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence            9999988887777666666666555444443333222            2367899999999999999999999999999


Q ss_pred             CCCCCCCCCCCC-cCCCCCCcchhhhhcCHHHHHHHHHHHHHh
Q 023764          228 YLGSLHDISDEP-VCMSPFSFDFEQHALTEGQMKELIYQEALA  269 (277)
Q Consensus       228 ~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (277)
                      ||+...++.... .+...++.+.++...+..+|+++|++|+++
T Consensus       313 w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (355)
T d2b1pa1         313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN  355 (355)
T ss_dssp             TTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHHHHC
T ss_pred             ccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence            999876544322 223344556677889999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=334.72  Aligned_cols=230  Identities=37%  Similarity=0.655  Sum_probs=191.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||++++++|.....+...++|++||++++++..+..  ....+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        70 pnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi  149 (305)
T d1blxa_          70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV  149 (305)
T ss_dssp             TTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             CCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE
Confidence            8999999999765444447899999999876554443  33579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      +.++.+||+|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+.
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  228 (305)
T d1blxa_         150 TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  228 (305)
T ss_dssp             CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9999999999999987665556677889999999999865 458999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      +..+.|....+........   .........+.....+.+++.+++||++||++||++|||++|+|+||||+.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         229 DVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             HHHCCCCGGGSCTTCSSCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HhhCCCchhcccccccchh---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            9999988765543211111   111122233445556678999999999999999999999999999999998754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=334.46  Aligned_cols=196  Identities=30%  Similarity=0.532  Sum_probs=167.9

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +.+|+|||||+ |+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        68 pnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~  142 (288)
T d1uu3a_          68 PFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN  142 (288)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCeeEEEEEEEEC-----CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence            8999999999987     89999999997 69999999889999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .+|.+||+|||+++.....   ......+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......
T Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~  221 (288)
T d1uu3a_         143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK  221 (288)
T ss_dssp             TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCceEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH
Confidence            9999999999999876432   233456799999999999654 589999999999999999999999998877666655


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED------ALAHPYLG  230 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------ll~hp~f~  230 (277)
                      +....  +                            .....+++++++||++||+.||++|||++|      +++||||+
T Consensus       222 i~~~~--~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~  271 (288)
T d1uu3a_         222 IIKLE--Y----------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE  271 (288)
T ss_dssp             HHTTC--C----------------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred             HHcCC--C----------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence            44210  0                            001257889999999999999999999987      58899998


Q ss_pred             CC
Q 023764          231 SL  232 (277)
Q Consensus       231 ~~  232 (277)
                      ++
T Consensus       272 ~i  273 (288)
T d1uu3a_         272 SV  273 (288)
T ss_dssp             TC
T ss_pred             CC
Confidence            76

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-49  Score=340.89  Aligned_cols=204  Identities=26%  Similarity=0.431  Sum_probs=177.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.+.     +++|+|||||+ |+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus        83 pnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll  157 (350)
T d1koaa2          83 PTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF  157 (350)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeee
Confidence            8999999999987     89999999996 699999854 4679999999999999999999999999999999999999


Q ss_pred             ec--CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +.  ++.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus       158 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  236 (350)
T d1koaa2         158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN  236 (350)
T ss_dssp             SSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            64  57899999999998777666677889999999999865 4589999999999999999999999998888777776


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  236 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~  236 (277)
                      +......++                          ....+.+|+++++||++||+.||++|||++|+|+||||+....+.
T Consensus       237 i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         237 VKSCDWNMD--------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             HHHTCCCSC--------------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             HHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence            654322211                          122346788999999999999999999999999999999865543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-49  Score=329.66  Aligned_cols=201  Identities=27%  Similarity=0.510  Sum_probs=176.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +++|||||||+ |+|.+++..++++++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        70 pnIv~~~~~~~~~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~  144 (277)
T d1phka_          70 PNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD  144 (277)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCeEEEEeecccC-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc
Confidence            8999999999987     99999999996 69999999889999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      .++.+||+|||++...+.........||+.|+|||.+.+     ...++.++||||+||++|+|++|++||.+.+.....
T Consensus       145 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~  224 (277)
T d1phka_         145 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML  224 (277)
T ss_dssp             TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence            999999999999998776655667789999999999852     334788999999999999999999999988877766


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ..+.+....++                          ....+++|+++++||.+||+.||++|||++|+|+||||+..
T Consensus       225 ~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         225 RMIMSGNYQFG--------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHHHHTCCCCC--------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHHHhCCCCCC--------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            65554211111                          11234688999999999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=333.12  Aligned_cols=199  Identities=24%  Similarity=0.430  Sum_probs=167.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus        69 pnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll  143 (288)
T d2jfla1          69 PNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF  143 (288)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE
Confidence            8999999999987     89999999996 699998765 4679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhC----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.+|.+||+|||++...... .......||+.|+|||++..    ...++.++||||+||++|+|++|++||.+.+..+.
T Consensus       144 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~  223 (288)
T d2jfla1         144 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV  223 (288)
T ss_dssp             CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred             CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH
Confidence            99999999999998754432 22345689999999999842    34578999999999999999999999988876665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +..+....  ++                         .....+.+|+++++||++||+.||++|||++|+++||||+.
T Consensus       224 ~~~i~~~~--~~-------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         224 LLKIAKSE--PP-------------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHSC--CC-------------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHcCC--CC-------------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            55444311  00                         00111357889999999999999999999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=331.68  Aligned_cols=200  Identities=30%  Similarity=0.485  Sum_probs=174.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +++|||||||+ |+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        73 pnIv~~~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~  147 (293)
T d1jksa_          73 PNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL  147 (293)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEe
Confidence            8999999999988     89999999997 69999999888999999999999999999999999999999999999998


Q ss_pred             cCC----CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++    .+|++|||++.............+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+.
T Consensus       148 ~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~  226 (293)
T d1jksa_         148 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  226 (293)
T ss_dssp             CSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH
Confidence            776    499999999988776666667789999999999864 458999999999999999999999999888777666


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      .+.......+                          ....+.+|+++++||++||+.||++|||++++++||||+..
T Consensus       227 ~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         227 NVSAVNYEFE--------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHTTCCCCC--------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHhcCCCCC--------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            5543221111                          12234688999999999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.5e-49  Score=339.08  Aligned_cols=201  Identities=26%  Similarity=0.468  Sum_probs=176.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+++++|.++     +++|||||||+ |+|.+.+.+. .++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        86 pnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl  160 (352)
T d1koba_          86 PKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC  160 (352)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccc
Confidence            8999999999987     89999999997 6999987665 469999999999999999999999999999999999999


Q ss_pred             e--cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 N--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +  .++.+||+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..
T Consensus       161 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  239 (352)
T d1koba_         161 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN  239 (352)
T ss_dssp             SSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             cccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            7  578999999999998877666677889999999999854 5589999999999999999999999999888777766


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      +......++                          ...++.+|+++++||++||++||.+|||++|+|+||||+...
T Consensus       240 i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         240 VKRCDWEFD--------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHCCCCCC--------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            654221111                          223457899999999999999999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=335.63  Aligned_cols=196  Identities=27%  Similarity=0.475  Sum_probs=172.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +.+|+|||||. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        65 p~Iv~l~~~~~~~-----~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~  139 (337)
T d1o6la_          65 PFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD  139 (337)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CCEEEEEeeeccc-----cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec
Confidence            8999999999998     99999999997 69999999989999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++.... .......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+.
T Consensus       140 ~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~  218 (337)
T d1o6la_         140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence            999999999999986543 345567789999999999865 458999999999999999999999999988766655544


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      ..  .+                            .....+|+++++||++||++||.+|++     ++++++||||+.+
T Consensus       219 ~~--~~----------------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         219 ME--EI----------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HC--CC----------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cC--CC----------------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            31  10                            011357899999999999999999994     9999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=327.05  Aligned_cols=199  Identities=21%  Similarity=0.375  Sum_probs=164.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~--i~H~di~~~nil   77 (277)
                      ||||++++++.+.. ++.+.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||
T Consensus        68 pnIv~~~~~~~~~~-~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NIL  146 (270)
T d1t4ha_          68 PNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF  146 (270)
T ss_dssp             TTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred             CCeeeEEEEEeecc-ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhce
Confidence            89999999987532 22267999999997 599999998889999999999999999999999999  999999999999


Q ss_pred             Ee-cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           78 LN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      ++ .++.+||+|||+++..... .....+||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+......+..
T Consensus       147 l~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~  223 (270)
T d1t4ha_         147 ITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  223 (270)
T ss_dssp             ESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             eeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH
Confidence            96 5789999999999754433 3456689999999998853  489999999999999999999999987655544332


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      .+.....|.                           ......++++++||.+||+.||++|||++|+|+||||+
T Consensus       224 ~i~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         224 RVTSGVKPA---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHTTTCCCG---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHcCCCCc---------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            221111110                           11124678899999999999999999999999999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=332.67  Aligned_cols=234  Identities=33%  Similarity=0.652  Sum_probs=192.9

Q ss_pred             CceeeeeccccCCC-CCCCCcEEEEeecCcccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~n   75 (277)
                      |||++++++|.... .++..++|+|||||++++.+.+    .....+++..++.++.||+.||+|||++||+||||||+|
T Consensus        73 ~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~N  152 (350)
T d1q5ka_          73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN  152 (350)
T ss_dssp             TTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred             CCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcce
Confidence            79999999997543 2333678999999997655544    345679999999999999999999999999999999999


Q ss_pred             EEEecCC-CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           76 LLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        76 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ||++.++ .+||+|||++.............|++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+
T Consensus       153 ILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l  232 (350)
T d1q5ka_         153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL  232 (350)
T ss_dssp             EEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred             EEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence            9999875 899999999988776666677889999999999877677899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..+.+..|.+....+.........  ...+.....++. ...+..++++.+||++||++||++||||.|+|+||||+.+.
T Consensus       233 ~~i~~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         233 VEIIKVLGTPTREQIREMNPNYTE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHHHCCCCHHHHHHHCC---C--CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHHhCCChHHhhhhhccchhh--ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            999999999998776554332211  112222222222 23457899999999999999999999999999999999887


Q ss_pred             CCC
Q 023764          234 DIS  236 (277)
Q Consensus       234 ~~~  236 (277)
                      ++.
T Consensus       311 ~~~  313 (350)
T d1q5ka_         311 DPN  313 (350)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-48  Score=337.80  Aligned_cols=199  Identities=27%  Similarity=0.433  Sum_probs=169.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||+++++|.++     +.+|+|||||+ |+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        67 pnIv~l~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~  141 (364)
T d1omwa3          67 PFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD  141 (364)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CcEEEEEEEEEEC-----CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc
Confidence            8999999999987     89999999997 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+||+|||++....... .....||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+...... +..
T Consensus       142 ~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~  219 (364)
T d1omwa3         142 EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR  219 (364)
T ss_dssp             SSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHH
T ss_pred             CCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH
Confidence            99999999999998765443 3456899999999999766668999999999999999999999998664332221 111


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~f~~~  232 (277)
                      .....                          .....+.+|+++++||.+||+.||++|||     |+++++||||+++
T Consensus       220 ~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         220 MTLTM--------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HSSSC--------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             hcccC--------------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            11000                          01112368899999999999999999999     8999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-48  Score=329.38  Aligned_cols=194  Identities=24%  Similarity=0.470  Sum_probs=172.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +.+|+|||||. |+|..++.....+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        64 pnIv~~~~~~~~~-----~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~  138 (316)
T d1fota_          64 PFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD  138 (316)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred             cChhheeeeEeeC-----CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc
Confidence            8999999999988     99999999997 59999999999999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+||+|||+++.....  ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+..
T Consensus       139 ~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~  215 (316)
T d1fota_         139 KNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN  215 (316)
T ss_dssp             TTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             CCCCEEEecCccceEeccc--cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence            9999999999999876644  346789999999999854 4589999999999999999999999998887776666543


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ...                              ...+.+|++++++|++||+.||.+|+     |++++++||||+.+
T Consensus       216 ~~~------------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         216 AEL------------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CCC------------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCC------------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            110                              11135788999999999999999996     99999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=337.16  Aligned_cols=223  Identities=22%  Similarity=0.391  Sum_probs=164.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~nil~   78 (277)
                      ||||+++++|.++     +++|+|||||. |+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||+
T Consensus        64 pnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl  138 (322)
T d1s9ja_          64 PYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV  138 (322)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred             CCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence            8999999999987     89999999997 5999999988899999999999999999999997 599999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHH
Q 023764           79 NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ-LRLL  157 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i  157 (277)
                      +.+|.+||+|||+|...... ...+.+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.... ....
T Consensus       139 ~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~  216 (322)
T d1s9ja_         139 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG  216 (322)
T ss_dssp             CTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-
T ss_pred             CCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99999999999999765432 23456899999999999764 599999999999999999999999987654332 2111


Q ss_pred             HHHhCCCChHhhhhhh--hh-------------HHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          158 IELIGTPSEAELGFLN--EN-------------AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      ....+.+.........  ..             ................  .....|.++++||.+||+.||.+|||++|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e  294 (322)
T d1s9ja_         217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQ  294 (322)
T ss_dssp             -----------------------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            1112211110000000  00             0000000000000000  01236889999999999999999999999


Q ss_pred             HhcCCCCCCC
Q 023764          223 ALAHPYLGSL  232 (277)
Q Consensus       223 ll~hp~f~~~  232 (277)
                      +|+||||++.
T Consensus       295 ~L~Hpf~~~~  304 (322)
T d1s9ja_         295 LMVHAFIKRS  304 (322)
T ss_dssp             HHTSHHHHHH
T ss_pred             HhhCHhhCcC
Confidence            9999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-48  Score=330.44  Aligned_cols=195  Identities=25%  Similarity=0.372  Sum_probs=167.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +++|+|||||.+ +|..++..++++++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        75 pnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~  149 (309)
T d1u5ra_          75 PNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS  149 (309)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred             CCEeeEEEEEEEC-----CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC
Confidence            8999999999987     899999999975 6766777778899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      .++.+||+|||++.....   .....||+.|+|||++.+  ...++.++||||+||++|+|++|..||.+.+..+.+..+
T Consensus       150 ~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i  226 (309)
T d1u5ra_         150 EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (309)
T ss_dssp             TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999976543   345689999999999854  235889999999999999999999999888776665555


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ......+                            ...+.+|+++++||.+||+.||.+|||++++|+||||..
T Consensus       227 ~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         227 AQNESPA----------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHSCCCC----------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HhCCCCC----------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            4311110                            011357889999999999999999999999999999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=323.66  Aligned_cols=196  Identities=30%  Similarity=0.488  Sum_probs=154.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN-----VLHRD   70 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~~-----i~H~d   70 (277)
                      ||||++++++.+...   +.+|+|||||+ |+|.+++.+    ++.+++..++.++.|++.||+|||+.|     |+|||
T Consensus        63 pnIv~~~~~~~~~~~---~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrD  139 (269)
T d2java1          63 PNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD  139 (269)
T ss_dssp             TTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------
T ss_pred             CCEeeEEEEEEeCCC---CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCc
Confidence            899999999975421   67999999996 699998863    467999999999999999999999976     99999


Q ss_pred             CCCCcEEEecCCCeEEeeccceeeccCC-CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           71 LKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        71 i~~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |||+||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus       140 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~  218 (269)
T d2java1         140 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFS  218 (269)
T ss_dssp             CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999999865543 23455789999999999854 458999999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      ..+....+.+..                             .......+|+++++||++||+.||.+|||++|+++|||+
T Consensus       219 ~~~~~~~i~~~~-----------------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         219 QKELAGKIREGK-----------------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHHTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHcCC-----------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            766555543310                             011123578899999999999999999999999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.1e-48  Score=324.32  Aligned_cols=225  Identities=39%  Similarity=0.708  Sum_probs=187.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     ++.|++||++++++...+ ...+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        60 pnIv~~~~~~~~~-----~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~  134 (286)
T d1ob3a_          60 SNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN  134 (286)
T ss_dssp             TTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CcEEeeeeecccC-----CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc
Confidence            8999999999988     899999999987555544 5567899999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .++.+|++|||.+....... ......+++.|+|||.+.+...++.++||||+||++++|++|++||.+.+..+.+..+.
T Consensus       135 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~  214 (286)
T d1ob3a_         135 REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF  214 (286)
T ss_dssp             TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99999999999997665432 23445689999999999877778999999999999999999999999999999999999


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      ...+.+....+...... .++..........+.....+.++++++|||++||++||++|||++|+|+||||+.
T Consensus       215 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         215 RILGTPNSKNWPNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HhhCCCChhhccchhhh-hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            99999887665443221 1222233333444556667789999999999999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-48  Score=330.92  Aligned_cols=194  Identities=23%  Similarity=0.408  Sum_probs=171.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.+.     +.+|+||||+. |+|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       101 pnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~  175 (350)
T d1rdqe_         101 PFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID  175 (350)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CcEeecccccccc-----cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC
Confidence            8999999999987     89999999996 69999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE  159 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  159 (277)
                      .+|.+||+|||+++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       176 ~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~  252 (350)
T d1rdqe_         176 QQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS  252 (350)
T ss_dssp             TTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEeeeceeeeecccc--cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence            9999999999999876543  346789999999999865 4589999999999999999999999998877766665543


Q ss_pred             HhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 023764          160 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~~  232 (277)
                      ....                              ..+.+++++.+||++||+.||.+|+     |++++++||||+.+
T Consensus       253 ~~~~------------------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         253 GKVR------------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CCCC------------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCCC------------------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            2111                              1135789999999999999999995     99999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=327.23  Aligned_cols=196  Identities=25%  Similarity=0.450  Sum_probs=172.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        63 p~Iv~~~~~~~~~-----~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~  137 (320)
T d1xjda_          63 PFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD  137 (320)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             CcEEEEEEEEccC-----CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec
Confidence            8999999999998     89999999997 69999999889999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccC-CCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI  158 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  158 (277)
                      .+|.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus       138 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~  216 (320)
T d1xjda_         138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  216 (320)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999976543 334455689999999999965 458999999999999999999999999888777666553


Q ss_pred             HHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCC
Q 023764          159 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSL  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-ell~hp~f~~~  232 (277)
                      .  +.+.                            ....+|+++++||++||+.||.+|||+. ++++||||+.+
T Consensus       217 ~--~~~~----------------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         217 M--DNPF----------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             H--CCCC----------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             c--CCCC----------------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            2  1111                            1125789999999999999999999996 89999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=328.19  Aligned_cols=199  Identities=24%  Similarity=0.448  Sum_probs=174.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+++++|.++     +++|+|||||+ |+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||++
T Consensus        61 pnIv~~~~~~~~~-----~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll  135 (321)
T d1tkia_          61 RNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY  135 (321)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCeEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceee
Confidence            8999999999987     89999999997 59999998765 79999999999999999999999999999999999999


Q ss_pred             ecC--CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           79 NAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        79 ~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      +.+  +.++|+|||++.............+++.|+|||...+ ..++.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus       136 ~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~  214 (321)
T d1tkia_         136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN  214 (321)
T ss_dssp             SSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             cCCCceEEEEcccchhhccccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            754  5799999999988776666667789999999998854 4589999999999999999999999999888877777


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~  231 (277)
                      +......++.                          ..++.+|+++++||++||+.||.+|||++|+++||||+.
T Consensus       215 i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         215 IMNAEYTFDE--------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHTCCCCCH--------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHhCCCCCCh--------------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            6653322222                          223468899999999999999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=330.96  Aligned_cols=208  Identities=28%  Similarity=0.434  Sum_probs=165.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||+++++|.+... ..+++|+|||||+ |+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        65 pnIv~l~~~~~~~~~-~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIl  143 (335)
T d2ozaa1          65 PHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL  143 (335)
T ss_dssp             TTBCCEEEEEEEEET-TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCeEEEEEeeccc-CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccc
Confidence            899999999975211 1278999999996 6999999874  46999999999999999999999999999999999999


Q ss_pred             Eec---CCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 023764           78 LNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  154 (277)
                      ++.   .+.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.....
T Consensus       144 l~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~  222 (335)
T d2ozaa1         144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  222 (335)
T ss_dssp             ESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred             cccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence            975   56799999999988776666677889999999998854 45899999999999999999999999876544433


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~  232 (277)
                      ..+...+....                      ........+.+|+++++||++||+.||++|||++|+++||||...
T Consensus       223 ~~~~~~i~~~~----------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         223 PGMKTRIRMGQ----------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -----CCCSCS----------------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHhcCC----------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            33222111100                      000001122578899999999999999999999999999999753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=315.68  Aligned_cols=191  Identities=27%  Similarity=0.462  Sum_probs=163.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.++     +.+|+||||+.  +++.+++.+++.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        69 ~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll  143 (273)
T d1xwsa_          69 SGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI  143 (273)
T ss_dssp             CSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCccEEEEEEeeC-----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEE
Confidence            7999999999988     89999999995  4888999888899999999999999999999999999999999999999


Q ss_pred             ecC-CCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 023764           79 NAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  157 (277)
Q Consensus        79 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  157 (277)
                      +.+ +.+||+|||++...... ......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.      +
T Consensus       144 ~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i  216 (273)
T d1xwsa_         144 DLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I  216 (273)
T ss_dssp             ETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred             ecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H
Confidence            855 78999999999865543 345678999999999987666567889999999999999999999965321      1


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  233 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~  233 (277)
                      ..  +.                         .   ...+.+|+++++||++||+.||++|||++|+++||||+.+.
T Consensus       217 ~~--~~-------------------------~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         217 IR--GQ-------------------------V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HH--CC-------------------------C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             hh--cc-------------------------c---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            10  00                         0   01135789999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=314.14  Aligned_cols=232  Identities=33%  Similarity=0.580  Sum_probs=178.8

Q ss_pred             CceeeeeccccCCC---CCCCCcEEEEeecCcccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 023764            1 MQVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   76 (277)
Q Consensus         1 pniv~l~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~ni   76 (277)
                      |||+++++++....   ....+++|+||||+++.+.... .....+++..++.++.|++.||+|||++||+||||||+||
T Consensus        69 ~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NI  148 (318)
T d3blha1          69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV  148 (318)
T ss_dssp             TTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchhe
Confidence            79999999986642   1223679999999987665544 4456799999999999999999999999999999999999


Q ss_pred             EEecCCCeEEeeccceeeccCC-----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 023764           77 LLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  151 (277)
Q Consensus        77 l~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  151 (277)
                      +++.++.+|++|||++......     ......+||+.|+|||++.+...++.++||||+||++++|++|++||.+.+..
T Consensus       149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~  228 (318)
T d3blha1         149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  228 (318)
T ss_dssp             EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH
Confidence            9999999999999999755432     23344578999999999977767899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  229 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f  229 (277)
                      .....+....+.++...+.........................++  ..+++++|||.+||++||++||||+|+|+||||
T Consensus       229 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            999999999988877654443221111111111111111111111  247789999999999999999999999999999


Q ss_pred             CCC
Q 023764          230 GSL  232 (277)
Q Consensus       230 ~~~  232 (277)
                      +..
T Consensus       309 ~~~  311 (318)
T d3blha1         309 WSD  311 (318)
T ss_dssp             SSS
T ss_pred             ccC
Confidence            864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=307.55  Aligned_cols=228  Identities=35%  Similarity=0.619  Sum_probs=186.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.+.     ++.++|++++.+ ++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~niv~~~~~~~~~-----~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~  135 (292)
T d1unla_          61 KNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN  135 (292)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CCEEeeccccccc-----cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence            7999999999998     899999999975 7777888888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC-cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF-PGRDHVHQLRLL  157 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i  157 (277)
                      .++.+||+|||.+....... ......+++.|+|||.+.....++.++||||+||++++|++|..|| .+.+..+.+..+
T Consensus       136 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~  215 (292)
T d1unla_         136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  215 (292)
T ss_dssp             TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred             cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence            99999999999998765543 3344567788999999877666799999999999999999998874 566777788888


Q ss_pred             HHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 023764          158 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  234 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~~~~~  234 (277)
                      ....+.+....+......... ................+.+++++++||++||+.||++||||+|+|+||||+.+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         216 FRLLGTPTEEQWPSMTKLPDY-KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             HHHHCCCCTTTCTTGGGSTTC-CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             HhhcCCCChhhhhhhhhcccc-cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            888888877654433221110 0000011122344455678999999999999999999999999999999998654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-45  Score=313.02  Aligned_cols=227  Identities=28%  Similarity=0.563  Sum_probs=175.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||++++++|....   .+++|+|||||+ ++|..+.   +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        90 pnIv~~~~~~~~~~---~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~  163 (328)
T d3bqca1          90 PNIITLADIVKDPV---SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID  163 (328)
T ss_dssp             TTBCCEEEEEECTT---TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             CCCcEEEEEEEecC---CCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence            89999999997542   267999999998 4776553   5699999999999999999999999999999999999998


Q ss_pred             cCC-CeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHH
Q 023764           80 ANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-DHVHQLRLL  157 (277)
Q Consensus        80 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i  157 (277)
                      .++ .++|+|||++.............+|+.|+|||.+.+...++.++||||+||++++|++|+.||... +...+...+
T Consensus       164 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i  243 (328)
T d3bqca1         164 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  243 (328)
T ss_dssp             TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence            765 589999999988776666677789999999999877777899999999999999999999999754 455566667


Q ss_pred             HHHhCCCChHhhhhhh--hhHHHHhhhCCcccCCcccc-----cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 023764          158 IELIGTPSEAELGFLN--ENAKKYICQLPRYQRQSFTE-----KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  230 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~f~  230 (277)
                      ....+.+....+....  .....+..............     ....++++++|||++||++||++|||++|+|+||||+
T Consensus       244 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             HHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            6666654433221110  00111111111111111111     2234688999999999999999999999999999999


Q ss_pred             CCC
Q 023764          231 SLH  233 (277)
Q Consensus       231 ~~~  233 (277)
                      .+.
T Consensus       324 ~v~  326 (328)
T d3bqca1         324 TVV  326 (328)
T ss_dssp             TSC
T ss_pred             CCC
Confidence            764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=303.72  Aligned_cols=196  Identities=20%  Similarity=0.300  Sum_probs=159.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||+++++...      +.+|+|||||+ |+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        64 pnIv~~~~~~~~------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl  137 (276)
T d1uwha_          64 VNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL  137 (276)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEeeeeEEEec------cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE
Confidence            899999998754      56899999997 6999999754 569999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  153 (277)
                      +.++.+||+|||+++.....   .......||+.|+|||++...  ..++.++||||+||++|||++|+.||.+.+....
T Consensus       138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~  217 (276)
T d1uwha_         138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ  217 (276)
T ss_dssp             ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred             cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence            99999999999999765432   233456789999999998542  3478999999999999999999999998777666


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +.........++                        ......+..++++.+||.+||+.||++|||+++++++
T Consensus       218 ~~~~~~~~~~~p------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         218 IIFMVGRGYLSP------------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHTSCCC------------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCC------------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            555544322211                        1223344678899999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=312.04  Aligned_cols=192  Identities=25%  Similarity=0.378  Sum_probs=160.8

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-----------------------CCCCHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------------------QALSEEHCQYFLYQILR   56 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------------------~~l~~~~~~~i~~qll~   56 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++.+.                       ..+++..+..++.|++.
T Consensus       101 pnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  175 (325)
T d1rjba_         101 ENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK  175 (325)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred             CcEeEEEEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence            8999999999987     88999999997 6999999764                       24899999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHH
Q 023764           57 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  133 (277)
Q Consensus        57 al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  133 (277)
                      ||+|||++||+||||||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++||||+||
T Consensus       176 gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gv  254 (325)
T d1rjba_         176 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGI  254 (325)
T ss_dssp             HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHH
T ss_pred             HHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhH
Confidence            9999999999999999999999999999999999997654432   22345679999999998654 5899999999999


Q ss_pred             HHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCC
Q 023764          134 IFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  212 (277)
Q Consensus       134 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  212 (277)
                      ++|||++ |.+||.+.+....+..++.....++                            ..+..|+++++||.+||+.
T Consensus       255 il~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~  306 (325)
T d1rjba_         255 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD----------------------------QPFYATEEIYIIMQSCWAF  306 (325)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------------CCCcCCHHHHHHHHHHcCC
Confidence            9999997 8999988766555554443211111                            1135788999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 023764          213 DPRQRITVEDALAH  226 (277)
Q Consensus       213 dP~~R~t~~ell~h  226 (277)
                      ||++|||++||++|
T Consensus       307 dP~~RPt~~ei~~~  320 (325)
T d1rjba_         307 DSRKRPSFPNLTSF  320 (325)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-45  Score=302.99  Aligned_cols=194  Identities=22%  Similarity=0.319  Sum_probs=160.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++.+      +..|||||||+ |+|.+++.+...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus        68 pnIv~~~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~  141 (277)
T d1xbba_          68 PYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV  141 (277)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             CCCceEEEEecc------CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc
Confidence            899999999854      55799999997 69999999989999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           80 ANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      .++.+||+|||+++......    ......||+.|+|||++... .++.++||||+||++|||++ |.+||.+.+..+..
T Consensus       142 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~  220 (277)
T d1xbba_         142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT  220 (277)
T ss_dssp             ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH
Confidence            99999999999998654432    12334688999999998654 48999999999999999997 89999988766554


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA---LAHPYLG  230 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el---l~hp~f~  230 (277)
                      ..+.+- ..+                            ...+..++++.+||.+||+.||++|||++++   |+|+|++
T Consensus       221 ~~i~~~-~~~----------------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         221 AMLEKG-ERM----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHTT-CCC----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcC-CCC----------------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            444321 000                            1113578899999999999999999999988   4566553

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-44  Score=301.35  Aligned_cols=191  Identities=23%  Similarity=0.343  Sum_probs=151.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        87 pnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          87 PNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV  161 (299)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCCccEEEEEeeC-----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE
Confidence            8999999999887     88999999997 6999988774 579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc------ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChH
Q 023764           79 NANCDLKICDFGLARVTSETDF------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  151 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  151 (277)
                      +.++.+||+|||+++.......      .....+|+.|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999976543321      112356889999999865 458999999999999999997 89999888776


Q ss_pred             HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          152 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +....+......+                             .....+.++.+||.+||+.||++|||+++++++
T Consensus       241 ~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         241 DVINAIEQDYRLP-----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC-----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6555543211111                             113578899999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-44  Score=294.13  Aligned_cols=191  Identities=20%  Similarity=0.334  Sum_probs=150.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++..+     +.+|+|||||. |+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus        60 pnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill  134 (263)
T d1sm2a_          60 PKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV  134 (263)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred             CCcccccceeccC-----CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence            8999999999887     88999999997 6999998765 568999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.+||+|||+++......  ......||+.|+|||++.+ ..++.++||||+||++|||++ |.+||.+.+..+...
T Consensus       135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~  213 (263)
T d1sm2a_         135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE  213 (263)
T ss_dssp             CGGGCEEECSCC------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH
T ss_pred             cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            999999999999997654432  2234568899999999865 458999999999999999998 567776666655555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+...... .                            .....++++.+||.+||+.||++|||++++++|
T Consensus       214 ~i~~~~~~-~----------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         214 DISTGFRL-Y----------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHTCCC-C----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCC-C----------------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            44331110 0                            012457889999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-43  Score=295.88  Aligned_cols=200  Identities=23%  Similarity=0.383  Sum_probs=157.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      ||||++++++......+ ..+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        67 pniv~~~~~~~~~~~~~-~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~  145 (277)
T d1o6ya_          67 PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS  145 (277)
T ss_dssp             TTBCCEEEEEEEECSSS-EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             CCCCcccceeeeccCCC-ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC
Confidence            89999999998753211 45899999997 59999998888999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC----CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      .++..+++|||.+......    .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+...
T Consensus       146 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  224 (277)
T d1o6ya_         146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY  224 (277)
T ss_dssp             TTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH
Confidence            9999999999988654332    23445679999999999854 458999999999999999999999999887766555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhcCCCC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-TVEDALAHPYL  229 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~~ell~hp~f  229 (277)
                      .+......                          ......+.+|+++.+||++||+.||.+|| |++++ .|+|.
T Consensus       225 ~~~~~~~~--------------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         225 QHVREDPI--------------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             HHHHCCCC--------------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             HHHhcCCC--------------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence            54432111                          11233457899999999999999999999 55555 44443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=299.61  Aligned_cols=194  Identities=20%  Similarity=0.309  Sum_probs=161.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.+      +.+|+|||||+ |+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        69 pnIv~l~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill  142 (285)
T d1u59a_          69 PYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL  142 (285)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCEeeEeeeecc------CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee
Confidence            899999999864      56899999997 6999987654 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.+||+|||+++......    ......+|+.|+|||++... .++.++||||+||++|||++ |..||.+.+..+.
T Consensus       143 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~  221 (285)
T d1u59a_         143 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV  221 (285)
T ss_dssp             EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred             ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999998765432    22344678999999998654 58999999999999999997 9999988877665


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCCCCC
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA---LAHPYLG  230 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el---l~hp~f~  230 (277)
                      ...+.+-. .                            ....+.+++++.+||.+||+.||++|||+.++   |+|+|++
T Consensus       222 ~~~i~~~~-~----------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         222 MAFIEQGK-R----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHTTC-C----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCC-C----------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            54443210 0                            01123678899999999999999999998877   6678775

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-44  Score=303.18  Aligned_cols=202  Identities=19%  Similarity=0.360  Sum_probs=167.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+++++++.++     +.+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        89 pnIv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~  163 (322)
T d1vzoa_          89 PFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD  163 (322)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             CeEEEeeeeeccC-----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec
Confidence            7999999999998     89999999997 69999999988999999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccceeeccCC--CcccccccccccCChhhhhCCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 023764           80 ANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  156 (277)
Q Consensus        80 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  156 (277)
                      .+|.++|+|||++......  .......|++.|++||.+.+.. .++.++|||||||++|+|++|..||.+.+.......
T Consensus       164 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~  243 (322)
T d1vzoa_         164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE  243 (322)
T ss_dssp             TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred             CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999765432  2345567899999999986543 468899999999999999999999987654433333


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  231 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~f~~  231 (277)
                      +.+....+                          ........|+++++||++||+.||.+||     |++|+++||||+.
T Consensus       244 i~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         244 ISRRILKS--------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHhcccC--------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            32211000                          0011235789999999999999999999     5899999999988


Q ss_pred             CC
Q 023764          232 LH  233 (277)
Q Consensus       232 ~~  233 (277)
                      +.
T Consensus       298 i~  299 (322)
T d1vzoa_         298 IN  299 (322)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-43  Score=295.33  Aligned_cols=191  Identities=23%  Similarity=0.316  Sum_probs=155.5

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||++++++.+.     +.+|+|||||+ |+|.+++.+.  ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        73 pnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL  147 (287)
T d1opja_          73 PNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  147 (287)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEecCCccEeeC-----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE
Confidence            8999999999887     88999999997 6999998754  57899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  155 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  155 (277)
                      ++.++.+||+|||+++......  ......+++.|+|||++.+. .++.++||||+||++|+|++|..||........+.
T Consensus       148 l~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~  226 (287)
T d1opja_         148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  226 (287)
T ss_dssp             ECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence            9999999999999997654432  22334578899999998654 58999999999999999999766654443333333


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .++.....+                            ...+..++++++||.+||+.||++|||++++++
T Consensus       227 ~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         227 ELLEKDYRM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCC----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            222211010                            112357889999999999999999999999966

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-43  Score=289.09  Aligned_cols=191  Identities=18%  Similarity=0.289  Sum_probs=161.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      |||+++++++.++     +.+|+||||++ |+|.+++.. ...+++..+.+++.|++.||+|||++||+||||||+||++
T Consensus        59 pnIv~~~g~~~~~-----~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill  133 (258)
T d1k2pa_          59 EKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV  133 (258)
T ss_dssp             TTBCCEEEEECCS-----SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE
T ss_pred             CceeeEEEEEeeC-----CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE
Confidence            8999999999887     88999999996 789888664 3579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.+||+|||+++......  ......+|+.|+|||.+... .++.++||||+||++|||++ |+.||.+.+..+...
T Consensus       134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~  212 (258)
T d1k2pa_         134 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE  212 (258)
T ss_dssp             CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH
T ss_pred             cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH
Confidence            999999999999997654432  22345688999999998654 58999999999999999998 899999888777665


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+.+....+.                             ....++++.+||++||+.||++|||++++++|
T Consensus       213 ~i~~~~~~~~-----------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         213 HIAQGLRLYR-----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCCCCC-----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCCCC-----------------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            5543111100                             12456789999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=296.64  Aligned_cols=195  Identities=23%  Similarity=0.374  Sum_probs=158.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||++++++.+      +.+|+||||++ |+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus        68 pnIv~~~g~~~~------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl  141 (272)
T d1qpca_          68 QRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL  141 (272)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCEeEEEeeecc------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence            899999998754      56799999997 6999877543  35999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~  154 (277)
                      ++.++.+||+|||+++......  ......+++.|+|||++... .++.++||||+||++|||++| .+||...+..+..
T Consensus       142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~  220 (272)
T d1qpca_         142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI  220 (272)
T ss_dssp             ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             eecccceeeccccceEEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998765442  23345688999999998654 589999999999999999985 5556565555544


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYLGS  231 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~f~~  231 (277)
                      ..+.... .+                            ...+..++++.+||.+||+.||++|||++++++  ++||++
T Consensus       221 ~~i~~~~-~~----------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         221 QNLERGY-RM----------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHTTC-CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcC-CC----------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            4432210 00                            011357889999999999999999999999998  777753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-43  Score=293.84  Aligned_cols=193  Identities=25%  Similarity=0.403  Sum_probs=152.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      |||+.+++++..++    +.+|+|||||+ |+|.+++...                ..+++..+..++.|++.||.|||+
T Consensus        77 ~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  152 (299)
T d1ywna1          77 LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  152 (299)
T ss_dssp             TTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh
Confidence            68999999987642    67899999997 6999999753                248999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +||+||||||+||+++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus       153 ~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt  231 (299)
T d1ywna1         153 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS  231 (299)
T ss_dssp             TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHh
Confidence            99999999999999999999999999999764432   22345678999999999965 458999999999999999998


Q ss_pred             C-CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 R-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                      | .+||.+......+.........+                            ...+..++++++||.+||+.||++|||
T Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt  283 (299)
T d1ywna1         232 LGASPYPGVKIDEEFCRRLKEGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPT  283 (299)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcC
Confidence            6 56887766554444433321111                            111357889999999999999999999


Q ss_pred             HHHHhcC
Q 023764          220 VEDALAH  226 (277)
Q Consensus       220 ~~ell~h  226 (277)
                      ++++++|
T Consensus       284 ~~eil~~  290 (299)
T d1ywna1         284 FSELVEH  290 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-43  Score=290.81  Aligned_cols=190  Identities=25%  Similarity=0.389  Sum_probs=149.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.+      +.+|+||||+. |+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        68 pnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll  141 (273)
T d1mp8a_          68 PHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV  141 (273)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee
Confidence            899999999954      67899999997 6898887654 579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLR  155 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  155 (277)
                      +.++.+||+|||+++......  ......+|+.|+|||++... .++.++||||+||++|+|++ |.+||.+.+..+...
T Consensus       142 ~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~  220 (273)
T d1mp8a_         142 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG  220 (273)
T ss_dssp             EETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999997654332  23345678999999998654 58999999999999999987 899998887766555


Q ss_pred             HHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          156 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      .+.+...                             ....+.+|+++.+||.+||+.||++|||++++++|
T Consensus       221 ~i~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         221 RIENGER-----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4432110                             11224678899999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=286.82  Aligned_cols=197  Identities=26%  Similarity=0.385  Sum_probs=155.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      ||||++++++.+      +.+|+||||+. |+|..++..  .+.+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        72 ~nIv~~~g~~~~------~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIl  145 (285)
T d1fmka3          72 EKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  145 (285)
T ss_dssp             TTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEeEEEEEEec------CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEE
Confidence            799999999854      55799999997 688888754  357999999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCC--cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCChHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQL  154 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~  154 (277)
                      ++.++.+||+|||+++......  ......+|+.|+|||.+... .++.++||||+||++|+|++|. +|+.+....+.+
T Consensus       146 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~  224 (285)
T d1fmka3         146 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  224 (285)
T ss_dssp             ECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             ECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997654332  23345689999999999654 5899999999999999999854 555555555554


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCCC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYLGSL  232 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~f~~~  232 (277)
                      ..+......                             ...+..+.++++||.+||+.||++|||++++++  ++||+..
T Consensus       225 ~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         225 DQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHhcCCC-----------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            444321111                             112357889999999999999999999999988  8899875


Q ss_pred             C
Q 023764          233 H  233 (277)
Q Consensus       233 ~  233 (277)
                      .
T Consensus       276 ~  276 (285)
T d1fmka3         276 E  276 (285)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=283.80  Aligned_cols=190  Identities=23%  Similarity=0.347  Sum_probs=148.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.+.     +.+|+|||||. +++.+++.+. +.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        69 ~nIv~~~g~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl  143 (283)
T d1mqba_          69 HNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV  143 (283)
T ss_dssp             TTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEeeeeEEEecC-----CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE
Confidence            8999999999887     88999999997 5788877654 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~  153 (277)
                      +.++.+||+|||+++......    ......||+.|+|||++.+ +.++.++||||+||++|||++|..| +.+.+..+.
T Consensus       144 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~  222 (283)
T d1mqba_         144 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV  222 (283)
T ss_dssp             CTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHH
Confidence            999999999999997654321    2223467899999999865 4589999999999999999986544 545454444


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+.... .+                            ......+.++.+||.+||+.||++|||+.++++
T Consensus       223 ~~~i~~~~-~~----------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         223 MKAINDGF-RL----------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHTTC-CC----------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHhccC-CC----------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            33332211 10                            111246788999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=286.28  Aligned_cols=190  Identities=26%  Similarity=0.410  Sum_probs=159.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      ||||++++++.++     +.+|+|||||. |+|.+++...                ..+++..+..++.|++.||+|||+
T Consensus        79 pnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~  153 (299)
T d1fgka_          79 KNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS  153 (299)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence            8999999999987     88999999997 6999999754                358999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  140 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  140 (277)
                      +||+||||||+|||++.++.+||+|||++.......   ......+++.|+|||.+.+ +.++.++|||||||++|+|++
T Consensus       154 ~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~  232 (299)
T d1fgka_         154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT  232 (299)
T ss_dssp             TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhcc
Confidence            999999999999999999999999999998655432   2344678899999999865 459999999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 023764          141 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       141 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                       |.+||.+.+.......+.. ...+                            ...+..++++++||.+||+.||++|||
T Consensus       233 ~g~~p~~~~~~~~~~~~i~~-~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps  283 (299)
T d1fgka_         233 LGGSPYPGVPVEELFKLLKE-GHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPT  283 (299)
T ss_dssp             TSCCSSTTCCHHHHHHHHHT-TCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHc-CCCC----------------------------CCCccchHHHHHHHHHHccCCHhHCcC
Confidence             7889987776554443321 1111                            111357889999999999999999999


Q ss_pred             HHHHhc
Q 023764          220 VEDALA  225 (277)
Q Consensus       220 ~~ell~  225 (277)
                      +.|+++
T Consensus       284 ~~eil~  289 (299)
T d1fgka_         284 FKQLVE  289 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-42  Score=289.38  Aligned_cols=191  Identities=25%  Similarity=0.327  Sum_probs=159.3

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS   63 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~LH~   63 (277)
                      ||||++++++.+.     +.+|+||||++ |+|.+++.++                ..+++..+..++.|++.|+.|||+
T Consensus        71 pnIv~~~~~~~~~-----~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~  145 (309)
T d1fvra_          71 PNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  145 (309)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEeeEEEEEecC-----CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence            8999999999987     89999999997 6999999754                569999999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCC-
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-  142 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-  142 (277)
                      +||+||||||+|||++.++.+||+|||+++............+|..|+|||.+... .++.++|||||||++|+|++|. 
T Consensus       146 ~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~  224 (309)
T d1fvra_         146 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGG  224 (309)
T ss_dssp             TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCC
Confidence            99999999999999999999999999999866554444566789999999999654 5899999999999999999965 


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 023764          143 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  222 (277)
Q Consensus       143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  222 (277)
                      +||.+.+..+....+.+.. .                            ......+++++++||.+||+.||++|||+++
T Consensus       225 ~p~~~~~~~~~~~~i~~~~-~----------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         225 TPYCGMTCAELYEKLPQGY-R----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             CTTTTCCHHHHHHHGGGTC-C----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHhcC-C----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            6787777666544432210 0                            0112357889999999999999999999999


Q ss_pred             HhcC
Q 023764          223 ALAH  226 (277)
Q Consensus       223 ll~h  226 (277)
                      ++++
T Consensus       276 il~~  279 (309)
T d1fvra_         276 ILVS  279 (309)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=280.98  Aligned_cols=190  Identities=21%  Similarity=0.281  Sum_probs=156.1

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.+      +.+|+||||++ |++.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        71 ~nIv~~~g~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll  144 (273)
T d1u46a_          71 RNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL  144 (273)
T ss_dssp             TTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEEEee------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc
Confidence            899999999965      45799999997 688887654 3579999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCCc----ccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 023764           79 NANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  153 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  153 (277)
                      +.++.+||+|||++........    .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.
T Consensus       145 ~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~  223 (273)
T d1u46a_         145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI  223 (273)
T ss_dssp             EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH
Confidence            9999999999999987654321    223456788999999965 458999999999999999997 8999998887776


Q ss_pred             HHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          154 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      ...+.+....+                            ...+.+++++++||.+||+.||++|||++++++
T Consensus       224 ~~~i~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         224 LHKIDKEGERL----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHTSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCCC----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66554321111                            122467889999999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=285.83  Aligned_cols=190  Identities=23%  Similarity=0.314  Sum_probs=153.4

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++.+      +..++++|++. |+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        71 pnIv~l~g~~~~------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll  144 (317)
T d1xkka_          71 PHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV  144 (317)
T ss_dssp             TTBCCEEEEEES------SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEeeEEEEEec------CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee
Confidence            899999999976      44677777775 7888877654 679999999999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 023764           79 NANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  154 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  154 (277)
                      +.++.+||+|||+++......   ......||+.|+|||++.+. .++.++||||+||++|||+| |.+||.+.+..+..
T Consensus       145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~  223 (317)
T d1xkka_         145 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  223 (317)
T ss_dssp             EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH
T ss_pred             CCCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            999999999999998654432   22334679999999998654 58999999999999999998 89999877655544


Q ss_pred             HHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          155 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ..+.. ...+                            ...+..++++.+||.+||+.||.+|||+.++++|
T Consensus       224 ~~i~~-~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         224 SILEK-GERL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHH-TCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHc-CCCC----------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            43322 1111                            1113578899999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=279.49  Aligned_cols=190  Identities=21%  Similarity=0.344  Sum_probs=149.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   77 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil   77 (277)
                      |||+++++++.++.    +.+|+||||++ |+|.+++.+++  .+++..+..++.||+.||.|||+.+++||||||+||+
T Consensus        60 pnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil  135 (262)
T d1byga_          60 SNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL  135 (262)
T ss_dssp             TTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhe
Confidence            89999999986531    66899999996 69999997643  4899999999999999999999999999999999999


Q ss_pred             EecCCCeEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 023764           78 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRL  156 (277)
Q Consensus        78 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  156 (277)
                      ++.++.++++|||+++.....  .....++..|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+....
T Consensus       136 ~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~  212 (262)
T d1byga_         136 VSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  212 (262)
T ss_dssp             ECTTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred             ecCCCCEeecccccceecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence            999999999999999865543  3345678899999998654 58999999999999999998 7888877665554443


Q ss_pred             HHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          157 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      +.+.                             ......+..++++++||++||+.||.+|||+.+++++
T Consensus       213 i~~~-----------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         213 VEKG-----------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HTTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcC-----------------------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            3210                             0011223578899999999999999999999999763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=280.66  Aligned_cols=191  Identities=27%  Similarity=0.385  Sum_probs=159.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------ALSEEHCQYFLYQILRGLKYI   61 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~~~~~i~~qll~al~~L   61 (277)
                      ||||++++++.++     +.+|+|||||+ |+|.+++.+..                  .+++..+..++.||+.|++||
T Consensus        87 pnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L  161 (311)
T d1t46a_          87 MNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL  161 (311)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            8999999999887     88999999997 69999987543                  589999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHH
Q 023764           62 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  138 (277)
Q Consensus        62 H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~l  138 (277)
                      |++|++||||||+||+++.++.++++|||.++......   ......+|+.|+|||.+.. ..++.++|||||||++++|
T Consensus       162 H~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~el  240 (311)
T d1t46a_         162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWEL  240 (311)
T ss_dssp             HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             HhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHH
Confidence            99999999999999999999999999999998665432   2234578999999999865 4589999999999999999


Q ss_pred             Hc-CCCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCC
Q 023764          139 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  217 (277)
Q Consensus       139 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  217 (277)
                      ++ |.+||.+.+....+..++.....+.                            .....++++.+||.+||+.||++|
T Consensus       241 lt~g~p~~~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~Li~~cl~~dP~~R  292 (311)
T d1t46a_         241 FSLGSSPYPGMPVDSKFYKMIKEGFRML----------------------------SPEHAPAEMYDIMKTCWDADPLKR  292 (311)
T ss_dssp             HTTTCCSSTTCCSSHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------------CcccccHHHHHHHHHHcCCChhHC
Confidence            98 6777777666555555443221111                            112567899999999999999999


Q ss_pred             CCHHHHhc
Q 023764          218 ITVEDALA  225 (277)
Q Consensus       218 ~t~~ell~  225 (277)
                      ||++++++
T Consensus       293 Ps~~~il~  300 (311)
T d1t46a_         293 PTFKQIVQ  300 (311)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-40  Score=279.37  Aligned_cols=190  Identities=22%  Similarity=0.311  Sum_probs=157.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHH
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------------ALSEEHCQYFLYQIL   55 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------~l~~~~~~~i~~qll   55 (277)
                      |||+++++++...     +..++||||++ |+|.+++....                        .+++..+..++.|++
T Consensus        76 ~niv~~~~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  150 (301)
T d1lufa_          76 PNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA  150 (301)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred             CCcccceeeeccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHH
Confidence            8999999999887     88999999997 69999986532                        388999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCC---CcccccccccccCChhhhhCCCCCCcchhHHHHH
Q 023764           56 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  132 (277)
Q Consensus        56 ~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  132 (277)
                      .||+|||++|++||||||+||+++.++.+||+|||+++.....   .......+++.|+|||.+.+. .++.++||||+|
T Consensus       151 ~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~G  229 (301)
T d1lufa_         151 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYG  229 (301)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred             HHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccch
Confidence            9999999999999999999999999999999999999754332   223345688999999998654 589999999999


Q ss_pred             HHHHHHHcCC-CCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcC
Q 023764          133 CIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       133 ~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  211 (277)
                      |++|||++|. +||.+.+..+....+.+..                             .....+.+++++.+||.+||+
T Consensus       230 vvl~ell~~~~~p~~~~~~~e~~~~v~~~~-----------------------------~~~~p~~~~~~~~~li~~cl~  280 (301)
T d1lufa_         230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-----------------------------ILACPENCPLELYNLMRLCWS  280 (301)
T ss_dssp             HHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             hhHHHHHccCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCccchHHHHHHHHHHcC
Confidence            9999999885 6888877776665543211                             011123678899999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 023764          212 FDPRQRITVEDALA  225 (277)
Q Consensus       212 ~dP~~R~t~~ell~  225 (277)
                      .||++|||+.++++
T Consensus       281 ~~P~~RPt~~ev~~  294 (301)
T d1lufa_         281 KLPADRPSFCSIHR  294 (301)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=273.70  Aligned_cols=196  Identities=24%  Similarity=0.373  Sum_probs=162.0

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANVLHR   69 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~~i~H~   69 (277)
                      ||||++++++...     +..++|||||. |+|.+++...          ..++...+..++.|++.||.|||+++|+||
T Consensus        83 ~nIv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHr  157 (308)
T d1p4oa_          83 HHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR  157 (308)
T ss_dssp             TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             CCEeeeeeEEecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence            8999999999887     88999999996 7999988642          347889999999999999999999999999


Q ss_pred             CCCCCcEEEecCCCeEEeeccceeeccCCC---cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcC-CCCC
Q 023764           70 DLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLF  145 (277)
Q Consensus        70 di~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf  145 (277)
                      ||||+|||++.++.+||+|||+++......   ......+++.|+|||.+.+. .++.++||||+||+++||++| .+||
T Consensus       158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~  236 (308)
T d1p4oa_         158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY  236 (308)
T ss_dssp             CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCC
Confidence            999999999999999999999997554332   23344689999999998654 588999999999999999987 5888


Q ss_pred             CCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 023764          146 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  225 (277)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  225 (277)
                      .+.+..+....+.+...                             ....+..++.+.+||.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         237 QGLSNEQVLRFVMEGGL-----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TTSCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHhCCC-----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88777766655543110                             1112356789999999999999999999999998


Q ss_pred             ------CCCCCC
Q 023764          226 ------HPYLGS  231 (277)
Q Consensus       226 ------hp~f~~  231 (277)
                            +|+|++
T Consensus       288 ~L~~~~~~~~~~  299 (308)
T d1p4oa_         288 SIKEEMEPGFRE  299 (308)
T ss_dssp             HHGGGSCTTHHH
T ss_pred             HHHHhcCCCCcC
Confidence                  566543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-39  Score=272.42  Aligned_cols=192  Identities=22%  Similarity=0.288  Sum_probs=151.7

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   78 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~   78 (277)
                      ||||++++++....    +.+|+|||||+ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus        88 pnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl  163 (311)
T d1r0pa_          88 PNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML  163 (311)
T ss_dssp             TTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE
Confidence            89999999976531    68999999997 6999988754 457888899999999999999999999999999999999


Q ss_pred             ecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-
Q 023764           79 NANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH-  152 (277)
Q Consensus        79 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  152 (277)
                      +.++.+||+|||+++......     ......||+.|+|||.+... .++.++|||||||++|||++|..||....... 
T Consensus       164 ~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~  242 (311)
T d1r0pa_         164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  242 (311)
T ss_dssp             CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------
T ss_pred             CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence            999999999999998654332     22234678999999998654 58999999999999999999777775443222 


Q ss_pred             HHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 023764          153 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  226 (277)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  226 (277)
                      ....+.. ...+                            ...+..++.+.+||.+||+.||++|||+.|+++|
T Consensus       243 ~~~~i~~-g~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         243 ITVYLLQ-GRRL----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CHHHHHT-TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHc-CCCC----------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            2221111 0000                            1113567899999999999999999999999997

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-38  Score=274.79  Aligned_cols=231  Identities=24%  Similarity=0.414  Sum_probs=167.2

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecC--cccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCc
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   75 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~--~~~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~-~~i~H~di~~~n   75 (277)
                      |||+++++++...+.   +..+++++++  .++......  ....+++..++.++.|++.|++|||+ .||+||||||+|
T Consensus        80 ~~iv~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N  156 (362)
T d1q8ya_          80 NHILKLLDHFNHKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  156 (362)
T ss_dssp             TTBCCCCEEEEEEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             CceEEEEEEeeeccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence            689999999876422   5566666665  344443333  34679999999999999999999998 899999999999


Q ss_pred             EEEecCCC------eEEeeccceeeccCCCcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           76 LLLNANCD------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        76 il~~~~~~------~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                      |+++.++.      ++++|||.+......  .....+|+.|+|||++... .++.++||||+||++++|++|+.||.+.+
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eeeeccCcccccceeeEeecccccccccc--cccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            99987654      899999998765543  4566899999999998754 48999999999999999999999996443


Q ss_pred             ------hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhh-----hCCcccCCcc----c---ccCCCCChhHHHHHHHhcC
Q 023764          150 ------HVHQLRLLIELIGTPSEAELGFLNENAKKYIC-----QLPRYQRQSF----T---EKFPNVHPSAIDLVEKMLT  211 (277)
Q Consensus       150 ------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~----~---~~~~~~~~~~~~li~~~L~  211 (277)
                            ..+.+......+|.++.............+..     ..........    .   ...+..+++++|||.+||+
T Consensus       234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~  313 (362)
T d1q8ya_         234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ  313 (362)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred             cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence                  44567777788888777654332211111100     0001000000    0   0112346789999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCCCCC
Q 023764          212 FDPRQRITVEDALAHPYLGSLHDISD  237 (277)
Q Consensus       212 ~dP~~R~t~~ell~hp~f~~~~~~~~  237 (277)
                      +||.+||||+|+|+||||+.......
T Consensus       314 ~dP~~Rpta~e~L~Hp~f~~~~~~~~  339 (362)
T d1q8ya_         314 LDPRKRADAGGLVNHPWLKDTLGMEE  339 (362)
T ss_dssp             SSTTTCBCHHHHHTCGGGTTCTTCTT
T ss_pred             CChhHCcCHHHHhcCcccCCCCCccc
Confidence            99999999999999999996654433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-38  Score=267.22  Aligned_cols=202  Identities=16%  Similarity=0.189  Sum_probs=153.8

Q ss_pred             ceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-
Q 023764            2 QVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-   79 (277)
Q Consensus         2 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~-   79 (277)
                      ||+.+.+++.+.     +..++||||+++++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++ 
T Consensus        64 ~i~~~~~~~~~~-----~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~  138 (299)
T d1ckia_          64 GIPTIRWCGAEG-----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL  138 (299)
T ss_dssp             TCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred             cccEEEEEEecC-----CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccc
Confidence            456666666665     88999999999988877654 46799999999999999999999999999999999999985 


Q ss_pred             --cCCCeEEeeccceeeccCCC--------cccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 023764           80 --ANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  149 (277)
Q Consensus        80 --~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  149 (277)
                        .+..++++|||+++......        ......||+.|+|||++.+ ..++.++||||+||++++|++|..||.+..
T Consensus       139 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         139 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             GGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             cCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence              45679999999998754332        2234579999999999865 458999999999999999999999998765


Q ss_pred             hHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH---HHhcC
Q 023764          150 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE---DALAH  226 (277)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---ell~h  226 (277)
                      .......+.....                      .....+.+...+++|+++.+||.+||+.||++||+++   ++|+|
T Consensus       218 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         218 AATKRQKYERISE----------------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             -------HHHHHH----------------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHhhc----------------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            5443332221100                      0000122233457889999999999999999999986   55677


Q ss_pred             CCCCC
Q 023764          227 PYLGS  231 (277)
Q Consensus       227 p~f~~  231 (277)
                      +|.+.
T Consensus       276 ~~~~~  280 (299)
T d1ckia_         276 LFHRQ  280 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHc
Confidence            76543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-37  Score=259.96  Aligned_cols=194  Identities=13%  Similarity=0.166  Sum_probs=156.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   79 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~   79 (277)
                      |||+.+++++...     ++.|+||||++++|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++
T Consensus        61 ~~i~~~~~~~~~~-----~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~  135 (293)
T d1csna_          61 TGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG  135 (293)
T ss_dssp             TTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred             CCCCEEEEEeecC-----CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence            6899999999887     899999999999999998765 4699999999999999999999999999999999999996


Q ss_pred             c-----CCCeEEeeccceeeccCC--------CcccccccccccCChhhhhCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 023764           80 A-----NCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  146 (277)
Q Consensus        80 ~-----~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  146 (277)
                      .     ++.++|+|||+++.....        .......||+.|+|||++.+ ..++.++|||||||++++|++|..||.
T Consensus       136 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            4     578999999999865432        12334579999999999865 458999999999999999999999997


Q ss_pred             CCChH---HHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 023764          147 GRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  223 (277)
Q Consensus       147 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  223 (277)
                      +....   .....+......                         .+..+..+.+++++.+++..|+..+|++||+.+.+
T Consensus       215 ~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l  269 (293)
T d1csna_         215 GLKAATNKQKYERIGEKKQS-------------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL  269 (293)
T ss_dssp             SCCSCCHHHHHHHHHHHHHH-------------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             CccchhHHHHHHHHHhccCC-------------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            65432   222222221100                         11223345678899999999999999999997766


Q ss_pred             hc
Q 023764          224 LA  225 (277)
Q Consensus       224 l~  225 (277)
                      .+
T Consensus       270 ~~  271 (293)
T d1csna_         270 QG  271 (293)
T ss_dssp             HH
T ss_pred             HH
Confidence            44

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=265.67  Aligned_cols=213  Identities=18%  Similarity=0.246  Sum_probs=148.6

Q ss_pred             CceeeeeccccCCCCCCCCcEEEEeecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCC
Q 023764            1 MQVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS--------ANVLHRDL   71 (277)
Q Consensus         1 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~--------~~i~H~di   71 (277)
                      ||||++++++.+++. +...+|+|||||. |+|.+++.+. .+++..+..++.|++.|+.|||+        +||+||||
T Consensus        57 pnIv~~~~~~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDl  134 (303)
T d1vjya_          57 ENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL  134 (303)
T ss_dssp             TTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred             CcCcceEEEEEeCCC-cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecccc
Confidence            899999999987531 2257999999996 6999999874 69999999999999999999996        59999999


Q ss_pred             CCCcEEEecCCCeEEeeccceeeccCCC-----cccccccccccCChhhhhCCC-----CCCcchhHHHHHHHHHHHHcC
Q 023764           72 KPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMDR  141 (277)
Q Consensus        72 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g  141 (277)
                      ||+||+++.++.+||+|||++.......     ......||+.|+|||++....     .++.++|||||||++|||++|
T Consensus       135 Kp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg  214 (303)
T d1vjya_         135 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  214 (303)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhC
Confidence            9999999999999999999998654332     233467899999999985432     146689999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHhhhhhhhhHHHHhhhCCcccCCcccccC--CCCChhHHHHHHHhcCCCCCCCCC
Q 023764          142 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQRIT  219 (277)
Q Consensus       142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t  219 (277)
                      .+||........... ......+.....       .... ..... ++.+....  +.....+.+|+.+||+.||++|||
T Consensus       215 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~-~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  284 (303)
T d1vjya_         215 CSIGGIHEDYQLPYY-DLVPSDPSVEEM-------RKVV-CEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLT  284 (303)
T ss_dssp             BCBTTBCCCCCCTTT-TTSCSSCCHHHH-------HHHH-TTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred             CCCCCcccccccchh-hcccccchHHHH-------HHHH-hcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence            988743221100000 000000000000       0000 00000 01111111  112245889999999999999999


Q ss_pred             HHHHhc
Q 023764          220 VEDALA  225 (277)
Q Consensus       220 ~~ell~  225 (277)
                      +.|+++
T Consensus       285 ~~ei~~  290 (303)
T d1vjya_         285 ALRIKK  290 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.61  E-value=6.8e-17  Score=125.54  Aligned_cols=102  Identities=19%  Similarity=0.153  Sum_probs=71.4

Q ss_pred             EEEeecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCCCeEEeeccceeeccCCCcc
Q 023764           22 YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM  101 (277)
Q Consensus        22 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  101 (277)
                      +++|||+++...      ..++...+..++.|++.|+.+||++||+||||||+||+++.++ ++|+|||.+.....+...
T Consensus        86 ~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~  158 (191)
T d1zara2          86 AVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR  158 (191)
T ss_dssp             EEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH
T ss_pred             EEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH
Confidence            799999986321      2245566778999999999999999999999999999998665 899999999776544211


Q ss_pred             cccccccccCChhhhhCCCCCCcchhHHHHHH
Q 023764          102 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  133 (277)
Q Consensus       102 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  133 (277)
                      .-...... ...+.+.  +.|+.++|+||+.-
T Consensus       159 ~~l~rd~~-~~~~~f~--r~y~~~~d~~s~~~  187 (191)
T d1zara2         159 EILERDVR-NIITYFS--RTYRTEKDINSAID  187 (191)
T ss_dssp             HHHHHHHH-HHHHHHH--HHHCCCCCHHHHHH
T ss_pred             HHHHHHHH-HHHHHHc--CCCCCcccHHHHHH
Confidence            10000000 0012221  34788899999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.15  E-value=0.00033  Score=54.95  Aligned_cols=28  Identities=25%  Similarity=0.306  Sum_probs=24.3

Q ss_pred             ceecCCCCCcEEEecCCCeEEeecccee
Q 023764           66 VLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      ++|+|+.|.||++++++...|+||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            7899999999999987666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.26  E-value=0.0018  Score=50.16  Aligned_cols=28  Identities=21%  Similarity=0.171  Sum_probs=24.5

Q ss_pred             ceecCCCCCcEEEecCCCeEEeecccee
Q 023764           66 VLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        66 i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      ++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.23  E-value=0.011  Score=49.13  Aligned_cols=29  Identities=21%  Similarity=0.319  Sum_probs=24.9

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      .++|+|+++.||+++.++ ++++||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            589999999999998764 89999987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.68  E-value=0.0045  Score=49.64  Aligned_cols=30  Identities=30%  Similarity=0.344  Sum_probs=26.7

Q ss_pred             CCceecCCCCCcEEEecCCCeEEeecccee
Q 023764           64 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   93 (277)
Q Consensus        64 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~   93 (277)
                      .|++|+|+.+.|++++.+....++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999998877999998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.59  E-value=0.13  Score=41.07  Aligned_cols=28  Identities=29%  Similarity=0.256  Sum_probs=22.8

Q ss_pred             CceecCCCCCcEEEecCCCeEEeeccceee
Q 023764           65 NVLHRDLKPSNLLLNANCDLKICDFGLARV   94 (277)
Q Consensus        65 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~   94 (277)
                      +++|+|+++.||++++ + ..++||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            6899999999999964 3 46899987753